data_1nho_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1nho _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.591 ' CE ' ' CD ' ' A' ' 83' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.876 0.846 . . . . 0.0 110.845 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.689 ' HA ' ' CZ ' ' A' ' 30' ' ' PHE . 1.4 p -80.04 -96.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.965 -1.084 . . . . 0.0 110.337 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.75 ' CG1' HG22 ' A' ' 36' ' ' VAL . 47.6 t -89.97 129.05 41.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 121.561 -0.712 . . . . 0.0 109.936 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.983 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 0.7 OUTLIER -149.05 101.91 3.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.792 -1.192 . . . . 0.0 108.633 -179.068 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.717 ' CD1' ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.37 138.93 52.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 113.847 -1.524 . . . . 0.0 113.651 -178.403 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 1.013 ' O ' ' CG2' ' A' ' 59' ' ' ILE . 13.6 tt0 -132.9 121.42 22.84 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 118.692 -2.505 . . . . 0.0 106.109 176.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.743 ' HA ' ' CG1' ' A' ' 59' ' ' ILE . 3.9 m -112.28 111.61 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.312 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -176.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.854 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -116.15 95.04 4.9 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.814 -178.252 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.708 ' O ' ' CD1' ' A' ' 41' ' ' ILE . 0.6 OUTLIER -126.31 -59.42 1.31 Allowed 'General case' 0 C--N 1.291 -1.946 0 O-C-N 121.207 -0.933 . . . . 0.0 108.853 178.284 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.69 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 0.2 OUTLIER 179.09 146.47 0.38 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.825 -1.172 . . . . 0.0 110.704 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.667 ' CD ' ' HB2' ' A' ' 40' ' ' ASP . 48.2 Cg_endo -75.91 -30.17 6.18 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 124.445 1.76 . . . . 0.0 110.359 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.431 HG23 ' N ' ' A' ' 13' ' ' CYS . 6.2 t -78.92 -14.34 59.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.58 -0.7 . . . . 0.0 110.081 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.469 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -124.74 179.14 1.17 Allowed Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.516 -0.74 . . . . 0.0 109.868 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.616 ' O ' ' O ' ' A' ' 15' ' ' TYR . 52.2 Cg_endo -83.58 107.02 1.35 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.959 1.505 . . . . 0.0 109.975 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.69 ' CE1' ' O ' ' A' ' 10' ' ' SER . 3.2 m-85 -50.18 -115.42 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.819 -0.551 . . . . 0.0 109.545 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.701 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 71.0 m -149.11 38.8 0.19 Allowed Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.941 -1.099 . . . . 0.0 109.423 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.701 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 53.2 Cg_endo -74.51 29.85 0.34 Allowed 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 123.829 1.436 . . . . 0.0 111.295 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.7 ' CG ' ' CZ ' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -106.37 -55.01 2.39 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.941 -1.099 . . . . 0.0 110.423 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.656 ' N ' ' HD3' ' A' ' 73' ' ' ARG . . . -59.17 -19.93 49.39 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.314 -0.866 . . . . 0.0 109.933 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.717 ' HB ' ' CD1' ' A' ' 5' ' ' ILE . 3.2 pt -72.52 -41.78 63.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-O 121.253 0.549 . . . . 0.0 109.742 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.563 ' N ' ' CG1' ' A' ' 20' ' ' ILE . 7.7 tt0 -53.58 -35.21 60.59 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 t -71.03 -45.78 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.734 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 1.0 OUTLIER -63.98 -33.92 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.07 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.661 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 31.0 t0 -66.81 -40.88 88.21 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.838 0.827 . . . . 0.0 109.673 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.29 -48.37 79.08 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.604 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.477 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.55 -39.09 47.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.77 -0.581 . . . . 0.0 110.443 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.722 ' HB2' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -72.96 -17.73 61.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.07 -1.019 . . . . 0.0 109.915 -178.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.661 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -71.51 -47.0 58.15 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.319 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.703 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -46.2 -37.42 7.08 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.863 0.839 . . . . 0.0 110.327 179.13 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.817 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -93.72 -72.4 0.61 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 178.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.817 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -82.98 89.82 1.52 Allowed Glycine 0 N--CA 1.487 2.047 0 C-N-CA 118.88 -1.628 . . . . 0.0 109.909 177.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.549 ' OD2' ' NZ ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -40.56 -29.62 0.09 Allowed 'General case' 0 N--CA 1.52 3.065 0 CA-C-N 122.217 3.008 . . . . 0.0 110.667 176.157 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.682 ' O ' ' CG2' ' A' ' 2' ' ' VAL . 9.4 mtmm -79.85 151.77 30.04 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.81 -0.556 . . . . 0.0 112.442 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.697 HD12 ' CG2' ' A' ' 3' ' ' VAL . 16.5 mm -129.26 160.28 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 120.466 -1.396 . . . . 0.0 110.055 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.735 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -151.25 70.1 0.96 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.487 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.75 HG22 ' CG1' ' A' ' 3' ' ' VAL 0.255 85.7 t -96.93 123.23 49.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -179.197 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.82 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 7.8 mt-10 -108.84 148.29 30.82 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -177.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.725 ' HA ' HG21 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -142.78 110.7 5.93 Favored 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -174.459 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.731 ' HB ' ' CB ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -111.76 165.0 7.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 122.266 1.032 . . . . 0.0 113.24 -178.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.668 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -100.13 161.13 13.8 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.718 0.771 . . . . 0.0 110.931 178.595 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.854 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -62.08 -18.74 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 120.473 -1.392 . . . . 0.0 110.99 179.438 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.668 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -91.23 -14.97 30.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.944 -1.097 . . . . 0.0 111.547 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.604 HG13 HG23 ' A' ' 39' ' ' ILE . 10.0 p -113.62 -31.35 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.131 -0.98 . . . . 0.0 110.63 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.731 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . 41.9 t0 -112.56 37.93 2.91 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.454 -0.899 . . . . 0.0 110.087 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.514 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.296 0.0 OUTLIER -65.04 -3.49 3.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 119.956 -1.715 . . . . 0.0 109.086 -179.51 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.779 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 1.7 mt-10 -60.0 -20.72 59.25 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.846 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -44.55 -63.37 0.91 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.305 -1.497 . . . . 0.0 109.072 -178.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.891 ' O ' ' N ' ' A' ' 50' ' ' GLU . . . -57.62 -11.23 1.94 Allowed 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.879 -1.51 . . . . 0.0 111.083 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.779 ' CG2' ' O ' ' A' ' 46' ' ' GLU . 2.7 pp -24.0 -38.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.237 -1.539 . . . . 0.0 107.922 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.891 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -56.22 -51.6 67.5 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.873 177.648 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.808 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.0 p90 -122.84 -30.93 3.75 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.467 -0.771 . . . . 0.0 110.122 178.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.707 ' HA2' ' HB3' ' A' ' 48' ' ' ALA . . . 45.05 4.8 0.01 OUTLIER Glycine 1 N--CA 1.52 4.25 0 O-C-N 121.589 -0.695 . . . . 0.0 111.759 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.645 ' H ' ' C ' ' A' ' 51' ' ' TYR . 8.9 mt -75.68 -79.76 0.09 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 175.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.696 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 1.9 mtm -94.21 65.98 3.41 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.31 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.865 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.294 . . -108.23 108.64 19.75 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.346 -1.471 . . . . 0.0 109.79 -177.118 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.824 ' O ' ' CG1' ' A' ' 41' ' ' ILE . 2.6 t -147.76 -65.16 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.28 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.354 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.753 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 59.9 Cg_endo -105.44 106.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.302 -1.897 0 N-CA-C 109.11 -1.15 . . . . 0.0 109.11 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.716 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -160.71 177.83 10.07 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 112.694 -2.048 . . . . 0.0 111.686 -176.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 1.013 ' CG2' ' O ' ' A' ' 6' ' ' GLU 0.271 1.3 mp -146.53 154.3 12.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.019 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.785 ' HA ' ' HA ' ' A' ' 66' ' ' ARG 0.29 . . -87.72 155.49 19.9 Favored 'General case' 0 CA--C 1.479 -1.77 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.696 HG13 ' N ' ' A' ' 66' ' ' ARG 0.312 1.6 mt -104.12 92.19 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.038 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 -175.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.983 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.2 OUTLIER -54.74 86.25 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 126.274 2.234 . . . . 0.0 106.256 -178.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.754 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 162.02 -44.95 0.37 Allowed Glycine 0 C--N 1.292 -1.863 0 N-CA-C 107.777 -2.129 . . . . 0.0 107.777 -177.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.665 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 11.5 m -126.69 -60.81 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.568 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.665 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 74.6 t -164.38 -99.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 120.929 -1.107 . . . . 0.0 112.379 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.807 ' HG3' ' O ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -165.25 157.86 15.81 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.61 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.846 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -146.62 176.19 10.02 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.325 -0.859 . . . . 0.0 111.698 -176.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.627 ' HA ' ' HB1' ' A' ' 58' ' ' ALA . 7.9 t -84.98 121.58 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.693 -0.63 . . . . 0.0 110.363 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.803 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.67 110.08 0.41 Allowed Glycine 0 N--CA 1.498 2.823 0 O-C-N 119.863 -1.773 . . . . 0.0 110.694 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.785 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -90.49 -79.97 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.388 -1.066 . . . . 0.0 108.624 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.785 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 57.2 Cg_endo -83.91 18.27 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 N-CA-C 109.012 -1.188 . . . . 0.0 109.012 177.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -102.69 63.62 0.86 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.528 0.68 . . . . 0.0 110.176 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.7 ' CZ ' ' CG ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -70.57 -42.17 71.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 108.759 178.552 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.633 ' N ' ' HB2' ' A' ' 19' ' ' ALA . 2.0 tt0 -44.07 -37.11 2.86 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.756 -0.59 . . . . 0.0 109.854 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.706 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -47.85 -37.79 14.65 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 120.029 -0.669 . . . . 0.0 109.894 179.354 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.708 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 9.7 mp -65.23 -41.52 94.3 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.734 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.2 -36.61 73.36 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 122.246 1.022 . . . . 0.0 109.873 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -78.9 -31.01 45.18 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 110.337 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.687 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -70.27 -38.01 75.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.514 -0.741 . . . . 0.0 111.158 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.743 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -65.66 -42.4 92.63 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 CA-C-O 121.75 0.786 . . . . 0.0 109.168 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.618 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -70.52 -21.09 62.77 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.618 176.302 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.416 ' O ' ' CG ' ' A' ' 82' ' ' ASP 0.356 0.3 OUTLIER -103.38 2.92 34.58 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 117.567 -1.653 . . . . 0.0 106.733 -178.65 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.81 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.33 -58.36 2.52 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 102.264 -3.235 . . . . 0.0 102.264 176.773 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.658 ' HE3' ' CE ' ' A' ' 27' ' ' LYS . 7.5 ptt? -69.47 -18.94 63.76 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.022 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.766 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.706 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.319 0.581 . . . . 0.0 110.217 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.731 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 1.3 p -79.92 -95.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 109.894 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.77 ' CG1' HG22 ' A' ' 36' ' ' VAL . 52.1 t -88.89 129.13 40.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.476 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 1.042 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.292 0.7 OUTLIER -151.16 103.23 3.01 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 125.108 2.385 . . . . 0.0 108.446 179.562 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.755 ' CD1' ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.5 137.26 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 CA-C-N 111.337 -2.665 . . . . 0.0 113.997 -178.165 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.994 ' O ' ' CG2' ' A' ' 59' ' ' ILE . 12.9 tt0 -131.72 119.89 21.97 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 115.458 -2.497 . . . . 0.0 105.862 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.796 ' HA ' ' CG1' ' A' ' 59' ' ' ILE . 4.2 m -111.61 111.6 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -176.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.87 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -116.4 93.71 4.34 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.021 -178.25 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.745 ' O ' ' CG1' ' A' ' 41' ' ' ILE . 0.6 OUTLIER -124.43 -60.02 1.43 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.774 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 0.2 OUTLIER 179.7 147.72 0.44 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 110.621 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.733 ' CD ' ' HB2' ' A' ' 40' ' ' ASP . 48.4 Cg_endo -76.53 -30.07 5.39 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.273 1.67 . . . . 0.0 110.316 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.464 HG23 ' N ' ' A' ' 13' ' ' CYS . 6.6 t -79.48 -13.55 59.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.938 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.547 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -125.03 179.58 1.09 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 109.946 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.648 ' O ' ' O ' ' A' ' 15' ' ' TYR . 52.1 Cg_endo -83.26 106.26 1.36 Allowed 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.984 1.518 . . . . 0.0 110.537 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.774 ' CE1' ' O ' ' A' ' 10' ' ' SER . 3.2 m-85 -49.73 -114.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.095 -1.003 . . . . 0.0 109.741 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.741 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 76.1 m -150.0 38.47 0.17 Allowed Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.404 -0.81 . . . . 0.0 109.921 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.741 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 50.9 Cg_endo -74.28 29.55 0.33 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.001 1.527 . . . . 0.0 111.129 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.794 ' CG ' ' CZ ' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -105.8 -56.28 2.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.082 -1.011 . . . . 0.0 110.253 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.718 ' CB ' ' C ' ' A' ' 73' ' ' ARG . . . -58.32 -20.13 40.65 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.314 -0.866 . . . . 0.0 109.622 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.756 ' CD1' ' CG1' ' A' ' 36' ' ' VAL . 3.1 pt -72.93 -41.82 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.521 -0.737 . . . . 0.0 109.737 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.592 ' N ' ' CG1' ' A' ' 20' ' ' ILE . 7.8 tt0 -52.73 -35.11 55.39 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.4 t -71.65 -44.73 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 121.799 0.809 . . . . 0.0 109.063 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.785 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 1.0 OUTLIER -64.66 -32.98 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.75 0.786 . . . . 0.0 109.107 177.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.696 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 28.5 t0 -68.53 -40.31 80.81 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.213 1.006 . . . . 0.0 109.477 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.43 -48.13 79.95 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.444 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.507 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -78.24 -39.4 40.39 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.635 -0.665 . . . . 0.0 110.672 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.751 ' HB2' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -71.56 -19.01 62.21 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.208 -178.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.696 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -70.86 -47.15 60.88 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 176.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.778 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -46.4 -37.89 8.21 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.781 0.8 . . . . 0.0 109.997 179.313 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.862 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -93.56 -70.3 0.71 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.509 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.862 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -84.82 87.71 1.56 Allowed Glycine 0 N--CA 1.504 3.213 0 C-N-CA 118.111 -1.995 . . . . 0.0 111.059 177.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.587 ' OD2' ' NZ ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -37.73 -28.93 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 O-C-N 118.337 -2.86 . . . . 0.0 111.017 176.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.728 ' O ' ' CG2' ' A' ' 2' ' ' VAL . 9.3 mtmm -81.27 151.77 27.93 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.748 HD12 ' CG2' ' A' ' 3' ' ' VAL . 16.3 mm -128.96 160.3 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 119.926 -1.734 . . . . 0.0 110.039 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.746 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -151.14 70.01 0.97 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.392 -0.817 . . . . 0.0 108.842 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.77 HG22 ' CG1' ' A' ' 3' ' ' VAL 0.257 81.0 t -96.98 121.87 47.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -178.836 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.873 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 7.6 mt-10 -108.39 147.41 31.61 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.739 ' HA ' HG21 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -141.41 111.59 6.8 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -174.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.793 ' HB ' ' CB ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -112.02 166.08 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.101 -0.999 . . . . 0.0 113.256 -178.182 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.733 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -100.6 160.61 14.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.546 -0.722 . . . . 0.0 111.376 178.164 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.934 ' CG1' ' O ' ' A' ' 56' ' ' VAL 0.251 0.2 OUTLIER -62.65 -16.2 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.735 -1.228 . . . . 0.0 110.584 179.737 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.725 ' N ' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -93.2 -14.18 27.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.723 -1.236 . . . . 0.0 111.664 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.631 HG13 HG23 ' A' ' 39' ' ' ILE . 9.9 p -114.11 -31.07 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.009 -1.057 . . . . 0.0 110.748 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.793 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . 43.0 t0 -112.51 37.32 3.09 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.116 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.533 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.341 0.0 OUTLIER -66.34 -1.26 3.23 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 117.49 -1.684 . . . . 0.0 108.666 -177.972 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.835 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 1.7 mt-10 -60.11 -21.16 61.2 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.916 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -44.48 -63.27 0.93 Allowed 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 123.626 1.679 . . . . 0.0 109.011 -177.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.931 ' CB ' ' CB ' ' A' ' 55' ' ' ALA . . . -55.86 -12.81 1.49 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 113.51 -1.677 . . . . 0.0 111.458 177.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.835 ' CG2' ' O ' ' A' ' 46' ' ' GLU . 2.7 pp -25.07 -38.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 O-C-N 119.524 -1.985 . . . . 0.0 107.244 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.896 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -55.55 -52.13 64.77 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.981 177.11 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.857 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 1.8 p90 -123.2 -28.63 3.98 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.239 -0.913 . . . . 0.0 110.014 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.771 ' HA2' ' HB3' ' A' ' 48' ' ' ALA . . . 43.22 5.12 0.01 OUTLIER Glycine 0 N--CA 1.504 3.179 0 CA-C-O 122.367 0.982 . . . . 0.0 111.835 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.739 ' N ' ' O ' ' A' ' 51' ' ' TYR . 8.7 mt -75.95 -75.95 0.17 Allowed 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 174.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.696 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 1.8 mtm -97.68 65.27 1.85 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.931 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.296 . . -108.57 109.27 20.46 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.165 -1.585 . . . . 0.0 109.074 -176.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.934 ' O ' ' CG1' ' A' ' 41' ' ' ILE . 2.6 t -147.83 -64.25 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.826 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.034 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.825 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 58.1 Cg_endo -105.64 104.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 N-CA-C 108.781 -1.276 . . . . 0.0 108.781 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.722 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -159.37 177.3 11.13 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 112.604 -2.089 . . . . 0.0 111.568 -176.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.994 ' CG2' ' O ' ' A' ' 6' ' ' GLU . 1.3 mp -146.07 153.04 13.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 O-C-N 121.502 -0.748 . . . . 0.0 109.124 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.833 ' HA ' ' CG ' ' A' ' 66' ' ' ARG 0.303 . . -87.3 154.62 20.55 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 102.67 -3.085 . . . . 0.0 102.67 -178.651 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.71 HG13 ' N ' ' A' ' 66' ' ' ARG 0.386 1.6 mt -103.72 93.42 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.599 0 N-CA-C 103.363 -2.828 . . . . 0.0 103.363 -175.357 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 1.042 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.2 OUTLIER -52.32 85.04 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 111.602 -2.545 . . . . 0.0 106.121 179.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.796 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 162.46 -44.64 0.35 Allowed Glycine 0 C--N 1.289 -2.037 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.75 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 11.3 m -127.44 -59.33 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.993 -0.71 . . . . 0.0 110.949 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.75 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 76.1 t -164.68 -101.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.488 0 O-C-N 120.346 -1.471 . . . . 0.0 112.529 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.833 ' CG ' ' HA ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -162.99 158.96 22.88 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.47 -0.769 . . . . 0.0 109.058 -178.173 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.868 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -147.07 178.25 8.51 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.804 -1.185 . . . . 0.0 111.498 -177.272 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.631 HG23 ' OH ' ' A' ' 51' ' ' TYR . 8.3 t -86.57 120.94 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.446 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.815 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.89 110.25 0.43 Allowed Glycine 0 N--CA 1.496 2.673 0 C-N-CA 118.066 -2.016 . . . . 0.0 110.349 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.844 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -90.34 -80.52 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.087 -1.243 . . . . 0.0 108.546 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.844 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 55.9 Cg_endo -83.48 17.99 1.58 Allowed 'Trans proline' 0 C--N 1.301 -1.966 0 N-CA-C 108.897 -1.232 . . . . 0.0 108.897 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -102.32 64.35 0.91 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.347 -0.846 . . . . 0.0 110.636 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.794 ' CZ ' ' CG ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -71.99 -40.43 68.57 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.04 -1.037 . . . . 0.0 109.293 178.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.71 ' N ' ' HB2' ' A' ' 19' ' ' ALA . 2.0 tt0 -45.24 -37.63 4.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.39 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.779 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -47.41 -38.05 12.6 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.293 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.751 ' HG ' ' CG2' ' A' ' 59' ' ' ILE . 9.5 mp -64.96 -40.95 95.78 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.425 -0.797 . . . . 0.0 109.214 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.785 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.55 -36.3 73.7 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.864 0.84 . . . . 0.0 109.847 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -78.3 -31.69 48.98 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.64 -0.662 . . . . 0.0 110.6 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.68 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -70.58 -38.46 74.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 0.0 111.048 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.803 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -64.2 -43.33 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 122.425 1.107 . . . . 0.0 109.183 179.079 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.645 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -70.24 -23.37 62.91 Favored 'General case' 0 C--O 1.2 -1.536 0 CA-C-O 117.899 -1.048 . . . . 0.0 109.179 176.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.371 0.2 OUTLIER -101.13 2.34 40.12 Favored 'General case' 0 C--O 1.263 1.778 0 C-N-CA 116.619 -2.032 . . . . 0.0 106.189 -178.064 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.846 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.12 -56.62 3.15 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 102.401 -3.185 . . . . 0.0 102.401 176.032 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.72 ' HE3' ' NZ ' ' A' ' 27' ' ' LYS . 8.2 ptt? -70.53 -18.5 62.94 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.836 -1.165 . . . . 0.0 110.729 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 117.889 -1.053 . . . . 0.0 109.94 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.653 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.303 0.573 . . . . 0.0 110.201 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.766 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 0.6 OUTLIER -89.95 -92.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 0.0 109.947 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.743 HG23 ' CD1' ' A' ' 34' ' ' ILE . 75.1 t -89.15 112.42 24.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.55 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.841 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 1.0 OUTLIER -132.86 105.4 7.1 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.664 -1.273 . . . . 0.0 108.755 178.316 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.753 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -120.4 138.17 51.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.812 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 1.052 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.3 122.76 26.99 Favored 'General case' 0 C--N 1.282 -2.335 0 C-N-CA 115.832 -2.347 . . . . 0.0 106.841 177.479 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.811 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 20.1 m -109.23 142.3 22.14 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.574 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.887 ' H ' HD13 ' A' ' 59' ' ' ILE . 2.0 t80 -139.79 80.99 1.8 Allowed 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 117.979 -1.489 . . . . 0.0 112.823 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.688 ' CB ' ' HA ' ' A' ' 15' ' ' TYR . 3.4 m -117.81 -68.75 0.89 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 119.144 -2.222 . . . . 0.0 110.373 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.768 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 1.3 p 179.55 164.49 0.78 Allowed Pre-proline 0 C--N 1.293 -1.859 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.381 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.671 ' HD3' ' CG ' ' A' ' 40' ' ' ASP . 50.1 Cg_endo -80.27 -28.4 3.03 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.221 1.643 . . . . 0.0 110.424 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -18.37 54.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.749 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.07 174.36 3.95 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.418 -0.801 . . . . 0.0 109.696 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.651 ' O ' ' O ' ' A' ' 15' ' ' TYR . 51.7 Cg_endo -83.01 114.55 2.26 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.914 1.481 . . . . 0.0 110.422 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.768 ' CE1' ' O ' ' A' ' 10' ' ' SER . 16.3 m-85 -49.26 -112.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.597 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.735 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 92.5 m -150.57 37.58 0.14 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.199 -0.938 . . . . 0.0 110.081 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.735 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 53.9 Cg_endo -76.51 17.06 0.81 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.92 1.484 . . . . 0.0 111.027 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.503 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -95.1 -67.97 0.83 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.075 -1.016 . . . . 0.0 110.79 -179.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.702 ' HB2' ' CB ' ' A' ' 73' ' ' ARG . . . -54.28 -22.59 12.26 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.216 -0.928 . . . . 0.0 109.512 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.753 ' HB ' ' CG2' ' A' ' 5' ' ' ILE . 5.1 pt -70.58 -39.18 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.485 -0.759 . . . . 0.0 109.678 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.715 ' N ' HG13 ' A' ' 20' ' ' ILE . 6.1 tt0 -48.88 -33.45 10.72 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.493 HG12 ' CD2' ' A' ' 77' ' ' PHE . 3.2 t -71.41 -47.42 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.791 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -61.4 -32.96 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.018 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.73 ' OD1' ' CD1' ' A' ' 34' ' ' ILE . 5.2 t70 -68.18 -40.38 82.25 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.994 0.902 . . . . 0.0 109.145 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -46.52 83.12 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.666 0.746 . . . . 0.0 109.626 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.461 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.31 -39.58 47.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.622 -0.674 . . . . 0.0 110.717 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.745 ' CE ' ' HA ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -70.66 -18.18 62.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.917 -1.114 . . . . 0.0 109.328 -179.149 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.799 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -73.57 -45.05 55.71 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.222 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.743 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -50.14 -32.92 17.27 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.959 0.885 . . . . 0.0 110.465 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.766 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -97.19 -67.01 0.87 Allowed 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 179.09 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.763 ' HA3' HG22 ' A' ' 2' ' ' VAL . . . -84.97 86.29 1.56 Allowed Glycine 0 N--CA 1.505 3.261 0 C-N-CA 117.899 -2.096 . . . . 0.0 110.154 177.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.595 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -37.54 -29.29 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 O-C-N 118.319 -2.871 . . . . 0.0 110.188 177.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.684 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -78.63 155.56 29.5 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.822 -0.549 . . . . 0.0 111.774 178.189 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.799 ' CD1' ' CG ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -130.04 151.46 35.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 120.327 -1.483 . . . . 0.0 109.902 178.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.592 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -151.81 78.09 1.24 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.709 ' CG1' HD11 ' A' ' 20' ' ' ILE . 56.0 t -96.99 129.09 47.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 1.052 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 78.3 mt-10 -113.48 133.1 55.4 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.811 ' HA ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -127.41 128.67 46.2 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 113.989 -1.459 . . . . 0.0 114.754 -177.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.771 ' HB ' ' CB ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -134.16 169.91 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 119.875 -1.766 . . . . 0.0 111.785 177.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.749 ' HB3' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -100.59 172.02 7.36 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.83 178.03 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.858 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -62.75 -37.88 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.711 -1.243 . . . . 0.0 109.36 178.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.684 ' HG3' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -80.95 -4.13 53.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.908 -1.12 . . . . 0.0 111.547 179.289 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.766 ' CG2' ' CG2' ' A' ' 39' ' ' ILE . 2.0 m -113.99 -45.97 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 120.954 -1.091 . . . . 0.0 110.033 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.771 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . 1.6 t70 -105.27 41.84 1.31 Allowed 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.498 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.599 ' NH2' ' HA3' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -65.21 -1.71 2.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.118 -1.614 . . . . 0.0 109.5 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.833 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 2.3 mm-40 -62.81 -23.42 67.25 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.265 178.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.888 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -44.45 -68.81 0.17 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.182 -0.949 . . . . 0.0 108.487 179.405 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.92 ' HA ' ' CE1' ' A' ' 51' ' ' TYR . . . -55.57 -10.14 0.62 Allowed 'General case' 0 C--O 1.194 -1.866 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.549 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.833 ' CG2' ' O ' ' A' ' 46' ' ' GLU . 2.6 pp -23.98 -41.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 119.412 -2.055 . . . . 0.0 105.956 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.898 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -54.0 -53.15 56.96 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.443 -0.798 . . . . 0.0 108.853 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.92 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 25.9 p90 -119.96 -32.24 4.26 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.269 -0.894 . . . . 0.0 110.161 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.697 ' N ' ' HB2' ' A' ' 48' ' ' ALA . . . 42.81 6.36 0.01 OUTLIER Glycine 0 N--CA 1.499 2.874 0 CA-C-O 122.288 0.938 . . . . 0.0 111.572 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.714 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 4.5 mt -74.43 -80.66 0.08 Allowed 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.541 ' C ' ' HE2' ' A' ' 51' ' ' TYR 0.265 4.1 mtp -95.37 67.24 2.92 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.135 177.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.89 ' CB ' ' HB1' ' A' ' 48' ' ' ALA . . . -109.46 120.2 41.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 119.62 -1.925 . . . . 0.0 109.922 -178.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.784 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -149.12 -56.39 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.936 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.722 -178.711 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.784 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 57.7 Cg_endo -111.63 109.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 122.931 0.964 . . . . 0.0 110.263 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.803 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -161.36 174.93 12.8 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.185 -1.371 . . . . 0.0 110.901 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.925 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -134.86 154.64 36.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.42 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.878 ' HA ' ' HG3' ' A' ' 66' ' ' ARG 0.26 . . -93.16 157.22 16.39 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 102.71 -3.07 . . . . 0.0 102.71 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.748 ' HB ' HG21 ' A' ' 64' ' ' VAL 0.263 1.1 mt -101.87 91.94 2.2 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 -176.317 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.841 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -53.71 83.08 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -178.072 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.718 ' HA3' ' HB2' ' A' ' 83' ' ' GLU . . . 162.36 -43.49 0.36 Allowed Glycine 0 C--N 1.283 -2.363 0 N-CA-C 107.649 -2.181 . . . . 0.0 107.649 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.763 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 11.9 m -126.95 -58.86 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.851 -0.794 . . . . 0.0 111.097 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.763 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 81.0 t -163.78 -100.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 120.32 -1.488 . . . . 0.0 113.268 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.925 ' HG3' ' O ' ' A' ' 59' ' ' ILE . 1.8 ttp180 -168.45 159.57 10.47 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.547 -0.72 . . . . 0.0 109.396 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.859 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -146.37 175.05 10.83 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.144 -0.973 . . . . 0.0 111.865 -177.33 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.619 ' N ' ' HZ1' ' A' ' 47' ' ' LYS . 79.8 t -82.41 119.33 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.665 -0.647 . . . . 0.0 110.133 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.824 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.77 107.63 0.31 Allowed Glycine 0 N--CA 1.492 2.426 0 C-N-CA 118.655 -1.736 . . . . 0.0 110.578 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.848 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . . . -88.57 -81.2 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.036 -1.273 . . . . 0.0 108.539 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.848 ' HD3' ' CB ' ' A' ' 70' ' ' ALA . 56.5 Cg_endo -84.5 18.52 1.54 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.407 1.214 . . . . 0.0 109.006 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.62 61.78 0.71 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.583 -0.698 . . . . 0.0 110.493 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.709 ' HG2' ' CB ' ' A' ' 16' ' ' CYS . 22.2 mtt180 -68.35 -32.25 72.21 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.849 -0.741 . . . . 0.0 109.276 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.688 ' HA ' ' HB3' ' A' ' 19' ' ' ALA . 1.2 tm-20 -47.44 -45.39 25.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 109.59 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.78 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -45.18 -29.11 0.88 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.061 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.757 ' CD1' HG21 ' A' ' 59' ' ' ILE . 3.2 mp -70.58 -39.96 73.56 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.511 -0.743 . . . . 0.0 109.059 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.791 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.11 -41.89 89.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.47 -0.769 . . . . 0.0 109.829 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.528 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 2.4 tm-20 -76.41 -27.99 56.5 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.248 0.547 . . . . 0.0 109.76 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.618 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -69.32 -42.54 75.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.04 -1.038 . . . . 0.0 111.286 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.742 ' CG2' ' CG ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -61.97 -45.36 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.043 -1.035 . . . . 0.0 108.814 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.635 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -71.68 -27.07 62.79 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.45 0.643 . . . . 0.0 109.442 178.237 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 1.068 ' O ' ' OD1' ' A' ' 82' ' ' ASP 0.287 0.2 OUTLIER -97.69 8.14 45.2 Favored 'General case' 0 C--O 1.196 -1.762 0 O-C-N 118.918 -2.364 . . . . 0.0 107.82 -178.69 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.784 ' HG2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -101.17 -57.77 2.02 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.721 ' HE3' ' NZ ' ' A' ' 27' ' ' LYS . 21.4 ptt? -68.23 -15.59 63.64 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.82 176.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.039 179.952 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.718 ' CE ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.31 0.576 . . . . 0.0 110.193 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.774 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -80.66 -94.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.157 -0.964 . . . . 0.0 110.195 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.712 ' CB ' HG23 ' A' ' 34' ' ' ILE . 54.6 t -93.03 91.31 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.422 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.773 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -116.88 108.01 15.3 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.942 0.877 . . . . 0.0 109.262 178.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.743 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.07 141.18 45.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.283 -0.886 . . . . 0.0 110.306 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.768 ' CG ' ' HB2' ' A' ' 60' ' ' ALA 0.255 5.4 tt0 -130.12 101.9 6.01 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 117.708 -1.597 . . . . 0.0 109.235 178.134 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.668 ' HA ' ' CG1' ' A' ' 59' ' ' ILE . 3.3 m -95.52 110.45 24.22 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.423 0 CA-C-O 123.412 1.577 . . . . 0.0 108.085 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.838 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 1.6 t80 -118.51 91.03 3.46 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.965 -1.084 . . . . 0.0 110.203 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.711 ' CG2' ' N ' ' A' ' 10' ' ' SER . 0.7 OUTLIER -120.22 -69.62 0.83 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.777 . . . . 0.0 109.629 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.711 ' N ' ' CG2' ' A' ' 9' ' ' THR . 21.6 t 179.68 152.14 0.56 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 110.831 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.673 ' HD3' ' HB2' ' A' ' 40' ' ' ASP . 49.8 Cg_endo -77.22 -15.94 15.83 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.175 1.618 . . . . 0.0 110.495 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 t -79.27 5.9 11.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.171 -0.956 . . . . 0.0 109.898 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.651 ' SG ' ' CD ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -160.8 -170.94 0.26 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 0.0 110.153 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.651 ' CD ' ' SG ' ' A' ' 13' ' ' CYS . 55.3 Cg_endo -84.2 113.54 1.79 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.882 1.464 . . . . 0.0 110.667 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.653 ' HB3' HG22 ' A' ' 7' ' ' VAL . 7.4 m-85 -49.55 -112.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.627 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.704 ' CB ' HD11 ' A' ' 59' ' ' ILE . 58.5 m -152.34 39.19 0.14 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.043 -1.036 . . . . 0.0 110.414 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 54.0 Cg_endo -76.9 17.17 0.85 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.9 1.474 . . . . 0.0 111.023 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.718 ' SD ' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -93.36 -64.71 1.06 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.092 -1.005 . . . . 0.0 112.078 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.718 ' N ' ' SD ' ' A' ' 18' ' ' MET . . . -55.96 -22.42 26.29 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.294 -0.879 . . . . 0.0 109.779 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.743 ' HB ' ' CG2' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -71.28 -39.69 72.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.503 -0.748 . . . . 0.0 109.531 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.703 ' N ' ' CD1' ' A' ' 20' ' ' ILE . 3.1 tt0 -48.77 -31.83 7.62 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.434 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 2.8 t -71.59 -44.96 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.321 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.777 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -68.71 -26.54 33.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.301 -0.874 . . . . 0.0 109.22 178.418 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.737 ' OD1' ' CG2' ' A' ' 34' ' ' ILE . 14.1 t0 -74.67 -38.72 62.34 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -44.53 91.62 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.666 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.508 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.76 -40.13 29.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.456 -0.777 . . . . 0.0 110.443 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.781 ' N ' ' HE3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.3 -22.79 64.7 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.092 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.711 ' CG ' HD12 ' A' ' 34' ' ' ILE . 3.5 mtpt -69.93 -44.59 69.3 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 177.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.799 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -50.14 -39.98 44.95 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.681 0.753 . . . . 0.0 109.079 178.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.799 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.67 -55.22 3.73 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.739 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -96.73 77.38 0.71 Allowed Glycine 0 N--CA 1.488 2.161 0 O-C-N 121.398 -0.814 . . . . 0.0 111.07 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.543 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -33.45 -24.64 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 118.998 1.399 . . . . 0.0 110.424 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.739 ' N ' ' O ' ' A' ' 31' ' ' GLY . 1.1 mtmp? -85.42 155.57 21.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.131 -0.98 . . . . 0.0 110.813 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.737 ' CG2' ' OD1' ' A' ' 24' ' ' ASP . 0.1 OUTLIER -129.33 149.48 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.939 178.634 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.67 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 36.3 t0 -150.31 71.9 1.08 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.495 -0.753 . . . . 0.0 109.254 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.64 ' HA ' HG12 ' A' ' 5' ' ' ILE . 58.4 t -91.34 117.39 34.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.57 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.753 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.25 91.1 mt-10 -100.5 138.06 38.07 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.433 -1.307 . . . . 0.0 108.301 -178.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.665 ' HA ' HG23 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -140.62 126.67 19.55 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.725 -1.235 . . . . 0.0 111.598 -177.383 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.743 ' CD1' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -139.65 176.0 6.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.486 -0.759 . . . . 0.0 109.653 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.736 ' OD1' ' N ' ' A' ' 42' ' ' MET . 2.1 p30 -114.22 172.9 6.73 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.858 -1.152 . . . . 0.0 111.947 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.838 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.7 OUTLIER -62.27 -5.29 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.41 -0.806 . . . . 0.0 112.03 176.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.736 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -99.94 -18.56 17.03 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.019 -1.051 . . . . 0.0 111.048 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.726 HG22 ' CG2' ' A' ' 39' ' ' ILE . 0.7 OUTLIER -113.01 -37.08 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.19 -0.944 . . . . 0.0 110.056 -178.389 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.786 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 5.2 t0 -114.22 52.52 0.83 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.2 -0.938 . . . . 0.0 110.977 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.255 72.2 ttt180 -65.87 -5.58 9.57 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.315 -1.354 . . . . 0.0 109.575 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.737 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 0.6 OUTLIER -60.11 -15.39 23.09 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.344 -0.848 . . . . 0.0 110.058 176.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.848 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -52.17 -58.46 6.54 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.124 -178.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.852 ' CB ' ' CB ' ' A' ' 55' ' ' ALA . . . -63.94 -0.8 1.2 Allowed 'General case' 0 C--N 1.279 -2.471 0 O-C-N 121.331 -0.856 . . . . 0.0 110.73 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.737 ' CG2' ' O ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -35.07 -38.7 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 -177.003 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.581 ' N ' ' C ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -53.73 -51.91 61.82 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.165 176.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.812 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 1.6 p90 -123.2 -28.22 4.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.085 -1.009 . . . . 0.0 110.449 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.8 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.45 14.18 0.01 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.732 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.4 mt -85.87 -64.92 1.07 Allowed 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 123.674 1.702 . . . . 0.0 107.931 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.503 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 10.0 mtt -105.86 58.12 0.66 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.253 -1.34 . . . . 0.0 107.776 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.852 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.264 . . -99.0 106.78 19.08 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 123.467 1.604 . . . . 0.0 110.782 -175.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.794 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -146.72 -60.63 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.21 179.037 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.794 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 46.8 Cg_endo -100.0 104.76 0.05 OUTLIER 'Trans proline' 0 C--O 1.199 -1.47 0 CA-C-O 123.495 1.373 . . . . 0.0 110.429 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.745 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -160.14 -177.86 6.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.538 -1.352 . . . . 0.0 111.572 -178.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.801 ' CD1' ' CD1' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -149.16 137.18 14.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.779 ' CB ' ' HD3' ' A' ' 66' ' ' ARG . . . -80.87 140.44 35.36 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 117.155 -1.818 . . . . 0.0 106.987 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.762 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.413 0.7 OUTLIER -89.39 85.91 2.52 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.539 0 C-N-CA 115.302 -2.559 . . . . 0.0 106.058 -175.994 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.773 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.7 OUTLIER -44.12 83.24 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 113.098 -1.865 . . . . 0.0 108.622 177.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.762 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.07 -44.24 0.37 Allowed Glycine 0 N--CA 1.484 1.891 0 N-CA-C 107.042 -2.423 . . . . 0.0 107.042 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.759 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 16.6 m -126.69 -59.13 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 O-C-N 121.622 -0.928 . . . . 0.0 111.378 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.759 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 97.0 t -163.85 -106.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 120.289 -1.507 . . . . 0.0 112.249 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.779 ' HD3' ' CB ' ' A' ' 60' ' ' ALA . 1.8 ttp180 -162.4 165.47 26.35 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.716 -0.615 . . . . 0.0 109.55 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.829 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -145.0 177.83 8.48 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.97 -1.082 . . . . 0.0 111.06 -178.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.72 HG23 ' CZ ' ' A' ' 51' ' ' TYR . 22.5 t -93.18 116.55 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.297 -0.877 . . . . 0.0 109.865 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.821 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.41 126.58 1.58 Allowed Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.229 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.831 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -94.03 -83.05 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.759 0 O-C-N 120.921 -1.341 . . . . 0.0 108.709 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.831 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 51.4 Cg_endo -80.73 23.81 0.7 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 N-CA-C 109.11 -1.15 . . . . 0.0 109.11 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.443 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -98.51 70.52 1.96 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.238 -0.913 . . . . 0.0 111.432 -179.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.718 ' CB ' ' HB2' ' A' ' 19' ' ' ALA . 11.9 mtm180 -76.77 -35.28 57.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.997 -1.064 . . . . 0.0 109.536 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.678 ' HA ' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -49.02 -32.29 9.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.664 179.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.791 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -50.9 -40.18 56.1 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.295 -0.878 . . . . 0.0 109.273 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.801 ' CD1' ' CD1' ' A' ' 59' ' ' ILE . 4.9 mp -64.32 -38.32 90.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.491 -0.755 . . . . 0.0 109.318 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.803 ' CD1' ' N ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -60.76 -42.94 98.43 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.868 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.803 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 4.5 tm-20 -78.54 -23.31 46.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 109.851 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.629 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -73.71 -37.01 65.3 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 109.446 -178.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.734 ' CG2' HG23 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -63.44 -46.08 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.067 -1.02 . . . . 0.0 109.076 178.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.633 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -70.11 -33.59 72.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.35 -0.844 . . . . 0.0 108.742 179.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.448 8.0 t70 -88.08 -6.9 57.67 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 114.79 -2.764 . . . . 0.0 107.582 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.748 ' OE1' ' CA ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -81.14 -60.79 2.16 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 120.114 -1.617 . . . . 0.0 109.596 171.234 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.725 ' HE3' ' CE ' ' A' ' 27' ' ' LYS . 10.3 ptt? -71.62 -12.29 61.27 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.71 -0.619 . . . . 0.0 110.497 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.599 ' CG ' ' OXT' ' A' ' 85' ' ' GLU . 2.1 tt0 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.177 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.2 ttm . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.248 0.547 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.752 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 0.9 OUTLIER -80.51 -92.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 110.389 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.704 HG21 ' CB ' ' A' ' 27' ' ' LYS . 54.6 t -92.76 119.76 40.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.671 -0.643 . . . . 0.0 110.495 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.8 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 9.4 t30 -138.49 114.57 10.14 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.571 1.177 . . . . 0.0 108.865 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.737 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -136.15 149.6 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.94 . . . . 0.0 110.724 -179.05 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.742 ' CG ' ' HB2' ' A' ' 60' ' ' ALA . 13.6 tt0 -135.09 106.11 6.64 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.007 -1.477 . . . . 0.0 109.701 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.781 ' CG2' ' CB ' ' A' ' 38' ' ' LYS . 22.3 m -95.16 104.3 15.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-O 123.1 1.429 . . . . 0.0 108.808 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.832 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 0.7 OUTLIER -117.08 87.91 2.8 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.049 -1.032 . . . . 0.0 109.564 -178.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.633 ' O ' HG22 ' A' ' 41' ' ' ILE . 6.6 m -120.72 -62.72 1.42 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.352 -0.842 . . . . 0.0 109.586 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.755 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 12.8 p 179.81 156.41 0.72 Allowed Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.369 -0.832 . . . . 0.0 111.009 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.662 ' HD3' ' CG ' ' A' ' 40' ' ' ASP . 50.8 Cg_endo -84.77 -23.71 2.51 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 124.222 1.643 . . . . 0.0 110.589 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 t -79.37 13.65 1.86 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.159 -0.963 . . . . 0.0 110.055 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.515 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -160.72 -174.27 0.42 Allowed Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 121.417 -0.802 . . . . 0.0 110.184 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.614 ' O ' ' O ' ' A' ' 15' ' ' TYR . 54.4 Cg_endo -84.16 112.09 1.67 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.909 1.478 . . . . 0.0 110.689 177.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.755 ' CE1' ' O ' ' A' ' 10' ' ' SER . 19.3 m-85 -49.45 -110.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.311 -0.868 . . . . 0.0 109.609 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.741 ' CA ' ' HG3' ' A' ' 73' ' ' ARG . 37.6 m -154.81 39.78 0.13 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.027 -1.046 . . . . 0.0 110.57 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.674 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.2 Cg_endo -77.26 16.56 1.0 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.767 1.404 . . . . 0.0 110.802 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.546 ' HB3' ' HG2' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -93.27 -64.28 1.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.996 -1.082 . . . . 0.0 112.142 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.704 ' CB ' ' HB3' ' A' ' 73' ' ' ARG . . . -57.48 -18.43 18.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.274 -0.891 . . . . 0.0 109.665 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.719 ' C ' ' CD1' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -75.71 -39.58 39.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.393 -0.817 . . . . 0.0 109.477 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.583 ' N ' ' CD1' ' A' ' 20' ' ' ILE . 29.8 tp10 -50.4 -32.84 18.72 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.29 -44.45 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.21 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.742 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.7 OUTLIER -69.23 -28.08 37.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.673 0.749 . . . . 0.0 109.379 178.578 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.654 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 8.4 t0 -76.11 -36.75 58.73 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.7 -43.6 94.04 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.535 0.683 . . . . 0.0 109.623 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.481 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.9 -40.05 29.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.478 -0.764 . . . . 0.0 110.11 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.75 ' CE ' ' HA ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -69.24 -22.23 63.87 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.218 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.722 ' CG ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -69.92 -43.22 72.13 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.775 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -49.48 -39.63 34.33 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.788 0.804 . . . . 0.0 109.037 178.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.775 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.2 -56.68 3.18 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.74 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -97.16 77.84 0.67 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.624 -0.991 . . . . 0.0 110.624 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.568 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -32.37 -27.16 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 119.105 1.452 . . . . 0.0 110.527 -179.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.74 ' N ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -85.95 157.05 20.24 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.347 -0.846 . . . . 0.0 110.938 178.202 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.722 HD12 ' CG ' ' A' ' 28' ' ' LYS . 1.7 mp -128.98 157.98 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.044 -1.035 . . . . 0.0 110.765 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.671 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 3.4 t0 -150.21 62.48 0.97 Allowed 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.459 -0.775 . . . . 0.0 109.166 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.646 HG22 ' CG1' ' A' ' 3' ' ' VAL . 63.5 t -91.27 115.86 31.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 122.264 1.031 . . . . 0.0 109.862 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.695 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 3.5 mm-40 -97.94 145.08 26.82 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.932 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.781 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.98 121.48 15.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.075 -1.016 . . . . 0.0 111.453 -176.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.788 ' CG2' ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -129.06 178.2 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 110.354 -179.152 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.737 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -113.88 165.65 12.37 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.217 -0.927 . . . . 0.0 111.06 178.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.832 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -49.58 -38.82 13.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.512 -0.743 . . . . 0.0 112.769 177.656 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.737 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.9 OUTLIER -86.88 -3.46 59.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.844 -1.16 . . . . 0.0 111.483 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.788 ' CG2' ' CG2' ' A' ' 39' ' ' ILE . 1.9 m -111.15 -44.07 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.97 -1.081 . . . . 0.0 109.801 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.732 ' HB2' ' CB ' ' A' ' 39' ' ' ILE . 4.0 t70 -112.37 45.37 1.3 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.356 -0.84 . . . . 0.0 110.029 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.671 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 2.4 ttt-85 -61.28 -4.64 1.26 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.849 -1.14 . . . . 0.0 109.469 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.752 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 2.1 mm-40 -55.02 -19.74 7.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.396 -0.815 . . . . 0.0 110.253 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.845 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -50.22 -59.1 4.28 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 122.413 1.102 . . . . 0.0 110.067 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.845 ' N ' ' HG3' ' A' ' 47' ' ' LYS . . . -65.37 -0.09 1.71 Allowed 'General case' 0 C--N 1.281 -2.399 0 O-C-N 121.555 -0.716 . . . . 0.0 111.094 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.785 ' CD1' ' N ' ' A' ' 50' ' ' GLU . 2.4 pp -35.64 -36.92 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.785 ' N ' ' CD1' ' A' ' 49' ' ' ILE . 0.8 OUTLIER -54.09 -52.54 60.67 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.047 176.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.787 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.0 p90 -122.75 -28.22 4.19 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.088 -1.007 . . . . 0.0 110.203 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.789 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.62 14.3 0.01 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.657 ' N ' ' O ' ' A' ' 51' ' ' TYR . 4.4 mt -86.09 -62.77 1.44 Allowed 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 123.122 1.439 . . . . 0.0 108.462 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 19.9 mtp -106.72 53.83 0.69 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.158 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.845 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.268 . . -98.94 111.14 23.62 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 123.189 1.471 . . . . 0.0 110.903 -176.142 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.799 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -146.68 -68.38 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 110.459 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.799 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 51.0 Cg_endo -96.14 103.81 0.1 OUTLIER 'Trans proline' 0 C--O 1.2 -1.423 0 CA-C-O 123.396 1.332 . . . . 0.0 109.742 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.8 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -158.11 175.14 14.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.75 -1.219 . . . . 0.0 111.562 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.715 HG12 ' CD2' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -138.39 135.58 44.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.613 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.767 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . . . -81.51 139.59 35.06 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 117.361 -1.736 . . . . 0.0 107.058 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.756 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.372 1.0 OUTLIER -88.55 83.4 2.2 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.346 0 CA-C-O 124.786 2.232 . . . . 0.0 106.824 -175.895 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.8 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 4.5 m120 -43.11 82.68 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.616 -1.629 . . . . 0.0 108.767 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.756 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.04 -44.52 0.37 Allowed Glycine 0 N--CA 1.481 1.694 0 N-CA-C 107.414 -2.275 . . . . 0.0 107.414 -177.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.749 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.0 m -125.78 -59.82 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 121.718 -0.872 . . . . 0.0 110.98 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.749 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 88.6 t -163.81 -107.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 120.312 -1.492 . . . . 0.0 112.288 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.767 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 2.0 ttp180 -164.7 163.53 21.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.631 -0.668 . . . . 0.0 109.671 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.841 ' CZ ' ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -144.76 176.86 9.13 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.896 -1.127 . . . . 0.0 111.366 -178.124 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.63 HG23 ' OH ' ' A' ' 51' ' ' TYR . 79.8 t -89.14 115.82 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.651 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.841 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.57 124.8 1.31 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.564 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.83 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -92.85 -79.68 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 120.882 -1.364 . . . . 0.0 108.396 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.83 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 55.2 Cg_endo -81.01 25.29 0.64 Allowed 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.595 1.313 . . . . 0.0 109.228 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . 0.273 28.5 m -102.67 82.84 2.19 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 123.269 1.509 . . . . 0.0 110.007 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.741 ' HG3' ' CA ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -77.94 -35.74 50.1 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.947 -1.096 . . . . 0.0 109.988 177.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.714 ' HG2' ' CD2' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -46.1 -30.13 1.78 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.362 -0.836 . . . . 0.0 109.99 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.799 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -50.91 -42.69 59.56 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.27 -0.894 . . . . 0.0 109.193 179.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.737 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -63.49 -45.57 90.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.604 -0.685 . . . . 0.0 109.492 178.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.742 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -60.93 -38.57 86.26 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.639 0.733 . . . . 0.0 110.245 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.581 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 25.4 tt0 -80.22 -21.9 42.39 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.267 -0.896 . . . . 0.0 110.202 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.649 ' HB3' ' HA ' ' A' ' 61' ' ' ILE . . . -77.95 -39.77 41.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.207 -0.933 . . . . 0.0 109.643 -177.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.715 HG12 ' CG1' ' A' ' 23' ' ' VAL . 1.5 mp -65.72 -39.7 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.038 -1.039 . . . . 0.0 109.156 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.573 ' C ' ' OD1' ' A' ' 81' ' ' ASN . 0.1 OUTLIER -75.53 -32.02 60.32 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.118 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.581 ' HB3' ' O ' ' A' ' 78' ' ' GLU 0.455 0.4 OUTLIER -89.03 -8.39 54.09 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 114.989 -2.685 . . . . 0.0 108.115 -179.159 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.713 ' CG ' ' HA2' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -78.9 -60.71 2.27 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 119.968 -1.708 . . . . 0.0 110.196 169.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.697 ' HE3' ' NZ ' ' A' ' 27' ' ' LYS . 4.7 ptt? -71.88 -9.16 57.93 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.782 -0.574 . . . . 0.0 110.822 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.572 ' OE2' ' C ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.898 -1.049 . . . . 0.0 109.973 -177.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.226 0.536 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.76 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 0.9 OUTLIER -80.5 -92.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.333 -0.854 . . . . 0.0 110.359 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.743 HG21 ' CB ' ' A' ' 27' ' ' LYS . 53.6 t -91.51 128.49 43.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.483 -0.76 . . . . 0.0 110.565 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.786 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 63.3 t30 -140.3 108.38 5.75 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 123.202 1.477 . . . . 0.0 108.604 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.759 ' CD1' HG13 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -136.15 135.92 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 O-C-N 120.747 -1.221 . . . . 0.0 112.061 -178.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.729 ' CG ' ' HB2' ' A' ' 60' ' ' ALA 0.253 1.4 tp10 -122.66 102.06 7.83 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 123.196 1.474 . . . . 0.0 108.587 176.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.8 ' CG2' ' CB ' ' A' ' 38' ' ' LYS . 29.5 m -95.42 106.39 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 123.582 1.658 . . . . 0.0 109.51 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.823 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 1.1 t80 -117.92 102.15 8.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.071 -1.018 . . . . 0.0 109.76 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.67 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.5 OUTLIER -134.0 -61.9 0.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.955 . . . . 0.0 110.214 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.669 ' HA ' HG23 ' A' ' 41' ' ' ILE . 3.1 t -175.13 144.63 0.82 Allowed Pre-proline 0 N--CA 1.487 1.386 0 O-C-N 121.118 -0.989 . . . . 0.0 111.152 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.731 ' N ' ' HB2' ' A' ' 40' ' ' ASP . 48.7 Cg_endo -76.76 -9.39 18.31 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 124.135 1.597 . . . . 0.0 110.475 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.95 -5.0 52.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.21 -0.931 . . . . 0.0 109.843 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.624 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 1.4 p -160.61 -166.15 0.14 Allowed Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.385 -0.822 . . . . 0.0 110.056 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.624 ' CD ' ' CB ' ' A' ' 13' ' ' CYS . 55.6 Cg_endo -84.17 117.8 2.23 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.863 1.454 . . . . 0.0 110.617 176.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.667 ' HB2' ' HB ' ' A' ' 7' ' ' VAL . 2.1 m-85 -49.27 -84.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.0 109.56 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.7 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 42.2 m -155.22 39.69 0.12 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.124 -0.985 . . . . 0.0 109.968 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.7 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 53.4 Cg_endo -73.78 30.4 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.881 1.464 . . . . 0.0 111.146 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.431 ' H ' ' C ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -110.17 -61.85 1.6 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.029 -1.044 . . . . 0.0 110.433 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.716 ' CB ' ' C ' ' A' ' 73' ' ' ARG . . . -58.1 -20.06 37.03 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.464 -0.773 . . . . 0.0 110.062 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.727 ' CG2' HG22 ' A' ' 5' ' ' ILE . 23.0 pt -75.62 -39.07 39.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.479 -0.763 . . . . 0.0 109.513 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.654 ' N ' HG13 ' A' ' 20' ' ' ILE . 49.7 tt0 -49.63 -35.86 22.56 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.8 -42.46 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.048 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.759 HG13 ' CD1' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -70.88 -26.66 28.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-O 121.825 0.821 . . . . 0.0 109.185 178.299 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.632 ' OD1' HG12 ' A' ' 34' ' ' ILE . 4.6 t70 -76.9 -35.84 57.09 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -43.99 91.07 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.622 0.725 . . . . 0.0 109.321 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.506 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.44 -41.01 28.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.622 -0.674 . . . . 0.0 110.165 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.813 ' CE ' ' CE ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -67.72 -23.38 65.26 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.306 -179.404 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.631 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -69.32 -46.42 67.14 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.792 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -47.47 -41.0 19.69 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.585 0.707 . . . . 0.0 109.124 178.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.792 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.57 -57.87 2.72 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.731 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -97.15 78.28 0.67 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.583 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -33.46 -27.24 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 119.394 1.597 . . . . 0.0 110.101 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.731 ' N ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -88.72 158.02 18.33 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.197 -0.939 . . . . 0.0 111.339 178.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.685 ' CD1' HG22 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -129.47 151.03 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.406 -0.917 . . . . 0.0 110.685 178.127 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -138.82 61.14 1.58 Allowed 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.445 -0.784 . . . . 0.0 108.97 179.649 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.74 ' CG2' ' CG1' ' A' ' 3' ' ' VAL . 44.6 t -91.59 115.48 30.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 122.454 1.121 . . . . 0.0 109.681 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.688 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.25 12.2 mt-10 -98.07 141.02 31.53 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.375 -178.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.8 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -138.45 130.9 28.94 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.765 -1.21 . . . . 0.0 112.127 -176.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.741 ' HB ' ' CB ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -138.53 173.12 12.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.525 -0.734 . . . . 0.0 110.006 179.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.756 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.6 OUTLIER -105.84 169.68 8.34 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.102 -0.999 . . . . 0.0 110.889 179.234 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.823 ' HA ' ' CE2' ' A' ' 8' ' ' PHE . 0.6 OUTLIER -73.16 -19.32 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.444 -0.785 . . . . 0.0 111.598 179.16 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.756 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 2.4 ptt? -90.62 -18.1 25.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.06 -1.025 . . . . 0.0 110.634 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.729 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 13.3 p -110.01 -29.78 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.344 -0.847 . . . . 0.0 110.77 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.8 ' O ' ' CE2' ' A' ' 8' ' ' PHE . 5.7 t0 -114.7 48.19 1.16 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.021 -1.049 . . . . 0.0 110.843 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.26 2.3 ttt180 -59.09 -8.29 1.45 Allowed 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 118.263 -1.375 . . . . 0.0 109.974 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.756 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 0.5 OUTLIER -61.34 -13.41 19.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 109.175 175.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.799 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -51.71 -60.16 3.47 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.168 0.985 . . . . 0.0 108.959 -178.521 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.853 ' CB ' ' CB ' ' A' ' 55' ' ' ALA . . . -64.2 1.57 0.71 Allowed 'General case' 0 C--N 1.278 -2.533 0 O-C-N 121.119 -0.988 . . . . 0.0 110.55 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.756 ' CG2' ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -35.67 -38.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 -177.457 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.56 ' N ' ' C ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -54.62 -49.36 70.68 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.668 176.717 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.808 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -124.93 -28.55 3.46 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.999 -1.063 . . . . 0.0 110.411 179.21 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.787 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.14 13.3 0.01 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.66 ' N ' ' O ' ' A' ' 51' ' ' TYR . 6.2 mt -86.52 -60.94 1.85 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 123.526 1.631 . . . . 0.0 107.88 177.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.527 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 26.0 mtm -110.55 62.35 0.6 Allowed 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.633 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.853 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.278 . . -98.35 107.78 20.32 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 123.622 1.677 . . . . 0.0 111.124 -174.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.82 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 1.6 t -146.66 -68.42 0.02 OUTLIER Pre-proline 0 N--CA 1.484 1.232 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.23 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.82 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 55.6 Cg_endo -104.22 93.46 0.03 OUTLIER 'Trans proline' 0 C--O 1.201 -1.327 0 CA-C-O 123.528 1.386 . . . . 0.0 111.257 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.753 ' CB ' ' HE2' ' A' ' 47' ' ' LYS . . . -151.2 179.32 8.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.32 -1.488 . . . . 0.0 110.957 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.829 ' CG2' ' CD2' ' A' ' 76' ' ' LEU . 1.4 mp -149.92 147.47 16.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.463 -0.773 . . . . 0.0 110.508 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.788 ' HA ' ' HG3' ' A' ' 66' ' ' ARG . . . -81.59 137.9 35.44 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.757 ' HB ' HG21 ' A' ' 64' ' ' VAL 0.406 1.0 OUTLIER -87.8 82.34 2.05 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.555 0 C-N-CA 115.318 -2.553 . . . . 0.0 105.277 -175.756 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.786 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -44.3 85.67 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 113.3 -1.773 . . . . 0.0 107.851 177.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.755 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.0 -47.12 0.38 Allowed Glycine 0 N--CA 1.482 1.716 0 N-CA-C 106.471 -2.652 . . . . 0.0 106.471 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.757 HG21 ' HB ' ' A' ' 61' ' ' ILE . 11.9 m -124.49 -60.86 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 121.82 -0.812 . . . . 0.0 111.094 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.751 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 96.7 t -164.01 -107.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 120.104 -1.623 . . . . 0.0 113.185 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.788 ' HG3' ' HA ' ' A' ' 60' ' ' ALA . 1.0 OUTLIER -156.18 153.69 29.64 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.671 -0.643 . . . . 0.0 110.13 -177.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.789 ' CZ ' ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -145.52 -174.93 4.53 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.905 -1.122 . . . . 0.0 111.836 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.695 ' HA ' ' HB1' ' A' ' 58' ' ' ALA . 21.4 t -95.92 122.95 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.789 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.33 105.59 0.26 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 118.865 -1.636 . . . . 0.0 111.153 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.825 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -89.74 -82.74 0.02 OUTLIER Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 120.824 -1.397 . . . . 0.0 108.146 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.825 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 55.7 Cg_endo -82.19 14.76 2.16 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 O-C-N 123.28 1.147 . . . . 0.0 109.499 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.48 64.48 1.32 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.218 -0.926 . . . . 0.0 111.587 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.716 ' C ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.59 -32.15 65.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.897 -1.127 . . . . 0.0 109.361 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.673 ' HA ' ' HB3' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -51.34 -40.99 60.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.923 . . . . 0.0 109.244 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.744 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -46.32 -29.31 1.6 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.465 -0.772 . . . . 0.0 109.344 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.829 ' CD2' ' CG2' ' A' ' 59' ' ' ILE . 13.1 mt -72.46 -40.85 66.69 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.747 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.94 -36.98 73.28 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.799 0.809 . . . . 0.0 109.646 179.279 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -79.44 -25.79 41.9 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.328 -0.858 . . . . 0.0 110.123 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.707 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -74.95 -37.91 61.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.161 -0.962 . . . . 0.0 109.743 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.735 ' CD1' HD12 ' A' ' 5' ' ' ILE . 1.5 mp -63.64 -37.41 79.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.957 -1.09 . . . . 0.0 108.807 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.421 ' ND2' ' C ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -72.94 -33.89 66.2 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.64 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.501 0.3 OUTLIER -90.95 -6.58 53.88 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 114.114 -3.035 . . . . 0.0 107.454 -179.059 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.749 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -78.7 -55.19 5.37 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 119.859 -1.776 . . . . 0.0 109.838 170.091 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.813 ' CE ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.04 -23.26 64.96 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.171 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.471 ' CD ' ' C ' ' A' ' 85' ' ' GLU . 3.3 tm-20 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.234 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.239 0.542 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.763 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 0.9 OUTLIER -80.45 -94.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.284 -0.885 . . . . 0.0 110.583 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.749 ' CG1' ' CG2' ' A' ' 36' ' ' VAL . 57.6 t -87.84 133.11 31.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 O-C-N 121.395 -0.816 . . . . 0.0 112.692 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.84 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.51 64.0 t30 -153.92 106.51 2.85 Favored 'General case' 0 N--CA 1.518 2.939 1 CA-C-O 129.399 4.428 . . . . 0.0 109.208 177.868 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.766 ' CD1' HG13 ' A' ' 23' ' ' VAL 0.414 0.2 OUTLIER -119.3 130.57 73.77 Favored 'Isoleucine or valine' 0 C--O 1.264 1.834 0 CA-C-N 108.689 -3.869 . . . . 0.0 117.903 -174.823 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.842 ' HA ' ' O ' ' A' ' 37' ' ' GLU 0.644 1.2 tp10 -133.7 123.3 24.72 Favored 'General case' 0 C--N 1.269 -2.895 2 CA-C-O 131.792 5.567 . . . . 0.0 106.17 166.824 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.764 ' CG2' ' CB ' ' A' ' 38' ' ' LYS 0.257 25.0 m -113.19 100.86 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.517 1 O-C-N 114.476 -5.14 . . . . 0.0 109.155 -171.42 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.836 ' CE2' ' O ' ' A' ' 44' ' ' ASP . 1.2 t80 -113.79 104.98 12.74 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 111.69 -2.505 . . . . 0.0 108.623 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.667 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.5 OUTLIER -135.6 -60.61 0.74 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.929 0.871 . . . . 0.0 110.564 177.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.677 ' HA ' HG23 ' A' ' 41' ' ' ILE . 3.1 t -177.57 143.62 0.51 Allowed Pre-proline 0 N--CA 1.487 1.414 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.41 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.732 ' CD ' ' HB2' ' A' ' 40' ' ' ASP . 47.2 Cg_endo -76.08 -9.52 19.28 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 124.119 1.589 . . . . 0.0 110.225 -178.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.14 -5.19 53.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.056 -1.027 . . . . 0.0 109.843 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.633 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 1.4 p -159.75 -165.88 0.13 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.353 -0.842 . . . . 0.0 110.138 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.633 ' CD ' ' CB ' ' A' ' 13' ' ' CYS . 55.3 Cg_endo -84.22 117.65 2.2 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.865 1.455 . . . . 0.0 110.582 176.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.666 ' HB2' ' HB ' ' A' ' 7' ' ' VAL . 2.0 m-85 -49.22 -83.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 109.625 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.707 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 42.7 m -155.29 39.59 0.12 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.146 -0.971 . . . . 0.0 109.962 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 52.9 Cg_endo -73.69 30.3 0.32 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.977 1.514 . . . . 0.0 111.141 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.435 ' H ' ' C ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -110.06 -61.98 1.58 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.966 -1.084 . . . . 0.0 110.348 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.705 ' CB ' ' C ' ' A' ' 73' ' ' ARG . . . -58.86 -19.11 38.91 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.099 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.731 ' CG2' HG22 ' A' ' 5' ' ' ILE . 22.8 pt -75.95 -38.0 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.141 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.658 ' N ' HG13 ' A' ' 20' ' ' ILE . 50.1 tt0 -49.0 -37.58 20.78 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.42 -44.87 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-O 122.05 0.929 . . . . 0.0 109.297 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.766 HG13 ' CD1' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -63.01 -35.71 72.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 122.789 1.281 . . . . 0.0 109.92 175.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.636 ' OD1' ' CG1' ' A' ' 34' ' ' ILE . 4.0 t70 -70.64 -39.03 73.92 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.903 1.335 . . . . 0.0 108.298 -177.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -46.35 81.94 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.062 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.499 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -76.74 -41.6 44.36 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.636 0.731 . . . . 0.0 110.297 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.821 ' CE ' ' CE ' ' A' ' 84' ' ' MET 0.272 0.0 OUTLIER -72.02 -17.71 62.01 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 117.471 -1.691 . . . . 0.0 109.632 -177.32 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.632 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -70.33 -45.86 65.35 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 120.923 -1.111 . . . . 0.0 108.223 173.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.724 ' HG3' ' N ' ' A' ' 30' ' ' PHE 0.317 0.0 OUTLIER -52.97 -28.8 25.45 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.014 -179.042 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.763 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -102.17 -59.16 1.75 Allowed 'General case' 0 C--N 1.274 -2.706 0 O-C-N 119.108 -2.245 . . . . 0.0 106.67 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.701 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -80.23 58.85 4.61 Favored Glycine 1 C--N 1.24 -4.8 1 CA-C-O 113.008 -4.218 . . . . 0.0 116.433 174.526 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.571 ' C ' ' O ' ' A' ' 31' ' ' GLY 0.428 0.0 OUTLIER -36.45 -19.65 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.219 1 CA-C-N 125.182 4.491 . . . . 0.0 112.901 -168.647 . . . . . . . . 5 4 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.709 ' O ' ' CG2' ' A' ' 2' ' ' VAL 0.293 0.0 OUTLIER -75.96 151.29 37.29 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 127.536 2.334 . . . . 0.0 115.69 167.953 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.69 ' CD1' HG22 ' A' ' 3' ' ' VAL 0.342 0.3 OUTLIER -130.67 155.77 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 C-N-CA 115.569 -2.452 . . . . 0.0 109.84 170.575 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.61 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.3 OUTLIER -139.96 64.76 1.44 Allowed 'General case' 0 C--N 1.313 -1.015 0 O-C-N 121.349 -0.844 . . . . 0.0 108.783 -178.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.749 ' CG2' ' CG1' ' A' ' 3' ' ' VAL 0.405 58.1 t -102.29 125.05 56.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 125.728 2.68 . . . . 0.0 108.709 -177.383 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.842 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.489 10.2 mt-10 -116.02 129.29 56.3 Favored 'General case' 0 C--O 1.176 -2.802 0 O-C-N 118.655 -2.528 . . . . 0.0 107.81 -173.201 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.764 ' CB ' ' CG2' ' A' ' 7' ' ' VAL 0.642 0.0 OUTLIER -106.83 111.18 23.58 Favored 'General case' 0 C--O 1.274 2.347 2 CA-C-O 107.928 -5.796 . . . . 0.0 121.166 -170.665 . . . . . . . . 5 4 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.749 ' HB ' ' CB ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -130.11 166.54 27.45 Favored 'Isoleucine or valine' 1 C--N 1.212 -5.405 1 CA-C-N 131.377 6.444 . . . . 0.0 109.713 178.267 . . . . . . . . 5 4 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.738 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.5 OUTLIER -97.82 169.84 9.38 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.776 -1.203 . . . . 0.0 112.279 173.193 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.828 ' HA ' ' CE2' ' A' ' 8' ' ' PHE . 0.7 OUTLIER -74.33 -21.34 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.03 -1.044 . . . . 0.0 111.402 176.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.738 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 2.0 ptt? -86.27 -16.62 37.0 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.901 -1.124 . . . . 0.0 112.915 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.733 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 14.5 p -112.83 -27.06 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.914 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.836 ' O ' ' CE2' ' A' ' 8' ' ' PHE . 5.7 t0 -115.14 51.13 0.93 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.184 -0.947 . . . . 0.0 110.6 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.457 2.6 ttt180 -70.31 0.99 5.41 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 115.833 -2.347 . . . . 0.0 109.793 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.778 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -53.92 -24.46 16.38 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.545 -1.347 . . . . 0.0 110.798 165.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.85 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -47.58 -62.49 1.42 Allowed 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 122.767 1.27 . . . . 0.0 109.023 -174.034 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.903 ' CB ' ' CB ' ' A' ' 55' ' ' ALA 0.425 . . -51.01 -13.66 0.17 Allowed 'General case' 0 C--N 1.268 -2.975 0 C-N-CA 125.105 1.362 . . . . 0.0 113.021 173.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.778 ' CG2' ' O ' ' A' ' 46' ' ' GLU 0.256 0.2 OUTLIER -32.92 -37.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 O-C-N 117.768 -3.083 . . . . 0.0 103.528 -168.342 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.637 ' N ' ' C ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -55.0 -49.27 71.92 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.581 176.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.8 ' CE1' ' HE3' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -124.95 -28.14 3.5 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.979 -1.076 . . . . 0.0 110.397 179.157 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.744 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 41.69 12.08 0.01 OUTLIER Glycine 0 C--O 1.19 -2.617 0 CA-C-O 122.025 0.792 . . . . 0.0 112.416 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 5.6 mt -83.84 -75.02 0.35 Allowed 'General case' 0 C--N 1.247 -3.85 0 N-CA-C 103.971 -2.603 . . . . 0.0 103.971 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.606 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 26.9 mtm -103.23 69.2 1.0 Allowed 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.228 -1.545 . . . . 0.0 107.092 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.903 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.579 . . -113.08 117.75 32.86 Favored 'General case' 0 C--O 1.195 -1.78 1 CA-C-O 129.698 4.571 . . . . 0.0 109.073 -175.749 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.828 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 1.7 t -152.77 -60.71 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.654 0 CA-C-N 109.02 -3.718 . . . . 0.0 112.242 -175.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.828 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.502 43.5 Cg_endo -119.83 105.87 0.0 OUTLIER 'Trans proline' 0 C--O 1.19 -1.88 0 CA-C-O 129.276 3.782 . . . . 0.0 110.974 172.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.755 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . . . -159.59 176.55 11.9 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 110.015 -3.266 . . . . 0.0 111.219 -176.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.835 ' CG2' ' CD2' ' A' ' 76' ' ' LEU 0.271 1.3 mp -149.55 160.75 4.99 Favored 'Isoleucine or valine' 0 C--O 1.272 2.274 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.743 -177.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.89 ' HA ' ' HA ' ' A' ' 66' ' ' ARG 0.699 . . -107.98 152.36 24.58 Favored 'General case' 0 CA--C 1.448 -2.955 2 O-C-N 115.554 -4.466 . . . . 0.0 102.705 -177.209 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.761 ' HB ' HG21 ' A' ' 64' ' ' VAL 0.619 1.5 mt -106.46 91.17 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.441 -3.221 1 CA-C-O 132.436 5.874 . . . . 0.0 101.871 -161.084 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.84 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -45.65 83.91 0.0 OUTLIER 'General case' 0 C--N 1.367 1.335 1 CA-C-N 106.099 -5.046 . . . . 0.0 107.29 177.735 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.725 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.06 -47.03 0.38 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 106.348 -2.701 . . . . 0.0 106.348 -177.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.762 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 12.1 m -124.64 -60.65 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 O-C-N 121.836 -0.802 . . . . 0.0 111.126 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.762 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 99.4 t -164.12 -103.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.406 0 O-C-N 120.123 -1.611 . . . . 0.0 113.312 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.89 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 1.0 OUTLIER -162.01 150.3 14.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.441 -0.787 . . . . 0.0 109.783 -175.002 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.831 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -146.06 -179.18 6.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.72 -1.238 . . . . 0.0 110.877 -176.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.655 ' HA ' ' HB1' ' A' ' 58' ' ' ALA . 12.2 t -85.89 120.89 36.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 116.761 -1.59 . . . . 0.0 110.299 176.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.795 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.24 106.42 0.28 Allowed Glycine 0 N--CA 1.497 2.705 0 CA-C-N 122.316 2.325 . . . . 0.0 110.674 177.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.825 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -90.24 -79.96 0.03 OUTLIER Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 120.81 -1.406 . . . . 0.0 108.787 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.825 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 48.3 Cg_endo -88.86 20.63 1.09 Allowed 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 117.312 -1.325 . . . . 0.0 108.969 177.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.61 63.88 1.09 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.017 -1.052 . . . . 0.0 112.227 176.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.705 ' C ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -69.81 -35.65 74.99 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.733 177.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.668 ' HA ' ' HB3' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -47.13 -44.09 21.32 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.092 0.949 . . . . 0.0 108.76 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.756 ' CD ' ' CE2' ' A' ' 67' ' ' PHE 0.274 0.0 OUTLIER -48.75 -26.02 2.13 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.182 -177.293 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.835 ' CD2' ' CG2' ' A' ' 59' ' ' ILE . 12.6 mt -72.48 -41.11 66.36 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.831 0.824 . . . . 0.0 109.629 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.758 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.29 -37.6 72.68 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 122.045 0.926 . . . . 0.0 110.287 179.173 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -74.43 -32.16 62.55 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.85 0.833 . . . . 0.0 110.354 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.713 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -73.77 -37.23 65.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.021 -1.049 . . . . 0.0 110.187 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.74 ' CD1' HD12 ' A' ' 5' ' ' ILE . 1.5 mp -60.33 -41.12 86.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 120.826 -1.172 . . . . 0.0 109.39 176.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.437 ' ND2' ' C ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -70.29 -32.76 70.69 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.764 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.632 0.1 OUTLIER -102.57 5.23 39.17 Favored 'General case' 0 CA--C 1.487 -1.445 0 C-N-CA 114.455 -2.898 . . . . 0.0 108.762 -176.61 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.761 ' HB2' ' O ' ' A' ' 62' ' ' ASN 0.299 0.2 OUTLIER -87.84 -55.84 3.59 Favored 'General case' 0 N--CA 1.489 1.498 1 O-C-N 115.611 -4.43 . . . . 0.0 107.568 164.472 . . . . . . . . 5 4 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.821 ' CE ' ' CE ' ' A' ' 27' ' ' LYS 0.27 0.0 OUTLIER -67.94 -18.37 64.74 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 119.963 1.256 . . . . 0.0 112.209 178.792 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.477 ' CD ' ' C ' ' A' ' 85' ' ' GLU . 3.2 tm-20 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 120.859 -1.151 . . . . 0.0 110.609 177.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.723 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.333 0.587 . . . . 0.0 110.153 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.733 ' CG2' ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -79.67 -89.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 110.236 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.764 HG21 ' CB ' ' A' ' 27' ' ' LYS . 48.3 t -90.95 111.13 23.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.462 -0.774 . . . . 0.0 110.595 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.819 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 3.9 m-20 -123.85 107.46 11.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.81 -1.181 . . . . 0.0 109.235 177.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.729 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.33 137.16 56.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.491 -0.756 . . . . 0.0 110.923 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.811 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 11.0 tt0 -128.4 110.67 12.55 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 118.896 -2.378 . . . . 0.0 108.966 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.786 ' CG2' ' CB ' ' A' ' 38' ' ' LYS 0.263 20.9 m -101.96 110.14 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -177.719 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.828 ' CE1' ' O ' ' A' ' 44' ' ' ASP . 5.4 t80 -117.98 83.65 2.04 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.05 -176.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.684 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -127.54 -45.92 1.47 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.157 0.503 . . . . 0.0 110.193 179.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.768 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 17.6 t 179.64 148.39 0.45 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.175 -0.953 . . . . 0.0 110.637 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.704 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 50.7 Cg_endo -86.16 -26.16 1.2 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.151 1.606 . . . . 0.0 110.704 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -78.79 12.26 2.21 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.12 -0.988 . . . . 0.0 109.985 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.547 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -157.22 -172.2 0.31 Allowed Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.415 -0.803 . . . . 0.0 110.68 178.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' A' ' 13' ' ' CYS . 51.6 Cg_endo -84.53 107.26 1.17 Allowed 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.125 1.592 . . . . 0.0 110.056 176.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.768 ' CE1' ' O ' ' A' ' 10' ' ' SER . 14.8 m-85 -49.45 -83.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.77 -1.206 . . . . 0.0 109.689 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.732 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . 34.6 m -155.86 47.21 0.3 Allowed Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.38 -0.825 . . . . 0.0 109.792 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.702 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . 47.1 Cg_endo -72.49 24.13 0.28 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 124.077 1.567 . . . . 0.0 111.111 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.464 ' H ' ' C ' ' A' ' 16' ' ' CYS . 6.5 tpt -110.07 -69.74 0.85 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.059 -1.026 . . . . 0.0 110.15 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.745 ' HB1' ' CB ' ' A' ' 73' ' ' ARG . . . -55.12 -19.84 8.55 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.247 -0.908 . . . . 0.0 109.343 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.702 ' CD1' ' HA ' ' A' ' 17' ' ' PRO . 13.0 pt -71.49 -40.34 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.405 -0.81 . . . . 0.0 109.15 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.69 ' N ' HG13 ' A' ' 20' ' ' ILE . 13.8 tp10 -53.67 -34.92 60.32 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.07 -42.9 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.441 -0.787 . . . . 0.0 109.017 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.806 ' CG1' ' HB ' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -67.77 -31.77 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.793 0.806 . . . . 0.0 109.515 178.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.721 ' OD1' ' CD ' ' A' ' 28' ' ' LYS . 3.2 t70 -72.53 -38.06 68.15 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 122.077 0.941 . . . . 0.0 108.466 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.43 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -60.42 -45.24 94.32 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.057 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.611 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -78.61 -39.43 37.31 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.591 -0.693 . . . . 0.0 110.853 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.764 ' CB ' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -73.1 -19.81 61.07 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 118.926 -1.11 . . . . 0.0 109.094 -178.717 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.721 ' CD ' ' OD1' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -70.76 -45.52 64.62 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 176.396 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.763 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -46.68 -39.57 11.65 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.975 0.893 . . . . 0.0 109.265 179.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.763 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -95.51 -58.2 2.19 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.75 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -94.03 82.43 0.99 Allowed Glycine 0 N--CA 1.499 2.867 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.565 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -37.43 -24.52 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 O-C-N 119.349 -2.265 . . . . 0.0 110.372 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.733 ' O ' ' CG2' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -82.83 151.99 25.82 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.579 -0.7 . . . . 0.0 111.845 177.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.725 ' CD1' ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -129.9 153.75 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.09 -1.631 . . . . 0.0 110.569 177.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.569 ' O ' ' O ' ' A' ' 3' ' ' VAL . 9.8 t0 -150.64 76.42 1.25 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.287 -0.883 . . . . 0.0 109.067 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.668 HG23 ' CG1' ' A' ' 5' ' ' ILE 0.254 51.5 t -94.4 122.47 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 120.697 -1.252 . . . . 0.0 109.014 -178.719 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.811 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.265 4.4 mt-10 -103.8 145.59 29.87 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -177.182 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.786 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -140.29 116.15 10.31 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.629 -174.107 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.725 ' CG2' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -116.56 166.04 11.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 O-C-N 120.575 -1.328 . . . . 0.0 111.269 -178.151 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.779 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -98.19 159.89 14.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.117 -0.989 . . . . 0.0 109.666 178.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.788 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -68.64 -37.44 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.077 -1.014 . . . . 0.0 112.19 -179.266 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.779 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.7 ptm -82.48 -3.81 56.42 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.055 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.665 HG12 ' HB3' ' A' ' 40' ' ' ASP . 13.6 p -112.24 -45.15 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 109.728 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.828 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 4.2 t70 -106.61 50.04 0.78 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.082 -1.011 . . . . 0.0 110.021 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.652 ' HA ' ' CZ ' ' A' ' 8' ' ' PHE 0.286 0.0 OUTLIER -64.01 -3.13 2.34 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 118.571 -1.252 . . . . 0.0 109.442 -177.929 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.714 ' O ' ' CG1' ' A' ' 49' ' ' ILE . 10.9 pt-20 -52.04 -20.87 2.68 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.491 -0.755 . . . . 0.0 110.088 175.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.929 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -50.36 -58.9 4.66 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.453 -1.405 . . . . 0.0 109.772 -178.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.929 ' N ' ' HG3' ' A' ' 47' ' ' LYS . . . -61.42 -5.7 1.87 Allowed 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.837 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.793 ' C ' ' O ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -32.44 -39.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 -175.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.832 ' OE1' ' O ' ' A' ' 47' ' ' LYS . 51.4 mp0 -51.34 -53.07 39.78 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.056 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.796 ' CZ ' ' CG2' ' A' ' 68' ' ' VAL . 2.4 p90 -124.5 -29.67 3.46 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.884 -1.135 . . . . 0.0 110.26 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.751 ' HA2' ' HB3' ' A' ' 48' ' ' ALA . . . 41.49 11.27 0.01 OUTLIER Glycine 0 N--CA 1.498 2.812 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.681 ' N ' ' O ' ' A' ' 51' ' ' TYR . 8.6 mt -81.13 -71.53 0.47 Allowed 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.52 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -102.4 59.3 0.81 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 -178.258 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.856 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.302 . . -103.67 116.2 31.9 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.24 -1.538 . . . . 0.0 109.905 -175.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.846 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 2.1 t -147.1 -66.93 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.472 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.846 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 53.1 Cg_endo -105.67 114.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.176 0 N-CA-C 109.586 -0.967 . . . . 0.0 109.586 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.74 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -161.28 175.57 12.14 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.296 1.046 . . . . 0.0 111.521 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.757 ' O ' ' HG3' ' A' ' 66' ' ' ARG 0.253 1.1 mp -141.67 144.67 25.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 108.995 179.383 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.804 ' HA ' ' HA ' ' A' ' 66' ' ' ARG 0.289 . . -84.93 147.51 26.7 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 -177.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.733 ' CG2' ' HB3' ' A' ' 79' ' ' ALA 0.39 0.7 OUTLIER -95.42 88.44 2.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 115.315 -2.554 . . . . 0.0 105.233 -175.126 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.819 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.2 OUTLIER -45.77 82.71 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 O-C-N 126.009 2.068 . . . . 0.0 109.094 177.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.818 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 161.99 -43.56 0.37 Allowed Glycine 0 C--N 1.288 -2.088 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.778 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.2 m -126.83 -59.37 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.882 -0.775 . . . . 0.0 111.052 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.778 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 59.8 t -164.04 -104.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 120.393 -1.442 . . . . 0.0 112.194 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.804 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 1.9 ttp180 -164.44 164.16 22.05 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.835 ' CZ ' ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -146.05 177.68 8.78 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.925 -1.11 . . . . 0.0 111.118 -177.306 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.796 ' CG2' ' CZ ' ' A' ' 51' ' ' TYR . 96.5 t -88.86 114.39 27.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.686 -0.634 . . . . 0.0 109.978 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.835 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.66 128.72 1.92 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 118.63 -1.748 . . . . 0.0 110.168 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.836 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -93.82 -82.72 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 121.098 -1.236 . . . . 0.0 108.032 177.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.836 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 52.8 Cg_endo -83.24 23.19 0.84 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 N-CA-C 108.541 -1.369 . . . . 0.0 108.541 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.553 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -99.59 61.45 1.17 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.445 -0.784 . . . . 0.0 111.334 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.745 ' CB ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -70.64 -26.75 63.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 0.0 109.926 178.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.611 ' HA ' ' HB3' ' A' ' 19' ' ' ALA . 1.6 tm-20 -50.56 -42.43 55.39 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.249 -0.907 . . . . 0.0 109.32 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.786 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -44.54 -34.81 2.25 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.371 -0.932 . . . . 0.0 108.819 179.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.748 ' CD1' ' CG2' ' A' ' 59' ' ' ILE . 7.4 mp -64.12 -42.76 96.71 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.801 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.74 -34.15 69.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 109.404 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.778 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -82.38 -30.57 30.17 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.481 -0.762 . . . . 0.0 110.405 178.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.733 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -73.37 -33.1 64.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.424 -0.798 . . . . 0.0 109.907 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.806 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -67.46 -42.37 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 0.0 108.756 178.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.43 -23.63 66.32 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.557 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.544 0.0 OUTLIER -100.94 -12.37 18.99 Favored 'General case' 0 C--O 1.198 -1.656 0 C-N-CA 115.357 -2.537 . . . . 0.0 108.838 -177.246 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.818 ' HB2' ' CA ' ' A' ' 63' ' ' GLY 0.251 0.0 OUTLIER -75.35 -54.04 7.73 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 119.517 -1.989 . . . . 0.0 108.454 165.215 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.737 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -79.14 -22.03 45.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.004 -1.06 . . . . 0.0 110.417 179.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 2.1 tp10 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.166 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.769 ' SD ' ' OE2' ' A' ' 83' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 121.925 0.869 . . . . 0.0 110.721 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.689 ' CG2' ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -79.89 -91.6 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 120.794 -1.191 . . . . 0.0 109.95 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.712 HG21 ' CB ' ' A' ' 27' ' ' LYS . 42.8 t -90.07 111.59 23.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.521 -0.737 . . . . 0.0 110.174 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.762 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 3.5 m-20 -124.1 107.43 11.26 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.786 -1.166 . . . . 0.0 108.679 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.713 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -123.09 139.55 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 122.059 -0.401 . . . . 0.0 110.58 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.776 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 12.8 tt0 -131.05 121.73 25.53 Favored 'General case' 0 C--N 1.284 -2.241 0 O-C-N 119.163 -2.21 . . . . 0.0 105.844 177.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 7' ' ' VAL . 26.8 m -113.07 106.23 20.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -176.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.847 ' CE1' ' HA ' ' A' ' 41' ' ' ILE 0.257 6.8 t80 -115.55 89.17 3.04 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.881 -178.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.627 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -131.24 -46.04 1.0 Allowed 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.21 -0.931 . . . . 0.0 109.739 178.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.688 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 17.6 t 179.08 147.05 0.39 Allowed Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.451 -0.781 . . . . 0.0 110.924 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.709 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 50.7 Cg_endo -85.44 -26.24 1.41 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 124.317 1.693 . . . . 0.0 110.868 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -77.25 6.41 6.75 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.203 -0.935 . . . . 0.0 110.01 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.51 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -152.2 -171.59 0.28 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.413 -0.804 . . . . 0.0 110.487 179.041 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 13' ' ' CYS . 47.0 Cg_endo -84.93 107.51 1.1 Allowed 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.419 1.413 . . . . 0.0 109.137 177.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.688 ' CE1' ' O ' ' A' ' 10' ' ' SER . 17.1 m-85 -49.85 -82.7 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.584 -0.697 . . . . 0.0 109.14 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.688 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . 35.4 m -155.61 46.65 0.28 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.314 -0.866 . . . . 0.0 109.544 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.678 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . 48.9 Cg_endo -72.34 24.36 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.973 1.512 . . . . 0.0 111.335 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.448 ' H ' ' C ' ' A' ' 16' ' ' CYS . 6.8 tpt -110.44 -69.09 0.89 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.155 -0.966 . . . . 0.0 110.489 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.674 ' HB1' ' CB ' ' A' ' 73' ' ' ARG . . . -55.98 -19.51 12.77 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.047 -1.033 . . . . 0.0 109.662 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.678 ' CD1' ' HA ' ' A' ' 17' ' ' PRO . 13.1 pt -70.72 -40.14 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.66 ' N ' HG13 ' A' ' 20' ' ' ILE . 13.8 tp10 -54.53 -35.87 63.66 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.0 t -68.17 -45.28 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.766 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -65.68 -35.53 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.639 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 2.4 t70 -67.95 -40.46 83.26 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.717 0.77 . . . . 0.0 109.124 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.433 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.6 OUTLIER -58.42 -46.95 85.45 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.371 0.605 . . . . 0.0 110.371 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.581 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.17 -38.68 51.26 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.935 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.712 ' CB ' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -74.82 -16.92 60.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.834 -1.166 . . . . 0.0 109.924 -179.005 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.639 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -73.31 -45.33 56.07 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 176.659 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.677 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -46.51 -37.06 7.37 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 122.057 0.932 . . . . 0.0 110.051 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.783 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -97.28 -68.09 0.82 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.783 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -84.35 88.97 1.56 Allowed Glycine 0 CA--C 1.544 1.86 0 C-N-CA 118.234 -1.936 . . . . 0.0 110.165 176.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.527 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -40.41 -27.7 0.05 Allowed 'General case' 0 N--CA 1.515 2.78 0 O-C-N 118.573 -2.722 . . . . 0.0 110.58 176.259 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.689 ' O ' ' CG2' ' A' ' 2' ' ' VAL . 0.2 OUTLIER -80.92 151.65 28.46 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.78 -0.575 . . . . 0.0 111.175 179.105 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.683 ' CD1' ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -130.2 154.8 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.79 -1.194 . . . . 0.0 110.064 179.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.619 ' O ' ' O ' ' A' ' 3' ' ' VAL . 14.2 t0 -151.74 80.8 1.28 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.64 HG23 ' CG1' ' A' ' 5' ' ' ILE . 46.5 t -97.44 129.42 47.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.776 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 5.0 mt-10 -108.86 146.02 34.38 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.706 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -142.38 112.24 6.87 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.457 1.122 . . . . 0.0 112.949 -175.231 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.691 ' CG2' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -112.21 164.31 8.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 112.218 -179.652 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.744 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -96.4 162.13 13.62 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.27 -0.894 . . . . 0.0 109.517 179.16 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.847 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -70.34 -39.49 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.116 -0.99 . . . . 0.0 111.73 -179.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.744 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.6 ptm -80.94 -2.6 48.36 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.929 -1.107 . . . . 0.0 110.972 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.621 HG12 ' HB3' ' A' ' 40' ' ' ASP . 14.9 p -113.23 -44.57 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.072 -1.018 . . . . 0.0 109.948 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.808 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 4.8 t70 -107.38 52.03 0.73 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.454 -0.779 . . . . 0.0 109.083 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.539 ' HA ' ' CZ ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -64.33 -1.98 1.96 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 119.797 -1.814 . . . . 0.0 110.34 -179.135 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.685 ' O ' ' CG1' ' A' ' 49' ' ' ILE . 10.6 pt-20 -56.16 -21.55 23.48 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.862 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -46.88 -64.3 0.81 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 119.909 -1.744 . . . . 0.0 108.708 179.395 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.857 ' N ' ' HG3' ' A' ' 47' ' ' LYS . . . -61.63 -6.01 2.25 Favored 'General case' 0 C--O 1.196 -1.72 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.864 -178.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.771 ' C ' ' O ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -25.92 -41.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 119.715 -1.866 . . . . 0.0 106.874 176.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.862 ' OE1' ' O ' ' A' ' 47' ' ' LYS . 52.7 mp0 -52.57 -52.45 55.02 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.136 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.822 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 3.0 p90 -123.81 -32.01 3.35 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.298 -0.876 . . . . 0.0 110.398 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.675 ' HA2' ' HB3' ' A' ' 48' ' ' ALA . . . 45.44 4.32 0.01 OUTLIER Glycine 1 N--CA 1.519 4.172 0 O-C-N 121.37 -0.832 . . . . 0.0 111.786 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.632 ' H ' ' C ' ' A' ' 51' ' ' TYR . 9.5 mt -75.24 -81.12 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 175.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.621 ' O ' ' HE2' ' A' ' 51' ' ' TYR 0.271 0.3 OUTLIER -93.64 66.65 3.82 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.3 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.818 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.275 . . -107.46 117.26 33.64 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 119.97 -1.707 . . . . 0.0 110.162 -178.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.773 ' HA ' ' CD1' ' A' ' 41' ' ' ILE . 2.1 t -148.89 -63.31 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.055 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.767 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 59.3 Cg_endo -109.12 117.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.186 0 N-CA-C 109.654 -0.941 . . . . 0.0 109.654 176.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.717 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -163.22 178.46 8.19 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.554 1.169 . . . . 0.0 111.625 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.881 ' O ' ' HG3' ' A' ' 66' ' ' ARG 0.258 1.1 mp -142.08 152.7 18.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.776 ' HA ' ' HA ' ' A' ' 66' ' ' ARG 0.263 . . -91.37 156.92 17.41 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.71 ' CG2' ' HB3' ' A' ' 79' ' ' ALA . 0.6 OUTLIER -102.38 91.83 2.12 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.449 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 -175.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.762 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -56.49 85.61 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -176.605 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.802 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 161.3 -42.83 0.4 Allowed Glycine 0 C--N 1.29 -1.986 0 N-CA-C 108.063 -2.015 . . . . 0.0 108.063 -177.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.695 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.7 m -126.69 -60.82 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.793 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.695 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 59.8 t -163.61 -99.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 120.758 -1.214 . . . . 0.0 112.565 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.881 ' HG3' ' O ' ' A' ' 59' ' ' ILE . 2.0 ttp180 -169.03 162.97 11.23 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.827 ' CZ ' ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -147.09 173.12 12.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.359 -0.838 . . . . 0.0 111.676 -177.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.733 ' CG2' ' CZ ' ' A' ' 51' ' ' TYR . 66.2 t -84.52 114.76 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.507 -0.746 . . . . 0.0 110.857 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.827 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.87 129.25 2.0 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 118.833 -1.651 . . . . 0.0 110.65 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.782 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -94.91 -81.41 0.02 OUTLIER Pre-proline 0 C--N 1.298 -1.641 0 O-C-N 121.177 -1.19 . . . . 0.0 107.946 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.782 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 56.7 Cg_endo -84.64 25.28 0.7 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 N-CA-C 108.831 -1.257 . . . . 0.0 108.831 176.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.544 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -101.53 59.65 0.88 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.426 0.632 . . . . 0.0 110.697 -179.209 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.782 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -69.3 -29.45 67.3 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.577 ' HA ' ' HB3' ' A' ' 19' ' ' ALA . 1.8 tm-20 -47.26 -42.55 20.8 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.197 -0.94 . . . . 0.0 110.471 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.738 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -45.44 -33.67 2.75 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.287 179.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.782 HD12 ' O ' ' A' ' 73' ' ' ARG . 7.4 mp -64.7 -43.54 93.14 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.766 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -56.1 -35.84 67.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.275 -0.891 . . . . 0.0 109.526 179.216 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.737 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -81.39 -33.17 32.43 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.103 0.478 . . . . 0.0 110.062 179.515 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.71 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -69.91 -34.34 73.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.386 -0.821 . . . . 0.0 111.178 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.761 ' CD1' ' O ' ' A' ' 4' ' ' ASN . 0.5 OUTLIER -68.12 -42.86 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.585 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -64.51 -18.16 64.55 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 175.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.534 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.347 0.0 OUTLIER -104.59 -5.48 21.42 Favored 'General case' 0 CA--C 1.477 -1.847 0 CA-C-O 124.702 2.192 . . . . 0.0 109.224 -179.433 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.802 ' HB2' ' CA ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -87.33 -55.55 3.76 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 101.846 -3.39 . . . . 0.0 101.846 176.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.7 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -78.47 -21.77 48.55 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.243 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 2.1 tp10 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.026 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.512 ' SD ' ' OD1' ' A' ' 4' ' ' ASN . 8.6 ttp . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.599 0.714 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.734 HG21 ' HA3' ' A' ' 31' ' ' GLY . 1.0 OUTLIER -80.38 -95.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.582 0.706 . . . . 0.0 110.291 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.716 HG21 ' HB2' ' A' ' 27' ' ' LYS . 53.0 t -90.12 114.9 28.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.416 -0.803 . . . . 0.0 109.397 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.814 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.257 2.8 t-20 -138.28 105.83 5.57 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 117.984 -1.486 . . . . 0.0 107.919 178.428 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.698 ' HA ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -121.35 139.55 48.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.235 -179.021 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 1.105 ' O ' HD23 ' A' ' 76' ' ' LEU . 6.8 tt0 -132.35 123.17 26.28 Favored 'General case' 0 C--N 1.285 -2.229 0 C-N-CA 116.438 -2.105 . . . . 0.0 105.911 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.743 HG23 ' HA ' ' A' ' 38' ' ' LYS . 3.0 m -113.21 104.18 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.926 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 4.8 t80 -113.5 96.26 5.79 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.28 -177.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.748 ' O ' ' O ' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -126.37 -69.02 0.79 Allowed 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.167 -0.958 . . . . 0.0 108.673 178.18 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.661 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 3.8 p 179.53 152.9 0.57 Allowed Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.273 -0.892 . . . . 0.0 110.793 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.602 ' HA ' ' OH ' ' A' ' 15' ' ' TYR . 50.8 Cg_endo -76.2 -27.33 8.23 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 124.437 1.756 . . . . 0.0 110.175 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.421 HG21 ' O ' ' A' ' 12' ' ' THR . 23.2 m -78.95 -17.0 56.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.678 -0.639 . . . . 0.0 109.949 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.55 179.94 0.99 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.885 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.628 ' O ' ' O ' ' A' ' 15' ' ' TYR . 51.3 Cg_endo -83.31 109.11 1.59 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 124.012 1.532 . . . . 0.0 109.817 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.661 ' CE1' ' O ' ' A' ' 10' ' ' SER . 4.7 m-85 -50.48 -117.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.661 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 18.7 m -155.16 40.32 0.13 Allowed Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.833 -1.167 . . . . 0.0 109.896 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.3 Cg_endo -75.76 30.3 0.38 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 O-C-N 123.653 1.344 . . . . 0.0 111.261 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.506 ' HE1' ' HD2' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -109.98 -59.49 1.92 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.969 -1.082 . . . . 0.0 110.713 -179.296 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.665 ' HB2' ' N ' ' A' ' 74' ' ' GLU . . . -56.19 -19.71 14.82 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.36 -0.838 . . . . 0.0 110.397 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.715 ' CG2' HD12 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -73.36 -39.93 55.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.486 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.579 ' N ' HD12 ' A' ' 20' ' ' ILE . 14.1 tt0 -53.73 -35.08 60.82 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -68.89 -50.89 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.717 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -61.66 -33.55 57.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.349 178.567 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.652 ' OD1' ' CG1' ' A' ' 34' ' ' ILE . 8.4 t0 -66.4 -41.05 89.86 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.726 0.774 . . . . 0.0 109.071 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.482 ' OE1' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -56.88 -48.39 78.28 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.626 0.726 . . . . 0.0 109.317 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.463 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.55 -39.09 47.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.842 -0.536 . . . . 0.0 110.439 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.716 ' HB2' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -72.01 -16.65 62.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.993 -1.067 . . . . 0.0 109.877 -178.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.699 ' CG ' HD12 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -73.56 -44.2 58.02 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.608 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.689 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -49.71 -34.23 18.23 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.909 0.861 . . . . 0.0 110.206 179.578 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.739 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -94.89 -69.06 0.77 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.739 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -83.82 84.86 1.55 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 118.788 -1.672 . . . . 0.0 110.101 177.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.579 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -36.69 -32.07 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.655 0 O-C-N 118.768 -2.607 . . . . 0.0 110.65 177.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.661 ' O ' HG11 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -78.51 151.4 32.57 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.492 178.405 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.699 HD12 ' CG ' ' A' ' 28' ' ' LYS . 0.4 OUTLIER -129.76 156.05 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.646 -1.283 . . . . 0.0 110.264 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.699 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 25.7 t0 -151.7 80.07 1.28 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.675 HG13 ' CD1' ' A' ' 20' ' ' ILE . 47.4 t -98.34 129.78 48.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.874 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 11.8 mm-40 -112.4 140.54 47.04 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.743 ' HA ' HG23 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -141.82 112.29 7.09 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -175.063 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.889 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -130.39 163.26 36.54 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 CA-C-O 121.77 0.795 . . . . 0.0 112.496 -179.103 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.645 ' OD1' ' N ' ' A' ' 43' ' ' VAL . 9.6 p-10 -98.69 178.82 4.87 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.277 -0.89 . . . . 0.0 111.379 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.926 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -69.28 -15.63 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.21 -0.931 . . . . 0.0 109.86 177.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.583 ' CG ' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -89.73 -14.61 34.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.814 -1.179 . . . . 0.0 111.981 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.645 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.9 p -113.95 -40.43 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.929 -1.107 . . . . 0.0 110.687 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.784 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 3.8 t70 -111.64 48.83 0.93 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.162 -0.961 . . . . 0.0 108.989 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.557 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 29.9 ttt180 -64.95 -1.08 1.81 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.08 -1.638 . . . . 0.0 109.814 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.754 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 25.8 mm-40 -60.48 -22.98 64.13 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.244 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.863 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 1.1 tptt -45.85 -65.35 0.56 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.274 -1.516 . . . . 0.0 109.147 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.863 ' N ' ' HG3' ' A' ' 47' ' ' LYS . . . -58.14 -11.18 2.36 Favored 'General case' 0 C--O 1.189 -2.083 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.264 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.778 ' C ' ' O ' ' A' ' 48' ' ' ALA . 2.7 pp -23.99 -40.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 119.933 -1.729 . . . . 0.0 107.262 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.835 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -56.02 -50.78 69.94 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 115.316 -0.857 . . . . 0.0 108.995 178.572 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.85 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 3.1 p90 -122.35 -34.24 3.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.729 -0.607 . . . . 0.0 110.292 178.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.677 ' HA2' ' CB ' ' A' ' 48' ' ' ALA . . . 47.64 3.13 0.01 OUTLIER Glycine 0 N--CA 1.514 3.837 0 O-C-N 121.192 -0.943 . . . . 0.0 111.291 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.673 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 4.1 mt -75.45 -80.49 0.09 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.702 ' O ' ' HE2' ' A' ' 51' ' ' TYR 0.255 26.3 mtp -92.02 67.49 5.14 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.863 177.397 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.814 ' CB ' ' HB1' ' A' ' 48' ' ' ALA 0.27 . . -108.9 110.7 22.09 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 120.448 -1.407 . . . . 0.0 109.048 -177.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.748 ' O ' ' O ' ' A' ' 9' ' ' THR . 1.0 OUTLIER -149.42 -54.52 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.877 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.942 -179.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.754 ' HB2' ' CA ' ' A' ' 70' ' ' ALA . 59.2 Cg_endo -110.91 106.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.169 1.089 . . . . 0.0 110.212 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.757 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -161.62 179.77 7.91 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.623 -1.626 . . . . 0.0 112.181 -176.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.874 ' O ' ' HG3' ' A' ' 66' ' ' ARG 0.264 0.3 OUTLIER -143.87 153.63 15.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 -179.808 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.827 ' HA ' ' HG3' ' A' ' 66' ' ' ARG 0.256 . . -92.16 153.78 19.11 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 101.82 -3.4 . . . . 0.0 101.82 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.765 ' CG2' ' HB3' ' A' ' 79' ' ' ALA 0.274 2.1 mt -102.66 93.6 2.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 -175.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.814 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.5 OUTLIER -55.6 84.76 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 113.12 -1.855 . . . . 0.0 107.145 -178.082 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.659 ' HA3' ' CB ' ' A' ' 83' ' ' GLU . . . 162.22 -45.8 0.36 Allowed Glycine 0 C--N 1.289 -2.038 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.686 HG21 ' HB ' ' A' ' 61' ' ' ILE . 4.6 m -123.33 -61.13 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.447 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.682 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 73.7 t -165.17 -101.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 O-C-N 120.909 -1.119 . . . . 0.0 112.235 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.874 ' HG3' ' O ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -156.01 166.24 34.05 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.539 -0.725 . . . . 0.0 109.747 -178.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.866 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -149.26 165.19 32.65 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.34 -0.85 . . . . 0.0 111.17 -178.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.513 HG23 ' CZ ' ' A' ' 51' ' ' TYR . 94.5 t -81.07 121.09 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.354 -0.841 . . . . 0.0 110.203 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.797 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -164.03 114.18 0.59 Allowed Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.182 -1.485 . . . . 0.0 110.549 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.787 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -91.65 -82.79 0.02 OUTLIER Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 121.578 -0.954 . . . . 0.0 109.034 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.787 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 57.0 Cg_endo -84.42 26.52 0.65 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 N-CA-C 107.982 -1.584 . . . . 0.0 107.982 176.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.671 ' CB ' ' OE2' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -112.26 83.42 1.8 Allowed 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.657 ' C ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -82.37 -44.04 16.64 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.665 ' N ' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -40.05 -30.91 0.1 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.158 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.735 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -49.7 -46.21 49.82 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.296 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 1.105 HD23 ' O ' ' A' ' 6' ' ' GLU . 27.3 mt -58.15 -43.54 87.4 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.717 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.27 -37.25 74.6 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.09 0.947 . . . . 0.0 109.857 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.64 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 3.2 tt0 -78.28 -30.94 48.76 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.348 -0.845 . . . . 0.0 110.298 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.765 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -70.15 -38.56 75.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.124 -0.985 . . . . 0.0 111.249 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.713 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -65.59 -42.59 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.327 -0.858 . . . . 0.0 108.726 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.64 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -68.46 -22.51 64.57 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.22 177.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.615 ' O ' ' OD1' ' A' ' 82' ' ' ASP 0.312 0.0 OUTLIER -102.1 2.42 37.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 118.232 -2.793 . . . . 0.0 107.114 -177.549 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.696 ' HG2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -94.14 -59.72 1.9 Allowed 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 103.321 -2.844 . . . . 0.0 103.321 176.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.621 ' HE3' ' CE ' ' A' ' 27' ' ' LYS . 3.3 ptt? -72.05 -17.96 61.98 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.601 177.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.533 ' OXT' ' HA ' ' A' ' 82' ' ' ASP . 3.2 mm-40 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.171 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.72 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.272 0.558 . . . . 0.0 110.184 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.724 ' CG2' ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -79.95 -90.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.359 -0.838 . . . . 0.0 109.848 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.749 HG21 ' CB ' ' A' ' 27' ' ' LYS . 48.6 t -89.6 110.89 22.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.446 -0.783 . . . . 0.0 111.124 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.846 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 3.9 m-20 -124.02 107.11 10.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.621 -1.3 . . . . 0.0 109.085 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.725 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.14 138.22 52.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 O-C-N 121.711 -0.618 . . . . 0.0 111.758 178.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.864 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 12.4 tt0 -130.64 119.78 22.96 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 115.614 -2.434 . . . . 0.0 106.079 177.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 7' ' ' VAL . 19.5 m -111.48 107.33 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -176.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.871 ' CE1' ' O ' ' A' ' 44' ' ' ASP . 6.3 t80 -116.74 87.28 2.66 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.958 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.675 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -130.14 -46.22 1.12 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.859 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.765 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 17.5 t 179.59 148.33 0.45 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.226 -0.921 . . . . 0.0 110.666 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.702 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 50.5 Cg_endo -86.16 -26.31 1.16 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.103 1.581 . . . . 0.0 110.649 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -78.06 8.34 4.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.12 -0.987 . . . . 0.0 109.9 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.551 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -152.38 -171.29 0.27 Allowed Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.62 178.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' A' ' 13' ' ' CYS . 45.2 Cg_endo -85.05 107.12 1.05 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.742 1.391 . . . . 0.0 109.579 176.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.765 ' CE1' ' O ' ' A' ' 10' ' ' SER . 14.8 m-85 -49.39 -82.79 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.053 -1.029 . . . . 0.0 109.753 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.733 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . 34.8 m -156.08 47.25 0.3 Allowed Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.36 -0.838 . . . . 0.0 109.724 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.702 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . 47.4 Cg_endo -72.62 24.17 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.031 1.543 . . . . 0.0 111.075 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.463 ' H ' ' C ' ' A' ' 16' ' ' CYS . 6.5 tpt -110.16 -69.66 0.85 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.126 -0.983 . . . . 0.0 110.247 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.746 ' HB1' ' CB ' ' A' ' 73' ' ' ARG . . . -55.02 -20.08 8.43 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.12 -0.988 . . . . 0.0 109.291 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.702 ' CD1' ' HA ' ' A' ' 17' ' ' PRO . 12.8 pt -71.28 -40.26 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.0 109.141 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.688 ' N ' HG13 ' A' ' 20' ' ' ILE . 13.8 tp10 -53.79 -35.51 61.44 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.1 t -68.89 -44.73 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.789 0.804 . . . . 0.0 108.872 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.815 ' CG1' ' HB ' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -65.84 -34.48 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 121.681 0.753 . . . . 0.0 109.435 178.29 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.722 ' OD1' ' CD ' ' A' ' 28' ' ' LYS . 2.6 t70 -69.55 -38.82 77.61 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.993 0.901 . . . . 0.0 109.57 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.428 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -59.79 -46.3 89.62 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.536 0.684 . . . . 0.0 110.044 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.618 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.74 -39.14 45.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.522 -0.736 . . . . 0.0 111.077 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.749 ' CB ' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -73.8 -18.04 61.01 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 118.886 -1.126 . . . . 0.0 109.373 -178.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.722 ' CD ' ' OD1' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -72.5 -45.14 60.84 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 176.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.75 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -47.25 -37.16 10.06 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.676 0.75 . . . . 0.0 109.816 179.304 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.817 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -96.99 -65.56 0.96 Allowed 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.414 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.817 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -85.18 84.71 1.59 Allowed Glycine 0 N--CA 1.511 3.66 0 C-N-CA 118.493 -1.813 . . . . 0.0 111.167 176.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.587 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -38.13 -26.73 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.397 0 CA-C-N 121.653 2.727 . . . . 0.0 110.813 177.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.741 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -80.09 151.41 29.87 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.514 -0.741 . . . . 0.0 112.459 177.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.741 ' CD1' ' O ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -130.24 154.02 39.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 120.242 -1.536 . . . . 0.0 109.829 178.47 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.629 ' O ' ' O ' ' A' ' 3' ' ' VAL . 10.4 t0 -151.26 79.18 1.29 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.676 HG23 ' CG1' ' A' ' 5' ' ' ILE 0.254 44.5 t -96.96 127.26 49.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -178.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.864 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 4.8 mt-10 -108.47 144.58 35.9 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -177.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.757 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.9 112.42 7.85 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -174.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.728 ' CG2' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -112.25 165.5 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.288 -0.965 . . . . 0.0 112.241 -178.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.782 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -97.26 161.38 13.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.134 -0.979 . . . . 0.0 109.739 178.827 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.82 ' CD1' ' HA ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -70.08 -38.2 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 111.735 -179.004 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.782 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.4 ptm -80.79 -4.26 53.95 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.251 -0.979 . . . . 0.0 111.245 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.659 HG12 ' HB3' ' A' ' 40' ' ' ASP . 14.1 p -112.34 -44.8 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.139 -0.976 . . . . 0.0 110.138 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.871 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 4.2 t70 -106.91 52.91 0.7 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.068 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.608 ' HA ' ' CZ ' ' A' ' 8' ' ' PHE 0.268 0.0 OUTLIER -66.36 -0.37 2.61 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.56 -1.256 . . . . 0.0 109.557 -178.548 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.723 ' O ' ' CG1' ' A' ' 49' ' ' ILE . 10.4 pt-20 -55.56 -21.45 17.19 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 177.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.938 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -47.43 -63.62 1.0 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 123.711 1.72 . . . . 0.0 109.057 -178.319 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.938 ' N ' ' HG3' ' A' ' 47' ' ' LYS . . . -57.75 -10.35 1.61 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.149 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.838 ' C ' ' O ' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -26.3 -41.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 O-C-N 119.57 -1.956 . . . . 0.0 107.1 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.896 ' OE1' ' O ' ' A' ' 47' ' ' LYS . 51.3 mp0 -51.95 -53.02 46.16 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.063 176.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.867 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.7 p90 -124.18 -30.0 3.51 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.224 -0.923 . . . . 0.0 110.152 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.762 ' HA2' ' HB3' ' A' ' 48' ' ' ALA . . . 43.31 5.73 0.01 OUTLIER Glycine 0 N--CA 1.506 3.309 0 CA-C-O 122.3 0.944 . . . . 0.0 111.576 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.722 ' N ' ' O ' ' A' ' 51' ' ' TYR . 9.3 mt -75.92 -77.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 175.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.619 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -96.11 64.38 2.34 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.116 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.9 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.295 . . -108.04 117.85 35.21 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 117.838 -1.545 . . . . 0.0 109.436 -177.14 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.846 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 2.1 t -148.64 -63.23 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.785 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.546 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.846 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.252 56.5 Cg_endo -110.67 116.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 N-CA-C 108.593 -1.349 . . . . 0.0 108.593 177.145 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.728 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -161.96 176.28 10.95 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.88 -177.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.88 ' O ' ' HG3' ' A' ' 66' ' ' ARG 0.25 1.1 mp -140.76 150.03 20.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.012 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.814 ' CB ' ' HD3' ' A' ' 66' ' ' ARG 0.308 . . -89.53 155.58 19.19 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 -178.177 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.748 ' CG2' ' HB3' ' A' ' 79' ' ' ALA 0.328 0.6 OUTLIER -101.94 93.16 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.918 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 -175.953 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.846 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -52.82 83.29 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 112.814 -1.994 . . . . 0.0 106.407 -178.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.825 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 162.47 -42.79 0.36 Allowed Glycine 0 C--N 1.293 -1.844 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.785 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.5 m -127.41 -59.3 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.808 -0.819 . . . . 0.0 111.035 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.785 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 58.7 t -164.32 -101.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 O-C-N 120.286 -1.509 . . . . 0.0 112.553 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.88 ' HG3' ' O ' ' A' ' 59' ' ' ILE . 2.0 ttp180 -166.91 163.73 16.17 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.835 ' CZ ' ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -147.01 175.17 10.89 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.013 -1.054 . . . . 0.0 111.218 -177.188 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.786 ' CG2' ' CZ ' ' A' ' 51' ' ' TYR . 70.3 t -85.58 113.88 24.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.11 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.835 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.08 129.95 2.19 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.063 -2.018 . . . . 0.0 109.903 177.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.846 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -94.84 -81.98 0.02 OUTLIER Pre-proline 0 C--N 1.294 -1.842 0 O-C-N 121.121 -1.223 . . . . 0.0 107.931 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.846 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 54.6 Cg_endo -84.34 24.53 0.75 Allowed 'Trans proline' 0 C--N 1.302 -1.904 0 N-CA-C 108.475 -1.394 . . . . 0.0 108.475 177.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.555 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -100.7 59.93 0.96 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.488 -0.757 . . . . 0.0 111.219 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.746 ' CB ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -68.87 -29.32 67.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.38 -0.825 . . . . 0.0 109.898 178.477 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.607 ' HA ' ' HB3' ' A' ' 19' ' ' ALA . 1.8 tm-20 -47.71 -43.5 26.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 109.932 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.786 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -44.38 -34.69 2.09 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.845 179.691 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.744 ' CD1' ' CG2' ' A' ' 59' ' ' ILE . 7.4 mp -64.22 -42.96 96.35 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.8 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.01 -35.31 69.09 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.901 0.858 . . . . 0.0 109.356 179.662 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.783 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -80.93 -32.87 34.45 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.498 -0.752 . . . . 0.0 110.38 178.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.748 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -70.95 -34.26 71.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.357 -0.839 . . . . 0.0 110.695 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.815 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -66.55 -43.33 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 122.179 0.99 . . . . 0.0 108.79 178.784 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -65.97 -19.51 65.89 Favored 'General case' 0 C--O 1.196 -1.759 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.042 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.62 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.421 0.0 OUTLIER -104.33 -5.74 21.49 Favored 'General case' 0 C--O 1.251 1.157 0 C-N-CA 116.525 -2.07 . . . . 0.0 105.898 -177.789 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.825 ' HB2' ' CA ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -85.69 -53.82 4.91 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 172.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.75 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -79.12 -21.28 46.81 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.372 -1.455 . . . . 0.0 110.567 -179.57 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 2.1 tp10 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.148 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.504 ' HB3' ' HE1' ' A' ' 1' ' ' MET . 8.0 ttp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.303 0.573 . . . . 0.0 110.249 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.749 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 0.9 OUTLIER -81.09 -92.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 0.0 110.412 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.731 HG22 ' CD1' ' A' ' 34' ' ' ILE . 55.4 t -92.2 108.83 20.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.703 -0.623 . . . . 0.0 110.644 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.81 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 2.4 t-20 -129.11 106.83 9.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.045 -1.034 . . . . 0.0 109.278 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.736 HD12 ' CG1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -124.22 138.17 54.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 O-C-N 121.785 -0.572 . . . . 0.0 110.44 178.669 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.783 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 5.3 tt0 -129.1 107.58 9.7 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 117.483 -1.687 . . . . 0.0 110.016 178.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.738 ' HA ' ' CG1' ' A' ' 59' ' ' ILE . 2.9 m -96.74 109.78 23.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 122.892 1.329 . . . . 0.0 107.663 -178.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.838 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 2.2 t80 -118.53 90.01 3.24 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.041 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.642 ' O ' ' O ' ' A' ' 56' ' ' VAL . 0.6 OUTLIER -120.92 -68.59 0.89 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.53 -0.731 . . . . 0.0 109.66 178.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.756 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 3.8 p 179.65 154.4 0.64 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 110.682 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.644 ' HD3' ' HB2' ' A' ' 40' ' ' ASP . 49.8 Cg_endo -76.94 -27.16 7.23 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.11 1.584 . . . . 0.0 110.468 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 12' ' ' THR . 21.3 m -79.58 -16.1 56.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.89 . . . . 0.0 109.924 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.455 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -125.0 -179.51 0.88 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 109.951 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.656 ' O ' ' O ' ' A' ' 15' ' ' TYR . 50.9 Cg_endo -83.5 108.07 1.46 Allowed 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.96 1.505 . . . . 0.0 110.319 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.756 ' CE1' ' O ' ' A' ' 10' ' ' SER . 4.8 m-85 -49.71 -117.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.932 . . . . 0.0 109.899 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.707 ' CB ' HD13 ' A' ' 59' ' ' ILE . 19.2 m -155.68 40.46 0.13 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.16 -0.962 . . . . 0.0 110.278 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.3 Cg_endo -76.0 30.07 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.961 1.506 . . . . 0.0 111.195 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.513 ' HE1' ' HD2' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -110.21 -59.37 1.95 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.816 -1.178 . . . . 0.0 110.671 -179.491 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.744 ' CB ' ' C ' ' A' ' 73' ' ' ARG . . . -55.92 -19.3 11.59 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.272 -0.893 . . . . 0.0 109.894 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.73 ' CG2' HG21 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -75.22 -39.48 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.832 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.649 ' N ' HD12 ' A' ' 20' ' ' ILE . 14.6 tt0 -53.35 -33.19 52.55 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.372 -0.83 . . . . 0.0 108.98 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -71.77 -46.94 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 109.385 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.752 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -66.14 -26.91 39.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.473 -0.767 . . . . 0.0 109.246 178.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.731 ' OD1' ' CG1' ' A' ' 34' ' ' ILE . 8.7 t0 -73.69 -39.25 64.51 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.53 ' OE1' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -57.92 -46.14 85.44 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.419 179.303 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.484 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -80.12 -40.21 27.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.553 -0.717 . . . . 0.0 110.061 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.765 ' N ' ' HE3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.42 -21.82 64.64 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.198 -179.165 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.712 ' CG ' HD12 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -69.61 -44.47 70.64 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.058 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.791 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -48.97 -39.65 27.37 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.869 0.843 . . . . 0.0 109.116 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.791 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.69 -57.98 2.68 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.382 -0.824 . . . . 0.0 109.23 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.734 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -95.92 77.87 0.79 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.258 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.568 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -32.9 -26.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 119.272 1.536 . . . . 0.0 110.726 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.734 ' N ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -85.3 153.13 22.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.535 -0.728 . . . . 0.0 110.889 177.779 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.731 ' CG1' ' OD1' ' A' ' 24' ' ' ASP . 0.4 OUTLIER -129.59 154.91 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.823 -1.173 . . . . 0.0 110.93 178.146 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.63 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 26.2 t0 -150.2 74.86 1.21 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.491 -0.756 . . . . 0.0 109.393 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.691 ' HA ' HG12 ' A' ' 5' ' ' ILE . 40.5 t -93.03 119.13 40.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 120.938 -1.101 . . . . 0.0 110.348 -178.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.783 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 11.6 mm-40 -102.44 141.68 34.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.958 -1.089 . . . . 0.0 108.919 -178.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.687 ' HA ' HG23 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -140.93 120.68 13.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.511 -0.743 . . . . 0.0 111.728 -174.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.704 ' CD1' ' HB2' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -137.38 169.81 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.035 -1.04 . . . . 0.0 110.109 -178.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.648 ' OD1' ' N ' ' A' ' 43' ' ' VAL . 7.9 p-10 -106.3 175.57 5.45 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.533 -0.729 . . . . 0.0 110.756 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.838 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -66.97 -9.58 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.975 -1.078 . . . . 0.0 111.09 177.23 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.642 ' HG2' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -95.25 -16.9 22.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 110.732 -179.695 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.648 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.7 p -112.69 -40.64 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.146 -0.971 . . . . 0.0 110.055 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.796 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 3.1 t70 -111.06 45.57 1.16 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.863 . . . . 0.0 110.361 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.618 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.272 30.9 ttt180 -62.69 -3.76 1.68 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.528 -178.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.764 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 21.8 mm-40 -57.54 -18.68 20.51 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.347 -0.846 . . . . 0.0 110.63 175.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.887 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -51.86 -56.74 12.2 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.381 1.086 . . . . 0.0 110.292 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.887 ' N ' ' HG3' ' A' ' 47' ' ' LYS . . . -62.35 -5.39 2.4 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.255 176.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.789 ' CD1' ' N ' ' A' ' 50' ' ' GLU . 2.4 pp -34.58 -39.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 -174.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.789 ' N ' ' CD1' ' A' ' 49' ' ' ILE . 1.0 OUTLIER -53.15 -51.49 61.82 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.038 177.592 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.827 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.1 p90 -123.56 -29.77 3.71 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.921 -1.112 . . . . 0.0 110.495 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.764 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 41.41 12.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.236 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.736 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.1 mt -84.09 -67.32 0.8 Allowed 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 122.767 1.27 . . . . 0.0 107.826 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.511 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 25.7 mtp -103.57 57.15 0.74 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.465 -1.243 . . . . 0.0 107.815 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.842 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.266 . . -99.75 108.34 20.64 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.863 1.316 . . . . 0.0 111.011 -176.173 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.811 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 0.9 OUTLIER -146.81 -59.65 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.29 -179.565 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.811 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 45.1 Cg_endo -103.1 105.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.257 1.135 . . . . 0.0 110.447 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.774 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -160.59 -178.04 6.61 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.963 0.887 . . . . 0.0 111.632 -176.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.803 ' CG2' ' CD2' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -149.11 141.56 17.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.781 -0.574 . . . . 0.0 109.66 -179.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.781 ' HA ' ' HA ' ' A' ' 66' ' ' ARG 0.253 . . -82.0 137.86 35.03 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 117.207 -1.797 . . . . 0.0 107.021 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.759 ' HB ' HG21 ' A' ' 64' ' ' VAL 0.395 1.7 mt -90.0 85.85 2.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 125.433 2.539 . . . . 0.0 106.266 -174.457 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.81 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.7 OUTLIER -43.55 83.34 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 112.231 -2.259 . . . . 0.0 108.439 177.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.731 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.02 -47.57 0.35 Allowed Glycine 0 N--CA 1.483 1.782 0 N-CA-C 106.783 -2.527 . . . . 0.0 106.783 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.759 HG21 ' HB ' ' A' ' 61' ' ' ILE . 4.2 m -123.15 -60.03 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.745 -0.856 . . . . 0.0 111.232 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.745 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 75.6 t -164.78 -104.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 120.454 -1.404 . . . . 0.0 112.001 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.781 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -154.46 165.24 37.02 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.638 -0.664 . . . . 0.0 109.956 -179.065 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.832 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -145.64 172.98 12.48 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.035 -1.041 . . . . 0.0 110.94 -179.351 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.535 HG23 ' OH ' ' A' ' 51' ' ' TYR . 77.1 t -88.67 120.04 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.536 -0.727 . . . . 0.0 109.286 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.815 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.18 114.33 0.6 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.198 -1.477 . . . . 0.0 110.66 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.828 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -91.91 -83.75 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 120.848 -1.383 . . . . 0.0 108.79 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.828 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 48.3 Cg_endo -81.61 19.24 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 N-CA-C 108.145 -1.521 . . . . 0.0 108.145 177.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.748 ' CB ' ' OE2' ' A' ' 75' ' ' GLU 0.278 0.6 OUTLIER -105.68 83.09 1.88 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 117.993 -1.483 . . . . 0.0 109.2 179.699 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.744 ' C ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -81.39 -41.11 22.43 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.31 177.425 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.73 ' HA ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -43.26 -29.33 0.39 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.001 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.809 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -49.69 -45.98 49.49 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.508 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.803 ' CD2' ' CG2' ' A' ' 59' ' ' ILE . 28.8 mt -58.82 -42.49 89.31 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.423 -0.798 . . . . 0.0 109.188 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.752 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.54 -34.88 73.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.494 -0.754 . . . . 0.0 110.209 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.633 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 3.4 tt0 -80.95 -26.78 36.39 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.697 -0.627 . . . . 0.0 110.358 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.725 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -75.22 -37.4 61.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -0.944 . . . . 0.0 109.773 -178.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.752 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -65.9 -39.37 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.043 -1.036 . . . . 0.0 109.344 178.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.633 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -72.93 -28.55 62.51 Favored 'General case' 0 C--O 1.258 1.552 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.546 ' HA ' ' OXT' ' A' ' 85' ' ' GLU 0.556 0.0 OUTLIER -95.6 -8.85 33.8 Favored 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 114.2 -3.0 . . . . 0.0 109.582 -178.186 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.716 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -71.35 -61.51 1.74 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 118.414 -2.679 . . . . 0.0 111.432 162.619 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.726 ' HE3' ' NZ ' ' A' ' 27' ' ' LYS . 3.5 ptt? -71.55 -20.64 62.0 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.499 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.546 ' OXT' ' HA ' ' A' ' 82' ' ' ASP . 3.2 mm-40 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.227 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.504 ' HB3' ' HE1' ' A' ' 1' ' ' MET . 7.9 ttp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.25 0.548 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.751 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 0.9 OUTLIER -81.05 -94.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 109.854 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.732 HG21 ' CB ' ' A' ' 27' ' ' LYS . 53.3 t -89.6 111.64 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.568 -0.707 . . . . 0.0 110.296 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.791 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.349 2.4 t-20 -135.4 107.57 7.21 Favored 'General case' 0 C--O 1.189 -2.123 0 CA-C-O 125.404 2.526 . . . . 0.0 107.24 177.301 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.735 HD12 ' CG1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -118.19 136.72 54.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 116.352 -1.785 . . . . 0.0 111.921 179.568 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.763 ' CG ' ' HB2' ' A' ' 60' ' ' ALA 0.48 5.8 tt0 -133.77 124.38 26.5 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 127.31 3.433 . . . . 0.0 101.919 174.069 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.723 ' HA ' ' CG1' ' A' ' 59' ' ' ILE 0.397 10.3 m -113.78 110.42 32.09 Favored 'Isoleucine or valine' 0 C--O 1.168 -3.208 0 O-C-N 116.613 -3.804 . . . . 0.0 101.483 -177.034 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.841 ' CE1' ' HA ' ' A' ' 41' ' ' ILE 0.306 1.7 t80 -117.28 96.68 5.53 Favored 'General case' 0 C--N 1.377 1.776 0 CA-C-N 110.611 -2.995 . . . . 0.0 108.663 -178.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.616 ' O ' ' O ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -124.53 -69.22 0.81 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.89 -1.131 . . . . 0.0 108.653 178.687 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.757 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 3.8 p 179.6 154.35 0.63 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.967 . . . . 0.0 110.713 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' A' ' 40' ' ' ASP . 50.1 Cg_endo -76.96 -27.06 7.29 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.146 1.603 . . . . 0.0 110.458 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 12' ' ' THR . 21.3 m -79.71 -16.04 56.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.873 . . . . 0.0 109.954 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.455 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -125.01 -179.44 0.86 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.347 -0.846 . . . . 0.0 109.915 179.691 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.654 ' O ' ' O ' ' A' ' 15' ' ' TYR . 52.0 Cg_endo -83.58 108.06 1.44 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.963 1.507 . . . . 0.0 110.367 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.757 ' CE1' ' O ' ' A' ' 10' ' ' SER . 5.0 m-85 -49.77 -117.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 109.788 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.708 ' CB ' HD13 ' A' ' 59' ' ' ILE . 19.2 m -155.54 40.27 0.13 Allowed Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.113 -0.992 . . . . 0.0 110.348 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.3 Cg_endo -75.98 30.12 0.39 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.926 1.487 . . . . 0.0 111.183 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.513 ' HE1' ' HD2' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -110.14 -59.32 1.95 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.901 -1.124 . . . . 0.0 110.728 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.736 ' HB2' ' N ' ' A' ' 74' ' ' GLU . . . -56.42 -18.5 11.37 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.063 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.73 ' CG2' HG21 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -75.72 -39.15 38.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.851 179.572 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.65 ' N ' HD12 ' A' ' 20' ' ' ILE . 14.5 tt0 -52.98 -34.25 55.19 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 108.757 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -70.73 -49.11 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.425 -0.797 . . . . 0.0 109.271 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.749 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -58.95 -35.55 57.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-O 122.707 1.241 . . . . 0.0 109.305 176.529 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.73 ' OD1' ' CG1' ' A' ' 34' ' ' ILE . 7.8 t0 -68.42 -41.57 80.18 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 122.848 1.308 . . . . 0.0 108.918 -178.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.53 ' OE1' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -56.19 -48.03 77.18 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.464 179.483 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.487 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -78.15 -39.68 40.24 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.854 0.835 . . . . 0.0 111.188 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.75 ' CA ' ' HE3' ' A' ' 27' ' ' LYS 0.288 0.0 OUTLIER -72.59 -16.13 61.74 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 117.17 -1.812 . . . . 0.0 109.013 -178.193 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.712 ' CG ' HD12 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -72.43 -43.25 64.08 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.736 ' HG3' ' N ' ' A' ' 30' ' ' PHE 0.287 0.0 OUTLIER -52.54 -32.59 41.41 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.765 179.794 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.751 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -94.42 -69.46 0.75 Allowed 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 102.954 -2.98 . . . . 0.0 102.954 -179.275 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.746 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -75.29 65.8 2.32 Favored Glycine 0 C--N 1.27 -3.111 1 CA-C-O 113.33 -4.039 . . . . 0.0 117.337 176.161 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.585 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -31.06 -29.61 0.01 OUTLIER 'General case' 0 C--N 1.254 -3.563 1 CA-C-N 124.806 4.303 . . . . 0.0 110.286 -175.408 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.693 ' N ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -74.73 149.53 39.78 Favored 'General case' 0 C--N 1.278 -2.52 0 O-C-N 120.132 -1.605 . . . . 0.0 113.903 174.076 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.731 ' CD1' HG22 ' A' ' 3' ' ' VAL 0.262 0.4 OUTLIER -131.05 156.42 42.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 120.854 1.661 . . . . 0.0 110.589 174.793 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.608 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 26.2 t0 -151.22 79.19 1.3 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.693 ' HA ' HG12 ' A' ' 5' ' ' ILE 0.351 61.9 t -100.63 127.41 53.75 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.94 0 CA-C-O 125.916 2.77 . . . . 0.0 104.764 -177.65 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.736 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.424 9.2 mm-40 -111.91 146.17 38.24 Favored 'General case' 0 C--O 1.183 -2.418 0 C-N-CA 113.685 -3.206 . . . . 0.0 103.99 -176.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.684 ' HA ' HG23 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.45 107.47 5.72 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 115.221 -2.323 . . . . 0.0 115.777 -170.036 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.705 ' CD1' ' HB2' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -131.72 166.87 27.72 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.556 0 CA-C-N 122.949 2.613 . . . . 0.0 112.311 -179.283 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.641 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 4.0 p-10 -98.27 175.64 6.0 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.57 -1.331 . . . . 0.0 113.464 177.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.841 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -64.63 -13.94 15.25 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.065 0 O-C-N 121.066 -1.021 . . . . 0.0 111.317 174.723 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.641 ' HG2' ' OD2' ' A' ' 40' ' ' ASP 0.379 0.0 OUTLIER -100.88 -5.07 26.62 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 115.276 -2.57 . . . . 0.0 110.538 -177.251 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.64 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 7.5 p -117.13 -41.11 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.967 -1.083 . . . . 0.0 109.048 177.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.786 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 3.1 t70 -111.56 46.69 1.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 110.254 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.6 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.378 30.3 ttt180 -66.2 -0.08 2.32 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 116.518 -2.073 . . . . 0.0 108.922 -177.754 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.757 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 18.8 mm-40 -53.12 -26.71 17.55 Favored 'General case' 0 C--N 1.287 -2.142 0 O-C-N 120.785 -1.197 . . . . 0.0 109.831 172.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.891 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -48.28 -61.0 2.22 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.571 -1.331 . . . . 0.0 109.343 -176.091 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.891 ' N ' ' HG3' ' A' ' 47' ' ' LYS 0.359 . . -54.3 -12.55 0.68 Allowed 'General case' 0 C--N 1.266 -3.054 0 C-N-CA 125.677 1.591 . . . . 0.0 112.053 176.101 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.793 ' CD1' ' N ' ' A' ' 50' ' ' GLU . 2.5 pp -33.13 -39.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.79 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -172.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.793 ' N ' ' CD1' ' A' ' 49' ' ' ILE . 1.0 OUTLIER -53.13 -51.6 61.42 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.251 176.522 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.835 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.1 p90 -123.44 -29.51 3.78 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.049 -1.032 . . . . 0.0 110.582 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.793 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.41 16.37 0.01 OUTLIER Glycine 0 N--CA 1.487 2.092 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.736 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.4 mt -87.55 -75.01 0.42 Allowed 'General case' 0 C--N 1.262 -3.197 0 N-CA-C 103.136 -2.912 . . . . 0.0 103.136 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.479 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 26.7 mtp -98.95 65.01 1.46 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.804 -1.544 . . . . 0.0 108.46 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.824 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.451 . . -110.98 112.48 24.33 Favored 'General case' 0 C--O 1.168 -3.184 1 CA-C-O 128.612 4.053 . . . . 0.0 105.685 -175.308 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.803 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 0.9 OUTLIER -148.32 -51.33 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.511 0 CA-C-N 110.476 -3.056 . . . . 0.0 112.15 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.803 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.473 19.3 Cg_endo -117.67 111.82 0.01 OUTLIER 'Trans proline' 0 C--O 1.148 -3.988 1 CA-C-O 130.685 4.369 . . . . 0.0 103.704 -179.756 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.76 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -160.88 178.32 9.53 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 109.578 -3.465 . . . . 0.0 111.405 -174.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.802 ' CG2' ' CD2' ' A' ' 76' ' ' LEU 0.26 0.3 OUTLIER -144.94 151.28 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.746 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.763 ' HB2' ' CG ' ' A' ' 6' ' ' GLU 0.503 . . -96.02 147.66 23.47 Favored 'General case' 0 C--O 1.187 -2.193 2 N-CA-C 98.196 -4.742 . . . . 0.0 98.196 -178.257 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.754 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.654 2.2 mt -99.68 96.55 5.02 Favored 'Isoleucine or valine' 0 C--N 1.408 3.112 3 C-N-CA 108.539 -5.264 . . . . 0.0 98.644 -170.689 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.791 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.6 OUTLIER -50.29 85.6 0.0 OUTLIER 'General case' 0 C--N 1.379 1.851 1 CA-C-N 107.205 -4.543 . . . . 0.0 107.516 177.499 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.754 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.95 -47.87 0.35 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 106.734 -2.546 . . . . 0.0 106.734 -178.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.754 HG21 ' HB ' ' A' ' 61' ' ' ILE . 4.2 m -122.94 -59.86 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.72 -0.871 . . . . 0.0 111.468 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.742 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 76.1 t -164.48 -104.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.264 -1.523 . . . . 0.0 111.827 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.758 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -153.89 166.11 33.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.703 -0.623 . . . . 0.0 110.111 -179.067 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.852 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -147.64 169.51 19.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.029 -1.044 . . . . 0.0 110.878 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.535 HG23 ' OH ' ' A' ' 51' ' ' TYR . 97.2 t -81.74 118.79 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.874 -1.141 . . . . 0.0 111.667 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.812 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.77 114.13 0.59 Allowed Glycine 0 C--N 1.281 -2.504 0 CA-C-N 120.595 1.543 . . . . 0.0 110.698 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.824 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -92.03 -83.08 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.754 0 O-C-N 120.742 -1.446 . . . . 0.0 109.04 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.824 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 43.1 Cg_endo -86.0 28.89 0.54 Allowed 'Trans proline' 0 C--N 1.318 -1.041 0 N-CA-C 107.894 -1.618 . . . . 0.0 107.894 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.746 ' CB ' ' OE2' ' A' ' 75' ' ' GLU 0.644 0.4 OUTLIER -120.76 95.02 4.54 Favored 'General case' 0 C--O 1.164 -3.427 2 C-N-CA 108.815 -5.154 . . . . 0.0 100.585 179.121 . . . . . . . . 5 4 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.727 ' C ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -83.15 -43.89 15.68 Favored 'General case' 0 C--N 1.371 1.537 1 CA-C-N 108.204 -4.089 . . . . 0.0 109.057 174.7 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.736 ' N ' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -39.85 -32.33 0.15 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.811 -1.18 . . . . 0.0 108.504 178.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.807 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -49.36 -45.43 45.73 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.173 -179.272 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.802 ' CD2' ' CG2' ' A' ' 59' ' ' ILE . 29.3 mt -58.55 -42.99 89.14 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.786 0.803 . . . . 0.0 109.36 178.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.749 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.68 -36.85 74.84 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.261 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.626 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 3.6 tt0 -74.05 -35.01 64.27 Favored 'General case' 0 C--N 1.286 -2.165 0 O-C-N 120.775 -1.203 . . . . 0.0 110.624 178.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.72 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -72.6 -37.6 68.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.821 -1.175 . . . . 0.0 110.222 -175.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.754 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -63.5 -42.87 97.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 121.056 -1.027 . . . . 0.0 109.168 178.047 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.626 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -70.48 -25.84 63.35 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 120.776 -1.203 . . . . 0.0 109.843 178.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.457 ' HA ' ' OXT' ' A' ' 85' ' ' GLU 1.012 0.0 OUTLIER -108.61 15.03 24.09 Favored 'General case' 0 C--O 1.302 3.828 2 C-N-CA 104.258 -6.977 . . . . 0.0 101.538 -176.267 . . . . . . . . 5 4 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.717 ' CB ' ' HA3' ' A' ' 63' ' ' GLY 0.258 0.0 OUTLIER -89.52 -59.45 2.21 Favored 'General case' 0 C--N 1.314 -0.966 1 O-C-N 113.892 -5.505 . . . . 0.0 104.468 164.096 . . . . . . . . 5 4 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.728 ' HE3' ' NZ ' ' A' ' 27' ' ' LYS 0.26 3.6 ptt? -73.42 -16.18 61.33 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.599 -1.24 . . . . 0.0 111.091 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.457 ' OXT' ' HA ' ' A' ' 82' ' ' ASP . 3.1 mm-40 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.81 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.564 ' SD ' ' OE1' ' A' ' 83' ' ' GLU . 2.8 ttp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.308 0.575 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.703 ' CG2' HG21 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -89.65 -91.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.401 -0.812 . . . . 0.0 110.438 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.74 HG22 ' HB2' ' A' ' 27' ' ' LYS . 79.0 t -91.13 111.93 24.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 O-C-N 121.811 -0.556 . . . . 0.0 110.665 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.806 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 1.9 m-80 -126.73 113.64 16.93 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.732 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -133.47 133.74 57.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.396 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.731 ' HA ' ' O ' ' A' ' 37' ' ' GLU 0.277 0.0 OUTLIER -127.93 110.58 12.69 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 116.755 -1.978 . . . . 0.0 109.454 176.472 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 7' ' ' VAL 0.255 33.3 m -99.51 100.64 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 124.107 1.908 . . . . 0.0 108.388 -177.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.829 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -116.98 95.0 4.8 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.617 -178.086 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.66 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 38.2 m -120.5 -79.78 0.61 Allowed 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.073 -1.017 . . . . 0.0 109.648 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.62 ' C ' ' OD1' ' A' ' 40' ' ' ASP . 0.2 OUTLIER 179.55 155.53 0.66 Allowed Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.853 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.689 ' N ' ' OD2' ' A' ' 40' ' ' ASP . 47.4 Cg_endo -73.95 -12.62 23.9 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 124.142 1.601 . . . . 0.0 110.465 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.45 0.75 28.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.066 -1.021 . . . . 0.0 109.86 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.547 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -157.47 -170.25 0.24 Allowed Pre-proline 0 N--CA 1.485 1.317 0 O-C-N 121.625 -0.672 . . . . 0.0 110.132 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.643 ' O ' ' O ' ' A' ' 15' ' ' TYR . 55.2 Cg_endo -84.6 118.02 2.12 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.751 1.395 . . . . 0.0 110.735 175.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.752 ' CE1' ' OD1' ' A' ' 40' ' ' ASP . 2.7 m-85 -49.54 -113.94 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.381 -0.825 . . . . 0.0 109.773 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.671 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 33.4 m -155.0 39.91 0.13 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.163 -0.961 . . . . 0.0 110.329 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.671 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.4 Cg_endo -75.75 27.17 0.39 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.715 1.376 . . . . 0.0 111.192 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.739 ' CG ' ' CD ' ' A' ' 73' ' ' ARG . 0.1 OUTLIER -110.11 -63.22 1.4 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.947 -1.095 . . . . 0.0 110.583 -179.275 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.739 ' CB ' ' C ' ' A' ' 73' ' ' ARG . . . -54.27 -21.43 9.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.284 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.687 ' HB ' ' CD1' ' A' ' 5' ' ' ILE . 2.6 pt -66.77 -42.19 88.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.489 0.662 . . . . 0.0 109.228 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.567 ' N ' ' CG1' ' A' ' 20' ' ' ILE . 2.5 tm-20 -54.16 -33.94 59.21 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.66 -41.42 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.785 0.802 . . . . 0.0 109.077 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.768 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -68.59 -30.06 46.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 121.667 0.746 . . . . 0.0 109.362 178.228 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.702 ' OD1' ' CG1' ' A' ' 34' ' ' ILE . 5.9 t70 -73.98 -38.09 64.26 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -45.55 88.3 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.699 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.501 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.65 -40.5 29.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.561 -0.712 . . . . 0.0 110.173 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.804 ' CE ' ' CE ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -70.78 -20.54 62.59 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.943 -1.103 . . . . 0.0 109.567 -178.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.726 ' CG ' HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -69.07 -47.88 64.17 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 176.261 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.744 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -45.64 -41.29 10.07 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.94 0.876 . . . . 0.0 109.21 179.02 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.744 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -90.63 -61.32 1.7 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 121.358 -0.839 . . . . 0.0 108.946 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.694 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -94.11 78.78 0.98 Allowed Glycine 0 N--CA 1.485 1.931 0 CA-C-O 118.805 -0.997 . . . . 0.0 111.413 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.538 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -35.58 -24.05 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 120.418 2.109 . . . . 0.0 111.164 -179.628 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.694 ' N ' ' O ' ' A' ' 31' ' ' GLY . 6.6 mtpt -83.52 154.52 23.81 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.699 -0.625 . . . . 0.0 111.44 176.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.726 ' CD1' HG23 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -127.97 157.41 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 118.839 -1.144 . . . . 0.0 111.072 177.449 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 7.2 t70 -150.38 64.31 0.95 Allowed 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.688 HG13 ' CG1' ' A' ' 5' ' ' ILE . 31.3 t -92.66 117.84 36.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 118.799 -1.161 . . . . 0.0 109.824 -178.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.731 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.273 3.1 mt-10 -101.56 147.57 26.25 Favored 'General case' 0 C--O 1.195 -1.793 0 CA-C-O 122.474 1.13 . . . . 0.0 108.728 -177.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.655 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.74 119.25 13.05 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.172 -0.955 . . . . 0.0 112.019 -173.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.69 ' CD1' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -130.4 178.41 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -0.962 . . . . 0.0 110.667 -178.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.752 ' OD1' ' CE1' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -109.28 179.55 4.12 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.637 -0.664 . . . . 0.0 111.401 176.023 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.829 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -61.76 -54.0 40.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.128 -0.982 . . . . 0.0 112.104 173.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.702 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 5.2 ptp -71.71 0.28 9.2 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.427 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.733 ' CG1' ' CB ' ' A' ' 40' ' ' ASP . 1.1 m -111.9 -45.19 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 109.814 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.76 ' OD2' ' CG ' ' A' ' 8' ' ' PHE . 9.7 t70 -114.54 45.55 1.53 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.339 -0.851 . . . . 0.0 109.839 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.5 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.288 0.0 OUTLIER -67.99 -5.57 17.95 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.41 -1.316 . . . . 0.0 110.225 -178.411 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.765 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 4.4 mt-10 -56.82 -18.93 14.71 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.312 -0.868 . . . . 0.0 110.471 173.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.821 ' HB3' ' CE2' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -49.92 -61.17 2.29 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 122.891 1.329 . . . . 0.0 110.306 -178.272 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.809 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -58.62 -4.93 0.48 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.84 177.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.765 ' CG2' ' O ' ' A' ' 46' ' ' GLU . 2.2 pp -35.99 -41.62 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 -173.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.722 ' N ' ' CD1' ' A' ' 49' ' ' ILE . 0.9 OUTLIER -50.43 -52.95 33.24 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.897 177.059 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.772 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 45.6 p90 -118.93 -36.86 3.33 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.088 -1.007 . . . . 0.0 110.354 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.766 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.96 14.0 0.01 OUTLIER Glycine 0 N--CA 1.495 2.584 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.693 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 42.7 mt -82.69 -63.3 1.4 Allowed 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 123.231 1.491 . . . . 0.0 109.256 177.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.442 ' C ' ' HE2' ' A' ' 51' ' ' TYR . 19.3 mtm -109.55 53.88 0.68 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.969 -1.468 . . . . 0.0 109.516 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.809 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.311 . . -103.52 124.44 48.77 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 117.821 -1.552 . . . . 0.0 111.117 -173.759 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.795 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -147.92 -60.74 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.408 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.656 -177.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.795 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.267 45.1 Cg_endo -108.14 113.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 CA-C-O 123.446 1.352 . . . . 0.0 110.334 177.814 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.704 ' CB ' ' O ' ' A' ' 67' ' ' PHE . . . -161.39 178.6 9.01 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.223 -175.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.774 ' CG2' ' CD1' ' A' ' 76' ' ' LEU . 1.2 mp -147.47 143.8 19.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.771 -0.58 . . . . 0.0 109.762 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.764 ' HA ' ' HA ' ' A' ' 66' ' ' ARG 0.285 . . -82.74 143.07 31.14 Favored 'General case' 0 CA--C 1.487 -1.446 0 C-N-CA 115.912 -2.315 . . . . 0.0 109.092 -179.107 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.752 ' HB ' HG21 ' A' ' 64' ' ' VAL 0.404 1.0 OUTLIER -91.09 87.5 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.731 0 CA-C-O 125.493 2.568 . . . . 0.0 107.478 -174.319 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.806 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.6 OUTLIER -42.28 80.61 0.0 OUTLIER 'General case' 0 C--O 1.2 -1.502 0 CA-C-N 112.601 -2.09 . . . . 0.0 109.618 177.296 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.754 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 161.33 -48.34 0.37 Allowed Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.56 -2.216 . . . . 0.0 107.56 -177.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.752 HG21 ' HB ' ' A' ' 61' ' ' ILE . 4.9 m -120.16 -59.73 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.763 -0.845 . . . . 0.0 110.922 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.733 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 74.5 t -164.64 -104.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.436 -1.415 . . . . 0.0 111.923 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.764 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 2.1 ttp180 -164.39 164.11 22.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.642 -0.661 . . . . 0.0 109.309 -178.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.848 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -145.1 -176.49 5.11 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.939 -1.101 . . . . 0.0 111.75 -176.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.665 ' HA ' ' HB1' ' A' ' 58' ' ' ALA . 79.5 t -94.63 114.98 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.818 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.85 125.16 1.35 Allowed Glycine 0 N--CA 1.49 2.282 0 C-N-CA 118.918 -1.611 . . . . 0.0 110.688 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.821 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -92.92 -79.8 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.047 -1.267 . . . . 0.0 108.326 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.821 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 54.0 Cg_endo -81.65 20.9 0.99 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.35 1.184 . . . . 0.0 109.355 177.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.587 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 1.5 p -98.55 64.67 1.55 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.362 -0.836 . . . . 0.0 111.378 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.739 ' CD ' ' CG ' ' A' ' 18' ' ' MET . 0.1 OUTLIER -73.93 -35.89 64.62 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.171 -0.955 . . . . 0.0 109.318 178.716 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.629 ' HA ' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -48.92 -37.42 19.85 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.049 -1.032 . . . . 0.0 109.236 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.74 ' CD ' ' CD2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -47.09 -36.86 8.75 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.515 -0.874 . . . . 0.0 108.83 179.541 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.774 ' CD1' ' CG2' ' A' ' 59' ' ' ILE . 8.9 mp -61.44 -44.74 96.59 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 177.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.768 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -56.85 -34.41 67.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.459 -0.776 . . . . 0.0 109.859 178.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -77.96 -31.75 51.0 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.684 -0.635 . . . . 0.0 109.708 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.56 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -68.56 -49.15 61.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.458 -0.776 . . . . 0.0 109.655 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.767 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 1.9 mp -51.96 -35.5 18.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 120.949 -1.094 . . . . 0.0 108.695 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.562 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 8.1 t-20 -68.1 -27.5 66.53 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.579 ' OD2' HG11 ' A' ' 64' ' ' VAL 0.553 37.8 t0 -95.25 -21.62 18.33 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 113.374 -3.33 . . . . 0.0 106.329 -177.698 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.754 ' HB2' ' CA ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -68.64 -46.1 70.08 Favored 'General case' 0 C--N 1.288 -2.076 0 O-C-N 119.504 -1.997 . . . . 0.0 108.916 170.054 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.804 ' CE ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -78.9 -23.38 44.84 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.484 178.378 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.489 ' O ' ' O ' ' A' ' 81' ' ' ASN . 11.3 tp10 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.289 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.583 ' SD ' ' OD1' ' A' ' 4' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.211 0.529 . . . . 0.0 110.232 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.706 HG22 ' O ' ' A' ' 31' ' ' GLY . 1.6 p -89.44 -96.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 0.0 110.265 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.747 HG21 ' CB ' ' A' ' 27' ' ' LYS . 55.4 t -92.17 119.55 39.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.453 -0.779 . . . . 0.0 110.18 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.751 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -135.78 111.78 9.58 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 123.082 1.42 . . . . 0.0 109.194 179.245 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.733 ' CG2' HG21 ' A' ' 20' ' ' ILE . 4.1 mt -126.05 133.48 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.115 -0.991 . . . . 0.0 109.965 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.78 ' HB3' ' CB ' ' A' ' 60' ' ' ALA 0.272 15.3 tt0 -125.28 101.81 7.15 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 116.963 -1.895 . . . . 0.0 109.17 178.599 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.827 ' CG2' ' CB ' ' A' ' 38' ' ' LYS 0.251 29.0 m -97.66 111.33 27.24 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.438 0 CA-C-O 123.734 1.73 . . . . 0.0 107.621 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.83 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -118.55 90.57 3.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.01 -1.056 . . . . 0.0 109.342 -178.448 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.669 ' O ' HG21 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -121.35 -72.92 0.67 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.355 -0.841 . . . . 0.0 110.322 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.762 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -170.66 149.49 2.96 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.02 -1.05 . . . . 0.0 110.85 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.71 ' N ' ' HB3' ' A' ' 40' ' ' ASP . 46.4 Cg_endo -75.67 -28.91 7.71 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 124.019 1.536 . . . . 0.0 110.153 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.59 -15.02 58.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.859 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.615 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -124.95 -179.69 0.92 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.388 -0.82 . . . . 0.0 109.875 179.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.619 ' O ' ' O ' ' A' ' 15' ' ' TYR . 51.2 Cg_endo -83.56 111.12 1.74 Allowed 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.999 1.526 . . . . 0.0 110.417 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.762 ' CE1' ' O ' ' A' ' 10' ' ' SER . 17.9 m-85 -49.53 -111.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.908 . . . . 0.0 109.685 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.694 ' CB ' ' HG2' ' A' ' 73' ' ' ARG . 26.3 m -155.09 39.39 0.11 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.149 -0.97 . . . . 0.0 110.308 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.4 Cg_endo -76.18 23.07 0.48 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.84 1.442 . . . . 0.0 110.92 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.708 ' HB3' ' CD ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -103.18 -66.79 0.92 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.049 -1.032 . . . . 0.0 110.889 -179.292 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.719 ' HB2' ' CB ' ' A' ' 73' ' ' ARG . . . -55.14 -21.87 14.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.276 -0.89 . . . . 0.0 109.84 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.733 HG21 ' CG2' ' A' ' 5' ' ' ILE . 0.3 OUTLIER -72.67 -39.45 60.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.504 -0.747 . . . . 0.0 109.533 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.556 ' N ' ' CD1' ' A' ' 20' ' ' ILE . 1.6 tt0 -49.17 -31.9 9.24 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 15.5 t -69.42 -45.59 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.534 -0.729 . . . . 0.0 109.386 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.768 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -68.9 -28.56 40.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.312 -0.868 . . . . 0.0 109.366 178.463 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.747 ' OD1' ' CG1' ' A' ' 34' ' ' ILE . 16.6 t0 -76.09 -36.71 58.82 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -58.75 -44.04 90.42 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.644 0.735 . . . . 0.0 109.381 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.479 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.54 -40.99 28.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.51 -0.744 . . . . 0.0 110.164 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.757 ' N ' ' HE3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -67.09 -23.35 65.84 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.932 -1.107 . . . . 0.0 109.082 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.801 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.82 -45.63 70.71 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.365 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.796 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -49.43 -40.3 36.03 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.796 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.9 -56.32 3.28 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.711 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -96.18 78.47 0.76 Allowed Glycine 0 N--CA 1.489 2.173 0 O-C-N 121.398 -0.813 . . . . 0.0 111.378 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.532 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -36.96 -21.62 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 119.309 1.555 . . . . 0.0 110.3 -179.468 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.702 ' N ' ' O ' ' A' ' 31' ' ' GLY . 27.3 mtmm -85.06 154.6 21.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -0.999 . . . . 0.0 111.145 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.801 ' CD1' ' CG ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -129.28 150.21 34.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 118.883 -1.127 . . . . 0.0 111.048 178.463 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.585 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -150.43 68.49 0.97 Allowed 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.479 -0.763 . . . . 0.0 109.159 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.6 HG13 HD12 ' A' ' 5' ' ' ILE . 65.6 t -91.92 118.37 37.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 122.413 1.102 . . . . 0.0 109.519 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.727 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.267 8.6 mm-40 -100.13 131.01 46.33 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 123.321 1.534 . . . . 0.0 108.185 -178.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.827 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.56 122.1 16.23 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.753 -1.217 . . . . 0.0 111.559 -176.723 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.784 ' N ' ' CD1' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -136.72 -163.54 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 122.31 1.052 . . . . 0.0 111.129 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.785 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -110.96 170.82 7.85 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.792 179.183 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.83 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -65.86 -54.33 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.593 -0.692 . . . . 0.0 111.548 177.474 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.62 ' HG3' HG12 ' A' ' 43' ' ' VAL . 6.4 ptm -65.26 -1.56 2.41 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.016 -1.073 . . . . 0.0 110.985 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.775 ' CG1' ' OD1' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -112.08 -48.9 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.018 -1.051 . . . . 0.0 110.705 178.063 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.724 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 3.0 t70 -105.9 48.51 0.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.954 . . . . 0.0 110.086 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.582 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.288 6.4 ttt-85 -63.35 -7.21 5.88 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 118.086 -1.445 . . . . 0.0 109.662 -178.554 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.732 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 2.3 mm-40 -51.33 -19.94 1.51 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.157 -0.964 . . . . 0.0 110.159 176.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.85 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -51.8 -58.72 5.61 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 122.188 0.994 . . . . 0.0 109.815 -179.399 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.868 ' CB ' ' CB ' ' A' ' 55' ' ' ALA . . . -62.88 -1.94 1.04 Allowed 'General case' 0 C--N 1.276 -2.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.68 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.732 ' CG2' ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -35.34 -42.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 104.027 -2.582 . . . . 0.0 104.027 -176.383 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.503 ' N ' ' C ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -48.93 -51.33 30.78 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.195 176.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.795 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -125.93 -32.54 2.78 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.107 -0.996 . . . . 0.0 110.432 179.124 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.813 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 61.07 -33.52 0.05 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.642 ' CD2' ' HB2' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -49.57 -81.43 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.644 -1.503 . . . . 0.0 109.858 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.587 ' HG3' HD11 ' A' ' 53' ' ' LEU . 24.7 mtt -79.45 54.3 1.7 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.401 -0.812 . . . . 0.0 108.944 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.868 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.288 . . -99.61 103.52 15.23 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 124.006 1.86 . . . . 0.0 110.174 -177.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.818 ' CG2' ' CD1' ' A' ' 41' ' ' ILE . 4.9 t -146.63 -72.86 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.414 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.801 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.813 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 51.4 Cg_endo -95.3 112.15 0.15 Allowed 'Trans proline' 0 C--O 1.197 -1.541 0 CA-C-O 123.872 1.53 . . . . 0.0 109.893 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.785 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -160.82 179.27 8.65 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.425 -1.422 . . . . 0.0 111.792 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.737 ' CG2' ' HG ' ' A' ' 76' ' ' LEU 0.253 0.3 OUTLIER -142.48 133.48 24.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.078 179.334 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.78 ' CB ' ' HB3' ' A' ' 6' ' ' GLU . . . -81.42 141.31 34.05 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 116.935 -1.906 . . . . 0.0 106.215 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.772 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.433 0.7 OUTLIER -90.09 86.75 2.6 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.69 0 C-N-CA 114.73 -2.788 . . . . 0.0 105.421 -175.576 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.751 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -44.31 82.34 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 112.634 -2.076 . . . . 0.0 108.76 177.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.772 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.49 -44.1 0.35 Allowed Glycine 0 N--CA 1.483 1.805 0 N-CA-C 107.207 -2.357 . . . . 0.0 107.207 -178.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.76 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.2 m -126.18 -59.01 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.537 -0.978 . . . . 0.0 111.302 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.76 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 93.2 t -163.59 -108.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 120.306 -1.496 . . . . 0.0 112.358 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.769 ' NH2' ' CB ' ' A' ' 8' ' ' PHE . 3.5 ttt180 -165.14 164.64 20.21 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.769 -0.582 . . . . 0.0 109.653 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.82 ' CZ ' ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -144.95 177.01 9.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.92 -1.112 . . . . 0.0 111.177 -178.11 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.736 ' CG2' ' CZ ' ' A' ' 51' ' ' TYR . 78.9 t -88.66 116.0 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.832 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.82 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.68 123.57 1.19 Allowed Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.72 -1.228 . . . . 0.0 110.447 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.826 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -93.9 -78.26 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 120.868 -1.372 . . . . 0.0 108.662 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.826 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 54.6 Cg_endo -79.26 20.39 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.654 1.344 . . . . 0.0 109.254 178.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.598 ' OG ' ' HA3' ' A' ' 69' ' ' GLY 0.3 2.3 p -103.88 81.78 1.91 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 124.024 1.869 . . . . 0.0 109.989 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.719 ' CB ' ' HB2' ' A' ' 19' ' ' ALA . 24.9 mtt180 -79.57 -36.12 38.68 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.643 -1.286 . . . . 0.0 110.03 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.661 ' HA ' ' HB3' ' A' ' 19' ' ' ALA . 1.5 tt0 -50.48 -25.35 3.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.319 -0.863 . . . . 0.0 109.726 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.791 ' HG3' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -53.67 -46.39 70.6 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.351 -0.843 . . . . 0.0 109.207 -179.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.737 ' HG ' ' CG2' ' A' ' 59' ' ' ILE . 0.7 OUTLIER -60.18 -42.19 94.5 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.009 178.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.768 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.09 -33.95 69.64 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.399 -0.813 . . . . 0.0 109.78 179.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.766 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 31.5 tt0 -81.58 -27.75 34.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 110.146 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.706 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -74.47 -38.07 63.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.637 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.703 ' CG2' HG12 ' A' ' 23' ' ' VAL . 1.8 mp -63.35 -39.8 86.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.144 -0.972 . . . . 0.0 108.985 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.681 ' HA ' ' SD ' ' A' ' 84' ' ' MET . 0.1 OUTLIER -74.96 -33.12 61.86 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.244 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.523 0.1 OUTLIER -91.34 -3.26 56.95 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 113.54 -3.264 . . . . 0.0 107.125 -178.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.722 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -82.26 -59.58 2.5 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 119.672 -1.893 . . . . 0.0 109.816 169.589 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.72 ' HE3' ' NZ ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.94 -13.48 62.47 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.405 179.525 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.487 ' N ' ' HG2' ' A' ' 84' ' ' MET . 2.7 tm-20 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.196 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.582 ' SD ' ' OD1' ' A' ' 4' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.252 0.549 . . . . 0.0 110.211 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.706 HG22 ' O ' ' A' ' 31' ' ' GLY . 1.6 p -89.53 -97.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.842 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.745 HG21 ' CB ' ' A' ' 27' ' ' LYS . 53.2 t -89.51 121.69 39.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.343 -0.848 . . . . 0.0 109.987 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.747 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.292 0.2 OUTLIER -140.17 111.26 7.02 Favored 'General case' 0 C--O 1.19 -2.076 0 CA-C-O 125.057 2.361 . . . . 0.0 108.135 178.23 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.733 ' CG2' HG21 ' A' ' 20' ' ' ILE . 4.2 mt -121.63 133.85 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.195 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.78 ' HB3' ' CB ' ' A' ' 60' ' ' ALA 0.371 16.4 tt0 -129.11 111.12 12.62 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 115.218 -2.593 . . . . 0.0 105.063 177.026 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.829 ' CG2' ' CB ' ' A' ' 38' ' ' LYS 0.352 15.0 m -108.86 111.17 34.89 Favored 'Isoleucine or valine' 0 C--O 1.177 -2.748 0 CA-C-O 126.761 3.172 . . . . 0.0 103.822 -178.425 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.83 ' CE1' ' HA ' ' A' ' 41' ' ' ILE 0.277 0.4 OUTLIER -117.27 94.74 4.68 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 111.947 -2.388 . . . . 0.0 108.532 -178.608 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.668 ' O ' HG21 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -124.02 -69.84 0.79 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.095 -1.003 . . . . 0.0 110.601 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.765 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -174.96 146.83 1.0 Allowed Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 120.876 -1.14 . . . . 0.0 110.734 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.72 ' N ' ' HB3' ' A' ' 40' ' ' ASP . 50.7 Cg_endo -73.78 -29.01 10.93 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 O-C-N 123.802 1.422 . . . . 0.0 110.565 -178.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.63 -14.95 58.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.381 -0.824 . . . . 0.0 109.884 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.615 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -124.94 -179.65 0.91 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.388 -0.82 . . . . 0.0 109.846 179.732 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.62 ' O ' ' O ' ' A' ' 15' ' ' TYR . 51.8 Cg_endo -83.69 111.14 1.71 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.958 1.504 . . . . 0.0 110.444 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.765 ' CE1' ' O ' ' A' ' 10' ' ' SER . 18.1 m-85 -49.59 -111.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 109.606 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.694 ' CB ' ' HG2' ' A' ' 73' ' ' ARG . 26.7 m -155.06 39.4 0.12 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.17 -0.957 . . . . 0.0 110.353 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.4 Cg_endo -76.2 23.12 0.48 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.84 1.442 . . . . 0.0 110.95 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.708 ' HB3' ' CD ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -103.24 -66.64 0.93 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.049 -1.032 . . . . 0.0 110.85 -179.293 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.719 ' HB2' ' CB ' ' A' ' 73' ' ' ARG . . . -55.53 -21.34 16.47 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.284 -0.885 . . . . 0.0 109.898 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.733 HG21 ' CG2' ' A' ' 5' ' ' ILE . 0.3 OUTLIER -73.0 -39.23 57.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.598 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.555 ' N ' ' CD1' ' A' ' 20' ' ' ILE . 1.6 tt0 -48.91 -32.66 9.34 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 16.4 t -68.54 -47.37 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.659 0.742 . . . . 0.0 109.279 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.765 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.7 OUTLIER -64.07 -34.45 68.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-O 122.476 1.131 . . . . 0.0 109.513 177.451 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.746 ' OD1' ' CG1' ' A' ' 34' ' ' ILE . 15.2 t0 -71.66 -39.01 70.59 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 122.78 1.276 . . . . 0.0 108.949 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -57.24 -45.31 84.06 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.569 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.48 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -78.28 -40.5 36.81 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.782 0.801 . . . . 0.0 110.808 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.749 ' CE ' ' HA ' ' A' ' 27' ' ' LYS 0.252 0.0 OUTLIER -70.23 -19.19 63.16 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 117.627 -1.629 . . . . 0.0 108.904 -178.715 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.801 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -70.9 -44.75 65.59 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.38 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.762 ' HG3' ' N ' ' A' ' 30' ' ' PHE 0.26 0.0 OUTLIER -51.92 -35.44 45.63 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.411 179.246 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.776 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -92.54 -66.33 0.93 Allowed 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 104.098 -2.556 . . . . 0.0 104.098 -179.731 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.776 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -81.05 72.43 2.74 Favored Glycine 0 C--N 1.279 -2.623 0 CA-C-O 115.402 -2.888 . . . . 0.0 115.87 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.546 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -36.28 -23.97 0.01 OUTLIER 'General case' 0 C--N 1.262 -3.218 0 CA-C-N 123.092 3.446 . . . . 0.0 110.183 -177.546 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.694 ' O ' HG21 ' A' ' 2' ' ' VAL . 29.1 mtmm -77.35 152.55 34.4 Favored 'General case' 0 C--N 1.284 -2.281 0 O-C-N 120.263 -1.523 . . . . 0.0 113.384 175.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.801 ' CD1' ' CG ' ' A' ' 28' ' ' LYS 0.259 0.3 OUTLIER -130.66 151.37 35.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 C-N-CA 118.366 -1.334 . . . . 0.0 110.547 176.014 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.581 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -151.27 71.95 1.03 Allowed 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.6 HG13 HD12 ' A' ' 5' ' ' ILE 0.307 84.2 t -97.38 125.19 50.54 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.596 0 CA-C-O 124.556 2.122 . . . . 0.0 105.635 -177.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.717 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.413 7.3 mm-40 -109.37 133.53 52.94 Favored 'General case' 0 C--O 1.179 -2.625 0 CA-C-O 126.326 2.965 . . . . 0.0 104.438 -177.09 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.829 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -138.24 114.08 9.89 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.36 -1.745 . . . . 0.0 113.95 -173.145 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.821 ' N ' ' CD1' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -133.88 -165.12 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 121.874 2.125 . . . . 0.0 111.835 179.468 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.793 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -104.54 172.14 6.95 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 178.398 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.83 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -68.25 -55.21 17.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 121.387 -0.821 . . . . 0.0 110.644 176.581 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.62 ' HG3' HG12 ' A' ' 43' ' ' VAL . 6.3 ptm -64.27 -0.46 1.26 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 118.612 -1.235 . . . . 0.0 111.594 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.774 ' CG1' ' OD1' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -113.09 -49.12 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.086 -1.009 . . . . 0.0 110.195 178.341 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.724 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 2.9 t70 -106.34 51.01 0.76 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 109.646 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.581 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.472 6.0 ttt-85 -71.26 2.27 4.96 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 115.044 -2.663 . . . . 0.0 108.711 -176.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.732 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 2.2 mm-40 -52.51 -23.87 7.05 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 120.348 -1.47 . . . . 0.0 109.108 172.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.877 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -49.18 -63.14 1.19 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.941 -1.099 . . . . 0.0 109.012 -178.161 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.877 ' N ' ' HG3' ' A' ' 47' ' ' LYS 0.414 . . -51.42 -13.91 0.25 Allowed 'General case' 0 C--N 1.256 -3.485 0 C-N-CA 126.886 2.075 . . . . 0.0 111.555 175.372 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.732 ' CG2' ' O ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -30.75 -43.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 104.824 -2.287 . . . . 0.0 104.824 -172.957 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.56 ' N ' ' C ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -49.14 -51.37 32.64 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.186 176.414 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.797 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -125.89 -32.6 2.79 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.013 -1.054 . . . . 0.0 110.408 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.814 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 60.99 -33.36 0.05 OUTLIER Glycine 0 N--CA 1.488 2.139 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.643 ' CD2' ' HB2' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -49.6 -81.42 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.608 -1.525 . . . . 0.0 109.851 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.587 ' HG3' HD11 ' A' ' 53' ' ' LEU . 24.7 mtt -80.28 58.92 3.22 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.859 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.394 . . -106.91 106.14 16.52 Favored 'General case' 0 C--O 1.179 -2.622 0 CA-C-O 126.912 3.244 . . . . 0.0 107.154 -176.623 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.816 ' CG2' ' CD1' ' A' ' 41' ' ' ILE . 4.8 t -147.77 -64.58 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.435 0 CA-C-N 112.149 -2.296 . . . . 0.0 112.84 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.805 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.449 18.0 Cg_endo -109.41 116.81 0.03 OUTLIER 'Trans proline' 0 C--O 1.157 -3.527 0 CA-C-O 129.507 3.878 . . . . 0.0 103.921 -179.544 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.778 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -160.85 177.54 10.3 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 110.639 -2.982 . . . . 0.0 111.646 -175.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.737 ' CG2' ' HG ' ' A' ' 76' ' ' LEU 0.294 0.2 OUTLIER -141.52 141.15 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.874 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.78 ' CB ' ' HB3' ' A' ' 6' ' ' GLU 0.399 . . -91.7 149.89 21.4 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 100.551 -3.87 . . . . 0.0 100.551 -177.225 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.772 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.728 1.1 mt -101.57 101.39 12.05 Favored 'Isoleucine or valine' 0 C--N 1.412 3.299 3 C-N-CA 107.032 -5.867 . . . . 0.0 97.379 -172.237 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.747 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -53.93 84.7 0.0 OUTLIER 'General case' 0 C--N 1.38 1.929 1 CA-C-N 106.549 -4.841 . . . . 0.0 106.888 178.083 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.772 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.24 -44.12 0.36 Allowed Glycine 0 N--CA 1.483 1.793 0 N-CA-C 107.176 -2.37 . . . . 0.0 107.176 -178.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.758 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.1 m -126.16 -59.15 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 O-C-N 121.503 -0.998 . . . . 0.0 111.311 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.758 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 93.8 t -163.1 -106.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 120.326 -1.484 . . . . 0.0 112.901 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.768 ' NH2' ' CB ' ' A' ' 8' ' ' PHE . 3.4 ttt180 -167.74 163.58 14.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.676 -0.64 . . . . 0.0 109.397 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.833 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -145.53 174.4 11.2 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.848 -1.157 . . . . 0.0 111.268 -177.571 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.738 ' CG2' ' CZ ' ' A' ' 51' ' ' TYR . 59.3 t -83.42 115.12 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.888 -1.133 . . . . 0.0 111.406 177.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.818 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.91 123.4 1.17 Allowed Glycine 0 C--N 1.281 -2.524 0 CA-C-N 119.755 1.161 . . . . 0.0 110.491 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.824 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -93.9 -76.74 0.03 OUTLIER Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 120.772 -1.428 . . . . 0.0 109.194 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.824 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 41.7 Cg_endo -83.23 24.93 0.71 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 N-CA-C 108.339 -1.447 . . . . 0.0 108.339 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.597 ' OG ' ' HA3' ' A' ' 69' ' ' GLY 0.449 1.5 p -109.63 87.95 2.63 Favored 'General case' 0 N--CA 1.506 2.372 0 C-N-CA 113.829 -3.149 . . . . 0.0 106.577 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.719 ' CB ' ' HB2' ' A' ' 19' ' ' ALA . 24.8 mtt180 -79.77 -40.38 28.84 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 112.871 -1.968 . . . . 0.0 109.201 175.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.67 ' N ' ' CB ' ' A' ' 19' ' ' ALA . 1.4 tt0 -46.41 -28.22 1.29 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.025 -1.047 . . . . 0.0 109.835 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.792 ' HG3' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -53.12 -46.16 68.62 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.24 -0.912 . . . . 0.0 109.34 -178.537 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.737 ' HG ' ' CG2' ' A' ' 59' ' ' ILE . 0.7 OUTLIER -60.0 -42.53 94.47 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.147 178.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.774 ' CD1' ' N ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -57.39 -34.99 69.44 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.821 179.364 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.774 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 31.1 tt0 -78.77 -31.32 46.08 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.031 -1.043 . . . . 0.0 110.216 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.707 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -73.07 -38.26 66.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.092 -1.005 . . . . 0.0 110.002 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.703 ' CG2' HG12 ' A' ' 23' ' ' VAL . 1.8 mp -61.61 -42.47 94.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.099 -1.001 . . . . 0.0 108.906 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.681 ' HA ' ' SD ' ' A' ' 84' ' ' MET . 0.1 OUTLIER -72.24 -33.52 67.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.961 -1.087 . . . . 0.0 109.604 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.596 0.1 OUTLIER -94.01 0.82 56.22 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 112.027 -3.869 . . . . 0.0 105.573 -177.411 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.721 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -85.95 -59.81 2.19 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 119.546 -1.971 . . . . 0.0 107.841 170.598 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.721 ' HE3' ' NZ ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.69 -12.67 61.68 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.737 179.656 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.483 ' N ' ' HG2' ' A' ' 84' ' ' MET . 2.7 tm-20 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.066 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.653 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.314 0.578 . . . . 0.0 110.224 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.769 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 0.6 OUTLIER -90.13 -91.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 0.0 109.976 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.741 HG23 ' CD1' ' A' ' 34' ' ' ILE . 74.1 t -89.22 111.03 22.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.627 -0.671 . . . . 0.0 110.633 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.841 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 1.0 OUTLIER -130.95 105.68 7.91 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.639 -1.224 . . . . 0.0 108.794 178.031 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.755 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -120.7 137.37 54.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.031 179.425 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.998 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.01 119.77 22.51 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 119.057 -2.277 . . . . 0.0 107.389 177.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.802 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 23.0 m -105.64 144.78 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.879 ' H ' HD13 ' A' ' 59' ' ' ILE . 2.1 t80 -141.0 79.52 1.7 Allowed 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 119.01 -1.076 . . . . 0.0 112.663 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.687 ' CB ' ' HA ' ' A' ' 15' ' ' TYR . 3.5 m -118.06 -68.64 0.9 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 118.852 -2.405 . . . . 0.0 110.238 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.774 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 1.3 p 179.61 164.61 0.79 Allowed Pre-proline 0 C--N 1.294 -1.843 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.732 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.666 ' HD3' ' CG ' ' A' ' 40' ' ' ASP . 49.8 Cg_endo -80.35 -28.3 3.03 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.278 1.673 . . . . 0.0 110.418 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -18.25 54.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 109.762 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.07 174.49 3.82 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.457 -0.777 . . . . 0.0 109.723 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.652 ' O ' ' O ' ' A' ' 15' ' ' TYR . 50.8 Cg_endo -83.18 114.53 2.21 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.925 1.487 . . . . 0.0 110.437 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.774 ' CE1' ' O ' ' A' ' 10' ' ' SER . 16.5 m-85 -49.22 -112.38 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.132 -0.98 . . . . 0.0 109.576 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.736 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 92.9 m -150.6 37.46 0.13 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.267 -0.895 . . . . 0.0 110.131 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.736 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 53.7 Cg_endo -76.49 17.16 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.021 1.538 . . . . 0.0 111.042 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.502 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -95.1 -68.04 0.82 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.012 -1.055 . . . . 0.0 110.752 -179.461 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.701 ' HB2' ' CB ' ' A' ' 73' ' ' ARG . . . -54.28 -22.51 12.05 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.23 -0.919 . . . . 0.0 109.53 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.755 ' HB ' ' CG2' ' A' ' 5' ' ' ILE . 5.2 pt -70.67 -39.25 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.507 -0.746 . . . . 0.0 109.623 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.712 ' N ' HG13 ' A' ' 20' ' ' ILE . 6.2 tt0 -48.83 -33.05 9.79 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.492 HG12 ' CD2' ' A' ' 77' ' ' PHE . 3.1 t -72.01 -46.73 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.787 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -62.26 -31.86 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.03 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.736 ' OD1' ' CD1' ' A' ' 34' ' ' ILE . 5.2 t70 -69.45 -39.88 77.5 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.01 0.91 . . . . 0.0 109.196 178.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -46.01 84.81 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.617 0.722 . . . . 0.0 109.674 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.461 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.68 -40.05 42.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.669 -0.645 . . . . 0.0 110.614 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.751 ' CE ' ' HA ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -69.95 -19.37 63.38 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.124 -1.03 . . . . 0.0 109.208 -179.057 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.799 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -72.52 -44.99 61.44 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.154 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.746 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -50.32 -33.39 19.99 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.851 0.834 . . . . 0.0 110.279 179.494 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.769 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -97.01 -65.79 0.94 Allowed 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 179.639 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.756 ' HA3' HG22 ' A' ' 2' ' ' VAL . . . -84.64 82.16 1.7 Allowed Glycine 0 N--CA 1.506 3.323 0 C-N-CA 119.182 -1.485 . . . . 0.0 111.427 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.593 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -35.43 -28.43 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 CA-C-N 121.463 2.631 . . . . 0.0 110.68 178.57 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.689 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -80.0 154.95 27.87 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.498 -0.751 . . . . 0.0 111.686 178.065 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.799 ' CD1' ' CG ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -129.66 151.48 35.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 O-C-N 120.353 -1.467 . . . . 0.0 110.048 178.646 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.584 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -151.3 76.78 1.23 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.718 ' CG1' HD11 ' A' ' 20' ' ' ILE 0.255 55.4 t -96.65 126.98 49.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -178.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.998 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.251 78.1 mt-10 -111.24 135.43 51.79 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -177.617 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.802 ' HA ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -129.49 128.92 43.85 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -176.716 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.771 ' HB ' ' CB ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -135.08 171.66 17.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 O-C-N 120.132 -1.605 . . . . 0.0 111.516 178.642 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.749 ' HB3' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -102.72 170.8 7.79 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.803 0.811 . . . . 0.0 111.757 178.246 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.869 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -61.87 -37.39 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.425 -1.422 . . . . 0.0 109.332 178.489 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.686 ' HG3' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -82.37 -3.09 54.85 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.935 -1.103 . . . . 0.0 111.252 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.769 ' CG2' ' CG2' ' A' ' 39' ' ' ILE . 2.0 m -114.24 -46.18 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.055 -1.028 . . . . 0.0 109.755 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.777 ' OD2' ' CD1' ' A' ' 8' ' ' PHE . 1.6 t70 -104.97 40.98 1.4 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.237 -0.914 . . . . 0.0 109.627 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.59 ' NH2' ' HA3' ' A' ' 52' ' ' GLY 0.283 0.0 OUTLIER -65.69 -0.35 2.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.494 -1.379 . . . . 0.0 109.435 -178.823 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.825 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 2.3 mm-40 -62.54 -22.68 66.5 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.886 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -46.38 -66.55 0.39 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.965 -1.084 . . . . 0.0 108.422 -179.075 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.923 ' HA ' ' CE1' ' A' ' 51' ' ' TYR . . . -57.23 -7.63 0.58 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.666 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.831 ' C ' ' O ' ' A' ' 48' ' ' ALA . 2.6 pp -26.35 -41.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 O-C-N 119.163 -2.21 . . . . 0.0 106.573 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.852 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -52.92 -53.75 44.86 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.998 177.183 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.923 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 25.8 p90 -119.86 -32.8 4.14 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.132 -0.98 . . . . 0.0 109.984 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.694 ' HA2' ' HB3' ' A' ' 48' ' ' ALA . . . 42.38 8.82 0.01 OUTLIER Glycine 0 N--CA 1.502 3.08 0 CA-C-O 122.124 0.847 . . . . 0.0 111.474 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.715 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 4.6 mt -75.55 -81.08 0.08 Allowed 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 175.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.526 ' C ' ' HE2' ' A' ' 51' ' ' TYR . 4.0 mtp -95.74 63.66 2.42 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.443 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.865 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.273 . . -107.38 120.26 41.68 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 119.489 -2.007 . . . . 0.0 110.356 -177.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.802 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -148.76 -57.98 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.481 -178.709 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.802 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 59.1 Cg_endo -109.81 109.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 CA-C-O 122.892 1.122 . . . . 0.0 110.323 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.797 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -161.88 173.88 13.92 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.186 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.879 HD13 ' H ' ' A' ' 8' ' ' PHE 0.253 0.3 OUTLIER -134.6 151.94 32.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 120.876 -1.14 . . . . 0.0 107.997 179.296 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.864 ' HA ' ' HG3' ' A' ' 66' ' ' ARG 0.297 . . -91.15 155.3 18.72 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.744 HG13 ' N ' ' A' ' 66' ' ' ARG 0.31 1.2 mt -101.29 91.29 2.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 -175.713 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.841 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -51.63 83.04 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 112.834 -1.984 . . . . 0.0 106.807 -178.369 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.725 ' HA3' ' HB2' ' A' ' 83' ' ' GLU . . . 162.41 -44.02 0.36 Allowed Glycine 0 C--N 1.29 -2.027 0 N-CA-C 107.733 -2.147 . . . . 0.0 107.733 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.763 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 11.6 m -126.67 -58.97 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.903 -0.763 . . . . 0.0 111.139 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.763 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 81.9 t -163.73 -101.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 120.338 -1.476 . . . . 0.0 112.955 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.864 ' HG3' ' HA ' ' A' ' 60' ' ' ALA . 1.8 ttp180 -167.17 160.09 13.5 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.444 -0.785 . . . . 0.0 109.343 -177.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.841 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -146.09 176.05 10.02 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.11 -0.994 . . . . 0.0 111.702 -177.236 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.614 ' N ' ' HZ1' ' A' ' 47' ' ' LYS . 79.0 t -83.42 118.96 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.708 -0.62 . . . . 0.0 110.246 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.82 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.5 107.88 0.33 Allowed Glycine 0 N--CA 1.494 2.516 0 C-N-CA 118.536 -1.792 . . . . 0.0 110.386 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.849 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -88.94 -81.42 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 120.989 -1.3 . . . . 0.0 108.511 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.849 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 57.1 Cg_endo -83.6 17.04 1.75 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.243 1.128 . . . . 0.0 109.422 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.33 62.52 0.79 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.498 -0.751 . . . . 0.0 110.661 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.713 ' HG2' ' CB ' ' A' ' 16' ' ' CYS . 22.1 mtt180 -69.09 -31.43 70.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.381 -0.825 . . . . 0.0 109.327 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.69 ' HA ' ' HB3' ' A' ' 19' ' ' ALA . 1.2 tm-20 -48.39 -45.13 35.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.427 -0.796 . . . . 0.0 109.449 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.785 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -45.25 -29.11 0.91 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.701 -0.8 . . . . 0.0 108.982 179.715 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.759 ' CD1' HG21 ' A' ' 59' ' ' ILE . 3.2 mp -70.47 -39.92 73.98 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.521 -0.737 . . . . 0.0 109.047 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.787 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.49 -41.16 89.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.401 -0.812 . . . . 0.0 109.824 -179.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.52 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 2.5 tm-20 -77.29 -26.62 52.52 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.192 0.52 . . . . 0.0 109.932 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.619 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -71.03 -41.9 70.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 110.978 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.742 ' CG2' ' CG ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -62.57 -44.28 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.125 -0.984 . . . . 0.0 109.122 179.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.649 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -72.83 -27.76 62.14 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 177.573 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 1.026 ' O ' ' OD1' ' A' ' 82' ' ' ASP 0.328 0.1 OUTLIER -96.06 5.63 50.69 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 119.638 -1.914 . . . . 0.0 107.855 -179.416 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.772 ' HG2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -96.08 -59.03 1.93 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 178.635 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.725 ' HE3' ' NZ ' ' A' ' 27' ' ' LYS . 21.4 ptt? -68.63 -14.52 63.07 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 119.266 -0.974 . . . . 0.0 110.986 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--N 1.3 -1.559 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.002 179.722 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.658 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.225 0.536 . . . . 0.0 110.21 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.77 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 0.6 OUTLIER -89.98 -91.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.303 -0.873 . . . . 0.0 110.59 179.846 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.745 HG21 ' CG2' ' A' ' 2' ' ' VAL 0.253 75.1 t -89.19 118.78 35.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.787 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.481 0.9 OUTLIER -143.6 106.82 4.54 Favored 'General case' 0 C--O 1.16 -3.624 1 CA-C-O 129.728 4.585 . . . . 0.0 105.063 175.064 . . . . . . . . 5 4 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.743 ' CG2' ' HB ' ' A' ' 20' ' ' ILE 0.253 0.0 OUTLIER -111.62 132.87 59.0 Favored 'Isoleucine or valine' 0 C--O 1.262 1.73 0 CA-C-N 109.986 -3.279 . . . . 0.0 114.688 178.217 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.765 ' HA ' ' O ' ' A' ' 37' ' ' GLU 0.593 0.0 OUTLIER -135.8 126.51 27.28 Favored 'General case' 0 C--O 1.197 -1.674 2 CA-C-O 131.334 5.349 . . . . 0.0 104.281 172.239 . . . . . . . . 5 4 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.76 ' HA ' ' CD1' ' A' ' 59' ' ' ILE 0.339 14.6 m -108.02 156.5 8.52 Favored 'Isoleucine or valine' 0 C--N 1.386 2.191 0 CA-C-N 109.642 -3.436 . . . . 0.0 104.322 -175.699 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.835 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 1.9 t80 -154.15 76.14 1.04 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.516 -1.365 . . . . 0.0 111.052 -172.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.686 ' CB ' ' HA ' ' A' ' 15' ' ' TYR . 3.5 m -118.96 -70.06 0.81 Allowed 'General case' 0 C--N 1.269 -2.914 0 CA-C-N 120.65 1.568 . . . . 0.0 109.188 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.777 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 1.3 p 179.66 165.05 0.79 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.179 -0.951 . . . . 0.0 110.923 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.667 ' HD3' ' CG ' ' A' ' 40' ' ' ASP . 51.5 Cg_endo -80.4 -28.2 3.05 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.17 1.616 . . . . 0.0 110.511 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -18.25 53.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -0.894 . . . . 0.0 109.74 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -124.95 174.75 3.54 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.417 -0.802 . . . . 0.0 109.664 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.649 ' O ' ' O ' ' A' ' 15' ' ' TYR . 51.8 Cg_endo -83.41 114.69 2.15 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 123.943 1.496 . . . . 0.0 110.309 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.777 ' CE1' ' O ' ' A' ' 10' ' ' SER . 17.3 m-85 -49.41 -112.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.44 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.723 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 94.0 m -149.97 37.39 0.14 Allowed Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.132 -0.98 . . . . 0.0 110.27 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.723 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 54.4 Cg_endo -76.34 17.17 0.78 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.867 1.456 . . . . 0.0 111.036 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.504 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -95.11 -68.0 0.82 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.966 -1.084 . . . . 0.0 110.614 -179.367 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.699 ' HB2' ' CB ' ' A' ' 73' ' ' ARG . . . -55.28 -20.8 12.22 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.737 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.743 ' HB ' ' CG2' ' A' ' 5' ' ' ILE . 5.2 pt -71.91 -38.78 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.809 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.711 ' N ' HG13 ' A' ' 20' ' ' ILE . 6.4 tt0 -48.03 -33.59 8.22 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.485 HG12 ' CD2' ' A' ' 77' ' ' PHE . 3.1 t -72.47 -45.46 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-O 121.94 0.876 . . . . 0.0 109.338 179.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.767 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -60.52 -33.09 53.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 122.737 1.256 . . . . 0.0 109.207 176.462 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.733 ' OD1' ' CD1' ' A' ' 34' ' ' ILE . 5.7 t70 -70.55 -40.67 73.26 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.933 1.349 . . . . 0.0 108.144 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.24 -46.45 82.98 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.712 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -76.76 -40.6 47.84 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.841 0.829 . . . . 0.0 110.827 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.748 ' CE ' ' HA ' ' A' ' 27' ' ' LYS 0.334 0.0 OUTLIER -73.86 -14.62 61.11 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 116.25 -2.18 . . . . 0.0 109.132 -177.337 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.792 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -72.47 -44.33 62.46 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.826 -1.171 . . . . 0.0 107.892 173.899 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.706 ' HG3' ' N ' ' A' ' 30' ' ' PHE 0.315 0.0 OUTLIER -53.96 -28.95 40.62 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.969 -179.315 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.77 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -99.85 -66.08 0.93 Allowed 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 -179.694 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.717 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -78.82 71.38 2.58 Favored Glycine 0 C--N 1.268 -3.232 0 CA-C-O 113.879 -3.734 . . . . 0.0 115.104 175.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.549 ' O ' ' OD1' ' A' ' 32' ' ' ASP 0.365 0.0 OUTLIER -39.06 -20.0 0.01 OUTLIER 'General case' 0 C--N 1.264 -3.109 1 CA-C-N 124.26 4.03 . . . . 0.0 111.81 -174.821 . . . . . . . . 5 4 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.705 ' N ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -75.01 150.71 38.87 Favored 'General case' 0 C--N 1.28 -2.418 0 C-N-CA 126.969 2.108 . . . . 0.0 113.943 171.053 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.792 ' CD1' ' CG ' ' A' ' 28' ' ' LYS 0.331 0.3 OUTLIER -131.09 155.07 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 C-N-CA 116.441 -2.104 . . . . 0.0 110.148 172.374 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.557 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -151.64 76.96 1.22 Allowed 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.09 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.732 ' CG1' HD11 ' A' ' 20' ' ' ILE 0.406 42.6 t -102.56 127.39 56.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 CA-C-O 126.947 3.261 . . . . 0.0 106.457 -177.56 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.765 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.505 68.6 mt-10 -116.01 134.47 54.92 Favored 'General case' 0 C--O 1.188 -2.156 0 O-C-N 118.861 -2.399 . . . . 0.0 107.114 -174.37 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.753 ' HA ' ' CG2' ' A' ' 7' ' ' VAL 0.576 0.0 OUTLIER -112.73 115.28 28.28 Favored 'General case' 0 C--O 1.298 3.649 2 CA-C-O 107.822 -5.847 . . . . 0.0 121.213 -170.817 . . . . . . . . 5 4 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.772 ' CG2' ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -132.54 178.24 5.92 Favored 'Isoleucine or valine' 1 C--N 1.232 -4.526 1 CA-C-N 131.381 6.446 . . . . 0.0 110.439 175.931 . . . . . . . . 5 4 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.738 ' OD2' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -103.22 166.05 10.66 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.068 -1.645 . . . . 0.0 113.04 177.022 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.835 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.4 OUTLIER -59.68 -38.01 73.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 118.15 -1.42 . . . . 0.0 111.899 173.032 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.682 ' HG3' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -80.84 -3.29 50.67 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.793 -1.163 . . . . 0.0 112.457 177.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.772 ' CG2' ' CG2' ' A' ' 39' ' ' ILE . 2.0 m -113.58 -46.24 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.062 -1.024 . . . . 0.0 109.787 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.785 ' OD2' ' CD1' ' A' ' 8' ' ' PHE . 1.6 t70 -103.82 37.08 2.13 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.28 -0.887 . . . . 0.0 110.473 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.576 ' NH2' ' HA3' ' A' ' 52' ' ' GLY 0.369 0.0 OUTLIER -65.04 -2.18 2.57 Favored 'General case' 0 C--O 1.2 -1.533 0 C-N-CA 116.783 -1.967 . . . . 0.0 109.789 -176.998 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.781 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 1.8 mm-40 -51.89 -26.71 10.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.021 -1.049 . . . . 0.0 111.635 170.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.852 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -50.15 -61.28 2.25 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.471 -1.393 . . . . 0.0 108.884 -175.018 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.852 ' N ' ' HG3' ' A' ' 47' ' ' LYS 0.388 . . -51.69 -13.36 0.25 Allowed 'General case' 0 C--N 1.264 -3.14 0 C-N-CA 126.48 1.912 . . . . 0.0 112.065 174.697 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.79 ' CD1' ' N ' ' A' ' 50' ' ' GLU . 2.3 pp -33.68 -38.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 -169.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.79 ' N ' ' CD1' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.99 -53.59 39.78 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.053 176.12 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.806 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 23.1 p90 -120.36 -31.51 4.33 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.083 -1.011 . . . . 0.0 110.29 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.777 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.93 14.65 0.01 OUTLIER Glycine 0 C--O 1.201 -1.962 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.485 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.731 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.4 mt -80.25 -76.03 0.24 Allowed 'General case' 0 C--N 1.253 -3.623 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 178.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.512 ' C ' ' HE2' ' A' ' 51' ' ' TYR . 3.8 mtp -103.07 61.5 0.79 Allowed 'General case' 0 C--O 1.25 1.095 0 O-C-N 119.546 -1.971 . . . . 0.0 108.405 -178.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.847 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.548 . . -113.97 125.45 54.03 Favored 'General case' 0 C--O 1.178 -2.68 1 CA-C-O 129.672 4.558 . . . . 0.0 106.724 -175.258 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.821 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -151.03 -55.04 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 CA-C-N 109.795 -3.366 . . . . 0.0 112.301 -175.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.821 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.559 38.6 Cg_endo -119.66 116.0 0.01 OUTLIER 'Trans proline' 0 C--O 1.157 -3.525 1 CA-C-O 132.508 5.129 . . . . 0.0 108.86 174.209 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.795 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -160.61 173.34 15.63 Favored 'General case' 0 C--N 1.378 1.811 1 CA-C-N 107.777 -4.283 . . . . 0.0 111.671 -174.36 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.76 ' CD1' ' HA ' ' A' ' 7' ' ' VAL 0.313 0.3 OUTLIER -137.2 156.95 34.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 117.833 -1.547 . . . . 0.0 107.404 177.724 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.796 ' CA ' ' HG3' ' A' ' 66' ' ' ARG 0.696 . . -106.41 155.57 19.42 Favored 'General case' 0 C--N 1.379 1.881 3 C-N-CA 107.591 -5.643 . . . . 0.0 97.618 -175.017 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.806 HG13 ' N ' ' A' ' 66' ' ' ARG 0.583 1.7 mt -103.67 91.07 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.186 -2.253 2 CA-C-O 131.758 5.551 . . . . 0.0 101.724 -164.733 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.787 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -42.97 81.58 0.0 OUTLIER 'General case' 0 C--N 1.37 1.462 1 CA-C-N 108.378 -4.01 . . . . 0.0 109.012 176.562 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.752 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.94 -45.71 0.37 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 106.908 -2.477 . . . . 0.0 106.908 -177.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.748 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 10.9 m -125.67 -58.86 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.679 -0.895 . . . . 0.0 111.431 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.748 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 80.3 t -163.42 -99.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.551 0 O-C-N 120.314 -1.491 . . . . 0.0 112.879 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.806 ' N ' HG13 ' A' ' 61' ' ' ILE . 1.6 ttp180 -171.55 157.58 4.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.964 -1.085 . . . . 0.0 109.252 -176.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.819 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -143.9 176.04 9.56 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.333 -1.479 . . . . 0.0 111.023 -174.281 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.616 ' N ' ' HZ1' ' A' ' 47' ' ' LYS . 70.8 t -80.79 117.26 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-O 117.386 -1.292 . . . . 0.0 110.942 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.806 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.81 108.28 0.34 Allowed Glycine 0 C--N 1.277 -2.74 0 CA-C-N 121.173 1.806 . . . . 0.0 110.577 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.827 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -90.16 -79.21 0.03 OUTLIER Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 120.734 -1.451 . . . . 0.0 108.936 178.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.827 ' CD ' ' CB ' ' A' ' 70' ' ' ALA 0.256 44.3 Cg_endo -88.53 20.0 1.22 Allowed 'Trans proline' 0 C--O 1.21 -0.918 0 C-N-CA 116.705 -1.73 . . . . 0.0 109.136 177.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.16 63.58 1.0 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.761 -1.212 . . . . 0.0 112.179 175.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.718 ' HG2' ' CB ' ' A' ' 16' ' ' CYS . 20.6 mtt180 -67.27 -33.36 75.15 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.889 -1.132 . . . . 0.0 109.708 177.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.68 ' HA ' ' HB3' ' A' ' 19' ' ' ALA . 1.2 tm-20 -47.31 -46.46 25.19 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.043 -1.035 . . . . 0.0 108.986 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.785 ' CD ' ' CE2' ' A' ' 67' ' ' PHE 0.268 0.0 OUTLIER -47.29 -26.43 1.24 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 118.561 -1.256 . . . . 0.0 109.047 -178.371 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.76 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 3.1 mp -70.71 -39.86 73.16 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.878 0.847 . . . . 0.0 109.368 177.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.767 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.69 -39.47 84.64 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-O 122.088 0.947 . . . . 0.0 111.14 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.474 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 2.6 tm-20 -75.84 -27.84 58.01 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 122.229 1.014 . . . . 0.0 110.058 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.612 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -74.71 -40.6 61.22 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 120.956 -1.09 . . . . 0.0 109.149 -175.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.744 ' CG2' ' CG ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -60.82 -45.17 98.48 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.572 0 CA-C-O 122.587 1.184 . . . . 0.0 110.151 177.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.655 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.2 OUTLIER -71.84 -32.94 68.03 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.654 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.645 0.1 OUTLIER -99.36 5.95 46.26 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 112.477 -3.689 . . . . 0.0 106.696 -175.258 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.734 ' OE1' ' CA ' ' A' ' 63' ' ' GLY 0.284 0.0 OUTLIER -86.35 -60.68 1.93 Allowed 'General case' 0 N--CA 1.48 1.03 1 O-C-N 116.169 -4.082 . . . . 0.0 108.132 165.739 . . . . . . . . 5 4 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.727 ' HE3' ' NZ ' ' A' ' 27' ' ' LYS . 21.4 ptt? -66.63 -14.84 62.95 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.946 -1.101 . . . . 0.0 111.456 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.778 -1.106 . . . . 0.0 110.253 177.939 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.675 ' O ' ' CZ ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.305 0.574 . . . . 0.0 110.276 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.744 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 11.5 p -84.65 -119.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.269 -0.894 . . . . 0.0 109.921 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.727 HG22 ' CB ' ' A' ' 27' ' ' LYS . 72.6 t -92.61 105.62 16.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.283 -0.886 . . . . 0.0 110.308 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.743 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 54.3 t30 -129.2 109.0 10.79 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.755 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.734 HD13 ' CG1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -123.87 136.99 58.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.082 -1.011 . . . . 0.0 110.409 179.747 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.75 ' O ' ' CD1' ' A' ' 59' ' ' ILE . 4.0 tp10 -125.05 104.07 8.35 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 117.916 -1.514 . . . . 0.0 108.782 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.822 ' CG2' ' CB ' ' A' ' 38' ' ' LYS . 15.7 m -93.88 104.73 16.07 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.434 0 CA-C-O 123.315 1.531 . . . . 0.0 108.43 -179.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.83 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 1.6 t80 -117.65 84.88 2.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.221 -0.924 . . . . 0.0 109.78 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.697 ' O ' HG23 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -120.28 -53.28 2.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.529 -0.732 . . . . 0.0 109.882 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.772 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 5.3 p 179.43 152.76 0.56 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.316 -0.865 . . . . 0.0 110.513 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.687 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 50.5 Cg_endo -84.52 -29.4 0.82 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.121 1.59 . . . . 0.0 110.205 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.549 ' OG1' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -79.81 -16.87 54.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.376 -0.828 . . . . 0.0 109.946 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.549 ' SG ' ' OG1' ' A' ' 12' ' ' THR . 1.4 m -124.97 179.97 1.0 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.417 -0.802 . . . . 0.0 109.954 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.631 ' O ' ' O ' ' A' ' 15' ' ' TYR . 52.3 Cg_endo -83.6 111.68 1.79 Allowed 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.993 1.522 . . . . 0.0 110.473 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.772 ' CE1' ' O ' ' A' ' 10' ' ' SER . 8.6 m-85 -49.51 -114.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.905 . . . . 0.0 109.728 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.681 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -155.19 40.7 0.14 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.167 -0.958 . . . . 0.0 110.054 179.543 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.723 ' CA ' HG12 ' A' ' 7' ' ' VAL . 50.1 Cg_endo -74.7 16.15 0.64 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.935 1.492 . . . . 0.0 111.039 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.714 ' CG ' ' HD3' ' A' ' 73' ' ' ARG . 5.1 ttm -84.81 -60.74 1.96 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.129 -0.982 . . . . 0.0 111.305 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.75 ' CB ' ' O ' ' A' ' 73' ' ' ARG . . . -56.41 -18.9 12.55 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.27 -0.894 . . . . 0.0 109.665 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.722 ' HB ' ' CG2' ' A' ' 5' ' ' ILE . 0.3 OUTLIER -73.83 -40.15 52.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.458 -0.776 . . . . 0.0 109.327 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.623 ' N ' HD11 ' A' ' 20' ' ' ILE . 6.0 tm-20 -53.7 -36.11 61.85 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.1 t -75.94 -39.39 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.758 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -70.39 -26.8 29.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-O 122.022 0.915 . . . . 0.0 108.88 177.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.722 ' OD1' ' CG2' ' A' ' 34' ' ' ILE . 4.8 t70 -74.62 -37.45 62.82 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -45.01 91.58 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.314 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.43 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.26 -40.59 30.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.492 -0.755 . . . . 0.0 110.095 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.808 ' CE ' ' CE ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -65.13 -26.31 68.13 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.182 -1.007 . . . . 0.0 108.871 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.741 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.89 -46.64 67.87 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.822 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.788 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -45.94 -42.08 12.4 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.654 0.74 . . . . 0.0 109.057 178.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.788 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -90.27 -56.04 3.37 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.414 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.738 ' HA3' ' CG2' ' A' ' 2' ' ' VAL . . . -96.08 79.05 0.77 Allowed Glycine 0 N--CA 1.489 2.196 0 O-C-N 121.482 -0.761 . . . . 0.0 111.276 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -37.71 -19.56 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 119.057 1.429 . . . . 0.0 110.767 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.726 ' O ' HG22 ' A' ' 2' ' ' VAL . 9.5 mtpt -85.74 160.09 19.61 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.911 -1.118 . . . . 0.0 111.289 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.741 ' CD1' ' CG ' ' A' ' 28' ' ' LYS . 0.6 OUTLIER -130.54 129.33 64.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.084 178.447 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.627 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 8.4 t0 -136.86 74.37 1.49 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.333 -0.854 . . . . 0.0 109.175 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.676 HG11 ' CG1' ' A' ' 5' ' ' ILE . 46.1 t -92.23 115.85 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-O 122.428 1.108 . . . . 0.0 109.406 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.72 ' CB ' ' OE2' ' A' ' 6' ' ' GLU . 9.0 mt-10 -97.6 148.15 23.58 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.345 -1.342 . . . . 0.0 108.328 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.822 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.94 120.84 14.51 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.62 -1.3 . . . . 0.0 111.654 -177.376 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.713 ' CD1' ' HG3' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -120.4 174.62 5.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.27 -0.894 . . . . 0.0 111.28 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.741 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -112.07 167.69 10.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.074 -1.016 . . . . 0.0 112.629 179.111 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.83 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -67.5 -36.21 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.646 -0.658 . . . . 0.0 112.53 178.315 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.741 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -90.61 -7.15 53.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.844 -1.16 . . . . 0.0 112.016 -179.09 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.698 ' CG1' ' OD2' ' A' ' 40' ' ' ASP . 14.0 p -111.27 -35.64 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.015 -1.053 . . . . 0.0 109.934 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.71 ' HB2' ' CG2' ' A' ' 39' ' ' ILE . 3.0 t70 -115.07 45.49 1.61 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.294 -0.879 . . . . 0.0 110.163 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 45' ' ' ARG 0.257 45.3 ttt180 -59.28 -5.69 0.79 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.462 -1.295 . . . . 0.0 109.406 -179.065 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.765 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 2.2 mm-40 -53.88 -20.88 6.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.335 -0.853 . . . . 0.0 110.329 177.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.862 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -51.95 -56.33 14.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.857 -1.152 . . . . 0.0 109.394 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.862 ' N ' ' HG3' ' A' ' 47' ' ' LYS . . . -64.7 -2.52 2.52 Favored 'General case' 0 C--N 1.276 -2.609 0 O-C-N 120.896 -1.128 . . . . 0.0 111.467 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.785 ' CD1' ' N ' ' A' ' 50' ' ' GLU . 2.5 pp -34.25 -37.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 -177.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.785 ' N ' ' CD1' ' A' ' 49' ' ' ILE . 0.5 OUTLIER -55.39 -52.33 63.89 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.153 176.807 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.833 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.5 p90 -121.97 -27.26 4.63 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.129 -0.982 . . . . 0.0 110.278 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.793 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.23 13.18 0.01 OUTLIER Glycine 0 N--CA 1.489 2.197 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.669 ' N ' ' O ' ' A' ' 51' ' ' TYR . 6.4 mt -84.7 -66.0 0.94 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 123.981 1.848 . . . . 0.0 108.375 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.459 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 15.9 mmt -103.87 56.43 0.73 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.021 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.862 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.263 . . -99.24 105.41 17.44 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 123.387 1.565 . . . . 0.0 110.661 -176.104 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.795 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 2.0 t -146.4 -65.47 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 121.197 -0.939 . . . . 0.0 110.408 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.795 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 40.8 Cg_endo -97.35 102.7 0.08 OUTLIER 'Trans proline' 0 C--O 1.195 -1.661 0 CA-C-O 124.131 1.638 . . . . 0.0 108.728 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.782 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -156.14 -178.46 7.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.46 -1.4 . . . . 0.0 111.304 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.766 HG13 ' CD2' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -144.38 140.76 24.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.763 -0.585 . . . . 0.0 109.869 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.747 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . . . -81.69 133.41 35.35 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.753 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.353 1.2 mt -85.36 81.25 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.221 0 C-N-CA 116.462 -2.095 . . . . 0.0 107.223 -176.283 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.798 ' O ' ' CG ' ' A' ' 83' ' ' GLU . 27.6 m-80 -44.3 85.87 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 114.512 -1.222 . . . . 0.0 107.895 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.753 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.73 -43.78 0.35 Allowed Glycine 0 N--CA 1.486 1.999 0 N-CA-C 106.177 -2.769 . . . . 0.0 106.177 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.744 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 14.9 m -128.73 -60.97 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 121.791 -0.829 . . . . 0.0 110.761 179.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.744 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 64.8 t -165.23 -103.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 120.321 -1.487 . . . . 0.0 111.679 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.752 ' HG2' ' CD ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -153.28 164.26 38.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.786 -0.572 . . . . 0.0 109.828 -179.083 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.823 ' CZ ' ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -145.42 178.18 8.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.079 -1.013 . . . . 0.0 110.862 -179.737 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.408 ' HA ' ' HB1' ' A' ' 58' ' ' ALA . 96.0 t -89.45 122.08 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.286 -0.884 . . . . 0.0 109.078 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.823 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -160.96 101.83 0.2 Allowed Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.055 -1.545 . . . . 0.0 111.148 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.825 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -90.29 -83.92 0.02 OUTLIER Pre-proline 0 C--N 1.293 -1.848 0 O-C-N 120.825 -1.397 . . . . 0.0 108.484 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.825 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 48.8 Cg_endo -82.55 15.2 2.09 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 N-CA-C 108.909 -1.227 . . . . 0.0 108.909 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.56 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 26.2 p -100.22 69.95 1.51 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.264 -0.897 . . . . 0.0 111.269 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.75 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -74.87 -40.45 60.95 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.916 -1.115 . . . . 0.0 109.376 179.007 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.714 ' HA ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -46.03 -36.37 5.62 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.185 -0.947 . . . . 0.0 109.153 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.575 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -48.44 -41.61 29.86 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.493 -0.883 . . . . 0.0 108.712 179.318 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.766 ' CD2' HG13 ' A' ' 59' ' ' ILE . 7.1 mp -56.77 -40.06 75.16 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.675 0.75 . . . . 0.0 109.015 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.758 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -60.69 -42.47 97.22 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.617 0.722 . . . . 0.0 109.918 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.491 ' N ' ' CD2' ' A' ' 77' ' ' PHE . 1.2 tt0 -78.0 -22.73 48.87 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.298 -0.876 . . . . 0.0 110.369 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.534 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -79.25 -39.58 32.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.106 -0.996 . . . . 0.0 109.937 -178.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.743 ' CD1' ' O ' ' A' ' 4' ' ' ASN . 0.2 OUTLIER -66.07 -32.14 56.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.909 -1.119 . . . . 0.0 108.862 178.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.501 ' HA ' ' HE1' ' A' ' 84' ' ' MET . 0.1 OUTLIER -78.38 -29.08 47.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.0 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.563 0.6 OUTLIER -93.36 -7.22 45.36 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 112.718 -3.593 . . . . 0.0 105.742 -179.003 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.798 ' CG ' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -74.99 -54.65 6.81 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.165 -1.584 . . . . 0.0 108.111 171.811 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.808 ' CE ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -75.51 -22.34 57.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.732 -0.605 . . . . 0.0 110.431 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 84' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.211 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.201 0.524 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.765 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 0.9 OUTLIER -80.72 -92.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.329 -0.857 . . . . 0.0 110.354 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.749 ' CG1' ' CG2' ' A' ' 36' ' ' VAL . 54.1 t -91.59 128.74 43.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.521 -0.737 . . . . 0.0 110.921 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.809 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 62.8 t30 -140.63 107.6 5.43 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 123.06 1.409 . . . . 0.0 109.126 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.766 ' CD1' HG13 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -135.91 136.18 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 O-C-N 121.032 -1.043 . . . . 0.0 112.032 -178.565 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.731 ' CG ' ' HB2' ' A' ' 60' ' ' ALA . 1.4 tp10 -122.5 102.54 8.14 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 118.136 -1.425 . . . . 0.0 108.53 176.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.802 ' CG2' ' CB ' ' A' ' 38' ' ' LYS . 30.0 m -96.19 106.28 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 123.11 1.433 . . . . 0.0 109.327 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.824 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 1.1 t80 -118.19 101.88 8.56 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.67 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.677 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.5 OUTLIER -134.03 -61.58 0.79 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.269 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.675 ' HA ' HG23 ' A' ' 41' ' ' ILE . 3.1 t -175.07 144.63 0.83 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.118 -0.988 . . . . 0.0 111.073 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.739 ' N ' ' HB2' ' A' ' 40' ' ' ASP . 50.6 Cg_endo -76.63 -9.43 18.5 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 124.212 1.638 . . . . 0.0 110.652 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.05 -5.21 53.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.996 -1.065 . . . . 0.0 109.794 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.631 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 1.5 p -160.45 -165.65 0.13 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.494 -0.754 . . . . 0.0 110.09 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.631 ' CD ' ' CB ' ' A' ' 13' ' ' CYS . 53.2 Cg_endo -84.32 117.78 2.18 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.895 1.471 . . . . 0.0 110.35 177.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.672 ' HB2' ' HB ' ' A' ' 7' ' ' VAL . 2.1 m-85 -49.27 -83.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.93 . . . . 0.0 109.632 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.708 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 42.5 m -155.41 39.61 0.11 Allowed Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.213 -0.93 . . . . 0.0 109.961 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.708 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 52.9 Cg_endo -73.72 30.35 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.013 1.533 . . . . 0.0 111.142 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.435 ' H ' ' C ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -110.16 -61.93 1.59 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.952 -1.093 . . . . 0.0 110.369 -179.653 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.722 ' CB ' ' C ' ' A' ' 73' ' ' ARG . . . -58.06 -20.11 36.85 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.457 -0.777 . . . . 0.0 110.033 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.733 ' CG2' HG22 ' A' ' 5' ' ' ILE . 23.0 pt -75.6 -38.99 39.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.492 -0.755 . . . . 0.0 109.531 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.658 ' N ' HG13 ' A' ' 20' ' ' ILE . 49.8 tt0 -49.43 -36.02 21.06 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.68 -43.02 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.766 HG13 ' CD1' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -69.85 -27.98 35.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.744 0.783 . . . . 0.0 109.234 178.117 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.636 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 4.4 t70 -75.77 -36.07 59.95 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -44.18 89.91 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.635 0.731 . . . . 0.0 109.289 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.511 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.45 -41.01 28.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.506 -0.746 . . . . 0.0 110.122 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.82 ' CE ' ' CE ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -67.67 -23.41 65.31 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.206 -179.327 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.636 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -69.35 -46.38 67.14 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.373 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.797 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -47.68 -40.66 20.6 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.726 0.774 . . . . 0.0 109.191 179.004 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.797 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.89 -58.06 2.64 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.489 -0.757 . . . . 0.0 109.017 179.587 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.736 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -96.64 77.85 0.72 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 111.341 -0.703 . . . . 0.0 111.341 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.588 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -32.94 -27.37 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 119.315 1.558 . . . . 0.0 110.168 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.736 ' N ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -88.68 158.37 18.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.417 -0.802 . . . . 0.0 111.259 178.253 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.69 ' CD1' HG22 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -129.57 150.86 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.081 -1.012 . . . . 0.0 110.581 178.095 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -138.69 61.45 1.58 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.414 -0.804 . . . . 0.0 108.875 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.749 ' CG2' ' CG1' ' A' ' 3' ' ' VAL . 44.7 t -91.76 115.75 31.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.663 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.715 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 12.4 mt-10 -98.59 140.43 32.83 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.01 -1.076 . . . . 0.0 108.368 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.802 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -138.45 130.81 28.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.411 -0.805 . . . . 0.0 111.845 -176.648 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.747 ' HB ' ' CB ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -138.17 172.8 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.848 . . . . 0.0 109.898 179.598 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.771 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.7 OUTLIER -105.33 169.84 8.23 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.175 -0.953 . . . . 0.0 110.975 179.008 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.824 ' HA ' ' CE2' ' A' ' 8' ' ' PHE . 0.6 OUTLIER -73.79 -17.88 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.254 -0.904 . . . . 0.0 111.593 179.251 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.771 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 2.6 ptt? -92.89 -15.59 26.21 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.809 -1.156 . . . . 0.0 110.21 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.733 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 14.0 p -111.2 -30.58 2.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 110.256 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.808 ' O ' ' CE2' ' A' ' 8' ' ' PHE . 5.7 t0 -114.5 48.91 1.07 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.047 -1.033 . . . . 0.0 110.869 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.264 2.5 ttt180 -59.99 -8.8 2.5 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.319 -1.352 . . . . 0.0 109.627 -179.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.767 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 0.4 OUTLIER -58.31 -17.08 17.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.634 174.639 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.82 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -48.96 -61.38 2.09 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.416 1.103 . . . . 0.0 109.68 -178.058 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.874 ' CB ' ' CB ' ' A' ' 55' ' ' ALA . . . -62.06 0.08 0.45 Allowed 'General case' 0 C--N 1.283 -2.308 0 O-C-N 121.613 -0.679 . . . . 0.0 111.566 177.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.767 ' CG2' ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -35.11 -38.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 -176.226 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.586 ' N ' ' C ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -54.81 -49.26 71.43 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.513 177.383 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.81 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -124.96 -28.47 3.46 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.953 -1.092 . . . . 0.0 110.361 179.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.777 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 41.15 11.17 0.01 OUTLIER Glycine 0 N--CA 1.486 2.023 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.68 ' N ' ' O ' ' A' ' 51' ' ' TYR . 6.2 mt -84.95 -61.52 1.76 Allowed 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 123.117 1.437 . . . . 0.0 108.344 177.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.545 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 26.0 mtm -110.21 62.88 0.6 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.031 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.874 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.268 . . -98.34 107.75 20.29 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 123.092 1.425 . . . . 0.0 111.327 -174.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.829 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 1.6 t -146.98 -66.81 0.02 OUTLIER Pre-proline 0 N--CA 1.486 1.368 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.487 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.829 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 41.8 Cg_endo -106.25 94.27 0.02 OUTLIER 'Trans proline' 0 C--O 1.206 -1.11 0 CA-C-O 122.701 1.042 . . . . 0.0 109.785 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.759 ' CB ' ' HE2' ' A' ' 47' ' ' LYS . . . -152.13 178.67 9.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.226 -0.922 . . . . 0.0 110.667 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.837 ' CG2' ' CD2' ' A' ' 76' ' ' LEU . 1.4 mp -149.91 147.38 16.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.619 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.805 ' HA ' ' HG3' ' A' ' 66' ' ' ARG . . . -81.58 138.03 35.44 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 117.4 -1.72 . . . . 0.0 106.452 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.767 ' HB ' HG21 ' A' ' 64' ' ' VAL 0.382 0.9 OUTLIER -87.93 81.11 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-O 124.807 2.241 . . . . 0.0 106.486 -175.635 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.809 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -42.69 84.88 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 113.466 -1.697 . . . . 0.0 108.006 177.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.754 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.08 -47.09 0.38 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 106.328 -2.709 . . . . 0.0 106.328 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.767 HG21 ' HB ' ' A' ' 61' ' ' ILE . 11.9 m -124.51 -60.76 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 121.846 -0.797 . . . . 0.0 111.19 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.764 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 97.6 t -164.04 -107.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.126 -1.609 . . . . 0.0 113.146 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.805 ' HG3' ' HA ' ' A' ' 60' ' ' ALA . 1.0 OUTLIER -156.23 153.65 29.49 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.769 -0.582 . . . . 0.0 109.947 -177.008 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.805 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -145.98 -175.65 4.83 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.982 -1.074 . . . . 0.0 111.75 -178.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.692 ' HA ' ' HB1' ' A' ' 58' ' ' ALA . 21.5 t -95.39 123.24 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.796 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.23 105.43 0.26 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 118.751 -1.69 . . . . 0.0 111.099 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.835 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -89.68 -82.34 0.03 OUTLIER Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 120.831 -1.394 . . . . 0.0 108.202 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.835 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 51.1 Cg_endo -82.99 15.22 2.14 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 N-CA-C 108.932 -1.218 . . . . 0.0 108.932 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.71 64.29 1.27 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.323 -0.86 . . . . 0.0 111.547 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.722 ' C ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.62 -32.15 65.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.04 -1.038 . . . . 0.0 109.358 178.754 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.679 ' HA ' ' HB3' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -51.23 -41.09 60.08 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.268 -0.895 . . . . 0.0 109.184 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.754 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -46.21 -29.36 1.55 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.465 -0.772 . . . . 0.0 109.267 179.581 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.837 ' CD2' ' CG2' ' A' ' 59' ' ' ILE . 13.1 mt -72.46 -40.84 66.7 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.756 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.87 -37.33 73.75 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.457 -0.777 . . . . 0.0 109.535 179.371 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -78.58 -26.76 45.57 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.512 -0.743 . . . . 0.0 110.297 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.71 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -74.21 -37.98 63.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.922 . . . . 0.0 110.063 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.739 ' CD1' HD12 ' A' ' 5' ' ' ILE . 1.5 mp -63.7 -37.35 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.975 -1.078 . . . . 0.0 108.788 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.43 ' ND2' ' C ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -73.29 -32.79 64.84 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.151 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.668 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.47 0.3 OUTLIER -91.79 -6.55 51.55 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 115.191 -2.604 . . . . 0.0 108.157 -179.419 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.757 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -79.85 -55.02 5.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.361 -1.462 . . . . 0.0 109.419 169.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.82 ' CE ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.01 -23.16 64.97 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.338 179.751 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.474 ' CD ' ' C ' ' A' ' 85' ' ' GLU . 3.3 tm-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.257 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.591 ' CE ' ' CD ' ' A' ' 83' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.876 0.846 . . . . 0.0 110.845 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.689 ' HA ' ' CZ ' ' A' ' 30' ' ' PHE . 1.4 p -80.04 -96.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.965 -1.084 . . . . 0.0 110.337 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.75 ' CG1' HG22 ' A' ' 36' ' ' VAL . 47.6 t -89.97 129.05 41.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 121.561 -0.712 . . . . 0.0 109.936 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.983 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 0.7 OUTLIER -149.05 101.91 3.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.792 -1.192 . . . . 0.0 108.633 -179.068 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.717 ' CD1' ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.37 138.93 52.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 113.847 -1.524 . . . . 0.0 113.651 -178.403 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 1.013 ' O ' ' CG2' ' A' ' 59' ' ' ILE . 13.6 tt0 -132.9 121.42 22.84 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 118.692 -2.505 . . . . 0.0 106.109 176.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.743 ' HA ' ' CG1' ' A' ' 59' ' ' ILE . 3.9 m -112.28 111.61 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.312 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -176.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.854 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -116.15 95.04 4.9 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.814 -178.252 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.708 ' O ' ' CD1' ' A' ' 41' ' ' ILE . 0.6 OUTLIER -126.31 -59.42 1.31 Allowed 'General case' 0 C--N 1.291 -1.946 0 O-C-N 121.207 -0.933 . . . . 0.0 108.853 178.284 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.69 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 0.2 OUTLIER 179.09 146.47 0.38 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.825 -1.172 . . . . 0.0 110.704 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.667 ' CD ' ' HB2' ' A' ' 40' ' ' ASP . 48.2 Cg_endo -75.91 -30.17 6.18 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 124.445 1.76 . . . . 0.0 110.359 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.431 HG23 ' N ' ' A' ' 13' ' ' CYS . 6.2 t -78.92 -14.34 59.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.58 -0.7 . . . . 0.0 110.081 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.469 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -124.74 179.14 1.17 Allowed Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.516 -0.74 . . . . 0.0 109.868 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.616 ' O ' ' O ' ' A' ' 15' ' ' TYR . 52.2 Cg_endo -83.58 107.02 1.35 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.959 1.505 . . . . 0.0 109.975 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.69 ' CE1' ' O ' ' A' ' 10' ' ' SER . 3.2 m-85 -50.18 -115.42 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.819 -0.551 . . . . 0.0 109.545 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.701 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 71.0 m -149.11 38.8 0.19 Allowed Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.941 -1.099 . . . . 0.0 109.423 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.701 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 53.2 Cg_endo -74.51 29.85 0.34 Allowed 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 123.829 1.436 . . . . 0.0 111.295 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.7 ' CG ' ' CZ ' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -106.37 -55.01 2.39 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.941 -1.099 . . . . 0.0 110.423 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.656 ' N ' ' HD3' ' A' ' 73' ' ' ARG . . . -59.17 -19.93 49.39 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.314 -0.866 . . . . 0.0 109.933 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.717 ' HB ' ' CD1' ' A' ' 5' ' ' ILE . 3.2 pt -72.52 -41.78 63.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-O 121.253 0.549 . . . . 0.0 109.742 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.563 ' N ' ' CG1' ' A' ' 20' ' ' ILE . 7.7 tt0 -53.58 -35.21 60.59 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 t -71.03 -45.78 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.734 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 1.0 OUTLIER -63.98 -33.92 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.07 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.661 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 31.0 t0 -66.81 -40.88 88.21 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.838 0.827 . . . . 0.0 109.673 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.29 -48.37 79.08 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.604 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.477 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.55 -39.09 47.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.77 -0.581 . . . . 0.0 110.443 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.722 ' HB2' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -72.96 -17.73 61.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.07 -1.019 . . . . 0.0 109.915 -178.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.661 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -71.51 -47.0 58.15 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.319 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.703 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -46.2 -37.42 7.08 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.863 0.839 . . . . 0.0 110.327 179.13 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.817 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -93.72 -72.4 0.61 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 178.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.817 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -82.98 89.82 1.52 Allowed Glycine 0 N--CA 1.487 2.047 0 C-N-CA 118.88 -1.628 . . . . 0.0 109.909 177.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.549 ' OD2' ' NZ ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -40.56 -29.62 0.09 Allowed 'General case' 0 N--CA 1.52 3.065 0 CA-C-N 122.217 3.008 . . . . 0.0 110.667 176.157 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.682 ' O ' ' CG2' ' A' ' 2' ' ' VAL . 9.4 mtmm -79.85 151.77 30.04 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.81 -0.556 . . . . 0.0 112.442 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.697 HD12 ' CG2' ' A' ' 3' ' ' VAL . 16.5 mm -129.26 160.28 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 120.466 -1.396 . . . . 0.0 110.055 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.735 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -151.25 70.1 0.96 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.487 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.75 HG22 ' CG1' ' A' ' 3' ' ' VAL 0.255 85.7 t -96.93 123.23 49.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -179.197 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.82 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 7.8 mt-10 -108.84 148.29 30.82 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -177.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.725 ' HA ' HG21 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -142.78 110.7 5.93 Favored 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -174.459 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.731 ' HB ' ' CB ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -111.76 165.0 7.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 122.266 1.032 . . . . 0.0 113.24 -178.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.668 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -100.13 161.13 13.8 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.718 0.771 . . . . 0.0 110.931 178.595 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.854 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -62.08 -18.74 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 120.473 -1.392 . . . . 0.0 110.99 179.438 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.668 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -91.23 -14.97 30.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.944 -1.097 . . . . 0.0 111.547 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.604 HG13 HG23 ' A' ' 39' ' ' ILE . 10.0 p -113.62 -31.35 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.131 -0.98 . . . . 0.0 110.63 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.731 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . 41.9 t0 -112.56 37.93 2.91 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.454 -0.899 . . . . 0.0 110.087 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.514 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.296 0.0 OUTLIER -65.04 -3.49 3.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 119.956 -1.715 . . . . 0.0 109.086 -179.51 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.779 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 1.7 mt-10 -60.0 -20.72 59.25 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.846 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -44.55 -63.37 0.91 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.305 -1.497 . . . . 0.0 109.072 -178.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.891 ' O ' ' N ' ' A' ' 50' ' ' GLU . . . -57.62 -11.23 1.94 Allowed 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.879 -1.51 . . . . 0.0 111.083 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.779 ' CG2' ' O ' ' A' ' 46' ' ' GLU . 2.7 pp -24.0 -38.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.237 -1.539 . . . . 0.0 107.922 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.891 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -56.22 -51.6 67.5 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.873 177.648 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.808 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.0 p90 -122.84 -30.93 3.75 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.467 -0.771 . . . . 0.0 110.122 178.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.707 ' HA2' ' HB3' ' A' ' 48' ' ' ALA . . . 45.05 4.8 0.01 OUTLIER Glycine 1 N--CA 1.52 4.25 0 O-C-N 121.589 -0.695 . . . . 0.0 111.759 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.645 ' H ' ' C ' ' A' ' 51' ' ' TYR . 8.9 mt -75.68 -79.76 0.09 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 175.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.696 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 1.9 mtm -94.21 65.98 3.41 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.31 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.865 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.294 . . -108.23 108.64 19.75 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.346 -1.471 . . . . 0.0 109.79 -177.118 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.824 ' O ' ' CG1' ' A' ' 41' ' ' ILE . 2.6 t -147.76 -65.16 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.28 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.354 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.753 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 59.9 Cg_endo -105.44 106.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.302 -1.897 0 N-CA-C 109.11 -1.15 . . . . 0.0 109.11 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.716 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -160.71 177.83 10.07 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 112.694 -2.048 . . . . 0.0 111.686 -176.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 1.013 ' CG2' ' O ' ' A' ' 6' ' ' GLU 0.271 1.3 mp -146.53 154.3 12.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.019 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.785 ' HA ' ' HA ' ' A' ' 66' ' ' ARG 0.29 . . -87.72 155.49 19.9 Favored 'General case' 0 CA--C 1.479 -1.77 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.696 HG13 ' N ' ' A' ' 66' ' ' ARG 0.312 1.6 mt -104.12 92.19 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.038 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 -175.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.983 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.2 OUTLIER -54.74 86.25 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 126.274 2.234 . . . . 0.0 106.256 -178.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.754 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 162.02 -44.95 0.37 Allowed Glycine 0 C--N 1.292 -1.863 0 N-CA-C 107.777 -2.129 . . . . 0.0 107.777 -177.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.665 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 11.5 m -126.69 -60.81 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.568 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.665 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 74.6 t -164.38 -99.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 120.929 -1.107 . . . . 0.0 112.379 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.807 ' HG3' ' O ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -165.25 157.86 15.81 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.61 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.846 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -146.62 176.19 10.02 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.325 -0.859 . . . . 0.0 111.698 -176.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.627 ' HA ' ' HB1' ' A' ' 58' ' ' ALA . 7.9 t -84.98 121.58 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.693 -0.63 . . . . 0.0 110.363 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.803 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.67 110.08 0.41 Allowed Glycine 0 N--CA 1.498 2.823 0 O-C-N 119.863 -1.773 . . . . 0.0 110.694 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.785 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -90.49 -79.97 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.388 -1.066 . . . . 0.0 108.624 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.785 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 57.2 Cg_endo -83.91 18.27 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 N-CA-C 109.012 -1.188 . . . . 0.0 109.012 177.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -102.69 63.62 0.86 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.528 0.68 . . . . 0.0 110.176 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.7 ' CZ ' ' CG ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -70.57 -42.17 71.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 108.759 178.552 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.633 ' N ' ' HB2' ' A' ' 19' ' ' ALA . 2.0 tt0 -44.07 -37.11 2.86 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.756 -0.59 . . . . 0.0 109.854 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.706 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -47.85 -37.79 14.65 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 120.029 -0.669 . . . . 0.0 109.894 179.354 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.708 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 9.7 mp -65.23 -41.52 94.3 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.734 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.2 -36.61 73.36 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 122.246 1.022 . . . . 0.0 109.873 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -78.9 -31.01 45.18 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 110.337 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.687 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -70.27 -38.01 75.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.514 -0.741 . . . . 0.0 111.158 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.743 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -65.66 -42.4 92.63 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 CA-C-O 121.75 0.786 . . . . 0.0 109.168 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.618 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -70.52 -21.09 62.77 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.618 176.302 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.416 ' O ' ' CG ' ' A' ' 82' ' ' ASP 0.356 0.3 OUTLIER -103.38 2.92 34.58 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 117.567 -1.653 . . . . 0.0 106.733 -178.65 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.81 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.33 -58.36 2.52 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 102.264 -3.235 . . . . 0.0 102.264 176.773 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.658 ' HE3' ' CE ' ' A' ' 27' ' ' LYS . 7.5 ptt? -69.47 -18.94 63.76 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.022 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.766 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.706 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.319 0.581 . . . . 0.0 110.217 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.731 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 1.3 p -79.92 -95.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 109.894 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.77 ' CG1' HG22 ' A' ' 36' ' ' VAL . 52.1 t -88.89 129.13 40.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.476 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 1.042 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.292 0.7 OUTLIER -151.16 103.23 3.01 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 125.108 2.385 . . . . 0.0 108.446 179.562 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.755 ' CD1' ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.5 137.26 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 CA-C-N 111.337 -2.665 . . . . 0.0 113.997 -178.165 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.994 ' O ' ' CG2' ' A' ' 59' ' ' ILE . 12.9 tt0 -131.72 119.89 21.97 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 115.458 -2.497 . . . . 0.0 105.862 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.796 ' HA ' ' CG1' ' A' ' 59' ' ' ILE . 4.2 m -111.61 111.6 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -176.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.87 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -116.4 93.71 4.34 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.021 -178.25 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.745 ' O ' ' CG1' ' A' ' 41' ' ' ILE . 0.6 OUTLIER -124.43 -60.02 1.43 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.408 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.774 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 0.2 OUTLIER 179.7 147.72 0.44 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 110.621 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.733 ' CD ' ' HB2' ' A' ' 40' ' ' ASP . 48.4 Cg_endo -76.53 -30.07 5.39 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.273 1.67 . . . . 0.0 110.316 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.464 HG23 ' N ' ' A' ' 13' ' ' CYS . 6.6 t -79.48 -13.55 59.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.938 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.547 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -125.03 179.58 1.09 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 109.946 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.648 ' O ' ' O ' ' A' ' 15' ' ' TYR . 52.1 Cg_endo -83.26 106.26 1.36 Allowed 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.984 1.518 . . . . 0.0 110.537 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.774 ' CE1' ' O ' ' A' ' 10' ' ' SER . 3.2 m-85 -49.73 -114.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.095 -1.003 . . . . 0.0 109.741 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.741 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 76.1 m -150.0 38.47 0.17 Allowed Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.404 -0.81 . . . . 0.0 109.921 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.741 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 50.9 Cg_endo -74.28 29.55 0.33 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.001 1.527 . . . . 0.0 111.129 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.794 ' CG ' ' CZ ' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -105.8 -56.28 2.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.082 -1.011 . . . . 0.0 110.253 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.718 ' CB ' ' C ' ' A' ' 73' ' ' ARG . . . -58.32 -20.13 40.65 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.314 -0.866 . . . . 0.0 109.622 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.756 ' CD1' ' CG1' ' A' ' 36' ' ' VAL . 3.1 pt -72.93 -41.82 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.521 -0.737 . . . . 0.0 109.737 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.592 ' N ' ' CG1' ' A' ' 20' ' ' ILE . 7.8 tt0 -52.73 -35.11 55.39 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.4 t -71.65 -44.73 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 121.799 0.809 . . . . 0.0 109.063 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.785 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 1.0 OUTLIER -64.66 -32.98 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.75 0.786 . . . . 0.0 109.107 177.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.696 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 28.5 t0 -68.53 -40.31 80.81 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.213 1.006 . . . . 0.0 109.477 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.43 -48.13 79.95 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.444 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.507 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -78.24 -39.4 40.39 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.635 -0.665 . . . . 0.0 110.672 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.751 ' HB2' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -71.56 -19.01 62.21 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.208 -178.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.696 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -70.86 -47.15 60.88 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 176.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.778 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -46.4 -37.89 8.21 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.781 0.8 . . . . 0.0 109.997 179.313 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.862 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -93.56 -70.3 0.71 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.509 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.862 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -84.82 87.71 1.56 Allowed Glycine 0 N--CA 1.504 3.213 0 C-N-CA 118.111 -1.995 . . . . 0.0 111.059 177.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.587 ' OD2' ' NZ ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -37.73 -28.93 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 O-C-N 118.337 -2.86 . . . . 0.0 111.017 176.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.728 ' O ' ' CG2' ' A' ' 2' ' ' VAL . 9.3 mtmm -81.27 151.77 27.93 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.748 HD12 ' CG2' ' A' ' 3' ' ' VAL . 16.3 mm -128.96 160.3 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 119.926 -1.734 . . . . 0.0 110.039 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.746 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -151.14 70.01 0.97 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.392 -0.817 . . . . 0.0 108.842 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.77 HG22 ' CG1' ' A' ' 3' ' ' VAL 0.257 81.0 t -96.98 121.87 47.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -178.836 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.873 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 7.6 mt-10 -108.39 147.41 31.61 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.739 ' HA ' HG21 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -141.41 111.59 6.8 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -174.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.793 ' HB ' ' CB ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -112.02 166.08 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.101 -0.999 . . . . 0.0 113.256 -178.182 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.733 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -100.6 160.61 14.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.546 -0.722 . . . . 0.0 111.376 178.164 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.934 ' CG1' ' O ' ' A' ' 56' ' ' VAL 0.251 0.2 OUTLIER -62.65 -16.2 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.735 -1.228 . . . . 0.0 110.584 179.737 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.725 ' N ' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -93.2 -14.18 27.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.723 -1.236 . . . . 0.0 111.664 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.631 HG13 HG23 ' A' ' 39' ' ' ILE . 9.9 p -114.11 -31.07 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.009 -1.057 . . . . 0.0 110.748 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.793 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . 43.0 t0 -112.51 37.32 3.09 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.116 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.533 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.341 0.0 OUTLIER -66.34 -1.26 3.23 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 117.49 -1.684 . . . . 0.0 108.666 -177.972 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.835 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 1.7 mt-10 -60.11 -21.16 61.2 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.916 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -44.48 -63.27 0.93 Allowed 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 123.626 1.679 . . . . 0.0 109.011 -177.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.931 ' CB ' ' CB ' ' A' ' 55' ' ' ALA . . . -55.86 -12.81 1.49 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 113.51 -1.677 . . . . 0.0 111.458 177.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.835 ' CG2' ' O ' ' A' ' 46' ' ' GLU . 2.7 pp -25.07 -38.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 O-C-N 119.524 -1.985 . . . . 0.0 107.244 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.896 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -55.55 -52.13 64.77 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.981 177.11 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.857 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 1.8 p90 -123.2 -28.63 3.98 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.239 -0.913 . . . . 0.0 110.014 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.771 ' HA2' ' HB3' ' A' ' 48' ' ' ALA . . . 43.22 5.12 0.01 OUTLIER Glycine 0 N--CA 1.504 3.179 0 CA-C-O 122.367 0.982 . . . . 0.0 111.835 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.739 ' N ' ' O ' ' A' ' 51' ' ' TYR . 8.7 mt -75.95 -75.95 0.17 Allowed 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 174.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.696 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 1.8 mtm -97.68 65.27 1.85 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.931 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.296 . . -108.57 109.27 20.46 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.165 -1.585 . . . . 0.0 109.074 -176.799 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.934 ' O ' ' CG1' ' A' ' 41' ' ' ILE . 2.6 t -147.83 -64.25 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.826 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.034 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.825 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 58.1 Cg_endo -105.64 104.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 N-CA-C 108.781 -1.276 . . . . 0.0 108.781 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.722 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -159.37 177.3 11.13 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 112.604 -2.089 . . . . 0.0 111.568 -176.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.994 ' CG2' ' O ' ' A' ' 6' ' ' GLU . 1.3 mp -146.07 153.04 13.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 O-C-N 121.502 -0.748 . . . . 0.0 109.124 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.833 ' HA ' ' CG ' ' A' ' 66' ' ' ARG 0.303 . . -87.3 154.62 20.55 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 102.67 -3.085 . . . . 0.0 102.67 -178.651 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.71 HG13 ' N ' ' A' ' 66' ' ' ARG 0.386 1.6 mt -103.72 93.42 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.599 0 N-CA-C 103.363 -2.828 . . . . 0.0 103.363 -175.357 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 1.042 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.2 OUTLIER -52.32 85.04 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 111.602 -2.545 . . . . 0.0 106.121 179.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.796 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 162.46 -44.64 0.35 Allowed Glycine 0 C--N 1.289 -2.037 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.75 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 11.3 m -127.44 -59.33 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.993 -0.71 . . . . 0.0 110.949 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.75 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 76.1 t -164.68 -101.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.488 0 O-C-N 120.346 -1.471 . . . . 0.0 112.529 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.833 ' CG ' ' HA ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -162.99 158.96 22.88 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.47 -0.769 . . . . 0.0 109.058 -178.173 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.868 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -147.07 178.25 8.51 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.804 -1.185 . . . . 0.0 111.498 -177.272 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.631 HG23 ' OH ' ' A' ' 51' ' ' TYR . 8.3 t -86.57 120.94 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.446 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.815 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.89 110.25 0.43 Allowed Glycine 0 N--CA 1.496 2.673 0 C-N-CA 118.066 -2.016 . . . . 0.0 110.349 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.844 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -90.34 -80.52 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.087 -1.243 . . . . 0.0 108.546 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.844 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 55.9 Cg_endo -83.48 17.99 1.58 Allowed 'Trans proline' 0 C--N 1.301 -1.966 0 N-CA-C 108.897 -1.232 . . . . 0.0 108.897 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -102.32 64.35 0.91 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.347 -0.846 . . . . 0.0 110.636 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.794 ' CZ ' ' CG ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -71.99 -40.43 68.57 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.04 -1.037 . . . . 0.0 109.293 178.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.71 ' N ' ' HB2' ' A' ' 19' ' ' ALA . 2.0 tt0 -45.24 -37.63 4.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.39 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.779 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -47.41 -38.05 12.6 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.293 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.751 ' HG ' ' CG2' ' A' ' 59' ' ' ILE . 9.5 mp -64.96 -40.95 95.78 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.425 -0.797 . . . . 0.0 109.214 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.785 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.55 -36.3 73.7 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.864 0.84 . . . . 0.0 109.847 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -78.3 -31.69 48.98 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.64 -0.662 . . . . 0.0 110.6 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.68 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -70.58 -38.46 74.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 0.0 111.048 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.803 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 0.3 OUTLIER -64.2 -43.33 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 122.425 1.107 . . . . 0.0 109.183 179.079 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.645 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -70.24 -23.37 62.91 Favored 'General case' 0 C--O 1.2 -1.536 0 CA-C-O 117.899 -1.048 . . . . 0.0 109.179 176.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.371 0.2 OUTLIER -101.13 2.34 40.12 Favored 'General case' 0 C--O 1.263 1.778 0 C-N-CA 116.619 -2.032 . . . . 0.0 106.189 -178.064 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.846 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.12 -56.62 3.15 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 102.401 -3.185 . . . . 0.0 102.401 176.032 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.72 ' HE3' ' NZ ' ' A' ' 27' ' ' LYS . 8.2 ptt? -70.53 -18.5 62.94 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.836 -1.165 . . . . 0.0 110.729 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 117.889 -1.053 . . . . 0.0 109.94 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.653 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.303 0.573 . . . . 0.0 110.201 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.766 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 0.6 OUTLIER -89.95 -92.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 0.0 109.947 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.743 HG23 ' CD1' ' A' ' 34' ' ' ILE . 75.1 t -89.15 112.42 24.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.55 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.841 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 1.0 OUTLIER -132.86 105.4 7.1 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.664 -1.273 . . . . 0.0 108.755 178.316 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.753 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -120.4 138.17 51.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.812 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 1.052 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.3 122.76 26.99 Favored 'General case' 0 C--N 1.282 -2.335 0 C-N-CA 115.832 -2.347 . . . . 0.0 106.841 177.479 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.811 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 20.1 m -109.23 142.3 22.14 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.574 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.887 ' H ' HD13 ' A' ' 59' ' ' ILE . 2.0 t80 -139.79 80.99 1.8 Allowed 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 117.979 -1.489 . . . . 0.0 112.823 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.688 ' CB ' ' HA ' ' A' ' 15' ' ' TYR . 3.4 m -117.81 -68.75 0.89 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 119.144 -2.222 . . . . 0.0 110.373 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.768 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 1.3 p 179.55 164.49 0.78 Allowed Pre-proline 0 C--N 1.293 -1.859 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.381 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.671 ' HD3' ' CG ' ' A' ' 40' ' ' ASP . 50.1 Cg_endo -80.27 -28.4 3.03 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.221 1.643 . . . . 0.0 110.424 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -18.37 54.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.749 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.07 174.36 3.95 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.418 -0.801 . . . . 0.0 109.696 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.651 ' O ' ' O ' ' A' ' 15' ' ' TYR . 51.7 Cg_endo -83.01 114.55 2.26 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.914 1.481 . . . . 0.0 110.422 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.768 ' CE1' ' O ' ' A' ' 10' ' ' SER . 16.3 m-85 -49.26 -112.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.597 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.735 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 92.5 m -150.57 37.58 0.14 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.199 -0.938 . . . . 0.0 110.081 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.735 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 53.9 Cg_endo -76.51 17.06 0.81 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.92 1.484 . . . . 0.0 111.027 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.503 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -95.1 -67.97 0.83 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.075 -1.016 . . . . 0.0 110.79 -179.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.702 ' HB2' ' CB ' ' A' ' 73' ' ' ARG . . . -54.28 -22.59 12.26 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.216 -0.928 . . . . 0.0 109.512 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.753 ' HB ' ' CG2' ' A' ' 5' ' ' ILE . 5.1 pt -70.58 -39.18 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.485 -0.759 . . . . 0.0 109.678 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.715 ' N ' HG13 ' A' ' 20' ' ' ILE . 6.1 tt0 -48.88 -33.45 10.72 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.493 HG12 ' CD2' ' A' ' 77' ' ' PHE . 3.2 t -71.41 -47.42 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.791 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -61.4 -32.96 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.018 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.73 ' OD1' ' CD1' ' A' ' 34' ' ' ILE . 5.2 t70 -68.18 -40.38 82.25 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.994 0.902 . . . . 0.0 109.145 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -46.52 83.12 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.666 0.746 . . . . 0.0 109.626 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.461 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.31 -39.58 47.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.622 -0.674 . . . . 0.0 110.717 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.745 ' CE ' ' HA ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -70.66 -18.18 62.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.917 -1.114 . . . . 0.0 109.328 -179.149 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.799 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -73.57 -45.05 55.71 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.222 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.743 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -50.14 -32.92 17.27 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.959 0.885 . . . . 0.0 110.465 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.766 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -97.19 -67.01 0.87 Allowed 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 179.09 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.763 ' HA3' HG22 ' A' ' 2' ' ' VAL . . . -84.97 86.29 1.56 Allowed Glycine 0 N--CA 1.505 3.261 0 C-N-CA 117.899 -2.096 . . . . 0.0 110.154 177.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.595 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -37.54 -29.29 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 O-C-N 118.319 -2.871 . . . . 0.0 110.188 177.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.684 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -78.63 155.56 29.5 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.822 -0.549 . . . . 0.0 111.774 178.189 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.799 ' CD1' ' CG ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -130.04 151.46 35.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 120.327 -1.483 . . . . 0.0 109.902 178.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.592 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -151.81 78.09 1.24 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.709 ' CG1' HD11 ' A' ' 20' ' ' ILE . 56.0 t -96.99 129.09 47.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 1.052 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 78.3 mt-10 -113.48 133.1 55.4 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.811 ' HA ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -127.41 128.67 46.2 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 113.989 -1.459 . . . . 0.0 114.754 -177.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.771 ' HB ' ' CB ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -134.16 169.91 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 119.875 -1.766 . . . . 0.0 111.785 177.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.749 ' HB3' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -100.59 172.02 7.36 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.83 178.03 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.858 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -62.75 -37.88 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.711 -1.243 . . . . 0.0 109.36 178.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.684 ' HG3' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -80.95 -4.13 53.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.908 -1.12 . . . . 0.0 111.547 179.289 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.766 ' CG2' ' CG2' ' A' ' 39' ' ' ILE . 2.0 m -113.99 -45.97 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 120.954 -1.091 . . . . 0.0 110.033 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.771 ' CB ' ' HB ' ' A' ' 39' ' ' ILE . 1.6 t70 -105.27 41.84 1.31 Allowed 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.498 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.599 ' NH2' ' HA3' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -65.21 -1.71 2.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.118 -1.614 . . . . 0.0 109.5 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.833 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 2.3 mm-40 -62.81 -23.42 67.25 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.265 178.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.888 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -44.45 -68.81 0.17 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.182 -0.949 . . . . 0.0 108.487 179.405 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.92 ' HA ' ' CE1' ' A' ' 51' ' ' TYR . . . -55.57 -10.14 0.62 Allowed 'General case' 0 C--O 1.194 -1.866 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.549 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.833 ' CG2' ' O ' ' A' ' 46' ' ' GLU . 2.6 pp -23.98 -41.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 119.412 -2.055 . . . . 0.0 105.956 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.898 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -54.0 -53.15 56.96 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.443 -0.798 . . . . 0.0 108.853 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.92 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 25.9 p90 -119.96 -32.24 4.26 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.269 -0.894 . . . . 0.0 110.161 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.697 ' N ' ' HB2' ' A' ' 48' ' ' ALA . . . 42.81 6.36 0.01 OUTLIER Glycine 0 N--CA 1.499 2.874 0 CA-C-O 122.288 0.938 . . . . 0.0 111.572 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.714 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 4.5 mt -74.43 -80.66 0.08 Allowed 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.541 ' C ' ' HE2' ' A' ' 51' ' ' TYR 0.265 4.1 mtp -95.37 67.24 2.92 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.135 177.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.89 ' CB ' ' HB1' ' A' ' 48' ' ' ALA . . . -109.46 120.2 41.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 119.62 -1.925 . . . . 0.0 109.922 -178.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.784 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -149.12 -56.39 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.936 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.722 -178.711 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.784 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 57.7 Cg_endo -111.63 109.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 122.931 0.964 . . . . 0.0 110.263 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.803 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -161.36 174.93 12.8 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.185 -1.371 . . . . 0.0 110.901 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.925 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -134.86 154.64 36.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.42 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.878 ' HA ' ' HG3' ' A' ' 66' ' ' ARG 0.26 . . -93.16 157.22 16.39 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 102.71 -3.07 . . . . 0.0 102.71 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.748 ' HB ' HG21 ' A' ' 64' ' ' VAL 0.263 1.1 mt -101.87 91.94 2.2 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 -176.317 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.841 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -53.71 83.08 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -178.072 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.718 ' HA3' ' HB2' ' A' ' 83' ' ' GLU . . . 162.36 -43.49 0.36 Allowed Glycine 0 C--N 1.283 -2.363 0 N-CA-C 107.649 -2.181 . . . . 0.0 107.649 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.763 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 11.9 m -126.95 -58.86 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.851 -0.794 . . . . 0.0 111.097 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.763 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 81.0 t -163.78 -100.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 120.32 -1.488 . . . . 0.0 113.268 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.925 ' HG3' ' O ' ' A' ' 59' ' ' ILE . 1.8 ttp180 -168.45 159.57 10.47 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.547 -0.72 . . . . 0.0 109.396 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.859 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -146.37 175.05 10.83 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.144 -0.973 . . . . 0.0 111.865 -177.33 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.619 ' N ' ' HZ1' ' A' ' 47' ' ' LYS . 79.8 t -82.41 119.33 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.665 -0.647 . . . . 0.0 110.133 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.824 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.77 107.63 0.31 Allowed Glycine 0 N--CA 1.492 2.426 0 C-N-CA 118.655 -1.736 . . . . 0.0 110.578 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.848 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . . . -88.57 -81.2 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.036 -1.273 . . . . 0.0 108.539 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.848 ' HD3' ' CB ' ' A' ' 70' ' ' ALA . 56.5 Cg_endo -84.5 18.52 1.54 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.407 1.214 . . . . 0.0 109.006 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.62 61.78 0.71 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.583 -0.698 . . . . 0.0 110.493 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.709 ' HG2' ' CB ' ' A' ' 16' ' ' CYS . 22.2 mtt180 -68.35 -32.25 72.21 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.849 -0.741 . . . . 0.0 109.276 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.688 ' HA ' ' HB3' ' A' ' 19' ' ' ALA . 1.2 tm-20 -47.44 -45.39 25.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 109.59 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.78 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -45.18 -29.11 0.88 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.061 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.757 ' CD1' HG21 ' A' ' 59' ' ' ILE . 3.2 mp -70.58 -39.96 73.56 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.511 -0.743 . . . . 0.0 109.059 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.791 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.11 -41.89 89.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.47 -0.769 . . . . 0.0 109.829 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.528 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 2.4 tm-20 -76.41 -27.99 56.5 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.248 0.547 . . . . 0.0 109.76 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.618 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -69.32 -42.54 75.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.04 -1.038 . . . . 0.0 111.286 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.742 ' CG2' ' CG ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -61.97 -45.36 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.043 -1.035 . . . . 0.0 108.814 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.635 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -71.68 -27.07 62.79 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.45 0.643 . . . . 0.0 109.442 178.237 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 1.068 ' O ' ' OD1' ' A' ' 82' ' ' ASP 0.287 0.2 OUTLIER -97.69 8.14 45.2 Favored 'General case' 0 C--O 1.196 -1.762 0 O-C-N 118.918 -2.364 . . . . 0.0 107.82 -178.69 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.784 ' HG2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -101.17 -57.77 2.02 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.721 ' HE3' ' NZ ' ' A' ' 27' ' ' LYS . 21.4 ptt? -68.23 -15.59 63.64 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.82 176.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.039 179.952 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.718 ' CE ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.31 0.576 . . . . 0.0 110.193 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.774 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -80.66 -94.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.157 -0.964 . . . . 0.0 110.195 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.712 ' CB ' HG23 ' A' ' 34' ' ' ILE . 54.6 t -93.03 91.31 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.422 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.773 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -116.88 108.01 15.3 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.942 0.877 . . . . 0.0 109.262 178.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.743 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.07 141.18 45.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.283 -0.886 . . . . 0.0 110.306 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.768 ' CG ' ' HB2' ' A' ' 60' ' ' ALA 0.255 5.4 tt0 -130.12 101.9 6.01 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 117.708 -1.597 . . . . 0.0 109.235 178.134 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.668 ' HA ' ' CG1' ' A' ' 59' ' ' ILE . 3.3 m -95.52 110.45 24.22 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.423 0 CA-C-O 123.412 1.577 . . . . 0.0 108.085 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.838 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 1.6 t80 -118.51 91.03 3.46 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.965 -1.084 . . . . 0.0 110.203 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.711 ' CG2' ' N ' ' A' ' 10' ' ' SER . 0.7 OUTLIER -120.22 -69.62 0.83 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.777 . . . . 0.0 109.629 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.711 ' N ' ' CG2' ' A' ' 9' ' ' THR . 21.6 t 179.68 152.14 0.56 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 110.831 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.673 ' HD3' ' HB2' ' A' ' 40' ' ' ASP . 49.8 Cg_endo -77.22 -15.94 15.83 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.175 1.618 . . . . 0.0 110.495 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 t -79.27 5.9 11.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.171 -0.956 . . . . 0.0 109.898 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.651 ' SG ' ' CD ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -160.8 -170.94 0.26 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 0.0 110.153 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.651 ' CD ' ' SG ' ' A' ' 13' ' ' CYS . 55.3 Cg_endo -84.2 113.54 1.79 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.882 1.464 . . . . 0.0 110.667 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.653 ' HB3' HG22 ' A' ' 7' ' ' VAL . 7.4 m-85 -49.55 -112.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.627 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.704 ' CB ' HD11 ' A' ' 59' ' ' ILE . 58.5 m -152.34 39.19 0.14 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.043 -1.036 . . . . 0.0 110.414 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.699 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 54.0 Cg_endo -76.9 17.17 0.85 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.9 1.474 . . . . 0.0 111.023 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.718 ' SD ' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -93.36 -64.71 1.06 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.092 -1.005 . . . . 0.0 112.078 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.718 ' N ' ' SD ' ' A' ' 18' ' ' MET . . . -55.96 -22.42 26.29 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.294 -0.879 . . . . 0.0 109.779 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.743 ' HB ' ' CG2' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -71.28 -39.69 72.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.503 -0.748 . . . . 0.0 109.531 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.703 ' N ' ' CD1' ' A' ' 20' ' ' ILE . 3.1 tt0 -48.77 -31.83 7.62 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.434 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 2.8 t -71.59 -44.96 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.321 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.777 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -68.71 -26.54 33.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.301 -0.874 . . . . 0.0 109.22 178.418 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.737 ' OD1' ' CG2' ' A' ' 34' ' ' ILE . 14.1 t0 -74.67 -38.72 62.34 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -44.53 91.62 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.666 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.508 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.76 -40.13 29.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.456 -0.777 . . . . 0.0 110.443 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.781 ' N ' ' HE3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.3 -22.79 64.7 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.092 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.711 ' CG ' HD12 ' A' ' 34' ' ' ILE . 3.5 mtpt -69.93 -44.59 69.3 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 177.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.799 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -50.14 -39.98 44.95 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.681 0.753 . . . . 0.0 109.079 178.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.799 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.67 -55.22 3.73 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.739 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -96.73 77.38 0.71 Allowed Glycine 0 N--CA 1.488 2.161 0 O-C-N 121.398 -0.814 . . . . 0.0 111.07 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.543 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -33.45 -24.64 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 118.998 1.399 . . . . 0.0 110.424 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.739 ' N ' ' O ' ' A' ' 31' ' ' GLY . 1.1 mtmp? -85.42 155.57 21.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.131 -0.98 . . . . 0.0 110.813 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.737 ' CG2' ' OD1' ' A' ' 24' ' ' ASP . 0.1 OUTLIER -129.33 149.48 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.939 178.634 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.67 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 36.3 t0 -150.31 71.9 1.08 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.495 -0.753 . . . . 0.0 109.254 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.64 ' HA ' HG12 ' A' ' 5' ' ' ILE . 58.4 t -91.34 117.39 34.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.57 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.753 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.25 91.1 mt-10 -100.5 138.06 38.07 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.433 -1.307 . . . . 0.0 108.301 -178.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.665 ' HA ' HG23 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -140.62 126.67 19.55 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.725 -1.235 . . . . 0.0 111.598 -177.383 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.743 ' CD1' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -139.65 176.0 6.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.486 -0.759 . . . . 0.0 109.653 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.736 ' OD1' ' N ' ' A' ' 42' ' ' MET . 2.1 p30 -114.22 172.9 6.73 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.858 -1.152 . . . . 0.0 111.947 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.838 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.7 OUTLIER -62.27 -5.29 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.41 -0.806 . . . . 0.0 112.03 176.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.736 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -99.94 -18.56 17.03 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.019 -1.051 . . . . 0.0 111.048 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.726 HG22 ' CG2' ' A' ' 39' ' ' ILE . 0.7 OUTLIER -113.01 -37.08 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.19 -0.944 . . . . 0.0 110.056 -178.389 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.786 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 5.2 t0 -114.22 52.52 0.83 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.2 -0.938 . . . . 0.0 110.977 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.255 72.2 ttt180 -65.87 -5.58 9.57 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.315 -1.354 . . . . 0.0 109.575 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.737 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 0.6 OUTLIER -60.11 -15.39 23.09 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.344 -0.848 . . . . 0.0 110.058 176.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.848 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -52.17 -58.46 6.54 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.124 -178.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.852 ' CB ' ' CB ' ' A' ' 55' ' ' ALA . . . -63.94 -0.8 1.2 Allowed 'General case' 0 C--N 1.279 -2.471 0 O-C-N 121.331 -0.856 . . . . 0.0 110.73 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.737 ' CG2' ' O ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -35.07 -38.7 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 -177.003 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.581 ' N ' ' C ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -53.73 -51.91 61.82 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.165 176.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.812 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 1.6 p90 -123.2 -28.22 4.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.085 -1.009 . . . . 0.0 110.449 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.8 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.45 14.18 0.01 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.732 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.4 mt -85.87 -64.92 1.07 Allowed 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 123.674 1.702 . . . . 0.0 107.931 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.503 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 10.0 mtt -105.86 58.12 0.66 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.253 -1.34 . . . . 0.0 107.776 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.852 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.264 . . -99.0 106.78 19.08 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 123.467 1.604 . . . . 0.0 110.782 -175.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.794 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -146.72 -60.63 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.21 179.037 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.794 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 46.8 Cg_endo -100.0 104.76 0.05 OUTLIER 'Trans proline' 0 C--O 1.199 -1.47 0 CA-C-O 123.495 1.373 . . . . 0.0 110.429 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.745 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -160.14 -177.86 6.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.538 -1.352 . . . . 0.0 111.572 -178.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.801 ' CD1' ' CD1' ' A' ' 76' ' ' LEU . 0.6 OUTLIER -149.16 137.18 14.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.779 ' CB ' ' HD3' ' A' ' 66' ' ' ARG . . . -80.87 140.44 35.36 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 117.155 -1.818 . . . . 0.0 106.987 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.762 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.413 0.7 OUTLIER -89.39 85.91 2.52 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.539 0 C-N-CA 115.302 -2.559 . . . . 0.0 106.058 -175.994 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.773 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.7 OUTLIER -44.12 83.24 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 113.098 -1.865 . . . . 0.0 108.622 177.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.762 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.07 -44.24 0.37 Allowed Glycine 0 N--CA 1.484 1.891 0 N-CA-C 107.042 -2.423 . . . . 0.0 107.042 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.759 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 16.6 m -126.69 -59.13 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 O-C-N 121.622 -0.928 . . . . 0.0 111.378 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.759 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 97.0 t -163.85 -106.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 120.289 -1.507 . . . . 0.0 112.249 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.779 ' HD3' ' CB ' ' A' ' 60' ' ' ALA . 1.8 ttp180 -162.4 165.47 26.35 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.716 -0.615 . . . . 0.0 109.55 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.829 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -145.0 177.83 8.48 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.97 -1.082 . . . . 0.0 111.06 -178.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.72 HG23 ' CZ ' ' A' ' 51' ' ' TYR . 22.5 t -93.18 116.55 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.297 -0.877 . . . . 0.0 109.865 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.821 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.41 126.58 1.58 Allowed Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.229 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.831 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -94.03 -83.05 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.759 0 O-C-N 120.921 -1.341 . . . . 0.0 108.709 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.831 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 51.4 Cg_endo -80.73 23.81 0.7 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 N-CA-C 109.11 -1.15 . . . . 0.0 109.11 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.443 ' H ' ' C ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -98.51 70.52 1.96 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.238 -0.913 . . . . 0.0 111.432 -179.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.718 ' CB ' ' HB2' ' A' ' 19' ' ' ALA . 11.9 mtm180 -76.77 -35.28 57.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.997 -1.064 . . . . 0.0 109.536 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.678 ' HA ' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -49.02 -32.29 9.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.664 179.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.791 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -50.9 -40.18 56.1 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.295 -0.878 . . . . 0.0 109.273 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.801 ' CD1' ' CD1' ' A' ' 59' ' ' ILE . 4.9 mp -64.32 -38.32 90.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.491 -0.755 . . . . 0.0 109.318 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.803 ' CD1' ' N ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -60.76 -42.94 98.43 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.868 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.803 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 4.5 tm-20 -78.54 -23.31 46.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 109.851 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.629 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -73.71 -37.01 65.3 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 109.446 -178.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.734 ' CG2' HG23 ' A' ' 23' ' ' VAL . 0.1 OUTLIER -63.44 -46.08 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.067 -1.02 . . . . 0.0 109.076 178.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.633 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -70.11 -33.59 72.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.35 -0.844 . . . . 0.0 108.742 179.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.448 8.0 t70 -88.08 -6.9 57.67 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 114.79 -2.764 . . . . 0.0 107.582 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.748 ' OE1' ' CA ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -81.14 -60.79 2.16 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 120.114 -1.617 . . . . 0.0 109.596 171.234 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.725 ' HE3' ' CE ' ' A' ' 27' ' ' LYS . 10.3 ptt? -71.62 -12.29 61.27 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.71 -0.619 . . . . 0.0 110.497 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.599 ' CG ' ' OXT' ' A' ' 85' ' ' GLU . 2.1 tt0 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.177 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.2 ttm . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.248 0.547 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.752 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 0.9 OUTLIER -80.51 -92.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 110.389 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.704 HG21 ' CB ' ' A' ' 27' ' ' LYS . 54.6 t -92.76 119.76 40.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.671 -0.643 . . . . 0.0 110.495 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.8 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 9.4 t30 -138.49 114.57 10.14 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.571 1.177 . . . . 0.0 108.865 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.737 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -136.15 149.6 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.94 . . . . 0.0 110.724 -179.05 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.742 ' CG ' ' HB2' ' A' ' 60' ' ' ALA . 13.6 tt0 -135.09 106.11 6.64 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.007 -1.477 . . . . 0.0 109.701 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.781 ' CG2' ' CB ' ' A' ' 38' ' ' LYS . 22.3 m -95.16 104.3 15.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-O 123.1 1.429 . . . . 0.0 108.808 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.832 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 0.7 OUTLIER -117.08 87.91 2.8 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.049 -1.032 . . . . 0.0 109.564 -178.756 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.633 ' O ' HG22 ' A' ' 41' ' ' ILE . 6.6 m -120.72 -62.72 1.42 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.352 -0.842 . . . . 0.0 109.586 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.755 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 12.8 p 179.81 156.41 0.72 Allowed Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.369 -0.832 . . . . 0.0 111.009 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.662 ' HD3' ' CG ' ' A' ' 40' ' ' ASP . 50.8 Cg_endo -84.77 -23.71 2.51 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 124.222 1.643 . . . . 0.0 110.589 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 t -79.37 13.65 1.86 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.159 -0.963 . . . . 0.0 110.055 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.515 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -160.72 -174.27 0.42 Allowed Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 121.417 -0.802 . . . . 0.0 110.184 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.614 ' O ' ' O ' ' A' ' 15' ' ' TYR . 54.4 Cg_endo -84.16 112.09 1.67 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.909 1.478 . . . . 0.0 110.689 177.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.755 ' CE1' ' O ' ' A' ' 10' ' ' SER . 19.3 m-85 -49.45 -110.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.311 -0.868 . . . . 0.0 109.609 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.741 ' CA ' ' HG3' ' A' ' 73' ' ' ARG . 37.6 m -154.81 39.78 0.13 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.027 -1.046 . . . . 0.0 110.57 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.674 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.2 Cg_endo -77.26 16.56 1.0 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.767 1.404 . . . . 0.0 110.802 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.546 ' HB3' ' HG2' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -93.27 -64.28 1.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.996 -1.082 . . . . 0.0 112.142 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.704 ' CB ' ' HB3' ' A' ' 73' ' ' ARG . . . -57.48 -18.43 18.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.274 -0.891 . . . . 0.0 109.665 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.719 ' C ' ' CD1' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -75.71 -39.58 39.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.393 -0.817 . . . . 0.0 109.477 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.583 ' N ' ' CD1' ' A' ' 20' ' ' ILE . 29.8 tp10 -50.4 -32.84 18.72 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.29 -44.45 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.21 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.742 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.7 OUTLIER -69.23 -28.08 37.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.673 0.749 . . . . 0.0 109.379 178.578 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.654 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 8.4 t0 -76.11 -36.75 58.73 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.7 -43.6 94.04 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.535 0.683 . . . . 0.0 109.623 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.481 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.9 -40.05 29.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.478 -0.764 . . . . 0.0 110.11 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.75 ' CE ' ' HA ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -69.24 -22.23 63.87 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.218 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.722 ' CG ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -69.92 -43.22 72.13 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.775 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -49.48 -39.63 34.33 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.788 0.804 . . . . 0.0 109.037 178.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.775 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.2 -56.68 3.18 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.74 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -97.16 77.84 0.67 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.624 -0.991 . . . . 0.0 110.624 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.568 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -32.37 -27.16 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 119.105 1.452 . . . . 0.0 110.527 -179.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.74 ' N ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -85.95 157.05 20.24 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.347 -0.846 . . . . 0.0 110.938 178.202 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.722 HD12 ' CG ' ' A' ' 28' ' ' LYS . 1.7 mp -128.98 157.98 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.044 -1.035 . . . . 0.0 110.765 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.671 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 3.4 t0 -150.21 62.48 0.97 Allowed 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.459 -0.775 . . . . 0.0 109.166 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.646 HG22 ' CG1' ' A' ' 3' ' ' VAL . 63.5 t -91.27 115.86 31.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 122.264 1.031 . . . . 0.0 109.862 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.695 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 3.5 mm-40 -97.94 145.08 26.82 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.932 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.781 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.98 121.48 15.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.075 -1.016 . . . . 0.0 111.453 -176.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.788 ' CG2' ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -129.06 178.2 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 110.354 -179.152 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.737 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -113.88 165.65 12.37 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.217 -0.927 . . . . 0.0 111.06 178.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.832 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -49.58 -38.82 13.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.512 -0.743 . . . . 0.0 112.769 177.656 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.737 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.9 OUTLIER -86.88 -3.46 59.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.844 -1.16 . . . . 0.0 111.483 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.788 ' CG2' ' CG2' ' A' ' 39' ' ' ILE . 1.9 m -111.15 -44.07 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.97 -1.081 . . . . 0.0 109.801 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.732 ' HB2' ' CB ' ' A' ' 39' ' ' ILE . 4.0 t70 -112.37 45.37 1.3 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.356 -0.84 . . . . 0.0 110.029 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.671 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 2.4 ttt-85 -61.28 -4.64 1.26 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.849 -1.14 . . . . 0.0 109.469 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.752 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 2.1 mm-40 -55.02 -19.74 7.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.396 -0.815 . . . . 0.0 110.253 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.845 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -50.22 -59.1 4.28 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 122.413 1.102 . . . . 0.0 110.067 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.845 ' N ' ' HG3' ' A' ' 47' ' ' LYS . . . -65.37 -0.09 1.71 Allowed 'General case' 0 C--N 1.281 -2.399 0 O-C-N 121.555 -0.716 . . . . 0.0 111.094 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.785 ' CD1' ' N ' ' A' ' 50' ' ' GLU . 2.4 pp -35.64 -36.92 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.785 ' N ' ' CD1' ' A' ' 49' ' ' ILE . 0.8 OUTLIER -54.09 -52.54 60.67 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.047 176.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.787 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.0 p90 -122.75 -28.22 4.19 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.088 -1.007 . . . . 0.0 110.203 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.789 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.62 14.3 0.01 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.657 ' N ' ' O ' ' A' ' 51' ' ' TYR . 4.4 mt -86.09 -62.77 1.44 Allowed 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 123.122 1.439 . . . . 0.0 108.462 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 19.9 mtp -106.72 53.83 0.69 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.158 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.845 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.268 . . -98.94 111.14 23.62 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 123.189 1.471 . . . . 0.0 110.903 -176.142 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.799 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 0.1 OUTLIER -146.68 -68.38 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 110.459 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.799 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 51.0 Cg_endo -96.14 103.81 0.1 OUTLIER 'Trans proline' 0 C--O 1.2 -1.423 0 CA-C-O 123.396 1.332 . . . . 0.0 109.742 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.8 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -158.11 175.14 14.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.75 -1.219 . . . . 0.0 111.562 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.715 HG12 ' CD2' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -138.39 135.58 44.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.613 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.767 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . . . -81.51 139.59 35.06 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 117.361 -1.736 . . . . 0.0 107.058 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.756 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.372 1.0 OUTLIER -88.55 83.4 2.2 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.346 0 CA-C-O 124.786 2.232 . . . . 0.0 106.824 -175.895 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.8 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 4.5 m120 -43.11 82.68 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.616 -1.629 . . . . 0.0 108.767 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.756 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.04 -44.52 0.37 Allowed Glycine 0 N--CA 1.481 1.694 0 N-CA-C 107.414 -2.275 . . . . 0.0 107.414 -177.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.749 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.0 m -125.78 -59.82 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 121.718 -0.872 . . . . 0.0 110.98 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.749 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 88.6 t -163.81 -107.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 120.312 -1.492 . . . . 0.0 112.288 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.767 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 2.0 ttp180 -164.7 163.53 21.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.631 -0.668 . . . . 0.0 109.671 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.841 ' CZ ' ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -144.76 176.86 9.13 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.896 -1.127 . . . . 0.0 111.366 -178.124 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.63 HG23 ' OH ' ' A' ' 51' ' ' TYR . 79.8 t -89.14 115.82 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.651 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.841 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.57 124.8 1.31 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.564 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.83 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -92.85 -79.68 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 120.882 -1.364 . . . . 0.0 108.396 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.83 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 55.2 Cg_endo -81.01 25.29 0.64 Allowed 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.595 1.313 . . . . 0.0 109.228 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . 0.273 28.5 m -102.67 82.84 2.19 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 123.269 1.509 . . . . 0.0 110.007 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.741 ' HG3' ' CA ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -77.94 -35.74 50.1 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.947 -1.096 . . . . 0.0 109.988 177.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.714 ' HG2' ' CD2' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -46.1 -30.13 1.78 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.362 -0.836 . . . . 0.0 109.99 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.799 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -50.91 -42.69 59.56 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.27 -0.894 . . . . 0.0 109.193 179.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.737 ' HB3' ' CG2' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -63.49 -45.57 90.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.604 -0.685 . . . . 0.0 109.492 178.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.742 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -60.93 -38.57 86.26 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.639 0.733 . . . . 0.0 110.245 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.581 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 25.4 tt0 -80.22 -21.9 42.39 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.267 -0.896 . . . . 0.0 110.202 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.649 ' HB3' ' HA ' ' A' ' 61' ' ' ILE . . . -77.95 -39.77 41.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.207 -0.933 . . . . 0.0 109.643 -177.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.715 HG12 ' CG1' ' A' ' 23' ' ' VAL . 1.5 mp -65.72 -39.7 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.038 -1.039 . . . . 0.0 109.156 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.573 ' C ' ' OD1' ' A' ' 81' ' ' ASN . 0.1 OUTLIER -75.53 -32.02 60.32 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.118 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.581 ' HB3' ' O ' ' A' ' 78' ' ' GLU 0.455 0.4 OUTLIER -89.03 -8.39 54.09 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 114.989 -2.685 . . . . 0.0 108.115 -179.159 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.713 ' CG ' ' HA2' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -78.9 -60.71 2.27 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 119.968 -1.708 . . . . 0.0 110.196 169.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.697 ' HE3' ' NZ ' ' A' ' 27' ' ' LYS . 4.7 ptt? -71.88 -9.16 57.93 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.782 -0.574 . . . . 0.0 110.822 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.572 ' OE2' ' C ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.898 -1.049 . . . . 0.0 109.973 -177.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.226 0.536 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.76 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 0.9 OUTLIER -80.5 -92.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.333 -0.854 . . . . 0.0 110.359 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.743 HG21 ' CB ' ' A' ' 27' ' ' LYS . 53.6 t -91.51 128.49 43.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.483 -0.76 . . . . 0.0 110.565 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.786 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 63.3 t30 -140.3 108.38 5.75 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 123.202 1.477 . . . . 0.0 108.604 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.759 ' CD1' HG13 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -136.15 135.92 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 O-C-N 120.747 -1.221 . . . . 0.0 112.061 -178.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.729 ' CG ' ' HB2' ' A' ' 60' ' ' ALA 0.253 1.4 tp10 -122.66 102.06 7.83 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 123.196 1.474 . . . . 0.0 108.587 176.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.8 ' CG2' ' CB ' ' A' ' 38' ' ' LYS . 29.5 m -95.42 106.39 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 123.582 1.658 . . . . 0.0 109.51 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.823 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 1.1 t80 -117.92 102.15 8.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.071 -1.018 . . . . 0.0 109.76 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.67 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.5 OUTLIER -134.0 -61.9 0.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.955 . . . . 0.0 110.214 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.669 ' HA ' HG23 ' A' ' 41' ' ' ILE . 3.1 t -175.13 144.63 0.82 Allowed Pre-proline 0 N--CA 1.487 1.386 0 O-C-N 121.118 -0.989 . . . . 0.0 111.152 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.731 ' N ' ' HB2' ' A' ' 40' ' ' ASP . 48.7 Cg_endo -76.76 -9.39 18.31 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 124.135 1.597 . . . . 0.0 110.475 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.95 -5.0 52.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.21 -0.931 . . . . 0.0 109.843 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.624 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 1.4 p -160.61 -166.15 0.14 Allowed Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.385 -0.822 . . . . 0.0 110.056 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.624 ' CD ' ' CB ' ' A' ' 13' ' ' CYS . 55.6 Cg_endo -84.17 117.8 2.23 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.863 1.454 . . . . 0.0 110.617 176.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.667 ' HB2' ' HB ' ' A' ' 7' ' ' VAL . 2.1 m-85 -49.27 -84.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.0 109.56 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.7 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 42.2 m -155.22 39.69 0.12 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.124 -0.985 . . . . 0.0 109.968 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.7 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 53.4 Cg_endo -73.78 30.4 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.881 1.464 . . . . 0.0 111.146 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.431 ' H ' ' C ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -110.17 -61.85 1.6 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.029 -1.044 . . . . 0.0 110.433 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.716 ' CB ' ' C ' ' A' ' 73' ' ' ARG . . . -58.1 -20.06 37.03 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.464 -0.773 . . . . 0.0 110.062 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.727 ' CG2' HG22 ' A' ' 5' ' ' ILE . 23.0 pt -75.62 -39.07 39.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.479 -0.763 . . . . 0.0 109.513 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.654 ' N ' HG13 ' A' ' 20' ' ' ILE . 49.7 tt0 -49.63 -35.86 22.56 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.8 -42.46 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.048 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.759 HG13 ' CD1' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -70.88 -26.66 28.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-O 121.825 0.821 . . . . 0.0 109.185 178.299 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.632 ' OD1' HG12 ' A' ' 34' ' ' ILE . 4.6 t70 -76.9 -35.84 57.09 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -43.99 91.07 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.622 0.725 . . . . 0.0 109.321 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.506 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.44 -41.01 28.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.622 -0.674 . . . . 0.0 110.165 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.813 ' CE ' ' CE ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -67.72 -23.38 65.26 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.306 -179.404 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.631 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -69.32 -46.42 67.14 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.792 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -47.47 -41.0 19.69 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.585 0.707 . . . . 0.0 109.124 178.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.792 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.57 -57.87 2.72 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.731 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -97.15 78.28 0.67 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.583 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -33.46 -27.24 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 119.394 1.597 . . . . 0.0 110.101 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.731 ' N ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -88.72 158.02 18.33 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.197 -0.939 . . . . 0.0 111.339 178.366 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.685 ' CD1' HG22 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -129.47 151.03 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.406 -0.917 . . . . 0.0 110.685 178.127 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -138.82 61.14 1.58 Allowed 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.445 -0.784 . . . . 0.0 108.97 179.649 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.74 ' CG2' ' CG1' ' A' ' 3' ' ' VAL . 44.6 t -91.59 115.48 30.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 122.454 1.121 . . . . 0.0 109.681 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.688 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.25 12.2 mt-10 -98.07 141.02 31.53 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.375 -178.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.8 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -138.45 130.9 28.94 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.765 -1.21 . . . . 0.0 112.127 -176.748 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.741 ' HB ' ' CB ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -138.53 173.12 12.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.525 -0.734 . . . . 0.0 110.006 179.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.756 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.6 OUTLIER -105.84 169.68 8.34 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.102 -0.999 . . . . 0.0 110.889 179.234 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.823 ' HA ' ' CE2' ' A' ' 8' ' ' PHE . 0.6 OUTLIER -73.16 -19.32 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.444 -0.785 . . . . 0.0 111.598 179.16 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.756 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 2.4 ptt? -90.62 -18.1 25.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.06 -1.025 . . . . 0.0 110.634 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.729 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 13.3 p -110.01 -29.78 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.344 -0.847 . . . . 0.0 110.77 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.8 ' O ' ' CE2' ' A' ' 8' ' ' PHE . 5.7 t0 -114.7 48.19 1.16 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.021 -1.049 . . . . 0.0 110.843 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.26 2.3 ttt180 -59.09 -8.29 1.45 Allowed 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 118.263 -1.375 . . . . 0.0 109.974 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.756 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 0.5 OUTLIER -61.34 -13.41 19.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 109.175 175.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.799 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -51.71 -60.16 3.47 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.168 0.985 . . . . 0.0 108.959 -178.521 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.853 ' CB ' ' CB ' ' A' ' 55' ' ' ALA . . . -64.2 1.57 0.71 Allowed 'General case' 0 C--N 1.278 -2.533 0 O-C-N 121.119 -0.988 . . . . 0.0 110.55 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.756 ' CG2' ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -35.67 -38.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 -177.457 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.56 ' N ' ' C ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -54.62 -49.36 70.68 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.668 176.717 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.808 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -124.93 -28.55 3.46 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.999 -1.063 . . . . 0.0 110.411 179.21 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.787 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.14 13.3 0.01 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.66 ' N ' ' O ' ' A' ' 51' ' ' TYR . 6.2 mt -86.52 -60.94 1.85 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 123.526 1.631 . . . . 0.0 107.88 177.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.527 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 26.0 mtm -110.55 62.35 0.6 Allowed 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.633 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.853 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.278 . . -98.35 107.78 20.32 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 123.622 1.677 . . . . 0.0 111.124 -174.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.82 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 1.6 t -146.66 -68.42 0.02 OUTLIER Pre-proline 0 N--CA 1.484 1.232 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.23 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.82 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 55.6 Cg_endo -104.22 93.46 0.03 OUTLIER 'Trans proline' 0 C--O 1.201 -1.327 0 CA-C-O 123.528 1.386 . . . . 0.0 111.257 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.753 ' CB ' ' HE2' ' A' ' 47' ' ' LYS . . . -151.2 179.32 8.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.32 -1.488 . . . . 0.0 110.957 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.829 ' CG2' ' CD2' ' A' ' 76' ' ' LEU . 1.4 mp -149.92 147.47 16.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.463 -0.773 . . . . 0.0 110.508 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.788 ' HA ' ' HG3' ' A' ' 66' ' ' ARG . . . -81.59 137.9 35.44 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.757 ' HB ' HG21 ' A' ' 64' ' ' VAL 0.406 1.0 OUTLIER -87.8 82.34 2.05 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.555 0 C-N-CA 115.318 -2.553 . . . . 0.0 105.277 -175.756 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.786 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -44.3 85.67 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 113.3 -1.773 . . . . 0.0 107.851 177.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.755 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.0 -47.12 0.38 Allowed Glycine 0 N--CA 1.482 1.716 0 N-CA-C 106.471 -2.652 . . . . 0.0 106.471 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.757 HG21 ' HB ' ' A' ' 61' ' ' ILE . 11.9 m -124.49 -60.86 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 121.82 -0.812 . . . . 0.0 111.094 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.751 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 96.7 t -164.01 -107.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 120.104 -1.623 . . . . 0.0 113.185 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.788 ' HG3' ' HA ' ' A' ' 60' ' ' ALA . 1.0 OUTLIER -156.18 153.69 29.64 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.671 -0.643 . . . . 0.0 110.13 -177.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.789 ' CZ ' ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -145.52 -174.93 4.53 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.905 -1.122 . . . . 0.0 111.836 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.695 ' HA ' ' HB1' ' A' ' 58' ' ' ALA . 21.4 t -95.92 122.95 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.789 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.33 105.59 0.26 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 118.865 -1.636 . . . . 0.0 111.153 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.825 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -89.74 -82.74 0.02 OUTLIER Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 120.824 -1.397 . . . . 0.0 108.146 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.825 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 55.7 Cg_endo -82.19 14.76 2.16 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 O-C-N 123.28 1.147 . . . . 0.0 109.499 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.48 64.48 1.32 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.218 -0.926 . . . . 0.0 111.587 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.716 ' C ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.59 -32.15 65.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.897 -1.127 . . . . 0.0 109.361 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.673 ' HA ' ' HB3' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -51.34 -40.99 60.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.923 . . . . 0.0 109.244 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.744 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -46.32 -29.31 1.6 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.465 -0.772 . . . . 0.0 109.344 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.829 ' CD2' ' CG2' ' A' ' 59' ' ' ILE . 13.1 mt -72.46 -40.85 66.69 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.747 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.94 -36.98 73.28 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.799 0.809 . . . . 0.0 109.646 179.279 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -79.44 -25.79 41.9 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.328 -0.858 . . . . 0.0 110.123 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.707 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -74.95 -37.91 61.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.161 -0.962 . . . . 0.0 109.743 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.735 ' CD1' HD12 ' A' ' 5' ' ' ILE . 1.5 mp -63.64 -37.41 79.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.957 -1.09 . . . . 0.0 108.807 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.421 ' ND2' ' C ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -72.94 -33.89 66.2 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.64 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.501 0.3 OUTLIER -90.95 -6.58 53.88 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 114.114 -3.035 . . . . 0.0 107.454 -179.059 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.749 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -78.7 -55.19 5.37 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 119.859 -1.776 . . . . 0.0 109.838 170.091 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.813 ' CE ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.04 -23.26 64.96 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.171 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.471 ' CD ' ' C ' ' A' ' 85' ' ' GLU . 3.3 tm-20 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.234 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.239 0.542 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.763 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 0.9 OUTLIER -80.45 -94.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.284 -0.885 . . . . 0.0 110.583 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.749 ' CG1' ' CG2' ' A' ' 36' ' ' VAL . 57.6 t -87.84 133.11 31.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 O-C-N 121.395 -0.816 . . . . 0.0 112.692 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.84 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.51 64.0 t30 -153.92 106.51 2.85 Favored 'General case' 0 N--CA 1.518 2.939 1 CA-C-O 129.399 4.428 . . . . 0.0 109.208 177.868 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.766 ' CD1' HG13 ' A' ' 23' ' ' VAL 0.414 0.2 OUTLIER -119.3 130.57 73.77 Favored 'Isoleucine or valine' 0 C--O 1.264 1.834 0 CA-C-N 108.689 -3.869 . . . . 0.0 117.903 -174.823 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.842 ' HA ' ' O ' ' A' ' 37' ' ' GLU 0.644 1.2 tp10 -133.7 123.3 24.72 Favored 'General case' 0 C--N 1.269 -2.895 2 CA-C-O 131.792 5.567 . . . . 0.0 106.17 166.824 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.764 ' CG2' ' CB ' ' A' ' 38' ' ' LYS 0.257 25.0 m -113.19 100.86 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.517 1 O-C-N 114.476 -5.14 . . . . 0.0 109.155 -171.42 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.836 ' CE2' ' O ' ' A' ' 44' ' ' ASP . 1.2 t80 -113.79 104.98 12.74 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 111.69 -2.505 . . . . 0.0 108.623 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.667 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.5 OUTLIER -135.6 -60.61 0.74 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.929 0.871 . . . . 0.0 110.564 177.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.677 ' HA ' HG23 ' A' ' 41' ' ' ILE . 3.1 t -177.57 143.62 0.51 Allowed Pre-proline 0 N--CA 1.487 1.414 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.41 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.732 ' CD ' ' HB2' ' A' ' 40' ' ' ASP . 47.2 Cg_endo -76.08 -9.52 19.28 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 124.119 1.589 . . . . 0.0 110.225 -178.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.14 -5.19 53.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.056 -1.027 . . . . 0.0 109.843 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.633 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 1.4 p -159.75 -165.88 0.13 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.353 -0.842 . . . . 0.0 110.138 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.633 ' CD ' ' CB ' ' A' ' 13' ' ' CYS . 55.3 Cg_endo -84.22 117.65 2.2 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.865 1.455 . . . . 0.0 110.582 176.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.666 ' HB2' ' HB ' ' A' ' 7' ' ' VAL . 2.0 m-85 -49.22 -83.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 109.625 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.707 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 42.7 m -155.29 39.59 0.12 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.146 -0.971 . . . . 0.0 109.962 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 52.9 Cg_endo -73.69 30.3 0.32 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.977 1.514 . . . . 0.0 111.141 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.435 ' H ' ' C ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -110.06 -61.98 1.58 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.966 -1.084 . . . . 0.0 110.348 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.705 ' CB ' ' C ' ' A' ' 73' ' ' ARG . . . -58.86 -19.11 38.91 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.099 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.731 ' CG2' HG22 ' A' ' 5' ' ' ILE . 22.8 pt -75.95 -38.0 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.141 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.658 ' N ' HG13 ' A' ' 20' ' ' ILE . 50.1 tt0 -49.0 -37.58 20.78 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.42 -44.87 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-O 122.05 0.929 . . . . 0.0 109.297 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.766 HG13 ' CD1' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -63.01 -35.71 72.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 122.789 1.281 . . . . 0.0 109.92 175.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.636 ' OD1' ' CG1' ' A' ' 34' ' ' ILE . 4.0 t70 -70.64 -39.03 73.92 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.903 1.335 . . . . 0.0 108.298 -177.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -46.35 81.94 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.062 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.499 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -76.74 -41.6 44.36 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.636 0.731 . . . . 0.0 110.297 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.821 ' CE ' ' CE ' ' A' ' 84' ' ' MET 0.272 0.0 OUTLIER -72.02 -17.71 62.01 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 117.471 -1.691 . . . . 0.0 109.632 -177.32 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.632 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -70.33 -45.86 65.35 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 120.923 -1.111 . . . . 0.0 108.223 173.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.724 ' HG3' ' N ' ' A' ' 30' ' ' PHE 0.317 0.0 OUTLIER -52.97 -28.8 25.45 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.014 -179.042 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.763 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -102.17 -59.16 1.75 Allowed 'General case' 0 C--N 1.274 -2.706 0 O-C-N 119.108 -2.245 . . . . 0.0 106.67 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.701 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -80.23 58.85 4.61 Favored Glycine 1 C--N 1.24 -4.8 1 CA-C-O 113.008 -4.218 . . . . 0.0 116.433 174.526 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.571 ' C ' ' O ' ' A' ' 31' ' ' GLY 0.428 0.0 OUTLIER -36.45 -19.65 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.219 1 CA-C-N 125.182 4.491 . . . . 0.0 112.901 -168.647 . . . . . . . . 5 4 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.709 ' O ' ' CG2' ' A' ' 2' ' ' VAL 0.293 0.0 OUTLIER -75.96 151.29 37.29 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 127.536 2.334 . . . . 0.0 115.69 167.953 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.69 ' CD1' HG22 ' A' ' 3' ' ' VAL 0.342 0.3 OUTLIER -130.67 155.77 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 C-N-CA 115.569 -2.452 . . . . 0.0 109.84 170.575 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.61 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.3 OUTLIER -139.96 64.76 1.44 Allowed 'General case' 0 C--N 1.313 -1.015 0 O-C-N 121.349 -0.844 . . . . 0.0 108.783 -178.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.749 ' CG2' ' CG1' ' A' ' 3' ' ' VAL 0.405 58.1 t -102.29 125.05 56.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 125.728 2.68 . . . . 0.0 108.709 -177.383 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.842 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.489 10.2 mt-10 -116.02 129.29 56.3 Favored 'General case' 0 C--O 1.176 -2.802 0 O-C-N 118.655 -2.528 . . . . 0.0 107.81 -173.201 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.764 ' CB ' ' CG2' ' A' ' 7' ' ' VAL 0.642 0.0 OUTLIER -106.83 111.18 23.58 Favored 'General case' 0 C--O 1.274 2.347 2 CA-C-O 107.928 -5.796 . . . . 0.0 121.166 -170.665 . . . . . . . . 5 4 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.749 ' HB ' ' CB ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -130.11 166.54 27.45 Favored 'Isoleucine or valine' 1 C--N 1.212 -5.405 1 CA-C-N 131.377 6.444 . . . . 0.0 109.713 178.267 . . . . . . . . 5 4 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.738 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.5 OUTLIER -97.82 169.84 9.38 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.776 -1.203 . . . . 0.0 112.279 173.193 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.828 ' HA ' ' CE2' ' A' ' 8' ' ' PHE . 0.7 OUTLIER -74.33 -21.34 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.03 -1.044 . . . . 0.0 111.402 176.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.738 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 2.0 ptt? -86.27 -16.62 37.0 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.901 -1.124 . . . . 0.0 112.915 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.733 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 14.5 p -112.83 -27.06 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.914 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.836 ' O ' ' CE2' ' A' ' 8' ' ' PHE . 5.7 t0 -115.14 51.13 0.93 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.184 -0.947 . . . . 0.0 110.6 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.457 2.6 ttt180 -70.31 0.99 5.41 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 115.833 -2.347 . . . . 0.0 109.793 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.778 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -53.92 -24.46 16.38 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.545 -1.347 . . . . 0.0 110.798 165.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.85 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -47.58 -62.49 1.42 Allowed 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 122.767 1.27 . . . . 0.0 109.023 -174.034 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.903 ' CB ' ' CB ' ' A' ' 55' ' ' ALA 0.425 . . -51.01 -13.66 0.17 Allowed 'General case' 0 C--N 1.268 -2.975 0 C-N-CA 125.105 1.362 . . . . 0.0 113.021 173.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.778 ' CG2' ' O ' ' A' ' 46' ' ' GLU 0.256 0.2 OUTLIER -32.92 -37.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 O-C-N 117.768 -3.083 . . . . 0.0 103.528 -168.342 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.637 ' N ' ' C ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -55.0 -49.27 71.92 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.581 176.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.8 ' CE1' ' HE3' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -124.95 -28.14 3.5 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.979 -1.076 . . . . 0.0 110.397 179.157 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.744 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 41.69 12.08 0.01 OUTLIER Glycine 0 C--O 1.19 -2.617 0 CA-C-O 122.025 0.792 . . . . 0.0 112.416 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 5.6 mt -83.84 -75.02 0.35 Allowed 'General case' 0 C--N 1.247 -3.85 0 N-CA-C 103.971 -2.603 . . . . 0.0 103.971 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.606 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 26.9 mtm -103.23 69.2 1.0 Allowed 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.228 -1.545 . . . . 0.0 107.092 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.903 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.579 . . -113.08 117.75 32.86 Favored 'General case' 0 C--O 1.195 -1.78 1 CA-C-O 129.698 4.571 . . . . 0.0 109.073 -175.749 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.828 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 1.7 t -152.77 -60.71 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.654 0 CA-C-N 109.02 -3.718 . . . . 0.0 112.242 -175.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.828 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.502 43.5 Cg_endo -119.83 105.87 0.0 OUTLIER 'Trans proline' 0 C--O 1.19 -1.88 0 CA-C-O 129.276 3.782 . . . . 0.0 110.974 172.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.755 ' HB2' ' HD3' ' A' ' 47' ' ' LYS . . . -159.59 176.55 11.9 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 110.015 -3.266 . . . . 0.0 111.219 -176.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.835 ' CG2' ' CD2' ' A' ' 76' ' ' LEU 0.271 1.3 mp -149.55 160.75 4.99 Favored 'Isoleucine or valine' 0 C--O 1.272 2.274 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.743 -177.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.89 ' HA ' ' HA ' ' A' ' 66' ' ' ARG 0.699 . . -107.98 152.36 24.58 Favored 'General case' 0 CA--C 1.448 -2.955 2 O-C-N 115.554 -4.466 . . . . 0.0 102.705 -177.209 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.761 ' HB ' HG21 ' A' ' 64' ' ' VAL 0.619 1.5 mt -106.46 91.17 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.441 -3.221 1 CA-C-O 132.436 5.874 . . . . 0.0 101.871 -161.084 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.84 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -45.65 83.91 0.0 OUTLIER 'General case' 0 C--N 1.367 1.335 1 CA-C-N 106.099 -5.046 . . . . 0.0 107.29 177.735 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.725 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.06 -47.03 0.38 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 106.348 -2.701 . . . . 0.0 106.348 -177.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.762 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 12.1 m -124.64 -60.65 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 O-C-N 121.836 -0.802 . . . . 0.0 111.126 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.762 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 99.4 t -164.12 -103.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.406 0 O-C-N 120.123 -1.611 . . . . 0.0 113.312 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.89 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 1.0 OUTLIER -162.01 150.3 14.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.441 -0.787 . . . . 0.0 109.783 -175.002 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.831 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -146.06 -179.18 6.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.72 -1.238 . . . . 0.0 110.877 -176.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.655 ' HA ' ' HB1' ' A' ' 58' ' ' ALA . 12.2 t -85.89 120.89 36.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 116.761 -1.59 . . . . 0.0 110.299 176.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.795 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.24 106.42 0.28 Allowed Glycine 0 N--CA 1.497 2.705 0 CA-C-N 122.316 2.325 . . . . 0.0 110.674 177.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.825 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -90.24 -79.96 0.03 OUTLIER Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 120.81 -1.406 . . . . 0.0 108.787 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.825 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 48.3 Cg_endo -88.86 20.63 1.09 Allowed 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 117.312 -1.325 . . . . 0.0 108.969 177.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.61 63.88 1.09 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.017 -1.052 . . . . 0.0 112.227 176.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.705 ' C ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -69.81 -35.65 74.99 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.733 177.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.668 ' HA ' ' HB3' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -47.13 -44.09 21.32 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.092 0.949 . . . . 0.0 108.76 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.756 ' CD ' ' CE2' ' A' ' 67' ' ' PHE 0.274 0.0 OUTLIER -48.75 -26.02 2.13 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.182 -177.293 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.835 ' CD2' ' CG2' ' A' ' 59' ' ' ILE . 12.6 mt -72.48 -41.11 66.36 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.831 0.824 . . . . 0.0 109.629 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.758 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.29 -37.6 72.68 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 122.045 0.926 . . . . 0.0 110.287 179.173 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -74.43 -32.16 62.55 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.85 0.833 . . . . 0.0 110.354 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.713 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -73.77 -37.23 65.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.021 -1.049 . . . . 0.0 110.187 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.74 ' CD1' HD12 ' A' ' 5' ' ' ILE . 1.5 mp -60.33 -41.12 86.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 120.826 -1.172 . . . . 0.0 109.39 176.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.437 ' ND2' ' C ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -70.29 -32.76 70.69 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.764 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.632 0.1 OUTLIER -102.57 5.23 39.17 Favored 'General case' 0 CA--C 1.487 -1.445 0 C-N-CA 114.455 -2.898 . . . . 0.0 108.762 -176.61 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.761 ' HB2' ' O ' ' A' ' 62' ' ' ASN 0.299 0.2 OUTLIER -87.84 -55.84 3.59 Favored 'General case' 0 N--CA 1.489 1.498 1 O-C-N 115.611 -4.43 . . . . 0.0 107.568 164.472 . . . . . . . . 5 4 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.821 ' CE ' ' CE ' ' A' ' 27' ' ' LYS 0.27 0.0 OUTLIER -67.94 -18.37 64.74 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 119.963 1.256 . . . . 0.0 112.209 178.792 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.477 ' CD ' ' C ' ' A' ' 85' ' ' GLU . 3.2 tm-20 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 120.859 -1.151 . . . . 0.0 110.609 177.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.723 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.333 0.587 . . . . 0.0 110.153 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.733 ' CG2' ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -79.67 -89.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 110.236 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.764 HG21 ' CB ' ' A' ' 27' ' ' LYS . 48.3 t -90.95 111.13 23.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.462 -0.774 . . . . 0.0 110.595 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.819 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 3.9 m-20 -123.85 107.46 11.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.81 -1.181 . . . . 0.0 109.235 177.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.729 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.33 137.16 56.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.491 -0.756 . . . . 0.0 110.923 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.811 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 11.0 tt0 -128.4 110.67 12.55 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 118.896 -2.378 . . . . 0.0 108.966 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.786 ' CG2' ' CB ' ' A' ' 38' ' ' LYS 0.263 20.9 m -101.96 110.14 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -177.719 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.828 ' CE1' ' O ' ' A' ' 44' ' ' ASP . 5.4 t80 -117.98 83.65 2.04 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.05 -176.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.684 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -127.54 -45.92 1.47 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.157 0.503 . . . . 0.0 110.193 179.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.768 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 17.6 t 179.64 148.39 0.45 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.175 -0.953 . . . . 0.0 110.637 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.704 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 50.7 Cg_endo -86.16 -26.16 1.2 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.151 1.606 . . . . 0.0 110.704 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -78.79 12.26 2.21 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.12 -0.988 . . . . 0.0 109.985 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.547 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -157.22 -172.2 0.31 Allowed Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.415 -0.803 . . . . 0.0 110.68 178.82 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' A' ' 13' ' ' CYS . 51.6 Cg_endo -84.53 107.26 1.17 Allowed 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.125 1.592 . . . . 0.0 110.056 176.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.768 ' CE1' ' O ' ' A' ' 10' ' ' SER . 14.8 m-85 -49.45 -83.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.77 -1.206 . . . . 0.0 109.689 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.732 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . 34.6 m -155.86 47.21 0.3 Allowed Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.38 -0.825 . . . . 0.0 109.792 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.702 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . 47.1 Cg_endo -72.49 24.13 0.28 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 124.077 1.567 . . . . 0.0 111.111 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.464 ' H ' ' C ' ' A' ' 16' ' ' CYS . 6.5 tpt -110.07 -69.74 0.85 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.059 -1.026 . . . . 0.0 110.15 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.745 ' HB1' ' CB ' ' A' ' 73' ' ' ARG . . . -55.12 -19.84 8.55 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.247 -0.908 . . . . 0.0 109.343 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.702 ' CD1' ' HA ' ' A' ' 17' ' ' PRO . 13.0 pt -71.49 -40.34 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.405 -0.81 . . . . 0.0 109.15 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.69 ' N ' HG13 ' A' ' 20' ' ' ILE . 13.8 tp10 -53.67 -34.92 60.32 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.07 -42.9 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.441 -0.787 . . . . 0.0 109.017 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.806 ' CG1' ' HB ' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -67.77 -31.77 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.793 0.806 . . . . 0.0 109.515 178.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.721 ' OD1' ' CD ' ' A' ' 28' ' ' LYS . 3.2 t70 -72.53 -38.06 68.15 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 122.077 0.941 . . . . 0.0 108.466 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.43 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -60.42 -45.24 94.32 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.057 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.611 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -78.61 -39.43 37.31 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.591 -0.693 . . . . 0.0 110.853 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.764 ' CB ' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -73.1 -19.81 61.07 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 118.926 -1.11 . . . . 0.0 109.094 -178.717 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.721 ' CD ' ' OD1' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -70.76 -45.52 64.62 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 176.396 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.763 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -46.68 -39.57 11.65 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.975 0.893 . . . . 0.0 109.265 179.358 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.763 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -95.51 -58.2 2.19 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.75 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -94.03 82.43 0.99 Allowed Glycine 0 N--CA 1.499 2.867 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.565 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -37.43 -24.52 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 O-C-N 119.349 -2.265 . . . . 0.0 110.372 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.733 ' O ' ' CG2' ' A' ' 2' ' ' VAL . 0.1 OUTLIER -82.83 151.99 25.82 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.579 -0.7 . . . . 0.0 111.845 177.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.725 ' CD1' ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -129.9 153.75 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.09 -1.631 . . . . 0.0 110.569 177.564 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.569 ' O ' ' O ' ' A' ' 3' ' ' VAL . 9.8 t0 -150.64 76.42 1.25 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.287 -0.883 . . . . 0.0 109.067 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.668 HG23 ' CG1' ' A' ' 5' ' ' ILE 0.254 51.5 t -94.4 122.47 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 120.697 -1.252 . . . . 0.0 109.014 -178.719 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.811 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.265 4.4 mt-10 -103.8 145.59 29.87 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -177.182 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.786 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -140.29 116.15 10.31 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.629 -174.107 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.725 ' CG2' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -116.56 166.04 11.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 O-C-N 120.575 -1.328 . . . . 0.0 111.269 -178.151 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.779 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -98.19 159.89 14.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.117 -0.989 . . . . 0.0 109.666 178.669 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.788 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -68.64 -37.44 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.077 -1.014 . . . . 0.0 112.19 -179.266 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.779 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.7 ptm -82.48 -3.81 56.42 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.055 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.665 HG12 ' HB3' ' A' ' 40' ' ' ASP . 13.6 p -112.24 -45.15 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 109.728 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.828 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 4.2 t70 -106.61 50.04 0.78 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.082 -1.011 . . . . 0.0 110.021 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.652 ' HA ' ' CZ ' ' A' ' 8' ' ' PHE 0.286 0.0 OUTLIER -64.01 -3.13 2.34 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 118.571 -1.252 . . . . 0.0 109.442 -177.929 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.714 ' O ' ' CG1' ' A' ' 49' ' ' ILE . 10.9 pt-20 -52.04 -20.87 2.68 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.491 -0.755 . . . . 0.0 110.088 175.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.929 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -50.36 -58.9 4.66 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.453 -1.405 . . . . 0.0 109.772 -178.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.929 ' N ' ' HG3' ' A' ' 47' ' ' LYS . . . -61.42 -5.7 1.87 Allowed 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.837 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.793 ' C ' ' O ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -32.44 -39.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 -175.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.832 ' OE1' ' O ' ' A' ' 47' ' ' LYS . 51.4 mp0 -51.34 -53.07 39.78 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.056 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.796 ' CZ ' ' CG2' ' A' ' 68' ' ' VAL . 2.4 p90 -124.5 -29.67 3.46 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.884 -1.135 . . . . 0.0 110.26 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.751 ' HA2' ' HB3' ' A' ' 48' ' ' ALA . . . 41.49 11.27 0.01 OUTLIER Glycine 0 N--CA 1.498 2.812 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.681 ' N ' ' O ' ' A' ' 51' ' ' TYR . 8.6 mt -81.13 -71.53 0.47 Allowed 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.52 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -102.4 59.3 0.81 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 -178.258 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.856 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.302 . . -103.67 116.2 31.9 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.24 -1.538 . . . . 0.0 109.905 -175.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.846 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 2.1 t -147.1 -66.93 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.472 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.846 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 53.1 Cg_endo -105.67 114.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.176 0 N-CA-C 109.586 -0.967 . . . . 0.0 109.586 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.74 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -161.28 175.57 12.14 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.296 1.046 . . . . 0.0 111.521 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.757 ' O ' ' HG3' ' A' ' 66' ' ' ARG 0.253 1.1 mp -141.67 144.67 25.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 108.995 179.383 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.804 ' HA ' ' HA ' ' A' ' 66' ' ' ARG 0.289 . . -84.93 147.51 26.7 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 -177.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.733 ' CG2' ' HB3' ' A' ' 79' ' ' ALA 0.39 0.7 OUTLIER -95.42 88.44 2.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 115.315 -2.554 . . . . 0.0 105.233 -175.126 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.819 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.2 OUTLIER -45.77 82.71 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 O-C-N 126.009 2.068 . . . . 0.0 109.094 177.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.818 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 161.99 -43.56 0.37 Allowed Glycine 0 C--N 1.288 -2.088 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.778 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.2 m -126.83 -59.37 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.882 -0.775 . . . . 0.0 111.052 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.778 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 59.8 t -164.04 -104.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 120.393 -1.442 . . . . 0.0 112.194 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.804 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 1.9 ttp180 -164.44 164.16 22.05 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.835 ' CZ ' ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -146.05 177.68 8.78 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.925 -1.11 . . . . 0.0 111.118 -177.306 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.796 ' CG2' ' CZ ' ' A' ' 51' ' ' TYR . 96.5 t -88.86 114.39 27.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.686 -0.634 . . . . 0.0 109.978 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.835 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.66 128.72 1.92 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 118.63 -1.748 . . . . 0.0 110.168 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.836 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -93.82 -82.72 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 121.098 -1.236 . . . . 0.0 108.032 177.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.836 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 52.8 Cg_endo -83.24 23.19 0.84 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 N-CA-C 108.541 -1.369 . . . . 0.0 108.541 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.553 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -99.59 61.45 1.17 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.445 -0.784 . . . . 0.0 111.334 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.745 ' CB ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -70.64 -26.75 63.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 0.0 109.926 178.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.611 ' HA ' ' HB3' ' A' ' 19' ' ' ALA . 1.6 tm-20 -50.56 -42.43 55.39 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.249 -0.907 . . . . 0.0 109.32 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.786 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -44.54 -34.81 2.25 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.371 -0.932 . . . . 0.0 108.819 179.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.748 ' CD1' ' CG2' ' A' ' 59' ' ' ILE . 7.4 mp -64.12 -42.76 96.71 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.801 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.74 -34.15 69.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 109.404 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.778 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -82.38 -30.57 30.17 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.481 -0.762 . . . . 0.0 110.405 178.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.733 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -73.37 -33.1 64.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.424 -0.798 . . . . 0.0 109.907 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.806 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -67.46 -42.37 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 0.0 108.756 178.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.43 -23.63 66.32 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.557 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.544 0.0 OUTLIER -100.94 -12.37 18.99 Favored 'General case' 0 C--O 1.198 -1.656 0 C-N-CA 115.357 -2.537 . . . . 0.0 108.838 -177.246 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.818 ' HB2' ' CA ' ' A' ' 63' ' ' GLY 0.251 0.0 OUTLIER -75.35 -54.04 7.73 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 119.517 -1.989 . . . . 0.0 108.454 165.215 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.737 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -79.14 -22.03 45.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.004 -1.06 . . . . 0.0 110.417 179.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 2.1 tp10 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.166 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.769 ' SD ' ' OE2' ' A' ' 83' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 121.925 0.869 . . . . 0.0 110.721 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.689 ' CG2' ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -79.89 -91.6 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 120.794 -1.191 . . . . 0.0 109.95 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.712 HG21 ' CB ' ' A' ' 27' ' ' LYS . 42.8 t -90.07 111.59 23.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.521 -0.737 . . . . 0.0 110.174 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.762 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 3.5 m-20 -124.1 107.43 11.26 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.786 -1.166 . . . . 0.0 108.679 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.713 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -123.09 139.55 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 122.059 -0.401 . . . . 0.0 110.58 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.776 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 12.8 tt0 -131.05 121.73 25.53 Favored 'General case' 0 C--N 1.284 -2.241 0 O-C-N 119.163 -2.21 . . . . 0.0 105.844 177.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 7' ' ' VAL . 26.8 m -113.07 106.23 20.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -176.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.847 ' CE1' ' HA ' ' A' ' 41' ' ' ILE 0.257 6.8 t80 -115.55 89.17 3.04 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.881 -178.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.627 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -131.24 -46.04 1.0 Allowed 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.21 -0.931 . . . . 0.0 109.739 178.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.688 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 17.6 t 179.08 147.05 0.39 Allowed Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.451 -0.781 . . . . 0.0 110.924 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.709 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 50.7 Cg_endo -85.44 -26.24 1.41 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 124.317 1.693 . . . . 0.0 110.868 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -77.25 6.41 6.75 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.203 -0.935 . . . . 0.0 110.01 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.51 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -152.2 -171.59 0.28 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.413 -0.804 . . . . 0.0 110.487 179.041 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 13' ' ' CYS . 47.0 Cg_endo -84.93 107.51 1.1 Allowed 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.419 1.413 . . . . 0.0 109.137 177.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.688 ' CE1' ' O ' ' A' ' 10' ' ' SER . 17.1 m-85 -49.85 -82.7 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.584 -0.697 . . . . 0.0 109.14 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.688 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . 35.4 m -155.61 46.65 0.28 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.314 -0.866 . . . . 0.0 109.544 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.678 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . 48.9 Cg_endo -72.34 24.36 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.973 1.512 . . . . 0.0 111.335 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.448 ' H ' ' C ' ' A' ' 16' ' ' CYS . 6.8 tpt -110.44 -69.09 0.89 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.155 -0.966 . . . . 0.0 110.489 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.674 ' HB1' ' CB ' ' A' ' 73' ' ' ARG . . . -55.98 -19.51 12.77 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.047 -1.033 . . . . 0.0 109.662 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.678 ' CD1' ' HA ' ' A' ' 17' ' ' PRO . 13.1 pt -70.72 -40.14 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.66 ' N ' HG13 ' A' ' 20' ' ' ILE . 13.8 tp10 -54.53 -35.87 63.66 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.0 t -68.17 -45.28 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.766 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -65.68 -35.53 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.639 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 2.4 t70 -67.95 -40.46 83.26 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.717 0.77 . . . . 0.0 109.124 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.433 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.6 OUTLIER -58.42 -46.95 85.45 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.371 0.605 . . . . 0.0 110.371 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.581 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.17 -38.68 51.26 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.935 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.712 ' CB ' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -74.82 -16.92 60.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.834 -1.166 . . . . 0.0 109.924 -179.005 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.639 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -73.31 -45.33 56.07 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 176.659 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.677 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -46.51 -37.06 7.37 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 122.057 0.932 . . . . 0.0 110.051 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.783 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -97.28 -68.09 0.82 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.783 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -84.35 88.97 1.56 Allowed Glycine 0 CA--C 1.544 1.86 0 C-N-CA 118.234 -1.936 . . . . 0.0 110.165 176.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.527 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -40.41 -27.7 0.05 Allowed 'General case' 0 N--CA 1.515 2.78 0 O-C-N 118.573 -2.722 . . . . 0.0 110.58 176.259 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.689 ' O ' ' CG2' ' A' ' 2' ' ' VAL . 0.2 OUTLIER -80.92 151.65 28.46 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.78 -0.575 . . . . 0.0 111.175 179.105 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.683 ' CD1' ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -130.2 154.8 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.79 -1.194 . . . . 0.0 110.064 179.128 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.619 ' O ' ' O ' ' A' ' 3' ' ' VAL . 14.2 t0 -151.74 80.8 1.28 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.64 HG23 ' CG1' ' A' ' 5' ' ' ILE . 46.5 t -97.44 129.42 47.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.776 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 5.0 mt-10 -108.86 146.02 34.38 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.706 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -142.38 112.24 6.87 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.457 1.122 . . . . 0.0 112.949 -175.231 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.691 ' CG2' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -112.21 164.31 8.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 112.218 -179.652 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.744 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -96.4 162.13 13.62 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.27 -0.894 . . . . 0.0 109.517 179.16 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.847 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -70.34 -39.49 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.116 -0.99 . . . . 0.0 111.73 -179.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.744 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.6 ptm -80.94 -2.6 48.36 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.929 -1.107 . . . . 0.0 110.972 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.621 HG12 ' HB3' ' A' ' 40' ' ' ASP . 14.9 p -113.23 -44.57 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.072 -1.018 . . . . 0.0 109.948 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.808 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 4.8 t70 -107.38 52.03 0.73 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.454 -0.779 . . . . 0.0 109.083 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.539 ' HA ' ' CZ ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -64.33 -1.98 1.96 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 119.797 -1.814 . . . . 0.0 110.34 -179.135 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.685 ' O ' ' CG1' ' A' ' 49' ' ' ILE . 10.6 pt-20 -56.16 -21.55 23.48 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.862 ' O ' ' OE1' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -46.88 -64.3 0.81 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 119.909 -1.744 . . . . 0.0 108.708 179.395 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.857 ' N ' ' HG3' ' A' ' 47' ' ' LYS . . . -61.63 -6.01 2.25 Favored 'General case' 0 C--O 1.196 -1.72 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.864 -178.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.771 ' C ' ' O ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -25.92 -41.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 119.715 -1.866 . . . . 0.0 106.874 176.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.862 ' OE1' ' O ' ' A' ' 47' ' ' LYS . 52.7 mp0 -52.57 -52.45 55.02 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.136 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.822 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 3.0 p90 -123.81 -32.01 3.35 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.298 -0.876 . . . . 0.0 110.398 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.675 ' HA2' ' HB3' ' A' ' 48' ' ' ALA . . . 45.44 4.32 0.01 OUTLIER Glycine 1 N--CA 1.519 4.172 0 O-C-N 121.37 -0.832 . . . . 0.0 111.786 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.632 ' H ' ' C ' ' A' ' 51' ' ' TYR . 9.5 mt -75.24 -81.12 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 175.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.621 ' O ' ' HE2' ' A' ' 51' ' ' TYR 0.271 0.3 OUTLIER -93.64 66.65 3.82 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.3 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.818 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.275 . . -107.46 117.26 33.64 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 119.97 -1.707 . . . . 0.0 110.162 -178.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.773 ' HA ' ' CD1' ' A' ' 41' ' ' ILE . 2.1 t -148.89 -63.31 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.055 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.767 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 59.3 Cg_endo -109.12 117.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.186 0 N-CA-C 109.654 -0.941 . . . . 0.0 109.654 176.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.717 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -163.22 178.46 8.19 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.554 1.169 . . . . 0.0 111.625 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.881 ' O ' ' HG3' ' A' ' 66' ' ' ARG 0.258 1.1 mp -142.08 152.7 18.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.776 ' HA ' ' HA ' ' A' ' 66' ' ' ARG 0.263 . . -91.37 156.92 17.41 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.71 ' CG2' ' HB3' ' A' ' 79' ' ' ALA . 0.6 OUTLIER -102.38 91.83 2.12 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.449 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 -175.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.762 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -56.49 85.61 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -176.605 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.802 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 161.3 -42.83 0.4 Allowed Glycine 0 C--N 1.29 -1.986 0 N-CA-C 108.063 -2.015 . . . . 0.0 108.063 -177.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.695 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.7 m -126.69 -60.82 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.793 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.695 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 59.8 t -163.61 -99.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 120.758 -1.214 . . . . 0.0 112.565 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.881 ' HG3' ' O ' ' A' ' 59' ' ' ILE . 2.0 ttp180 -169.03 162.97 11.23 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.827 ' CZ ' ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -147.09 173.12 12.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.359 -0.838 . . . . 0.0 111.676 -177.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.733 ' CG2' ' CZ ' ' A' ' 51' ' ' TYR . 66.2 t -84.52 114.76 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.507 -0.746 . . . . 0.0 110.857 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.827 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.87 129.25 2.0 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 118.833 -1.651 . . . . 0.0 110.65 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.782 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -94.91 -81.41 0.02 OUTLIER Pre-proline 0 C--N 1.298 -1.641 0 O-C-N 121.177 -1.19 . . . . 0.0 107.946 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.782 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 56.7 Cg_endo -84.64 25.28 0.7 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 N-CA-C 108.831 -1.257 . . . . 0.0 108.831 176.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.544 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -101.53 59.65 0.88 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.426 0.632 . . . . 0.0 110.697 -179.209 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.782 ' O ' HD12 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -69.3 -29.45 67.3 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.577 ' HA ' ' HB3' ' A' ' 19' ' ' ALA . 1.8 tm-20 -47.26 -42.55 20.8 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.197 -0.94 . . . . 0.0 110.471 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.738 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -45.44 -33.67 2.75 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.287 179.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.782 HD12 ' O ' ' A' ' 73' ' ' ARG . 7.4 mp -64.7 -43.54 93.14 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.766 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -56.1 -35.84 67.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.275 -0.891 . . . . 0.0 109.526 179.216 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.737 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -81.39 -33.17 32.43 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.103 0.478 . . . . 0.0 110.062 179.515 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.71 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -69.91 -34.34 73.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.386 -0.821 . . . . 0.0 111.178 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.761 ' CD1' ' O ' ' A' ' 4' ' ' ASN . 0.5 OUTLIER -68.12 -42.86 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.585 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -64.51 -18.16 64.55 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 175.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.534 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.347 0.0 OUTLIER -104.59 -5.48 21.42 Favored 'General case' 0 CA--C 1.477 -1.847 0 CA-C-O 124.702 2.192 . . . . 0.0 109.224 -179.433 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.802 ' HB2' ' CA ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -87.33 -55.55 3.76 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 101.846 -3.39 . . . . 0.0 101.846 176.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.7 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -78.47 -21.77 48.55 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.243 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 2.1 tp10 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.026 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.512 ' SD ' ' OD1' ' A' ' 4' ' ' ASN . 8.6 ttp . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.599 0.714 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.734 HG21 ' HA3' ' A' ' 31' ' ' GLY . 1.0 OUTLIER -80.38 -95.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.582 0.706 . . . . 0.0 110.291 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.716 HG21 ' HB2' ' A' ' 27' ' ' LYS . 53.0 t -90.12 114.9 28.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.416 -0.803 . . . . 0.0 109.397 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.814 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.257 2.8 t-20 -138.28 105.83 5.57 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 117.984 -1.486 . . . . 0.0 107.919 178.428 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.698 ' HA ' HD13 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -121.35 139.55 48.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.235 -179.021 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 1.105 ' O ' HD23 ' A' ' 76' ' ' LEU . 6.8 tt0 -132.35 123.17 26.28 Favored 'General case' 0 C--N 1.285 -2.229 0 C-N-CA 116.438 -2.105 . . . . 0.0 105.911 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.743 HG23 ' HA ' ' A' ' 38' ' ' LYS . 3.0 m -113.21 104.18 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.926 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 4.8 t80 -113.5 96.26 5.79 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.28 -177.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.748 ' O ' ' O ' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -126.37 -69.02 0.79 Allowed 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.167 -0.958 . . . . 0.0 108.673 178.18 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.661 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 3.8 p 179.53 152.9 0.57 Allowed Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.273 -0.892 . . . . 0.0 110.793 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.602 ' HA ' ' OH ' ' A' ' 15' ' ' TYR . 50.8 Cg_endo -76.2 -27.33 8.23 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 124.437 1.756 . . . . 0.0 110.175 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.421 HG21 ' O ' ' A' ' 12' ' ' THR . 23.2 m -78.95 -17.0 56.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.678 -0.639 . . . . 0.0 109.949 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -124.55 179.94 0.99 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.885 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.628 ' O ' ' O ' ' A' ' 15' ' ' TYR . 51.3 Cg_endo -83.31 109.11 1.59 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 124.012 1.532 . . . . 0.0 109.817 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.661 ' CE1' ' O ' ' A' ' 10' ' ' SER . 4.7 m-85 -50.48 -117.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.661 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 18.7 m -155.16 40.32 0.13 Allowed Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.833 -1.167 . . . . 0.0 109.896 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.3 Cg_endo -75.76 30.3 0.38 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 O-C-N 123.653 1.344 . . . . 0.0 111.261 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.506 ' HE1' ' HD2' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -109.98 -59.49 1.92 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.969 -1.082 . . . . 0.0 110.713 -179.296 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.665 ' HB2' ' N ' ' A' ' 74' ' ' GLU . . . -56.19 -19.71 14.82 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.36 -0.838 . . . . 0.0 110.397 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.715 ' CG2' HD12 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -73.36 -39.93 55.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.486 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.579 ' N ' HD12 ' A' ' 20' ' ' ILE . 14.1 tt0 -53.73 -35.08 60.82 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -68.89 -50.89 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.717 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -61.66 -33.55 57.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.349 178.567 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.652 ' OD1' ' CG1' ' A' ' 34' ' ' ILE . 8.4 t0 -66.4 -41.05 89.86 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.726 0.774 . . . . 0.0 109.071 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.482 ' OE1' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -56.88 -48.39 78.28 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.626 0.726 . . . . 0.0 109.317 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.463 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.55 -39.09 47.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.842 -0.536 . . . . 0.0 110.439 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.716 ' HB2' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -72.01 -16.65 62.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.993 -1.067 . . . . 0.0 109.877 -178.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.699 ' CG ' HD12 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -73.56 -44.2 58.02 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.608 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.689 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -49.71 -34.23 18.23 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.909 0.861 . . . . 0.0 110.206 179.578 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.739 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -94.89 -69.06 0.77 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.739 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -83.82 84.86 1.55 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 118.788 -1.672 . . . . 0.0 110.101 177.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.579 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -36.69 -32.07 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.655 0 O-C-N 118.768 -2.607 . . . . 0.0 110.65 177.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.661 ' O ' HG11 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -78.51 151.4 32.57 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.492 178.405 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.699 HD12 ' CG ' ' A' ' 28' ' ' LYS . 0.4 OUTLIER -129.76 156.05 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.646 -1.283 . . . . 0.0 110.264 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.699 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 25.7 t0 -151.7 80.07 1.28 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.675 HG13 ' CD1' ' A' ' 20' ' ' ILE . 47.4 t -98.34 129.78 48.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.874 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 11.8 mm-40 -112.4 140.54 47.04 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.743 ' HA ' HG23 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -141.82 112.29 7.09 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -175.063 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.889 ' O ' ' HA ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -130.39 163.26 36.54 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 CA-C-O 121.77 0.795 . . . . 0.0 112.496 -179.103 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.645 ' OD1' ' N ' ' A' ' 43' ' ' VAL . 9.6 p-10 -98.69 178.82 4.87 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.277 -0.89 . . . . 0.0 111.379 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.926 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -69.28 -15.63 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.21 -0.931 . . . . 0.0 109.86 177.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.583 ' CG ' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -89.73 -14.61 34.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.814 -1.179 . . . . 0.0 111.981 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.645 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.9 p -113.95 -40.43 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.929 -1.107 . . . . 0.0 110.687 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.784 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 3.8 t70 -111.64 48.83 0.93 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.162 -0.961 . . . . 0.0 108.989 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.557 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 29.9 ttt180 -64.95 -1.08 1.81 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.08 -1.638 . . . . 0.0 109.814 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.754 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 25.8 mm-40 -60.48 -22.98 64.13 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.244 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.863 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 1.1 tptt -45.85 -65.35 0.56 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.274 -1.516 . . . . 0.0 109.147 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.863 ' N ' ' HG3' ' A' ' 47' ' ' LYS . . . -58.14 -11.18 2.36 Favored 'General case' 0 C--O 1.189 -2.083 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.264 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.778 ' C ' ' O ' ' A' ' 48' ' ' ALA . 2.7 pp -23.99 -40.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 119.933 -1.729 . . . . 0.0 107.262 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.835 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -56.02 -50.78 69.94 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 115.316 -0.857 . . . . 0.0 108.995 178.572 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.85 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 3.1 p90 -122.35 -34.24 3.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.729 -0.607 . . . . 0.0 110.292 178.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.677 ' HA2' ' CB ' ' A' ' 48' ' ' ALA . . . 47.64 3.13 0.01 OUTLIER Glycine 0 N--CA 1.514 3.837 0 O-C-N 121.192 -0.943 . . . . 0.0 111.291 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.673 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 4.1 mt -75.45 -80.49 0.09 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.702 ' O ' ' HE2' ' A' ' 51' ' ' TYR 0.255 26.3 mtp -92.02 67.49 5.14 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.863 177.397 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.814 ' CB ' ' HB1' ' A' ' 48' ' ' ALA 0.27 . . -108.9 110.7 22.09 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 120.448 -1.407 . . . . 0.0 109.048 -177.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.748 ' O ' ' O ' ' A' ' 9' ' ' THR . 1.0 OUTLIER -149.42 -54.52 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.877 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.942 -179.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.754 ' HB2' ' CA ' ' A' ' 70' ' ' ALA . 59.2 Cg_endo -110.91 106.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.169 1.089 . . . . 0.0 110.212 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.757 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -161.62 179.77 7.91 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.623 -1.626 . . . . 0.0 112.181 -176.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.874 ' O ' ' HG3' ' A' ' 66' ' ' ARG 0.264 0.3 OUTLIER -143.87 153.63 15.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 -179.808 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.827 ' HA ' ' HG3' ' A' ' 66' ' ' ARG 0.256 . . -92.16 153.78 19.11 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 101.82 -3.4 . . . . 0.0 101.82 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.765 ' CG2' ' HB3' ' A' ' 79' ' ' ALA 0.274 2.1 mt -102.66 93.6 2.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 -175.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.814 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.5 OUTLIER -55.6 84.76 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 113.12 -1.855 . . . . 0.0 107.145 -178.082 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.659 ' HA3' ' CB ' ' A' ' 83' ' ' GLU . . . 162.22 -45.8 0.36 Allowed Glycine 0 C--N 1.289 -2.038 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.686 HG21 ' HB ' ' A' ' 61' ' ' ILE . 4.6 m -123.33 -61.13 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.447 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.682 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 73.7 t -165.17 -101.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 O-C-N 120.909 -1.119 . . . . 0.0 112.235 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.874 ' HG3' ' O ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -156.01 166.24 34.05 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.539 -0.725 . . . . 0.0 109.747 -178.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.866 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -149.26 165.19 32.65 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.34 -0.85 . . . . 0.0 111.17 -178.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.513 HG23 ' CZ ' ' A' ' 51' ' ' TYR . 94.5 t -81.07 121.09 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.354 -0.841 . . . . 0.0 110.203 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.797 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -164.03 114.18 0.59 Allowed Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.182 -1.485 . . . . 0.0 110.549 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.787 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -91.65 -82.79 0.02 OUTLIER Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 121.578 -0.954 . . . . 0.0 109.034 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.787 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 57.0 Cg_endo -84.42 26.52 0.65 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 N-CA-C 107.982 -1.584 . . . . 0.0 107.982 176.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.671 ' CB ' ' OE2' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -112.26 83.42 1.8 Allowed 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.657 ' C ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -82.37 -44.04 16.64 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.665 ' N ' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -40.05 -30.91 0.1 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.158 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.735 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -49.7 -46.21 49.82 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.296 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 1.105 HD23 ' O ' ' A' ' 6' ' ' GLU . 27.3 mt -58.15 -43.54 87.4 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.717 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.27 -37.25 74.6 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.09 0.947 . . . . 0.0 109.857 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.64 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 3.2 tt0 -78.28 -30.94 48.76 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.348 -0.845 . . . . 0.0 110.298 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.765 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -70.15 -38.56 75.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.124 -0.985 . . . . 0.0 111.249 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.713 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -65.59 -42.59 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.327 -0.858 . . . . 0.0 108.726 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.64 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -68.46 -22.51 64.57 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.22 177.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.615 ' O ' ' OD1' ' A' ' 82' ' ' ASP 0.312 0.0 OUTLIER -102.1 2.42 37.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 118.232 -2.793 . . . . 0.0 107.114 -177.549 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.696 ' HG2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -94.14 -59.72 1.9 Allowed 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 103.321 -2.844 . . . . 0.0 103.321 176.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.621 ' HE3' ' CE ' ' A' ' 27' ' ' LYS . 3.3 ptt? -72.05 -17.96 61.98 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.601 177.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.533 ' OXT' ' HA ' ' A' ' 82' ' ' ASP . 3.2 mm-40 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.171 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.72 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.272 0.558 . . . . 0.0 110.184 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.724 ' CG2' ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -79.95 -90.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.359 -0.838 . . . . 0.0 109.848 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.749 HG21 ' CB ' ' A' ' 27' ' ' LYS . 48.6 t -89.6 110.89 22.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.446 -0.783 . . . . 0.0 111.124 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.846 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 3.9 m-20 -124.02 107.11 10.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.621 -1.3 . . . . 0.0 109.085 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.725 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.14 138.22 52.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 O-C-N 121.711 -0.618 . . . . 0.0 111.758 178.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.864 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 12.4 tt0 -130.64 119.78 22.96 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 115.614 -2.434 . . . . 0.0 106.079 177.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.785 HG23 ' O ' ' A' ' 7' ' ' VAL . 19.5 m -111.48 107.33 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -176.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.871 ' CE1' ' O ' ' A' ' 44' ' ' ASP . 6.3 t80 -116.74 87.28 2.66 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.958 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.675 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -130.14 -46.22 1.12 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.859 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.765 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 17.5 t 179.59 148.33 0.45 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.226 -0.921 . . . . 0.0 110.666 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.702 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 50.5 Cg_endo -86.16 -26.31 1.16 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.103 1.581 . . . . 0.0 110.649 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -78.06 8.34 4.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.12 -0.987 . . . . 0.0 109.9 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.551 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -152.38 -171.29 0.27 Allowed Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.62 178.806 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' A' ' 13' ' ' CYS . 45.2 Cg_endo -85.05 107.12 1.05 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.742 1.391 . . . . 0.0 109.579 176.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.765 ' CE1' ' O ' ' A' ' 10' ' ' SER . 14.8 m-85 -49.39 -82.79 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.053 -1.029 . . . . 0.0 109.753 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.733 ' HB2' ' CG1' ' A' ' 7' ' ' VAL . 34.8 m -156.08 47.25 0.3 Allowed Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.36 -0.838 . . . . 0.0 109.724 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.702 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . 47.4 Cg_endo -72.62 24.17 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.031 1.543 . . . . 0.0 111.075 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.463 ' H ' ' C ' ' A' ' 16' ' ' CYS . 6.5 tpt -110.16 -69.66 0.85 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.126 -0.983 . . . . 0.0 110.247 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.746 ' HB1' ' CB ' ' A' ' 73' ' ' ARG . . . -55.02 -20.08 8.43 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.12 -0.988 . . . . 0.0 109.291 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.702 ' CD1' ' HA ' ' A' ' 17' ' ' PRO . 12.8 pt -71.28 -40.26 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.0 109.141 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.688 ' N ' HG13 ' A' ' 20' ' ' ILE . 13.8 tp10 -53.79 -35.51 61.44 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.1 t -68.89 -44.73 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.789 0.804 . . . . 0.0 108.872 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.815 ' CG1' ' HB ' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -65.84 -34.48 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 121.681 0.753 . . . . 0.0 109.435 178.29 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.722 ' OD1' ' CD ' ' A' ' 28' ' ' LYS . 2.6 t70 -69.55 -38.82 77.61 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.993 0.901 . . . . 0.0 109.57 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.428 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -59.79 -46.3 89.62 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.536 0.684 . . . . 0.0 110.044 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.618 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.74 -39.14 45.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.522 -0.736 . . . . 0.0 111.077 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.749 ' CB ' HG21 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -73.8 -18.04 61.01 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 118.886 -1.126 . . . . 0.0 109.373 -178.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.722 ' CD ' ' OD1' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -72.5 -45.14 60.84 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 176.775 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.75 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -47.25 -37.16 10.06 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.676 0.75 . . . . 0.0 109.816 179.304 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.817 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -96.99 -65.56 0.96 Allowed 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.414 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.817 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -85.18 84.71 1.59 Allowed Glycine 0 N--CA 1.511 3.66 0 C-N-CA 118.493 -1.813 . . . . 0.0 111.167 176.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.587 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -38.13 -26.73 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.397 0 CA-C-N 121.653 2.727 . . . . 0.0 110.813 177.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.741 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -80.09 151.41 29.87 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.514 -0.741 . . . . 0.0 112.459 177.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.741 ' CD1' ' O ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -130.24 154.02 39.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 120.242 -1.536 . . . . 0.0 109.829 178.47 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.629 ' O ' ' O ' ' A' ' 3' ' ' VAL . 10.4 t0 -151.26 79.18 1.29 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.676 HG23 ' CG1' ' A' ' 5' ' ' ILE 0.254 44.5 t -96.96 127.26 49.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -178.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.864 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 4.8 mt-10 -108.47 144.58 35.9 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -177.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.757 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.9 112.42 7.85 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -174.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.728 ' CG2' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -112.25 165.5 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.288 -0.965 . . . . 0.0 112.241 -178.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.782 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -97.26 161.38 13.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.134 -0.979 . . . . 0.0 109.739 178.827 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.82 ' CD1' ' HA ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -70.08 -38.2 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 111.735 -179.004 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.782 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.4 ptm -80.79 -4.26 53.95 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.251 -0.979 . . . . 0.0 111.245 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.659 HG12 ' HB3' ' A' ' 40' ' ' ASP . 14.1 p -112.34 -44.8 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.139 -0.976 . . . . 0.0 110.138 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.871 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 4.2 t70 -106.91 52.91 0.7 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.068 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.608 ' HA ' ' CZ ' ' A' ' 8' ' ' PHE 0.268 0.0 OUTLIER -66.36 -0.37 2.61 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.56 -1.256 . . . . 0.0 109.557 -178.548 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.723 ' O ' ' CG1' ' A' ' 49' ' ' ILE . 10.4 pt-20 -55.56 -21.45 17.19 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 177.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.938 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -47.43 -63.62 1.0 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 123.711 1.72 . . . . 0.0 109.057 -178.319 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.938 ' N ' ' HG3' ' A' ' 47' ' ' LYS . . . -57.75 -10.35 1.61 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.149 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.838 ' C ' ' O ' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -26.3 -41.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 O-C-N 119.57 -1.956 . . . . 0.0 107.1 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.896 ' OE1' ' O ' ' A' ' 47' ' ' LYS . 51.3 mp0 -51.95 -53.02 46.16 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.063 176.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.867 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.7 p90 -124.18 -30.0 3.51 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.224 -0.923 . . . . 0.0 110.152 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.762 ' HA2' ' HB3' ' A' ' 48' ' ' ALA . . . 43.31 5.73 0.01 OUTLIER Glycine 0 N--CA 1.506 3.309 0 CA-C-O 122.3 0.944 . . . . 0.0 111.576 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.722 ' N ' ' O ' ' A' ' 51' ' ' TYR . 9.3 mt -75.92 -77.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 175.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.619 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -96.11 64.38 2.34 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.116 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.9 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.295 . . -108.04 117.85 35.21 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 117.838 -1.545 . . . . 0.0 109.436 -177.14 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.846 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 2.1 t -148.64 -63.23 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.785 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.546 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.846 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.252 56.5 Cg_endo -110.67 116.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 N-CA-C 108.593 -1.349 . . . . 0.0 108.593 177.145 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.728 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -161.96 176.28 10.95 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.88 -177.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.88 ' O ' ' HG3' ' A' ' 66' ' ' ARG 0.25 1.1 mp -140.76 150.03 20.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.012 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.814 ' CB ' ' HD3' ' A' ' 66' ' ' ARG 0.308 . . -89.53 155.58 19.19 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 -178.177 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.748 ' CG2' ' HB3' ' A' ' 79' ' ' ALA 0.328 0.6 OUTLIER -101.94 93.16 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.918 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 -175.953 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.846 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -52.82 83.29 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 112.814 -1.994 . . . . 0.0 106.407 -178.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.825 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 162.47 -42.79 0.36 Allowed Glycine 0 C--N 1.293 -1.844 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.785 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.5 m -127.41 -59.3 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.808 -0.819 . . . . 0.0 111.035 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.785 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 58.7 t -164.32 -101.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 O-C-N 120.286 -1.509 . . . . 0.0 112.553 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.88 ' HG3' ' O ' ' A' ' 59' ' ' ILE . 2.0 ttp180 -166.91 163.73 16.17 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.835 ' CZ ' ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -147.01 175.17 10.89 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.013 -1.054 . . . . 0.0 111.218 -177.188 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.786 ' CG2' ' CZ ' ' A' ' 51' ' ' TYR . 70.3 t -85.58 113.88 24.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.11 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.835 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.08 129.95 2.19 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.063 -2.018 . . . . 0.0 109.903 177.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.846 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -94.84 -81.98 0.02 OUTLIER Pre-proline 0 C--N 1.294 -1.842 0 O-C-N 121.121 -1.223 . . . . 0.0 107.931 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.846 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 54.6 Cg_endo -84.34 24.53 0.75 Allowed 'Trans proline' 0 C--N 1.302 -1.904 0 N-CA-C 108.475 -1.394 . . . . 0.0 108.475 177.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.555 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -100.7 59.93 0.96 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.488 -0.757 . . . . 0.0 111.219 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.746 ' CB ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -68.87 -29.32 67.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.38 -0.825 . . . . 0.0 109.898 178.477 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.607 ' HA ' ' HB3' ' A' ' 19' ' ' ALA . 1.8 tm-20 -47.71 -43.5 26.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 109.932 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.786 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -44.38 -34.69 2.09 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.845 179.691 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.744 ' CD1' ' CG2' ' A' ' 59' ' ' ILE . 7.4 mp -64.22 -42.96 96.35 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.8 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.01 -35.31 69.09 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.901 0.858 . . . . 0.0 109.356 179.662 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.783 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -80.93 -32.87 34.45 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.498 -0.752 . . . . 0.0 110.38 178.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.748 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -70.95 -34.26 71.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.357 -0.839 . . . . 0.0 110.695 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.815 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -66.55 -43.33 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 122.179 0.99 . . . . 0.0 108.79 178.784 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -65.97 -19.51 65.89 Favored 'General case' 0 C--O 1.196 -1.759 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.042 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.62 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.421 0.0 OUTLIER -104.33 -5.74 21.49 Favored 'General case' 0 C--O 1.251 1.157 0 C-N-CA 116.525 -2.07 . . . . 0.0 105.898 -177.789 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.825 ' HB2' ' CA ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -85.69 -53.82 4.91 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 172.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.75 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -79.12 -21.28 46.81 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.372 -1.455 . . . . 0.0 110.567 -179.57 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 2.1 tp10 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.148 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.504 ' HB3' ' HE1' ' A' ' 1' ' ' MET . 8.0 ttp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.303 0.573 . . . . 0.0 110.249 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.749 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 0.9 OUTLIER -81.09 -92.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 0.0 110.412 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.731 HG22 ' CD1' ' A' ' 34' ' ' ILE . 55.4 t -92.2 108.83 20.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.703 -0.623 . . . . 0.0 110.644 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.81 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 2.4 t-20 -129.11 106.83 9.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.045 -1.034 . . . . 0.0 109.278 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.736 HD12 ' CG1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -124.22 138.17 54.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 O-C-N 121.785 -0.572 . . . . 0.0 110.44 178.669 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.783 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 5.3 tt0 -129.1 107.58 9.7 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 117.483 -1.687 . . . . 0.0 110.016 178.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.738 ' HA ' ' CG1' ' A' ' 59' ' ' ILE . 2.9 m -96.74 109.78 23.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 122.892 1.329 . . . . 0.0 107.663 -178.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.838 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 2.2 t80 -118.53 90.01 3.24 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.041 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.642 ' O ' ' O ' ' A' ' 56' ' ' VAL . 0.6 OUTLIER -120.92 -68.59 0.89 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.53 -0.731 . . . . 0.0 109.66 178.814 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.756 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 3.8 p 179.65 154.4 0.64 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 110.682 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.644 ' HD3' ' HB2' ' A' ' 40' ' ' ASP . 49.8 Cg_endo -76.94 -27.16 7.23 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.11 1.584 . . . . 0.0 110.468 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 12' ' ' THR . 21.3 m -79.58 -16.1 56.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.89 . . . . 0.0 109.924 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.455 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -125.0 -179.51 0.88 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 109.951 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.656 ' O ' ' O ' ' A' ' 15' ' ' TYR . 50.9 Cg_endo -83.5 108.07 1.46 Allowed 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.96 1.505 . . . . 0.0 110.319 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.756 ' CE1' ' O ' ' A' ' 10' ' ' SER . 4.8 m-85 -49.71 -117.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.932 . . . . 0.0 109.899 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.707 ' CB ' HD13 ' A' ' 59' ' ' ILE . 19.2 m -155.68 40.46 0.13 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.16 -0.962 . . . . 0.0 110.278 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.3 Cg_endo -76.0 30.07 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.961 1.506 . . . . 0.0 111.195 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.513 ' HE1' ' HD2' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -110.21 -59.37 1.95 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.816 -1.178 . . . . 0.0 110.671 -179.491 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.744 ' CB ' ' C ' ' A' ' 73' ' ' ARG . . . -55.92 -19.3 11.59 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.272 -0.893 . . . . 0.0 109.894 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.73 ' CG2' HG21 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -75.22 -39.48 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.832 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.649 ' N ' HD12 ' A' ' 20' ' ' ILE . 14.6 tt0 -53.35 -33.19 52.55 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.372 -0.83 . . . . 0.0 108.98 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -71.77 -46.94 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 109.385 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.752 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -66.14 -26.91 39.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.473 -0.767 . . . . 0.0 109.246 178.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.731 ' OD1' ' CG1' ' A' ' 34' ' ' ILE . 8.7 t0 -73.69 -39.25 64.51 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.53 ' OE1' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -57.92 -46.14 85.44 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.419 179.303 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.484 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -80.12 -40.21 27.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.553 -0.717 . . . . 0.0 110.061 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.765 ' N ' ' HE3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.42 -21.82 64.64 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.198 -179.165 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.712 ' CG ' HD12 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -69.61 -44.47 70.64 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.058 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.791 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -48.97 -39.65 27.37 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.869 0.843 . . . . 0.0 109.116 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.791 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.69 -57.98 2.68 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.382 -0.824 . . . . 0.0 109.23 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.734 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -95.92 77.87 0.79 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.258 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.568 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -32.9 -26.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 119.272 1.536 . . . . 0.0 110.726 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.734 ' N ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -85.3 153.13 22.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.535 -0.728 . . . . 0.0 110.889 177.779 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.731 ' CG1' ' OD1' ' A' ' 24' ' ' ASP . 0.4 OUTLIER -129.59 154.91 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.823 -1.173 . . . . 0.0 110.93 178.146 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.63 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 26.2 t0 -150.2 74.86 1.21 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.491 -0.756 . . . . 0.0 109.393 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.691 ' HA ' HG12 ' A' ' 5' ' ' ILE . 40.5 t -93.03 119.13 40.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 120.938 -1.101 . . . . 0.0 110.348 -178.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.783 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 11.6 mm-40 -102.44 141.68 34.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.958 -1.089 . . . . 0.0 108.919 -178.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.687 ' HA ' HG23 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -140.93 120.68 13.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.511 -0.743 . . . . 0.0 111.728 -174.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.704 ' CD1' ' HB2' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -137.38 169.81 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.035 -1.04 . . . . 0.0 110.109 -178.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.648 ' OD1' ' N ' ' A' ' 43' ' ' VAL . 7.9 p-10 -106.3 175.57 5.45 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.533 -0.729 . . . . 0.0 110.756 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.838 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -66.97 -9.58 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.975 -1.078 . . . . 0.0 111.09 177.23 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.642 ' HG2' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -95.25 -16.9 22.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 110.732 -179.695 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.648 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.7 p -112.69 -40.64 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.146 -0.971 . . . . 0.0 110.055 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.796 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 3.1 t70 -111.06 45.57 1.16 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.863 . . . . 0.0 110.361 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.618 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.272 30.9 ttt180 -62.69 -3.76 1.68 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.528 -178.578 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.764 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 21.8 mm-40 -57.54 -18.68 20.51 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.347 -0.846 . . . . 0.0 110.63 175.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.887 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -51.86 -56.74 12.2 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.381 1.086 . . . . 0.0 110.292 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.887 ' N ' ' HG3' ' A' ' 47' ' ' LYS . . . -62.35 -5.39 2.4 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.255 176.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.789 ' CD1' ' N ' ' A' ' 50' ' ' GLU . 2.4 pp -34.58 -39.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 -174.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.789 ' N ' ' CD1' ' A' ' 49' ' ' ILE . 1.0 OUTLIER -53.15 -51.49 61.82 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.038 177.592 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.827 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.1 p90 -123.56 -29.77 3.71 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.921 -1.112 . . . . 0.0 110.495 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.764 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 41.41 12.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.236 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.736 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.1 mt -84.09 -67.32 0.8 Allowed 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 122.767 1.27 . . . . 0.0 107.826 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.511 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 25.7 mtp -103.57 57.15 0.74 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.465 -1.243 . . . . 0.0 107.815 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.842 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.266 . . -99.75 108.34 20.64 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.863 1.316 . . . . 0.0 111.011 -176.173 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.811 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 0.9 OUTLIER -146.81 -59.65 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.29 -179.565 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.811 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 45.1 Cg_endo -103.1 105.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.257 1.135 . . . . 0.0 110.447 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.774 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -160.59 -178.04 6.61 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.963 0.887 . . . . 0.0 111.632 -176.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.803 ' CG2' ' CD2' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -149.11 141.56 17.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.781 -0.574 . . . . 0.0 109.66 -179.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.781 ' HA ' ' HA ' ' A' ' 66' ' ' ARG 0.253 . . -82.0 137.86 35.03 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 117.207 -1.797 . . . . 0.0 107.021 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.759 ' HB ' HG21 ' A' ' 64' ' ' VAL 0.395 1.7 mt -90.0 85.85 2.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 125.433 2.539 . . . . 0.0 106.266 -174.457 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.81 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.7 OUTLIER -43.55 83.34 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 112.231 -2.259 . . . . 0.0 108.439 177.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.731 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.02 -47.57 0.35 Allowed Glycine 0 N--CA 1.483 1.782 0 N-CA-C 106.783 -2.527 . . . . 0.0 106.783 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.759 HG21 ' HB ' ' A' ' 61' ' ' ILE . 4.2 m -123.15 -60.03 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.745 -0.856 . . . . 0.0 111.232 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.745 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 75.6 t -164.78 -104.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 120.454 -1.404 . . . . 0.0 112.001 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.781 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -154.46 165.24 37.02 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.638 -0.664 . . . . 0.0 109.956 -179.065 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.832 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -145.64 172.98 12.48 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.035 -1.041 . . . . 0.0 110.94 -179.351 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.535 HG23 ' OH ' ' A' ' 51' ' ' TYR . 77.1 t -88.67 120.04 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.536 -0.727 . . . . 0.0 109.286 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.815 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.18 114.33 0.6 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.198 -1.477 . . . . 0.0 110.66 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.828 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -91.91 -83.75 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 120.848 -1.383 . . . . 0.0 108.79 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.828 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 48.3 Cg_endo -81.61 19.24 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 N-CA-C 108.145 -1.521 . . . . 0.0 108.145 177.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.748 ' CB ' ' OE2' ' A' ' 75' ' ' GLU 0.278 0.6 OUTLIER -105.68 83.09 1.88 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 117.993 -1.483 . . . . 0.0 109.2 179.699 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.744 ' C ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -81.39 -41.11 22.43 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.31 177.425 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.73 ' HA ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -43.26 -29.33 0.39 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.001 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.809 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -49.69 -45.98 49.49 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.508 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.803 ' CD2' ' CG2' ' A' ' 59' ' ' ILE . 28.8 mt -58.82 -42.49 89.31 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.423 -0.798 . . . . 0.0 109.188 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.752 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.54 -34.88 73.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.494 -0.754 . . . . 0.0 110.209 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.633 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 3.4 tt0 -80.95 -26.78 36.39 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.697 -0.627 . . . . 0.0 110.358 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.725 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -75.22 -37.4 61.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -0.944 . . . . 0.0 109.773 -178.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.752 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -65.9 -39.37 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.043 -1.036 . . . . 0.0 109.344 178.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.633 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -72.93 -28.55 62.51 Favored 'General case' 0 C--O 1.258 1.552 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.546 ' HA ' ' OXT' ' A' ' 85' ' ' GLU 0.556 0.0 OUTLIER -95.6 -8.85 33.8 Favored 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 114.2 -3.0 . . . . 0.0 109.582 -178.186 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.716 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -71.35 -61.51 1.74 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 118.414 -2.679 . . . . 0.0 111.432 162.619 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.726 ' HE3' ' NZ ' ' A' ' 27' ' ' LYS . 3.5 ptt? -71.55 -20.64 62.0 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.499 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.546 ' OXT' ' HA ' ' A' ' 82' ' ' ASP . 3.2 mm-40 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.227 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.504 ' HB3' ' HE1' ' A' ' 1' ' ' MET . 7.9 ttp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.25 0.548 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.751 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 0.9 OUTLIER -81.05 -94.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 109.854 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.732 HG21 ' CB ' ' A' ' 27' ' ' LYS . 53.3 t -89.6 111.64 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.568 -0.707 . . . . 0.0 110.296 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.791 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.349 2.4 t-20 -135.4 107.57 7.21 Favored 'General case' 0 C--O 1.189 -2.123 0 CA-C-O 125.404 2.526 . . . . 0.0 107.24 177.301 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.735 HD12 ' CG1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -118.19 136.72 54.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 116.352 -1.785 . . . . 0.0 111.921 179.568 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.763 ' CG ' ' HB2' ' A' ' 60' ' ' ALA 0.48 5.8 tt0 -133.77 124.38 26.5 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 127.31 3.433 . . . . 0.0 101.919 174.069 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.723 ' HA ' ' CG1' ' A' ' 59' ' ' ILE 0.397 10.3 m -113.78 110.42 32.09 Favored 'Isoleucine or valine' 0 C--O 1.168 -3.208 0 O-C-N 116.613 -3.804 . . . . 0.0 101.483 -177.034 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.841 ' CE1' ' HA ' ' A' ' 41' ' ' ILE 0.306 1.7 t80 -117.28 96.68 5.53 Favored 'General case' 0 C--N 1.377 1.776 0 CA-C-N 110.611 -2.995 . . . . 0.0 108.663 -178.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.616 ' O ' ' O ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -124.53 -69.22 0.81 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.89 -1.131 . . . . 0.0 108.653 178.687 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.757 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 3.8 p 179.6 154.35 0.63 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.967 . . . . 0.0 110.713 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' A' ' 40' ' ' ASP . 50.1 Cg_endo -76.96 -27.06 7.29 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.146 1.603 . . . . 0.0 110.458 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 12' ' ' THR . 21.3 m -79.71 -16.04 56.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.873 . . . . 0.0 109.954 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.455 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -125.01 -179.44 0.86 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.347 -0.846 . . . . 0.0 109.915 179.691 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.654 ' O ' ' O ' ' A' ' 15' ' ' TYR . 52.0 Cg_endo -83.58 108.06 1.44 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.963 1.507 . . . . 0.0 110.367 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.757 ' CE1' ' O ' ' A' ' 10' ' ' SER . 5.0 m-85 -49.77 -117.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 109.788 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.708 ' CB ' HD13 ' A' ' 59' ' ' ILE . 19.2 m -155.54 40.27 0.13 Allowed Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.113 -0.992 . . . . 0.0 110.348 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.3 Cg_endo -75.98 30.12 0.39 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.926 1.487 . . . . 0.0 111.183 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.513 ' HE1' ' HD2' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -110.14 -59.32 1.95 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.901 -1.124 . . . . 0.0 110.728 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.736 ' HB2' ' N ' ' A' ' 74' ' ' GLU . . . -56.42 -18.5 11.37 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.063 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.73 ' CG2' HG21 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -75.72 -39.15 38.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.851 179.572 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.65 ' N ' HD12 ' A' ' 20' ' ' ILE . 14.5 tt0 -52.98 -34.25 55.19 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 108.757 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -70.73 -49.11 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.425 -0.797 . . . . 0.0 109.271 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.749 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.9 OUTLIER -58.95 -35.55 57.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-O 122.707 1.241 . . . . 0.0 109.305 176.529 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.73 ' OD1' ' CG1' ' A' ' 34' ' ' ILE . 7.8 t0 -68.42 -41.57 80.18 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 122.848 1.308 . . . . 0.0 108.918 -178.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.53 ' OE1' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -56.19 -48.03 77.18 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.464 179.483 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.487 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -78.15 -39.68 40.24 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.854 0.835 . . . . 0.0 111.188 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.75 ' CA ' ' HE3' ' A' ' 27' ' ' LYS 0.288 0.0 OUTLIER -72.59 -16.13 61.74 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 117.17 -1.812 . . . . 0.0 109.013 -178.193 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.712 ' CG ' HD12 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -72.43 -43.25 64.08 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.736 ' HG3' ' N ' ' A' ' 30' ' ' PHE 0.287 0.0 OUTLIER -52.54 -32.59 41.41 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.765 179.794 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.751 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -94.42 -69.46 0.75 Allowed 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 102.954 -2.98 . . . . 0.0 102.954 -179.275 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.746 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -75.29 65.8 2.32 Favored Glycine 0 C--N 1.27 -3.111 1 CA-C-O 113.33 -4.039 . . . . 0.0 117.337 176.161 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.585 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -31.06 -29.61 0.01 OUTLIER 'General case' 0 C--N 1.254 -3.563 1 CA-C-N 124.806 4.303 . . . . 0.0 110.286 -175.408 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.693 ' N ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -74.73 149.53 39.78 Favored 'General case' 0 C--N 1.278 -2.52 0 O-C-N 120.132 -1.605 . . . . 0.0 113.903 174.076 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.731 ' CD1' HG22 ' A' ' 3' ' ' VAL 0.262 0.4 OUTLIER -131.05 156.42 42.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 120.854 1.661 . . . . 0.0 110.589 174.793 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.608 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 26.2 t0 -151.22 79.19 1.3 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.693 ' HA ' HG12 ' A' ' 5' ' ' ILE 0.351 61.9 t -100.63 127.41 53.75 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.94 0 CA-C-O 125.916 2.77 . . . . 0.0 104.764 -177.65 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.736 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.424 9.2 mm-40 -111.91 146.17 38.24 Favored 'General case' 0 C--O 1.183 -2.418 0 C-N-CA 113.685 -3.206 . . . . 0.0 103.99 -176.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.684 ' HA ' HG23 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.45 107.47 5.72 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 115.221 -2.323 . . . . 0.0 115.777 -170.036 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.705 ' CD1' ' HB2' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -131.72 166.87 27.72 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.556 0 CA-C-N 122.949 2.613 . . . . 0.0 112.311 -179.283 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.641 ' HB2' ' HD3' ' A' ' 11' ' ' PRO . 4.0 p-10 -98.27 175.64 6.0 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.57 -1.331 . . . . 0.0 113.464 177.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.841 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -64.63 -13.94 15.25 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.065 0 O-C-N 121.066 -1.021 . . . . 0.0 111.317 174.723 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.641 ' HG2' ' OD2' ' A' ' 40' ' ' ASP 0.379 0.0 OUTLIER -100.88 -5.07 26.62 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 115.276 -2.57 . . . . 0.0 110.538 -177.251 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.64 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 7.5 p -117.13 -41.11 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.967 -1.083 . . . . 0.0 109.048 177.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.786 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 3.1 t70 -111.56 46.69 1.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 110.254 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.6 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.378 30.3 ttt180 -66.2 -0.08 2.32 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 116.518 -2.073 . . . . 0.0 108.922 -177.754 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.757 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 18.8 mm-40 -53.12 -26.71 17.55 Favored 'General case' 0 C--N 1.287 -2.142 0 O-C-N 120.785 -1.197 . . . . 0.0 109.831 172.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.891 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -48.28 -61.0 2.22 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.571 -1.331 . . . . 0.0 109.343 -176.091 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.891 ' N ' ' HG3' ' A' ' 47' ' ' LYS 0.359 . . -54.3 -12.55 0.68 Allowed 'General case' 0 C--N 1.266 -3.054 0 C-N-CA 125.677 1.591 . . . . 0.0 112.053 176.101 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.793 ' CD1' ' N ' ' A' ' 50' ' ' GLU . 2.5 pp -33.13 -39.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.79 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -172.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.793 ' N ' ' CD1' ' A' ' 49' ' ' ILE . 1.0 OUTLIER -53.13 -51.6 61.42 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.251 176.522 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.835 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.1 p90 -123.44 -29.51 3.78 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.049 -1.032 . . . . 0.0 110.582 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.793 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.41 16.37 0.01 OUTLIER Glycine 0 N--CA 1.487 2.092 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.736 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.4 mt -87.55 -75.01 0.42 Allowed 'General case' 0 C--N 1.262 -3.197 0 N-CA-C 103.136 -2.912 . . . . 0.0 103.136 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.479 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 26.7 mtp -98.95 65.01 1.46 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.804 -1.544 . . . . 0.0 108.46 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.824 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.451 . . -110.98 112.48 24.33 Favored 'General case' 0 C--O 1.168 -3.184 1 CA-C-O 128.612 4.053 . . . . 0.0 105.685 -175.308 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.803 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 0.9 OUTLIER -148.32 -51.33 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.511 0 CA-C-N 110.476 -3.056 . . . . 0.0 112.15 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.803 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.473 19.3 Cg_endo -117.67 111.82 0.01 OUTLIER 'Trans proline' 0 C--O 1.148 -3.988 1 CA-C-O 130.685 4.369 . . . . 0.0 103.704 -179.756 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.76 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -160.88 178.32 9.53 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 109.578 -3.465 . . . . 0.0 111.405 -174.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.802 ' CG2' ' CD2' ' A' ' 76' ' ' LEU 0.26 0.3 OUTLIER -144.94 151.28 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.746 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.763 ' HB2' ' CG ' ' A' ' 6' ' ' GLU 0.503 . . -96.02 147.66 23.47 Favored 'General case' 0 C--O 1.187 -2.193 2 N-CA-C 98.196 -4.742 . . . . 0.0 98.196 -178.257 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.754 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.654 2.2 mt -99.68 96.55 5.02 Favored 'Isoleucine or valine' 0 C--N 1.408 3.112 3 C-N-CA 108.539 -5.264 . . . . 0.0 98.644 -170.689 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.791 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.6 OUTLIER -50.29 85.6 0.0 OUTLIER 'General case' 0 C--N 1.379 1.851 1 CA-C-N 107.205 -4.543 . . . . 0.0 107.516 177.499 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.754 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.95 -47.87 0.35 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 106.734 -2.546 . . . . 0.0 106.734 -178.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.754 HG21 ' HB ' ' A' ' 61' ' ' ILE . 4.2 m -122.94 -59.86 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.72 -0.871 . . . . 0.0 111.468 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.742 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 76.1 t -164.48 -104.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.264 -1.523 . . . . 0.0 111.827 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.758 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -153.89 166.11 33.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.703 -0.623 . . . . 0.0 110.111 -179.067 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.852 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -147.64 169.51 19.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.029 -1.044 . . . . 0.0 110.878 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.535 HG23 ' OH ' ' A' ' 51' ' ' TYR . 97.2 t -81.74 118.79 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.874 -1.141 . . . . 0.0 111.667 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.812 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.77 114.13 0.59 Allowed Glycine 0 C--N 1.281 -2.504 0 CA-C-N 120.595 1.543 . . . . 0.0 110.698 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.824 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -92.03 -83.08 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.754 0 O-C-N 120.742 -1.446 . . . . 0.0 109.04 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.824 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 43.1 Cg_endo -86.0 28.89 0.54 Allowed 'Trans proline' 0 C--N 1.318 -1.041 0 N-CA-C 107.894 -1.618 . . . . 0.0 107.894 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.746 ' CB ' ' OE2' ' A' ' 75' ' ' GLU 0.644 0.4 OUTLIER -120.76 95.02 4.54 Favored 'General case' 0 C--O 1.164 -3.427 2 C-N-CA 108.815 -5.154 . . . . 0.0 100.585 179.121 . . . . . . . . 5 4 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.727 ' C ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -83.15 -43.89 15.68 Favored 'General case' 0 C--N 1.371 1.537 1 CA-C-N 108.204 -4.089 . . . . 0.0 109.057 174.7 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.736 ' N ' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -39.85 -32.33 0.15 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.811 -1.18 . . . . 0.0 108.504 178.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.807 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -49.36 -45.43 45.73 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.173 -179.272 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.802 ' CD2' ' CG2' ' A' ' 59' ' ' ILE . 29.3 mt -58.55 -42.99 89.14 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.786 0.803 . . . . 0.0 109.36 178.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.749 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.68 -36.85 74.84 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.261 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.626 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 3.6 tt0 -74.05 -35.01 64.27 Favored 'General case' 0 C--N 1.286 -2.165 0 O-C-N 120.775 -1.203 . . . . 0.0 110.624 178.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.72 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -72.6 -37.6 68.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.821 -1.175 . . . . 0.0 110.222 -175.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.754 ' N ' ' CD1' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -63.5 -42.87 97.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 121.056 -1.027 . . . . 0.0 109.168 178.047 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.626 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -70.48 -25.84 63.35 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 120.776 -1.203 . . . . 0.0 109.843 178.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.457 ' HA ' ' OXT' ' A' ' 85' ' ' GLU 1.012 0.0 OUTLIER -108.61 15.03 24.09 Favored 'General case' 0 C--O 1.302 3.828 2 C-N-CA 104.258 -6.977 . . . . 0.0 101.538 -176.267 . . . . . . . . 5 4 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.717 ' CB ' ' HA3' ' A' ' 63' ' ' GLY 0.258 0.0 OUTLIER -89.52 -59.45 2.21 Favored 'General case' 0 C--N 1.314 -0.966 1 O-C-N 113.892 -5.505 . . . . 0.0 104.468 164.096 . . . . . . . . 5 4 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.728 ' HE3' ' NZ ' ' A' ' 27' ' ' LYS 0.26 3.6 ptt? -73.42 -16.18 61.33 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.599 -1.24 . . . . 0.0 111.091 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.457 ' OXT' ' HA ' ' A' ' 82' ' ' ASP . 3.1 mm-40 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.81 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.564 ' SD ' ' OE1' ' A' ' 83' ' ' GLU . 2.8 ttp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.308 0.575 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.703 ' CG2' HG21 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -89.65 -91.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.401 -0.812 . . . . 0.0 110.438 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.74 HG22 ' HB2' ' A' ' 27' ' ' LYS . 79.0 t -91.13 111.93 24.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 O-C-N 121.811 -0.556 . . . . 0.0 110.665 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.806 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 1.9 m-80 -126.73 113.64 16.93 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.732 ' CG2' ' HB3' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -133.47 133.74 57.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.396 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.731 ' HA ' ' O ' ' A' ' 37' ' ' GLU 0.277 0.0 OUTLIER -127.93 110.58 12.69 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 116.755 -1.978 . . . . 0.0 109.454 176.472 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.691 HG22 ' O ' ' A' ' 7' ' ' VAL 0.255 33.3 m -99.51 100.64 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 124.107 1.908 . . . . 0.0 108.388 -177.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.829 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -116.98 95.0 4.8 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.617 -178.086 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.66 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 38.2 m -120.5 -79.78 0.61 Allowed 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.073 -1.017 . . . . 0.0 109.648 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.62 ' C ' ' OD1' ' A' ' 40' ' ' ASP . 0.2 OUTLIER 179.55 155.53 0.66 Allowed Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.853 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.689 ' N ' ' OD2' ' A' ' 40' ' ' ASP . 47.4 Cg_endo -73.95 -12.62 23.9 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 124.142 1.601 . . . . 0.0 110.465 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.45 0.75 28.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.066 -1.021 . . . . 0.0 109.86 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.547 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -157.47 -170.25 0.24 Allowed Pre-proline 0 N--CA 1.485 1.317 0 O-C-N 121.625 -0.672 . . . . 0.0 110.132 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.643 ' O ' ' O ' ' A' ' 15' ' ' TYR . 55.2 Cg_endo -84.6 118.02 2.12 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.751 1.395 . . . . 0.0 110.735 175.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.752 ' CE1' ' OD1' ' A' ' 40' ' ' ASP . 2.7 m-85 -49.54 -113.94 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.381 -0.825 . . . . 0.0 109.773 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.671 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 33.4 m -155.0 39.91 0.13 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.163 -0.961 . . . . 0.0 110.329 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.671 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.4 Cg_endo -75.75 27.17 0.39 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.715 1.376 . . . . 0.0 111.192 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.739 ' CG ' ' CD ' ' A' ' 73' ' ' ARG . 0.1 OUTLIER -110.11 -63.22 1.4 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.947 -1.095 . . . . 0.0 110.583 -179.275 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.739 ' CB ' ' C ' ' A' ' 73' ' ' ARG . . . -54.27 -21.43 9.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.284 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.687 ' HB ' ' CD1' ' A' ' 5' ' ' ILE . 2.6 pt -66.77 -42.19 88.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.489 0.662 . . . . 0.0 109.228 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.567 ' N ' ' CG1' ' A' ' 20' ' ' ILE . 2.5 tm-20 -54.16 -33.94 59.21 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.66 -41.42 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.785 0.802 . . . . 0.0 109.077 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.768 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -68.59 -30.06 46.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 121.667 0.746 . . . . 0.0 109.362 178.228 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.702 ' OD1' ' CG1' ' A' ' 34' ' ' ILE . 5.9 t70 -73.98 -38.09 64.26 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -45.55 88.3 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.699 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.501 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.65 -40.5 29.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.561 -0.712 . . . . 0.0 110.173 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.804 ' CE ' ' CE ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -70.78 -20.54 62.59 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.943 -1.103 . . . . 0.0 109.567 -178.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.726 ' CG ' HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -69.07 -47.88 64.17 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 176.261 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.744 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -45.64 -41.29 10.07 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.94 0.876 . . . . 0.0 109.21 179.02 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.744 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -90.63 -61.32 1.7 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 121.358 -0.839 . . . . 0.0 108.946 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.694 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -94.11 78.78 0.98 Allowed Glycine 0 N--CA 1.485 1.931 0 CA-C-O 118.805 -0.997 . . . . 0.0 111.413 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.538 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -35.58 -24.05 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 120.418 2.109 . . . . 0.0 111.164 -179.628 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.694 ' N ' ' O ' ' A' ' 31' ' ' GLY . 6.6 mtpt -83.52 154.52 23.81 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.699 -0.625 . . . . 0.0 111.44 176.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.726 ' CD1' HG23 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -127.97 157.41 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 118.839 -1.144 . . . . 0.0 111.072 177.449 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 7.2 t70 -150.38 64.31 0.95 Allowed 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.688 HG13 ' CG1' ' A' ' 5' ' ' ILE . 31.3 t -92.66 117.84 36.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 118.799 -1.161 . . . . 0.0 109.824 -178.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.731 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.273 3.1 mt-10 -101.56 147.57 26.25 Favored 'General case' 0 C--O 1.195 -1.793 0 CA-C-O 122.474 1.13 . . . . 0.0 108.728 -177.744 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.655 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.74 119.25 13.05 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.172 -0.955 . . . . 0.0 112.019 -173.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.69 ' CD1' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -130.4 178.41 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -0.962 . . . . 0.0 110.667 -178.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.752 ' OD1' ' CE1' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -109.28 179.55 4.12 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.637 -0.664 . . . . 0.0 111.401 176.023 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.829 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -61.76 -54.0 40.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.128 -0.982 . . . . 0.0 112.104 173.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.702 ' N ' ' CG2' ' A' ' 41' ' ' ILE . 5.2 ptp -71.71 0.28 9.2 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.427 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.733 ' CG1' ' CB ' ' A' ' 40' ' ' ASP . 1.1 m -111.9 -45.19 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 109.814 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.76 ' OD2' ' CG ' ' A' ' 8' ' ' PHE . 9.7 t70 -114.54 45.55 1.53 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.339 -0.851 . . . . 0.0 109.839 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.5 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.288 0.0 OUTLIER -67.99 -5.57 17.95 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.41 -1.316 . . . . 0.0 110.225 -178.411 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.765 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 4.4 mt-10 -56.82 -18.93 14.71 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.312 -0.868 . . . . 0.0 110.471 173.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.821 ' HB3' ' CE2' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -49.92 -61.17 2.29 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 122.891 1.329 . . . . 0.0 110.306 -178.272 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.809 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -58.62 -4.93 0.48 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.84 177.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.765 ' CG2' ' O ' ' A' ' 46' ' ' GLU . 2.2 pp -35.99 -41.62 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 -173.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.722 ' N ' ' CD1' ' A' ' 49' ' ' ILE . 0.9 OUTLIER -50.43 -52.95 33.24 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.897 177.059 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.772 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 45.6 p90 -118.93 -36.86 3.33 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.088 -1.007 . . . . 0.0 110.354 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.766 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.96 14.0 0.01 OUTLIER Glycine 0 N--CA 1.495 2.584 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.693 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 42.7 mt -82.69 -63.3 1.4 Allowed 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 123.231 1.491 . . . . 0.0 109.256 177.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.442 ' C ' ' HE2' ' A' ' 51' ' ' TYR . 19.3 mtm -109.55 53.88 0.68 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.969 -1.468 . . . . 0.0 109.516 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.809 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.311 . . -103.52 124.44 48.77 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 117.821 -1.552 . . . . 0.0 111.117 -173.759 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.795 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -147.92 -60.74 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.408 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.656 -177.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.795 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.267 45.1 Cg_endo -108.14 113.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 CA-C-O 123.446 1.352 . . . . 0.0 110.334 177.814 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.704 ' CB ' ' O ' ' A' ' 67' ' ' PHE . . . -161.39 178.6 9.01 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.223 -175.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.774 ' CG2' ' CD1' ' A' ' 76' ' ' LEU . 1.2 mp -147.47 143.8 19.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.771 -0.58 . . . . 0.0 109.762 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.764 ' HA ' ' HA ' ' A' ' 66' ' ' ARG 0.285 . . -82.74 143.07 31.14 Favored 'General case' 0 CA--C 1.487 -1.446 0 C-N-CA 115.912 -2.315 . . . . 0.0 109.092 -179.107 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.752 ' HB ' HG21 ' A' ' 64' ' ' VAL 0.404 1.0 OUTLIER -91.09 87.5 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.731 0 CA-C-O 125.493 2.568 . . . . 0.0 107.478 -174.319 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.806 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.6 OUTLIER -42.28 80.61 0.0 OUTLIER 'General case' 0 C--O 1.2 -1.502 0 CA-C-N 112.601 -2.09 . . . . 0.0 109.618 177.296 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.754 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 161.33 -48.34 0.37 Allowed Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.56 -2.216 . . . . 0.0 107.56 -177.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.752 HG21 ' HB ' ' A' ' 61' ' ' ILE . 4.9 m -120.16 -59.73 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.763 -0.845 . . . . 0.0 110.922 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.733 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 74.5 t -164.64 -104.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.436 -1.415 . . . . 0.0 111.923 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.764 ' HA ' ' HA ' ' A' ' 60' ' ' ALA . 2.1 ttp180 -164.39 164.11 22.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.642 -0.661 . . . . 0.0 109.309 -178.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.848 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -145.1 -176.49 5.11 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.939 -1.101 . . . . 0.0 111.75 -176.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.665 ' HA ' ' HB1' ' A' ' 58' ' ' ALA . 79.5 t -94.63 114.98 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.818 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.85 125.16 1.35 Allowed Glycine 0 N--CA 1.49 2.282 0 C-N-CA 118.918 -1.611 . . . . 0.0 110.688 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.821 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -92.92 -79.8 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.047 -1.267 . . . . 0.0 108.326 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.821 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 54.0 Cg_endo -81.65 20.9 0.99 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.35 1.184 . . . . 0.0 109.355 177.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.587 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 1.5 p -98.55 64.67 1.55 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.362 -0.836 . . . . 0.0 111.378 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.739 ' CD ' ' CG ' ' A' ' 18' ' ' MET . 0.1 OUTLIER -73.93 -35.89 64.62 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.171 -0.955 . . . . 0.0 109.318 178.716 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.629 ' HA ' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -48.92 -37.42 19.85 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.049 -1.032 . . . . 0.0 109.236 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.74 ' CD ' ' CD2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -47.09 -36.86 8.75 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.515 -0.874 . . . . 0.0 108.83 179.541 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.774 ' CD1' ' CG2' ' A' ' 59' ' ' ILE . 8.9 mp -61.44 -44.74 96.59 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 177.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.768 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -56.85 -34.41 67.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.459 -0.776 . . . . 0.0 109.859 178.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -77.96 -31.75 51.0 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.684 -0.635 . . . . 0.0 109.708 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.56 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -68.56 -49.15 61.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.458 -0.776 . . . . 0.0 109.655 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.767 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 1.9 mp -51.96 -35.5 18.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 120.949 -1.094 . . . . 0.0 108.695 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.562 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 8.1 t-20 -68.1 -27.5 66.53 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.579 ' OD2' HG11 ' A' ' 64' ' ' VAL 0.553 37.8 t0 -95.25 -21.62 18.33 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 113.374 -3.33 . . . . 0.0 106.329 -177.698 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.754 ' HB2' ' CA ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -68.64 -46.1 70.08 Favored 'General case' 0 C--N 1.288 -2.076 0 O-C-N 119.504 -1.997 . . . . 0.0 108.916 170.054 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.804 ' CE ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -78.9 -23.38 44.84 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.484 178.378 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.489 ' O ' ' O ' ' A' ' 81' ' ' ASN . 11.3 tp10 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.289 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.583 ' SD ' ' OD1' ' A' ' 4' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.211 0.529 . . . . 0.0 110.232 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.706 HG22 ' O ' ' A' ' 31' ' ' GLY . 1.6 p -89.44 -96.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 0.0 110.265 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.747 HG21 ' CB ' ' A' ' 27' ' ' LYS . 55.4 t -92.17 119.55 39.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.453 -0.779 . . . . 0.0 110.18 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.751 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -135.78 111.78 9.58 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 123.082 1.42 . . . . 0.0 109.194 179.245 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.733 ' CG2' HG21 ' A' ' 20' ' ' ILE . 4.1 mt -126.05 133.48 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.115 -0.991 . . . . 0.0 109.965 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.78 ' HB3' ' CB ' ' A' ' 60' ' ' ALA 0.272 15.3 tt0 -125.28 101.81 7.15 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 116.963 -1.895 . . . . 0.0 109.17 178.599 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.827 ' CG2' ' CB ' ' A' ' 38' ' ' LYS 0.251 29.0 m -97.66 111.33 27.24 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.438 0 CA-C-O 123.734 1.73 . . . . 0.0 107.621 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.83 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -118.55 90.57 3.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.01 -1.056 . . . . 0.0 109.342 -178.448 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.669 ' O ' HG21 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -121.35 -72.92 0.67 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.355 -0.841 . . . . 0.0 110.322 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.762 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -170.66 149.49 2.96 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.02 -1.05 . . . . 0.0 110.85 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.71 ' N ' ' HB3' ' A' ' 40' ' ' ASP . 46.4 Cg_endo -75.67 -28.91 7.71 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 124.019 1.536 . . . . 0.0 110.153 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.59 -15.02 58.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.859 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.615 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -124.95 -179.69 0.92 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.388 -0.82 . . . . 0.0 109.875 179.774 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.619 ' O ' ' O ' ' A' ' 15' ' ' TYR . 51.2 Cg_endo -83.56 111.12 1.74 Allowed 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.999 1.526 . . . . 0.0 110.417 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.762 ' CE1' ' O ' ' A' ' 10' ' ' SER . 17.9 m-85 -49.53 -111.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.908 . . . . 0.0 109.685 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.694 ' CB ' ' HG2' ' A' ' 73' ' ' ARG . 26.3 m -155.09 39.39 0.11 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.149 -0.97 . . . . 0.0 110.308 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.4 Cg_endo -76.18 23.07 0.48 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.84 1.442 . . . . 0.0 110.92 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.708 ' HB3' ' CD ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -103.18 -66.79 0.92 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.049 -1.032 . . . . 0.0 110.889 -179.292 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.719 ' HB2' ' CB ' ' A' ' 73' ' ' ARG . . . -55.14 -21.87 14.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.276 -0.89 . . . . 0.0 109.84 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.733 HG21 ' CG2' ' A' ' 5' ' ' ILE . 0.3 OUTLIER -72.67 -39.45 60.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.504 -0.747 . . . . 0.0 109.533 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.556 ' N ' ' CD1' ' A' ' 20' ' ' ILE . 1.6 tt0 -49.17 -31.9 9.24 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 15.5 t -69.42 -45.59 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.534 -0.729 . . . . 0.0 109.386 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.768 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -68.9 -28.56 40.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.312 -0.868 . . . . 0.0 109.366 178.463 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.747 ' OD1' ' CG1' ' A' ' 34' ' ' ILE . 16.6 t0 -76.09 -36.71 58.82 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -58.75 -44.04 90.42 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.644 0.735 . . . . 0.0 109.381 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.479 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.54 -40.99 28.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.51 -0.744 . . . . 0.0 110.164 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.757 ' N ' ' HE3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -67.09 -23.35 65.84 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.932 -1.107 . . . . 0.0 109.082 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.801 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.82 -45.63 70.71 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.365 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.796 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -49.43 -40.3 36.03 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.783 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.796 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.9 -56.32 3.28 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.711 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -96.18 78.47 0.76 Allowed Glycine 0 N--CA 1.489 2.173 0 O-C-N 121.398 -0.813 . . . . 0.0 111.378 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.532 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -36.96 -21.62 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 119.309 1.555 . . . . 0.0 110.3 -179.468 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.702 ' N ' ' O ' ' A' ' 31' ' ' GLY . 27.3 mtmm -85.06 154.6 21.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -0.999 . . . . 0.0 111.145 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.801 ' CD1' ' CG ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -129.28 150.21 34.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 118.883 -1.127 . . . . 0.0 111.048 178.463 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.585 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -150.43 68.49 0.97 Allowed 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.479 -0.763 . . . . 0.0 109.159 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.6 HG13 HD12 ' A' ' 5' ' ' ILE . 65.6 t -91.92 118.37 37.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 122.413 1.102 . . . . 0.0 109.519 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.727 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.267 8.6 mm-40 -100.13 131.01 46.33 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 123.321 1.534 . . . . 0.0 108.185 -178.678 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.827 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.56 122.1 16.23 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.753 -1.217 . . . . 0.0 111.559 -176.723 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.784 ' N ' ' CD1' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -136.72 -163.54 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 122.31 1.052 . . . . 0.0 111.129 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.785 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -110.96 170.82 7.85 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.792 179.183 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.83 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -65.86 -54.33 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.593 -0.692 . . . . 0.0 111.548 177.474 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.62 ' HG3' HG12 ' A' ' 43' ' ' VAL . 6.4 ptm -65.26 -1.56 2.41 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.016 -1.073 . . . . 0.0 110.985 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.775 ' CG1' ' OD1' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -112.08 -48.9 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.018 -1.051 . . . . 0.0 110.705 178.063 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.724 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 3.0 t70 -105.9 48.51 0.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.954 . . . . 0.0 110.086 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.582 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.288 6.4 ttt-85 -63.35 -7.21 5.88 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 118.086 -1.445 . . . . 0.0 109.662 -178.554 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.732 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 2.3 mm-40 -51.33 -19.94 1.51 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.157 -0.964 . . . . 0.0 110.159 176.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.85 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -51.8 -58.72 5.61 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 122.188 0.994 . . . . 0.0 109.815 -179.399 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.868 ' CB ' ' CB ' ' A' ' 55' ' ' ALA . . . -62.88 -1.94 1.04 Allowed 'General case' 0 C--N 1.276 -2.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.68 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.732 ' CG2' ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -35.34 -42.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 104.027 -2.582 . . . . 0.0 104.027 -176.383 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.503 ' N ' ' C ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -48.93 -51.33 30.78 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.195 176.754 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.795 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -125.93 -32.54 2.78 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.107 -0.996 . . . . 0.0 110.432 179.124 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.813 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 61.07 -33.52 0.05 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.642 ' CD2' ' HB2' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -49.57 -81.43 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.644 -1.503 . . . . 0.0 109.858 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.587 ' HG3' HD11 ' A' ' 53' ' ' LEU . 24.7 mtt -79.45 54.3 1.7 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.401 -0.812 . . . . 0.0 108.944 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.868 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.288 . . -99.61 103.52 15.23 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 124.006 1.86 . . . . 0.0 110.174 -177.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.818 ' CG2' ' CD1' ' A' ' 41' ' ' ILE . 4.9 t -146.63 -72.86 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.414 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.801 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.813 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 51.4 Cg_endo -95.3 112.15 0.15 Allowed 'Trans proline' 0 C--O 1.197 -1.541 0 CA-C-O 123.872 1.53 . . . . 0.0 109.893 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.785 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -160.82 179.27 8.65 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.425 -1.422 . . . . 0.0 111.792 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.737 ' CG2' ' HG ' ' A' ' 76' ' ' LEU 0.253 0.3 OUTLIER -142.48 133.48 24.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.078 179.334 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.78 ' CB ' ' HB3' ' A' ' 6' ' ' GLU . . . -81.42 141.31 34.05 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 116.935 -1.906 . . . . 0.0 106.215 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.772 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.433 0.7 OUTLIER -90.09 86.75 2.6 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.69 0 C-N-CA 114.73 -2.788 . . . . 0.0 105.421 -175.576 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.751 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -44.31 82.34 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 112.634 -2.076 . . . . 0.0 108.76 177.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.772 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.49 -44.1 0.35 Allowed Glycine 0 N--CA 1.483 1.805 0 N-CA-C 107.207 -2.357 . . . . 0.0 107.207 -178.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.76 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.2 m -126.18 -59.01 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.537 -0.978 . . . . 0.0 111.302 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.76 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 93.2 t -163.59 -108.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 120.306 -1.496 . . . . 0.0 112.358 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.769 ' NH2' ' CB ' ' A' ' 8' ' ' PHE . 3.5 ttt180 -165.14 164.64 20.21 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.769 -0.582 . . . . 0.0 109.653 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.82 ' CZ ' ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -144.95 177.01 9.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.92 -1.112 . . . . 0.0 111.177 -178.11 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.736 ' CG2' ' CZ ' ' A' ' 51' ' ' TYR . 78.9 t -88.66 116.0 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.832 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.82 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.68 123.57 1.19 Allowed Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.72 -1.228 . . . . 0.0 110.447 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.826 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -93.9 -78.26 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 120.868 -1.372 . . . . 0.0 108.662 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.826 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 54.6 Cg_endo -79.26 20.39 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.654 1.344 . . . . 0.0 109.254 178.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.598 ' OG ' ' HA3' ' A' ' 69' ' ' GLY 0.3 2.3 p -103.88 81.78 1.91 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 124.024 1.869 . . . . 0.0 109.989 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.719 ' CB ' ' HB2' ' A' ' 19' ' ' ALA . 24.9 mtt180 -79.57 -36.12 38.68 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.643 -1.286 . . . . 0.0 110.03 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.661 ' HA ' ' HB3' ' A' ' 19' ' ' ALA . 1.5 tt0 -50.48 -25.35 3.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.319 -0.863 . . . . 0.0 109.726 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.791 ' HG3' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -53.67 -46.39 70.6 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.351 -0.843 . . . . 0.0 109.207 -179.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.737 ' HG ' ' CG2' ' A' ' 59' ' ' ILE . 0.7 OUTLIER -60.18 -42.19 94.5 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.009 178.808 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.768 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.09 -33.95 69.64 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.399 -0.813 . . . . 0.0 109.78 179.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.766 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 31.5 tt0 -81.58 -27.75 34.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 110.146 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.706 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -74.47 -38.07 63.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.637 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.703 ' CG2' HG12 ' A' ' 23' ' ' VAL . 1.8 mp -63.35 -39.8 86.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.144 -0.972 . . . . 0.0 108.985 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.681 ' HA ' ' SD ' ' A' ' 84' ' ' MET . 0.1 OUTLIER -74.96 -33.12 61.86 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.244 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.523 0.1 OUTLIER -91.34 -3.26 56.95 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 113.54 -3.264 . . . . 0.0 107.125 -178.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.722 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -82.26 -59.58 2.5 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 119.672 -1.893 . . . . 0.0 109.816 169.589 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.72 ' HE3' ' NZ ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.94 -13.48 62.47 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.405 179.525 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.487 ' N ' ' HG2' ' A' ' 84' ' ' MET . 2.7 tm-20 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.196 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.582 ' SD ' ' OD1' ' A' ' 4' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.252 0.549 . . . . 0.0 110.211 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.706 HG22 ' O ' ' A' ' 31' ' ' GLY . 1.6 p -89.53 -97.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.842 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.745 HG21 ' CB ' ' A' ' 27' ' ' LYS . 53.2 t -89.51 121.69 39.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.343 -0.848 . . . . 0.0 109.987 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.747 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.292 0.2 OUTLIER -140.17 111.26 7.02 Favored 'General case' 0 C--O 1.19 -2.076 0 CA-C-O 125.057 2.361 . . . . 0.0 108.135 178.23 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.733 ' CG2' HG21 ' A' ' 20' ' ' ILE . 4.2 mt -121.63 133.85 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.195 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.78 ' HB3' ' CB ' ' A' ' 60' ' ' ALA 0.371 16.4 tt0 -129.11 111.12 12.62 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 115.218 -2.593 . . . . 0.0 105.063 177.026 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.829 ' CG2' ' CB ' ' A' ' 38' ' ' LYS 0.352 15.0 m -108.86 111.17 34.89 Favored 'Isoleucine or valine' 0 C--O 1.177 -2.748 0 CA-C-O 126.761 3.172 . . . . 0.0 103.822 -178.425 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.83 ' CE1' ' HA ' ' A' ' 41' ' ' ILE 0.277 0.4 OUTLIER -117.27 94.74 4.68 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 111.947 -2.388 . . . . 0.0 108.532 -178.608 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.668 ' O ' HG21 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -124.02 -69.84 0.79 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.095 -1.003 . . . . 0.0 110.601 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.765 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -174.96 146.83 1.0 Allowed Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 120.876 -1.14 . . . . 0.0 110.734 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.72 ' N ' ' HB3' ' A' ' 40' ' ' ASP . 50.7 Cg_endo -73.78 -29.01 10.93 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 O-C-N 123.802 1.422 . . . . 0.0 110.565 -178.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.63 -14.95 58.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.381 -0.824 . . . . 0.0 109.884 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.615 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -124.94 -179.65 0.91 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.388 -0.82 . . . . 0.0 109.846 179.732 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.62 ' O ' ' O ' ' A' ' 15' ' ' TYR . 51.8 Cg_endo -83.69 111.14 1.71 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.958 1.504 . . . . 0.0 110.444 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.765 ' CE1' ' O ' ' A' ' 10' ' ' SER . 18.1 m-85 -49.59 -111.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 109.606 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.694 ' CB ' ' HG2' ' A' ' 73' ' ' ARG . 26.7 m -155.06 39.4 0.12 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.17 -0.957 . . . . 0.0 110.353 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.4 Cg_endo -76.2 23.12 0.48 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.84 1.442 . . . . 0.0 110.95 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.708 ' HB3' ' CD ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -103.24 -66.64 0.93 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.049 -1.032 . . . . 0.0 110.85 -179.293 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.719 ' HB2' ' CB ' ' A' ' 73' ' ' ARG . . . -55.53 -21.34 16.47 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.284 -0.885 . . . . 0.0 109.898 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.733 HG21 ' CG2' ' A' ' 5' ' ' ILE . 0.3 OUTLIER -73.0 -39.23 57.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.598 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.555 ' N ' ' CD1' ' A' ' 20' ' ' ILE . 1.6 tt0 -48.91 -32.66 9.34 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.425 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 16.4 t -68.54 -47.37 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.659 0.742 . . . . 0.0 109.279 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.765 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.7 OUTLIER -64.07 -34.45 68.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-O 122.476 1.131 . . . . 0.0 109.513 177.451 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.746 ' OD1' ' CG1' ' A' ' 34' ' ' ILE . 15.2 t0 -71.66 -39.01 70.59 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 122.78 1.276 . . . . 0.0 108.949 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -57.24 -45.31 84.06 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.569 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.48 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -78.28 -40.5 36.81 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.782 0.801 . . . . 0.0 110.808 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.749 ' CE ' ' HA ' ' A' ' 27' ' ' LYS 0.252 0.0 OUTLIER -70.23 -19.19 63.16 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 117.627 -1.629 . . . . 0.0 108.904 -178.715 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.801 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -70.9 -44.75 65.59 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.38 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.762 ' HG3' ' N ' ' A' ' 30' ' ' PHE 0.26 0.0 OUTLIER -51.92 -35.44 45.63 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.411 179.246 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.776 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -92.54 -66.33 0.93 Allowed 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 104.098 -2.556 . . . . 0.0 104.098 -179.731 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.776 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -81.05 72.43 2.74 Favored Glycine 0 C--N 1.279 -2.623 0 CA-C-O 115.402 -2.888 . . . . 0.0 115.87 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.546 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -36.28 -23.97 0.01 OUTLIER 'General case' 0 C--N 1.262 -3.218 0 CA-C-N 123.092 3.446 . . . . 0.0 110.183 -177.546 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.694 ' O ' HG21 ' A' ' 2' ' ' VAL . 29.1 mtmm -77.35 152.55 34.4 Favored 'General case' 0 C--N 1.284 -2.281 0 O-C-N 120.263 -1.523 . . . . 0.0 113.384 175.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.801 ' CD1' ' CG ' ' A' ' 28' ' ' LYS 0.259 0.3 OUTLIER -130.66 151.37 35.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 C-N-CA 118.366 -1.334 . . . . 0.0 110.547 176.014 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.581 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -151.27 71.95 1.03 Allowed 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.6 HG13 HD12 ' A' ' 5' ' ' ILE 0.307 84.2 t -97.38 125.19 50.54 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.596 0 CA-C-O 124.556 2.122 . . . . 0.0 105.635 -177.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.717 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.413 7.3 mm-40 -109.37 133.53 52.94 Favored 'General case' 0 C--O 1.179 -2.625 0 CA-C-O 126.326 2.965 . . . . 0.0 104.438 -177.09 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.829 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -138.24 114.08 9.89 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.36 -1.745 . . . . 0.0 113.95 -173.145 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.821 ' N ' ' CD1' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -133.88 -165.12 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 121.874 2.125 . . . . 0.0 111.835 179.468 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.793 ' OD1' ' N ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -104.54 172.14 6.95 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 178.398 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.83 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -68.25 -55.21 17.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 121.387 -0.821 . . . . 0.0 110.644 176.581 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.62 ' HG3' HG12 ' A' ' 43' ' ' VAL . 6.3 ptm -64.27 -0.46 1.26 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 118.612 -1.235 . . . . 0.0 111.594 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.774 ' CG1' ' OD1' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -113.09 -49.12 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.086 -1.009 . . . . 0.0 110.195 178.341 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.724 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 2.9 t70 -106.34 51.01 0.76 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 109.646 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.581 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.472 6.0 ttt-85 -71.26 2.27 4.96 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 115.044 -2.663 . . . . 0.0 108.711 -176.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.732 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 2.2 mm-40 -52.51 -23.87 7.05 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 120.348 -1.47 . . . . 0.0 109.108 172.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.877 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -49.18 -63.14 1.19 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.941 -1.099 . . . . 0.0 109.012 -178.161 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.877 ' N ' ' HG3' ' A' ' 47' ' ' LYS 0.414 . . -51.42 -13.91 0.25 Allowed 'General case' 0 C--N 1.256 -3.485 0 C-N-CA 126.886 2.075 . . . . 0.0 111.555 175.372 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.732 ' CG2' ' O ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -30.75 -43.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 104.824 -2.287 . . . . 0.0 104.824 -172.957 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.56 ' N ' ' C ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -49.14 -51.37 32.64 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.186 176.414 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.797 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -125.89 -32.6 2.79 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.013 -1.054 . . . . 0.0 110.408 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.814 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 60.99 -33.36 0.05 OUTLIER Glycine 0 N--CA 1.488 2.139 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.643 ' CD2' ' HB2' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -49.6 -81.42 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.608 -1.525 . . . . 0.0 109.851 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.587 ' HG3' HD11 ' A' ' 53' ' ' LEU . 24.7 mtt -80.28 58.92 3.22 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.859 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.394 . . -106.91 106.14 16.52 Favored 'General case' 0 C--O 1.179 -2.622 0 CA-C-O 126.912 3.244 . . . . 0.0 107.154 -176.623 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.816 ' CG2' ' CD1' ' A' ' 41' ' ' ILE . 4.8 t -147.77 -64.58 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.435 0 CA-C-N 112.149 -2.296 . . . . 0.0 112.84 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.805 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.449 18.0 Cg_endo -109.41 116.81 0.03 OUTLIER 'Trans proline' 0 C--O 1.157 -3.527 0 CA-C-O 129.507 3.878 . . . . 0.0 103.921 -179.544 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.778 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -160.85 177.54 10.3 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 110.639 -2.982 . . . . 0.0 111.646 -175.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.737 ' CG2' ' HG ' ' A' ' 76' ' ' LEU 0.294 0.2 OUTLIER -141.52 141.15 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.874 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.78 ' CB ' ' HB3' ' A' ' 6' ' ' GLU 0.399 . . -91.7 149.89 21.4 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 100.551 -3.87 . . . . 0.0 100.551 -177.225 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.772 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.728 1.1 mt -101.57 101.39 12.05 Favored 'Isoleucine or valine' 0 C--N 1.412 3.299 3 C-N-CA 107.032 -5.867 . . . . 0.0 97.379 -172.237 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.747 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -53.93 84.7 0.0 OUTLIER 'General case' 0 C--N 1.38 1.929 1 CA-C-N 106.549 -4.841 . . . . 0.0 106.888 178.083 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.772 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.24 -44.12 0.36 Allowed Glycine 0 N--CA 1.483 1.793 0 N-CA-C 107.176 -2.37 . . . . 0.0 107.176 -178.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.758 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.1 m -126.16 -59.15 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 O-C-N 121.503 -0.998 . . . . 0.0 111.311 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.758 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 93.8 t -163.1 -106.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 120.326 -1.484 . . . . 0.0 112.901 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.768 ' NH2' ' CB ' ' A' ' 8' ' ' PHE . 3.4 ttt180 -167.74 163.58 14.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.676 -0.64 . . . . 0.0 109.397 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.833 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -145.53 174.4 11.2 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.848 -1.157 . . . . 0.0 111.268 -177.571 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.738 ' CG2' ' CZ ' ' A' ' 51' ' ' TYR . 59.3 t -83.42 115.12 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.888 -1.133 . . . . 0.0 111.406 177.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.818 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.91 123.4 1.17 Allowed Glycine 0 C--N 1.281 -2.524 0 CA-C-N 119.755 1.161 . . . . 0.0 110.491 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.824 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -93.9 -76.74 0.03 OUTLIER Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 120.772 -1.428 . . . . 0.0 109.194 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.824 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 41.7 Cg_endo -83.23 24.93 0.71 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 N-CA-C 108.339 -1.447 . . . . 0.0 108.339 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.597 ' OG ' ' HA3' ' A' ' 69' ' ' GLY 0.449 1.5 p -109.63 87.95 2.63 Favored 'General case' 0 N--CA 1.506 2.372 0 C-N-CA 113.829 -3.149 . . . . 0.0 106.577 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.719 ' CB ' ' HB2' ' A' ' 19' ' ' ALA . 24.8 mtt180 -79.77 -40.38 28.84 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 112.871 -1.968 . . . . 0.0 109.201 175.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.67 ' N ' ' CB ' ' A' ' 19' ' ' ALA . 1.4 tt0 -46.41 -28.22 1.29 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.025 -1.047 . . . . 0.0 109.835 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.792 ' HG3' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -53.12 -46.16 68.62 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.24 -0.912 . . . . 0.0 109.34 -178.537 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.737 ' HG ' ' CG2' ' A' ' 59' ' ' ILE . 0.7 OUTLIER -60.0 -42.53 94.47 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.147 178.526 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.774 ' CD1' ' N ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -57.39 -34.99 69.44 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.821 179.364 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.774 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 31.1 tt0 -78.77 -31.32 46.08 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.031 -1.043 . . . . 0.0 110.216 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.707 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -73.07 -38.26 66.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.092 -1.005 . . . . 0.0 110.002 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.703 ' CG2' HG12 ' A' ' 23' ' ' VAL . 1.8 mp -61.61 -42.47 94.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.099 -1.001 . . . . 0.0 108.906 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.681 ' HA ' ' SD ' ' A' ' 84' ' ' MET . 0.1 OUTLIER -72.24 -33.52 67.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.961 -1.087 . . . . 0.0 109.604 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.596 0.1 OUTLIER -94.01 0.82 56.22 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 112.027 -3.869 . . . . 0.0 105.573 -177.411 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.721 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -85.95 -59.81 2.19 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 119.546 -1.971 . . . . 0.0 107.841 170.598 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.721 ' HE3' ' NZ ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.69 -12.67 61.68 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.737 179.656 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.483 ' N ' ' HG2' ' A' ' 84' ' ' MET . 2.7 tm-20 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.066 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.653 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.314 0.578 . . . . 0.0 110.224 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.769 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 0.6 OUTLIER -90.13 -91.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 0.0 109.976 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.741 HG23 ' CD1' ' A' ' 34' ' ' ILE . 74.1 t -89.22 111.03 22.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.627 -0.671 . . . . 0.0 110.633 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.841 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 1.0 OUTLIER -130.95 105.68 7.91 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.639 -1.224 . . . . 0.0 108.794 178.031 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.755 ' CG2' ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -120.7 137.37 54.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.031 179.425 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.998 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.01 119.77 22.51 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 119.057 -2.277 . . . . 0.0 107.389 177.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.802 ' CG2' ' HA ' ' A' ' 38' ' ' LYS . 23.0 m -105.64 144.78 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.879 ' H ' HD13 ' A' ' 59' ' ' ILE . 2.1 t80 -141.0 79.52 1.7 Allowed 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 119.01 -1.076 . . . . 0.0 112.663 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.687 ' CB ' ' HA ' ' A' ' 15' ' ' TYR . 3.5 m -118.06 -68.64 0.9 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 118.852 -2.405 . . . . 0.0 110.238 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.774 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 1.3 p 179.61 164.61 0.79 Allowed Pre-proline 0 C--N 1.294 -1.843 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.732 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.666 ' HD3' ' CG ' ' A' ' 40' ' ' ASP . 49.8 Cg_endo -80.35 -28.3 3.03 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.278 1.673 . . . . 0.0 110.418 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -18.25 54.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 109.762 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.07 174.49 3.82 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.457 -0.777 . . . . 0.0 109.723 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.652 ' O ' ' O ' ' A' ' 15' ' ' TYR . 50.8 Cg_endo -83.18 114.53 2.21 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.925 1.487 . . . . 0.0 110.437 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.774 ' CE1' ' O ' ' A' ' 10' ' ' SER . 16.5 m-85 -49.22 -112.38 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.132 -0.98 . . . . 0.0 109.576 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.736 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 92.9 m -150.6 37.46 0.13 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.267 -0.895 . . . . 0.0 110.131 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.736 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 53.7 Cg_endo -76.49 17.16 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.021 1.538 . . . . 0.0 111.042 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.502 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -95.1 -68.04 0.82 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.012 -1.055 . . . . 0.0 110.752 -179.461 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.701 ' HB2' ' CB ' ' A' ' 73' ' ' ARG . . . -54.28 -22.51 12.05 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.23 -0.919 . . . . 0.0 109.53 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.755 ' HB ' ' CG2' ' A' ' 5' ' ' ILE . 5.2 pt -70.67 -39.25 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.507 -0.746 . . . . 0.0 109.623 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.712 ' N ' HG13 ' A' ' 20' ' ' ILE . 6.2 tt0 -48.83 -33.05 9.79 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.492 HG12 ' CD2' ' A' ' 77' ' ' PHE . 3.1 t -72.01 -46.73 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.787 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.4 OUTLIER -62.26 -31.86 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.03 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.736 ' OD1' ' CD1' ' A' ' 34' ' ' ILE . 5.2 t70 -69.45 -39.88 77.5 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.01 0.91 . . . . 0.0 109.196 178.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -46.01 84.81 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.617 0.722 . . . . 0.0 109.674 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.461 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.68 -40.05 42.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.669 -0.645 . . . . 0.0 110.614 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.751 ' CE ' ' HA ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -69.95 -19.37 63.38 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.124 -1.03 . . . . 0.0 109.208 -179.057 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.799 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -72.52 -44.99 61.44 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.154 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.746 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -50.32 -33.39 19.99 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.851 0.834 . . . . 0.0 110.279 179.494 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.769 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -97.01 -65.79 0.94 Allowed 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 179.639 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.756 ' HA3' HG22 ' A' ' 2' ' ' VAL . . . -84.64 82.16 1.7 Allowed Glycine 0 N--CA 1.506 3.323 0 C-N-CA 119.182 -1.485 . . . . 0.0 111.427 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.593 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -35.43 -28.43 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 CA-C-N 121.463 2.631 . . . . 0.0 110.68 178.57 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.689 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -80.0 154.95 27.87 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.498 -0.751 . . . . 0.0 111.686 178.065 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.799 ' CD1' ' CG ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -129.66 151.48 35.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 O-C-N 120.353 -1.467 . . . . 0.0 110.048 178.646 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.584 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -151.3 76.78 1.23 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.718 ' CG1' HD11 ' A' ' 20' ' ' ILE 0.255 55.4 t -96.65 126.98 49.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -178.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.998 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.251 78.1 mt-10 -111.24 135.43 51.79 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -177.617 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.802 ' HA ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -129.49 128.92 43.85 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -176.716 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.771 ' HB ' ' CB ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -135.08 171.66 17.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 O-C-N 120.132 -1.605 . . . . 0.0 111.516 178.642 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.749 ' HB3' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -102.72 170.8 7.79 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.803 0.811 . . . . 0.0 111.757 178.246 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.869 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -61.87 -37.39 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.425 -1.422 . . . . 0.0 109.332 178.489 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.686 ' HG3' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -82.37 -3.09 54.85 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.935 -1.103 . . . . 0.0 111.252 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.769 ' CG2' ' CG2' ' A' ' 39' ' ' ILE . 2.0 m -114.24 -46.18 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.055 -1.028 . . . . 0.0 109.755 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.777 ' OD2' ' CD1' ' A' ' 8' ' ' PHE . 1.6 t70 -104.97 40.98 1.4 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.237 -0.914 . . . . 0.0 109.627 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.59 ' NH2' ' HA3' ' A' ' 52' ' ' GLY 0.283 0.0 OUTLIER -65.69 -0.35 2.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.494 -1.379 . . . . 0.0 109.435 -178.823 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.825 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 2.3 mm-40 -62.54 -22.68 66.5 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.886 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -46.38 -66.55 0.39 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.965 -1.084 . . . . 0.0 108.422 -179.075 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.923 ' HA ' ' CE1' ' A' ' 51' ' ' TYR . . . -57.23 -7.63 0.58 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.666 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.831 ' C ' ' O ' ' A' ' 48' ' ' ALA . 2.6 pp -26.35 -41.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 O-C-N 119.163 -2.21 . . . . 0.0 106.573 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.852 ' N ' ' O ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -52.92 -53.75 44.86 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.998 177.183 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.923 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 25.8 p90 -119.86 -32.8 4.14 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.132 -0.98 . . . . 0.0 109.984 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.694 ' HA2' ' HB3' ' A' ' 48' ' ' ALA . . . 42.38 8.82 0.01 OUTLIER Glycine 0 N--CA 1.502 3.08 0 CA-C-O 122.124 0.847 . . . . 0.0 111.474 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.715 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 4.6 mt -75.55 -81.08 0.08 Allowed 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 175.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.526 ' C ' ' HE2' ' A' ' 51' ' ' TYR . 4.0 mtp -95.74 63.66 2.42 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.443 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.865 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.273 . . -107.38 120.26 41.68 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 119.489 -2.007 . . . . 0.0 110.356 -177.803 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.802 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -148.76 -57.98 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.481 -178.709 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.802 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 59.1 Cg_endo -109.81 109.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 CA-C-O 122.892 1.122 . . . . 0.0 110.323 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.797 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -161.88 173.88 13.92 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.186 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.879 HD13 ' H ' ' A' ' 8' ' ' PHE 0.253 0.3 OUTLIER -134.6 151.94 32.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 120.876 -1.14 . . . . 0.0 107.997 179.296 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.864 ' HA ' ' HG3' ' A' ' 66' ' ' ARG 0.297 . . -91.15 155.3 18.72 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.744 HG13 ' N ' ' A' ' 66' ' ' ARG 0.31 1.2 mt -101.29 91.29 2.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 -175.713 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.841 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -51.63 83.04 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 112.834 -1.984 . . . . 0.0 106.807 -178.369 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.725 ' HA3' ' HB2' ' A' ' 83' ' ' GLU . . . 162.41 -44.02 0.36 Allowed Glycine 0 C--N 1.29 -2.027 0 N-CA-C 107.733 -2.147 . . . . 0.0 107.733 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.763 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 11.6 m -126.67 -58.97 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.903 -0.763 . . . . 0.0 111.139 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.763 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 81.9 t -163.73 -101.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 120.338 -1.476 . . . . 0.0 112.955 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.864 ' HG3' ' HA ' ' A' ' 60' ' ' ALA . 1.8 ttp180 -167.17 160.09 13.5 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.444 -0.785 . . . . 0.0 109.343 -177.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.841 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -146.09 176.05 10.02 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.11 -0.994 . . . . 0.0 111.702 -177.236 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.614 ' N ' ' HZ1' ' A' ' 47' ' ' LYS . 79.0 t -83.42 118.96 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.708 -0.62 . . . . 0.0 110.246 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.82 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.5 107.88 0.33 Allowed Glycine 0 N--CA 1.494 2.516 0 C-N-CA 118.536 -1.792 . . . . 0.0 110.386 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.849 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -88.94 -81.42 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 120.989 -1.3 . . . . 0.0 108.511 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.849 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 57.1 Cg_endo -83.6 17.04 1.75 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.243 1.128 . . . . 0.0 109.422 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.33 62.52 0.79 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.498 -0.751 . . . . 0.0 110.661 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.713 ' HG2' ' CB ' ' A' ' 16' ' ' CYS . 22.1 mtt180 -69.09 -31.43 70.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.381 -0.825 . . . . 0.0 109.327 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.69 ' HA ' ' HB3' ' A' ' 19' ' ' ALA . 1.2 tm-20 -48.39 -45.13 35.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.427 -0.796 . . . . 0.0 109.449 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.785 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -45.25 -29.11 0.91 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.701 -0.8 . . . . 0.0 108.982 179.715 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.759 ' CD1' HG21 ' A' ' 59' ' ' ILE . 3.2 mp -70.47 -39.92 73.98 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.521 -0.737 . . . . 0.0 109.047 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.787 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.49 -41.16 89.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.401 -0.812 . . . . 0.0 109.824 -179.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.52 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 2.5 tm-20 -77.29 -26.62 52.52 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.192 0.52 . . . . 0.0 109.932 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.619 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -71.03 -41.9 70.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 110.978 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.742 ' CG2' ' CG ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -62.57 -44.28 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.125 -0.984 . . . . 0.0 109.122 179.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.649 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -72.83 -27.76 62.14 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 177.573 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 1.026 ' O ' ' OD1' ' A' ' 82' ' ' ASP 0.328 0.1 OUTLIER -96.06 5.63 50.69 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 119.638 -1.914 . . . . 0.0 107.855 -179.416 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.772 ' HG2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -96.08 -59.03 1.93 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 178.635 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.725 ' HE3' ' NZ ' ' A' ' 27' ' ' LYS . 21.4 ptt? -68.63 -14.52 63.07 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 119.266 -0.974 . . . . 0.0 110.986 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--N 1.3 -1.559 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.002 179.722 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.658 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.225 0.536 . . . . 0.0 110.21 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.77 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 0.6 OUTLIER -89.98 -91.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.303 -0.873 . . . . 0.0 110.59 179.846 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.745 HG21 ' CG2' ' A' ' 2' ' ' VAL 0.253 75.1 t -89.19 118.78 35.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.787 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.481 0.9 OUTLIER -143.6 106.82 4.54 Favored 'General case' 0 C--O 1.16 -3.624 1 CA-C-O 129.728 4.585 . . . . 0.0 105.063 175.064 . . . . . . . . 5 4 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.743 ' CG2' ' HB ' ' A' ' 20' ' ' ILE 0.253 0.0 OUTLIER -111.62 132.87 59.0 Favored 'Isoleucine or valine' 0 C--O 1.262 1.73 0 CA-C-N 109.986 -3.279 . . . . 0.0 114.688 178.217 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.765 ' HA ' ' O ' ' A' ' 37' ' ' GLU 0.593 0.0 OUTLIER -135.8 126.51 27.28 Favored 'General case' 0 C--O 1.197 -1.674 2 CA-C-O 131.334 5.349 . . . . 0.0 104.281 172.239 . . . . . . . . 5 4 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.76 ' HA ' ' CD1' ' A' ' 59' ' ' ILE 0.339 14.6 m -108.02 156.5 8.52 Favored 'Isoleucine or valine' 0 C--N 1.386 2.191 0 CA-C-N 109.642 -3.436 . . . . 0.0 104.322 -175.699 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.835 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 1.9 t80 -154.15 76.14 1.04 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.516 -1.365 . . . . 0.0 111.052 -172.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.686 ' CB ' ' HA ' ' A' ' 15' ' ' TYR . 3.5 m -118.96 -70.06 0.81 Allowed 'General case' 0 C--N 1.269 -2.914 0 CA-C-N 120.65 1.568 . . . . 0.0 109.188 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.777 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 1.3 p 179.66 165.05 0.79 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.179 -0.951 . . . . 0.0 110.923 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.667 ' HD3' ' CG ' ' A' ' 40' ' ' ASP . 51.5 Cg_endo -80.4 -28.2 3.05 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.17 1.616 . . . . 0.0 110.511 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -18.25 53.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -0.894 . . . . 0.0 109.74 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -124.95 174.75 3.54 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.417 -0.802 . . . . 0.0 109.664 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.649 ' O ' ' O ' ' A' ' 15' ' ' TYR . 51.8 Cg_endo -83.41 114.69 2.15 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 123.943 1.496 . . . . 0.0 110.309 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.777 ' CE1' ' O ' ' A' ' 10' ' ' SER . 17.3 m-85 -49.41 -112.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.44 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.723 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 94.0 m -149.97 37.39 0.14 Allowed Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.132 -0.98 . . . . 0.0 110.27 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.723 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 54.4 Cg_endo -76.34 17.17 0.78 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.867 1.456 . . . . 0.0 111.036 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.504 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -95.11 -68.0 0.82 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.966 -1.084 . . . . 0.0 110.614 -179.367 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.699 ' HB2' ' CB ' ' A' ' 73' ' ' ARG . . . -55.28 -20.8 12.22 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.737 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.743 ' HB ' ' CG2' ' A' ' 5' ' ' ILE . 5.2 pt -71.91 -38.78 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.809 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.711 ' N ' HG13 ' A' ' 20' ' ' ILE . 6.4 tt0 -48.03 -33.59 8.22 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.485 HG12 ' CD2' ' A' ' 77' ' ' PHE . 3.1 t -72.47 -45.46 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-O 121.94 0.876 . . . . 0.0 109.338 179.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.767 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -60.52 -33.09 53.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 122.737 1.256 . . . . 0.0 109.207 176.462 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.733 ' OD1' ' CD1' ' A' ' 34' ' ' ILE . 5.7 t70 -70.55 -40.67 73.26 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.933 1.349 . . . . 0.0 108.144 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.24 -46.45 82.98 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.712 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -76.76 -40.6 47.84 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.841 0.829 . . . . 0.0 110.827 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.748 ' CE ' ' HA ' ' A' ' 27' ' ' LYS 0.334 0.0 OUTLIER -73.86 -14.62 61.11 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 116.25 -2.18 . . . . 0.0 109.132 -177.337 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.792 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -72.47 -44.33 62.46 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.826 -1.171 . . . . 0.0 107.892 173.899 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.706 ' HG3' ' N ' ' A' ' 30' ' ' PHE 0.315 0.0 OUTLIER -53.96 -28.95 40.62 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.969 -179.315 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.77 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -99.85 -66.08 0.93 Allowed 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 -179.694 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.717 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -78.82 71.38 2.58 Favored Glycine 0 C--N 1.268 -3.232 0 CA-C-O 113.879 -3.734 . . . . 0.0 115.104 175.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.549 ' O ' ' OD1' ' A' ' 32' ' ' ASP 0.365 0.0 OUTLIER -39.06 -20.0 0.01 OUTLIER 'General case' 0 C--N 1.264 -3.109 1 CA-C-N 124.26 4.03 . . . . 0.0 111.81 -174.821 . . . . . . . . 5 4 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.705 ' N ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -75.01 150.71 38.87 Favored 'General case' 0 C--N 1.28 -2.418 0 C-N-CA 126.969 2.108 . . . . 0.0 113.943 171.053 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.792 ' CD1' ' CG ' ' A' ' 28' ' ' LYS 0.331 0.3 OUTLIER -131.09 155.07 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 C-N-CA 116.441 -2.104 . . . . 0.0 110.148 172.374 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.557 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -151.64 76.96 1.22 Allowed 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.09 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.732 ' CG1' HD11 ' A' ' 20' ' ' ILE 0.406 42.6 t -102.56 127.39 56.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 CA-C-O 126.947 3.261 . . . . 0.0 106.457 -177.56 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.765 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.505 68.6 mt-10 -116.01 134.47 54.92 Favored 'General case' 0 C--O 1.188 -2.156 0 O-C-N 118.861 -2.399 . . . . 0.0 107.114 -174.37 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.753 ' HA ' ' CG2' ' A' ' 7' ' ' VAL 0.576 0.0 OUTLIER -112.73 115.28 28.28 Favored 'General case' 0 C--O 1.298 3.649 2 CA-C-O 107.822 -5.847 . . . . 0.0 121.213 -170.817 . . . . . . . . 5 4 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.772 ' CG2' ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -132.54 178.24 5.92 Favored 'Isoleucine or valine' 1 C--N 1.232 -4.526 1 CA-C-N 131.381 6.446 . . . . 0.0 110.439 175.931 . . . . . . . . 5 4 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.738 ' OD2' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -103.22 166.05 10.66 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.068 -1.645 . . . . 0.0 113.04 177.022 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.835 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.4 OUTLIER -59.68 -38.01 73.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 118.15 -1.42 . . . . 0.0 111.899 173.032 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.682 ' HG3' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -80.84 -3.29 50.67 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.793 -1.163 . . . . 0.0 112.457 177.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.772 ' CG2' ' CG2' ' A' ' 39' ' ' ILE . 2.0 m -113.58 -46.24 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.062 -1.024 . . . . 0.0 109.787 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.785 ' OD2' ' CD1' ' A' ' 8' ' ' PHE . 1.6 t70 -103.82 37.08 2.13 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.28 -0.887 . . . . 0.0 110.473 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.576 ' NH2' ' HA3' ' A' ' 52' ' ' GLY 0.369 0.0 OUTLIER -65.04 -2.18 2.57 Favored 'General case' 0 C--O 1.2 -1.533 0 C-N-CA 116.783 -1.967 . . . . 0.0 109.789 -176.998 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.781 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 1.8 mm-40 -51.89 -26.71 10.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.021 -1.049 . . . . 0.0 111.635 170.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.852 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -50.15 -61.28 2.25 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.471 -1.393 . . . . 0.0 108.884 -175.018 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.852 ' N ' ' HG3' ' A' ' 47' ' ' LYS 0.388 . . -51.69 -13.36 0.25 Allowed 'General case' 0 C--N 1.264 -3.14 0 C-N-CA 126.48 1.912 . . . . 0.0 112.065 174.697 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.79 ' CD1' ' N ' ' A' ' 50' ' ' GLU . 2.3 pp -33.68 -38.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 -169.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.79 ' N ' ' CD1' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.99 -53.59 39.78 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.053 176.12 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.806 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 23.1 p90 -120.36 -31.51 4.33 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.083 -1.011 . . . . 0.0 110.29 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.777 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.93 14.65 0.01 OUTLIER Glycine 0 C--O 1.201 -1.962 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.485 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.731 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.4 mt -80.25 -76.03 0.24 Allowed 'General case' 0 C--N 1.253 -3.623 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 178.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.512 ' C ' ' HE2' ' A' ' 51' ' ' TYR . 3.8 mtp -103.07 61.5 0.79 Allowed 'General case' 0 C--O 1.25 1.095 0 O-C-N 119.546 -1.971 . . . . 0.0 108.405 -178.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.847 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.548 . . -113.97 125.45 54.03 Favored 'General case' 0 C--O 1.178 -2.68 1 CA-C-O 129.672 4.558 . . . . 0.0 106.724 -175.258 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.821 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -151.03 -55.04 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 CA-C-N 109.795 -3.366 . . . . 0.0 112.301 -175.957 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.821 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.559 38.6 Cg_endo -119.66 116.0 0.01 OUTLIER 'Trans proline' 0 C--O 1.157 -3.525 1 CA-C-O 132.508 5.129 . . . . 0.0 108.86 174.209 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.795 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -160.61 173.34 15.63 Favored 'General case' 0 C--N 1.378 1.811 1 CA-C-N 107.777 -4.283 . . . . 0.0 111.671 -174.36 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.76 ' CD1' ' HA ' ' A' ' 7' ' ' VAL 0.313 0.3 OUTLIER -137.2 156.95 34.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 117.833 -1.547 . . . . 0.0 107.404 177.724 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.796 ' CA ' ' HG3' ' A' ' 66' ' ' ARG 0.696 . . -106.41 155.57 19.42 Favored 'General case' 0 C--N 1.379 1.881 3 C-N-CA 107.591 -5.643 . . . . 0.0 97.618 -175.017 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.806 HG13 ' N ' ' A' ' 66' ' ' ARG 0.583 1.7 mt -103.67 91.07 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.186 -2.253 2 CA-C-O 131.758 5.551 . . . . 0.0 101.724 -164.733 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.787 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -42.97 81.58 0.0 OUTLIER 'General case' 0 C--N 1.37 1.462 1 CA-C-N 108.378 -4.01 . . . . 0.0 109.012 176.562 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.752 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.94 -45.71 0.37 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 106.908 -2.477 . . . . 0.0 106.908 -177.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.748 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 10.9 m -125.67 -58.86 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.679 -0.895 . . . . 0.0 111.431 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.748 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 80.3 t -163.42 -99.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.551 0 O-C-N 120.314 -1.491 . . . . 0.0 112.879 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.806 ' N ' HG13 ' A' ' 61' ' ' ILE . 1.6 ttp180 -171.55 157.58 4.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.964 -1.085 . . . . 0.0 109.252 -176.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.819 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -143.9 176.04 9.56 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.333 -1.479 . . . . 0.0 111.023 -174.281 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.616 ' N ' ' HZ1' ' A' ' 47' ' ' LYS . 70.8 t -80.79 117.26 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-O 117.386 -1.292 . . . . 0.0 110.942 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.806 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.81 108.28 0.34 Allowed Glycine 0 C--N 1.277 -2.74 0 CA-C-N 121.173 1.806 . . . . 0.0 110.577 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.827 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -90.16 -79.21 0.03 OUTLIER Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 120.734 -1.451 . . . . 0.0 108.936 178.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.827 ' CD ' ' CB ' ' A' ' 70' ' ' ALA 0.256 44.3 Cg_endo -88.53 20.0 1.22 Allowed 'Trans proline' 0 C--O 1.21 -0.918 0 C-N-CA 116.705 -1.73 . . . . 0.0 109.136 177.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.16 63.58 1.0 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.761 -1.212 . . . . 0.0 112.179 175.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.718 ' HG2' ' CB ' ' A' ' 16' ' ' CYS . 20.6 mtt180 -67.27 -33.36 75.15 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.889 -1.132 . . . . 0.0 109.708 177.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.68 ' HA ' ' HB3' ' A' ' 19' ' ' ALA . 1.2 tm-20 -47.31 -46.46 25.19 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.043 -1.035 . . . . 0.0 108.986 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.785 ' CD ' ' CE2' ' A' ' 67' ' ' PHE 0.268 0.0 OUTLIER -47.29 -26.43 1.24 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 118.561 -1.256 . . . . 0.0 109.047 -178.371 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.76 ' CD1' ' N ' ' A' ' 76' ' ' LEU . 3.1 mp -70.71 -39.86 73.16 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.878 0.847 . . . . 0.0 109.368 177.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.767 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.69 -39.47 84.64 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-O 122.088 0.947 . . . . 0.0 111.14 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.474 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 2.6 tm-20 -75.84 -27.84 58.01 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 122.229 1.014 . . . . 0.0 110.058 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.612 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -74.71 -40.6 61.22 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 120.956 -1.09 . . . . 0.0 109.149 -175.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.744 ' CG2' ' CG ' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -60.82 -45.17 98.48 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.572 0 CA-C-O 122.587 1.184 . . . . 0.0 110.151 177.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.655 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.2 OUTLIER -71.84 -32.94 68.03 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.654 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.645 0.1 OUTLIER -99.36 5.95 46.26 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 112.477 -3.689 . . . . 0.0 106.696 -175.258 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.734 ' OE1' ' CA ' ' A' ' 63' ' ' GLY 0.284 0.0 OUTLIER -86.35 -60.68 1.93 Allowed 'General case' 0 N--CA 1.48 1.03 1 O-C-N 116.169 -4.082 . . . . 0.0 108.132 165.739 . . . . . . . . 5 4 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.727 ' HE3' ' NZ ' ' A' ' 27' ' ' LYS . 21.4 ptt? -66.63 -14.84 62.95 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.946 -1.101 . . . . 0.0 111.456 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.778 -1.106 . . . . 0.0 110.253 177.939 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.675 ' O ' ' CZ ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.305 0.574 . . . . 0.0 110.276 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.744 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 11.5 p -84.65 -119.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.269 -0.894 . . . . 0.0 109.921 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.727 HG22 ' CB ' ' A' ' 27' ' ' LYS . 72.6 t -92.61 105.62 16.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.283 -0.886 . . . . 0.0 110.308 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.743 ' O ' ' CD1' ' A' ' 80' ' ' ILE . 54.3 t30 -129.2 109.0 10.79 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.755 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.734 HD13 ' CG1' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -123.87 136.99 58.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.082 -1.011 . . . . 0.0 110.409 179.747 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.75 ' O ' ' CD1' ' A' ' 59' ' ' ILE . 4.0 tp10 -125.05 104.07 8.35 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 117.916 -1.514 . . . . 0.0 108.782 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.822 ' CG2' ' CB ' ' A' ' 38' ' ' LYS . 15.7 m -93.88 104.73 16.07 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.434 0 CA-C-O 123.315 1.531 . . . . 0.0 108.43 -179.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.83 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 1.6 t80 -117.65 84.88 2.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.221 -0.924 . . . . 0.0 109.78 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.697 ' O ' HG23 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -120.28 -53.28 2.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.529 -0.732 . . . . 0.0 109.882 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.772 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 5.3 p 179.43 152.76 0.56 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.316 -0.865 . . . . 0.0 110.513 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.687 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 50.5 Cg_endo -84.52 -29.4 0.82 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.121 1.59 . . . . 0.0 110.205 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.549 ' OG1' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -79.81 -16.87 54.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.376 -0.828 . . . . 0.0 109.946 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.549 ' SG ' ' OG1' ' A' ' 12' ' ' THR . 1.4 m -124.97 179.97 1.0 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.417 -0.802 . . . . 0.0 109.954 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.631 ' O ' ' O ' ' A' ' 15' ' ' TYR . 52.3 Cg_endo -83.6 111.68 1.79 Allowed 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.993 1.522 . . . . 0.0 110.473 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.772 ' CE1' ' O ' ' A' ' 10' ' ' SER . 8.6 m-85 -49.51 -114.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.905 . . . . 0.0 109.728 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.681 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -155.19 40.7 0.14 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.167 -0.958 . . . . 0.0 110.054 179.543 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.723 ' CA ' HG12 ' A' ' 7' ' ' VAL . 50.1 Cg_endo -74.7 16.15 0.64 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.935 1.492 . . . . 0.0 111.039 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.714 ' CG ' ' HD3' ' A' ' 73' ' ' ARG . 5.1 ttm -84.81 -60.74 1.96 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.129 -0.982 . . . . 0.0 111.305 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.75 ' CB ' ' O ' ' A' ' 73' ' ' ARG . . . -56.41 -18.9 12.55 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.27 -0.894 . . . . 0.0 109.665 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.722 ' HB ' ' CG2' ' A' ' 5' ' ' ILE . 0.3 OUTLIER -73.83 -40.15 52.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.458 -0.776 . . . . 0.0 109.327 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.623 ' N ' HD11 ' A' ' 20' ' ' ILE . 6.0 tm-20 -53.7 -36.11 61.85 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.1 t -75.94 -39.39 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.758 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -70.39 -26.8 29.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-O 122.022 0.915 . . . . 0.0 108.88 177.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.722 ' OD1' ' CG2' ' A' ' 34' ' ' ILE . 4.8 t70 -74.62 -37.45 62.82 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -45.01 91.58 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.314 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.43 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.26 -40.59 30.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.492 -0.755 . . . . 0.0 110.095 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.808 ' CE ' ' CE ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -65.13 -26.31 68.13 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.182 -1.007 . . . . 0.0 108.871 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.741 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.89 -46.64 67.87 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.822 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.788 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -45.94 -42.08 12.4 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.654 0.74 . . . . 0.0 109.057 178.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.788 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -90.27 -56.04 3.37 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.414 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.738 ' HA3' ' CG2' ' A' ' 2' ' ' VAL . . . -96.08 79.05 0.77 Allowed Glycine 0 N--CA 1.489 2.196 0 O-C-N 121.482 -0.761 . . . . 0.0 111.276 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -37.71 -19.56 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 119.057 1.429 . . . . 0.0 110.767 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.726 ' O ' HG22 ' A' ' 2' ' ' VAL . 9.5 mtpt -85.74 160.09 19.61 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.911 -1.118 . . . . 0.0 111.289 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.741 ' CD1' ' CG ' ' A' ' 28' ' ' LYS . 0.6 OUTLIER -130.54 129.33 64.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.084 178.447 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.627 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 8.4 t0 -136.86 74.37 1.49 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.333 -0.854 . . . . 0.0 109.175 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.676 HG11 ' CG1' ' A' ' 5' ' ' ILE . 46.1 t -92.23 115.85 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-O 122.428 1.108 . . . . 0.0 109.406 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.72 ' CB ' ' OE2' ' A' ' 6' ' ' GLU . 9.0 mt-10 -97.6 148.15 23.58 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.345 -1.342 . . . . 0.0 108.328 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.822 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.94 120.84 14.51 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.62 -1.3 . . . . 0.0 111.654 -177.376 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.713 ' CD1' ' HG3' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -120.4 174.62 5.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.27 -0.894 . . . . 0.0 111.28 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.741 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -112.07 167.69 10.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.074 -1.016 . . . . 0.0 112.629 179.111 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.83 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -67.5 -36.21 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.646 -0.658 . . . . 0.0 112.53 178.315 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.741 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -90.61 -7.15 53.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.844 -1.16 . . . . 0.0 112.016 -179.09 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.698 ' CG1' ' OD2' ' A' ' 40' ' ' ASP . 14.0 p -111.27 -35.64 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.015 -1.053 . . . . 0.0 109.934 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.71 ' HB2' ' CG2' ' A' ' 39' ' ' ILE . 3.0 t70 -115.07 45.49 1.61 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.294 -0.879 . . . . 0.0 110.163 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.522 ' HG2' ' O ' ' A' ' 45' ' ' ARG 0.257 45.3 ttt180 -59.28 -5.69 0.79 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.462 -1.295 . . . . 0.0 109.406 -179.065 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.765 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 2.2 mm-40 -53.88 -20.88 6.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.335 -0.853 . . . . 0.0 110.329 177.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.862 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -51.95 -56.33 14.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.857 -1.152 . . . . 0.0 109.394 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.862 ' N ' ' HG3' ' A' ' 47' ' ' LYS . . . -64.7 -2.52 2.52 Favored 'General case' 0 C--N 1.276 -2.609 0 O-C-N 120.896 -1.128 . . . . 0.0 111.467 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.785 ' CD1' ' N ' ' A' ' 50' ' ' GLU . 2.5 pp -34.25 -37.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 -177.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.785 ' N ' ' CD1' ' A' ' 49' ' ' ILE . 0.5 OUTLIER -55.39 -52.33 63.89 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.153 176.807 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.833 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.5 p90 -121.97 -27.26 4.63 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.129 -0.982 . . . . 0.0 110.278 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.793 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.23 13.18 0.01 OUTLIER Glycine 0 N--CA 1.489 2.197 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.669 ' N ' ' O ' ' A' ' 51' ' ' TYR . 6.4 mt -84.7 -66.0 0.94 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 123.981 1.848 . . . . 0.0 108.375 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.459 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 15.9 mmt -103.87 56.43 0.73 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.021 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.862 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.263 . . -99.24 105.41 17.44 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 123.387 1.565 . . . . 0.0 110.661 -176.104 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.795 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 2.0 t -146.4 -65.47 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 121.197 -0.939 . . . . 0.0 110.408 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.795 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 40.8 Cg_endo -97.35 102.7 0.08 OUTLIER 'Trans proline' 0 C--O 1.195 -1.661 0 CA-C-O 124.131 1.638 . . . . 0.0 108.728 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.782 ' CB ' ' HG2' ' A' ' 47' ' ' LYS . . . -156.14 -178.46 7.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.46 -1.4 . . . . 0.0 111.304 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.766 HG13 ' CD2' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -144.38 140.76 24.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.763 -0.585 . . . . 0.0 109.869 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.747 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . . . -81.69 133.41 35.35 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.753 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.353 1.2 mt -85.36 81.25 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.221 0 C-N-CA 116.462 -2.095 . . . . 0.0 107.223 -176.283 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.798 ' O ' ' CG ' ' A' ' 83' ' ' GLU . 27.6 m-80 -44.3 85.87 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 114.512 -1.222 . . . . 0.0 107.895 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.753 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.73 -43.78 0.35 Allowed Glycine 0 N--CA 1.486 1.999 0 N-CA-C 106.177 -2.769 . . . . 0.0 106.177 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.744 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 14.9 m -128.73 -60.97 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 121.791 -0.829 . . . . 0.0 110.761 179.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.744 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 64.8 t -165.23 -103.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 120.321 -1.487 . . . . 0.0 111.679 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.752 ' HG2' ' CD ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -153.28 164.26 38.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.786 -0.572 . . . . 0.0 109.828 -179.083 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.823 ' CZ ' ' HA3' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -145.42 178.18 8.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.079 -1.013 . . . . 0.0 110.862 -179.737 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.408 ' HA ' ' HB1' ' A' ' 58' ' ' ALA . 96.0 t -89.45 122.08 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.286 -0.884 . . . . 0.0 109.078 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.823 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -160.96 101.83 0.2 Allowed Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.055 -1.545 . . . . 0.0 111.148 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.825 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -90.29 -83.92 0.02 OUTLIER Pre-proline 0 C--N 1.293 -1.848 0 O-C-N 120.825 -1.397 . . . . 0.0 108.484 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.825 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 48.8 Cg_endo -82.55 15.2 2.09 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 N-CA-C 108.909 -1.227 . . . . 0.0 108.909 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.56 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 26.2 p -100.22 69.95 1.51 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.264 -0.897 . . . . 0.0 111.269 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.75 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -74.87 -40.45 60.95 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.916 -1.115 . . . . 0.0 109.376 179.007 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.714 ' HA ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -46.03 -36.37 5.62 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.185 -0.947 . . . . 0.0 109.153 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.575 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -48.44 -41.61 29.86 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.493 -0.883 . . . . 0.0 108.712 179.318 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.766 ' CD2' HG13 ' A' ' 59' ' ' ILE . 7.1 mp -56.77 -40.06 75.16 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.675 0.75 . . . . 0.0 109.015 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.758 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -60.69 -42.47 97.22 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.617 0.722 . . . . 0.0 109.918 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.491 ' N ' ' CD2' ' A' ' 77' ' ' PHE . 1.2 tt0 -78.0 -22.73 48.87 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.298 -0.876 . . . . 0.0 110.369 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.534 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -79.25 -39.58 32.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.106 -0.996 . . . . 0.0 109.937 -178.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.743 ' CD1' ' O ' ' A' ' 4' ' ' ASN . 0.2 OUTLIER -66.07 -32.14 56.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.909 -1.119 . . . . 0.0 108.862 178.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.501 ' HA ' ' HE1' ' A' ' 84' ' ' MET . 0.1 OUTLIER -78.38 -29.08 47.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.0 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.563 0.6 OUTLIER -93.36 -7.22 45.36 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 112.718 -3.593 . . . . 0.0 105.742 -179.003 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.798 ' CG ' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -74.99 -54.65 6.81 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.165 -1.584 . . . . 0.0 108.111 171.811 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.808 ' CE ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -75.51 -22.34 57.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.732 -0.605 . . . . 0.0 110.431 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 84' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.211 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.201 0.524 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.765 ' HA ' ' CE2' ' A' ' 30' ' ' PHE . 0.9 OUTLIER -80.72 -92.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.329 -0.857 . . . . 0.0 110.354 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.749 ' CG1' ' CG2' ' A' ' 36' ' ' VAL . 54.1 t -91.59 128.74 43.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.521 -0.737 . . . . 0.0 110.921 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.809 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 62.8 t30 -140.63 107.6 5.43 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 123.06 1.409 . . . . 0.0 109.126 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.766 ' CD1' HG13 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -135.91 136.18 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 O-C-N 121.032 -1.043 . . . . 0.0 112.032 -178.565 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.731 ' CG ' ' HB2' ' A' ' 60' ' ' ALA . 1.4 tp10 -122.5 102.54 8.14 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 118.136 -1.425 . . . . 0.0 108.53 176.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.802 ' CG2' ' CB ' ' A' ' 38' ' ' LYS . 30.0 m -96.19 106.28 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 123.11 1.433 . . . . 0.0 109.327 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.824 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 1.1 t80 -118.19 101.88 8.56 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.67 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.677 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.5 OUTLIER -134.03 -61.58 0.79 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.269 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.675 ' HA ' HG23 ' A' ' 41' ' ' ILE . 3.1 t -175.07 144.63 0.83 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.118 -0.988 . . . . 0.0 111.073 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.739 ' N ' ' HB2' ' A' ' 40' ' ' ASP . 50.6 Cg_endo -76.63 -9.43 18.5 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 124.212 1.638 . . . . 0.0 110.652 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.05 -5.21 53.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.996 -1.065 . . . . 0.0 109.794 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.631 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 1.5 p -160.45 -165.65 0.13 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.494 -0.754 . . . . 0.0 110.09 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.631 ' CD ' ' CB ' ' A' ' 13' ' ' CYS . 53.2 Cg_endo -84.32 117.78 2.18 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.895 1.471 . . . . 0.0 110.35 177.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.672 ' HB2' ' HB ' ' A' ' 7' ' ' VAL . 2.1 m-85 -49.27 -83.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.93 . . . . 0.0 109.632 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.708 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 42.5 m -155.41 39.61 0.11 Allowed Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.213 -0.93 . . . . 0.0 109.961 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.708 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 52.9 Cg_endo -73.72 30.35 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.013 1.533 . . . . 0.0 111.142 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.435 ' H ' ' C ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -110.16 -61.93 1.59 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.952 -1.093 . . . . 0.0 110.369 -179.653 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.722 ' CB ' ' C ' ' A' ' 73' ' ' ARG . . . -58.06 -20.11 36.85 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.457 -0.777 . . . . 0.0 110.033 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.733 ' CG2' HG22 ' A' ' 5' ' ' ILE . 23.0 pt -75.6 -38.99 39.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.492 -0.755 . . . . 0.0 109.531 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.658 ' N ' HG13 ' A' ' 20' ' ' ILE . 49.8 tt0 -49.43 -36.02 21.06 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.68 -43.02 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.766 HG13 ' CD1' ' A' ' 5' ' ' ILE . 0.5 OUTLIER -69.85 -27.98 35.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.744 0.783 . . . . 0.0 109.234 178.117 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.636 ' O ' ' HB2' ' A' ' 28' ' ' LYS . 4.4 t70 -75.77 -36.07 59.95 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -44.18 89.91 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.635 0.731 . . . . 0.0 109.289 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.511 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.45 -41.01 28.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.506 -0.746 . . . . 0.0 110.122 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.82 ' CE ' ' CE ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -67.67 -23.41 65.31 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.206 -179.327 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.636 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -69.35 -46.38 67.14 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.373 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.797 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -47.68 -40.66 20.6 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.726 0.774 . . . . 0.0 109.191 179.004 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.797 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.89 -58.06 2.64 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.489 -0.757 . . . . 0.0 109.017 179.587 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.736 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -96.64 77.85 0.72 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 111.341 -0.703 . . . . 0.0 111.341 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.588 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -32.94 -27.37 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 119.315 1.558 . . . . 0.0 110.168 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.736 ' N ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -88.68 158.37 18.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.417 -0.802 . . . . 0.0 111.259 178.253 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.69 ' CD1' HG22 ' A' ' 3' ' ' VAL . 0.3 OUTLIER -129.57 150.86 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.081 -1.012 . . . . 0.0 110.581 178.095 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -138.69 61.45 1.58 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.414 -0.804 . . . . 0.0 108.875 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.749 ' CG2' ' CG1' ' A' ' 3' ' ' VAL . 44.7 t -91.76 115.75 31.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.663 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.715 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 12.4 mt-10 -98.59 140.43 32.83 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.01 -1.076 . . . . 0.0 108.368 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.802 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -138.45 130.81 28.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.411 -0.805 . . . . 0.0 111.845 -176.648 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.747 ' HB ' ' CB ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -138.17 172.8 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.848 . . . . 0.0 109.898 179.598 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.771 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.7 OUTLIER -105.33 169.84 8.23 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.175 -0.953 . . . . 0.0 110.975 179.008 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.824 ' HA ' ' CE2' ' A' ' 8' ' ' PHE . 0.6 OUTLIER -73.79 -17.88 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.254 -0.904 . . . . 0.0 111.593 179.251 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.771 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 2.6 ptt? -92.89 -15.59 26.21 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.809 -1.156 . . . . 0.0 110.21 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.733 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 14.0 p -111.2 -30.58 2.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 110.256 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.808 ' O ' ' CE2' ' A' ' 8' ' ' PHE . 5.7 t0 -114.5 48.91 1.07 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.047 -1.033 . . . . 0.0 110.869 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.264 2.5 ttt180 -59.99 -8.8 2.5 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.319 -1.352 . . . . 0.0 109.627 -179.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.767 ' O ' ' CG2' ' A' ' 49' ' ' ILE . 0.4 OUTLIER -58.31 -17.08 17.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.634 174.639 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.82 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -48.96 -61.38 2.09 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.416 1.103 . . . . 0.0 109.68 -178.058 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.874 ' CB ' ' CB ' ' A' ' 55' ' ' ALA . . . -62.06 0.08 0.45 Allowed 'General case' 0 C--N 1.283 -2.308 0 O-C-N 121.613 -0.679 . . . . 0.0 111.566 177.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.767 ' CG2' ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -35.11 -38.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 -176.226 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.586 ' N ' ' C ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -54.81 -49.26 71.43 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.513 177.383 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.81 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -124.96 -28.47 3.46 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.953 -1.092 . . . . 0.0 110.361 179.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.777 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 41.15 11.17 0.01 OUTLIER Glycine 0 N--CA 1.486 2.023 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.68 ' N ' ' O ' ' A' ' 51' ' ' TYR . 6.2 mt -84.95 -61.52 1.76 Allowed 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 123.117 1.437 . . . . 0.0 108.344 177.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.545 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 26.0 mtm -110.21 62.88 0.6 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.031 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.874 ' CB ' ' CB ' ' A' ' 48' ' ' ALA 0.268 . . -98.34 107.75 20.29 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 123.092 1.425 . . . . 0.0 111.327 -174.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.829 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 1.6 t -146.98 -66.81 0.02 OUTLIER Pre-proline 0 N--CA 1.486 1.368 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.487 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.829 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 41.8 Cg_endo -106.25 94.27 0.02 OUTLIER 'Trans proline' 0 C--O 1.206 -1.11 0 CA-C-O 122.701 1.042 . . . . 0.0 109.785 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.759 ' CB ' ' HE2' ' A' ' 47' ' ' LYS . . . -152.13 178.67 9.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.226 -0.922 . . . . 0.0 110.667 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.837 ' CG2' ' CD2' ' A' ' 76' ' ' LEU . 1.4 mp -149.91 147.38 16.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.619 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.805 ' HA ' ' HG3' ' A' ' 66' ' ' ARG . . . -81.58 138.03 35.44 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 117.4 -1.72 . . . . 0.0 106.452 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.767 ' HB ' HG21 ' A' ' 64' ' ' VAL 0.382 0.9 OUTLIER -87.93 81.11 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-O 124.807 2.241 . . . . 0.0 106.486 -175.635 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.809 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -42.69 84.88 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 113.466 -1.697 . . . . 0.0 108.006 177.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.754 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.08 -47.09 0.38 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 106.328 -2.709 . . . . 0.0 106.328 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.767 HG21 ' HB ' ' A' ' 61' ' ' ILE . 11.9 m -124.51 -60.76 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 121.846 -0.797 . . . . 0.0 111.19 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.764 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 97.6 t -164.04 -107.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.126 -1.609 . . . . 0.0 113.146 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.805 ' HG3' ' HA ' ' A' ' 60' ' ' ALA . 1.0 OUTLIER -156.23 153.65 29.49 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.769 -0.582 . . . . 0.0 109.947 -177.008 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.805 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -145.98 -175.65 4.83 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.982 -1.074 . . . . 0.0 111.75 -178.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.692 ' HA ' ' HB1' ' A' ' 58' ' ' ALA . 21.5 t -95.39 123.24 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.796 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.23 105.43 0.26 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 118.751 -1.69 . . . . 0.0 111.099 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.835 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . . . -89.68 -82.34 0.03 OUTLIER Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 120.831 -1.394 . . . . 0.0 108.202 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.835 ' CD ' ' CB ' ' A' ' 70' ' ' ALA . 51.1 Cg_endo -82.99 15.22 2.14 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 N-CA-C 108.932 -1.218 . . . . 0.0 108.932 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.71 64.29 1.27 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.323 -0.86 . . . . 0.0 111.547 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.722 ' C ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.62 -32.15 65.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.04 -1.038 . . . . 0.0 109.358 178.754 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.679 ' HA ' ' HB3' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -51.23 -41.09 60.08 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.268 -0.895 . . . . 0.0 109.184 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.754 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -46.21 -29.36 1.55 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.465 -0.772 . . . . 0.0 109.267 179.581 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.837 ' CD2' ' CG2' ' A' ' 59' ' ' ILE . 13.1 mt -72.46 -40.84 66.7 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.756 ' O ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.87 -37.33 73.75 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.457 -0.777 . . . . 0.0 109.535 179.371 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -78.58 -26.76 45.57 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.512 -0.743 . . . . 0.0 110.297 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.71 ' HB3' ' CG2' ' A' ' 61' ' ' ILE . . . -74.21 -37.98 63.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.922 . . . . 0.0 110.063 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.739 ' CD1' HD12 ' A' ' 5' ' ' ILE . 1.5 mp -63.7 -37.35 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.975 -1.078 . . . . 0.0 108.788 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.43 ' ND2' ' C ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -73.29 -32.79 64.84 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.151 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.668 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.47 0.3 OUTLIER -91.79 -6.55 51.55 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 115.191 -2.604 . . . . 0.0 108.157 -179.419 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.757 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -79.85 -55.02 5.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.361 -1.462 . . . . 0.0 109.419 169.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.82 ' CE ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.01 -23.16 64.97 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.338 179.751 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.474 ' CD ' ' C ' ' A' ' 85' ' ' GLU . 3.3 tm-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.257 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.591 ' CE ' ' CD ' ' A' ' 83' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.876 0.846 . . . . 0.0 110.845 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.004 HG21 ' O ' ' A' ' 33' ' ' LYS . 1.4 p -80.04 -96.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.965 -1.084 . . . . 0.0 110.337 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.047 HG21 HD12 ' A' ' 34' ' ' ILE . 47.6 t -89.97 129.05 41.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 121.561 -0.712 . . . . 0.0 109.936 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.983 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 1.5 m-20 -149.05 101.91 3.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.792 -1.192 . . . . 0.0 108.633 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.046 HD12 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.37 138.93 52.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 113.847 -1.524 . . . . 0.0 113.651 -178.403 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 1.263 ' O ' HG23 ' A' ' 59' ' ' ILE . 13.6 tt0 -132.9 121.42 22.84 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 118.692 -2.505 . . . . 0.0 106.109 176.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.006 HG12 ' CD2' ' A' ' 76' ' ' LEU . 3.9 m -112.28 111.61 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.312 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -176.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.878 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -116.15 95.04 4.9 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.814 -178.252 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.824 ' O ' HD12 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -126.31 -59.42 1.31 Allowed 'General case' 0 C--N 1.291 -1.946 0 O-C-N 121.207 -0.933 . . . . 0.0 108.853 178.284 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.69 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 0.2 OUTLIER 179.09 146.47 0.38 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.825 -1.172 . . . . 0.0 110.704 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.668 ' CD ' ' HB2' ' A' ' 40' ' ' ASP . 48.2 Cg_endo -75.91 -30.17 6.18 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 124.445 1.76 . . . . 0.0 110.359 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.2 t -78.92 -14.34 59.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.58 -0.7 . . . . 0.0 110.081 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.512 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -124.74 179.14 1.17 Allowed Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.516 -0.74 . . . . 0.0 109.868 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.616 ' O ' ' O ' ' A' ' 15' ' ' TYR . 52.2 Cg_endo -83.58 107.02 1.35 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.959 1.505 . . . . 0.0 109.975 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.69 ' CE1' ' O ' ' A' ' 10' ' ' SER . 3.2 m-85 -50.18 -115.42 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.819 -0.551 . . . . 0.0 109.545 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.864 ' SG ' HD11 ' A' ' 59' ' ' ILE . 71.0 m -149.11 38.8 0.19 Allowed Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.941 -1.099 . . . . 0.0 109.423 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.893 ' HA ' HD13 ' A' ' 20' ' ' ILE . 53.2 Cg_endo -74.51 29.85 0.34 Allowed 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 123.829 1.436 . . . . 0.0 111.295 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.7 ' CG ' ' CZ ' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -106.37 -55.01 2.39 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.941 -1.099 . . . . 0.0 110.423 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.754 ' HB2' ' HD3' ' A' ' 73' ' ' ARG . . . -59.17 -19.93 49.39 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.314 -0.866 . . . . 0.0 109.933 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.228 HD12 ' CG1' ' A' ' 36' ' ' VAL . 3.2 pt -72.52 -41.78 63.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-O 121.253 0.549 . . . . 0.0 109.742 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.563 ' N ' ' CG1' ' A' ' 20' ' ' ILE . 7.7 tt0 -53.58 -35.21 60.59 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 t -71.03 -45.78 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.896 ' CG1' HG21 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -63.98 -33.92 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.07 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.701 ' OD2' HG21 ' A' ' 34' ' ' ILE . 31.0 t0 -66.81 -40.88 88.21 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.838 0.827 . . . . 0.0 109.673 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.29 -48.37 79.08 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.604 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.501 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.55 -39.09 47.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.77 -0.581 . . . . 0.0 110.443 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.772 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -72.96 -17.73 61.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.07 -1.019 . . . . 0.0 109.915 -178.744 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.933 ' HG2' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -71.51 -47.0 58.15 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.319 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.704 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -46.2 -37.42 7.08 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.863 0.839 . . . . 0.0 110.327 179.13 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.817 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -93.72 -72.4 0.61 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 178.754 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.817 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -82.98 89.82 1.52 Allowed Glycine 0 N--CA 1.487 2.047 0 C-N-CA 118.88 -1.628 . . . . 0.0 109.909 177.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.549 ' OD2' ' NZ ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -40.56 -29.62 0.09 Allowed 'General case' 0 N--CA 1.52 3.065 0 CA-C-N 122.217 3.008 . . . . 0.0 110.667 176.157 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 1.068 ' O ' HD13 ' A' ' 34' ' ' ILE . 9.4 mtmm -79.85 151.77 30.04 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.81 -0.556 . . . . 0.0 112.442 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.068 HD13 ' O ' ' A' ' 33' ' ' LYS . 16.5 mm -129.26 160.28 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 120.466 -1.396 . . . . 0.0 110.055 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.735 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -151.25 70.1 0.96 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.487 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.228 ' CG1' HD12 ' A' ' 20' ' ' ILE 0.255 85.7 t -96.93 123.23 49.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -179.197 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.847 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 7.8 mt-10 -108.84 148.29 30.82 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -177.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.703 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -142.78 110.7 5.93 Favored 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -174.459 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.9 HD12 ' CG ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -111.76 165.0 7.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 122.266 1.032 . . . . 0.0 113.24 -178.213 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.668 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -100.13 161.13 13.8 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.718 0.771 . . . . 0.0 110.931 178.595 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 1.015 HD11 ' C ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER -62.08 -18.74 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 120.473 -1.392 . . . . 0.0 110.99 179.438 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.668 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -91.23 -14.97 30.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.944 -1.097 . . . . 0.0 111.547 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.64 HG13 HG22 ' A' ' 39' ' ' ILE . 10.0 p -113.62 -31.35 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.131 -0.98 . . . . 0.0 110.63 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.9 ' CG ' HD12 ' A' ' 39' ' ' ILE . 41.9 t0 -112.56 37.93 2.91 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.454 -0.899 . . . . 0.0 110.087 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.522 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.296 0.0 OUTLIER -65.04 -3.49 3.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 119.956 -1.715 . . . . 0.0 109.086 -179.51 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 1.123 ' O ' HG23 ' A' ' 49' ' ' ILE . 1.7 mt-10 -60.0 -20.72 59.25 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.848 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -44.55 -63.37 0.91 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.305 -1.497 . . . . 0.0 109.072 -178.75 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.121 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -57.62 -11.23 1.94 Allowed 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.879 -1.51 . . . . 0.0 111.083 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.161 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.7 pp -24.0 -38.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.237 -1.539 . . . . 0.0 107.922 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 1.161 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -56.22 -51.6 67.5 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.873 177.648 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.83 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.0 p90 -122.84 -30.93 3.75 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.467 -0.771 . . . . 0.0 110.122 178.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.716 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 45.05 4.8 0.01 OUTLIER Glycine 1 N--CA 1.52 4.25 0 O-C-N 121.589 -0.695 . . . . 0.0 111.759 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.676 ' H ' ' C ' ' A' ' 51' ' ' TYR . 8.9 mt -75.68 -79.76 0.09 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 175.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.705 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 1.9 mtm -94.21 65.98 3.41 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.31 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 1.121 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.294 . . -108.23 108.64 19.75 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.346 -1.471 . . . . 0.0 109.79 -177.118 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.015 ' C ' HD11 ' A' ' 41' ' ' ILE . 2.6 t -147.76 -65.16 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.28 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.354 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.825 ' HD3' ' HB ' ' A' ' 56' ' ' VAL . 59.9 Cg_endo -105.44 106.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.302 -1.897 0 N-CA-C 109.11 -1.15 . . . . 0.0 109.11 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.962 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -160.71 177.83 10.07 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 112.694 -2.048 . . . . 0.0 111.686 -176.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.263 HG23 ' O ' ' A' ' 6' ' ' GLU 0.271 1.3 mp -146.53 154.3 12.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.019 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.993 ' HB3' ' HB3' ' A' ' 6' ' ' GLU 0.29 . . -87.72 155.49 19.9 Favored 'General case' 0 CA--C 1.479 -1.77 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.706 HG13 ' N ' ' A' ' 66' ' ' ARG 0.312 1.6 mt -104.12 92.19 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.038 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 -175.075 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.983 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.2 OUTLIER -54.74 86.25 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 126.274 2.234 . . . . 0.0 106.256 -178.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.761 ' HA3' ' HB2' ' A' ' 83' ' ' GLU . . . 162.02 -44.95 0.37 Allowed Glycine 0 C--N 1.292 -1.863 0 N-CA-C 107.777 -2.129 . . . . 0.0 107.777 -177.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.782 ' O ' HG23 ' A' ' 65' ' ' VAL . 11.5 m -126.69 -60.81 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.568 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 64' ' ' VAL . 74.6 t -164.38 -99.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 120.929 -1.107 . . . . 0.0 112.379 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.966 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -165.25 157.86 15.81 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.61 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.962 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -146.62 176.19 10.02 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.325 -0.859 . . . . 0.0 111.698 -176.706 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.748 HG22 ' OH ' ' A' ' 51' ' ' TYR . 7.9 t -84.98 121.58 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.693 -0.63 . . . . 0.0 110.363 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.82 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.67 110.08 0.41 Allowed Glycine 0 N--CA 1.498 2.823 0 O-C-N 119.863 -1.773 . . . . 0.0 110.694 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.051 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -90.49 -79.97 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.388 -1.066 . . . . 0.0 108.624 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 1.051 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 57.2 Cg_endo -83.91 18.27 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 N-CA-C 109.012 -1.188 . . . . 0.0 109.012 177.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -102.69 63.62 0.86 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.528 0.68 . . . . 0.0 110.176 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.754 ' HD3' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -70.57 -42.17 71.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 108.759 178.552 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.707 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 2.0 tt0 -44.07 -37.11 2.86 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.756 -0.59 . . . . 0.0 109.854 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.706 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -47.85 -37.79 14.65 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 120.029 -0.669 . . . . 0.0 109.894 179.354 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.161 ' CG ' HG21 ' A' ' 59' ' ' ILE . 9.7 mp -65.23 -41.52 94.3 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.804 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.2 -36.61 73.36 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 122.246 1.022 . . . . 0.0 109.873 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -78.9 -31.01 45.18 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 110.337 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.27 -38.01 75.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.514 -0.741 . . . . 0.0 111.158 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.896 HG21 ' CG1' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -65.66 -42.4 92.63 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 CA-C-O 121.75 0.786 . . . . 0.0 109.168 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.45 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -70.52 -21.09 62.77 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.618 176.302 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.416 ' O ' ' CG ' ' A' ' 82' ' ' ASP 0.356 0.3 OUTLIER -103.38 2.92 34.58 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 117.567 -1.653 . . . . 0.0 106.733 -178.65 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.82 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.33 -58.36 2.52 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 102.264 -3.235 . . . . 0.0 102.264 176.773 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.638 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 7.5 ptt? -69.47 -18.94 63.76 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.022 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.766 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.661 ' O ' ' SD ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.319 0.581 . . . . 0.0 110.217 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.051 HG21 ' O ' ' A' ' 33' ' ' LYS . 1.3 p -79.92 -95.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 109.894 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.042 HG21 HD12 ' A' ' 34' ' ' ILE . 52.1 t -88.89 129.13 40.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.476 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 1.042 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.292 1.5 m-20 -151.16 103.23 3.01 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 125.108 2.385 . . . . 0.0 108.446 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.067 HD12 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.5 137.26 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 CA-C-N 111.337 -2.665 . . . . 0.0 113.997 -178.165 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 1.244 ' O ' HG23 ' A' ' 59' ' ' ILE . 12.9 tt0 -131.72 119.89 21.97 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 115.458 -2.497 . . . . 0.0 105.862 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.035 HG12 ' CD2' ' A' ' 76' ' ' LEU . 4.2 m -111.61 111.6 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -176.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.879 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -116.4 93.71 4.34 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.021 -178.25 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.791 ' O ' HD12 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -124.43 -60.02 1.43 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.408 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.774 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 0.2 OUTLIER 179.7 147.72 0.44 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 110.621 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.732 ' CD ' ' HB2' ' A' ' 40' ' ' ASP . 48.4 Cg_endo -76.53 -30.07 5.39 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.273 1.67 . . . . 0.0 110.316 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.6 t -79.48 -13.55 59.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.938 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.58 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -125.03 179.58 1.09 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 109.946 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.648 ' O ' ' O ' ' A' ' 15' ' ' TYR . 52.1 Cg_endo -83.26 106.26 1.36 Allowed 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.984 1.518 . . . . 0.0 110.537 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.774 ' CE1' ' O ' ' A' ' 10' ' ' SER . 3.2 m-85 -49.73 -114.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.095 -1.003 . . . . 0.0 109.741 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.854 ' SG ' HD11 ' A' ' 59' ' ' ILE . 76.1 m -150.0 38.47 0.17 Allowed Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.404 -0.81 . . . . 0.0 109.921 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.889 ' HA ' HD13 ' A' ' 20' ' ' ILE . 50.9 Cg_endo -74.28 29.55 0.33 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.001 1.527 . . . . 0.0 111.129 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.794 ' CG ' ' CZ ' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -105.8 -56.28 2.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.082 -1.011 . . . . 0.0 110.253 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.779 ' HB2' ' HD3' ' A' ' 73' ' ' ARG . . . -58.32 -20.13 40.65 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.314 -0.866 . . . . 0.0 109.622 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.291 HD12 ' CG1' ' A' ' 36' ' ' VAL . 3.1 pt -72.93 -41.82 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.521 -0.737 . . . . 0.0 109.737 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.592 ' N ' ' CG1' ' A' ' 20' ' ' ILE . 7.8 tt0 -52.73 -35.11 55.39 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.4 t -71.65 -44.73 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 121.799 0.809 . . . . 0.0 109.063 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.936 ' CG1' HG21 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -64.66 -32.98 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.75 0.786 . . . . 0.0 109.107 177.824 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.76 ' OD2' HG21 ' A' ' 34' ' ' ILE . 28.5 t0 -68.53 -40.31 80.81 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.213 1.006 . . . . 0.0 109.477 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.43 -48.13 79.95 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.444 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.524 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -78.24 -39.4 40.39 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.635 -0.665 . . . . 0.0 110.672 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.781 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -71.56 -19.01 62.21 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.208 -178.781 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.904 ' HG2' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -70.86 -47.15 60.88 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 176.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.768 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -46.4 -37.89 8.21 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.781 0.8 . . . . 0.0 109.997 179.313 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.862 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -93.56 -70.3 0.71 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.509 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.862 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -84.82 87.71 1.56 Allowed Glycine 0 N--CA 1.504 3.213 0 C-N-CA 118.111 -1.995 . . . . 0.0 111.059 177.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.587 ' OD2' ' NZ ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -37.73 -28.93 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 O-C-N 118.337 -2.86 . . . . 0.0 111.017 176.703 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 1.105 ' O ' HD13 ' A' ' 34' ' ' ILE . 9.3 mtmm -81.27 151.77 27.93 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.105 HD13 ' O ' ' A' ' 33' ' ' LYS . 16.3 mm -128.96 160.3 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 119.926 -1.734 . . . . 0.0 110.039 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.778 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -151.14 70.01 0.97 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.392 -0.817 . . . . 0.0 108.842 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.291 ' CG1' HD12 ' A' ' 20' ' ' ILE 0.257 81.0 t -96.98 121.87 47.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -178.836 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.881 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 7.6 mt-10 -108.39 147.41 31.61 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.705 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -141.41 111.59 6.8 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -174.569 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.946 HD12 ' CG ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -112.02 166.08 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.101 -0.999 . . . . 0.0 113.256 -178.182 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.732 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -100.6 160.61 14.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.546 -0.722 . . . . 0.0 111.376 178.164 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 1.137 HD11 ' C ' ' A' ' 56' ' ' VAL 0.251 0.2 OUTLIER -62.65 -16.2 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.735 -1.228 . . . . 0.0 110.584 179.737 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.725 ' N ' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -93.2 -14.18 27.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.723 -1.236 . . . . 0.0 111.664 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.653 HG12 ' OD1' ' A' ' 40' ' ' ASP . 9.9 p -114.11 -31.07 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.009 -1.057 . . . . 0.0 110.748 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.946 ' CG ' HD12 ' A' ' 39' ' ' ILE . 43.0 t0 -112.51 37.32 3.09 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.116 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.544 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.341 0.0 OUTLIER -66.34 -1.26 3.23 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 117.49 -1.684 . . . . 0.0 108.666 -177.972 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 1.19 ' O ' HG23 ' A' ' 49' ' ' ILE . 1.7 mt-10 -60.11 -21.16 61.2 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.903 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -44.48 -63.27 0.93 Allowed 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 123.626 1.679 . . . . 0.0 109.011 -177.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.193 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -55.86 -12.81 1.49 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 113.51 -1.677 . . . . 0.0 111.458 177.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.229 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.7 pp -25.07 -38.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 O-C-N 119.524 -1.985 . . . . 0.0 107.244 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 1.229 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -55.55 -52.13 64.77 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.981 177.11 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.883 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 1.8 p90 -123.2 -28.63 3.98 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.239 -0.913 . . . . 0.0 110.014 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.767 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 43.22 5.12 0.01 OUTLIER Glycine 0 N--CA 1.504 3.179 0 CA-C-O 122.367 0.982 . . . . 0.0 111.835 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.739 ' N ' ' O ' ' A' ' 51' ' ' TYR . 8.7 mt -75.95 -75.95 0.17 Allowed 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 174.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.696 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 1.8 mtm -97.68 65.27 1.85 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 1.193 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.296 . . -108.57 109.27 20.46 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.165 -1.585 . . . . 0.0 109.074 -176.799 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.137 ' C ' HD11 ' A' ' 41' ' ' ILE . 2.6 t -147.83 -64.25 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.826 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.034 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.854 ' HD3' ' HB ' ' A' ' 56' ' ' VAL . 58.1 Cg_endo -105.64 104.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 N-CA-C 108.781 -1.276 . . . . 0.0 108.781 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 1.025 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -159.37 177.3 11.13 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 112.604 -2.089 . . . . 0.0 111.568 -176.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.244 HG23 ' O ' ' A' ' 6' ' ' GLU . 1.3 mp -146.07 153.04 13.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 O-C-N 121.502 -0.748 . . . . 0.0 109.124 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 1.014 ' HB3' ' HB3' ' A' ' 6' ' ' GLU 0.303 . . -87.3 154.62 20.55 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 102.67 -3.085 . . . . 0.0 102.67 -178.651 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.719 HG13 ' N ' ' A' ' 66' ' ' ARG 0.386 1.6 mt -103.72 93.42 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.599 0 N-CA-C 103.363 -2.828 . . . . 0.0 103.363 -175.357 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 1.042 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.2 OUTLIER -52.32 85.04 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 111.602 -2.545 . . . . 0.0 106.121 179.719 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.792 ' HA3' ' HB2' ' A' ' 83' ' ' GLU . . . 162.46 -44.64 0.35 Allowed Glycine 0 C--N 1.289 -2.037 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.857 ' O ' HG23 ' A' ' 65' ' ' VAL . 11.3 m -127.44 -59.33 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.993 -0.71 . . . . 0.0 110.949 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 64' ' ' VAL . 76.1 t -164.68 -101.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.488 0 O-C-N 120.346 -1.471 . . . . 0.0 112.529 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 1.009 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -162.99 158.96 22.88 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.47 -0.769 . . . . 0.0 109.058 -178.173 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 1.025 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -147.07 178.25 8.51 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.804 -1.185 . . . . 0.0 111.498 -177.272 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.78 HG22 ' OH ' ' A' ' 51' ' ' TYR . 8.3 t -86.57 120.94 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.446 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.826 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.89 110.25 0.43 Allowed Glycine 0 N--CA 1.496 2.673 0 C-N-CA 118.066 -2.016 . . . . 0.0 110.349 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.115 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -90.34 -80.52 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.087 -1.243 . . . . 0.0 108.546 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 1.115 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 55.9 Cg_endo -83.48 17.99 1.58 Allowed 'Trans proline' 0 C--N 1.301 -1.966 0 N-CA-C 108.897 -1.232 . . . . 0.0 108.897 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -102.32 64.35 0.91 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.347 -0.846 . . . . 0.0 110.636 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.794 ' CZ ' ' CG ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -71.99 -40.43 68.57 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.04 -1.037 . . . . 0.0 109.293 178.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.764 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 2.0 tt0 -45.24 -37.63 4.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.39 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.779 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -47.41 -38.05 12.6 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.293 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.234 ' CG ' HG21 ' A' ' 59' ' ' ILE . 9.5 mp -64.96 -40.95 95.78 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.425 -0.797 . . . . 0.0 109.214 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.847 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.55 -36.3 73.7 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.864 0.84 . . . . 0.0 109.847 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -78.3 -31.69 48.98 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.64 -0.662 . . . . 0.0 110.6 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -70.58 -38.46 74.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 0.0 111.048 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.936 HG21 ' CG1' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -64.2 -43.33 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 122.425 1.107 . . . . 0.0 109.183 179.079 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.452 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -70.24 -23.37 62.91 Favored 'General case' 0 C--O 1.2 -1.536 0 CA-C-O 117.899 -1.048 . . . . 0.0 109.179 176.692 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.371 0.2 OUTLIER -101.13 2.34 40.12 Favored 'General case' 0 C--O 1.263 1.778 0 C-N-CA 116.619 -2.032 . . . . 0.0 106.189 -178.064 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.844 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.12 -56.62 3.15 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 102.401 -3.185 . . . . 0.0 102.401 176.032 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.702 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 8.2 ptt? -70.53 -18.5 62.94 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.836 -1.165 . . . . 0.0 110.729 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 117.889 -1.053 . . . . 0.0 109.94 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.726 ' SD ' ' ND2' ' A' ' 4' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.303 0.573 . . . . 0.0 110.201 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.027 HG22 ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -89.95 -92.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 0.0 109.947 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.186 HG11 ' OD2' ' A' ' 24' ' ' ASP . 75.1 t -89.15 112.42 24.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.55 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.841 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 2.0 m120 -132.86 105.4 7.1 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.664 -1.273 . . . . 0.0 108.755 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.067 HG21 ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -120.4 138.17 51.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.812 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 1.063 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.3 122.76 26.99 Favored 'General case' 0 C--N 1.282 -2.335 0 C-N-CA 115.832 -2.347 . . . . 0.0 106.841 177.479 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.958 HG22 ' HA ' ' A' ' 38' ' ' LYS . 20.1 m -109.23 142.3 22.14 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.574 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.986 ' CD2' ' HB3' ' A' ' 58' ' ' ALA . 2.0 t80 -139.79 80.99 1.8 Allowed 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 117.979 -1.489 . . . . 0.0 112.823 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.701 ' OG1' ' HA ' ' A' ' 15' ' ' TYR . 3.4 m -117.81 -68.75 0.89 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 119.144 -2.222 . . . . 0.0 110.373 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.768 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 1.3 p 179.55 164.49 0.78 Allowed Pre-proline 0 C--N 1.293 -1.859 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.381 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.672 ' HD3' ' CG ' ' A' ' 40' ' ' ASP . 50.1 Cg_endo -80.27 -28.4 3.03 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.221 1.643 . . . . 0.0 110.424 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -18.37 54.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.749 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.07 174.36 3.95 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.418 -0.801 . . . . 0.0 109.696 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.651 ' O ' ' O ' ' A' ' 15' ' ' TYR . 51.7 Cg_endo -83.01 114.55 2.26 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.914 1.481 . . . . 0.0 110.422 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.768 ' CE1' ' O ' ' A' ' 10' ' ' SER . 16.3 m-85 -49.26 -112.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.597 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.735 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 92.5 m -150.57 37.58 0.14 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.199 -0.938 . . . . 0.0 110.081 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.735 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 53.9 Cg_endo -76.51 17.06 0.81 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.92 1.484 . . . . 0.0 111.027 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.551 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -95.1 -67.97 0.83 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.075 -1.016 . . . . 0.0 110.79 -179.462 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.781 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -54.28 -22.59 12.26 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.216 -0.928 . . . . 0.0 109.512 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.067 ' HB ' HG21 ' A' ' 5' ' ' ILE . 5.1 pt -70.58 -39.18 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.485 -0.759 . . . . 0.0 109.678 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.739 ' N ' HG13 ' A' ' 20' ' ' ILE . 6.1 tt0 -48.88 -33.45 10.72 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 3.2 t -71.41 -47.42 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.898 HG21 ' HB ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -61.4 -32.96 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.018 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 1.186 ' OD2' HG11 ' A' ' 3' ' ' VAL . 5.2 t70 -68.18 -40.38 82.25 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.994 0.902 . . . . 0.0 109.145 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -46.52 83.12 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.666 0.746 . . . . 0.0 109.626 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.485 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.31 -39.58 47.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.622 -0.674 . . . . 0.0 110.717 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.905 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -70.66 -18.18 62.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.917 -1.114 . . . . 0.0 109.328 -179.149 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.799 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -73.57 -45.05 55.71 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.222 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.74 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -50.14 -32.92 17.27 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.959 0.885 . . . . 0.0 110.465 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.783 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -97.19 -67.01 0.87 Allowed 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 179.09 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.755 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -84.97 86.29 1.56 Allowed Glycine 0 N--CA 1.505 3.261 0 C-N-CA 117.899 -2.096 . . . . 0.0 110.154 177.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.595 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -37.54 -29.29 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 O-C-N 118.319 -2.871 . . . . 0.0 110.188 177.799 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.836 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -78.63 155.56 29.5 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.822 -0.549 . . . . 0.0 111.774 178.189 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.799 ' CD1' ' CG ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -130.04 151.46 35.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 120.327 -1.483 . . . . 0.0 109.902 178.651 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.611 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -151.81 78.09 1.24 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.626 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.939 HG22 ' CD1' ' A' ' 5' ' ' ILE . 56.0 t -96.99 129.09 47.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 1.063 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 78.3 mt-10 -113.48 133.1 55.4 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.958 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -127.41 128.67 46.2 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 113.989 -1.459 . . . . 0.0 114.754 -177.589 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.069 HG22 ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -134.16 169.91 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 119.875 -1.766 . . . . 0.0 111.785 177.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.764 ' OD1' HG22 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -100.59 172.02 7.36 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.83 178.03 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.894 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -62.75 -37.88 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.711 -1.243 . . . . 0.0 109.36 178.569 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.678 ' HG3' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -80.95 -4.13 53.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.908 -1.12 . . . . 0.0 111.547 179.289 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.069 ' CG2' HG22 ' A' ' 39' ' ' ILE . 2.0 m -113.99 -45.97 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 120.954 -1.091 . . . . 0.0 110.033 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.933 ' HB2' HD12 ' A' ' 39' ' ' ILE . 1.6 t70 -105.27 41.84 1.31 Allowed 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.498 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.61 ' NH2' ' HA3' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -65.21 -1.71 2.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.118 -1.614 . . . . 0.0 109.5 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 1.151 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.3 mm-40 -62.81 -23.42 67.25 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.265 178.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.87 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -44.45 -68.81 0.17 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.182 -0.949 . . . . 0.0 108.487 179.405 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.138 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -55.57 -10.14 0.62 Allowed 'General case' 0 C--O 1.194 -1.866 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.549 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.207 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.6 pp -23.98 -41.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 119.412 -2.055 . . . . 0.0 105.956 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 1.207 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -54.0 -53.15 56.96 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.443 -0.798 . . . . 0.0 108.853 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.916 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 25.9 p90 -119.96 -32.24 4.26 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.269 -0.894 . . . . 0.0 110.161 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.723 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 42.81 6.36 0.01 OUTLIER Glycine 0 N--CA 1.499 2.874 0 CA-C-O 122.288 0.938 . . . . 0.0 111.572 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.714 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 4.5 mt -74.43 -80.66 0.08 Allowed 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.542 ' C ' ' HE2' ' A' ' 51' ' ' TYR 0.265 4.1 mtp -95.37 67.24 2.92 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.135 177.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 1.138 ' HB2' ' CB ' ' A' ' 48' ' ' ALA . . . -109.46 120.2 41.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 119.62 -1.925 . . . . 0.0 109.922 -178.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.828 HG23 ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -149.12 -56.39 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.936 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.722 -178.711 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.828 ' HD3' HG23 ' A' ' 56' ' ' VAL . 57.7 Cg_endo -111.63 109.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 122.931 0.964 . . . . 0.0 110.263 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 1.002 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -161.36 174.93 12.8 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.185 -1.371 . . . . 0.0 110.901 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.039 ' CG1' HD21 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -134.86 154.64 36.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.42 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 1.01 ' HB3' ' HB3' ' A' ' 6' ' ' GLU 0.26 . . -93.16 157.22 16.39 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 102.71 -3.07 . . . . 0.0 102.71 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.761 HG13 ' N ' ' A' ' 66' ' ' ARG 0.263 1.1 mt -101.87 91.94 2.2 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 -176.317 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.841 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -53.71 83.08 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -178.072 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.708 ' HA3' ' HB2' ' A' ' 83' ' ' GLU . . . 162.36 -43.49 0.36 Allowed Glycine 0 C--N 1.283 -2.363 0 N-CA-C 107.649 -2.181 . . . . 0.0 107.649 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.821 ' O ' HG23 ' A' ' 65' ' ' VAL . 11.9 m -126.95 -58.86 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.851 -0.794 . . . . 0.0 111.097 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 64' ' ' VAL . 81.0 t -163.78 -100.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 120.32 -1.488 . . . . 0.0 113.268 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 1.002 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 1.8 ttp180 -168.45 159.57 10.47 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.547 -0.72 . . . . 0.0 109.396 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 1.002 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -146.37 175.05 10.83 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.144 -0.973 . . . . 0.0 111.865 -177.33 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.756 ' CG2' ' HZ1' ' A' ' 47' ' ' LYS . 79.8 t -82.41 119.33 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.665 -0.647 . . . . 0.0 110.133 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.84 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.77 107.63 0.31 Allowed Glycine 0 N--CA 1.492 2.426 0 C-N-CA 118.655 -1.736 . . . . 0.0 110.578 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.118 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -88.57 -81.2 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.036 -1.273 . . . . 0.0 108.539 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 1.118 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 56.5 Cg_endo -84.5 18.52 1.54 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.407 1.214 . . . . 0.0 109.006 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.62 61.78 0.71 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.583 -0.698 . . . . 0.0 110.493 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.726 ' HG2' ' CB ' ' A' ' 16' ' ' CYS . 22.2 mtt180 -68.35 -32.25 72.21 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.849 -0.741 . . . . 0.0 109.276 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.781 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.2 tm-20 -47.44 -45.39 25.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 109.59 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.78 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -45.18 -29.11 0.88 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.061 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.039 HD21 ' CG1' ' A' ' 59' ' ' ILE . 3.2 mp -70.58 -39.96 73.56 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.511 -0.743 . . . . 0.0 109.059 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.855 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.11 -41.89 89.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.47 -0.769 . . . . 0.0 109.829 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.528 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 2.4 tm-20 -76.41 -27.99 56.5 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.248 0.547 . . . . 0.0 109.76 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.655 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -69.32 -42.54 75.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.04 -1.038 . . . . 0.0 111.286 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.044 ' CD1' HG23 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -61.97 -45.36 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.043 -1.035 . . . . 0.0 108.814 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.697 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -71.68 -27.07 62.79 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.45 0.643 . . . . 0.0 109.442 178.237 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 1.068 ' O ' ' OD1' ' A' ' 82' ' ' ASP 0.287 0.2 OUTLIER -97.69 8.14 45.2 Favored 'General case' 0 C--O 1.196 -1.762 0 O-C-N 118.918 -2.364 . . . . 0.0 107.82 -178.69 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.783 ' HG2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -101.17 -57.77 2.02 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.697 ' HE2' ' HA ' ' A' ' 81' ' ' ASN . 21.4 ptt? -68.23 -15.59 63.64 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.82 176.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.039 179.952 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.922 ' O ' ' HE3' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.31 0.576 . . . . 0.0 110.193 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.951 HG22 ' N ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -80.66 -94.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.157 -0.964 . . . . 0.0 110.195 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.96 HG11 ' CG ' ' A' ' 24' ' ' ASP . 54.6 t -93.03 91.31 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.422 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 1.053 ' H ' HD11 ' A' ' 80' ' ' ILE . 1.9 m-20 -116.88 108.01 15.3 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.942 0.877 . . . . 0.0 109.262 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.119 HG21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.07 141.18 45.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.283 -0.886 . . . . 0.0 110.306 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 1.135 ' CB ' ' HB3' ' A' ' 60' ' ' ALA 0.255 5.4 tt0 -130.12 101.9 6.01 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 117.708 -1.597 . . . . 0.0 109.235 178.134 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.86 HG12 ' CD2' ' A' ' 76' ' ' LEU . 3.3 m -95.52 110.45 24.22 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.423 0 CA-C-O 123.412 1.577 . . . . 0.0 108.085 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.883 ' CD2' ' HB3' ' A' ' 58' ' ' ALA . 1.6 t80 -118.51 91.03 3.46 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.965 -1.084 . . . . 0.0 110.203 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.94 HG22 ' N ' ' A' ' 10' ' ' SER . 0.7 OUTLIER -120.22 -69.62 0.83 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.777 . . . . 0.0 109.629 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.94 ' N ' HG22 ' A' ' 9' ' ' THR . 21.6 t 179.68 152.14 0.56 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 110.831 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 40' ' ' ASP . 49.8 Cg_endo -77.22 -15.94 15.83 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.175 1.618 . . . . 0.0 110.495 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 t -79.27 5.9 11.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.171 -0.956 . . . . 0.0 109.898 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.651 ' SG ' ' CD ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -160.8 -170.94 0.26 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 0.0 110.153 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.651 ' CD ' ' SG ' ' A' ' 13' ' ' CYS . 55.3 Cg_endo -84.2 113.54 1.79 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.882 1.464 . . . . 0.0 110.667 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.662 ' HA ' ' HB ' ' A' ' 9' ' ' THR . 7.4 m-85 -49.55 -112.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.627 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.866 ' CB ' HD11 ' A' ' 59' ' ' ILE . 58.5 m -152.34 39.19 0.14 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.043 -1.036 . . . . 0.0 110.414 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.706 ' HD3' ' N ' ' A' ' 16' ' ' CYS . 54.0 Cg_endo -76.9 17.17 0.85 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.9 1.474 . . . . 0.0 111.023 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.718 ' SD ' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -93.36 -64.71 1.06 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.092 -1.005 . . . . 0.0 112.078 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.825 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -55.96 -22.42 26.29 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.294 -0.879 . . . . 0.0 109.779 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.119 ' HB ' HG21 ' A' ' 5' ' ' ILE . 0.6 OUTLIER -71.28 -39.69 72.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.503 -0.748 . . . . 0.0 109.531 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.92 ' N ' HD12 ' A' ' 20' ' ' ILE . 3.1 tt0 -48.77 -31.83 7.62 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 2.8 t -71.59 -44.96 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.321 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.833 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -68.71 -26.54 33.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.301 -0.874 . . . . 0.0 109.22 178.418 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.96 ' CG ' HG11 ' A' ' 3' ' ' VAL . 14.1 t0 -74.67 -38.72 62.34 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -44.53 91.62 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.666 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.529 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.76 -40.13 29.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.456 -0.777 . . . . 0.0 110.443 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.778 ' N ' ' HE3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.3 -22.79 64.7 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.092 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 1.049 ' HG3' HD12 ' A' ' 34' ' ' ILE . 3.5 mtpt -69.93 -44.59 69.3 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 177.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.802 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -50.14 -39.98 44.95 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.681 0.753 . . . . 0.0 109.079 178.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.802 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.67 -55.22 3.73 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.786 ' O ' HG21 ' A' ' 2' ' ' VAL . . . -96.73 77.38 0.71 Allowed Glycine 0 N--CA 1.488 2.161 0 O-C-N 121.398 -0.814 . . . . 0.0 111.07 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.543 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -33.45 -24.64 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 118.998 1.399 . . . . 0.0 110.424 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.994 ' C ' HD13 ' A' ' 34' ' ' ILE . 1.1 mtmp? -85.42 155.57 21.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.131 -0.98 . . . . 0.0 110.813 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.049 HD12 ' HG3' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -129.33 149.48 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.939 178.634 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.688 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 36.3 t0 -150.31 71.9 1.08 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.495 -0.753 . . . . 0.0 109.254 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.824 HG22 ' CG1' ' A' ' 5' ' ' ILE . 58.4 t -91.34 117.39 34.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.57 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.809 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.25 91.1 mt-10 -100.5 138.06 38.07 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.433 -1.307 . . . . 0.0 108.301 -178.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.737 ' HB3' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -140.62 126.67 19.55 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.725 -1.235 . . . . 0.0 111.598 -177.383 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.116 HG22 HG21 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -139.65 176.0 6.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.486 -0.759 . . . . 0.0 109.653 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.738 ' CG ' HG13 ' A' ' 43' ' ' VAL . 2.1 p30 -114.22 172.9 6.73 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.858 -1.152 . . . . 0.0 111.947 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.856 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.7 OUTLIER -62.27 -5.29 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.41 -0.806 . . . . 0.0 112.03 176.916 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.738 ' HG3' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -99.94 -18.56 17.03 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.019 -1.051 . . . . 0.0 111.048 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.116 HG21 HG22 ' A' ' 39' ' ' ILE . 0.7 OUTLIER -113.01 -37.08 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.19 -0.944 . . . . 0.0 110.056 -178.389 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 1.034 ' HB2' HD12 ' A' ' 39' ' ' ILE . 5.2 t0 -114.22 52.52 0.83 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.2 -0.938 . . . . 0.0 110.977 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.416 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.255 72.2 ttt180 -65.87 -5.58 9.57 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.315 -1.354 . . . . 0.0 109.575 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 1.0 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.6 OUTLIER -60.11 -15.39 23.09 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.344 -0.848 . . . . 0.0 110.058 176.551 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.842 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -52.17 -58.46 6.54 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.124 -178.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.139 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -63.94 -0.8 1.2 Allowed 'General case' 0 C--N 1.279 -2.471 0 O-C-N 121.331 -0.856 . . . . 0.0 110.73 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.0 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -35.07 -38.7 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 -177.003 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.581 ' N ' ' C ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -53.73 -51.91 61.82 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.165 176.731 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.994 ' CZ ' HG22 ' A' ' 68' ' ' VAL . 1.6 p90 -123.2 -28.22 4.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.085 -1.009 . . . . 0.0 110.449 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.8 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.45 14.18 0.01 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.732 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.4 mt -85.87 -64.92 1.07 Allowed 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 123.674 1.702 . . . . 0.0 107.931 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.503 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 10.0 mtt -105.86 58.12 0.66 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.253 -1.34 . . . . 0.0 107.776 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 1.139 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.264 . . -99.0 106.78 19.08 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 123.467 1.604 . . . . 0.0 110.782 -175.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.789 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -146.72 -60.63 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.21 179.037 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.789 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 46.8 Cg_endo -100.0 104.76 0.05 OUTLIER 'Trans proline' 0 C--O 1.199 -1.47 0 CA-C-O 123.495 1.373 . . . . 0.0 110.429 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 1.031 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -160.14 -177.86 6.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.538 -1.352 . . . . 0.0 111.572 -178.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.266 ' CG1' HD11 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -149.16 137.18 14.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 1.135 ' HB3' ' CB ' ' A' ' 6' ' ' GLU . . . -80.87 140.44 35.36 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 117.155 -1.818 . . . . 0.0 106.987 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.762 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.413 0.7 OUTLIER -89.39 85.91 2.52 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.539 0 C-N-CA 115.302 -2.559 . . . . 0.0 106.058 -175.994 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.773 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.7 OUTLIER -44.12 83.24 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 113.098 -1.865 . . . . 0.0 108.622 177.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.762 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.07 -44.24 0.37 Allowed Glycine 0 N--CA 1.484 1.891 0 N-CA-C 107.042 -2.423 . . . . 0.0 107.042 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.786 ' O ' HG23 ' A' ' 65' ' ' VAL . 16.6 m -126.69 -59.13 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 O-C-N 121.622 -0.928 . . . . 0.0 111.378 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 64' ' ' VAL . 97.0 t -163.85 -106.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 120.289 -1.507 . . . . 0.0 112.249 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 1.072 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 1.8 ttp180 -162.4 165.47 26.35 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.716 -0.615 . . . . 0.0 109.55 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 1.031 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.0 177.83 8.48 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.97 -1.082 . . . . 0.0 111.06 -178.522 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.994 HG22 ' CZ ' ' A' ' 51' ' ' TYR . 22.5 t -93.18 116.55 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.297 -0.877 . . . . 0.0 109.865 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.832 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.41 126.58 1.58 Allowed Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.229 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.063 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -94.03 -83.05 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.759 0 O-C-N 120.921 -1.341 . . . . 0.0 108.709 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 1.063 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 51.4 Cg_endo -80.73 23.81 0.7 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 N-CA-C 109.11 -1.15 . . . . 0.0 109.11 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.51 70.52 1.96 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.238 -0.913 . . . . 0.0 111.432 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.742 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 11.9 mtm180 -76.77 -35.28 57.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.997 -1.064 . . . . 0.0 109.536 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.825 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -49.02 -32.29 9.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.664 179.504 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.781 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -50.9 -40.18 56.1 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.295 -0.878 . . . . 0.0 109.273 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.266 HD11 ' CG1' ' A' ' 59' ' ' ILE . 4.9 mp -64.32 -38.32 90.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.491 -0.755 . . . . 0.0 109.318 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.833 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -60.76 -42.94 98.43 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.868 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.803 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 4.5 tm-20 -78.54 -23.31 46.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 109.851 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.658 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -73.71 -37.01 65.3 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 109.446 -178.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.053 HD11 ' H ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -63.44 -46.08 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.067 -1.02 . . . . 0.0 109.076 178.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.593 ' N ' HG22 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -70.11 -33.59 72.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.35 -0.844 . . . . 0.0 108.742 179.522 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.448 8.0 t70 -88.08 -6.9 57.67 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 114.79 -2.764 . . . . 0.0 107.582 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.748 ' OE1' ' CA ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -81.14 -60.79 2.16 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 120.114 -1.617 . . . . 0.0 109.596 171.234 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.721 ' HE2' ' HZ3' ' A' ' 27' ' ' LYS . 10.3 ptt? -71.62 -12.29 61.27 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.71 -0.619 . . . . 0.0 110.497 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.599 ' CG ' ' OXT' ' A' ' 85' ' ' GLU . 2.1 tt0 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.177 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.2 ttm . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.248 0.547 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.972 HG22 ' N ' ' A' ' 3' ' ' VAL . 0.9 OUTLIER -80.51 -92.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 110.389 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.972 ' N ' HG22 ' A' ' 2' ' ' VAL . 54.6 t -92.76 119.76 40.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.671 -0.643 . . . . 0.0 110.495 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.8 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 9.4 t30 -138.49 114.57 10.14 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.571 1.177 . . . . 0.0 108.865 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.083 HD12 HD13 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -136.15 149.6 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.94 . . . . 0.0 110.724 -179.05 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 1.084 ' HB3' ' HB3' ' A' ' 60' ' ' ALA . 13.6 tt0 -135.09 106.11 6.64 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.007 -1.477 . . . . 0.0 109.701 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.855 HG22 ' HA ' ' A' ' 38' ' ' LYS . 22.3 m -95.16 104.3 15.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-O 123.1 1.429 . . . . 0.0 108.808 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.893 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 0.7 OUTLIER -117.08 87.91 2.8 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.049 -1.032 . . . . 0.0 109.564 -178.756 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 6.6 m -120.72 -62.72 1.42 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.352 -0.842 . . . . 0.0 109.586 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . 1.055 ' HA ' HG22 ' A' ' 41' ' ' ILE . 12.8 p 179.81 156.41 0.72 Allowed Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.369 -0.832 . . . . 0.0 111.009 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.644 ' HD3' ' CG ' ' A' ' 40' ' ' ASP . 50.8 Cg_endo -84.77 -23.71 2.51 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 124.222 1.643 . . . . 0.0 110.589 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 t -79.37 13.65 1.86 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.159 -0.963 . . . . 0.0 110.055 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.543 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -160.72 -174.27 0.42 Allowed Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 121.417 -0.802 . . . . 0.0 110.184 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.614 ' O ' ' O ' ' A' ' 15' ' ' TYR . 54.4 Cg_endo -84.16 112.09 1.67 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.909 1.478 . . . . 0.0 110.689 177.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.755 ' CE1' ' O ' ' A' ' 10' ' ' SER . 19.3 m-85 -49.45 -110.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.311 -0.868 . . . . 0.0 109.609 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.757 ' CA ' ' HG3' ' A' ' 73' ' ' ARG . 37.6 m -154.81 39.78 0.13 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.027 -1.046 . . . . 0.0 110.57 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.688 ' HD3' ' N ' ' A' ' 16' ' ' CYS . 55.2 Cg_endo -77.26 16.56 1.0 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.767 1.404 . . . . 0.0 110.802 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.559 ' HB3' ' HG2' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -93.27 -64.28 1.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.996 -1.082 . . . . 0.0 112.142 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.722 ' CB ' ' HB3' ' A' ' 73' ' ' ARG . . . -57.48 -18.43 18.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.274 -0.891 . . . . 0.0 109.665 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.096 HG22 ' CB ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -75.71 -39.58 39.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.393 -0.817 . . . . 0.0 109.477 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.722 ' N ' HD12 ' A' ' 20' ' ' ILE . 29.8 tp10 -50.4 -32.84 18.72 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.29 -44.45 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.21 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.865 HG13 HG21 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -69.23 -28.08 37.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.673 0.749 . . . . 0.0 109.379 178.578 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.901 ' CG ' HG11 ' A' ' 3' ' ' VAL . 8.4 t0 -76.11 -36.75 58.73 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.7 -43.6 94.04 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.535 0.683 . . . . 0.0 109.623 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.502 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.9 -40.05 29.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.478 -0.764 . . . . 0.0 110.11 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.748 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -69.24 -22.23 63.87 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.218 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 1.036 ' CG ' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -69.92 -43.22 72.13 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.351 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.773 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -49.48 -39.63 34.33 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.788 0.804 . . . . 0.0 109.037 178.921 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.773 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.2 -56.68 3.18 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.746 ' O ' HG21 ' A' ' 2' ' ' VAL . . . -97.16 77.84 0.67 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.624 -0.991 . . . . 0.0 110.624 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.568 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -32.37 -27.16 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 119.105 1.452 . . . . 0.0 110.527 -179.705 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 1.129 ' C ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -85.95 157.05 20.24 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.347 -0.846 . . . . 0.0 110.938 178.202 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.129 HD12 ' C ' ' A' ' 33' ' ' LYS . 1.7 mp -128.98 157.98 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.044 -1.035 . . . . 0.0 110.765 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.692 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 3.4 t0 -150.21 62.48 0.97 Allowed 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.459 -0.775 . . . . 0.0 109.166 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.753 HG22 ' CD1' ' A' ' 5' ' ' ILE . 63.5 t -91.27 115.86 31.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 122.264 1.031 . . . . 0.0 109.862 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.74 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 3.5 mm-40 -97.94 145.08 26.82 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.932 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 1.033 ' C ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -139.98 121.48 15.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.075 -1.016 . . . . 0.0 111.453 -176.807 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.033 HD13 ' C ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -129.06 178.2 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 110.354 -179.152 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.737 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -113.88 165.65 12.37 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.217 -0.927 . . . . 0.0 111.06 178.242 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 1.238 ' CD1' HG12 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -49.58 -38.82 13.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.512 -0.743 . . . . 0.0 112.769 177.656 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.737 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.9 OUTLIER -86.88 -3.46 59.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.844 -1.16 . . . . 0.0 111.483 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.026 ' CG2' HG22 ' A' ' 39' ' ' ILE . 1.9 m -111.15 -44.07 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.97 -1.081 . . . . 0.0 109.801 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.761 ' HB2' ' CB ' ' A' ' 39' ' ' ILE . 4.0 t70 -112.37 45.37 1.3 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.356 -0.84 . . . . 0.0 110.029 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.682 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 2.4 ttt-85 -61.28 -4.64 1.26 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.849 -1.14 . . . . 0.0 109.469 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 1.071 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.1 mm-40 -55.02 -19.74 7.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.396 -0.815 . . . . 0.0 110.253 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.843 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -50.22 -59.1 4.28 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 122.413 1.102 . . . . 0.0 110.067 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.157 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -65.37 -0.09 1.71 Allowed 'General case' 0 C--N 1.281 -2.399 0 O-C-N 121.555 -0.716 . . . . 0.0 111.094 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.27 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.4 pp -35.64 -36.92 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 1.27 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.8 OUTLIER -54.09 -52.54 60.67 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.047 176.783 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 1.049 ' OH ' HG22 ' A' ' 68' ' ' VAL . 2.0 p90 -122.75 -28.22 4.19 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.088 -1.007 . . . . 0.0 110.203 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.789 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.62 14.3 0.01 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.657 ' N ' ' O ' ' A' ' 51' ' ' TYR . 4.4 mt -86.09 -62.77 1.44 Allowed 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 123.122 1.439 . . . . 0.0 108.462 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 19.9 mtp -106.72 53.83 0.69 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.158 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 1.157 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.268 . . -98.94 111.14 23.62 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 123.189 1.471 . . . . 0.0 110.903 -176.142 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.238 HG12 ' CD1' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -146.68 -68.38 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 110.459 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.844 ' HD3' ' CG2' ' A' ' 56' ' ' VAL . 51.0 Cg_endo -96.14 103.81 0.1 OUTLIER 'Trans proline' 0 C--O 1.2 -1.423 0 CA-C-O 123.396 1.332 . . . . 0.0 109.742 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 1.035 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -158.11 175.14 14.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.75 -1.219 . . . . 0.0 111.562 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.03 ' CG1' HD21 ' A' ' 76' ' ' LEU . 1.0 OUTLIER -138.39 135.58 44.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.613 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 1.084 ' HB3' ' HB3' ' A' ' 6' ' ' GLU . . . -81.51 139.59 35.06 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 117.361 -1.736 . . . . 0.0 107.058 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.756 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.372 1.0 OUTLIER -88.55 83.4 2.2 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.346 0 CA-C-O 124.786 2.232 . . . . 0.0 106.824 -175.895 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.8 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 4.5 m120 -43.11 82.68 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.616 -1.629 . . . . 0.0 108.767 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.756 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.04 -44.52 0.37 Allowed Glycine 0 N--CA 1.481 1.694 0 N-CA-C 107.414 -2.275 . . . . 0.0 107.414 -177.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.761 ' O ' HG23 ' A' ' 65' ' ' VAL . 17.0 m -125.78 -59.82 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 121.718 -0.872 . . . . 0.0 110.98 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.766 HG12 ' N ' ' A' ' 66' ' ' ARG . 88.6 t -163.81 -107.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 120.312 -1.492 . . . . 0.0 112.288 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 1.045 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 2.0 ttp180 -164.7 163.53 21.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.631 -0.668 . . . . 0.0 109.671 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 1.035 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -144.76 176.86 9.13 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.896 -1.127 . . . . 0.0 111.366 -178.124 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.049 HG22 ' OH ' ' A' ' 51' ' ' TYR . 79.8 t -89.14 115.82 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.651 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.858 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.57 124.8 1.31 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.564 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.093 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -92.85 -79.68 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 120.882 -1.364 . . . . 0.0 108.396 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 1.093 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 55.2 Cg_endo -81.01 25.29 0.64 Allowed 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.595 1.313 . . . . 0.0 109.228 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . 0.273 28.5 m -102.67 82.84 2.19 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 123.269 1.509 . . . . 0.0 110.007 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.757 ' HG3' ' CA ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -77.94 -35.74 50.1 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.947 -1.096 . . . . 0.0 109.988 177.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.71 ' HG2' ' CD2' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -46.1 -30.13 1.78 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.362 -0.836 . . . . 0.0 109.99 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.806 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -50.91 -42.69 59.56 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.27 -0.894 . . . . 0.0 109.193 179.738 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.096 ' CB ' HG22 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -63.49 -45.57 90.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.604 -0.685 . . . . 0.0 109.492 178.657 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.798 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -60.93 -38.57 86.26 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.639 0.733 . . . . 0.0 110.245 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.613 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 25.4 tt0 -80.22 -21.9 42.39 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.267 -0.896 . . . . 0.0 110.202 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.476 ' HB1' ' HA ' ' A' ' 61' ' ' ILE . . . -77.95 -39.77 41.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.207 -0.933 . . . . 0.0 109.643 -177.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.014 ' CD1' HG23 ' A' ' 5' ' ' ILE . 1.5 mp -65.72 -39.7 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.038 -1.039 . . . . 0.0 109.156 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.573 ' C ' ' OD1' ' A' ' 81' ' ' ASN . 0.1 OUTLIER -75.53 -32.02 60.32 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.118 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.613 ' HB3' ' O ' ' A' ' 78' ' ' GLU 0.455 0.4 OUTLIER -89.03 -8.39 54.09 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 114.989 -2.685 . . . . 0.0 108.115 -179.159 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.744 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -78.9 -60.71 2.27 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 119.968 -1.708 . . . . 0.0 110.196 169.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.639 ' SD ' ' HD2' ' A' ' 27' ' ' LYS . 4.7 ptt? -71.88 -9.16 57.93 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.782 -0.574 . . . . 0.0 110.822 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.572 ' OE2' ' C ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.898 -1.049 . . . . 0.0 109.973 -177.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.226 0.536 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.065 HG21 ' O ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -80.5 -92.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.333 -0.854 . . . . 0.0 110.359 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.954 ' N ' HG22 ' A' ' 2' ' ' VAL . 53.6 t -91.51 128.49 43.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.483 -0.76 . . . . 0.0 110.565 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.786 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 6.3 t-20 -140.3 108.38 5.75 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 123.202 1.477 . . . . 0.0 108.604 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.047 HD12 ' HB ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -136.15 135.92 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 O-C-N 120.747 -1.221 . . . . 0.0 112.061 -178.768 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 1.15 ' O ' HG23 ' A' ' 59' ' ' ILE 0.253 1.4 tp10 -122.66 102.06 7.83 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 123.196 1.474 . . . . 0.0 108.587 176.756 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.8 ' CG2' ' CB ' ' A' ' 38' ' ' LYS . 29.5 m -95.42 106.39 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 123.582 1.658 . . . . 0.0 109.51 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.841 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 1.1 t80 -117.92 102.15 8.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.071 -1.018 . . . . 0.0 109.76 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.846 HG22 ' N ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -134.0 -61.9 0.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.955 . . . . 0.0 110.214 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . 1.027 ' HA ' HG22 ' A' ' 41' ' ' ILE . 3.1 t -175.13 144.63 0.82 Allowed Pre-proline 0 N--CA 1.487 1.386 0 O-C-N 121.118 -0.989 . . . . 0.0 111.152 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.752 ' N ' ' HB2' ' A' ' 40' ' ' ASP . 48.7 Cg_endo -76.76 -9.39 18.31 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 124.135 1.597 . . . . 0.0 110.475 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.95 -5.0 52.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.21 -0.931 . . . . 0.0 109.843 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.624 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 1.4 p -160.61 -166.15 0.14 Allowed Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.385 -0.822 . . . . 0.0 110.056 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.624 ' CD ' ' CB ' ' A' ' 13' ' ' CYS . 55.6 Cg_endo -84.17 117.8 2.23 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.863 1.454 . . . . 0.0 110.617 176.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.773 ' HD2' HG23 ' A' ' 7' ' ' VAL . 2.1 m-85 -49.27 -84.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.0 109.56 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.814 ' HB3' HD11 ' A' ' 76' ' ' LEU . 42.2 m -155.22 39.69 0.12 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.124 -0.985 . . . . 0.0 109.968 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.7 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 53.4 Cg_endo -73.78 30.4 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.881 1.464 . . . . 0.0 111.146 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.4 ' H ' ' C ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -110.17 -61.85 1.6 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.029 -1.044 . . . . 0.0 110.433 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.9 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -58.1 -20.06 37.03 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.464 -0.773 . . . . 0.0 110.062 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.047 ' HB ' HD12 ' A' ' 5' ' ' ILE . 23.0 pt -75.62 -39.07 39.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.479 -0.763 . . . . 0.0 109.513 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.672 ' N ' HG13 ' A' ' 20' ' ' ILE . 49.7 tt0 -49.63 -35.86 22.56 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.8 -42.46 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.048 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.912 HG13 HG21 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -70.88 -26.66 28.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-O 121.825 0.821 . . . . 0.0 109.185 178.299 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.698 ' OD2' HG11 ' A' ' 3' ' ' VAL . 4.6 t70 -76.9 -35.84 57.09 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -43.99 91.07 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.622 0.725 . . . . 0.0 109.321 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.529 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.44 -41.01 28.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.622 -0.674 . . . . 0.0 110.165 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.813 ' CE ' ' CE ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -67.72 -23.38 65.26 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.306 -179.404 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -69.32 -46.42 67.14 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.322 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.791 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -47.47 -41.0 19.69 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.585 0.707 . . . . 0.0 109.124 178.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.791 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.57 -57.87 2.72 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.731 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -97.15 78.28 0.67 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.583 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -33.46 -27.24 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 119.394 1.597 . . . . 0.0 110.101 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 1.065 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -88.72 158.02 18.33 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.197 -0.939 . . . . 0.0 111.339 178.366 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.792 HG23 HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -129.47 151.03 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.406 -0.917 . . . . 0.0 110.685 178.127 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -138.82 61.14 1.58 Allowed 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.445 -0.784 . . . . 0.0 108.97 179.649 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.025 HG13 ' HB ' ' A' ' 5' ' ' ILE . 44.6 t -91.59 115.48 30.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 122.454 1.121 . . . . 0.0 109.681 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.753 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.25 12.2 mt-10 -98.07 141.02 31.53 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.375 -178.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.8 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -138.45 130.9 28.94 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.765 -1.21 . . . . 0.0 112.127 -176.748 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.013 HD12 ' CG ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -138.53 173.12 12.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.525 -0.734 . . . . 0.0 110.006 179.531 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 1.071 ' CG ' HG12 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -105.84 169.68 8.34 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.102 -0.999 . . . . 0.0 110.889 179.234 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 1.258 ' CD1' HG22 ' A' ' 56' ' ' VAL . 0.6 OUTLIER -73.16 -19.32 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.444 -0.785 . . . . 0.0 111.598 179.16 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.756 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 2.4 ptt? -90.62 -18.1 25.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.06 -1.025 . . . . 0.0 110.634 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.071 HG12 ' CG ' ' A' ' 40' ' ' ASP . 13.3 p -110.01 -29.78 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.344 -0.847 . . . . 0.0 110.77 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 1.013 ' CG ' HD12 ' A' ' 39' ' ' ILE . 5.7 t0 -114.7 48.19 1.16 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.021 -1.049 . . . . 0.0 110.843 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.26 2.3 ttt180 -59.09 -8.29 1.45 Allowed 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 118.263 -1.375 . . . . 0.0 109.974 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.988 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.5 OUTLIER -61.34 -13.41 19.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 109.175 175.903 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.813 ' HG2' ' HB3' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -51.71 -60.16 3.47 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.168 0.985 . . . . 0.0 108.959 -178.521 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.134 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -64.2 1.57 0.71 Allowed 'General case' 0 C--N 1.278 -2.533 0 O-C-N 121.119 -0.988 . . . . 0.0 110.55 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.077 HD11 ' NE ' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -35.67 -38.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 -177.457 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.56 ' N ' ' C ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -54.62 -49.36 70.68 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.668 176.717 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.825 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -124.93 -28.55 3.46 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.999 -1.063 . . . . 0.0 110.411 179.21 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.787 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.14 13.3 0.01 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.66 ' N ' ' O ' ' A' ' 51' ' ' TYR . 6.2 mt -86.52 -60.94 1.85 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 123.526 1.631 . . . . 0.0 107.88 177.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.533 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 26.0 mtm -110.55 62.35 0.6 Allowed 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.633 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 1.134 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.278 . . -98.35 107.78 20.32 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 123.622 1.677 . . . . 0.0 111.124 -174.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.258 HG22 ' CD1' ' A' ' 41' ' ' ILE . 1.6 t -146.66 -68.42 0.02 OUTLIER Pre-proline 0 N--CA 1.484 1.232 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.23 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.845 ' CD ' HG12 ' A' ' 56' ' ' VAL . 55.6 Cg_endo -104.22 93.46 0.03 OUTLIER 'Trans proline' 0 C--O 1.201 -1.327 0 CA-C-O 123.528 1.386 . . . . 0.0 111.257 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 1.097 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -151.2 179.32 8.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.32 -1.488 . . . . 0.0 110.957 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.264 HG21 ' CD2' ' A' ' 76' ' ' LEU . 1.4 mp -149.92 147.47 16.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.463 -0.773 . . . . 0.0 110.508 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.927 ' HB3' ' CB ' ' A' ' 6' ' ' GLU . . . -81.59 137.9 35.44 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.755 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.406 1.0 OUTLIER -87.8 82.34 2.05 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.555 0 C-N-CA 115.318 -2.553 . . . . 0.0 105.277 -175.756 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.786 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -44.3 85.67 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 113.3 -1.773 . . . . 0.0 107.851 177.816 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.755 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.0 -47.12 0.38 Allowed Glycine 0 N--CA 1.482 1.716 0 N-CA-C 106.471 -2.652 . . . . 0.0 106.471 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.787 ' O ' HG23 ' A' ' 65' ' ' VAL . 11.9 m -124.49 -60.86 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 121.82 -0.812 . . . . 0.0 111.094 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.805 HG12 ' N ' ' A' ' 66' ' ' ARG . 96.7 t -164.01 -107.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 120.104 -1.623 . . . . 0.0 113.185 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 1.077 ' NE ' HD11 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -156.18 153.69 29.64 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.671 -0.643 . . . . 0.0 110.13 -177.194 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 1.097 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.52 -174.93 4.53 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.905 -1.122 . . . . 0.0 111.836 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.92 122.95 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.812 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.33 105.59 0.26 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 118.865 -1.636 . . . . 0.0 111.153 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.103 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -89.74 -82.74 0.02 OUTLIER Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 120.824 -1.397 . . . . 0.0 108.146 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 1.103 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 55.7 Cg_endo -82.19 14.76 2.16 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 O-C-N 123.28 1.147 . . . . 0.0 109.499 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.48 64.48 1.32 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.218 -0.926 . . . . 0.0 111.587 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.746 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.59 -32.15 65.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.897 -1.127 . . . . 0.0 109.361 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.9 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -51.34 -40.99 60.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.923 . . . . 0.0 109.244 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.744 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -46.32 -29.31 1.6 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.465 -0.772 . . . . 0.0 109.344 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.264 ' CD2' HG21 ' A' ' 59' ' ' ILE . 13.1 mt -72.46 -40.85 66.69 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.803 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.94 -36.98 73.28 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.799 0.809 . . . . 0.0 109.646 179.279 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -79.44 -25.79 41.9 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.328 -0.858 . . . . 0.0 110.123 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.463 ' HB1' HG22 ' A' ' 61' ' ' ILE . . . -74.95 -37.91 61.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.161 -0.962 . . . . 0.0 109.743 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.912 HG21 HG13 ' A' ' 23' ' ' VAL . 1.5 mp -63.64 -37.41 79.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.957 -1.09 . . . . 0.0 108.807 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -72.94 -33.89 66.2 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.64 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.501 0.3 OUTLIER -90.95 -6.58 53.88 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 114.114 -3.035 . . . . 0.0 107.454 -179.059 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.756 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -78.7 -55.19 5.37 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 119.859 -1.776 . . . . 0.0 109.838 170.091 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.813 ' CE ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.04 -23.26 64.96 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.171 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.471 ' CD ' ' C ' ' A' ' 85' ' ' GLU . 3.3 tm-20 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.234 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.239 0.542 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.06 HG21 ' O ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -80.45 -94.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.284 -0.885 . . . . 0.0 110.583 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.981 ' N ' HG22 ' A' ' 2' ' ' VAL . 57.6 t -87.84 133.11 31.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 O-C-N 121.395 -0.816 . . . . 0.0 112.692 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.84 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.51 7.3 t-20 -153.92 106.51 2.85 Favored 'General case' 0 N--CA 1.518 2.939 1 CA-C-O 129.399 4.428 . . . . 0.0 109.208 177.868 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.05 HD12 ' HB ' ' A' ' 20' ' ' ILE 0.414 0.2 OUTLIER -119.3 130.57 73.77 Favored 'Isoleucine or valine' 0 C--O 1.264 1.834 0 CA-C-N 108.689 -3.869 . . . . 0.0 117.903 -174.823 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 1.27 ' O ' HG23 ' A' ' 59' ' ' ILE 0.644 1.2 tp10 -133.7 123.3 24.72 Favored 'General case' 0 C--N 1.269 -2.895 2 CA-C-O 131.792 5.567 . . . . 0.0 106.17 166.824 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.797 HG23 ' HD2' ' A' ' 15' ' ' TYR 0.257 25.0 m -113.19 100.86 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.517 1 O-C-N 114.476 -5.14 . . . . 0.0 109.155 -171.42 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.862 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 1.2 t80 -113.79 104.98 12.74 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 111.69 -2.505 . . . . 0.0 108.623 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.838 HG22 ' N ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -135.6 -60.61 0.74 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.929 0.871 . . . . 0.0 110.564 177.762 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . 1.044 ' HA ' HG22 ' A' ' 41' ' ' ILE . 3.1 t -177.57 143.62 0.51 Allowed Pre-proline 0 N--CA 1.487 1.414 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.41 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.75 ' N ' ' HB2' ' A' ' 40' ' ' ASP . 47.2 Cg_endo -76.08 -9.52 19.28 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 124.119 1.589 . . . . 0.0 110.225 -178.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.14 -5.19 53.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.056 -1.027 . . . . 0.0 109.843 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.633 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 1.4 p -159.75 -165.88 0.13 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.353 -0.842 . . . . 0.0 110.138 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.633 ' CD ' ' CB ' ' A' ' 13' ' ' CYS . 55.3 Cg_endo -84.22 117.65 2.2 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.865 1.455 . . . . 0.0 110.582 176.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.797 ' HD2' HG23 ' A' ' 7' ' ' VAL . 2.0 m-85 -49.22 -83.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 109.625 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.814 ' HB3' HD11 ' A' ' 76' ' ' LEU . 42.7 m -155.29 39.59 0.12 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.146 -0.971 . . . . 0.0 109.962 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 52.9 Cg_endo -73.69 30.3 0.32 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.977 1.514 . . . . 0.0 111.141 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.401 ' H ' ' C ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -110.06 -61.98 1.58 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.966 -1.084 . . . . 0.0 110.348 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.862 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -58.86 -19.11 38.91 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.099 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.05 ' HB ' HD12 ' A' ' 5' ' ' ILE . 22.8 pt -75.95 -38.0 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.141 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.675 ' N ' HG13 ' A' ' 20' ' ' ILE . 50.1 tt0 -49.0 -37.58 20.78 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.42 -44.87 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-O 122.05 0.929 . . . . 0.0 109.297 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.909 HG13 HG21 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -63.01 -35.71 72.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 122.789 1.281 . . . . 0.0 109.92 175.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.698 ' OD2' HG11 ' A' ' 3' ' ' VAL . 4.0 t70 -70.64 -39.03 73.92 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.903 1.335 . . . . 0.0 108.298 -177.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -46.35 81.94 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.062 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.518 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -76.74 -41.6 44.36 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.636 0.731 . . . . 0.0 110.297 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.821 ' CE ' ' CE ' ' A' ' 84' ' ' MET 0.272 0.0 OUTLIER -72.02 -17.71 62.01 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 117.471 -1.691 . . . . 0.0 109.632 -177.32 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.626 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -70.33 -45.86 65.35 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 120.923 -1.111 . . . . 0.0 108.223 173.764 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.722 ' HG3' ' N ' ' A' ' 30' ' ' PHE 0.317 0.0 OUTLIER -52.97 -28.8 25.45 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.014 -179.042 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.777 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -102.17 -59.16 1.75 Allowed 'General case' 0 C--N 1.274 -2.706 0 O-C-N 119.108 -2.245 . . . . 0.0 106.67 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.772 ' HA3' ' CG2' ' A' ' 2' ' ' VAL . . . -80.23 58.85 4.61 Favored Glycine 1 C--N 1.24 -4.8 1 CA-C-O 113.008 -4.218 . . . . 0.0 116.433 174.526 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.571 ' C ' ' O ' ' A' ' 31' ' ' GLY 0.428 0.0 OUTLIER -36.45 -19.65 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.219 1 CA-C-N 125.182 4.491 . . . . 0.0 112.901 -168.647 . . . . . . . . 5 4 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 1.06 ' O ' HG21 ' A' ' 2' ' ' VAL 0.293 0.0 OUTLIER -75.96 151.29 37.29 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 127.536 2.334 . . . . 0.0 115.69 167.953 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.799 HG23 HG23 ' A' ' 36' ' ' VAL 0.342 0.3 OUTLIER -130.67 155.77 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 C-N-CA 115.569 -2.452 . . . . 0.0 109.84 170.575 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.71 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.3 OUTLIER -139.96 64.76 1.44 Allowed 'General case' 0 C--N 1.313 -1.015 0 O-C-N 121.349 -0.844 . . . . 0.0 108.783 -178.203 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.027 HG13 ' HB ' ' A' ' 5' ' ' ILE 0.405 58.1 t -102.29 125.05 56.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 125.728 2.68 . . . . 0.0 108.709 -177.383 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 1.049 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.489 10.2 mt-10 -116.02 129.29 56.3 Favored 'General case' 0 C--O 1.176 -2.802 0 O-C-N 118.655 -2.528 . . . . 0.0 107.81 -173.201 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.764 ' CB ' ' CG2' ' A' ' 7' ' ' VAL 0.642 0.0 OUTLIER -106.83 111.18 23.58 Favored 'General case' 0 C--O 1.274 2.347 2 CA-C-O 107.928 -5.796 . . . . 0.0 121.166 -170.665 . . . . . . . . 5 4 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.016 HD12 ' CG ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -130.11 166.54 27.45 Favored 'Isoleucine or valine' 1 C--N 1.212 -5.405 1 CA-C-N 131.377 6.444 . . . . 0.0 109.713 178.267 . . . . . . . . 5 4 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 1.077 ' CG ' HG12 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -97.82 169.84 9.38 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.776 -1.203 . . . . 0.0 112.279 173.193 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 1.258 ' CD1' HG22 ' A' ' 56' ' ' VAL . 0.7 OUTLIER -74.33 -21.34 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.03 -1.044 . . . . 0.0 111.402 176.834 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.738 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 2.0 ptt? -86.27 -16.62 37.0 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.901 -1.124 . . . . 0.0 112.915 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.077 HG12 ' CG ' ' A' ' 40' ' ' ASP . 14.5 p -112.83 -27.06 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.914 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 1.016 ' CG ' HD12 ' A' ' 39' ' ' ILE . 5.7 t0 -115.14 51.13 0.93 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.184 -0.947 . . . . 0.0 110.6 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.457 2.6 ttt180 -70.31 0.99 5.41 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 115.833 -2.347 . . . . 0.0 109.793 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 1.013 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -53.92 -24.46 16.38 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.545 -1.347 . . . . 0.0 110.798 165.917 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.825 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -47.58 -62.49 1.42 Allowed 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 122.767 1.27 . . . . 0.0 109.023 -174.034 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.125 ' CB ' ' HB2' ' A' ' 55' ' ' ALA 0.425 . . -51.01 -13.66 0.17 Allowed 'General case' 0 C--N 1.268 -2.975 0 C-N-CA 125.105 1.362 . . . . 0.0 113.021 173.55 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.076 HD11 ' NE ' ' A' ' 66' ' ' ARG 0.256 0.2 OUTLIER -32.92 -37.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 O-C-N 117.768 -3.083 . . . . 0.0 103.528 -168.342 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.637 ' N ' ' C ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -55.0 -49.27 71.92 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.581 176.744 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.816 ' CE1' ' HE3' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -124.95 -28.14 3.5 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.979 -1.076 . . . . 0.0 110.397 179.157 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.761 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 41.69 12.08 0.01 OUTLIER Glycine 0 C--O 1.19 -2.617 0 CA-C-O 122.025 0.792 . . . . 0.0 112.416 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 5.6 mt -83.84 -75.02 0.35 Allowed 'General case' 0 C--N 1.247 -3.85 0 N-CA-C 103.971 -2.603 . . . . 0.0 103.971 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.607 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 26.9 mtm -103.23 69.2 1.0 Allowed 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.228 -1.545 . . . . 0.0 107.092 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 1.125 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.579 . . -113.08 117.75 32.86 Favored 'General case' 0 C--O 1.195 -1.78 1 CA-C-O 129.698 4.571 . . . . 0.0 109.073 -175.749 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.258 HG22 ' CD1' ' A' ' 41' ' ' ILE . 1.7 t -152.77 -60.71 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.654 0 CA-C-N 109.02 -3.718 . . . . 0.0 112.242 -175.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.817 ' CD ' HG12 ' A' ' 56' ' ' VAL 0.502 43.5 Cg_endo -119.83 105.87 0.0 OUTLIER 'Trans proline' 0 C--O 1.19 -1.88 0 CA-C-O 129.276 3.782 . . . . 0.0 110.974 172.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 1.067 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -159.59 176.55 11.9 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 110.015 -3.266 . . . . 0.0 111.219 -176.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.279 HG21 ' CD2' ' A' ' 76' ' ' LEU 0.271 1.3 mp -149.55 160.75 4.99 Favored 'Isoleucine or valine' 0 C--O 1.272 2.274 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.743 -177.59 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.961 ' HA ' ' HA ' ' A' ' 66' ' ' ARG 0.699 . . -107.98 152.36 24.58 Favored 'General case' 0 CA--C 1.448 -2.955 2 O-C-N 115.554 -4.466 . . . . 0.0 102.705 -177.209 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.725 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.619 1.5 mt -106.46 91.17 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.441 -3.221 1 CA-C-O 132.436 5.874 . . . . 0.0 101.871 -161.084 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.84 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -45.65 83.91 0.0 OUTLIER 'General case' 0 C--N 1.367 1.335 1 CA-C-N 106.099 -5.046 . . . . 0.0 107.29 177.735 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.725 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.06 -47.03 0.38 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 106.348 -2.701 . . . . 0.0 106.348 -177.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.799 ' O ' HG23 ' A' ' 65' ' ' VAL . 12.1 m -124.64 -60.65 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 O-C-N 121.836 -0.802 . . . . 0.0 111.126 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 64' ' ' VAL . 99.4 t -164.12 -103.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.406 0 O-C-N 120.123 -1.611 . . . . 0.0 113.312 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 1.076 ' NE ' HD11 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -162.01 150.3 14.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.441 -0.787 . . . . 0.0 109.783 -175.002 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 1.067 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -146.06 -179.18 6.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.72 -1.238 . . . . 0.0 110.877 -176.382 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.2 t -85.89 120.89 36.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 116.761 -1.59 . . . . 0.0 110.299 176.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.817 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.24 106.42 0.28 Allowed Glycine 0 N--CA 1.497 2.705 0 CA-C-N 122.316 2.325 . . . . 0.0 110.674 177.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.105 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -90.24 -79.96 0.03 OUTLIER Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 120.81 -1.406 . . . . 0.0 108.787 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 1.105 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 48.3 Cg_endo -88.86 20.63 1.09 Allowed 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 117.312 -1.325 . . . . 0.0 108.969 177.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.61 63.88 1.09 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.017 -1.052 . . . . 0.0 112.227 176.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.727 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -69.81 -35.65 74.99 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.733 177.665 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.862 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -47.13 -44.09 21.32 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.092 0.949 . . . . 0.0 108.76 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.756 ' CD ' ' CE2' ' A' ' 67' ' ' PHE 0.274 0.0 OUTLIER -48.75 -26.02 2.13 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.182 -177.293 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.279 ' CD2' HG21 ' A' ' 59' ' ' ILE . 12.6 mt -72.48 -41.11 66.36 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.831 0.824 . . . . 0.0 109.629 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.812 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.29 -37.6 72.68 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 122.045 0.926 . . . . 0.0 110.287 179.173 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -74.43 -32.16 62.55 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.85 0.833 . . . . 0.0 110.354 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 83' ' ' GLU . . . -73.77 -37.23 65.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.021 -1.049 . . . . 0.0 110.187 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.909 HG21 HG13 ' A' ' 23' ' ' VAL . 1.5 mp -60.33 -41.12 86.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 120.826 -1.172 . . . . 0.0 109.39 176.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -70.29 -32.76 70.69 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.764 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.632 0.1 OUTLIER -102.57 5.23 39.17 Favored 'General case' 0 CA--C 1.487 -1.445 0 C-N-CA 114.455 -2.898 . . . . 0.0 108.762 -176.61 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.777 ' HB2' ' O ' ' A' ' 62' ' ' ASN 0.299 0.2 OUTLIER -87.84 -55.84 3.59 Favored 'General case' 0 N--CA 1.489 1.498 1 O-C-N 115.611 -4.43 . . . . 0.0 107.568 164.472 . . . . . . . . 5 4 . 1 . 007 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.821 ' CE ' ' CE ' ' A' ' 27' ' ' LYS 0.27 0.0 OUTLIER -67.94 -18.37 64.74 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 119.963 1.256 . . . . 0.0 112.209 178.792 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.477 ' CD ' ' C ' ' A' ' 85' ' ' GLU . 3.2 tm-20 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 120.859 -1.151 . . . . 0.0 110.609 177.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.689 ' SD ' ' OE2' ' A' ' 83' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.333 0.587 . . . . 0.0 110.153 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.062 HG21 ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -79.67 -89.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 110.236 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.993 HG11 ' OD2' ' A' ' 24' ' ' ASP . 48.3 t -90.95 111.13 23.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.462 -0.774 . . . . 0.0 110.595 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.819 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 3.9 m-20 -123.85 107.46 11.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.81 -1.181 . . . . 0.0 109.235 177.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.064 ' CG1' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -122.33 137.16 56.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.491 -0.756 . . . . 0.0 110.923 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 1.023 ' O ' HG23 ' A' ' 59' ' ' ILE . 11.0 tt0 -128.4 110.67 12.55 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 118.896 -2.378 . . . . 0.0 108.966 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.986 HG12 ' HB2' ' A' ' 16' ' ' CYS 0.263 20.9 m -101.96 110.14 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -177.719 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.855 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 5.4 t80 -117.98 83.65 2.04 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.05 -176.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.686 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -127.54 -45.92 1.47 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.157 0.503 . . . . 0.0 110.193 179.263 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.768 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 17.6 t 179.64 148.39 0.45 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.175 -0.953 . . . . 0.0 110.637 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.712 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 50.7 Cg_endo -86.16 -26.16 1.2 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.151 1.606 . . . . 0.0 110.704 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -78.79 12.26 2.21 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.12 -0.988 . . . . 0.0 109.985 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.546 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -157.22 -172.2 0.31 Allowed Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.415 -0.803 . . . . 0.0 110.68 178.82 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 13' ' ' CYS . 51.6 Cg_endo -84.53 107.26 1.17 Allowed 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.125 1.592 . . . . 0.0 110.056 176.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.768 ' CE1' ' O ' ' A' ' 10' ' ' SER . 14.8 m-85 -49.45 -83.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.77 -1.206 . . . . 0.0 109.689 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 1.062 ' SG ' HD11 ' A' ' 59' ' ' ILE . 34.6 m -155.86 47.21 0.3 Allowed Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.38 -0.825 . . . . 0.0 109.792 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.767 ' HA ' HD13 ' A' ' 20' ' ' ILE . 47.1 Cg_endo -72.49 24.13 0.28 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 124.077 1.567 . . . . 0.0 111.111 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.429 ' H ' ' C ' ' A' ' 16' ' ' CYS . 6.5 tpt -110.07 -69.74 0.85 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.059 -1.026 . . . . 0.0 110.15 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.791 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -55.12 -19.84 8.55 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.247 -0.908 . . . . 0.0 109.343 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.1 HD12 HG11 ' A' ' 36' ' ' VAL . 13.0 pt -71.49 -40.34 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.405 -0.81 . . . . 0.0 109.15 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.708 ' N ' HG13 ' A' ' 20' ' ' ILE . 13.8 tp10 -53.67 -34.92 60.32 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.07 -42.9 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.441 -0.787 . . . . 0.0 109.017 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.811 ' CG1' ' HB ' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -67.77 -31.77 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.793 0.806 . . . . 0.0 109.515 178.11 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.993 ' OD2' HG11 ' A' ' 3' ' ' VAL . 3.2 t70 -72.53 -38.06 68.15 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 122.077 0.941 . . . . 0.0 108.466 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.478 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -60.42 -45.24 94.32 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.057 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.648 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -78.61 -39.43 37.31 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.591 -0.693 . . . . 0.0 110.853 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.817 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -73.1 -19.81 61.07 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 118.926 -1.11 . . . . 0.0 109.094 -178.717 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.721 ' CD ' ' OD1' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -70.76 -45.52 64.62 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 176.396 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.744 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -46.68 -39.57 11.65 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.975 0.893 . . . . 0.0 109.265 179.358 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.75 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -95.51 -58.2 2.19 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.75 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -94.03 82.43 0.99 Allowed Glycine 0 N--CA 1.499 2.867 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.565 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -37.43 -24.52 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 O-C-N 119.349 -2.265 . . . . 0.0 110.372 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 1.062 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -82.83 151.99 25.82 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.579 -0.7 . . . . 0.0 111.845 177.473 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.801 HD12 ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -129.9 153.75 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.09 -1.631 . . . . 0.0 110.569 177.564 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.569 ' O ' ' O ' ' A' ' 3' ' ' VAL . 9.8 t0 -150.64 76.42 1.25 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.287 -0.883 . . . . 0.0 109.067 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.1 HG11 HD12 ' A' ' 20' ' ' ILE 0.254 51.5 t -94.4 122.47 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 120.697 -1.252 . . . . 0.0 109.014 -178.719 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.814 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.265 4.4 mt-10 -103.8 145.59 29.87 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -177.182 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.811 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -140.29 116.15 10.31 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.629 -174.107 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.745 ' CG2' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -116.56 166.04 11.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 O-C-N 120.575 -1.328 . . . . 0.0 111.269 -178.151 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.779 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -98.19 159.89 14.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.117 -0.989 . . . . 0.0 109.666 178.669 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 1.025 HD11 HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -68.64 -37.44 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.077 -1.014 . . . . 0.0 112.19 -179.266 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.779 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.7 ptm -82.48 -3.81 56.42 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.055 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.771 HG12 ' CG ' ' A' ' 40' ' ' ASP . 13.6 p -112.24 -45.15 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 109.728 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.828 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 4.2 t70 -106.61 50.04 0.78 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.082 -1.011 . . . . 0.0 110.021 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.647 ' HA ' ' CZ ' ' A' ' 8' ' ' PHE 0.286 0.0 OUTLIER -64.01 -3.13 2.34 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 118.571 -1.252 . . . . 0.0 109.442 -177.929 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.953 ' O ' HG23 ' A' ' 49' ' ' ILE . 10.9 pt-20 -52.04 -20.87 2.68 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.491 -0.755 . . . . 0.0 110.088 175.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.907 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -50.36 -58.9 4.66 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.453 -1.405 . . . . 0.0 109.772 -178.496 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.083 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -61.42 -5.7 1.87 Allowed 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.837 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.953 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -32.44 -39.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 -175.687 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.832 ' OE1' ' O ' ' A' ' 47' ' ' LYS . 51.4 mp0 -51.34 -53.07 39.78 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.056 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 1.2 ' OH ' HG22 ' A' ' 68' ' ' VAL . 2.4 p90 -124.5 -29.67 3.46 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.884 -1.135 . . . . 0.0 110.26 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.726 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 41.49 11.27 0.01 OUTLIER Glycine 0 N--CA 1.498 2.812 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.681 ' N ' ' O ' ' A' ' 51' ' ' TYR . 8.6 mt -81.13 -71.53 0.47 Allowed 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.52 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -102.4 59.3 0.81 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 -178.258 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 1.083 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.302 . . -103.67 116.2 31.9 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.24 -1.538 . . . . 0.0 109.905 -175.685 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.025 HG22 HD11 ' A' ' 41' ' ' ILE . 2.1 t -147.1 -66.93 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.472 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.846 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 53.1 Cg_endo -105.67 114.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.176 0 N-CA-C 109.586 -0.967 . . . . 0.0 109.586 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 1.057 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -161.28 175.57 12.14 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.296 1.046 . . . . 0.0 111.521 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.272 HG21 ' CD1' ' A' ' 76' ' ' LEU 0.253 1.1 mp -141.67 144.67 25.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 108.995 179.383 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 1.027 ' HB2' ' HD3' ' A' ' 66' ' ' ARG 0.289 . . -84.93 147.51 26.7 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 -177.842 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.712 HG23 ' HB2' ' A' ' 79' ' ' ALA 0.39 0.7 OUTLIER -95.42 88.44 2.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 115.315 -2.554 . . . . 0.0 105.233 -175.126 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.819 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.2 OUTLIER -45.77 82.71 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 O-C-N 126.009 2.068 . . . . 0.0 109.094 177.7 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.819 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 161.99 -43.56 0.37 Allowed Glycine 0 C--N 1.288 -2.088 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.778 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.2 m -126.83 -59.37 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.882 -0.775 . . . . 0.0 111.052 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.778 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 59.8 t -164.04 -104.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 120.393 -1.442 . . . . 0.0 112.194 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 1.027 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 1.9 ttp180 -164.44 164.16 22.05 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 1.057 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -146.05 177.68 8.78 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.925 -1.11 . . . . 0.0 111.118 -177.306 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.2 HG22 ' OH ' ' A' ' 51' ' ' TYR . 96.5 t -88.86 114.39 27.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.686 -0.634 . . . . 0.0 109.978 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.856 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.66 128.72 1.92 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 118.63 -1.748 . . . . 0.0 110.168 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.083 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -93.82 -82.72 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 121.098 -1.236 . . . . 0.0 108.032 177.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 1.083 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 52.8 Cg_endo -83.24 23.19 0.84 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 N-CA-C 108.541 -1.369 . . . . 0.0 108.541 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.553 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -99.59 61.45 1.17 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.445 -0.784 . . . . 0.0 111.334 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.749 ' CB ' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -70.64 -26.75 63.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 0.0 109.926 178.28 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.604 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.6 tm-20 -50.56 -42.43 55.39 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.249 -0.907 . . . . 0.0 109.32 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.768 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -44.54 -34.81 2.25 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.371 -0.932 . . . . 0.0 108.819 179.735 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.272 ' CD1' HG21 ' A' ' 59' ' ' ILE . 7.4 mp -64.12 -42.76 96.71 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.809 ' HA ' ' CG1' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.74 -34.15 69.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 109.404 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.778 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -82.38 -30.57 30.17 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.481 -0.762 . . . . 0.0 110.405 178.761 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.712 ' HB2' HG23 ' A' ' 61' ' ' ILE . . . -73.37 -33.1 64.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.424 -0.798 . . . . 0.0 109.907 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.816 HG22 ' HD3' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -67.46 -42.37 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 0.0 108.756 178.451 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.43 -23.63 66.32 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.557 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.544 0.0 OUTLIER -100.94 -12.37 18.99 Favored 'General case' 0 C--O 1.198 -1.656 0 C-N-CA 115.357 -2.537 . . . . 0.0 108.838 -177.246 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.819 ' HB2' ' CA ' ' A' ' 63' ' ' GLY 0.251 0.0 OUTLIER -75.35 -54.04 7.73 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 119.517 -1.989 . . . . 0.0 108.454 165.215 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.724 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -79.14 -22.03 45.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.004 -1.06 . . . . 0.0 110.417 179.284 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 2.1 tp10 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.166 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.769 ' SD ' ' OE2' ' A' ' 83' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 121.925 0.869 . . . . 0.0 110.721 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.011 HG21 ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -79.89 -91.6 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 120.794 -1.191 . . . . 0.0 109.95 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.956 HG11 ' OD2' ' A' ' 24' ' ' ASP . 42.8 t -90.07 111.59 23.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.521 -0.737 . . . . 0.0 110.174 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.762 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 3.5 m-20 -124.1 107.43 11.26 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.786 -1.166 . . . . 0.0 108.679 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.054 ' CG1' HG22 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -123.09 139.55 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 122.059 -0.401 . . . . 0.0 110.58 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 1.191 ' O ' HG23 ' A' ' 59' ' ' ILE . 12.8 tt0 -131.05 121.73 25.53 Favored 'General case' 0 C--N 1.284 -2.241 0 O-C-N 119.163 -2.21 . . . . 0.0 105.844 177.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.913 HG12 ' HB2' ' A' ' 16' ' ' CYS . 26.8 m -113.07 106.23 20.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -176.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.906 ' CE1' ' HA ' ' A' ' 41' ' ' ILE 0.257 6.8 t80 -115.55 89.17 3.04 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.881 -178.624 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.638 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -131.24 -46.04 1.0 Allowed 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.21 -0.931 . . . . 0.0 109.739 178.765 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.736 ' HA ' HG22 ' A' ' 41' ' ' ILE . 17.6 t 179.08 147.05 0.39 Allowed Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.451 -0.781 . . . . 0.0 110.924 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.721 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 50.7 Cg_endo -85.44 -26.24 1.41 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 124.317 1.693 . . . . 0.0 110.868 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -77.25 6.41 6.75 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.203 -0.935 . . . . 0.0 110.01 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.512 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -152.2 -171.59 0.28 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.413 -0.804 . . . . 0.0 110.487 179.041 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 13' ' ' CYS . 47.0 Cg_endo -84.93 107.51 1.1 Allowed 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.419 1.413 . . . . 0.0 109.137 177.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.688 ' CE1' ' O ' ' A' ' 10' ' ' SER . 17.1 m-85 -49.85 -82.7 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.584 -0.697 . . . . 0.0 109.14 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 1.049 ' SG ' HD11 ' A' ' 59' ' ' ILE . 35.4 m -155.61 46.65 0.28 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.314 -0.866 . . . . 0.0 109.544 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.749 ' HA ' HD13 ' A' ' 20' ' ' ILE . 48.9 Cg_endo -72.34 24.36 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.973 1.512 . . . . 0.0 111.335 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.416 ' H ' ' C ' ' A' ' 16' ' ' CYS . 6.8 tpt -110.44 -69.09 0.89 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.155 -0.966 . . . . 0.0 110.489 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.766 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -55.98 -19.51 12.77 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.047 -1.033 . . . . 0.0 109.662 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.093 HD12 HG11 ' A' ' 36' ' ' VAL . 13.1 pt -70.72 -40.14 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.682 ' N ' HG13 ' A' ' 20' ' ' ILE . 13.8 tp10 -54.53 -35.87 63.66 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.0 t -68.17 -45.28 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.801 ' CG1' ' HA ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -65.68 -35.53 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.732 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.956 ' OD2' HG11 ' A' ' 3' ' ' VAL . 2.4 t70 -67.95 -40.46 83.26 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.717 0.77 . . . . 0.0 109.124 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.479 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.6 OUTLIER -58.42 -46.95 85.45 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.371 0.605 . . . . 0.0 110.371 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.623 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.17 -38.68 51.26 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.935 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.802 ' HD3' HG22 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -74.82 -16.92 60.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.834 -1.166 . . . . 0.0 109.924 -179.005 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.632 ' CD ' ' OD1' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -73.31 -45.33 56.07 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 176.659 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.673 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -46.51 -37.06 7.37 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 122.057 0.932 . . . . 0.0 110.051 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.783 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -97.28 -68.09 0.82 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.783 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -84.35 88.97 1.56 Allowed Glycine 0 CA--C 1.544 1.86 0 C-N-CA 118.234 -1.936 . . . . 0.0 110.165 176.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.527 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -40.41 -27.7 0.05 Allowed 'General case' 0 N--CA 1.515 2.78 0 O-C-N 118.573 -2.722 . . . . 0.0 110.58 176.259 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 1.011 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -80.92 151.65 28.46 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.78 -0.575 . . . . 0.0 111.175 179.105 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.763 HD12 ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -130.2 154.8 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.79 -1.194 . . . . 0.0 110.064 179.128 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.619 ' O ' ' O ' ' A' ' 3' ' ' VAL . 14.2 t0 -151.74 80.8 1.28 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.093 HG11 HD12 ' A' ' 20' ' ' ILE . 46.5 t -97.44 129.42 47.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.78 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 5.0 mt-10 -108.86 146.02 34.38 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.772 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -142.38 112.24 6.87 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.457 1.122 . . . . 0.0 112.949 -175.231 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.72 ' CG2' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -112.21 164.31 8.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 112.218 -179.652 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.744 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -96.4 162.13 13.62 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.27 -0.894 . . . . 0.0 109.517 179.16 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 1.003 HD11 HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -70.34 -39.49 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.116 -0.99 . . . . 0.0 111.73 -179.452 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.744 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.6 ptm -80.94 -2.6 48.36 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.929 -1.107 . . . . 0.0 110.972 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.73 HG12 ' CG ' ' A' ' 40' ' ' ASP . 14.9 p -113.23 -44.57 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.072 -1.018 . . . . 0.0 109.948 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.808 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 4.8 t70 -107.38 52.03 0.73 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.454 -0.779 . . . . 0.0 109.083 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.574 ' HA ' ' CZ ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -64.33 -1.98 1.96 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 119.797 -1.814 . . . . 0.0 110.34 -179.135 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.912 ' O ' HG23 ' A' ' 49' ' ' ILE . 10.6 pt-20 -56.16 -21.55 23.48 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.864 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -46.88 -64.3 0.81 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 119.909 -1.744 . . . . 0.0 108.708 179.395 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.052 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -61.63 -6.01 2.25 Favored 'General case' 0 C--O 1.196 -1.72 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.864 -178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.912 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.7 OUTLIER -25.92 -41.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 119.715 -1.866 . . . . 0.0 106.874 176.721 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.862 ' OE1' ' O ' ' A' ' 47' ' ' LYS . 52.7 mp0 -52.57 -52.45 55.02 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.136 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 1.119 ' OH ' HG22 ' A' ' 68' ' ' VAL . 3.0 p90 -123.81 -32.01 3.35 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.298 -0.876 . . . . 0.0 110.398 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.668 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 45.44 4.32 0.01 OUTLIER Glycine 1 N--CA 1.519 4.172 0 O-C-N 121.37 -0.832 . . . . 0.0 111.786 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.677 ' H ' ' C ' ' A' ' 51' ' ' TYR . 9.5 mt -75.24 -81.12 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 175.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.63 ' O ' ' HE2' ' A' ' 51' ' ' TYR 0.271 0.3 OUTLIER -93.64 66.65 3.82 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.3 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 1.052 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.275 . . -107.46 117.26 33.64 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 119.97 -1.707 . . . . 0.0 110.162 -178.483 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.003 HG22 HD11 ' A' ' 41' ' ' ILE . 2.1 t -148.89 -63.31 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.055 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.79 ' HD3' ' HB ' ' A' ' 56' ' ' VAL . 59.3 Cg_endo -109.12 117.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.186 0 N-CA-C 109.654 -0.941 . . . . 0.0 109.654 176.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.956 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -163.22 178.46 8.19 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.554 1.169 . . . . 0.0 111.625 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.203 HG21 ' CD1' ' A' ' 76' ' ' LEU 0.258 1.1 mp -142.08 152.7 18.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 1.032 ' HB2' ' HD3' ' A' ' 66' ' ' ARG 0.263 . . -91.37 156.92 17.41 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.796 HG23 ' HB2' ' A' ' 79' ' ' ALA . 0.6 OUTLIER -102.38 91.83 2.12 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.449 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 -175.81 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.762 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -56.49 85.61 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -176.605 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.793 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 161.3 -42.83 0.4 Allowed Glycine 0 C--N 1.29 -1.986 0 N-CA-C 108.063 -2.015 . . . . 0.0 108.063 -177.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.699 ' C ' HG23 ' A' ' 65' ' ' VAL . 17.7 m -126.69 -60.82 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.793 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.699 HG23 ' C ' ' A' ' 64' ' ' VAL . 59.8 t -163.61 -99.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 120.758 -1.214 . . . . 0.0 112.565 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 1.032 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 2.0 ttp180 -169.03 162.97 11.23 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.956 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -147.09 173.12 12.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.359 -0.838 . . . . 0.0 111.676 -177.264 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.119 HG22 ' OH ' ' A' ' 51' ' ' TYR . 66.2 t -84.52 114.76 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.507 -0.746 . . . . 0.0 110.857 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.851 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.87 129.25 2.0 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 118.833 -1.651 . . . . 0.0 110.65 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.029 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -94.91 -81.41 0.02 OUTLIER Pre-proline 0 C--N 1.298 -1.641 0 O-C-N 121.177 -1.19 . . . . 0.0 107.946 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 1.029 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 56.7 Cg_endo -84.64 25.28 0.7 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 N-CA-C 108.831 -1.257 . . . . 0.0 108.831 176.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.544 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -101.53 59.65 0.88 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.426 0.632 . . . . 0.0 110.697 -179.209 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.698 ' HA ' HD13 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -69.3 -29.45 67.3 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.046 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.588 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.8 tm-20 -47.26 -42.55 20.8 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.197 -0.94 . . . . 0.0 110.471 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.726 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -45.44 -33.67 2.75 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.287 179.442 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.203 ' CD1' HG21 ' A' ' 59' ' ' ILE . 7.4 mp -64.7 -43.54 93.14 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.801 ' HA ' ' CG1' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -56.1 -35.84 67.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.275 -0.891 . . . . 0.0 109.526 179.216 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.737 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -81.39 -33.17 32.43 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.103 0.478 . . . . 0.0 110.062 179.515 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.796 ' HB2' HG23 ' A' ' 61' ' ' ILE . . . -69.91 -34.34 73.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.386 -0.821 . . . . 0.0 111.178 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.802 HG22 ' HD3' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -68.12 -42.86 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.585 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -64.51 -18.16 64.55 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 175.798 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.534 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.347 0.0 OUTLIER -104.59 -5.48 21.42 Favored 'General case' 0 CA--C 1.477 -1.847 0 CA-C-O 124.702 2.192 . . . . 0.0 109.224 -179.433 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.793 ' HB2' ' CA ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -87.33 -55.55 3.76 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 101.846 -3.39 . . . . 0.0 101.846 176.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.679 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -78.47 -21.77 48.55 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.243 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 2.1 tp10 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.026 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.512 ' SD ' ' OD1' ' A' ' 4' ' ' ASN . 8.6 ttp . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.599 0.714 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.93 HG22 ' N ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -80.38 -95.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.582 0.706 . . . . 0.0 110.291 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.93 ' N ' HG22 ' A' ' 2' ' ' VAL . 53.0 t -90.12 114.9 28.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.416 -0.803 . . . . 0.0 109.397 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.814 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.257 2.8 t-20 -138.28 105.83 5.57 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 117.984 -1.486 . . . . 0.0 107.919 178.428 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.865 ' CG1' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -121.35 139.55 48.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.235 -179.021 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 1.095 ' O ' HD21 ' A' ' 76' ' ' LEU . 6.8 tt0 -132.35 123.17 26.28 Favored 'General case' 0 C--N 1.285 -2.229 0 C-N-CA 116.438 -2.105 . . . . 0.0 105.911 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.064 HG12 ' CD1' ' A' ' 76' ' ' LEU . 3.0 m -113.21 104.18 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.944 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 4.8 t80 -113.5 96.26 5.79 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.28 -177.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.748 ' O ' ' O ' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -126.37 -69.02 0.79 Allowed 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.167 -0.958 . . . . 0.0 108.673 178.18 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.661 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 3.8 p 179.53 152.9 0.57 Allowed Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.273 -0.892 . . . . 0.0 110.793 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.619 ' HA ' ' OH ' ' A' ' 15' ' ' TYR . 50.8 Cg_endo -76.2 -27.33 8.23 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 124.437 1.756 . . . . 0.0 110.175 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.2 m -78.95 -17.0 56.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.678 -0.639 . . . . 0.0 109.949 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.415 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -124.55 179.94 0.99 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.885 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.628 ' O ' ' O ' ' A' ' 15' ' ' TYR . 51.3 Cg_endo -83.31 109.11 1.59 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 124.012 1.532 . . . . 0.0 109.817 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.661 ' CE1' ' O ' ' A' ' 10' ' ' SER . 4.7 m-85 -50.48 -117.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.938 ' CB ' HD11 ' A' ' 59' ' ' ILE . 18.7 m -155.16 40.32 0.13 Allowed Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.833 -1.167 . . . . 0.0 109.896 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.3 Cg_endo -75.76 30.3 0.38 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 O-C-N 123.653 1.344 . . . . 0.0 111.261 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.465 ' HG2' ' HG3' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -109.98 -59.49 1.92 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.969 -1.082 . . . . 0.0 110.713 -179.296 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.86 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -56.19 -19.71 14.82 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.36 -0.838 . . . . 0.0 110.397 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.92 HD12 ' C ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -73.36 -39.93 55.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.486 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.615 ' N ' HD12 ' A' ' 20' ' ' ILE . 14.1 tt0 -53.73 -35.08 60.82 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -68.89 -50.89 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.917 ' CG1' HG21 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -61.66 -33.55 57.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.349 178.567 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.773 ' OD2' HG11 ' A' ' 3' ' ' VAL . 8.4 t0 -66.4 -41.05 89.86 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.726 0.774 . . . . 0.0 109.071 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.482 ' OE1' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -56.88 -48.39 78.28 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.626 0.726 . . . . 0.0 109.317 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.487 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.55 -39.09 47.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.842 -0.536 . . . . 0.0 110.439 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.773 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -72.01 -16.65 62.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.993 -1.067 . . . . 0.0 109.877 -178.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.624 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -73.56 -44.2 58.02 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.608 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.684 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -49.71 -34.23 18.23 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.909 0.861 . . . . 0.0 110.206 179.578 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.739 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -94.89 -69.06 0.77 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.739 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -83.82 84.86 1.55 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 118.788 -1.672 . . . . 0.0 110.101 177.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.579 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -36.69 -32.07 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.655 0 O-C-N 118.768 -2.607 . . . . 0.0 110.65 177.55 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.887 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -78.51 151.4 32.57 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.492 178.405 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.776 HD12 ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -129.76 156.05 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.646 -1.283 . . . . 0.0 110.264 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.714 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 25.7 t0 -151.7 80.07 1.28 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.978 HG12 ' NZ ' ' A' ' 38' ' ' LYS . 47.4 t -98.34 129.78 48.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.868 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 11.8 mm-40 -112.4 140.54 47.04 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.978 ' NZ ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -141.82 112.29 7.09 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -175.063 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.935 HD13 ' HB2' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -130.39 163.26 36.54 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 CA-C-O 121.77 0.795 . . . . 0.0 112.496 -179.103 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.645 ' OD1' ' N ' ' A' ' 43' ' ' VAL . 9.6 p-10 -98.69 178.82 4.87 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.277 -0.89 . . . . 0.0 111.379 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 1.037 HD12 HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -69.28 -15.63 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.21 -0.931 . . . . 0.0 109.86 177.765 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.601 ' HG2' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -89.73 -14.61 34.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.814 -1.179 . . . . 0.0 111.981 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.8 HG11 HG22 ' A' ' 39' ' ' ILE . 8.9 p -113.95 -40.43 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.929 -1.107 . . . . 0.0 110.687 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.784 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 3.8 t70 -111.64 48.83 0.93 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.162 -0.961 . . . . 0.0 108.989 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.561 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 29.9 ttt180 -64.95 -1.08 1.81 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.08 -1.638 . . . . 0.0 109.814 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 1.071 ' O ' HG23 ' A' ' 49' ' ' ILE . 25.8 mm-40 -60.48 -22.98 64.13 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.244 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.856 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 1.1 tptt -45.85 -65.35 0.56 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.274 -1.516 . . . . 0.0 109.147 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.059 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -58.14 -11.18 2.36 Favored 'General case' 0 C--O 1.189 -2.083 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.264 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.108 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.7 pp -23.99 -40.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 119.933 -1.729 . . . . 0.0 107.262 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 1.108 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.9 OUTLIER -56.02 -50.78 69.94 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 115.316 -0.857 . . . . 0.0 108.995 178.572 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.872 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 3.1 p90 -122.35 -34.24 3.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.729 -0.607 . . . . 0.0 110.292 178.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.724 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 47.64 3.13 0.01 OUTLIER Glycine 0 N--CA 1.514 3.837 0 O-C-N 121.192 -0.943 . . . . 0.0 111.291 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.673 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 4.1 mt -75.45 -80.49 0.09 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.712 ' O ' ' HE2' ' A' ' 51' ' ' TYR 0.255 26.3 mtp -92.02 67.49 5.14 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.863 177.397 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 1.059 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.27 . . -108.9 110.7 22.09 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 120.448 -1.407 . . . . 0.0 109.048 -177.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.037 HG22 HD12 ' A' ' 41' ' ' ILE . 1.0 OUTLIER -149.42 -54.52 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.877 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.942 -179.146 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.796 ' HB2' ' CA ' ' A' ' 70' ' ' ALA . 59.2 Cg_endo -110.91 106.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.169 1.089 . . . . 0.0 110.212 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.912 ' HB3' ' CD2' ' A' ' 8' ' ' PHE . . . -161.62 179.77 7.91 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.623 -1.626 . . . . 0.0 112.181 -176.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.938 HD11 ' CB ' ' A' ' 16' ' ' CYS 0.264 0.3 OUTLIER -143.87 153.63 15.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 -179.808 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.92 ' HB3' ' CB ' ' A' ' 6' ' ' GLU 0.256 . . -92.16 153.78 19.11 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 101.82 -3.4 . . . . 0.0 101.82 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.62 HG23 ' CB ' ' A' ' 79' ' ' ALA 0.274 2.1 mt -102.66 93.6 2.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 -175.726 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.814 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.5 OUTLIER -55.6 84.76 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 113.12 -1.855 . . . . 0.0 107.145 -178.082 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.7 ' HA3' ' CB ' ' A' ' 83' ' ' GLU . . . 162.22 -45.8 0.36 Allowed Glycine 0 C--N 1.289 -2.038 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.796 ' O ' HG23 ' A' ' 65' ' ' VAL . 4.6 m -123.33 -61.13 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.447 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.8 HG12 ' N ' ' A' ' 66' ' ' ARG . 73.7 t -165.17 -101.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 O-C-N 120.909 -1.119 . . . . 0.0 112.235 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.901 ' HG3' ' O ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -156.01 166.24 34.05 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.539 -0.725 . . . . 0.0 109.747 -178.935 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.866 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -149.26 165.19 32.65 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.34 -0.85 . . . . 0.0 111.17 -178.752 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.652 HG22 ' OH ' ' A' ' 51' ' ' TYR . 94.5 t -81.07 121.09 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.354 -0.841 . . . . 0.0 110.203 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.825 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -164.03 114.18 0.59 Allowed Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.182 -1.485 . . . . 0.0 110.549 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.034 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -91.65 -82.79 0.02 OUTLIER Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 121.578 -0.954 . . . . 0.0 109.034 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 1.034 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 57.0 Cg_endo -84.42 26.52 0.65 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 N-CA-C 107.982 -1.584 . . . . 0.0 107.982 176.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.671 ' CB ' ' OE2' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -112.26 83.42 1.8 Allowed 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.657 ' C ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -82.37 -44.04 16.64 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.701 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.86 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -40.05 -30.91 0.1 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.158 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.751 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -49.7 -46.21 49.82 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.296 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.095 HD21 ' O ' ' A' ' 6' ' ' GLU . 27.3 mt -58.15 -43.54 87.4 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.785 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.27 -37.25 74.6 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.09 0.947 . . . . 0.0 109.857 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.788 ' O ' ' ND2' ' A' ' 81' ' ' ASN . 3.2 tt0 -78.28 -30.94 48.76 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.348 -0.845 . . . . 0.0 110.298 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.62 ' CB ' HG23 ' A' ' 61' ' ' ILE . . . -70.15 -38.56 75.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.124 -0.985 . . . . 0.0 111.249 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.917 HG21 ' CG1' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.59 -42.59 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.327 -0.858 . . . . 0.0 108.726 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.788 ' ND2' ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -68.46 -22.51 64.57 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.22 177.225 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.615 ' O ' ' OD1' ' A' ' 82' ' ' ASP 0.312 0.0 OUTLIER -102.1 2.42 37.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 118.232 -2.793 . . . . 0.0 107.114 -177.549 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.7 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -94.14 -59.72 1.9 Allowed 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 103.321 -2.844 . . . . 0.0 103.321 176.689 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.597 ' SD ' ' HD2' ' A' ' 27' ' ' LYS . 3.3 ptt? -72.05 -17.96 61.98 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.601 177.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.587 ' OXT' ' HA ' ' A' ' 82' ' ' ASP . 3.2 mm-40 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.171 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.697 ' SD ' ' OE2' ' A' ' 83' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.272 0.558 . . . . 0.0 110.184 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.056 HG21 ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -79.95 -90.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.359 -0.838 . . . . 0.0 109.848 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.99 HG11 ' OD2' ' A' ' 24' ' ' ASP . 48.6 t -89.6 110.89 22.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.446 -0.783 . . . . 0.0 111.124 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.846 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 3.9 m-20 -124.02 107.11 10.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.621 -1.3 . . . . 0.0 109.085 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.076 ' CG1' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -121.14 138.22 52.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 O-C-N 121.711 -0.618 . . . . 0.0 111.758 178.865 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 1.201 ' O ' HG23 ' A' ' 59' ' ' ILE . 12.4 tt0 -130.64 119.78 22.96 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 115.614 -2.434 . . . . 0.0 106.079 177.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.979 HG12 ' HB2' ' A' ' 16' ' ' CYS . 19.5 m -111.48 107.33 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -176.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.871 ' CE1' ' O ' ' A' ' 44' ' ' ASP . 6.3 t80 -116.74 87.28 2.66 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.958 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.673 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -130.14 -46.22 1.12 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.859 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.765 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 17.5 t 179.59 148.33 0.45 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.226 -0.921 . . . . 0.0 110.666 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.711 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 50.5 Cg_endo -86.16 -26.31 1.16 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.103 1.581 . . . . 0.0 110.649 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -78.06 8.34 4.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.12 -0.987 . . . . 0.0 109.9 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.55 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -152.38 -171.29 0.27 Allowed Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.62 178.806 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.55 ' HD2' ' HB3' ' A' ' 13' ' ' CYS . 45.2 Cg_endo -85.05 107.12 1.05 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.742 1.391 . . . . 0.0 109.579 176.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.765 ' CE1' ' O ' ' A' ' 10' ' ' SER . 14.8 m-85 -49.39 -82.79 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.053 -1.029 . . . . 0.0 109.753 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 1.06 ' SG ' HD11 ' A' ' 59' ' ' ILE . 34.8 m -156.08 47.25 0.3 Allowed Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.36 -0.838 . . . . 0.0 109.724 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.767 ' HA ' HD13 ' A' ' 20' ' ' ILE . 47.4 Cg_endo -72.62 24.17 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.031 1.543 . . . . 0.0 111.075 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.427 ' H ' ' C ' ' A' ' 16' ' ' CYS . 6.5 tpt -110.16 -69.66 0.85 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.126 -0.983 . . . . 0.0 110.247 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.792 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -55.02 -20.08 8.43 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.12 -0.988 . . . . 0.0 109.291 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.086 HD12 HG11 ' A' ' 36' ' ' VAL . 12.8 pt -71.28 -40.26 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.0 109.141 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.707 ' N ' HG13 ' A' ' 20' ' ' ILE . 13.8 tp10 -53.79 -35.51 61.44 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.1 t -68.89 -44.73 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.789 0.804 . . . . 0.0 108.872 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.823 ' CG1' ' HB ' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -65.84 -34.48 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 121.681 0.753 . . . . 0.0 109.435 178.29 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.99 ' OD2' HG11 ' A' ' 3' ' ' VAL . 2.6 t70 -69.55 -38.82 77.61 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.993 0.901 . . . . 0.0 109.57 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.474 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -59.79 -46.3 89.62 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.536 0.684 . . . . 0.0 110.044 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.655 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.74 -39.14 45.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.522 -0.736 . . . . 0.0 111.077 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.815 ' HD3' HG22 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -73.8 -18.04 61.01 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 118.886 -1.126 . . . . 0.0 109.373 -178.904 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.722 ' CD ' ' OD1' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -72.5 -45.14 60.84 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 176.775 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.732 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -47.25 -37.16 10.06 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.676 0.75 . . . . 0.0 109.816 179.304 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.817 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -96.99 -65.56 0.96 Allowed 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.414 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.817 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -85.18 84.71 1.59 Allowed Glycine 0 N--CA 1.511 3.66 0 C-N-CA 118.493 -1.813 . . . . 0.0 111.167 176.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.587 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -38.13 -26.73 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.397 0 CA-C-N 121.653 2.727 . . . . 0.0 110.813 177.625 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 1.056 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -80.09 151.41 29.87 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.514 -0.741 . . . . 0.0 112.459 177.676 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.816 HD12 ' O ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -130.24 154.02 39.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 120.242 -1.536 . . . . 0.0 109.829 178.47 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.629 ' O ' ' O ' ' A' ' 3' ' ' VAL . 10.4 t0 -151.26 79.18 1.29 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.086 HG11 HD12 ' A' ' 20' ' ' ILE 0.254 44.5 t -96.96 127.26 49.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -178.723 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.861 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 4.8 mt-10 -108.47 144.58 35.9 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -177.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.807 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.9 112.42 7.85 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -174.855 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.751 ' CG2' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -112.25 165.5 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.288 -0.965 . . . . 0.0 112.241 -178.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.782 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -97.26 161.38 13.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.134 -0.979 . . . . 0.0 109.739 178.827 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 1.014 HD11 HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -70.08 -38.2 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 111.735 -179.004 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.782 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.4 ptm -80.79 -4.26 53.95 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.251 -0.979 . . . . 0.0 111.245 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.77 HG12 ' CG ' ' A' ' 40' ' ' ASP . 14.1 p -112.34 -44.8 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.139 -0.976 . . . . 0.0 110.138 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.871 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 4.2 t70 -106.91 52.91 0.7 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.068 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.624 ' HA ' ' CZ ' ' A' ' 8' ' ' PHE 0.268 0.0 OUTLIER -66.36 -0.37 2.61 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.56 -1.256 . . . . 0.0 109.557 -178.548 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.982 ' O ' HG23 ' A' ' 49' ' ' ILE . 10.4 pt-20 -55.56 -21.45 17.19 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 177.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.921 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -47.43 -63.62 1.0 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 123.711 1.72 . . . . 0.0 109.057 -178.319 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.134 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -57.75 -10.35 1.61 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.149 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.982 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -26.3 -41.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 O-C-N 119.57 -1.956 . . . . 0.0 107.1 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.896 ' OE1' ' O ' ' A' ' 47' ' ' LYS . 51.3 mp0 -51.95 -53.02 46.16 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.063 176.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 1.19 ' OH ' HG22 ' A' ' 68' ' ' VAL . 2.7 p90 -124.18 -30.0 3.51 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.224 -0.923 . . . . 0.0 110.152 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.744 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 43.31 5.73 0.01 OUTLIER Glycine 0 N--CA 1.506 3.309 0 CA-C-O 122.3 0.944 . . . . 0.0 111.576 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.722 ' N ' ' O ' ' A' ' 51' ' ' TYR . 9.3 mt -75.92 -77.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 175.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.619 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -96.11 64.38 2.34 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.116 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 1.134 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.295 . . -108.04 117.85 35.21 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 117.838 -1.545 . . . . 0.0 109.436 -177.14 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.014 HG22 HD11 ' A' ' 41' ' ' ILE . 2.1 t -148.64 -63.23 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.785 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.546 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.832 ' HD3' ' HB ' ' A' ' 56' ' ' VAL 0.252 56.5 Cg_endo -110.67 116.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 N-CA-C 108.593 -1.349 . . . . 0.0 108.593 177.145 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 1.007 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -161.96 176.28 10.95 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.88 -177.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.268 HG21 ' CD1' ' A' ' 76' ' ' LEU 0.25 1.1 mp -140.76 150.03 20.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.012 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 1.065 ' HB2' ' HD3' ' A' ' 66' ' ' ARG 0.308 . . -89.53 155.58 19.19 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 -178.177 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.799 HG23 ' HB2' ' A' ' 79' ' ' ALA 0.328 0.6 OUTLIER -101.94 93.16 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.918 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 -175.953 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.846 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -52.82 83.29 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 112.814 -1.994 . . . . 0.0 106.407 -178.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.834 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 162.47 -42.79 0.36 Allowed Glycine 0 C--N 1.293 -1.844 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.785 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.5 m -127.41 -59.3 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.808 -0.819 . . . . 0.0 111.035 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.785 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 58.7 t -164.32 -101.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 O-C-N 120.286 -1.509 . . . . 0.0 112.553 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 1.065 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 2.0 ttp180 -166.91 163.73 16.17 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 1.007 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -147.01 175.17 10.89 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.013 -1.054 . . . . 0.0 111.218 -177.188 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.19 HG22 ' OH ' ' A' ' 51' ' ' TYR . 70.3 t -85.58 113.88 24.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.11 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.854 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.08 129.95 2.19 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.063 -2.018 . . . . 0.0 109.903 177.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.101 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -94.84 -81.98 0.02 OUTLIER Pre-proline 0 C--N 1.294 -1.842 0 O-C-N 121.121 -1.223 . . . . 0.0 107.931 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 1.101 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 54.6 Cg_endo -84.34 24.53 0.75 Allowed 'Trans proline' 0 C--N 1.302 -1.904 0 N-CA-C 108.475 -1.394 . . . . 0.0 108.475 177.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.555 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -100.7 59.93 0.96 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.488 -0.757 . . . . 0.0 111.219 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.753 ' CB ' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -68.87 -29.32 67.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.38 -0.825 . . . . 0.0 109.898 178.477 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.599 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.8 tm-20 -47.71 -43.5 26.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 109.932 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.769 ' CD ' ' CD2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -44.38 -34.69 2.09 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.845 179.691 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.268 ' CD1' HG21 ' A' ' 59' ' ' ILE . 7.4 mp -64.22 -42.96 96.35 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.816 ' HA ' ' CG1' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.01 -35.31 69.09 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.901 0.858 . . . . 0.0 109.356 179.662 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.783 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -80.93 -32.87 34.45 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.498 -0.752 . . . . 0.0 110.38 178.927 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.799 ' HB2' HG23 ' A' ' 61' ' ' ILE . . . -70.95 -34.26 71.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.357 -0.839 . . . . 0.0 110.695 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.823 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -66.55 -43.33 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 122.179 0.99 . . . . 0.0 108.79 178.784 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -65.97 -19.51 65.89 Favored 'General case' 0 C--O 1.196 -1.759 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.042 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.62 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.421 0.0 OUTLIER -104.33 -5.74 21.49 Favored 'General case' 0 C--O 1.251 1.157 0 C-N-CA 116.525 -2.07 . . . . 0.0 105.898 -177.789 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.834 ' HB2' ' CA ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -85.69 -53.82 4.91 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 172.935 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.734 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -79.12 -21.28 46.81 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.372 -1.455 . . . . 0.0 110.567 -179.57 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 2.1 tp10 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.148 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.487 ' SD ' ' OD1' ' A' ' 4' ' ' ASN . 8.0 ttp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.303 0.573 . . . . 0.0 110.249 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.971 HG22 ' N ' ' A' ' 3' ' ' VAL . 0.9 OUTLIER -81.09 -92.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 0.0 110.412 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.971 ' N ' HG22 ' A' ' 2' ' ' VAL . 55.4 t -92.2 108.83 20.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.703 -0.623 . . . . 0.0 110.644 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.81 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 2.4 t-20 -129.11 106.83 9.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.045 -1.034 . . . . 0.0 109.278 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.888 HG21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.22 138.17 54.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 O-C-N 121.785 -0.572 . . . . 0.0 110.44 178.669 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 1.082 ' CB ' ' HB3' ' A' ' 60' ' ' ALA . 5.3 tt0 -129.1 107.58 9.7 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 117.483 -1.687 . . . . 0.0 110.016 178.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.092 HG12 ' CD1' ' A' ' 76' ' ' LEU . 2.9 m -96.74 109.78 23.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 122.892 1.329 . . . . 0.0 107.663 -178.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.955 ' HB2' HD13 ' A' ' 39' ' ' ILE . 2.2 t80 -118.53 90.01 3.24 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.041 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.664 HG23 ' HA ' ' A' ' 57' ' ' PRO . 0.6 OUTLIER -120.92 -68.59 0.89 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.53 -0.731 . . . . 0.0 109.66 178.814 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.756 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 3.8 p 179.65 154.4 0.64 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 110.682 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.657 ' N ' ' HB2' ' A' ' 40' ' ' ASP . 49.8 Cg_endo -76.94 -27.16 7.23 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.11 1.584 . . . . 0.0 110.468 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -79.58 -16.1 56.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.89 . . . . 0.0 109.924 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.486 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -125.0 -179.51 0.88 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 109.951 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.656 ' O ' ' O ' ' A' ' 15' ' ' TYR . 50.9 Cg_endo -83.5 108.07 1.46 Allowed 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.96 1.505 . . . . 0.0 110.319 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.756 ' CE1' ' O ' ' A' ' 10' ' ' SER . 4.8 m-85 -49.71 -117.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.932 . . . . 0.0 109.899 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.986 ' CB ' HD11 ' A' ' 59' ' ' ILE . 19.2 m -155.68 40.46 0.13 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.16 -0.962 . . . . 0.0 110.278 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.3 Cg_endo -76.0 30.07 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.961 1.506 . . . . 0.0 111.195 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.457 ' HG2' ' HG3' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -110.21 -59.37 1.95 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.816 -1.178 . . . . 0.0 110.671 -179.491 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.941 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -55.92 -19.3 11.59 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.272 -0.893 . . . . 0.0 109.894 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.986 HD12 ' C ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -75.22 -39.48 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.832 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.654 ' N ' HD12 ' A' ' 20' ' ' ILE . 14.6 tt0 -53.35 -33.19 52.55 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.372 -0.83 . . . . 0.0 108.98 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -71.77 -46.94 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 109.385 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.974 ' CG1' HG21 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -66.14 -26.91 39.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.473 -0.767 . . . . 0.0 109.246 178.171 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.839 ' OD2' HG11 ' A' ' 3' ' ' VAL . 8.7 t0 -73.69 -39.25 64.51 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.53 ' OE1' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -57.92 -46.14 85.44 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.419 179.303 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.504 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -80.12 -40.21 27.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.553 -0.717 . . . . 0.0 110.061 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.764 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -68.42 -21.82 64.64 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.198 -179.165 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.67 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -69.61 -44.47 70.64 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.058 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.786 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -48.97 -39.65 27.37 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.869 0.843 . . . . 0.0 109.116 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.786 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.69 -57.98 2.68 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.382 -0.824 . . . . 0.0 109.23 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.734 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -95.92 77.87 0.79 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.258 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.568 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -32.9 -26.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 119.272 1.536 . . . . 0.0 110.726 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.941 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -85.3 153.13 22.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.535 -0.728 . . . . 0.0 110.889 177.779 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.824 HD12 ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -129.59 154.91 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.823 -1.173 . . . . 0.0 110.93 178.146 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.636 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 26.2 t0 -150.2 74.86 1.21 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.491 -0.756 . . . . 0.0 109.393 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.991 HG12 ' NZ ' ' A' ' 38' ' ' LYS . 40.5 t -93.03 119.13 40.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 120.938 -1.101 . . . . 0.0 110.348 -178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.826 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 11.6 mm-40 -102.44 141.68 34.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.958 -1.089 . . . . 0.0 108.919 -178.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.991 ' NZ ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -140.93 120.68 13.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.511 -0.743 . . . . 0.0 111.728 -174.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.955 HD13 ' HB2' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -137.38 169.81 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.035 -1.04 . . . . 0.0 110.109 -178.95 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.662 ' OD2' ' HG2' ' A' ' 42' ' ' MET . 7.9 p-10 -106.3 175.57 5.45 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.533 -0.729 . . . . 0.0 110.756 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 1.02 HD12 HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -66.97 -9.58 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.975 -1.078 . . . . 0.0 111.09 177.23 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.662 ' HG2' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -95.25 -16.9 22.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 110.732 -179.695 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.846 HG11 HG22 ' A' ' 39' ' ' ILE . 8.7 p -112.69 -40.64 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.146 -0.971 . . . . 0.0 110.055 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.796 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 3.1 t70 -111.06 45.57 1.16 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.863 . . . . 0.0 110.361 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.653 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.272 30.9 ttt180 -62.69 -3.76 1.68 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.528 -178.578 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 1.068 ' O ' HG23 ' A' ' 49' ' ' ILE . 21.8 mm-40 -57.54 -18.68 20.51 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.347 -0.846 . . . . 0.0 110.63 175.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.87 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -51.86 -56.74 12.2 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.381 1.086 . . . . 0.0 110.292 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.103 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -62.35 -5.39 2.4 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.255 176.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.225 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.4 pp -34.58 -39.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 -174.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 1.225 ' N ' HD12 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -53.15 -51.49 61.82 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.038 177.592 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.853 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.1 p90 -123.56 -29.77 3.71 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.921 -1.112 . . . . 0.0 110.495 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.764 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 41.41 12.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.236 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.736 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.1 mt -84.09 -67.32 0.8 Allowed 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 122.767 1.27 . . . . 0.0 107.826 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.511 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 25.7 mtp -103.57 57.15 0.74 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.465 -1.243 . . . . 0.0 107.815 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 1.103 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.266 . . -99.75 108.34 20.64 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.863 1.316 . . . . 0.0 111.011 -176.173 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.02 HG22 HD12 ' A' ' 41' ' ' ILE . 0.9 OUTLIER -146.81 -59.65 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.29 -179.565 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.802 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 45.1 Cg_endo -103.1 105.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.257 1.135 . . . . 0.0 110.447 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.95 ' HB3' ' CD2' ' A' ' 8' ' ' PHE . . . -160.59 -178.04 6.61 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.963 0.887 . . . . 0.0 111.632 -176.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.986 HD11 ' CB ' ' A' ' 16' ' ' CYS . 0.3 OUTLIER -149.11 141.56 17.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.781 -0.574 . . . . 0.0 109.66 -179.657 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 1.082 ' HB3' ' CB ' ' A' ' 6' ' ' GLU 0.253 . . -82.0 137.86 35.03 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 117.207 -1.797 . . . . 0.0 107.021 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.731 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.395 1.7 mt -90.0 85.85 2.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 125.433 2.539 . . . . 0.0 106.266 -174.457 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.81 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.7 OUTLIER -43.55 83.34 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 112.231 -2.259 . . . . 0.0 108.439 177.741 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.752 ' HA3' ' CB ' ' A' ' 83' ' ' GLU . . . 162.02 -47.57 0.35 Allowed Glycine 0 N--CA 1.483 1.782 0 N-CA-C 106.783 -2.527 . . . . 0.0 106.783 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.847 ' O ' HG23 ' A' ' 65' ' ' VAL . 4.2 m -123.15 -60.03 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.745 -0.856 . . . . 0.0 111.232 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 64' ' ' VAL . 75.6 t -164.78 -104.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 120.454 -1.404 . . . . 0.0 112.001 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.839 ' N ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -154.46 165.24 37.02 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.638 -0.664 . . . . 0.0 109.956 -179.065 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.882 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.64 172.98 12.48 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.035 -1.041 . . . . 0.0 110.94 -179.351 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.681 HG22 ' OH ' ' A' ' 51' ' ' TYR . 77.1 t -88.67 120.04 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.536 -0.727 . . . . 0.0 109.286 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.839 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.18 114.33 0.6 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.198 -1.477 . . . . 0.0 110.66 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.074 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -91.91 -83.75 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 120.848 -1.383 . . . . 0.0 108.79 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 1.074 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 48.3 Cg_endo -81.61 19.24 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 N-CA-C 108.145 -1.521 . . . . 0.0 108.145 177.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.748 ' CB ' ' OE2' ' A' ' 75' ' ' GLU 0.278 0.6 OUTLIER -105.68 83.09 1.88 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 117.993 -1.483 . . . . 0.0 109.2 179.699 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.744 ' C ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -81.39 -41.11 22.43 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.31 177.425 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.941 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -43.26 -29.33 0.39 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.001 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.819 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -49.69 -45.98 49.49 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.508 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.092 ' CD1' HG12 ' A' ' 7' ' ' VAL . 28.8 mt -58.82 -42.49 89.31 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.423 -0.798 . . . . 0.0 109.188 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.805 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.54 -34.88 73.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.494 -0.754 . . . . 0.0 110.209 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.633 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 3.4 tt0 -80.95 -26.78 36.39 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.697 -0.627 . . . . 0.0 110.358 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.519 ' CB ' HG23 ' A' ' 61' ' ' ILE . . . -75.22 -37.4 61.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -0.944 . . . . 0.0 109.773 -178.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.974 HG21 ' CG1' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.9 -39.37 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.043 -1.036 . . . . 0.0 109.344 178.84 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.633 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -72.93 -28.55 62.51 Favored 'General case' 0 C--O 1.258 1.552 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.668 ' HA ' ' OXT' ' A' ' 85' ' ' GLU 0.556 0.0 OUTLIER -95.6 -8.85 33.8 Favored 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 114.2 -3.0 . . . . 0.0 109.582 -178.186 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.752 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -71.35 -61.51 1.74 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 118.414 -2.679 . . . . 0.0 111.432 162.619 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.67 ' SD ' ' HD2' ' A' ' 27' ' ' LYS . 3.5 ptt? -71.55 -20.64 62.0 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.499 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.668 ' OXT' ' HA ' ' A' ' 82' ' ' ASP . 3.2 mm-40 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.227 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.488 ' SD ' ' OD1' ' A' ' 4' ' ' ASN . 7.9 ttp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.25 0.548 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.979 HG22 ' N ' ' A' ' 3' ' ' VAL . 0.9 OUTLIER -81.05 -94.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 109.854 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.979 ' N ' HG22 ' A' ' 2' ' ' VAL . 53.3 t -89.6 111.64 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.568 -0.707 . . . . 0.0 110.296 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.791 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.349 2.4 t-20 -135.4 107.57 7.21 Favored 'General case' 0 C--O 1.189 -2.123 0 CA-C-O 125.404 2.526 . . . . 0.0 107.24 177.301 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.892 HG21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -118.19 136.72 54.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 116.352 -1.785 . . . . 0.0 111.921 179.568 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 1.077 ' CB ' ' HB3' ' A' ' 60' ' ' ALA 0.48 5.8 tt0 -133.77 124.38 26.5 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 127.31 3.433 . . . . 0.0 101.919 174.069 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 1.089 HG12 ' CD1' ' A' ' 76' ' ' LEU 0.397 10.3 m -113.78 110.42 32.09 Favored 'Isoleucine or valine' 0 C--O 1.168 -3.208 0 O-C-N 116.613 -3.804 . . . . 0.0 101.483 -177.034 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.944 ' HB2' HD13 ' A' ' 39' ' ' ILE 0.306 1.7 t80 -117.28 96.68 5.53 Favored 'General case' 0 C--N 1.377 1.776 0 CA-C-N 110.611 -2.995 . . . . 0.0 108.663 -178.292 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.672 HG23 ' HA ' ' A' ' 57' ' ' PRO . 0.7 OUTLIER -124.53 -69.22 0.81 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.89 -1.131 . . . . 0.0 108.653 178.687 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.757 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 3.8 p 179.6 154.35 0.63 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.967 . . . . 0.0 110.713 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.652 ' HA ' ' OH ' ' A' ' 15' ' ' TYR . 50.1 Cg_endo -76.96 -27.06 7.29 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.146 1.603 . . . . 0.0 110.458 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -79.71 -16.04 56.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.873 . . . . 0.0 109.954 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.487 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -125.01 -179.44 0.86 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.347 -0.846 . . . . 0.0 109.915 179.691 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.654 ' O ' ' O ' ' A' ' 15' ' ' TYR . 52.0 Cg_endo -83.58 108.06 1.44 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.963 1.507 . . . . 0.0 110.367 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.757 ' CE1' ' O ' ' A' ' 10' ' ' SER . 5.0 m-85 -49.77 -117.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 109.788 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.986 ' CB ' HD11 ' A' ' 59' ' ' ILE . 19.2 m -155.54 40.27 0.13 Allowed Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.113 -0.992 . . . . 0.0 110.348 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.3 Cg_endo -75.98 30.12 0.39 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.926 1.487 . . . . 0.0 111.183 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.455 ' HG2' ' HG3' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -110.14 -59.32 1.95 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.901 -1.124 . . . . 0.0 110.728 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.903 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -56.42 -18.5 11.37 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.063 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.988 HD12 ' C ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -75.72 -39.15 38.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.851 179.572 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.655 ' N ' HD12 ' A' ' 20' ' ' ILE . 14.5 tt0 -52.98 -34.25 55.19 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 108.757 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -70.73 -49.11 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.425 -0.797 . . . . 0.0 109.271 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.968 ' CG1' HG21 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -58.95 -35.55 57.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-O 122.707 1.241 . . . . 0.0 109.305 176.529 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.841 ' OD2' HG11 ' A' ' 3' ' ' VAL . 7.8 t0 -68.42 -41.57 80.18 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 122.848 1.308 . . . . 0.0 108.918 -178.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.53 ' OE1' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -56.19 -48.03 77.18 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.464 179.483 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.507 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -78.15 -39.68 40.24 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.854 0.835 . . . . 0.0 111.188 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.768 ' CB ' HG22 ' A' ' 3' ' ' VAL 0.288 0.0 OUTLIER -72.59 -16.13 61.74 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 117.17 -1.812 . . . . 0.0 109.013 -178.193 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.672 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -72.43 -43.25 64.08 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.821 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.735 ' HG3' ' N ' ' A' ' 30' ' ' PHE 0.287 0.0 OUTLIER -52.54 -32.59 41.41 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.765 179.794 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.769 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -94.42 -69.46 0.75 Allowed 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 102.954 -2.98 . . . . 0.0 102.954 -179.275 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.746 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -75.29 65.8 2.32 Favored Glycine 0 C--N 1.27 -3.111 1 CA-C-O 113.33 -4.039 . . . . 0.0 117.337 176.161 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.585 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -31.06 -29.61 0.01 OUTLIER 'General case' 0 C--N 1.254 -3.563 1 CA-C-N 124.806 4.303 . . . . 0.0 110.286 -175.408 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.946 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -74.73 149.53 39.78 Favored 'General case' 0 C--N 1.278 -2.52 0 O-C-N 120.132 -1.605 . . . . 0.0 113.903 174.076 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.821 HD12 ' O ' ' A' ' 33' ' ' LYS 0.262 0.4 OUTLIER -131.05 156.42 42.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 120.854 1.661 . . . . 0.0 110.589 174.793 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.68 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 26.2 t0 -151.22 79.19 1.3 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.983 HG12 ' NZ ' ' A' ' 38' ' ' LYS 0.351 61.9 t -100.63 127.41 53.75 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.94 0 CA-C-O 125.916 2.77 . . . . 0.0 104.764 -177.65 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.871 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.424 9.2 mm-40 -111.91 146.17 38.24 Favored 'General case' 0 C--O 1.183 -2.418 0 C-N-CA 113.685 -3.206 . . . . 0.0 103.99 -176.853 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.983 ' NZ ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -139.45 107.47 5.72 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 115.221 -2.323 . . . . 0.0 115.777 -170.036 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.944 HD13 ' HB2' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -131.72 166.87 27.72 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.556 0 CA-C-N 122.949 2.613 . . . . 0.0 112.311 -179.283 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.663 ' OD2' ' HG2' ' A' ' 42' ' ' MET . 4.0 p-10 -98.27 175.64 6.0 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.57 -1.331 . . . . 0.0 113.464 177.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 1.019 HD12 HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -64.63 -13.94 15.25 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.065 0 O-C-N 121.066 -1.021 . . . . 0.0 111.317 174.723 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.663 ' HG2' ' OD2' ' A' ' 40' ' ' ASP 0.379 0.0 OUTLIER -100.88 -5.07 26.62 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 115.276 -2.57 . . . . 0.0 110.538 -177.251 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.849 HG11 HG22 ' A' ' 39' ' ' ILE . 7.5 p -117.13 -41.11 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.967 -1.083 . . . . 0.0 109.048 177.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.786 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 3.1 t70 -111.56 46.69 1.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 110.254 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.708 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.378 30.3 ttt180 -66.2 -0.08 2.32 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 116.518 -2.073 . . . . 0.0 108.922 -177.754 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 1.052 ' O ' HG23 ' A' ' 49' ' ' ILE . 18.8 mm-40 -53.12 -26.71 17.55 Favored 'General case' 0 C--N 1.287 -2.142 0 O-C-N 120.785 -1.197 . . . . 0.0 109.831 172.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.88 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -48.28 -61.0 2.22 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.571 -1.331 . . . . 0.0 109.343 -176.091 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.026 ' CB ' ' HB2' ' A' ' 55' ' ' ALA 0.359 . . -54.3 -12.55 0.68 Allowed 'General case' 0 C--N 1.266 -3.054 0 C-N-CA 125.677 1.591 . . . . 0.0 112.053 176.101 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.229 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.5 pp -33.13 -39.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.79 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -172.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 1.229 ' N ' HD12 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -53.13 -51.6 61.42 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.251 176.522 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.846 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.1 p90 -123.44 -29.51 3.78 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.049 -1.032 . . . . 0.0 110.582 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.793 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.41 16.37 0.01 OUTLIER Glycine 0 N--CA 1.487 2.092 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.736 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.4 mt -87.55 -75.01 0.42 Allowed 'General case' 0 C--N 1.262 -3.197 0 N-CA-C 103.136 -2.912 . . . . 0.0 103.136 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.48 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 26.7 mtp -98.95 65.01 1.46 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.804 -1.544 . . . . 0.0 108.46 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 1.026 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.451 . . -110.98 112.48 24.33 Favored 'General case' 0 C--O 1.168 -3.184 1 CA-C-O 128.612 4.053 . . . . 0.0 105.685 -175.308 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.019 HG22 HD12 ' A' ' 41' ' ' ILE . 0.9 OUTLIER -148.32 -51.33 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.511 0 CA-C-N 110.476 -3.056 . . . . 0.0 112.15 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.839 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.473 19.3 Cg_endo -117.67 111.82 0.01 OUTLIER 'Trans proline' 0 C--O 1.148 -3.988 1 CA-C-O 130.685 4.369 . . . . 0.0 103.704 -179.756 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.934 ' HB3' ' CD2' ' A' ' 8' ' ' PHE . . . -160.88 178.32 9.53 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 109.578 -3.465 . . . . 0.0 111.405 -174.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.986 HD11 ' CB ' ' A' ' 16' ' ' CYS 0.26 0.3 OUTLIER -144.94 151.28 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.746 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 1.077 ' HB3' ' CB ' ' A' ' 6' ' ' GLU 0.503 . . -96.02 147.66 23.47 Favored 'General case' 0 C--O 1.187 -2.193 2 N-CA-C 98.196 -4.742 . . . . 0.0 98.196 -178.257 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.754 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.654 2.2 mt -99.68 96.55 5.02 Favored 'Isoleucine or valine' 0 C--N 1.408 3.112 3 C-N-CA 108.539 -5.264 . . . . 0.0 98.644 -170.689 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.791 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.6 OUTLIER -50.29 85.6 0.0 OUTLIER 'General case' 0 C--N 1.379 1.851 1 CA-C-N 107.205 -4.543 . . . . 0.0 107.516 177.499 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.757 ' HA3' ' CB ' ' A' ' 83' ' ' GLU . . . 161.95 -47.87 0.35 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 106.734 -2.546 . . . . 0.0 106.734 -178.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.844 ' O ' HG23 ' A' ' 65' ' ' VAL . 4.2 m -122.94 -59.86 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.72 -0.871 . . . . 0.0 111.468 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 64' ' ' VAL . 76.1 t -164.48 -104.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.264 -1.523 . . . . 0.0 111.827 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.837 ' N ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -153.89 166.11 33.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.703 -0.623 . . . . 0.0 110.111 -179.067 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.879 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -147.64 169.51 19.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.029 -1.044 . . . . 0.0 110.878 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.687 HG22 ' OH ' ' A' ' 51' ' ' TYR . 97.2 t -81.74 118.79 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.874 -1.141 . . . . 0.0 111.667 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.837 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.77 114.13 0.59 Allowed Glycine 0 C--N 1.281 -2.504 0 CA-C-N 120.595 1.543 . . . . 0.0 110.698 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.066 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -92.03 -83.08 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.754 0 O-C-N 120.742 -1.446 . . . . 0.0 109.04 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 1.066 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 43.1 Cg_endo -86.0 28.89 0.54 Allowed 'Trans proline' 0 C--N 1.318 -1.041 0 N-CA-C 107.894 -1.618 . . . . 0.0 107.894 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.746 ' CB ' ' OE2' ' A' ' 75' ' ' GLU 0.644 0.4 OUTLIER -120.76 95.02 4.54 Favored 'General case' 0 C--O 1.164 -3.427 2 C-N-CA 108.815 -5.154 . . . . 0.0 100.585 179.121 . . . . . . . . 5 4 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.727 ' C ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -83.15 -43.89 15.68 Favored 'General case' 0 C--N 1.371 1.537 1 CA-C-N 108.204 -4.089 . . . . 0.0 109.057 174.7 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.903 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -39.85 -32.33 0.15 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.811 -1.18 . . . . 0.0 108.504 178.987 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.818 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -49.36 -45.43 45.73 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.173 -179.272 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.089 ' CD1' HG12 ' A' ' 7' ' ' VAL . 29.3 mt -58.55 -42.99 89.14 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.786 0.803 . . . . 0.0 109.36 178.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.803 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.68 -36.85 74.84 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.261 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.626 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 3.6 tt0 -74.05 -35.01 64.27 Favored 'General case' 0 C--N 1.286 -2.165 0 O-C-N 120.775 -1.203 . . . . 0.0 110.624 178.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.486 ' CB ' HG23 ' A' ' 61' ' ' ILE . . . -72.6 -37.6 68.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.821 -1.175 . . . . 0.0 110.222 -175.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.968 HG21 ' CG1' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.5 -42.87 97.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 121.056 -1.027 . . . . 0.0 109.168 178.047 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.626 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -70.48 -25.84 63.35 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 120.776 -1.203 . . . . 0.0 109.843 178.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.797 ' HA ' ' OXT' ' A' ' 85' ' ' GLU 1.012 0.0 OUTLIER -108.61 15.03 24.09 Favored 'General case' 0 C--O 1.302 3.828 2 C-N-CA 104.258 -6.977 . . . . 0.0 101.538 -176.267 . . . . . . . . 5 4 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.757 ' CB ' ' HA3' ' A' ' 63' ' ' GLY 0.258 0.0 OUTLIER -89.52 -59.45 2.21 Favored 'General case' 0 C--N 1.314 -0.966 1 O-C-N 113.892 -5.505 . . . . 0.0 104.468 164.096 . . . . . . . . 5 4 . 1 . 013 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.67 ' SD ' ' HD2' ' A' ' 27' ' ' LYS 0.26 3.6 ptt? -73.42 -16.18 61.33 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.599 -1.24 . . . . 0.0 111.091 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.797 ' OXT' ' HA ' ' A' ' 82' ' ' ASP . 3.1 mm-40 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.81 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.623 ' HE3' ' OE2' ' A' ' 83' ' ' GLU . 2.8 ttp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.308 0.575 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.006 HG22 HG23 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -89.65 -91.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.401 -0.812 . . . . 0.0 110.438 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.006 HG23 HG22 ' A' ' 2' ' ' VAL . 79.0 t -91.13 111.93 24.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 O-C-N 121.811 -0.556 . . . . 0.0 110.665 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.806 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 1.9 m-80 -126.73 113.64 16.93 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.993 HD12 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -133.47 133.74 57.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.396 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 1.012 ' HB3' ' HB3' ' A' ' 60' ' ' ALA 0.277 0.0 OUTLIER -127.93 110.58 12.69 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 116.755 -1.978 . . . . 0.0 109.454 176.472 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.922 HG22 ' HA ' ' A' ' 38' ' ' LYS 0.255 33.3 m -99.51 100.64 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 124.107 1.908 . . . . 0.0 108.388 -177.752 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.899 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -116.98 95.0 4.8 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.617 -178.086 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.656 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 38.2 m -120.5 -79.78 0.61 Allowed 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.073 -1.017 . . . . 0.0 109.648 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.62 ' C ' ' OD1' ' A' ' 40' ' ' ASP . 0.2 OUTLIER 179.55 155.53 0.66 Allowed Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.853 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.699 ' HG3' ' CE ' ' A' ' 42' ' ' MET . 47.4 Cg_endo -73.95 -12.62 23.9 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 124.142 1.601 . . . . 0.0 110.465 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 12' ' ' THR . 0.5 OUTLIER -79.45 0.75 28.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.066 -1.021 . . . . 0.0 109.86 179.675 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.547 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -157.47 -170.25 0.24 Allowed Pre-proline 0 N--CA 1.485 1.317 0 O-C-N 121.625 -0.672 . . . . 0.0 110.132 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.643 ' O ' ' O ' ' A' ' 15' ' ' TYR . 55.2 Cg_endo -84.6 118.02 2.12 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.751 1.395 . . . . 0.0 110.735 175.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.752 ' CE1' ' OD1' ' A' ' 40' ' ' ASP . 2.7 m-85 -49.54 -113.94 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.381 -0.825 . . . . 0.0 109.773 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 1.179 ' SG ' HD11 ' A' ' 59' ' ' ILE . 33.4 m -155.0 39.91 0.13 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.163 -0.961 . . . . 0.0 110.329 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.952 ' HA ' HD13 ' A' ' 20' ' ' ILE . 55.4 Cg_endo -75.75 27.17 0.39 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.715 1.376 . . . . 0.0 111.192 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.739 ' CG ' ' CD ' ' A' ' 73' ' ' ARG . 0.1 OUTLIER -110.11 -63.22 1.4 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.947 -1.095 . . . . 0.0 110.583 -179.275 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.834 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -54.27 -21.43 9.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.284 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.993 ' HB ' HD12 ' A' ' 5' ' ' ILE . 2.6 pt -66.77 -42.19 88.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.489 0.662 . . . . 0.0 109.228 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.567 ' N ' ' CG1' ' A' ' 20' ' ' ILE . 2.5 tm-20 -54.16 -33.94 59.21 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.66 -41.42 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.785 0.802 . . . . 0.0 109.077 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -68.59 -30.06 46.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 121.667 0.746 . . . . 0.0 109.362 178.228 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.702 ' OD1' ' CG1' ' A' ' 34' ' ' ILE . 5.9 t70 -73.98 -38.09 64.26 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -45.55 88.3 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.699 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.529 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.65 -40.5 29.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.561 -0.712 . . . . 0.0 110.173 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.898 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -70.78 -20.54 62.59 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.943 -1.103 . . . . 0.0 109.567 -178.898 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.68 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -69.07 -47.88 64.17 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 176.261 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.749 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -45.64 -41.29 10.07 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.94 0.876 . . . . 0.0 109.21 179.02 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.749 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -90.63 -61.32 1.7 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 121.358 -0.839 . . . . 0.0 108.946 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.694 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -94.11 78.78 0.98 Allowed Glycine 0 N--CA 1.485 1.931 0 CA-C-O 118.805 -0.997 . . . . 0.0 111.413 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.538 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -35.58 -24.05 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 120.418 2.109 . . . . 0.0 111.164 -179.628 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.942 ' O ' HG21 ' A' ' 2' ' ' VAL . 6.6 mtpt -83.52 154.52 23.81 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.699 -0.625 . . . . 0.0 111.44 176.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.914 HD12 ' O ' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -127.97 157.41 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 118.839 -1.144 . . . . 0.0 111.072 177.449 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.596 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 7.2 t70 -150.38 64.31 0.95 Allowed 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.987 HG11 HD12 ' A' ' 20' ' ' ILE . 31.3 t -92.66 117.84 36.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 118.799 -1.161 . . . . 0.0 109.824 -178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.802 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.273 3.1 mt-10 -101.56 147.57 26.25 Favored 'General case' 0 C--O 1.195 -1.793 0 CA-C-O 122.474 1.13 . . . . 0.0 108.728 -177.744 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.922 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.74 119.25 13.05 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.172 -0.955 . . . . 0.0 112.019 -173.681 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.018 HD12 ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -130.4 178.41 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -0.962 . . . . 0.0 110.667 -178.903 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.752 ' OD1' ' CE1' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -109.28 179.55 4.12 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.637 -0.664 . . . . 0.0 111.401 176.023 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.882 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -61.76 -54.0 40.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.128 -0.982 . . . . 0.0 112.104 173.411 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.709 ' N ' HG22 ' A' ' 41' ' ' ILE . 5.2 ptp -71.71 0.28 9.2 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.427 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.742 HG21 HG22 ' A' ' 39' ' ' ILE . 1.1 m -111.9 -45.19 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 109.814 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 1.018 ' HB2' HD12 ' A' ' 39' ' ' ILE . 9.7 t70 -114.54 45.55 1.53 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.339 -0.851 . . . . 0.0 109.839 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.517 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.288 0.0 OUTLIER -67.99 -5.57 17.95 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.41 -1.316 . . . . 0.0 110.225 -178.411 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 1.026 ' O ' HG23 ' A' ' 49' ' ' ILE . 4.4 mt-10 -56.82 -18.93 14.71 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.312 -0.868 . . . . 0.0 110.471 173.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.843 ' HB3' ' CE2' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -49.92 -61.17 2.29 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 122.891 1.329 . . . . 0.0 110.306 -178.272 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.972 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -58.62 -4.93 0.48 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.84 177.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.164 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.2 pp -35.99 -41.62 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 -173.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 1.164 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.9 OUTLIER -50.43 -52.95 33.24 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.897 177.059 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.84 ' OH ' HG22 ' A' ' 68' ' ' VAL . 45.6 p90 -118.93 -36.86 3.33 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.088 -1.007 . . . . 0.0 110.354 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.766 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.96 14.0 0.01 OUTLIER Glycine 0 N--CA 1.495 2.584 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.701 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 42.7 mt -82.69 -63.3 1.4 Allowed 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 123.231 1.491 . . . . 0.0 109.256 177.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.454 ' C ' ' HE2' ' A' ' 51' ' ' TYR . 19.3 mtm -109.55 53.88 0.68 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.969 -1.468 . . . . 0.0 109.516 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.972 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.311 . . -103.52 124.44 48.77 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 117.821 -1.552 . . . . 0.0 111.117 -173.759 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.808 ' HA ' ' CG1' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -147.92 -60.74 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.408 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.656 -177.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.782 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.267 45.1 Cg_endo -108.14 113.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 CA-C-O 123.446 1.352 . . . . 0.0 110.334 177.814 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 1.111 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -161.39 178.6 9.01 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.223 -175.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.252 HG21 ' CD1' ' A' ' 76' ' ' LEU . 1.2 mp -147.47 143.8 19.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.771 -0.58 . . . . 0.0 109.762 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 1.012 ' HB3' ' HB3' ' A' ' 6' ' ' GLU 0.285 . . -82.74 143.07 31.14 Favored 'General case' 0 CA--C 1.487 -1.446 0 C-N-CA 115.912 -2.315 . . . . 0.0 109.092 -179.107 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.705 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.404 1.0 OUTLIER -91.09 87.5 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.731 0 CA-C-O 125.493 2.568 . . . . 0.0 107.478 -174.319 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.806 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.6 OUTLIER -42.28 80.61 0.0 OUTLIER 'General case' 0 C--O 1.2 -1.502 0 CA-C-N 112.601 -2.09 . . . . 0.0 109.618 177.296 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.782 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 161.33 -48.34 0.37 Allowed Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.56 -2.216 . . . . 0.0 107.56 -177.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.811 ' O ' HG23 ' A' ' 65' ' ' VAL . 4.9 m -120.16 -59.73 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.763 -0.845 . . . . 0.0 110.922 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 64' ' ' VAL . 74.5 t -164.64 -104.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.436 -1.415 . . . . 0.0 111.923 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.964 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 2.1 ttp180 -164.39 164.11 22.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.642 -0.661 . . . . 0.0 109.309 -178.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 1.111 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.1 -176.49 5.11 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.939 -1.101 . . . . 0.0 111.75 -176.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.84 HG22 ' OH ' ' A' ' 51' ' ' TYR . 79.5 t -94.63 114.98 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.83 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.85 125.16 1.35 Allowed Glycine 0 N--CA 1.49 2.282 0 C-N-CA 118.918 -1.611 . . . . 0.0 110.688 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.089 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -92.92 -79.8 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.047 -1.267 . . . . 0.0 108.326 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 1.089 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 54.0 Cg_endo -81.65 20.9 0.99 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.35 1.184 . . . . 0.0 109.355 177.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.602 ' OG ' ' HA3' ' A' ' 69' ' ' GLY . 1.5 p -98.55 64.67 1.55 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.362 -0.836 . . . . 0.0 111.378 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.739 ' CD ' ' CG ' ' A' ' 18' ' ' MET . 0.1 OUTLIER -73.93 -35.89 64.62 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.171 -0.955 . . . . 0.0 109.318 178.716 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.543 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -48.92 -37.42 19.85 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.049 -1.032 . . . . 0.0 109.236 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.74 ' CD ' ' CD2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -47.09 -36.86 8.75 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.515 -0.874 . . . . 0.0 108.83 179.541 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.252 ' CD1' HG21 ' A' ' 59' ' ' ILE . 8.9 mp -61.44 -44.74 96.59 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 177.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.789 ' HA ' ' CG1' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -56.85 -34.41 67.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.459 -0.776 . . . . 0.0 109.859 178.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -77.96 -31.75 51.0 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.684 -0.635 . . . . 0.0 109.708 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.426 ' HB2' HG23 ' A' ' 61' ' ' ILE . . . -68.56 -49.15 61.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.458 -0.776 . . . . 0.0 109.655 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.779 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 1.9 mp -51.96 -35.5 18.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 120.949 -1.094 . . . . 0.0 108.695 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.562 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 8.1 t-20 -68.1 -27.5 66.53 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.575 ' OD2' HG11 ' A' ' 64' ' ' VAL 0.553 37.8 t0 -95.25 -21.62 18.33 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 113.374 -3.33 . . . . 0.0 106.329 -177.698 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.782 ' HB2' ' CA ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -68.64 -46.1 70.08 Favored 'General case' 0 C--N 1.288 -2.076 0 O-C-N 119.504 -1.997 . . . . 0.0 108.916 170.054 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.804 ' CE ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -78.9 -23.38 44.84 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.484 178.378 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.489 ' O ' ' O ' ' A' ' 81' ' ' ASN . 11.3 tp10 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.289 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.732 ' SD ' ' ND2' ' A' ' 4' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.211 0.529 . . . . 0.0 110.232 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.953 HG21 ' O ' ' A' ' 33' ' ' LYS . 1.6 p -89.44 -96.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 0.0 110.265 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.999 HG11 ' OD1' ' A' ' 24' ' ' ASP . 55.4 t -92.17 119.55 39.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.453 -0.779 . . . . 0.0 110.18 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.751 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 4.6 t-20 -135.78 111.78 9.58 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 123.082 1.42 . . . . 0.0 109.194 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.055 ' HB ' HG13 ' A' ' 36' ' ' VAL . 4.1 mt -126.05 133.48 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.115 -0.991 . . . . 0.0 109.965 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 1.145 ' CB ' ' HB3' ' A' ' 60' ' ' ALA 0.272 15.3 tt0 -125.28 101.81 7.15 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 116.963 -1.895 . . . . 0.0 109.17 178.599 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.827 ' CG2' ' CB ' ' A' ' 38' ' ' LYS 0.251 29.0 m -97.66 111.33 27.24 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.438 0 CA-C-O 123.734 1.73 . . . . 0.0 107.621 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.911 ' CD2' ' HB3' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -118.55 90.57 3.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.01 -1.056 . . . . 0.0 109.342 -178.448 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.667 ' OG1' ' HA ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -121.35 -72.92 0.67 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.355 -0.841 . . . . 0.0 110.322 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.876 ' HA ' HG22 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -170.66 149.49 2.96 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.02 -1.05 . . . . 0.0 110.85 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.745 ' N ' ' HB3' ' A' ' 40' ' ' ASP . 46.4 Cg_endo -75.67 -28.91 7.71 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 124.019 1.536 . . . . 0.0 110.153 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.59 -15.02 58.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.859 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.644 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -124.95 -179.69 0.92 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.388 -0.82 . . . . 0.0 109.875 179.774 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.644 ' HD2' ' SG ' ' A' ' 13' ' ' CYS . 51.2 Cg_endo -83.56 111.12 1.74 Allowed 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.999 1.526 . . . . 0.0 110.417 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.762 ' CE1' ' O ' ' A' ' 10' ' ' SER . 17.9 m-85 -49.53 -111.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.908 . . . . 0.0 109.685 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.96 ' SG ' HD11 ' A' ' 59' ' ' ILE . 26.3 m -155.09 39.39 0.11 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.149 -0.97 . . . . 0.0 110.308 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.4 Cg_endo -76.18 23.07 0.48 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.84 1.442 . . . . 0.0 110.92 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.718 ' HB3' ' CD ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -103.18 -66.79 0.92 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.049 -1.032 . . . . 0.0 110.889 -179.292 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.968 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -55.14 -21.87 14.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.276 -0.89 . . . . 0.0 109.84 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.034 ' CD1' HD13 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -72.67 -39.45 60.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.504 -0.747 . . . . 0.0 109.533 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.673 ' N ' HD12 ' A' ' 20' ' ' ILE . 1.6 tt0 -49.17 -31.9 9.24 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 15.5 t -69.42 -45.59 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.534 -0.729 . . . . 0.0 109.386 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.905 HG13 HG21 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -68.9 -28.56 40.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.312 -0.868 . . . . 0.0 109.366 178.463 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.999 ' OD1' HG11 ' A' ' 3' ' ' VAL . 16.6 t0 -76.09 -36.71 58.82 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -58.75 -44.04 90.42 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.644 0.735 . . . . 0.0 109.381 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.497 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.54 -40.99 28.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.51 -0.744 . . . . 0.0 110.164 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.792 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -67.09 -23.35 65.84 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.932 -1.107 . . . . 0.0 109.082 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.801 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.82 -45.63 70.71 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.365 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.797 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -49.43 -40.3 36.03 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.783 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.797 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.9 -56.32 3.28 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.829 ' HA3' HG23 ' A' ' 2' ' ' VAL . . . -96.18 78.47 0.76 Allowed Glycine 0 N--CA 1.489 2.173 0 O-C-N 121.398 -0.813 . . . . 0.0 111.378 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.532 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -36.96 -21.62 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 119.309 1.555 . . . . 0.0 110.3 -179.468 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.953 ' O ' HG21 ' A' ' 2' ' ' VAL . 27.3 mtmm -85.06 154.6 21.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -0.999 . . . . 0.0 111.145 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.801 ' CD1' ' CG ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -129.28 150.21 34.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 118.883 -1.127 . . . . 0.0 111.048 178.463 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.618 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -150.43 68.49 0.97 Allowed 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.479 -0.763 . . . . 0.0 109.159 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.055 HG13 ' HB ' ' A' ' 5' ' ' ILE . 65.6 t -91.92 118.37 37.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 122.413 1.102 . . . . 0.0 109.519 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.806 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.267 8.6 mm-40 -100.13 131.01 46.33 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 123.321 1.534 . . . . 0.0 108.185 -178.678 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 1.067 ' C ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -139.56 122.1 16.23 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.753 -1.217 . . . . 0.0 111.559 -176.723 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.067 HD13 ' C ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -136.72 -163.54 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 122.31 1.052 . . . . 0.0 111.129 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.937 ' OD1' HG11 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -110.96 170.82 7.85 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.792 179.183 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 1.273 ' CD1' HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -65.86 -54.33 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.593 -0.692 . . . . 0.0 111.548 177.474 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.629 ' H ' HG23 ' A' ' 41' ' ' ILE . 6.4 ptm -65.26 -1.56 2.41 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.016 -1.073 . . . . 0.0 110.985 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.937 HG11 ' OD1' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -112.08 -48.9 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.018 -1.051 . . . . 0.0 110.705 178.063 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.724 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 3.0 t70 -105.9 48.51 0.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.954 . . . . 0.0 110.086 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.644 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.288 6.4 ttt-85 -63.35 -7.21 5.88 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 118.086 -1.445 . . . . 0.0 109.662 -178.554 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.983 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.3 mm-40 -51.33 -19.94 1.51 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.157 -0.964 . . . . 0.0 110.159 176.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.841 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -51.8 -58.72 5.61 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 122.188 0.994 . . . . 0.0 109.815 -179.399 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.057 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -62.88 -1.94 1.04 Allowed 'General case' 0 C--N 1.276 -2.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.68 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.983 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -35.34 -42.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 104.027 -2.582 . . . . 0.0 104.027 -176.383 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.503 ' N ' ' C ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -48.93 -51.33 30.78 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.195 176.754 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 1.261 ' OH ' HG22 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -125.93 -32.54 2.78 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.107 -0.996 . . . . 0.0 110.432 179.124 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.813 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 61.07 -33.52 0.05 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.804 HD12 ' H ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -49.57 -81.43 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.644 -1.503 . . . . 0.0 109.858 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.804 ' H ' HD12 ' A' ' 53' ' ' LEU . 24.7 mtt -79.45 54.3 1.7 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.401 -0.812 . . . . 0.0 108.944 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 1.057 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.288 . . -99.61 103.52 15.23 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 124.006 1.86 . . . . 0.0 110.174 -177.328 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.273 HG22 ' CD1' ' A' ' 41' ' ' ILE . 4.9 t -146.63 -72.86 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.414 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.801 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.829 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 51.4 Cg_endo -95.3 112.15 0.15 Allowed 'Trans proline' 0 C--O 1.197 -1.541 0 CA-C-O 123.872 1.53 . . . . 0.0 109.893 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 1.006 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -160.82 179.27 8.65 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.425 -1.422 . . . . 0.0 111.792 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.96 HD11 ' SG ' ' A' ' 16' ' ' CYS 0.253 0.3 OUTLIER -142.48 133.48 24.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.078 179.334 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 1.145 ' HB3' ' CB ' ' A' ' 6' ' ' GLU . . . -81.42 141.31 34.05 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 116.935 -1.906 . . . . 0.0 106.215 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.772 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.433 0.7 OUTLIER -90.09 86.75 2.6 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.69 0 C-N-CA 114.73 -2.788 . . . . 0.0 105.421 -175.576 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.751 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -44.31 82.34 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 112.634 -2.076 . . . . 0.0 108.76 177.78 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.772 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.49 -44.1 0.35 Allowed Glycine 0 N--CA 1.483 1.805 0 N-CA-C 107.207 -2.357 . . . . 0.0 107.207 -178.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.76 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.2 m -126.18 -59.01 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.537 -0.978 . . . . 0.0 111.302 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.76 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 93.2 t -163.59 -108.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 120.306 -1.496 . . . . 0.0 112.358 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.786 ' CZ ' ' HB2' ' A' ' 60' ' ' ALA . 3.5 ttt180 -165.14 164.64 20.21 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.769 -0.582 . . . . 0.0 109.653 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 1.006 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -144.95 177.01 9.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.92 -1.112 . . . . 0.0 111.177 -178.11 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.261 HG22 ' OH ' ' A' ' 51' ' ' TYR . 78.9 t -88.66 116.0 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.832 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.836 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.68 123.57 1.19 Allowed Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.72 -1.228 . . . . 0.0 110.447 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.115 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -93.9 -78.26 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 120.868 -1.372 . . . . 0.0 108.662 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 1.115 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 54.6 Cg_endo -79.26 20.39 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.654 1.344 . . . . 0.0 109.254 178.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.732 ' O ' HD13 ' A' ' 59' ' ' ILE 0.3 2.3 p -103.88 81.78 1.91 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 124.024 1.869 . . . . 0.0 109.989 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 1.196 ' O ' HD12 ' A' ' 76' ' ' LEU . 24.9 mtt180 -79.57 -36.12 38.68 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.643 -1.286 . . . . 0.0 110.03 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.968 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.5 tt0 -50.48 -25.35 3.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.319 -0.863 . . . . 0.0 109.726 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.781 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -53.67 -46.39 70.6 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.351 -0.843 . . . . 0.0 109.207 -179.594 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.196 HD12 ' O ' ' A' ' 73' ' ' ARG . 0.7 OUTLIER -60.18 -42.19 94.5 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.009 178.808 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.826 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.09 -33.95 69.64 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.399 -0.813 . . . . 0.0 109.78 179.548 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.766 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 31.5 tt0 -81.58 -27.75 34.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 110.146 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.606 ' CB ' ' HA ' ' A' ' 61' ' ' ILE . . . -74.47 -38.07 63.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.637 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.905 HG21 HG13 ' A' ' 23' ' ' VAL . 1.8 mp -63.35 -39.8 86.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.144 -0.972 . . . . 0.0 108.985 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.667 ' HA ' ' SD ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -74.96 -33.12 61.86 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.244 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 78' ' ' GLU 0.523 0.1 OUTLIER -91.34 -3.26 56.95 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 113.54 -3.264 . . . . 0.0 107.125 -178.814 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.758 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -82.26 -59.58 2.5 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 119.672 -1.893 . . . . 0.0 109.816 169.589 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.674 ' SD ' ' HD2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.94 -13.48 62.47 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.405 179.525 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.494 ' N ' ' HG2' ' A' ' 84' ' ' MET . 2.7 tm-20 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.196 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.731 ' SD ' ' ND2' ' A' ' 4' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.252 0.549 . . . . 0.0 110.211 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.955 HG21 ' O ' ' A' ' 33' ' ' LYS . 1.6 p -89.53 -97.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.842 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.003 HG11 ' OD1' ' A' ' 24' ' ' ASP . 53.2 t -89.51 121.69 39.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.343 -0.848 . . . . 0.0 109.987 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.747 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.292 5.3 t-20 -140.17 111.26 7.02 Favored 'General case' 0 C--O 1.19 -2.076 0 CA-C-O 125.057 2.361 . . . . 0.0 108.135 178.23 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.045 ' HB ' HG13 ' A' ' 36' ' ' VAL . 4.2 mt -121.63 133.85 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.195 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 1.151 ' CB ' ' HB3' ' A' ' 60' ' ' ALA 0.371 16.4 tt0 -129.11 111.12 12.62 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 115.218 -2.593 . . . . 0.0 105.063 177.026 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.829 ' CG2' ' CB ' ' A' ' 38' ' ' LYS 0.352 15.0 m -108.86 111.17 34.89 Favored 'Isoleucine or valine' 0 C--O 1.177 -2.748 0 CA-C-O 126.761 3.172 . . . . 0.0 103.822 -178.425 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.909 ' CD2' ' HB3' ' A' ' 58' ' ' ALA 0.277 0.4 OUTLIER -117.27 94.74 4.68 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 111.947 -2.388 . . . . 0.0 108.532 -178.608 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.668 ' OG1' ' HA ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -124.02 -69.84 0.79 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.095 -1.003 . . . . 0.0 110.601 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.885 ' HA ' HG22 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -174.96 146.83 1.0 Allowed Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 120.876 -1.14 . . . . 0.0 110.734 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.744 ' N ' ' HB3' ' A' ' 40' ' ' ASP . 50.7 Cg_endo -73.78 -29.01 10.93 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 O-C-N 123.802 1.422 . . . . 0.0 110.565 -178.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.63 -14.95 58.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.381 -0.824 . . . . 0.0 109.884 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.645 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -124.94 -179.65 0.91 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.388 -0.82 . . . . 0.0 109.846 179.732 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.645 ' HD2' ' SG ' ' A' ' 13' ' ' CYS . 51.8 Cg_endo -83.69 111.14 1.71 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.958 1.504 . . . . 0.0 110.444 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.765 ' CE1' ' O ' ' A' ' 10' ' ' SER . 18.1 m-85 -49.59 -111.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 109.606 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.96 ' SG ' HD11 ' A' ' 59' ' ' ILE . 26.7 m -155.06 39.4 0.12 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.17 -0.957 . . . . 0.0 110.353 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.4 Cg_endo -76.2 23.12 0.48 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.84 1.442 . . . . 0.0 110.95 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.719 ' HB3' ' CD ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -103.24 -66.64 0.93 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.049 -1.032 . . . . 0.0 110.85 -179.293 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.942 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -55.53 -21.34 16.47 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.284 -0.885 . . . . 0.0 109.898 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.035 ' CD1' HD13 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -73.0 -39.23 57.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.598 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.672 ' N ' HD12 ' A' ' 20' ' ' ILE . 1.6 tt0 -48.91 -32.66 9.34 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.434 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 16.4 t -68.54 -47.37 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.659 0.742 . . . . 0.0 109.279 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.898 HG13 HG21 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -64.07 -34.45 68.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-O 122.476 1.131 . . . . 0.0 109.513 177.451 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 1.003 ' OD1' HG11 ' A' ' 3' ' ' VAL . 15.2 t0 -71.66 -39.01 70.59 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 122.78 1.276 . . . . 0.0 108.949 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -57.24 -45.31 84.06 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.569 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.5 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -78.28 -40.5 36.81 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.782 0.801 . . . . 0.0 110.808 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.793 ' CB ' HG22 ' A' ' 3' ' ' VAL 0.252 0.0 OUTLIER -70.23 -19.19 63.16 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 117.627 -1.629 . . . . 0.0 108.904 -178.715 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.801 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -70.9 -44.75 65.59 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.38 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.763 ' HG3' ' N ' ' A' ' 30' ' ' PHE 0.26 0.0 OUTLIER -51.92 -35.44 45.63 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.411 179.246 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.776 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -92.54 -66.33 0.93 Allowed 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 104.098 -2.556 . . . . 0.0 104.098 -179.731 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.951 ' HA3' HG23 ' A' ' 2' ' ' VAL . . . -81.05 72.43 2.74 Favored Glycine 0 C--N 1.279 -2.623 0 CA-C-O 115.402 -2.888 . . . . 0.0 115.87 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.546 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -36.28 -23.97 0.01 OUTLIER 'General case' 0 C--N 1.262 -3.218 0 CA-C-N 123.092 3.446 . . . . 0.0 110.183 -177.546 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.955 ' O ' HG21 ' A' ' 2' ' ' VAL . 29.1 mtmm -77.35 152.55 34.4 Favored 'General case' 0 C--N 1.284 -2.281 0 O-C-N 120.263 -1.523 . . . . 0.0 113.384 175.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.801 ' CD1' ' CG ' ' A' ' 28' ' ' LYS 0.259 0.3 OUTLIER -130.66 151.37 35.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 C-N-CA 118.366 -1.334 . . . . 0.0 110.547 176.014 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.643 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -151.27 71.95 1.03 Allowed 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.045 HG13 ' HB ' ' A' ' 5' ' ' ILE 0.307 84.2 t -97.38 125.19 50.54 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.596 0 CA-C-O 124.556 2.122 . . . . 0.0 105.635 -177.869 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.822 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.413 7.3 mm-40 -109.37 133.53 52.94 Favored 'General case' 0 C--O 1.179 -2.625 0 CA-C-O 126.326 2.965 . . . . 0.0 104.438 -177.09 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 1.044 ' C ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -138.24 114.08 9.89 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.36 -1.745 . . . . 0.0 113.95 -173.145 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.044 HD13 ' C ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -133.88 -165.12 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 121.874 2.125 . . . . 0.0 111.835 179.468 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.936 ' OD1' HG11 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -104.54 172.14 6.95 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 178.398 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 1.271 ' CD1' HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -68.25 -55.21 17.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 121.387 -0.821 . . . . 0.0 110.644 176.581 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.646 ' H ' HG23 ' A' ' 41' ' ' ILE . 6.3 ptm -64.27 -0.46 1.26 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 118.612 -1.235 . . . . 0.0 111.594 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.936 HG11 ' OD1' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -113.09 -49.12 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.086 -1.009 . . . . 0.0 110.195 178.341 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.724 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 2.9 t70 -106.34 51.01 0.76 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 109.646 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.728 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.472 6.0 ttt-85 -71.26 2.27 4.96 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 115.044 -2.663 . . . . 0.0 108.711 -176.954 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.983 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.2 mm-40 -52.51 -23.87 7.05 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 120.348 -1.47 . . . . 0.0 109.108 172.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.869 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -49.18 -63.14 1.19 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.941 -1.099 . . . . 0.0 109.012 -178.161 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.999 ' CB ' ' HB2' ' A' ' 55' ' ' ALA 0.414 . . -51.42 -13.91 0.25 Allowed 'General case' 0 C--N 1.256 -3.485 0 C-N-CA 126.886 2.075 . . . . 0.0 111.555 175.372 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.983 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -30.75 -43.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 104.824 -2.287 . . . . 0.0 104.824 -172.957 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.56 ' N ' ' C ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -49.14 -51.37 32.64 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.186 176.414 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 1.261 ' OH ' HG22 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -125.89 -32.6 2.79 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.013 -1.054 . . . . 0.0 110.408 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.814 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 60.99 -33.36 0.05 OUTLIER Glycine 0 N--CA 1.488 2.139 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.805 HD12 ' H ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -49.6 -81.42 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.608 -1.525 . . . . 0.0 109.851 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.805 ' H ' HD12 ' A' ' 53' ' ' LEU . 24.7 mtt -80.28 58.92 3.22 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.999 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.394 . . -106.91 106.14 16.52 Favored 'General case' 0 C--O 1.179 -2.622 0 CA-C-O 126.912 3.244 . . . . 0.0 107.154 -176.623 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.271 HG22 ' CD1' ' A' ' 41' ' ' ILE . 4.8 t -147.77 -64.58 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.435 0 CA-C-N 112.149 -2.296 . . . . 0.0 112.84 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.848 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.449 18.0 Cg_endo -109.41 116.81 0.03 OUTLIER 'Trans proline' 0 C--O 1.157 -3.527 0 CA-C-O 129.507 3.878 . . . . 0.0 103.921 -179.544 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 1.003 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -160.85 177.54 10.3 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 110.639 -2.982 . . . . 0.0 111.646 -175.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.96 HD11 ' SG ' ' A' ' 16' ' ' CYS 0.294 0.2 OUTLIER -141.52 141.15 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.874 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 1.151 ' HB3' ' CB ' ' A' ' 6' ' ' GLU 0.399 . . -91.7 149.89 21.4 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 100.551 -3.87 . . . . 0.0 100.551 -177.225 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.772 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.728 1.1 mt -101.57 101.39 12.05 Favored 'Isoleucine or valine' 0 C--N 1.412 3.299 3 C-N-CA 107.032 -5.867 . . . . 0.0 97.379 -172.237 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.747 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -53.93 84.7 0.0 OUTLIER 'General case' 0 C--N 1.38 1.929 1 CA-C-N 106.549 -4.841 . . . . 0.0 106.888 178.083 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.772 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.24 -44.12 0.36 Allowed Glycine 0 N--CA 1.483 1.793 0 N-CA-C 107.176 -2.37 . . . . 0.0 107.176 -178.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.758 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.1 m -126.16 -59.15 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 O-C-N 121.503 -0.998 . . . . 0.0 111.311 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.758 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 93.8 t -163.1 -106.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 120.326 -1.484 . . . . 0.0 112.901 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.851 ' CZ ' ' HB2' ' A' ' 60' ' ' ALA . 3.4 ttt180 -167.74 163.58 14.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.676 -0.64 . . . . 0.0 109.397 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 1.003 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.53 174.4 11.2 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.848 -1.157 . . . . 0.0 111.268 -177.571 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.261 HG22 ' OH ' ' A' ' 51' ' ' TYR . 59.3 t -83.42 115.12 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.888 -1.133 . . . . 0.0 111.406 177.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.834 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.91 123.4 1.17 Allowed Glycine 0 C--N 1.281 -2.524 0 CA-C-N 119.755 1.161 . . . . 0.0 110.491 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.111 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -93.9 -76.74 0.03 OUTLIER Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 120.772 -1.428 . . . . 0.0 109.194 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 1.111 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 41.7 Cg_endo -83.23 24.93 0.71 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 N-CA-C 108.339 -1.447 . . . . 0.0 108.339 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.729 ' O ' HD13 ' A' ' 59' ' ' ILE 0.449 1.5 p -109.63 87.95 2.63 Favored 'General case' 0 N--CA 1.506 2.372 0 C-N-CA 113.829 -3.149 . . . . 0.0 106.577 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 1.195 ' O ' HD12 ' A' ' 76' ' ' LEU . 24.8 mtt180 -79.77 -40.38 28.84 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 112.871 -1.968 . . . . 0.0 109.201 175.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.942 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.4 tt0 -46.41 -28.22 1.29 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.025 -1.047 . . . . 0.0 109.835 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.778 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -53.12 -46.16 68.62 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.24 -0.912 . . . . 0.0 109.34 -178.537 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.195 HD12 ' O ' ' A' ' 73' ' ' ARG . 0.7 OUTLIER -60.0 -42.53 94.47 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.147 178.526 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.825 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.39 -34.99 69.44 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.821 179.364 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.774 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 31.1 tt0 -78.77 -31.32 46.08 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.031 -1.043 . . . . 0.0 110.216 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.637 ' CB ' ' HA ' ' A' ' 61' ' ' ILE . . . -73.07 -38.26 66.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.092 -1.005 . . . . 0.0 110.002 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.898 HG21 HG13 ' A' ' 23' ' ' VAL . 1.8 mp -61.61 -42.47 94.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.099 -1.001 . . . . 0.0 108.906 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.655 ' HA ' ' SD ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -72.24 -33.52 67.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.961 -1.087 . . . . 0.0 109.604 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 78' ' ' GLU 0.596 0.1 OUTLIER -94.01 0.82 56.22 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 112.027 -3.869 . . . . 0.0 105.573 -177.411 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.76 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -85.95 -59.81 2.19 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 119.546 -1.971 . . . . 0.0 107.841 170.598 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.674 ' SD ' ' HD2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.69 -12.67 61.68 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.737 179.656 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.491 ' N ' ' HG2' ' A' ' 84' ' ' MET . 2.7 tm-20 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.066 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.73 ' SD ' ' ND2' ' A' ' 4' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.314 0.578 . . . . 0.0 110.224 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.029 HG22 ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -90.13 -91.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 0.0 109.976 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.185 HG11 ' OD2' ' A' ' 24' ' ' ASP . 74.1 t -89.22 111.03 22.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.627 -0.671 . . . . 0.0 110.633 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.841 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 2.0 m120 -130.95 105.68 7.91 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.639 -1.224 . . . . 0.0 108.794 178.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.053 HG21 ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -120.7 137.37 54.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.031 179.425 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 1.037 ' HB3' ' HB3' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -131.01 119.77 22.51 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 119.057 -2.277 . . . . 0.0 107.389 177.939 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.968 HG22 ' HA ' ' A' ' 38' ' ' LYS . 23.0 m -105.64 144.78 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.982 ' CD2' ' HB3' ' A' ' 58' ' ' ALA . 2.1 t80 -141.0 79.52 1.7 Allowed 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 119.01 -1.076 . . . . 0.0 112.663 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.698 ' OG1' ' HA ' ' A' ' 15' ' ' TYR . 3.5 m -118.06 -68.64 0.9 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 118.852 -2.405 . . . . 0.0 110.238 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.774 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 1.3 p 179.61 164.61 0.79 Allowed Pre-proline 0 C--N 1.294 -1.843 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.732 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.666 ' HD3' ' CG ' ' A' ' 40' ' ' ASP . 49.8 Cg_endo -80.35 -28.3 3.03 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.278 1.673 . . . . 0.0 110.418 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -18.25 54.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 109.762 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.07 174.49 3.82 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.457 -0.777 . . . . 0.0 109.723 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.652 ' O ' ' O ' ' A' ' 15' ' ' TYR . 50.8 Cg_endo -83.18 114.53 2.21 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.925 1.487 . . . . 0.0 110.437 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.774 ' CE1' ' O ' ' A' ' 10' ' ' SER . 16.5 m-85 -49.22 -112.38 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.132 -0.98 . . . . 0.0 109.576 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.736 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 92.9 m -150.6 37.46 0.13 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.267 -0.895 . . . . 0.0 110.131 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.736 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 53.7 Cg_endo -76.49 17.16 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.021 1.538 . . . . 0.0 111.042 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.553 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -95.1 -68.04 0.82 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.012 -1.055 . . . . 0.0 110.752 -179.461 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.782 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -54.28 -22.51 12.05 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.23 -0.919 . . . . 0.0 109.53 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.053 ' HB ' HG21 ' A' ' 5' ' ' ILE . 5.2 pt -70.67 -39.25 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.507 -0.746 . . . . 0.0 109.623 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.734 ' N ' HG13 ' A' ' 20' ' ' ILE . 6.2 tt0 -48.83 -33.05 9.79 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 3.1 t -72.01 -46.73 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.896 HG21 ' HB ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -62.26 -31.86 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.03 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 1.185 ' OD2' HG11 ' A' ' 3' ' ' VAL . 5.2 t70 -69.45 -39.88 77.5 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.01 0.91 . . . . 0.0 109.196 178.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -46.01 84.81 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.617 0.722 . . . . 0.0 109.674 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.485 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.68 -40.05 42.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.669 -0.645 . . . . 0.0 110.614 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.904 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -69.95 -19.37 63.38 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.124 -1.03 . . . . 0.0 109.208 -179.057 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.799 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -72.52 -44.99 61.44 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.154 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.744 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -50.32 -33.39 19.99 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.851 0.834 . . . . 0.0 110.279 179.494 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.787 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -97.01 -65.79 0.94 Allowed 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 179.639 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.749 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -84.64 82.16 1.7 Allowed Glycine 0 N--CA 1.506 3.323 0 C-N-CA 119.182 -1.485 . . . . 0.0 111.427 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.593 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -35.43 -28.43 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 CA-C-N 121.463 2.631 . . . . 0.0 110.68 178.57 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.837 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -80.0 154.95 27.87 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.498 -0.751 . . . . 0.0 111.686 178.065 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.799 ' CD1' ' CG ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -129.66 151.48 35.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 O-C-N 120.353 -1.467 . . . . 0.0 110.048 178.646 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.598 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -151.3 76.78 1.23 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.943 HG22 ' CD1' ' A' ' 5' ' ' ILE 0.255 55.4 t -96.65 126.98 49.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -178.959 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 1.021 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.251 78.1 mt-10 -111.24 135.43 51.79 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -177.617 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.968 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -129.49 128.92 43.85 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -176.716 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.066 HG22 ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -135.08 171.66 17.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 O-C-N 120.132 -1.605 . . . . 0.0 111.516 178.642 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.767 ' OD1' HG22 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -102.72 170.8 7.79 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.803 0.811 . . . . 0.0 111.757 178.246 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.892 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -61.87 -37.39 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.425 -1.422 . . . . 0.0 109.332 178.489 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.678 ' HG3' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -82.37 -3.09 54.85 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.935 -1.103 . . . . 0.0 111.252 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.066 ' CG2' HG22 ' A' ' 39' ' ' ILE . 2.0 m -114.24 -46.18 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.055 -1.028 . . . . 0.0 109.755 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.937 ' HB2' HD12 ' A' ' 39' ' ' ILE . 1.6 t70 -104.97 40.98 1.4 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.237 -0.914 . . . . 0.0 109.627 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.607 ' NH2' ' HA3' ' A' ' 52' ' ' GLY 0.283 0.0 OUTLIER -65.69 -0.35 2.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.494 -1.379 . . . . 0.0 109.435 -178.823 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 1.148 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.3 mm-40 -62.54 -22.68 66.5 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.867 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -46.38 -66.55 0.39 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.965 -1.084 . . . . 0.0 108.422 -179.075 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.145 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -57.23 -7.63 0.58 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.666 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.225 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.6 pp -26.35 -41.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 O-C-N 119.163 -2.21 . . . . 0.0 106.573 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 1.225 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -52.92 -53.75 44.86 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.998 177.183 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.899 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 25.8 p90 -119.86 -32.8 4.14 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.132 -0.98 . . . . 0.0 109.984 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.722 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 42.38 8.82 0.01 OUTLIER Glycine 0 N--CA 1.502 3.08 0 CA-C-O 122.124 0.847 . . . . 0.0 111.474 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.715 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 4.6 mt -75.55 -81.08 0.08 Allowed 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 175.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.525 ' C ' ' HE2' ' A' ' 51' ' ' TYR . 4.0 mtp -95.74 63.66 2.42 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.443 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 1.145 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.273 . . -107.38 120.26 41.68 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 119.489 -2.007 . . . . 0.0 110.356 -177.803 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.816 ' CG2' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -148.76 -57.98 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.481 -178.709 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.816 ' HD3' ' CG2' ' A' ' 56' ' ' VAL . 59.1 Cg_endo -109.81 109.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 CA-C-O 122.892 1.122 . . . . 0.0 110.323 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 1.011 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -161.88 173.88 13.92 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.186 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.038 ' CG1' HD21 ' A' ' 76' ' ' LEU 0.253 0.3 OUTLIER -134.6 151.94 32.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 120.876 -1.14 . . . . 0.0 107.997 179.296 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 1.037 ' HB3' ' HB3' ' A' ' 6' ' ' GLU 0.297 . . -91.15 155.3 18.72 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.749 HG13 ' N ' ' A' ' 66' ' ' ARG 0.31 1.2 mt -101.29 91.29 2.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 -175.713 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.841 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -51.63 83.04 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 112.834 -1.984 . . . . 0.0 106.807 -178.369 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.714 ' HA3' ' HB2' ' A' ' 83' ' ' GLU . . . 162.41 -44.02 0.36 Allowed Glycine 0 C--N 1.29 -2.027 0 N-CA-C 107.733 -2.147 . . . . 0.0 107.733 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.821 ' O ' HG23 ' A' ' 65' ' ' VAL . 11.6 m -126.67 -58.97 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.903 -0.763 . . . . 0.0 111.139 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 64' ' ' VAL . 81.9 t -163.73 -101.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 120.338 -1.476 . . . . 0.0 112.955 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 1.016 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 1.8 ttp180 -167.17 160.09 13.5 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.444 -0.785 . . . . 0.0 109.343 -177.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 1.011 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -146.09 176.05 10.02 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.11 -0.994 . . . . 0.0 111.702 -177.236 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.816 ' CG2' ' HZ1' ' A' ' 47' ' ' LYS . 79.0 t -83.42 118.96 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.708 -0.62 . . . . 0.0 110.246 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.834 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.5 107.88 0.33 Allowed Glycine 0 N--CA 1.494 2.516 0 C-N-CA 118.536 -1.792 . . . . 0.0 110.386 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.124 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -88.94 -81.42 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 120.989 -1.3 . . . . 0.0 108.511 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 1.124 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 57.1 Cg_endo -83.6 17.04 1.75 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.243 1.128 . . . . 0.0 109.422 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.33 62.52 0.79 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.498 -0.751 . . . . 0.0 110.661 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.725 ' HG2' ' CB ' ' A' ' 16' ' ' CYS . 22.1 mtt180 -69.09 -31.43 70.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.381 -0.825 . . . . 0.0 109.327 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.782 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.2 tm-20 -48.39 -45.13 35.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.427 -0.796 . . . . 0.0 109.449 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.785 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -45.25 -29.11 0.91 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.701 -0.8 . . . . 0.0 108.982 179.715 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.038 HD21 ' CG1' ' A' ' 59' ' ' ILE . 3.2 mp -70.47 -39.92 73.98 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.521 -0.737 . . . . 0.0 109.047 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.853 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.49 -41.16 89.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.401 -0.812 . . . . 0.0 109.824 -179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.52 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 2.5 tm-20 -77.29 -26.62 52.52 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.192 0.52 . . . . 0.0 109.932 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.644 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -71.03 -41.9 70.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 110.978 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.041 ' CD1' HG23 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -62.57 -44.28 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.125 -0.984 . . . . 0.0 109.122 179.416 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.676 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -72.83 -27.76 62.14 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 177.573 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 1.026 ' O ' ' OD1' ' A' ' 82' ' ' ASP 0.328 0.1 OUTLIER -96.06 5.63 50.69 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 119.638 -1.914 . . . . 0.0 107.855 -179.416 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.763 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -96.08 -59.03 1.93 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 178.635 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.683 ' SD ' ' HD2' ' A' ' 27' ' ' LYS . 21.4 ptt? -68.63 -14.52 63.07 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 119.266 -0.974 . . . . 0.0 110.986 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--N 1.3 -1.559 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.002 179.722 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.734 ' SD ' ' ND2' ' A' ' 4' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.225 0.536 . . . . 0.0 110.21 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.029 HG22 ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -89.98 -91.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.303 -0.873 . . . . 0.0 110.59 179.846 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 1.179 HG11 ' OD2' ' A' ' 24' ' ' ASP 0.253 75.1 t -89.19 118.78 35.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.679 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.787 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.481 1.6 m120 -143.6 106.82 4.54 Favored 'General case' 0 C--O 1.16 -3.624 1 CA-C-O 129.728 4.585 . . . . 0.0 105.063 175.064 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.051 HG23 ' CD1' ' A' ' 80' ' ' ILE 0.253 0.0 OUTLIER -111.62 132.87 59.0 Favored 'Isoleucine or valine' 0 C--O 1.262 1.73 0 CA-C-N 109.986 -3.279 . . . . 0.0 114.688 178.217 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 1.017 ' HB3' ' HB3' ' A' ' 60' ' ' ALA 0.593 0.0 OUTLIER -135.8 126.51 27.28 Favored 'General case' 0 C--O 1.197 -1.674 2 CA-C-O 131.334 5.349 . . . . 0.0 104.281 172.239 . . . . . . . . 5 4 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.896 HG22 ' HA ' ' A' ' 38' ' ' LYS 0.339 14.6 m -108.02 156.5 8.52 Favored 'Isoleucine or valine' 0 C--N 1.386 2.191 0 CA-C-N 109.642 -3.436 . . . . 0.0 104.322 -175.699 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.956 ' CD2' ' HB3' ' A' ' 58' ' ' ALA . 1.9 t80 -154.15 76.14 1.04 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.516 -1.365 . . . . 0.0 111.052 -172.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.695 ' CB ' ' HA ' ' A' ' 15' ' ' TYR . 3.5 m -118.96 -70.06 0.81 Allowed 'General case' 0 C--N 1.269 -2.914 0 CA-C-N 120.65 1.568 . . . . 0.0 109.188 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.777 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 1.3 p 179.66 165.05 0.79 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.179 -0.951 . . . . 0.0 110.923 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.667 ' HD3' ' CG ' ' A' ' 40' ' ' ASP . 51.5 Cg_endo -80.4 -28.2 3.05 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.17 1.616 . . . . 0.0 110.511 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -18.25 53.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -0.894 . . . . 0.0 109.74 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -124.95 174.75 3.54 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.417 -0.802 . . . . 0.0 109.664 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.649 ' O ' ' O ' ' A' ' 15' ' ' TYR . 51.8 Cg_endo -83.41 114.69 2.15 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 123.943 1.496 . . . . 0.0 110.309 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.777 ' CE1' ' O ' ' A' ' 10' ' ' SER . 17.3 m-85 -49.41 -112.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.44 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.733 ' CB ' ' HG2' ' A' ' 73' ' ' ARG . 94.0 m -149.97 37.39 0.14 Allowed Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.132 -0.98 . . . . 0.0 110.27 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.723 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 54.4 Cg_endo -76.34 17.17 0.78 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.867 1.456 . . . . 0.0 111.036 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.554 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -95.11 -68.0 0.82 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.966 -1.084 . . . . 0.0 110.614 -179.367 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.751 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -55.28 -20.8 12.22 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.737 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.042 ' HB ' HG21 ' A' ' 5' ' ' ILE . 5.2 pt -71.91 -38.78 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.809 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.736 ' N ' HG13 ' A' ' 20' ' ' ILE . 6.4 tt0 -48.03 -33.59 8.22 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 3.1 t -72.47 -45.46 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-O 121.94 0.876 . . . . 0.0 109.338 179.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.881 HG21 ' HB ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -60.52 -33.09 53.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 122.737 1.256 . . . . 0.0 109.207 176.462 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 1.179 ' OD2' HG11 ' A' ' 3' ' ' VAL . 5.7 t70 -70.55 -40.67 73.26 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.933 1.349 . . . . 0.0 108.144 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.24 -46.45 82.98 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.712 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.474 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -76.76 -40.6 47.84 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.841 0.829 . . . . 0.0 110.827 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.908 ' CB ' HG22 ' A' ' 3' ' ' VAL 0.334 0.0 OUTLIER -73.86 -14.62 61.11 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 116.25 -2.18 . . . . 0.0 109.132 -177.337 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.792 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -72.47 -44.33 62.46 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.826 -1.171 . . . . 0.0 107.892 173.899 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.709 ' HG3' ' N ' ' A' ' 30' ' ' PHE 0.315 0.0 OUTLIER -53.96 -28.95 40.62 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.969 -179.315 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.783 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -99.85 -66.08 0.93 Allowed 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 -179.694 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.775 ' HA3' ' CG2' ' A' ' 2' ' ' VAL . . . -78.82 71.38 2.58 Favored Glycine 0 C--N 1.268 -3.232 0 CA-C-O 113.879 -3.734 . . . . 0.0 115.104 175.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.549 ' O ' ' OD1' ' A' ' 32' ' ' ASP 0.365 0.0 OUTLIER -39.06 -20.0 0.01 OUTLIER 'General case' 0 C--N 1.264 -3.109 1 CA-C-N 124.26 4.03 . . . . 0.0 111.81 -174.821 . . . . . . . . 5 4 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.844 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -75.01 150.71 38.87 Favored 'General case' 0 C--N 1.28 -2.418 0 C-N-CA 126.969 2.108 . . . . 0.0 113.943 171.053 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.792 ' CD1' ' CG ' ' A' ' 28' ' ' LYS 0.331 0.3 OUTLIER -131.09 155.07 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 C-N-CA 116.441 -2.104 . . . . 0.0 110.148 172.374 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.677 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -151.64 76.96 1.22 Allowed 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.09 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.953 HG22 ' CD1' ' A' ' 5' ' ' ILE 0.406 42.6 t -102.56 127.39 56.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 CA-C-O 126.947 3.261 . . . . 0.0 106.457 -177.56 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.976 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.505 68.6 mt-10 -116.01 134.47 54.92 Favored 'General case' 0 C--O 1.188 -2.156 0 O-C-N 118.861 -2.399 . . . . 0.0 107.114 -174.37 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.896 ' HA ' HG22 ' A' ' 7' ' ' VAL 0.576 0.0 OUTLIER -112.73 115.28 28.28 Favored 'General case' 0 C--O 1.298 3.649 2 CA-C-O 107.822 -5.847 . . . . 0.0 121.213 -170.817 . . . . . . . . 5 4 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.067 HG22 ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -132.54 178.24 5.92 Favored 'Isoleucine or valine' 1 C--N 1.232 -4.526 1 CA-C-N 131.381 6.446 . . . . 0.0 110.439 175.931 . . . . . . . . 5 4 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.762 ' OD1' HG22 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -103.22 166.05 10.66 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.068 -1.645 . . . . 0.0 113.04 177.022 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.9 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.4 OUTLIER -59.68 -38.01 73.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 118.15 -1.42 . . . . 0.0 111.899 173.032 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.678 ' HG3' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -80.84 -3.29 50.67 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.793 -1.163 . . . . 0.0 112.457 177.958 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.067 ' CG2' HG22 ' A' ' 39' ' ' ILE . 2.0 m -113.58 -46.24 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.062 -1.024 . . . . 0.0 109.787 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.941 ' HB2' HD12 ' A' ' 39' ' ' ILE . 1.6 t70 -103.82 37.08 2.13 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.28 -0.887 . . . . 0.0 110.473 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.597 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.369 0.0 OUTLIER -65.04 -2.18 2.57 Favored 'General case' 0 C--O 1.2 -1.533 0 C-N-CA 116.783 -1.967 . . . . 0.0 109.789 -176.998 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 1.092 ' O ' HG23 ' A' ' 49' ' ' ILE . 1.8 mm-40 -51.89 -26.71 10.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.021 -1.049 . . . . 0.0 111.635 170.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.832 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -50.15 -61.28 2.25 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.471 -1.393 . . . . 0.0 108.884 -175.018 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.064 ' CB ' ' HB2' ' A' ' 55' ' ' ALA 0.388 . . -51.69 -13.36 0.25 Allowed 'General case' 0 C--N 1.264 -3.14 0 C-N-CA 126.48 1.912 . . . . 0.0 112.065 174.697 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.244 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.3 pp -33.68 -38.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 -169.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 1.244 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.99 -53.59 39.78 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.053 176.12 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.88 ' CZ ' ' HB2' ' A' ' 48' ' ' ALA . 23.1 p90 -120.36 -31.51 4.33 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.083 -1.011 . . . . 0.0 110.29 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.777 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.93 14.65 0.01 OUTLIER Glycine 0 C--O 1.201 -1.962 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.485 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.731 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.4 mt -80.25 -76.03 0.24 Allowed 'General case' 0 C--N 1.253 -3.623 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 178.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.512 ' C ' ' HE2' ' A' ' 51' ' ' TYR . 3.8 mtp -103.07 61.5 0.79 Allowed 'General case' 0 C--O 1.25 1.095 0 O-C-N 119.546 -1.971 . . . . 0.0 108.405 -178.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 1.064 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.548 . . -113.97 125.45 54.03 Favored 'General case' 0 C--O 1.178 -2.68 1 CA-C-O 129.672 4.558 . . . . 0.0 106.724 -175.258 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.8 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -151.03 -55.04 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 CA-C-N 109.795 -3.366 . . . . 0.0 112.301 -175.957 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.8 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.559 38.6 Cg_endo -119.66 116.0 0.01 OUTLIER 'Trans proline' 0 C--O 1.157 -3.525 1 CA-C-O 132.508 5.129 . . . . 0.0 108.86 174.209 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 1.057 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -160.61 173.34 15.63 Favored 'General case' 0 C--N 1.378 1.811 1 CA-C-N 107.777 -4.283 . . . . 0.0 111.671 -174.36 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.039 ' CG1' HD21 ' A' ' 76' ' ' LEU 0.313 0.3 OUTLIER -137.2 156.95 34.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 117.833 -1.547 . . . . 0.0 107.404 177.724 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 1.017 ' HB3' ' HB3' ' A' ' 6' ' ' GLU 0.696 . . -106.41 155.57 19.42 Favored 'General case' 0 C--N 1.379 1.881 3 C-N-CA 107.591 -5.643 . . . . 0.0 97.618 -175.017 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.809 HG13 ' N ' ' A' ' 66' ' ' ARG 0.583 1.7 mt -103.67 91.07 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.186 -2.253 2 CA-C-O 131.758 5.551 . . . . 0.0 101.724 -164.733 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.787 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -42.97 81.58 0.0 OUTLIER 'General case' 0 C--N 1.37 1.462 1 CA-C-N 108.378 -4.01 . . . . 0.0 109.012 176.562 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.752 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.94 -45.71 0.37 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 106.908 -2.477 . . . . 0.0 106.908 -177.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.811 ' O ' HG23 ' A' ' 65' ' ' VAL . 10.9 m -125.67 -58.86 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.679 -0.895 . . . . 0.0 111.431 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 64' ' ' VAL . 80.3 t -163.42 -99.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.551 0 O-C-N 120.314 -1.491 . . . . 0.0 112.879 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 1.013 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 1.6 ttp180 -171.55 157.58 4.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.964 -1.085 . . . . 0.0 109.252 -176.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 1.057 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -143.9 176.04 9.56 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.333 -1.479 . . . . 0.0 111.023 -174.281 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.817 ' CG2' ' HZ1' ' A' ' 47' ' ' LYS . 70.8 t -80.79 117.26 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-O 117.386 -1.292 . . . . 0.0 110.942 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.824 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.81 108.28 0.34 Allowed Glycine 0 C--N 1.277 -2.74 0 CA-C-N 121.173 1.806 . . . . 0.0 110.577 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.101 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -90.16 -79.21 0.03 OUTLIER Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 120.734 -1.451 . . . . 0.0 108.936 178.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 1.101 ' CD ' ' HB3' ' A' ' 70' ' ' ALA 0.256 44.3 Cg_endo -88.53 20.0 1.22 Allowed 'Trans proline' 0 C--O 1.21 -0.918 0 C-N-CA 116.705 -1.73 . . . . 0.0 109.136 177.894 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.16 63.58 1.0 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.761 -1.212 . . . . 0.0 112.179 175.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.733 ' HG2' ' CB ' ' A' ' 16' ' ' CYS . 20.6 mtt180 -67.27 -33.36 75.15 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.889 -1.132 . . . . 0.0 109.708 177.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.751 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.2 tm-20 -47.31 -46.46 25.19 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.043 -1.035 . . . . 0.0 108.986 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.785 ' CD ' ' CE2' ' A' ' 67' ' ' PHE 0.268 0.0 OUTLIER -47.29 -26.43 1.24 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 118.561 -1.256 . . . . 0.0 109.047 -178.371 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.039 HD21 ' CG1' ' A' ' 59' ' ' ILE . 3.1 mp -70.71 -39.86 73.16 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.878 0.847 . . . . 0.0 109.368 177.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.825 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.69 -39.47 84.64 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-O 122.088 0.947 . . . . 0.0 111.14 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 2.6 tm-20 -75.84 -27.84 58.01 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 122.229 1.014 . . . . 0.0 110.058 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.629 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -74.71 -40.6 61.22 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 120.956 -1.09 . . . . 0.0 109.149 -175.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.051 ' CD1' HG23 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -60.82 -45.17 98.48 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.572 0 CA-C-O 122.587 1.184 . . . . 0.0 110.151 177.777 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.726 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.2 OUTLIER -71.84 -32.94 68.03 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.654 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.645 0.1 OUTLIER -99.36 5.95 46.26 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 112.477 -3.689 . . . . 0.0 106.696 -175.258 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.734 ' OE1' ' CA ' ' A' ' 63' ' ' GLY 0.284 0.0 OUTLIER -86.35 -60.68 1.93 Allowed 'General case' 0 N--CA 1.48 1.03 1 O-C-N 116.169 -4.082 . . . . 0.0 108.132 165.739 . . . . . . . . 5 4 . 1 . 018 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.726 ' HE2' ' HA ' ' A' ' 81' ' ' ASN . 21.4 ptt? -66.63 -14.84 62.95 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.946 -1.101 . . . . 0.0 111.456 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.778 -1.106 . . . . 0.0 110.253 177.939 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.675 ' O ' ' CZ ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.305 0.574 . . . . 0.0 110.276 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.995 HG23 ' HA3' ' A' ' 31' ' ' GLY . 11.5 p -84.65 -119.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.269 -0.894 . . . . 0.0 109.921 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.991 HG11 ' OD2' ' A' ' 24' ' ' ASP . 72.6 t -92.61 105.62 16.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.283 -0.886 . . . . 0.0 110.308 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.924 ' ND2' ' ND2' ' A' ' 62' ' ' ASN . 1.3 t-20 -129.2 109.0 10.79 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.755 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.028 HG21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -123.87 136.99 58.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.082 -1.011 . . . . 0.0 110.409 179.747 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 1.084 ' CB ' ' HB3' ' A' ' 60' ' ' ALA . 4.0 tp10 -125.05 104.07 8.35 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 117.916 -1.514 . . . . 0.0 108.782 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.822 ' CG2' ' CB ' ' A' ' 38' ' ' LYS . 15.7 m -93.88 104.73 16.07 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.434 0 CA-C-O 123.315 1.531 . . . . 0.0 108.43 -179.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.884 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 1.6 t80 -117.65 84.88 2.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.221 -0.924 . . . . 0.0 109.78 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.683 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -120.28 -53.28 2.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.529 -0.732 . . . . 0.0 109.882 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . 1.073 ' HA ' HG22 ' A' ' 41' ' ' ILE . 5.3 p 179.43 152.76 0.56 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.316 -0.865 . . . . 0.0 110.513 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.696 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 50.5 Cg_endo -84.52 -29.4 0.82 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.121 1.59 . . . . 0.0 110.205 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.549 ' OG1' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -79.81 -16.87 54.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.376 -0.828 . . . . 0.0 109.946 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.549 ' SG ' ' OG1' ' A' ' 12' ' ' THR . 1.4 m -124.97 179.97 1.0 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.417 -0.802 . . . . 0.0 109.954 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.631 ' O ' ' O ' ' A' ' 15' ' ' TYR . 52.3 Cg_endo -83.6 111.68 1.79 Allowed 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.993 1.522 . . . . 0.0 110.473 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.772 ' CE1' ' O ' ' A' ' 10' ' ' SER . 8.6 m-85 -49.51 -114.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.905 . . . . 0.0 109.728 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.91 ' O ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -155.19 40.7 0.14 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.167 -0.958 . . . . 0.0 110.054 179.543 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.698 ' CA ' HG11 ' A' ' 7' ' ' VAL . 50.1 Cg_endo -74.7 16.15 0.64 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.935 1.492 . . . . 0.0 111.039 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.746 ' CG ' ' HD3' ' A' ' 73' ' ' ARG . 5.1 ttm -84.81 -60.74 1.96 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.129 -0.982 . . . . 0.0 111.305 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.75 ' CB ' ' O ' ' A' ' 73' ' ' ARG . . . -56.41 -18.9 12.55 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.27 -0.894 . . . . 0.0 109.665 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.028 ' HB ' HG21 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -73.83 -40.15 52.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.458 -0.776 . . . . 0.0 109.327 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.72 ' N ' HD12 ' A' ' 20' ' ' ILE . 6.0 tm-20 -53.7 -36.11 61.85 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.1 t -75.94 -39.39 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.959 HG13 HG21 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -70.39 -26.8 29.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-O 122.022 0.915 . . . . 0.0 108.88 177.853 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.991 ' OD2' HG11 ' A' ' 3' ' ' VAL . 4.8 t70 -74.62 -37.45 62.82 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -45.01 91.58 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.314 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.457 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.26 -40.59 30.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.492 -0.755 . . . . 0.0 110.095 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.892 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -65.13 -26.31 68.13 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.182 -1.007 . . . . 0.0 108.871 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 1.024 ' CE ' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.89 -46.64 67.87 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.822 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.78 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -45.94 -42.08 12.4 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.654 0.74 . . . . 0.0 109.057 178.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.78 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -90.27 -56.04 3.37 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.414 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.995 ' HA3' HG23 ' A' ' 2' ' ' VAL . . . -96.08 79.05 0.77 Allowed Glycine 0 N--CA 1.489 2.196 0 O-C-N 121.482 -0.761 . . . . 0.0 111.276 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -37.71 -19.56 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 119.057 1.429 . . . . 0.0 110.767 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.684 ' N ' ' O ' ' A' ' 31' ' ' GLY . 9.5 mtpt -85.74 160.09 19.61 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.911 -1.118 . . . . 0.0 111.289 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.024 HD11 ' CE ' ' A' ' 28' ' ' LYS . 0.6 OUTLIER -130.54 129.33 64.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.084 178.447 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.661 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 8.4 t0 -136.86 74.37 1.49 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.333 -0.854 . . . . 0.0 109.175 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.695 HG13 ' CG1' ' A' ' 5' ' ' ILE . 46.1 t -92.23 115.85 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-O 122.428 1.108 . . . . 0.0 109.406 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.723 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 9.0 mt-10 -97.6 148.15 23.58 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.345 -1.342 . . . . 0.0 108.328 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.822 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.94 120.84 14.51 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.62 -1.3 . . . . 0.0 111.654 -177.376 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.993 HD12 ' CG ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -120.4 174.62 5.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.27 -0.894 . . . . 0.0 111.28 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.856 ' CG ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -112.07 167.69 10.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.074 -1.016 . . . . 0.0 112.629 179.111 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 1.073 HG22 ' HA ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -67.5 -36.21 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.646 -0.658 . . . . 0.0 112.53 178.315 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.776 ' N ' HD13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -90.61 -7.15 53.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.844 -1.16 . . . . 0.0 112.016 -179.09 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.856 HG12 ' CG ' ' A' ' 40' ' ' ASP . 14.0 p -111.27 -35.64 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.015 -1.053 . . . . 0.0 109.934 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.993 ' CG ' HD12 ' A' ' 39' ' ' ILE . 3.0 t70 -115.07 45.49 1.61 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.294 -0.879 . . . . 0.0 110.163 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 45' ' ' ARG 0.257 45.3 ttt180 -59.28 -5.69 0.79 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.462 -1.295 . . . . 0.0 109.406 -179.065 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 1.093 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.2 mm-40 -53.88 -20.88 6.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.335 -0.853 . . . . 0.0 110.329 177.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.855 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -51.95 -56.33 14.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.857 -1.152 . . . . 0.0 109.394 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.16 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -64.7 -2.52 2.52 Favored 'General case' 0 C--N 1.276 -2.609 0 O-C-N 120.896 -1.128 . . . . 0.0 111.467 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.261 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.5 pp -34.25 -37.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 -177.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 1.261 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.5 OUTLIER -55.39 -52.33 63.89 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.153 176.807 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.842 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.5 p90 -121.97 -27.26 4.63 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.129 -0.982 . . . . 0.0 110.278 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.793 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.23 13.18 0.01 OUTLIER Glycine 0 N--CA 1.489 2.197 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.669 ' N ' ' O ' ' A' ' 51' ' ' TYR . 6.4 mt -84.7 -66.0 0.94 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 123.981 1.848 . . . . 0.0 108.375 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.458 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 15.9 mmt -103.87 56.43 0.73 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.021 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 1.16 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.263 . . -99.24 105.41 17.44 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 123.387 1.565 . . . . 0.0 110.661 -176.104 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.966 HG22 HG13 ' A' ' 41' ' ' ILE . 2.0 t -146.4 -65.47 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 121.197 -0.939 . . . . 0.0 110.408 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.815 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 40.8 Cg_endo -97.35 102.7 0.08 OUTLIER 'Trans proline' 0 C--O 1.195 -1.661 0 CA-C-O 124.131 1.638 . . . . 0.0 108.728 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.912 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -156.14 -178.46 7.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.46 -1.4 . . . . 0.0 111.304 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.913 HG13 HD21 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -144.38 140.76 24.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.763 -0.585 . . . . 0.0 109.869 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 1.084 ' HB3' ' CB ' ' A' ' 6' ' ' GLU . . . -81.69 133.41 35.35 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.753 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.353 1.2 mt -85.36 81.25 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.221 0 C-N-CA 116.462 -2.095 . . . . 0.0 107.223 -176.283 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.924 ' ND2' ' ND2' ' A' ' 4' ' ' ASN . 8.3 m120 -44.3 85.87 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 114.512 -1.222 . . . . 0.0 107.895 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.753 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.73 -43.78 0.35 Allowed Glycine 0 N--CA 1.486 1.999 0 N-CA-C 106.177 -2.769 . . . . 0.0 106.177 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.88 ' O ' HG23 ' A' ' 65' ' ' VAL . 14.9 m -128.73 -60.97 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 121.791 -0.829 . . . . 0.0 110.761 179.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 64' ' ' VAL . 64.8 t -165.23 -103.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 120.321 -1.487 . . . . 0.0 111.679 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.843 ' N ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -153.28 164.26 38.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.786 -0.572 . . . . 0.0 109.828 -179.083 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.912 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.42 178.18 8.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.079 -1.013 . . . . 0.0 110.862 -179.737 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.476 HG22 ' OH ' ' A' ' 51' ' ' TYR . 96.0 t -89.45 122.08 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.286 -0.884 . . . . 0.0 109.078 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.847 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -160.96 101.83 0.2 Allowed Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.055 -1.545 . . . . 0.0 111.148 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.054 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -90.29 -83.92 0.02 OUTLIER Pre-proline 0 C--N 1.293 -1.848 0 O-C-N 120.825 -1.397 . . . . 0.0 108.484 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 1.054 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 48.8 Cg_endo -82.55 15.2 2.09 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 N-CA-C 108.909 -1.227 . . . . 0.0 108.909 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.56 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 26.2 p -100.22 69.95 1.51 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.264 -0.897 . . . . 0.0 111.269 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.76 ' HA ' HD13 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -74.87 -40.45 60.95 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.916 -1.115 . . . . 0.0 109.376 179.007 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.707 ' HA ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -46.03 -36.37 5.62 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.185 -0.947 . . . . 0.0 109.153 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.575 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -48.44 -41.61 29.86 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.493 -0.883 . . . . 0.0 108.712 179.318 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.913 HD21 HG13 ' A' ' 59' ' ' ILE . 7.1 mp -56.77 -40.06 75.16 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.675 0.75 . . . . 0.0 109.015 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.816 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -60.69 -42.47 97.22 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.617 0.722 . . . . 0.0 109.918 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.491 ' N ' ' CD2' ' A' ' 77' ' ' PHE . 1.2 tt0 -78.0 -22.73 48.87 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.298 -0.876 . . . . 0.0 110.369 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.567 ' HB1' HG23 ' A' ' 61' ' ' ILE . . . -79.25 -39.58 32.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.106 -0.996 . . . . 0.0 109.937 -178.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.959 HG21 HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -66.07 -32.14 56.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.909 -1.119 . . . . 0.0 108.862 178.861 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.516 ' HA ' ' HE3' ' A' ' 84' ' ' MET . 0.1 OUTLIER -78.38 -29.08 47.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.0 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.563 0.6 OUTLIER -93.36 -7.22 45.36 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 112.718 -3.593 . . . . 0.0 105.742 -179.003 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.798 ' CG ' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -74.99 -54.65 6.81 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.165 -1.584 . . . . 0.0 108.111 171.811 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.808 ' CE ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -75.51 -22.34 57.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.732 -0.605 . . . . 0.0 110.431 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 84' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.211 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.201 0.524 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 1.072 HG21 ' O ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -80.72 -92.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.329 -0.857 . . . . 0.0 110.354 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.963 ' N ' HG22 ' A' ' 2' ' ' VAL . 54.1 t -91.59 128.74 43.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.521 -0.737 . . . . 0.0 110.921 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.809 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 6.4 t-20 -140.63 107.6 5.43 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 123.06 1.409 . . . . 0.0 109.126 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.051 HD12 ' HB ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -135.91 136.18 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 O-C-N 121.032 -1.043 . . . . 0.0 112.032 -178.565 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 1.171 ' O ' HG23 ' A' ' 59' ' ' ILE . 1.4 tp10 -122.5 102.54 8.14 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 118.136 -1.425 . . . . 0.0 108.53 176.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.802 ' CG2' ' CB ' ' A' ' 38' ' ' LYS . 30.0 m -96.19 106.28 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 123.11 1.433 . . . . 0.0 109.327 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.847 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 1.1 t80 -118.19 101.88 8.56 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.67 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.848 HG22 ' N ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -134.03 -61.58 0.79 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.269 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . 1.024 ' HA ' HG22 ' A' ' 41' ' ' ILE . 3.1 t -175.07 144.63 0.83 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.118 -0.988 . . . . 0.0 111.073 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.756 ' N ' ' HB2' ' A' ' 40' ' ' ASP . 50.6 Cg_endo -76.63 -9.43 18.5 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 124.212 1.638 . . . . 0.0 110.652 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.05 -5.21 53.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.996 -1.065 . . . . 0.0 109.794 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.631 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 1.5 p -160.45 -165.65 0.13 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.494 -0.754 . . . . 0.0 110.09 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.631 ' CD ' ' CB ' ' A' ' 13' ' ' CYS . 53.2 Cg_endo -84.32 117.78 2.18 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.895 1.471 . . . . 0.0 110.35 177.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.772 ' HD2' HG23 ' A' ' 7' ' ' VAL . 2.1 m-85 -49.27 -83.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.93 . . . . 0.0 109.632 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.82 ' HB3' HD11 ' A' ' 76' ' ' LEU . 42.5 m -155.41 39.61 0.11 Allowed Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.213 -0.93 . . . . 0.0 109.961 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.708 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 52.9 Cg_endo -73.72 30.35 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.013 1.533 . . . . 0.0 111.142 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.402 ' H ' ' C ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -110.16 -61.93 1.59 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.952 -1.093 . . . . 0.0 110.369 -179.653 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.905 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -58.06 -20.11 36.85 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.457 -0.777 . . . . 0.0 110.033 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.051 ' HB ' HD12 ' A' ' 5' ' ' ILE . 23.0 pt -75.6 -38.99 39.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.492 -0.755 . . . . 0.0 109.531 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.675 ' N ' HG13 ' A' ' 20' ' ' ILE . 49.8 tt0 -49.43 -36.02 21.06 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.68 -43.02 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.917 HG13 HG21 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -69.85 -27.98 35.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.744 0.783 . . . . 0.0 109.234 178.117 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.702 ' OD2' HG11 ' A' ' 3' ' ' VAL . 4.4 t70 -75.77 -36.07 59.95 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -44.18 89.91 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.635 0.731 . . . . 0.0 109.289 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.53 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.45 -41.01 28.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.506 -0.746 . . . . 0.0 110.122 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.82 ' CE ' ' CE ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -67.67 -23.41 65.31 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.206 -179.327 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -69.35 -46.38 67.14 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.373 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.795 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -47.68 -40.66 20.6 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.726 0.774 . . . . 0.0 109.191 179.004 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.795 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.89 -58.06 2.64 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.489 -0.757 . . . . 0.0 109.017 179.587 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.736 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -96.64 77.85 0.72 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 111.341 -0.703 . . . . 0.0 111.341 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.588 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -32.94 -27.37 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 119.315 1.558 . . . . 0.0 110.168 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 1.072 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -88.68 158.37 18.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.417 -0.802 . . . . 0.0 111.259 178.253 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.79 HG23 HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -129.57 150.86 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.081 -1.012 . . . . 0.0 110.581 178.095 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -138.69 61.45 1.58 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.414 -0.804 . . . . 0.0 108.875 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.035 HG13 ' HB ' ' A' ' 5' ' ' ILE . 44.7 t -91.76 115.75 31.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.663 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.759 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 12.4 mt-10 -98.59 140.43 32.83 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.01 -1.076 . . . . 0.0 108.368 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.802 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -138.45 130.81 28.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.411 -0.805 . . . . 0.0 111.845 -176.648 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 1.016 HD12 ' CG ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -138.17 172.8 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.848 . . . . 0.0 109.898 179.598 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 1.083 ' CG ' HG12 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -105.33 169.84 8.23 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.175 -0.953 . . . . 0.0 110.975 179.008 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 1.267 ' CD1' HG22 ' A' ' 56' ' ' VAL . 0.6 OUTLIER -73.79 -17.88 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.254 -0.904 . . . . 0.0 111.593 179.251 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.771 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 2.6 ptt? -92.89 -15.59 26.21 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.809 -1.156 . . . . 0.0 110.21 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 1.083 HG12 ' CG ' ' A' ' 40' ' ' ASP . 14.0 p -111.2 -30.58 2.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 110.256 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 1.016 ' CG ' HD12 ' A' ' 39' ' ' ILE . 5.7 t0 -114.5 48.91 1.07 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.047 -1.033 . . . . 0.0 110.869 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.264 2.5 ttt180 -59.99 -8.8 2.5 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.319 -1.352 . . . . 0.0 109.627 -179.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 1.004 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -58.31 -17.08 17.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.634 174.639 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.816 ' HG2' ' CE1' ' A' ' 8' ' ' PHE . 0.6 OUTLIER -48.96 -61.38 2.09 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.416 1.103 . . . . 0.0 109.68 -178.058 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.155 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -62.06 0.08 0.45 Allowed 'General case' 0 C--N 1.283 -2.308 0 O-C-N 121.613 -0.679 . . . . 0.0 111.566 177.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.078 HD11 ' NE ' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -35.11 -38.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 -176.226 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.586 ' N ' ' C ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -54.81 -49.26 71.43 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.513 177.383 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.825 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -124.96 -28.47 3.46 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.953 -1.092 . . . . 0.0 110.361 179.173 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.777 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 41.15 11.17 0.01 OUTLIER Glycine 0 N--CA 1.486 2.023 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.68 ' N ' ' O ' ' A' ' 51' ' ' TYR . 6.2 mt -84.95 -61.52 1.76 Allowed 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 123.117 1.437 . . . . 0.0 108.344 177.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.545 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 26.0 mtm -110.21 62.88 0.6 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.031 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 1.155 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.268 . . -98.34 107.75 20.29 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 123.092 1.425 . . . . 0.0 111.327 -174.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.267 HG22 ' CD1' ' A' ' 41' ' ' ILE . 1.6 t -146.98 -66.81 0.02 OUTLIER Pre-proline 0 N--CA 1.486 1.368 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.487 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.856 ' CD ' HG12 ' A' ' 56' ' ' VAL . 41.8 Cg_endo -106.25 94.27 0.02 OUTLIER 'Trans proline' 0 C--O 1.206 -1.11 0 CA-C-O 122.701 1.042 . . . . 0.0 109.785 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 1.098 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -152.13 178.67 9.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.226 -0.922 . . . . 0.0 110.667 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 1.272 HG21 ' CD2' ' A' ' 76' ' ' LEU . 1.4 mp -149.91 147.38 16.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.619 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.923 ' HB3' ' CB ' ' A' ' 6' ' ' GLU . . . -81.58 138.03 35.44 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 117.4 -1.72 . . . . 0.0 106.452 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.754 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.382 0.9 OUTLIER -87.93 81.11 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-O 124.807 2.241 . . . . 0.0 106.486 -175.635 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.809 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -42.69 84.88 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 113.466 -1.697 . . . . 0.0 108.006 177.661 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.754 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.08 -47.09 0.38 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 106.328 -2.709 . . . . 0.0 106.328 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.797 ' O ' HG23 ' A' ' 65' ' ' VAL . 11.9 m -124.51 -60.76 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 121.846 -0.797 . . . . 0.0 111.19 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.811 HG12 ' N ' ' A' ' 66' ' ' ARG . 97.6 t -164.04 -107.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.126 -1.609 . . . . 0.0 113.146 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 1.078 ' NE ' HD11 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -156.23 153.65 29.49 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.769 -0.582 . . . . 0.0 109.947 -177.008 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 1.098 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.98 -175.65 4.83 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.982 -1.074 . . . . 0.0 111.75 -178.815 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.39 123.24 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.814 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.23 105.43 0.26 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 118.751 -1.69 . . . . 0.0 111.099 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 1.113 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -89.68 -82.34 0.03 OUTLIER Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 120.831 -1.394 . . . . 0.0 108.202 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 1.113 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 51.1 Cg_endo -82.99 15.22 2.14 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 N-CA-C 108.932 -1.218 . . . . 0.0 108.932 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.71 64.29 1.27 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.323 -0.86 . . . . 0.0 111.547 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.75 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.62 -32.15 65.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.04 -1.038 . . . . 0.0 109.358 178.754 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.905 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -51.23 -41.09 60.08 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.268 -0.895 . . . . 0.0 109.184 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.754 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -46.21 -29.36 1.55 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.465 -0.772 . . . . 0.0 109.267 179.581 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.272 ' CD2' HG21 ' A' ' 59' ' ' ILE . 13.1 mt -72.46 -40.84 66.7 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.812 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.87 -37.33 73.75 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.457 -0.777 . . . . 0.0 109.535 179.371 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -78.58 -26.76 45.57 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.512 -0.743 . . . . 0.0 110.297 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 83' ' ' GLU . . . -74.21 -37.98 63.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.922 . . . . 0.0 110.063 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.917 HG21 HG13 ' A' ' 23' ' ' VAL . 1.5 mp -63.7 -37.35 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.975 -1.078 . . . . 0.0 108.788 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -73.29 -32.79 64.84 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.151 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.668 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.47 0.3 OUTLIER -91.79 -6.55 51.55 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 115.191 -2.604 . . . . 0.0 108.157 -179.419 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.768 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -79.85 -55.02 5.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.361 -1.462 . . . . 0.0 109.419 169.992 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.82 ' CE ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.01 -23.16 64.97 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.338 179.751 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.474 ' CD ' ' C ' ' A' ' 85' ' ' GLU . 3.3 tm-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.257 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.591 ' CE ' ' CD ' ' A' ' 83' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.876 0.846 . . . . 0.0 110.845 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.004 HG21 ' O ' ' A' ' 33' ' ' LYS . 1.4 p -80.04 -96.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.965 -1.084 . . . . 0.0 110.337 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.047 HG21 HD12 ' A' ' 34' ' ' ILE . 47.6 t -89.97 129.05 41.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 121.561 -0.712 . . . . 0.0 109.936 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.983 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 1.5 m-20 -149.05 101.91 3.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.792 -1.192 . . . . 0.0 108.633 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.046 HD12 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.37 138.93 52.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 113.847 -1.524 . . . . 0.0 113.651 -178.403 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.263 ' O ' HG23 ' A' ' 59' ' ' ILE . 13.6 tt0 -132.9 121.42 22.84 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 118.692 -2.505 . . . . 0.0 106.109 176.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.006 HG12 ' CD2' ' A' ' 76' ' ' LEU . 3.9 m -112.28 111.61 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.312 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -176.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.878 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -116.15 95.04 4.9 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.814 -178.252 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.824 ' O ' HD12 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -126.31 -59.42 1.31 Allowed 'General case' 0 C--N 1.291 -1.946 0 O-C-N 121.207 -0.933 . . . . 0.0 108.853 178.284 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.69 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 0.2 OUTLIER 179.09 146.47 0.38 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.825 -1.172 . . . . 0.0 110.704 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.668 ' CD ' ' HB2' ' A' ' 40' ' ' ASP . 48.2 Cg_endo -75.91 -30.17 6.18 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 124.445 1.76 . . . . 0.0 110.359 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.2 t -78.92 -14.34 59.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.58 -0.7 . . . . 0.0 110.081 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.512 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -124.74 179.14 1.17 Allowed Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.516 -0.74 . . . . 0.0 109.868 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.616 ' O ' ' O ' ' A' ' 15' ' ' TYR . 52.2 Cg_endo -83.58 107.02 1.35 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.959 1.505 . . . . 0.0 109.975 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.69 ' CE1' ' O ' ' A' ' 10' ' ' SER . 3.2 m-85 -50.18 -115.42 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.819 -0.551 . . . . 0.0 109.545 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.864 ' SG ' HD11 ' A' ' 59' ' ' ILE . 71.0 m -149.11 38.8 0.19 Allowed Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.941 -1.099 . . . . 0.0 109.423 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.893 ' HA ' HD13 ' A' ' 20' ' ' ILE . 53.2 Cg_endo -74.51 29.85 0.34 Allowed 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 123.829 1.436 . . . . 0.0 111.295 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.7 ' CG ' ' CZ ' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -106.37 -55.01 2.39 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.941 -1.099 . . . . 0.0 110.423 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.754 ' HB2' ' HD3' ' A' ' 73' ' ' ARG . . . -59.17 -19.93 49.39 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.314 -0.866 . . . . 0.0 109.933 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.228 HD12 ' CG1' ' A' ' 36' ' ' VAL . 3.2 pt -72.52 -41.78 63.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-O 121.253 0.549 . . . . 0.0 109.742 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.563 ' N ' ' CG1' ' A' ' 20' ' ' ILE . 7.7 tt0 -53.58 -35.21 60.59 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 t -71.03 -45.78 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.896 ' CG1' HG21 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -63.98 -33.92 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.07 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.701 ' OD2' HG21 ' A' ' 34' ' ' ILE . 31.0 t0 -66.81 -40.88 88.21 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.838 0.827 . . . . 0.0 109.673 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.29 -48.37 79.08 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.604 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.501 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.55 -39.09 47.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.77 -0.581 . . . . 0.0 110.443 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.772 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -72.96 -17.73 61.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.07 -1.019 . . . . 0.0 109.915 -178.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.933 ' HG2' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -71.51 -47.0 58.15 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.319 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.704 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -46.2 -37.42 7.08 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.863 0.839 . . . . 0.0 110.327 179.13 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.817 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -93.72 -72.4 0.61 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 178.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.817 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -82.98 89.82 1.52 Allowed Glycine 0 N--CA 1.487 2.047 0 C-N-CA 118.88 -1.628 . . . . 0.0 109.909 177.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.549 ' OD2' ' NZ ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -40.56 -29.62 0.09 Allowed 'General case' 0 N--CA 1.52 3.065 0 CA-C-N 122.217 3.008 . . . . 0.0 110.667 176.157 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 1.068 ' O ' HD13 ' A' ' 34' ' ' ILE . 9.4 mtmm -79.85 151.77 30.04 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.81 -0.556 . . . . 0.0 112.442 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.068 HD13 ' O ' ' A' ' 33' ' ' LYS . 16.5 mm -129.26 160.28 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 120.466 -1.396 . . . . 0.0 110.055 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.735 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -151.25 70.1 0.96 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.487 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.228 ' CG1' HD12 ' A' ' 20' ' ' ILE 0.255 85.7 t -96.93 123.23 49.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -179.197 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.847 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 7.8 mt-10 -108.84 148.29 30.82 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -177.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.703 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -142.78 110.7 5.93 Favored 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -174.459 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.9 HD12 ' CG ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -111.76 165.0 7.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 122.266 1.032 . . . . 0.0 113.24 -178.213 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.668 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -100.13 161.13 13.8 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.718 0.771 . . . . 0.0 110.931 178.595 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 1.015 HD11 ' C ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER -62.08 -18.74 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 120.473 -1.392 . . . . 0.0 110.99 179.438 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.668 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -91.23 -14.97 30.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.944 -1.097 . . . . 0.0 111.547 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.64 HG13 HG22 ' A' ' 39' ' ' ILE . 10.0 p -113.62 -31.35 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.131 -0.98 . . . . 0.0 110.63 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.9 ' CG ' HD12 ' A' ' 39' ' ' ILE . 41.9 t0 -112.56 37.93 2.91 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.454 -0.899 . . . . 0.0 110.087 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.522 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.296 0.0 OUTLIER -65.04 -3.49 3.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 119.956 -1.715 . . . . 0.0 109.086 -179.51 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 1.123 ' O ' HG23 ' A' ' 49' ' ' ILE . 1.7 mt-10 -60.0 -20.72 59.25 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.848 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -44.55 -63.37 0.91 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.305 -1.497 . . . . 0.0 109.072 -178.75 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.121 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -57.62 -11.23 1.94 Allowed 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.879 -1.51 . . . . 0.0 111.083 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.161 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.7 pp -24.0 -38.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.237 -1.539 . . . . 0.0 107.922 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 1.161 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -56.22 -51.6 67.5 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.873 177.648 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.83 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.0 p90 -122.84 -30.93 3.75 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.467 -0.771 . . . . 0.0 110.122 178.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.716 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 45.05 4.8 0.01 OUTLIER Glycine 1 N--CA 1.52 4.25 0 O-C-N 121.589 -0.695 . . . . 0.0 111.759 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.676 ' H ' ' C ' ' A' ' 51' ' ' TYR . 8.9 mt -75.68 -79.76 0.09 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 175.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.705 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 1.9 mtm -94.21 65.98 3.41 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.31 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 1.121 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.294 . . -108.23 108.64 19.75 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.346 -1.471 . . . . 0.0 109.79 -177.118 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.015 ' C ' HD11 ' A' ' 41' ' ' ILE . 2.6 t -147.76 -65.16 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.28 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.354 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.825 ' HD3' ' HB ' ' A' ' 56' ' ' VAL . 59.9 Cg_endo -105.44 106.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.302 -1.897 0 N-CA-C 109.11 -1.15 . . . . 0.0 109.11 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.962 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -160.71 177.83 10.07 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 112.694 -2.048 . . . . 0.0 111.686 -176.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.263 HG23 ' O ' ' A' ' 6' ' ' GLU 0.271 1.3 mp -146.53 154.3 12.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.019 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.993 ' HB3' ' HB3' ' A' ' 6' ' ' GLU 0.29 . . -87.72 155.49 19.9 Favored 'General case' 0 CA--C 1.479 -1.77 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.706 HG13 ' N ' ' A' ' 66' ' ' ARG 0.312 1.6 mt -104.12 92.19 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.038 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 -175.075 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.983 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.2 OUTLIER -54.74 86.25 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 126.274 2.234 . . . . 0.0 106.256 -178.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.761 ' HA3' ' HB2' ' A' ' 83' ' ' GLU . . . 162.02 -44.95 0.37 Allowed Glycine 0 C--N 1.292 -1.863 0 N-CA-C 107.777 -2.129 . . . . 0.0 107.777 -177.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.782 ' O ' HG23 ' A' ' 65' ' ' VAL . 11.5 m -126.69 -60.81 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.568 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 64' ' ' VAL . 74.6 t -164.38 -99.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 120.929 -1.107 . . . . 0.0 112.379 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.966 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -165.25 157.86 15.81 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.61 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.962 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -146.62 176.19 10.02 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.325 -0.859 . . . . 0.0 111.698 -176.706 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.748 HG22 ' OH ' ' A' ' 51' ' ' TYR . 7.9 t -84.98 121.58 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.693 -0.63 . . . . 0.0 110.363 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.82 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.67 110.08 0.41 Allowed Glycine 0 N--CA 1.498 2.823 0 O-C-N 119.863 -1.773 . . . . 0.0 110.694 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.051 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -90.49 -79.97 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.388 -1.066 . . . . 0.0 108.624 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 1.051 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 57.2 Cg_endo -83.91 18.27 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 N-CA-C 109.012 -1.188 . . . . 0.0 109.012 177.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -102.69 63.62 0.86 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.528 0.68 . . . . 0.0 110.176 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.754 ' HD3' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -70.57 -42.17 71.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 108.759 178.552 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.707 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 2.0 tt0 -44.07 -37.11 2.86 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.756 -0.59 . . . . 0.0 109.854 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.706 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -47.85 -37.79 14.65 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 120.029 -0.669 . . . . 0.0 109.894 179.354 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.161 ' CG ' HG21 ' A' ' 59' ' ' ILE . 9.7 mp -65.23 -41.52 94.3 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.804 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.2 -36.61 73.36 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 122.246 1.022 . . . . 0.0 109.873 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -78.9 -31.01 45.18 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 110.337 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.27 -38.01 75.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.514 -0.741 . . . . 0.0 111.158 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.896 HG21 ' CG1' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -65.66 -42.4 92.63 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 CA-C-O 121.75 0.786 . . . . 0.0 109.168 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.45 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -70.52 -21.09 62.77 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.618 176.302 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.416 ' O ' ' CG ' ' A' ' 82' ' ' ASP 0.356 0.3 OUTLIER -103.38 2.92 34.58 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 117.567 -1.653 . . . . 0.0 106.733 -178.65 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.82 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.33 -58.36 2.52 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 102.264 -3.235 . . . . 0.0 102.264 176.773 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.638 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 7.5 ptt? -69.47 -18.94 63.76 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.022 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.766 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.661 ' O ' ' SD ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.319 0.581 . . . . 0.0 110.217 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.051 HG21 ' O ' ' A' ' 33' ' ' LYS . 1.3 p -79.92 -95.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 109.894 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.042 HG21 HD12 ' A' ' 34' ' ' ILE . 52.1 t -88.89 129.13 40.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.476 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 1.042 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.292 1.5 m-20 -151.16 103.23 3.01 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 125.108 2.385 . . . . 0.0 108.446 179.562 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.067 HD12 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.5 137.26 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 CA-C-N 111.337 -2.665 . . . . 0.0 113.997 -178.165 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.244 ' O ' HG23 ' A' ' 59' ' ' ILE . 12.9 tt0 -131.72 119.89 21.97 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 115.458 -2.497 . . . . 0.0 105.862 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.035 HG12 ' CD2' ' A' ' 76' ' ' LEU . 4.2 m -111.61 111.6 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -176.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.879 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -116.4 93.71 4.34 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.021 -178.25 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.791 ' O ' HD12 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -124.43 -60.02 1.43 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.408 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.774 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 0.2 OUTLIER 179.7 147.72 0.44 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 110.621 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.732 ' CD ' ' HB2' ' A' ' 40' ' ' ASP . 48.4 Cg_endo -76.53 -30.07 5.39 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.273 1.67 . . . . 0.0 110.316 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.6 t -79.48 -13.55 59.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.938 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.58 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -125.03 179.58 1.09 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 109.946 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.648 ' O ' ' O ' ' A' ' 15' ' ' TYR . 52.1 Cg_endo -83.26 106.26 1.36 Allowed 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.984 1.518 . . . . 0.0 110.537 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.774 ' CE1' ' O ' ' A' ' 10' ' ' SER . 3.2 m-85 -49.73 -114.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.095 -1.003 . . . . 0.0 109.741 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.854 ' SG ' HD11 ' A' ' 59' ' ' ILE . 76.1 m -150.0 38.47 0.17 Allowed Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.404 -0.81 . . . . 0.0 109.921 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.889 ' HA ' HD13 ' A' ' 20' ' ' ILE . 50.9 Cg_endo -74.28 29.55 0.33 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.001 1.527 . . . . 0.0 111.129 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.794 ' CG ' ' CZ ' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -105.8 -56.28 2.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.082 -1.011 . . . . 0.0 110.253 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.779 ' HB2' ' HD3' ' A' ' 73' ' ' ARG . . . -58.32 -20.13 40.65 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.314 -0.866 . . . . 0.0 109.622 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.291 HD12 ' CG1' ' A' ' 36' ' ' VAL . 3.1 pt -72.93 -41.82 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.521 -0.737 . . . . 0.0 109.737 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.592 ' N ' ' CG1' ' A' ' 20' ' ' ILE . 7.8 tt0 -52.73 -35.11 55.39 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.4 t -71.65 -44.73 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 121.799 0.809 . . . . 0.0 109.063 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.936 ' CG1' HG21 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -64.66 -32.98 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.75 0.786 . . . . 0.0 109.107 177.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.76 ' OD2' HG21 ' A' ' 34' ' ' ILE . 28.5 t0 -68.53 -40.31 80.81 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.213 1.006 . . . . 0.0 109.477 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.43 -48.13 79.95 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.444 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.524 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -78.24 -39.4 40.39 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.635 -0.665 . . . . 0.0 110.672 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.781 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -71.56 -19.01 62.21 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.208 -178.781 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.904 ' HG2' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -70.86 -47.15 60.88 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 176.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.768 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -46.4 -37.89 8.21 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.781 0.8 . . . . 0.0 109.997 179.313 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.862 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -93.56 -70.3 0.71 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.509 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.862 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -84.82 87.71 1.56 Allowed Glycine 0 N--CA 1.504 3.213 0 C-N-CA 118.111 -1.995 . . . . 0.0 111.059 177.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.587 ' OD2' ' NZ ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -37.73 -28.93 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 O-C-N 118.337 -2.86 . . . . 0.0 111.017 176.703 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 1.105 ' O ' HD13 ' A' ' 34' ' ' ILE . 9.3 mtmm -81.27 151.77 27.93 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.105 HD13 ' O ' ' A' ' 33' ' ' LYS . 16.3 mm -128.96 160.3 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 119.926 -1.734 . . . . 0.0 110.039 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.778 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -151.14 70.01 0.97 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.392 -0.817 . . . . 0.0 108.842 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.291 ' CG1' HD12 ' A' ' 20' ' ' ILE 0.257 81.0 t -96.98 121.87 47.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -178.836 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.881 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 7.6 mt-10 -108.39 147.41 31.61 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.705 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -141.41 111.59 6.8 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -174.569 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.946 HD12 ' CG ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -112.02 166.08 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.101 -0.999 . . . . 0.0 113.256 -178.182 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.732 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -100.6 160.61 14.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.546 -0.722 . . . . 0.0 111.376 178.164 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 1.137 HD11 ' C ' ' A' ' 56' ' ' VAL 0.251 0.2 OUTLIER -62.65 -16.2 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.735 -1.228 . . . . 0.0 110.584 179.737 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.725 ' N ' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -93.2 -14.18 27.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.723 -1.236 . . . . 0.0 111.664 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.653 HG12 ' OD1' ' A' ' 40' ' ' ASP . 9.9 p -114.11 -31.07 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.009 -1.057 . . . . 0.0 110.748 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.946 ' CG ' HD12 ' A' ' 39' ' ' ILE . 43.0 t0 -112.51 37.32 3.09 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.116 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.544 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.341 0.0 OUTLIER -66.34 -1.26 3.23 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 117.49 -1.684 . . . . 0.0 108.666 -177.972 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 1.19 ' O ' HG23 ' A' ' 49' ' ' ILE . 1.7 mt-10 -60.11 -21.16 61.2 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.903 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -44.48 -63.27 0.93 Allowed 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 123.626 1.679 . . . . 0.0 109.011 -177.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.193 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -55.86 -12.81 1.49 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 113.51 -1.677 . . . . 0.0 111.458 177.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.229 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.7 pp -25.07 -38.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 O-C-N 119.524 -1.985 . . . . 0.0 107.244 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 1.229 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -55.55 -52.13 64.77 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.981 177.11 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.883 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 1.8 p90 -123.2 -28.63 3.98 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.239 -0.913 . . . . 0.0 110.014 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.767 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 43.22 5.12 0.01 OUTLIER Glycine 0 N--CA 1.504 3.179 0 CA-C-O 122.367 0.982 . . . . 0.0 111.835 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.739 ' N ' ' O ' ' A' ' 51' ' ' TYR . 8.7 mt -75.95 -75.95 0.17 Allowed 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 174.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.696 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 1.8 mtm -97.68 65.27 1.85 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 1.193 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.296 . . -108.57 109.27 20.46 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.165 -1.585 . . . . 0.0 109.074 -176.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.137 ' C ' HD11 ' A' ' 41' ' ' ILE . 2.6 t -147.83 -64.25 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.826 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.034 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.854 ' HD3' ' HB ' ' A' ' 56' ' ' VAL . 58.1 Cg_endo -105.64 104.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 N-CA-C 108.781 -1.276 . . . . 0.0 108.781 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 1.025 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -159.37 177.3 11.13 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 112.604 -2.089 . . . . 0.0 111.568 -176.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.244 HG23 ' O ' ' A' ' 6' ' ' GLU . 1.3 mp -146.07 153.04 13.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 O-C-N 121.502 -0.748 . . . . 0.0 109.124 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 1.014 ' HB3' ' HB3' ' A' ' 6' ' ' GLU 0.303 . . -87.3 154.62 20.55 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 102.67 -3.085 . . . . 0.0 102.67 -178.651 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.719 HG13 ' N ' ' A' ' 66' ' ' ARG 0.386 1.6 mt -103.72 93.42 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.599 0 N-CA-C 103.363 -2.828 . . . . 0.0 103.363 -175.357 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 1.042 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.2 OUTLIER -52.32 85.04 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 111.602 -2.545 . . . . 0.0 106.121 179.719 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.792 ' HA3' ' HB2' ' A' ' 83' ' ' GLU . . . 162.46 -44.64 0.35 Allowed Glycine 0 C--N 1.289 -2.037 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.857 ' O ' HG23 ' A' ' 65' ' ' VAL . 11.3 m -127.44 -59.33 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.993 -0.71 . . . . 0.0 110.949 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 64' ' ' VAL . 76.1 t -164.68 -101.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.488 0 O-C-N 120.346 -1.471 . . . . 0.0 112.529 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 1.009 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -162.99 158.96 22.88 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.47 -0.769 . . . . 0.0 109.058 -178.173 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 1.025 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -147.07 178.25 8.51 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.804 -1.185 . . . . 0.0 111.498 -177.272 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.78 HG22 ' OH ' ' A' ' 51' ' ' TYR . 8.3 t -86.57 120.94 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.446 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.826 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.89 110.25 0.43 Allowed Glycine 0 N--CA 1.496 2.673 0 C-N-CA 118.066 -2.016 . . . . 0.0 110.349 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.115 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -90.34 -80.52 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.087 -1.243 . . . . 0.0 108.546 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 1.115 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 55.9 Cg_endo -83.48 17.99 1.58 Allowed 'Trans proline' 0 C--N 1.301 -1.966 0 N-CA-C 108.897 -1.232 . . . . 0.0 108.897 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -102.32 64.35 0.91 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.347 -0.846 . . . . 0.0 110.636 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.794 ' CZ ' ' CG ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -71.99 -40.43 68.57 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.04 -1.037 . . . . 0.0 109.293 178.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.764 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 2.0 tt0 -45.24 -37.63 4.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.39 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.779 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -47.41 -38.05 12.6 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.293 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.234 ' CG ' HG21 ' A' ' 59' ' ' ILE . 9.5 mp -64.96 -40.95 95.78 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.425 -0.797 . . . . 0.0 109.214 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.847 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.55 -36.3 73.7 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.864 0.84 . . . . 0.0 109.847 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -78.3 -31.69 48.98 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.64 -0.662 . . . . 0.0 110.6 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -70.58 -38.46 74.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 0.0 111.048 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.936 HG21 ' CG1' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -64.2 -43.33 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 122.425 1.107 . . . . 0.0 109.183 179.079 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.452 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -70.24 -23.37 62.91 Favored 'General case' 0 C--O 1.2 -1.536 0 CA-C-O 117.899 -1.048 . . . . 0.0 109.179 176.692 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.371 0.2 OUTLIER -101.13 2.34 40.12 Favored 'General case' 0 C--O 1.263 1.778 0 C-N-CA 116.619 -2.032 . . . . 0.0 106.189 -178.064 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.844 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.12 -56.62 3.15 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 102.401 -3.185 . . . . 0.0 102.401 176.032 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.702 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 8.2 ptt? -70.53 -18.5 62.94 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.836 -1.165 . . . . 0.0 110.729 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 117.889 -1.053 . . . . 0.0 109.94 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.726 ' SD ' ' ND2' ' A' ' 4' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.303 0.573 . . . . 0.0 110.201 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.027 HG22 ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -89.95 -92.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 0.0 109.947 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.186 HG11 ' OD2' ' A' ' 24' ' ' ASP . 75.1 t -89.15 112.42 24.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.55 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.841 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 2.0 m120 -132.86 105.4 7.1 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.664 -1.273 . . . . 0.0 108.755 178.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.067 HG21 ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -120.4 138.17 51.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.812 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.063 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.3 122.76 26.99 Favored 'General case' 0 C--N 1.282 -2.335 0 C-N-CA 115.832 -2.347 . . . . 0.0 106.841 177.479 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.958 HG22 ' HA ' ' A' ' 38' ' ' LYS . 20.1 m -109.23 142.3 22.14 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.574 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.986 ' CD2' ' HB3' ' A' ' 58' ' ' ALA . 2.0 t80 -139.79 80.99 1.8 Allowed 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 117.979 -1.489 . . . . 0.0 112.823 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.701 ' OG1' ' HA ' ' A' ' 15' ' ' TYR . 3.4 m -117.81 -68.75 0.89 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 119.144 -2.222 . . . . 0.0 110.373 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.768 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 1.3 p 179.55 164.49 0.78 Allowed Pre-proline 0 C--N 1.293 -1.859 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.381 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.672 ' HD3' ' CG ' ' A' ' 40' ' ' ASP . 50.1 Cg_endo -80.27 -28.4 3.03 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.221 1.643 . . . . 0.0 110.424 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -18.37 54.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.749 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.07 174.36 3.95 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.418 -0.801 . . . . 0.0 109.696 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.651 ' O ' ' O ' ' A' ' 15' ' ' TYR . 51.7 Cg_endo -83.01 114.55 2.26 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.914 1.481 . . . . 0.0 110.422 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.768 ' CE1' ' O ' ' A' ' 10' ' ' SER . 16.3 m-85 -49.26 -112.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.597 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.735 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 92.5 m -150.57 37.58 0.14 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.199 -0.938 . . . . 0.0 110.081 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.735 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 53.9 Cg_endo -76.51 17.06 0.81 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.92 1.484 . . . . 0.0 111.027 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.551 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -95.1 -67.97 0.83 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.075 -1.016 . . . . 0.0 110.79 -179.462 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.781 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -54.28 -22.59 12.26 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.216 -0.928 . . . . 0.0 109.512 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.067 ' HB ' HG21 ' A' ' 5' ' ' ILE . 5.1 pt -70.58 -39.18 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.485 -0.759 . . . . 0.0 109.678 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.739 ' N ' HG13 ' A' ' 20' ' ' ILE . 6.1 tt0 -48.88 -33.45 10.72 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 3.2 t -71.41 -47.42 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.898 HG21 ' HB ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -61.4 -32.96 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.018 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 1.186 ' OD2' HG11 ' A' ' 3' ' ' VAL . 5.2 t70 -68.18 -40.38 82.25 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.994 0.902 . . . . 0.0 109.145 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -46.52 83.12 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.666 0.746 . . . . 0.0 109.626 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.485 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.31 -39.58 47.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.622 -0.674 . . . . 0.0 110.717 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.905 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -70.66 -18.18 62.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.917 -1.114 . . . . 0.0 109.328 -179.149 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.799 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -73.57 -45.05 55.71 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.222 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.74 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -50.14 -32.92 17.27 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.959 0.885 . . . . 0.0 110.465 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.783 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -97.19 -67.01 0.87 Allowed 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 179.09 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.755 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -84.97 86.29 1.56 Allowed Glycine 0 N--CA 1.505 3.261 0 C-N-CA 117.899 -2.096 . . . . 0.0 110.154 177.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.595 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -37.54 -29.29 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 O-C-N 118.319 -2.871 . . . . 0.0 110.188 177.799 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.836 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -78.63 155.56 29.5 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.822 -0.549 . . . . 0.0 111.774 178.189 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.799 ' CD1' ' CG ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -130.04 151.46 35.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 120.327 -1.483 . . . . 0.0 109.902 178.651 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.611 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -151.81 78.09 1.24 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.626 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.939 HG22 ' CD1' ' A' ' 5' ' ' ILE . 56.0 t -96.99 129.09 47.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 1.063 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 78.3 mt-10 -113.48 133.1 55.4 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.958 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -127.41 128.67 46.2 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 113.989 -1.459 . . . . 0.0 114.754 -177.589 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.069 HG22 ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -134.16 169.91 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 119.875 -1.766 . . . . 0.0 111.785 177.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.764 ' OD1' HG22 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -100.59 172.02 7.36 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.83 178.03 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.894 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -62.75 -37.88 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.711 -1.243 . . . . 0.0 109.36 178.569 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.678 ' HG3' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -80.95 -4.13 53.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.908 -1.12 . . . . 0.0 111.547 179.289 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.069 ' CG2' HG22 ' A' ' 39' ' ' ILE . 2.0 m -113.99 -45.97 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 120.954 -1.091 . . . . 0.0 110.033 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.933 ' HB2' HD12 ' A' ' 39' ' ' ILE . 1.6 t70 -105.27 41.84 1.31 Allowed 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.498 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.61 ' NH2' ' HA3' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -65.21 -1.71 2.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.118 -1.614 . . . . 0.0 109.5 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 1.151 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.3 mm-40 -62.81 -23.42 67.25 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.265 178.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.87 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -44.45 -68.81 0.17 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.182 -0.949 . . . . 0.0 108.487 179.405 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.138 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -55.57 -10.14 0.62 Allowed 'General case' 0 C--O 1.194 -1.866 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.549 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.207 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.6 pp -23.98 -41.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 119.412 -2.055 . . . . 0.0 105.956 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 1.207 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -54.0 -53.15 56.96 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.443 -0.798 . . . . 0.0 108.853 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.916 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 25.9 p90 -119.96 -32.24 4.26 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.269 -0.894 . . . . 0.0 110.161 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.723 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 42.81 6.36 0.01 OUTLIER Glycine 0 N--CA 1.499 2.874 0 CA-C-O 122.288 0.938 . . . . 0.0 111.572 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.714 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 4.5 mt -74.43 -80.66 0.08 Allowed 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.542 ' C ' ' HE2' ' A' ' 51' ' ' TYR 0.265 4.1 mtp -95.37 67.24 2.92 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.135 177.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 1.138 ' HB2' ' CB ' ' A' ' 48' ' ' ALA . . . -109.46 120.2 41.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 119.62 -1.925 . . . . 0.0 109.922 -178.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.828 HG23 ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -149.12 -56.39 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.936 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.722 -178.711 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.828 ' HD3' HG23 ' A' ' 56' ' ' VAL . 57.7 Cg_endo -111.63 109.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 122.931 0.964 . . . . 0.0 110.263 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 1.002 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -161.36 174.93 12.8 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.185 -1.371 . . . . 0.0 110.901 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.039 ' CG1' HD21 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -134.86 154.64 36.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.42 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 1.01 ' HB3' ' HB3' ' A' ' 6' ' ' GLU 0.26 . . -93.16 157.22 16.39 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 102.71 -3.07 . . . . 0.0 102.71 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.761 HG13 ' N ' ' A' ' 66' ' ' ARG 0.263 1.1 mt -101.87 91.94 2.2 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 -176.317 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.841 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -53.71 83.08 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -178.072 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.708 ' HA3' ' HB2' ' A' ' 83' ' ' GLU . . . 162.36 -43.49 0.36 Allowed Glycine 0 C--N 1.283 -2.363 0 N-CA-C 107.649 -2.181 . . . . 0.0 107.649 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.821 ' O ' HG23 ' A' ' 65' ' ' VAL . 11.9 m -126.95 -58.86 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.851 -0.794 . . . . 0.0 111.097 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 64' ' ' VAL . 81.0 t -163.78 -100.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 120.32 -1.488 . . . . 0.0 113.268 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 1.002 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 1.8 ttp180 -168.45 159.57 10.47 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.547 -0.72 . . . . 0.0 109.396 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 1.002 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -146.37 175.05 10.83 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.144 -0.973 . . . . 0.0 111.865 -177.33 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.756 ' CG2' ' HZ1' ' A' ' 47' ' ' LYS . 79.8 t -82.41 119.33 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.665 -0.647 . . . . 0.0 110.133 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.84 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.77 107.63 0.31 Allowed Glycine 0 N--CA 1.492 2.426 0 C-N-CA 118.655 -1.736 . . . . 0.0 110.578 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.118 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -88.57 -81.2 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.036 -1.273 . . . . 0.0 108.539 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 1.118 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 56.5 Cg_endo -84.5 18.52 1.54 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.407 1.214 . . . . 0.0 109.006 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.62 61.78 0.71 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.583 -0.698 . . . . 0.0 110.493 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.726 ' HG2' ' CB ' ' A' ' 16' ' ' CYS . 22.2 mtt180 -68.35 -32.25 72.21 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.849 -0.741 . . . . 0.0 109.276 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.781 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.2 tm-20 -47.44 -45.39 25.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 109.59 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.78 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -45.18 -29.11 0.88 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.061 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.039 HD21 ' CG1' ' A' ' 59' ' ' ILE . 3.2 mp -70.58 -39.96 73.56 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.511 -0.743 . . . . 0.0 109.059 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.855 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.11 -41.89 89.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.47 -0.769 . . . . 0.0 109.829 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.528 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 2.4 tm-20 -76.41 -27.99 56.5 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.248 0.547 . . . . 0.0 109.76 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.655 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -69.32 -42.54 75.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.04 -1.038 . . . . 0.0 111.286 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.044 ' CD1' HG23 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -61.97 -45.36 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.043 -1.035 . . . . 0.0 108.814 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.697 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -71.68 -27.07 62.79 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.45 0.643 . . . . 0.0 109.442 178.237 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 1.068 ' O ' ' OD1' ' A' ' 82' ' ' ASP 0.287 0.2 OUTLIER -97.69 8.14 45.2 Favored 'General case' 0 C--O 1.196 -1.762 0 O-C-N 118.918 -2.364 . . . . 0.0 107.82 -178.69 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.783 ' HG2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -101.17 -57.77 2.02 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.697 ' HE2' ' HA ' ' A' ' 81' ' ' ASN . 21.4 ptt? -68.23 -15.59 63.64 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.82 176.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.039 179.952 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.922 ' O ' ' HE3' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.31 0.576 . . . . 0.0 110.193 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.951 HG22 ' N ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -80.66 -94.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.157 -0.964 . . . . 0.0 110.195 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.96 HG11 ' CG ' ' A' ' 24' ' ' ASP . 54.6 t -93.03 91.31 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.422 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 1.053 ' H ' HD11 ' A' ' 80' ' ' ILE . 1.9 m-20 -116.88 108.01 15.3 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.942 0.877 . . . . 0.0 109.262 178.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.119 HG21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.07 141.18 45.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.283 -0.886 . . . . 0.0 110.306 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.135 ' CB ' ' HB3' ' A' ' 60' ' ' ALA 0.255 5.4 tt0 -130.12 101.9 6.01 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 117.708 -1.597 . . . . 0.0 109.235 178.134 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.86 HG12 ' CD2' ' A' ' 76' ' ' LEU . 3.3 m -95.52 110.45 24.22 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.423 0 CA-C-O 123.412 1.577 . . . . 0.0 108.085 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.883 ' CD2' ' HB3' ' A' ' 58' ' ' ALA . 1.6 t80 -118.51 91.03 3.46 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.965 -1.084 . . . . 0.0 110.203 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.94 HG22 ' N ' ' A' ' 10' ' ' SER . 0.7 OUTLIER -120.22 -69.62 0.83 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.777 . . . . 0.0 109.629 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.94 ' N ' HG22 ' A' ' 9' ' ' THR . 21.6 t 179.68 152.14 0.56 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 110.831 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 40' ' ' ASP . 49.8 Cg_endo -77.22 -15.94 15.83 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.175 1.618 . . . . 0.0 110.495 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 t -79.27 5.9 11.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.171 -0.956 . . . . 0.0 109.898 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.651 ' SG ' ' CD ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -160.8 -170.94 0.26 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 0.0 110.153 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.651 ' CD ' ' SG ' ' A' ' 13' ' ' CYS . 55.3 Cg_endo -84.2 113.54 1.79 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.882 1.464 . . . . 0.0 110.667 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.662 ' HA ' ' HB ' ' A' ' 9' ' ' THR . 7.4 m-85 -49.55 -112.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.627 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.866 ' CB ' HD11 ' A' ' 59' ' ' ILE . 58.5 m -152.34 39.19 0.14 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.043 -1.036 . . . . 0.0 110.414 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.706 ' HD3' ' N ' ' A' ' 16' ' ' CYS . 54.0 Cg_endo -76.9 17.17 0.85 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.9 1.474 . . . . 0.0 111.023 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.718 ' SD ' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -93.36 -64.71 1.06 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.092 -1.005 . . . . 0.0 112.078 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.825 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -55.96 -22.42 26.29 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.294 -0.879 . . . . 0.0 109.779 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.119 ' HB ' HG21 ' A' ' 5' ' ' ILE . 0.6 OUTLIER -71.28 -39.69 72.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.503 -0.748 . . . . 0.0 109.531 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.92 ' N ' HD12 ' A' ' 20' ' ' ILE . 3.1 tt0 -48.77 -31.83 7.62 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 2.8 t -71.59 -44.96 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.321 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.833 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -68.71 -26.54 33.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.301 -0.874 . . . . 0.0 109.22 178.418 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.96 ' CG ' HG11 ' A' ' 3' ' ' VAL . 14.1 t0 -74.67 -38.72 62.34 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -44.53 91.62 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.666 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.529 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.76 -40.13 29.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.456 -0.777 . . . . 0.0 110.443 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.778 ' N ' ' HE3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.3 -22.79 64.7 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.092 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 1.049 ' HG3' HD12 ' A' ' 34' ' ' ILE . 3.5 mtpt -69.93 -44.59 69.3 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 177.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.802 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -50.14 -39.98 44.95 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.681 0.753 . . . . 0.0 109.079 178.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.802 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.67 -55.22 3.73 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.786 ' O ' HG21 ' A' ' 2' ' ' VAL . . . -96.73 77.38 0.71 Allowed Glycine 0 N--CA 1.488 2.161 0 O-C-N 121.398 -0.814 . . . . 0.0 111.07 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.543 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -33.45 -24.64 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 118.998 1.399 . . . . 0.0 110.424 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.994 ' C ' HD13 ' A' ' 34' ' ' ILE . 1.1 mtmp? -85.42 155.57 21.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.131 -0.98 . . . . 0.0 110.813 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.049 HD12 ' HG3' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -129.33 149.48 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.939 178.634 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.688 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 36.3 t0 -150.31 71.9 1.08 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.495 -0.753 . . . . 0.0 109.254 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.824 HG22 ' CG1' ' A' ' 5' ' ' ILE . 58.4 t -91.34 117.39 34.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.57 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.809 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.25 91.1 mt-10 -100.5 138.06 38.07 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.433 -1.307 . . . . 0.0 108.301 -178.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.737 ' HB3' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -140.62 126.67 19.55 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.725 -1.235 . . . . 0.0 111.598 -177.383 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.116 HG22 HG21 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -139.65 176.0 6.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.486 -0.759 . . . . 0.0 109.653 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.738 ' CG ' HG13 ' A' ' 43' ' ' VAL . 2.1 p30 -114.22 172.9 6.73 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.858 -1.152 . . . . 0.0 111.947 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.856 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.7 OUTLIER -62.27 -5.29 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.41 -0.806 . . . . 0.0 112.03 176.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.738 ' HG3' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -99.94 -18.56 17.03 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.019 -1.051 . . . . 0.0 111.048 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.116 HG21 HG22 ' A' ' 39' ' ' ILE . 0.7 OUTLIER -113.01 -37.08 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.19 -0.944 . . . . 0.0 110.056 -178.389 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 1.034 ' HB2' HD12 ' A' ' 39' ' ' ILE . 5.2 t0 -114.22 52.52 0.83 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.2 -0.938 . . . . 0.0 110.977 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.416 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.255 72.2 ttt180 -65.87 -5.58 9.57 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.315 -1.354 . . . . 0.0 109.575 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 1.0 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.6 OUTLIER -60.11 -15.39 23.09 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.344 -0.848 . . . . 0.0 110.058 176.551 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.842 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -52.17 -58.46 6.54 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.124 -178.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.139 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -63.94 -0.8 1.2 Allowed 'General case' 0 C--N 1.279 -2.471 0 O-C-N 121.331 -0.856 . . . . 0.0 110.73 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.0 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -35.07 -38.7 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 -177.003 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.581 ' N ' ' C ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -53.73 -51.91 61.82 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.165 176.731 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.994 ' CZ ' HG22 ' A' ' 68' ' ' VAL . 1.6 p90 -123.2 -28.22 4.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.085 -1.009 . . . . 0.0 110.449 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.8 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.45 14.18 0.01 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.732 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.4 mt -85.87 -64.92 1.07 Allowed 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 123.674 1.702 . . . . 0.0 107.931 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.503 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 10.0 mtt -105.86 58.12 0.66 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.253 -1.34 . . . . 0.0 107.776 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 1.139 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.264 . . -99.0 106.78 19.08 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 123.467 1.604 . . . . 0.0 110.782 -175.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.789 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -146.72 -60.63 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.21 179.037 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.789 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 46.8 Cg_endo -100.0 104.76 0.05 OUTLIER 'Trans proline' 0 C--O 1.199 -1.47 0 CA-C-O 123.495 1.373 . . . . 0.0 110.429 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 1.031 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -160.14 -177.86 6.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.538 -1.352 . . . . 0.0 111.572 -178.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.266 ' CG1' HD11 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -149.16 137.18 14.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 1.135 ' HB3' ' CB ' ' A' ' 6' ' ' GLU . . . -80.87 140.44 35.36 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 117.155 -1.818 . . . . 0.0 106.987 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.762 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.413 0.7 OUTLIER -89.39 85.91 2.52 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.539 0 C-N-CA 115.302 -2.559 . . . . 0.0 106.058 -175.994 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.773 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.7 OUTLIER -44.12 83.24 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 113.098 -1.865 . . . . 0.0 108.622 177.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.762 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.07 -44.24 0.37 Allowed Glycine 0 N--CA 1.484 1.891 0 N-CA-C 107.042 -2.423 . . . . 0.0 107.042 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.786 ' O ' HG23 ' A' ' 65' ' ' VAL . 16.6 m -126.69 -59.13 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 O-C-N 121.622 -0.928 . . . . 0.0 111.378 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 64' ' ' VAL . 97.0 t -163.85 -106.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 120.289 -1.507 . . . . 0.0 112.249 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 1.072 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 1.8 ttp180 -162.4 165.47 26.35 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.716 -0.615 . . . . 0.0 109.55 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 1.031 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.0 177.83 8.48 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.97 -1.082 . . . . 0.0 111.06 -178.522 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.994 HG22 ' CZ ' ' A' ' 51' ' ' TYR . 22.5 t -93.18 116.55 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.297 -0.877 . . . . 0.0 109.865 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.832 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.41 126.58 1.58 Allowed Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.229 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.063 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -94.03 -83.05 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.759 0 O-C-N 120.921 -1.341 . . . . 0.0 108.709 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 1.063 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 51.4 Cg_endo -80.73 23.81 0.7 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 N-CA-C 109.11 -1.15 . . . . 0.0 109.11 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.51 70.52 1.96 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.238 -0.913 . . . . 0.0 111.432 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.742 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 11.9 mtm180 -76.77 -35.28 57.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.997 -1.064 . . . . 0.0 109.536 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.825 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -49.02 -32.29 9.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.664 179.504 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.781 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -50.9 -40.18 56.1 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.295 -0.878 . . . . 0.0 109.273 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.266 HD11 ' CG1' ' A' ' 59' ' ' ILE . 4.9 mp -64.32 -38.32 90.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.491 -0.755 . . . . 0.0 109.318 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.833 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -60.76 -42.94 98.43 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.868 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.803 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 4.5 tm-20 -78.54 -23.31 46.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 109.851 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.658 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -73.71 -37.01 65.3 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 109.446 -178.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.053 HD11 ' H ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -63.44 -46.08 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.067 -1.02 . . . . 0.0 109.076 178.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.593 ' N ' HG22 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -70.11 -33.59 72.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.35 -0.844 . . . . 0.0 108.742 179.522 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.448 8.0 t70 -88.08 -6.9 57.67 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 114.79 -2.764 . . . . 0.0 107.582 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.748 ' OE1' ' CA ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -81.14 -60.79 2.16 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 120.114 -1.617 . . . . 0.0 109.596 171.234 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.721 ' HE2' ' HZ3' ' A' ' 27' ' ' LYS . 10.3 ptt? -71.62 -12.29 61.27 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.71 -0.619 . . . . 0.0 110.497 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.599 ' CG ' ' OXT' ' A' ' 85' ' ' GLU . 2.1 tt0 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.177 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.2 ttm . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.248 0.547 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.972 HG22 ' N ' ' A' ' 3' ' ' VAL . 0.9 OUTLIER -80.51 -92.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 110.389 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.972 ' N ' HG22 ' A' ' 2' ' ' VAL . 54.6 t -92.76 119.76 40.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.671 -0.643 . . . . 0.0 110.495 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.8 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 9.4 t30 -138.49 114.57 10.14 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.571 1.177 . . . . 0.0 108.865 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.083 HD12 HD13 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -136.15 149.6 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.94 . . . . 0.0 110.724 -179.05 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.084 ' HB3' ' HB3' ' A' ' 60' ' ' ALA . 13.6 tt0 -135.09 106.11 6.64 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.007 -1.477 . . . . 0.0 109.701 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.855 HG22 ' HA ' ' A' ' 38' ' ' LYS . 22.3 m -95.16 104.3 15.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-O 123.1 1.429 . . . . 0.0 108.808 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.893 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 0.7 OUTLIER -117.08 87.91 2.8 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.049 -1.032 . . . . 0.0 109.564 -178.756 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 6.6 m -120.72 -62.72 1.42 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.352 -0.842 . . . . 0.0 109.586 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . 1.055 ' HA ' HG22 ' A' ' 41' ' ' ILE . 12.8 p 179.81 156.41 0.72 Allowed Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.369 -0.832 . . . . 0.0 111.009 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.644 ' HD3' ' CG ' ' A' ' 40' ' ' ASP . 50.8 Cg_endo -84.77 -23.71 2.51 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 124.222 1.643 . . . . 0.0 110.589 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 t -79.37 13.65 1.86 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.159 -0.963 . . . . 0.0 110.055 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.543 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -160.72 -174.27 0.42 Allowed Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 121.417 -0.802 . . . . 0.0 110.184 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.614 ' O ' ' O ' ' A' ' 15' ' ' TYR . 54.4 Cg_endo -84.16 112.09 1.67 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.909 1.478 . . . . 0.0 110.689 177.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.755 ' CE1' ' O ' ' A' ' 10' ' ' SER . 19.3 m-85 -49.45 -110.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.311 -0.868 . . . . 0.0 109.609 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.757 ' CA ' ' HG3' ' A' ' 73' ' ' ARG . 37.6 m -154.81 39.78 0.13 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.027 -1.046 . . . . 0.0 110.57 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.688 ' HD3' ' N ' ' A' ' 16' ' ' CYS . 55.2 Cg_endo -77.26 16.56 1.0 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.767 1.404 . . . . 0.0 110.802 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.559 ' HB3' ' HG2' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -93.27 -64.28 1.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.996 -1.082 . . . . 0.0 112.142 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.722 ' CB ' ' HB3' ' A' ' 73' ' ' ARG . . . -57.48 -18.43 18.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.274 -0.891 . . . . 0.0 109.665 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.096 HG22 ' CB ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -75.71 -39.58 39.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.393 -0.817 . . . . 0.0 109.477 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.722 ' N ' HD12 ' A' ' 20' ' ' ILE . 29.8 tp10 -50.4 -32.84 18.72 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.29 -44.45 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.21 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.865 HG13 HG21 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -69.23 -28.08 37.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.673 0.749 . . . . 0.0 109.379 178.578 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.901 ' CG ' HG11 ' A' ' 3' ' ' VAL . 8.4 t0 -76.11 -36.75 58.73 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.7 -43.6 94.04 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.535 0.683 . . . . 0.0 109.623 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.502 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.9 -40.05 29.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.478 -0.764 . . . . 0.0 110.11 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.748 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -69.24 -22.23 63.87 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.218 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 1.036 ' CG ' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -69.92 -43.22 72.13 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.351 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.773 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -49.48 -39.63 34.33 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.788 0.804 . . . . 0.0 109.037 178.921 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.773 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.2 -56.68 3.18 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.746 ' O ' HG21 ' A' ' 2' ' ' VAL . . . -97.16 77.84 0.67 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.624 -0.991 . . . . 0.0 110.624 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.568 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -32.37 -27.16 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 119.105 1.452 . . . . 0.0 110.527 -179.705 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 1.129 ' C ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -85.95 157.05 20.24 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.347 -0.846 . . . . 0.0 110.938 178.202 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.129 HD12 ' C ' ' A' ' 33' ' ' LYS . 1.7 mp -128.98 157.98 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.044 -1.035 . . . . 0.0 110.765 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.692 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 3.4 t0 -150.21 62.48 0.97 Allowed 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.459 -0.775 . . . . 0.0 109.166 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.753 HG22 ' CD1' ' A' ' 5' ' ' ILE . 63.5 t -91.27 115.86 31.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 122.264 1.031 . . . . 0.0 109.862 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.74 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 3.5 mm-40 -97.94 145.08 26.82 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.932 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 1.033 ' C ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -139.98 121.48 15.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.075 -1.016 . . . . 0.0 111.453 -176.807 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.033 HD13 ' C ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -129.06 178.2 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 110.354 -179.152 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.737 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -113.88 165.65 12.37 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.217 -0.927 . . . . 0.0 111.06 178.242 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 1.238 ' CD1' HG12 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -49.58 -38.82 13.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.512 -0.743 . . . . 0.0 112.769 177.656 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.737 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.9 OUTLIER -86.88 -3.46 59.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.844 -1.16 . . . . 0.0 111.483 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.026 ' CG2' HG22 ' A' ' 39' ' ' ILE . 1.9 m -111.15 -44.07 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.97 -1.081 . . . . 0.0 109.801 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.761 ' HB2' ' CB ' ' A' ' 39' ' ' ILE . 4.0 t70 -112.37 45.37 1.3 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.356 -0.84 . . . . 0.0 110.029 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.682 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 2.4 ttt-85 -61.28 -4.64 1.26 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.849 -1.14 . . . . 0.0 109.469 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 1.071 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.1 mm-40 -55.02 -19.74 7.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.396 -0.815 . . . . 0.0 110.253 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.843 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -50.22 -59.1 4.28 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 122.413 1.102 . . . . 0.0 110.067 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.157 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -65.37 -0.09 1.71 Allowed 'General case' 0 C--N 1.281 -2.399 0 O-C-N 121.555 -0.716 . . . . 0.0 111.094 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.27 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.4 pp -35.64 -36.92 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 1.27 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.8 OUTLIER -54.09 -52.54 60.67 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.047 176.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 1.049 ' OH ' HG22 ' A' ' 68' ' ' VAL . 2.0 p90 -122.75 -28.22 4.19 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.088 -1.007 . . . . 0.0 110.203 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.789 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.62 14.3 0.01 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.657 ' N ' ' O ' ' A' ' 51' ' ' TYR . 4.4 mt -86.09 -62.77 1.44 Allowed 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 123.122 1.439 . . . . 0.0 108.462 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 19.9 mtp -106.72 53.83 0.69 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.158 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 1.157 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.268 . . -98.94 111.14 23.62 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 123.189 1.471 . . . . 0.0 110.903 -176.142 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.238 HG12 ' CD1' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -146.68 -68.38 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 110.459 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.844 ' HD3' ' CG2' ' A' ' 56' ' ' VAL . 51.0 Cg_endo -96.14 103.81 0.1 OUTLIER 'Trans proline' 0 C--O 1.2 -1.423 0 CA-C-O 123.396 1.332 . . . . 0.0 109.742 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 1.035 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -158.11 175.14 14.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.75 -1.219 . . . . 0.0 111.562 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.03 ' CG1' HD21 ' A' ' 76' ' ' LEU . 1.0 OUTLIER -138.39 135.58 44.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.613 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 1.084 ' HB3' ' HB3' ' A' ' 6' ' ' GLU . . . -81.51 139.59 35.06 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 117.361 -1.736 . . . . 0.0 107.058 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.756 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.372 1.0 OUTLIER -88.55 83.4 2.2 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.346 0 CA-C-O 124.786 2.232 . . . . 0.0 106.824 -175.895 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.8 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 4.5 m120 -43.11 82.68 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.616 -1.629 . . . . 0.0 108.767 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.756 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.04 -44.52 0.37 Allowed Glycine 0 N--CA 1.481 1.694 0 N-CA-C 107.414 -2.275 . . . . 0.0 107.414 -177.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.761 ' O ' HG23 ' A' ' 65' ' ' VAL . 17.0 m -125.78 -59.82 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 121.718 -0.872 . . . . 0.0 110.98 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.766 HG12 ' N ' ' A' ' 66' ' ' ARG . 88.6 t -163.81 -107.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 120.312 -1.492 . . . . 0.0 112.288 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 1.045 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 2.0 ttp180 -164.7 163.53 21.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.631 -0.668 . . . . 0.0 109.671 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 1.035 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -144.76 176.86 9.13 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.896 -1.127 . . . . 0.0 111.366 -178.124 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.049 HG22 ' OH ' ' A' ' 51' ' ' TYR . 79.8 t -89.14 115.82 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.651 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.858 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.57 124.8 1.31 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.564 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.093 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -92.85 -79.68 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 120.882 -1.364 . . . . 0.0 108.396 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 1.093 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 55.2 Cg_endo -81.01 25.29 0.64 Allowed 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.595 1.313 . . . . 0.0 109.228 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . 0.273 28.5 m -102.67 82.84 2.19 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 123.269 1.509 . . . . 0.0 110.007 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.757 ' HG3' ' CA ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -77.94 -35.74 50.1 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.947 -1.096 . . . . 0.0 109.988 177.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.71 ' HG2' ' CD2' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -46.1 -30.13 1.78 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.362 -0.836 . . . . 0.0 109.99 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.806 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -50.91 -42.69 59.56 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.27 -0.894 . . . . 0.0 109.193 179.738 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.096 ' CB ' HG22 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -63.49 -45.57 90.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.604 -0.685 . . . . 0.0 109.492 178.657 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.798 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -60.93 -38.57 86.26 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.639 0.733 . . . . 0.0 110.245 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.613 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 25.4 tt0 -80.22 -21.9 42.39 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.267 -0.896 . . . . 0.0 110.202 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.476 ' HB1' ' HA ' ' A' ' 61' ' ' ILE . . . -77.95 -39.77 41.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.207 -0.933 . . . . 0.0 109.643 -177.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.014 ' CD1' HG23 ' A' ' 5' ' ' ILE . 1.5 mp -65.72 -39.7 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.038 -1.039 . . . . 0.0 109.156 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.573 ' C ' ' OD1' ' A' ' 81' ' ' ASN . 0.1 OUTLIER -75.53 -32.02 60.32 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.118 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.613 ' HB3' ' O ' ' A' ' 78' ' ' GLU 0.455 0.4 OUTLIER -89.03 -8.39 54.09 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 114.989 -2.685 . . . . 0.0 108.115 -179.159 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.744 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -78.9 -60.71 2.27 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 119.968 -1.708 . . . . 0.0 110.196 169.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.639 ' SD ' ' HD2' ' A' ' 27' ' ' LYS . 4.7 ptt? -71.88 -9.16 57.93 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.782 -0.574 . . . . 0.0 110.822 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.572 ' OE2' ' C ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.898 -1.049 . . . . 0.0 109.973 -177.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.226 0.536 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.065 HG21 ' O ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -80.5 -92.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.333 -0.854 . . . . 0.0 110.359 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.954 ' N ' HG22 ' A' ' 2' ' ' VAL . 53.6 t -91.51 128.49 43.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.483 -0.76 . . . . 0.0 110.565 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.786 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 6.3 t-20 -140.3 108.38 5.75 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 123.202 1.477 . . . . 0.0 108.604 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.047 HD12 ' HB ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -136.15 135.92 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 O-C-N 120.747 -1.221 . . . . 0.0 112.061 -178.768 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.15 ' O ' HG23 ' A' ' 59' ' ' ILE 0.253 1.4 tp10 -122.66 102.06 7.83 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 123.196 1.474 . . . . 0.0 108.587 176.756 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.8 ' CG2' ' CB ' ' A' ' 38' ' ' LYS . 29.5 m -95.42 106.39 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 123.582 1.658 . . . . 0.0 109.51 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.841 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 1.1 t80 -117.92 102.15 8.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.071 -1.018 . . . . 0.0 109.76 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.846 HG22 ' N ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -134.0 -61.9 0.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.955 . . . . 0.0 110.214 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 1.027 ' HA ' HG22 ' A' ' 41' ' ' ILE . 3.1 t -175.13 144.63 0.82 Allowed Pre-proline 0 N--CA 1.487 1.386 0 O-C-N 121.118 -0.989 . . . . 0.0 111.152 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.752 ' N ' ' HB2' ' A' ' 40' ' ' ASP . 48.7 Cg_endo -76.76 -9.39 18.31 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 124.135 1.597 . . . . 0.0 110.475 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.95 -5.0 52.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.21 -0.931 . . . . 0.0 109.843 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.624 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 1.4 p -160.61 -166.15 0.14 Allowed Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.385 -0.822 . . . . 0.0 110.056 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.624 ' CD ' ' CB ' ' A' ' 13' ' ' CYS . 55.6 Cg_endo -84.17 117.8 2.23 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.863 1.454 . . . . 0.0 110.617 176.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.773 ' HD2' HG23 ' A' ' 7' ' ' VAL . 2.1 m-85 -49.27 -84.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.0 109.56 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.814 ' HB3' HD11 ' A' ' 76' ' ' LEU . 42.2 m -155.22 39.69 0.12 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.124 -0.985 . . . . 0.0 109.968 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.7 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 53.4 Cg_endo -73.78 30.4 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.881 1.464 . . . . 0.0 111.146 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.4 ' H ' ' C ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -110.17 -61.85 1.6 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.029 -1.044 . . . . 0.0 110.433 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.9 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -58.1 -20.06 37.03 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.464 -0.773 . . . . 0.0 110.062 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.047 ' HB ' HD12 ' A' ' 5' ' ' ILE . 23.0 pt -75.62 -39.07 39.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.479 -0.763 . . . . 0.0 109.513 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.672 ' N ' HG13 ' A' ' 20' ' ' ILE . 49.7 tt0 -49.63 -35.86 22.56 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.8 -42.46 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.048 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.912 HG13 HG21 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -70.88 -26.66 28.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-O 121.825 0.821 . . . . 0.0 109.185 178.299 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.698 ' OD2' HG11 ' A' ' 3' ' ' VAL . 4.6 t70 -76.9 -35.84 57.09 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -43.99 91.07 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.622 0.725 . . . . 0.0 109.321 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.529 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.44 -41.01 28.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.622 -0.674 . . . . 0.0 110.165 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.813 ' CE ' ' CE ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -67.72 -23.38 65.26 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.306 -179.404 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -69.32 -46.42 67.14 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.322 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.791 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -47.47 -41.0 19.69 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.585 0.707 . . . . 0.0 109.124 178.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.791 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.57 -57.87 2.72 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.731 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -97.15 78.28 0.67 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.583 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -33.46 -27.24 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 119.394 1.597 . . . . 0.0 110.101 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 1.065 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -88.72 158.02 18.33 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.197 -0.939 . . . . 0.0 111.339 178.366 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.792 HG23 HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -129.47 151.03 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.406 -0.917 . . . . 0.0 110.685 178.127 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -138.82 61.14 1.58 Allowed 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.445 -0.784 . . . . 0.0 108.97 179.649 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.025 HG13 ' HB ' ' A' ' 5' ' ' ILE . 44.6 t -91.59 115.48 30.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 122.454 1.121 . . . . 0.0 109.681 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.753 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.25 12.2 mt-10 -98.07 141.02 31.53 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.375 -178.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.8 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -138.45 130.9 28.94 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.765 -1.21 . . . . 0.0 112.127 -176.748 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.013 HD12 ' CG ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -138.53 173.12 12.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.525 -0.734 . . . . 0.0 110.006 179.531 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 1.071 ' CG ' HG12 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -105.84 169.68 8.34 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.102 -0.999 . . . . 0.0 110.889 179.234 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 1.258 ' CD1' HG22 ' A' ' 56' ' ' VAL . 0.6 OUTLIER -73.16 -19.32 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.444 -0.785 . . . . 0.0 111.598 179.16 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.756 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 2.4 ptt? -90.62 -18.1 25.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.06 -1.025 . . . . 0.0 110.634 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.071 HG12 ' CG ' ' A' ' 40' ' ' ASP . 13.3 p -110.01 -29.78 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.344 -0.847 . . . . 0.0 110.77 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 1.013 ' CG ' HD12 ' A' ' 39' ' ' ILE . 5.7 t0 -114.7 48.19 1.16 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.021 -1.049 . . . . 0.0 110.843 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.26 2.3 ttt180 -59.09 -8.29 1.45 Allowed 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 118.263 -1.375 . . . . 0.0 109.974 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.988 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.5 OUTLIER -61.34 -13.41 19.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 109.175 175.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.813 ' HG2' ' HB3' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -51.71 -60.16 3.47 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.168 0.985 . . . . 0.0 108.959 -178.521 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.134 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -64.2 1.57 0.71 Allowed 'General case' 0 C--N 1.278 -2.533 0 O-C-N 121.119 -0.988 . . . . 0.0 110.55 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.077 HD11 ' NE ' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -35.67 -38.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 -177.457 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.56 ' N ' ' C ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -54.62 -49.36 70.68 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.668 176.717 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.825 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -124.93 -28.55 3.46 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.999 -1.063 . . . . 0.0 110.411 179.21 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.787 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.14 13.3 0.01 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.66 ' N ' ' O ' ' A' ' 51' ' ' TYR . 6.2 mt -86.52 -60.94 1.85 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 123.526 1.631 . . . . 0.0 107.88 177.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.533 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 26.0 mtm -110.55 62.35 0.6 Allowed 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.633 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 1.134 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.278 . . -98.35 107.78 20.32 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 123.622 1.677 . . . . 0.0 111.124 -174.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.258 HG22 ' CD1' ' A' ' 41' ' ' ILE . 1.6 t -146.66 -68.42 0.02 OUTLIER Pre-proline 0 N--CA 1.484 1.232 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.23 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.845 ' CD ' HG12 ' A' ' 56' ' ' VAL . 55.6 Cg_endo -104.22 93.46 0.03 OUTLIER 'Trans proline' 0 C--O 1.201 -1.327 0 CA-C-O 123.528 1.386 . . . . 0.0 111.257 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 1.097 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -151.2 179.32 8.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.32 -1.488 . . . . 0.0 110.957 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.264 HG21 ' CD2' ' A' ' 76' ' ' LEU . 1.4 mp -149.92 147.47 16.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.463 -0.773 . . . . 0.0 110.508 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.927 ' HB3' ' CB ' ' A' ' 6' ' ' GLU . . . -81.59 137.9 35.44 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.755 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.406 1.0 OUTLIER -87.8 82.34 2.05 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.555 0 C-N-CA 115.318 -2.553 . . . . 0.0 105.277 -175.756 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.786 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -44.3 85.67 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 113.3 -1.773 . . . . 0.0 107.851 177.816 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.755 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.0 -47.12 0.38 Allowed Glycine 0 N--CA 1.482 1.716 0 N-CA-C 106.471 -2.652 . . . . 0.0 106.471 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.787 ' O ' HG23 ' A' ' 65' ' ' VAL . 11.9 m -124.49 -60.86 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 121.82 -0.812 . . . . 0.0 111.094 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.805 HG12 ' N ' ' A' ' 66' ' ' ARG . 96.7 t -164.01 -107.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 120.104 -1.623 . . . . 0.0 113.185 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 1.077 ' NE ' HD11 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -156.18 153.69 29.64 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.671 -0.643 . . . . 0.0 110.13 -177.194 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 1.097 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.52 -174.93 4.53 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.905 -1.122 . . . . 0.0 111.836 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.92 122.95 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.812 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.33 105.59 0.26 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 118.865 -1.636 . . . . 0.0 111.153 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.103 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -89.74 -82.74 0.02 OUTLIER Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 120.824 -1.397 . . . . 0.0 108.146 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 1.103 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 55.7 Cg_endo -82.19 14.76 2.16 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 O-C-N 123.28 1.147 . . . . 0.0 109.499 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.48 64.48 1.32 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.218 -0.926 . . . . 0.0 111.587 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.746 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.59 -32.15 65.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.897 -1.127 . . . . 0.0 109.361 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.9 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -51.34 -40.99 60.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.923 . . . . 0.0 109.244 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.744 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -46.32 -29.31 1.6 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.465 -0.772 . . . . 0.0 109.344 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.264 ' CD2' HG21 ' A' ' 59' ' ' ILE . 13.1 mt -72.46 -40.85 66.69 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.803 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.94 -36.98 73.28 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.799 0.809 . . . . 0.0 109.646 179.279 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -79.44 -25.79 41.9 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.328 -0.858 . . . . 0.0 110.123 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.463 ' HB1' HG22 ' A' ' 61' ' ' ILE . . . -74.95 -37.91 61.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.161 -0.962 . . . . 0.0 109.743 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.912 HG21 HG13 ' A' ' 23' ' ' VAL . 1.5 mp -63.64 -37.41 79.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.957 -1.09 . . . . 0.0 108.807 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -72.94 -33.89 66.2 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.64 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.501 0.3 OUTLIER -90.95 -6.58 53.88 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 114.114 -3.035 . . . . 0.0 107.454 -179.059 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.756 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -78.7 -55.19 5.37 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 119.859 -1.776 . . . . 0.0 109.838 170.091 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.813 ' CE ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.04 -23.26 64.96 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.171 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.471 ' CD ' ' C ' ' A' ' 85' ' ' GLU . 3.3 tm-20 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.234 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.239 0.542 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.06 HG21 ' O ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -80.45 -94.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.284 -0.885 . . . . 0.0 110.583 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.981 ' N ' HG22 ' A' ' 2' ' ' VAL . 57.6 t -87.84 133.11 31.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 O-C-N 121.395 -0.816 . . . . 0.0 112.692 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.84 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.51 7.3 t-20 -153.92 106.51 2.85 Favored 'General case' 0 N--CA 1.518 2.939 1 CA-C-O 129.399 4.428 . . . . 0.0 109.208 177.868 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.05 HD12 ' HB ' ' A' ' 20' ' ' ILE 0.414 0.2 OUTLIER -119.3 130.57 73.77 Favored 'Isoleucine or valine' 0 C--O 1.264 1.834 0 CA-C-N 108.689 -3.869 . . . . 0.0 117.903 -174.823 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.27 ' O ' HG23 ' A' ' 59' ' ' ILE 0.644 1.2 tp10 -133.7 123.3 24.72 Favored 'General case' 0 C--N 1.269 -2.895 2 CA-C-O 131.792 5.567 . . . . 0.0 106.17 166.824 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.797 HG23 ' HD2' ' A' ' 15' ' ' TYR 0.257 25.0 m -113.19 100.86 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.517 1 O-C-N 114.476 -5.14 . . . . 0.0 109.155 -171.42 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.862 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 1.2 t80 -113.79 104.98 12.74 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 111.69 -2.505 . . . . 0.0 108.623 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.838 HG22 ' N ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -135.6 -60.61 0.74 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.929 0.871 . . . . 0.0 110.564 177.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . 1.044 ' HA ' HG22 ' A' ' 41' ' ' ILE . 3.1 t -177.57 143.62 0.51 Allowed Pre-proline 0 N--CA 1.487 1.414 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.41 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.75 ' N ' ' HB2' ' A' ' 40' ' ' ASP . 47.2 Cg_endo -76.08 -9.52 19.28 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 124.119 1.589 . . . . 0.0 110.225 -178.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.14 -5.19 53.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.056 -1.027 . . . . 0.0 109.843 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.633 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 1.4 p -159.75 -165.88 0.13 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.353 -0.842 . . . . 0.0 110.138 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.633 ' CD ' ' CB ' ' A' ' 13' ' ' CYS . 55.3 Cg_endo -84.22 117.65 2.2 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.865 1.455 . . . . 0.0 110.582 176.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.797 ' HD2' HG23 ' A' ' 7' ' ' VAL . 2.0 m-85 -49.22 -83.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 109.625 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.814 ' HB3' HD11 ' A' ' 76' ' ' LEU . 42.7 m -155.29 39.59 0.12 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.146 -0.971 . . . . 0.0 109.962 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 52.9 Cg_endo -73.69 30.3 0.32 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.977 1.514 . . . . 0.0 111.141 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.401 ' H ' ' C ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -110.06 -61.98 1.58 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.966 -1.084 . . . . 0.0 110.348 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.862 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -58.86 -19.11 38.91 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.099 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.05 ' HB ' HD12 ' A' ' 5' ' ' ILE . 22.8 pt -75.95 -38.0 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.141 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.675 ' N ' HG13 ' A' ' 20' ' ' ILE . 50.1 tt0 -49.0 -37.58 20.78 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.42 -44.87 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-O 122.05 0.929 . . . . 0.0 109.297 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.909 HG13 HG21 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -63.01 -35.71 72.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 122.789 1.281 . . . . 0.0 109.92 175.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.698 ' OD2' HG11 ' A' ' 3' ' ' VAL . 4.0 t70 -70.64 -39.03 73.92 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.903 1.335 . . . . 0.0 108.298 -177.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -46.35 81.94 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.062 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.518 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -76.74 -41.6 44.36 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.636 0.731 . . . . 0.0 110.297 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.821 ' CE ' ' CE ' ' A' ' 84' ' ' MET 0.272 0.0 OUTLIER -72.02 -17.71 62.01 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 117.471 -1.691 . . . . 0.0 109.632 -177.32 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.626 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -70.33 -45.86 65.35 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 120.923 -1.111 . . . . 0.0 108.223 173.764 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.722 ' HG3' ' N ' ' A' ' 30' ' ' PHE 0.317 0.0 OUTLIER -52.97 -28.8 25.45 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.014 -179.042 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.777 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -102.17 -59.16 1.75 Allowed 'General case' 0 C--N 1.274 -2.706 0 O-C-N 119.108 -2.245 . . . . 0.0 106.67 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.772 ' HA3' ' CG2' ' A' ' 2' ' ' VAL . . . -80.23 58.85 4.61 Favored Glycine 1 C--N 1.24 -4.8 1 CA-C-O 113.008 -4.218 . . . . 0.0 116.433 174.526 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.571 ' C ' ' O ' ' A' ' 31' ' ' GLY 0.428 0.0 OUTLIER -36.45 -19.65 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.219 1 CA-C-N 125.182 4.491 . . . . 0.0 112.901 -168.647 . . . . . . . . 5 4 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 1.06 ' O ' HG21 ' A' ' 2' ' ' VAL 0.293 0.0 OUTLIER -75.96 151.29 37.29 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 127.536 2.334 . . . . 0.0 115.69 167.953 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.799 HG23 HG23 ' A' ' 36' ' ' VAL 0.342 0.3 OUTLIER -130.67 155.77 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 C-N-CA 115.569 -2.452 . . . . 0.0 109.84 170.575 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.71 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.3 OUTLIER -139.96 64.76 1.44 Allowed 'General case' 0 C--N 1.313 -1.015 0 O-C-N 121.349 -0.844 . . . . 0.0 108.783 -178.203 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.027 HG13 ' HB ' ' A' ' 5' ' ' ILE 0.405 58.1 t -102.29 125.05 56.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 125.728 2.68 . . . . 0.0 108.709 -177.383 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 1.049 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.489 10.2 mt-10 -116.02 129.29 56.3 Favored 'General case' 0 C--O 1.176 -2.802 0 O-C-N 118.655 -2.528 . . . . 0.0 107.81 -173.201 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.764 ' CB ' ' CG2' ' A' ' 7' ' ' VAL 0.642 0.0 OUTLIER -106.83 111.18 23.58 Favored 'General case' 0 C--O 1.274 2.347 2 CA-C-O 107.928 -5.796 . . . . 0.0 121.166 -170.665 . . . . . . . . 5 4 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.016 HD12 ' CG ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -130.11 166.54 27.45 Favored 'Isoleucine or valine' 1 C--N 1.212 -5.405 1 CA-C-N 131.377 6.444 . . . . 0.0 109.713 178.267 . . . . . . . . 5 4 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 1.077 ' CG ' HG12 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -97.82 169.84 9.38 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.776 -1.203 . . . . 0.0 112.279 173.193 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 1.258 ' CD1' HG22 ' A' ' 56' ' ' VAL . 0.7 OUTLIER -74.33 -21.34 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.03 -1.044 . . . . 0.0 111.402 176.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.738 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 2.0 ptt? -86.27 -16.62 37.0 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.901 -1.124 . . . . 0.0 112.915 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.077 HG12 ' CG ' ' A' ' 40' ' ' ASP . 14.5 p -112.83 -27.06 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.914 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 1.016 ' CG ' HD12 ' A' ' 39' ' ' ILE . 5.7 t0 -115.14 51.13 0.93 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.184 -0.947 . . . . 0.0 110.6 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.457 2.6 ttt180 -70.31 0.99 5.41 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 115.833 -2.347 . . . . 0.0 109.793 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 1.013 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -53.92 -24.46 16.38 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.545 -1.347 . . . . 0.0 110.798 165.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.825 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -47.58 -62.49 1.42 Allowed 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 122.767 1.27 . . . . 0.0 109.023 -174.034 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.125 ' CB ' ' HB2' ' A' ' 55' ' ' ALA 0.425 . . -51.01 -13.66 0.17 Allowed 'General case' 0 C--N 1.268 -2.975 0 C-N-CA 125.105 1.362 . . . . 0.0 113.021 173.55 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.076 HD11 ' NE ' ' A' ' 66' ' ' ARG 0.256 0.2 OUTLIER -32.92 -37.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 O-C-N 117.768 -3.083 . . . . 0.0 103.528 -168.342 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.637 ' N ' ' C ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -55.0 -49.27 71.92 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.581 176.744 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.816 ' CE1' ' HE3' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -124.95 -28.14 3.5 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.979 -1.076 . . . . 0.0 110.397 179.157 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.761 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 41.69 12.08 0.01 OUTLIER Glycine 0 C--O 1.19 -2.617 0 CA-C-O 122.025 0.792 . . . . 0.0 112.416 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 5.6 mt -83.84 -75.02 0.35 Allowed 'General case' 0 C--N 1.247 -3.85 0 N-CA-C 103.971 -2.603 . . . . 0.0 103.971 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.607 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 26.9 mtm -103.23 69.2 1.0 Allowed 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.228 -1.545 . . . . 0.0 107.092 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 1.125 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.579 . . -113.08 117.75 32.86 Favored 'General case' 0 C--O 1.195 -1.78 1 CA-C-O 129.698 4.571 . . . . 0.0 109.073 -175.749 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.258 HG22 ' CD1' ' A' ' 41' ' ' ILE . 1.7 t -152.77 -60.71 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.654 0 CA-C-N 109.02 -3.718 . . . . 0.0 112.242 -175.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.817 ' CD ' HG12 ' A' ' 56' ' ' VAL 0.502 43.5 Cg_endo -119.83 105.87 0.0 OUTLIER 'Trans proline' 0 C--O 1.19 -1.88 0 CA-C-O 129.276 3.782 . . . . 0.0 110.974 172.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 1.067 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -159.59 176.55 11.9 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 110.015 -3.266 . . . . 0.0 111.219 -176.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.279 HG21 ' CD2' ' A' ' 76' ' ' LEU 0.271 1.3 mp -149.55 160.75 4.99 Favored 'Isoleucine or valine' 0 C--O 1.272 2.274 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.743 -177.59 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.961 ' HA ' ' HA ' ' A' ' 66' ' ' ARG 0.699 . . -107.98 152.36 24.58 Favored 'General case' 0 CA--C 1.448 -2.955 2 O-C-N 115.554 -4.466 . . . . 0.0 102.705 -177.209 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.725 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.619 1.5 mt -106.46 91.17 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.441 -3.221 1 CA-C-O 132.436 5.874 . . . . 0.0 101.871 -161.084 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.84 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -45.65 83.91 0.0 OUTLIER 'General case' 0 C--N 1.367 1.335 1 CA-C-N 106.099 -5.046 . . . . 0.0 107.29 177.735 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.725 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.06 -47.03 0.38 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 106.348 -2.701 . . . . 0.0 106.348 -177.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.799 ' O ' HG23 ' A' ' 65' ' ' VAL . 12.1 m -124.64 -60.65 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 O-C-N 121.836 -0.802 . . . . 0.0 111.126 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 64' ' ' VAL . 99.4 t -164.12 -103.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.406 0 O-C-N 120.123 -1.611 . . . . 0.0 113.312 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 1.076 ' NE ' HD11 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -162.01 150.3 14.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.441 -0.787 . . . . 0.0 109.783 -175.002 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 1.067 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -146.06 -179.18 6.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.72 -1.238 . . . . 0.0 110.877 -176.382 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.2 t -85.89 120.89 36.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 116.761 -1.59 . . . . 0.0 110.299 176.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.817 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.24 106.42 0.28 Allowed Glycine 0 N--CA 1.497 2.705 0 CA-C-N 122.316 2.325 . . . . 0.0 110.674 177.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.105 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -90.24 -79.96 0.03 OUTLIER Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 120.81 -1.406 . . . . 0.0 108.787 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 1.105 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 48.3 Cg_endo -88.86 20.63 1.09 Allowed 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 117.312 -1.325 . . . . 0.0 108.969 177.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.61 63.88 1.09 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.017 -1.052 . . . . 0.0 112.227 176.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.727 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -69.81 -35.65 74.99 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.733 177.665 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.862 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -47.13 -44.09 21.32 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.092 0.949 . . . . 0.0 108.76 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.756 ' CD ' ' CE2' ' A' ' 67' ' ' PHE 0.274 0.0 OUTLIER -48.75 -26.02 2.13 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.182 -177.293 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.279 ' CD2' HG21 ' A' ' 59' ' ' ILE . 12.6 mt -72.48 -41.11 66.36 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.831 0.824 . . . . 0.0 109.629 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.812 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.29 -37.6 72.68 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 122.045 0.926 . . . . 0.0 110.287 179.173 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -74.43 -32.16 62.55 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.85 0.833 . . . . 0.0 110.354 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 83' ' ' GLU . . . -73.77 -37.23 65.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.021 -1.049 . . . . 0.0 110.187 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.909 HG21 HG13 ' A' ' 23' ' ' VAL . 1.5 mp -60.33 -41.12 86.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 120.826 -1.172 . . . . 0.0 109.39 176.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -70.29 -32.76 70.69 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.764 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.632 0.1 OUTLIER -102.57 5.23 39.17 Favored 'General case' 0 CA--C 1.487 -1.445 0 C-N-CA 114.455 -2.898 . . . . 0.0 108.762 -176.61 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.777 ' HB2' ' O ' ' A' ' 62' ' ' ASN 0.299 0.2 OUTLIER -87.84 -55.84 3.59 Favored 'General case' 0 N--CA 1.489 1.498 1 O-C-N 115.611 -4.43 . . . . 0.0 107.568 164.472 . . . . . . . . 5 4 . 1 . 007 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.821 ' CE ' ' CE ' ' A' ' 27' ' ' LYS 0.27 0.0 OUTLIER -67.94 -18.37 64.74 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 119.963 1.256 . . . . 0.0 112.209 178.792 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.477 ' CD ' ' C ' ' A' ' 85' ' ' GLU . 3.2 tm-20 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 120.859 -1.151 . . . . 0.0 110.609 177.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.689 ' SD ' ' OE2' ' A' ' 83' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.333 0.587 . . . . 0.0 110.153 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.062 HG21 ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -79.67 -89.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 110.236 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.993 HG11 ' OD2' ' A' ' 24' ' ' ASP . 48.3 t -90.95 111.13 23.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.462 -0.774 . . . . 0.0 110.595 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.819 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 3.9 m-20 -123.85 107.46 11.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.81 -1.181 . . . . 0.0 109.235 177.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.064 ' CG1' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -122.33 137.16 56.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.491 -0.756 . . . . 0.0 110.923 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.023 ' O ' HG23 ' A' ' 59' ' ' ILE . 11.0 tt0 -128.4 110.67 12.55 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 118.896 -2.378 . . . . 0.0 108.966 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.986 HG12 ' HB2' ' A' ' 16' ' ' CYS 0.263 20.9 m -101.96 110.14 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -177.719 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.855 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 5.4 t80 -117.98 83.65 2.04 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.05 -176.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.686 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -127.54 -45.92 1.47 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.157 0.503 . . . . 0.0 110.193 179.263 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.768 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 17.6 t 179.64 148.39 0.45 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.175 -0.953 . . . . 0.0 110.637 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.712 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 50.7 Cg_endo -86.16 -26.16 1.2 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.151 1.606 . . . . 0.0 110.704 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -78.79 12.26 2.21 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.12 -0.988 . . . . 0.0 109.985 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.546 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -157.22 -172.2 0.31 Allowed Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.415 -0.803 . . . . 0.0 110.68 178.82 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 13' ' ' CYS . 51.6 Cg_endo -84.53 107.26 1.17 Allowed 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.125 1.592 . . . . 0.0 110.056 176.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.768 ' CE1' ' O ' ' A' ' 10' ' ' SER . 14.8 m-85 -49.45 -83.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.77 -1.206 . . . . 0.0 109.689 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 1.062 ' SG ' HD11 ' A' ' 59' ' ' ILE . 34.6 m -155.86 47.21 0.3 Allowed Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.38 -0.825 . . . . 0.0 109.792 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.767 ' HA ' HD13 ' A' ' 20' ' ' ILE . 47.1 Cg_endo -72.49 24.13 0.28 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 124.077 1.567 . . . . 0.0 111.111 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.429 ' H ' ' C ' ' A' ' 16' ' ' CYS . 6.5 tpt -110.07 -69.74 0.85 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.059 -1.026 . . . . 0.0 110.15 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.791 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -55.12 -19.84 8.55 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.247 -0.908 . . . . 0.0 109.343 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.1 HD12 HG11 ' A' ' 36' ' ' VAL . 13.0 pt -71.49 -40.34 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.405 -0.81 . . . . 0.0 109.15 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.708 ' N ' HG13 ' A' ' 20' ' ' ILE . 13.8 tp10 -53.67 -34.92 60.32 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.07 -42.9 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.441 -0.787 . . . . 0.0 109.017 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.811 ' CG1' ' HB ' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -67.77 -31.77 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.793 0.806 . . . . 0.0 109.515 178.11 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.993 ' OD2' HG11 ' A' ' 3' ' ' VAL . 3.2 t70 -72.53 -38.06 68.15 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 122.077 0.941 . . . . 0.0 108.466 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.478 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -60.42 -45.24 94.32 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.057 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.648 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -78.61 -39.43 37.31 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.591 -0.693 . . . . 0.0 110.853 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.817 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -73.1 -19.81 61.07 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 118.926 -1.11 . . . . 0.0 109.094 -178.717 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.721 ' CD ' ' OD1' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -70.76 -45.52 64.62 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 176.396 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.744 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -46.68 -39.57 11.65 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.975 0.893 . . . . 0.0 109.265 179.358 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.75 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -95.51 -58.2 2.19 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.75 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -94.03 82.43 0.99 Allowed Glycine 0 N--CA 1.499 2.867 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.565 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -37.43 -24.52 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 O-C-N 119.349 -2.265 . . . . 0.0 110.372 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 1.062 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -82.83 151.99 25.82 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.579 -0.7 . . . . 0.0 111.845 177.473 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.801 HD12 ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -129.9 153.75 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.09 -1.631 . . . . 0.0 110.569 177.564 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.569 ' O ' ' O ' ' A' ' 3' ' ' VAL . 9.8 t0 -150.64 76.42 1.25 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.287 -0.883 . . . . 0.0 109.067 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.1 HG11 HD12 ' A' ' 20' ' ' ILE 0.254 51.5 t -94.4 122.47 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 120.697 -1.252 . . . . 0.0 109.014 -178.719 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.814 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.265 4.4 mt-10 -103.8 145.59 29.87 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -177.182 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.811 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -140.29 116.15 10.31 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.629 -174.107 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.745 ' CG2' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -116.56 166.04 11.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 O-C-N 120.575 -1.328 . . . . 0.0 111.269 -178.151 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.779 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -98.19 159.89 14.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.117 -0.989 . . . . 0.0 109.666 178.669 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 1.025 HD11 HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -68.64 -37.44 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.077 -1.014 . . . . 0.0 112.19 -179.266 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.779 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.7 ptm -82.48 -3.81 56.42 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.055 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.771 HG12 ' CG ' ' A' ' 40' ' ' ASP . 13.6 p -112.24 -45.15 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 109.728 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.828 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 4.2 t70 -106.61 50.04 0.78 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.082 -1.011 . . . . 0.0 110.021 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.647 ' HA ' ' CZ ' ' A' ' 8' ' ' PHE 0.286 0.0 OUTLIER -64.01 -3.13 2.34 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 118.571 -1.252 . . . . 0.0 109.442 -177.929 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.953 ' O ' HG23 ' A' ' 49' ' ' ILE . 10.9 pt-20 -52.04 -20.87 2.68 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.491 -0.755 . . . . 0.0 110.088 175.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.907 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -50.36 -58.9 4.66 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.453 -1.405 . . . . 0.0 109.772 -178.496 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.083 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -61.42 -5.7 1.87 Allowed 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.837 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.953 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -32.44 -39.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 -175.687 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.832 ' OE1' ' O ' ' A' ' 47' ' ' LYS . 51.4 mp0 -51.34 -53.07 39.78 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.056 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 1.2 ' OH ' HG22 ' A' ' 68' ' ' VAL . 2.4 p90 -124.5 -29.67 3.46 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.884 -1.135 . . . . 0.0 110.26 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.726 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 41.49 11.27 0.01 OUTLIER Glycine 0 N--CA 1.498 2.812 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.681 ' N ' ' O ' ' A' ' 51' ' ' TYR . 8.6 mt -81.13 -71.53 0.47 Allowed 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.52 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -102.4 59.3 0.81 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 -178.258 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 1.083 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.302 . . -103.67 116.2 31.9 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.24 -1.538 . . . . 0.0 109.905 -175.685 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.025 HG22 HD11 ' A' ' 41' ' ' ILE . 2.1 t -147.1 -66.93 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.472 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.846 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 53.1 Cg_endo -105.67 114.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.176 0 N-CA-C 109.586 -0.967 . . . . 0.0 109.586 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 1.057 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -161.28 175.57 12.14 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.296 1.046 . . . . 0.0 111.521 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.272 HG21 ' CD1' ' A' ' 76' ' ' LEU 0.253 1.1 mp -141.67 144.67 25.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 108.995 179.383 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 1.027 ' HB2' ' HD3' ' A' ' 66' ' ' ARG 0.289 . . -84.93 147.51 26.7 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 -177.842 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.712 HG23 ' HB2' ' A' ' 79' ' ' ALA 0.39 0.7 OUTLIER -95.42 88.44 2.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 115.315 -2.554 . . . . 0.0 105.233 -175.126 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.819 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.2 OUTLIER -45.77 82.71 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 O-C-N 126.009 2.068 . . . . 0.0 109.094 177.7 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.819 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 161.99 -43.56 0.37 Allowed Glycine 0 C--N 1.288 -2.088 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.778 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.2 m -126.83 -59.37 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.882 -0.775 . . . . 0.0 111.052 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.778 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 59.8 t -164.04 -104.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 120.393 -1.442 . . . . 0.0 112.194 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 1.027 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 1.9 ttp180 -164.44 164.16 22.05 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 1.057 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -146.05 177.68 8.78 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.925 -1.11 . . . . 0.0 111.118 -177.306 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.2 HG22 ' OH ' ' A' ' 51' ' ' TYR . 96.5 t -88.86 114.39 27.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.686 -0.634 . . . . 0.0 109.978 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.856 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.66 128.72 1.92 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 118.63 -1.748 . . . . 0.0 110.168 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.083 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -93.82 -82.72 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 121.098 -1.236 . . . . 0.0 108.032 177.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 1.083 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 52.8 Cg_endo -83.24 23.19 0.84 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 N-CA-C 108.541 -1.369 . . . . 0.0 108.541 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.553 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -99.59 61.45 1.17 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.445 -0.784 . . . . 0.0 111.334 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.749 ' CB ' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -70.64 -26.75 63.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 0.0 109.926 178.28 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.604 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.6 tm-20 -50.56 -42.43 55.39 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.249 -0.907 . . . . 0.0 109.32 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.768 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -44.54 -34.81 2.25 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.371 -0.932 . . . . 0.0 108.819 179.735 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.272 ' CD1' HG21 ' A' ' 59' ' ' ILE . 7.4 mp -64.12 -42.76 96.71 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.809 ' HA ' ' CG1' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.74 -34.15 69.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 109.404 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.778 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -82.38 -30.57 30.17 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.481 -0.762 . . . . 0.0 110.405 178.761 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.712 ' HB2' HG23 ' A' ' 61' ' ' ILE . . . -73.37 -33.1 64.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.424 -0.798 . . . . 0.0 109.907 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.816 HG22 ' HD3' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -67.46 -42.37 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 0.0 108.756 178.451 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.43 -23.63 66.32 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.557 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.544 0.0 OUTLIER -100.94 -12.37 18.99 Favored 'General case' 0 C--O 1.198 -1.656 0 C-N-CA 115.357 -2.537 . . . . 0.0 108.838 -177.246 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.819 ' HB2' ' CA ' ' A' ' 63' ' ' GLY 0.251 0.0 OUTLIER -75.35 -54.04 7.73 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 119.517 -1.989 . . . . 0.0 108.454 165.215 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.724 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -79.14 -22.03 45.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.004 -1.06 . . . . 0.0 110.417 179.284 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 2.1 tp10 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.166 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.769 ' SD ' ' OE2' ' A' ' 83' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 121.925 0.869 . . . . 0.0 110.721 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.011 HG21 ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -79.89 -91.6 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 120.794 -1.191 . . . . 0.0 109.95 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.956 HG11 ' OD2' ' A' ' 24' ' ' ASP . 42.8 t -90.07 111.59 23.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.521 -0.737 . . . . 0.0 110.174 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.762 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 3.5 m-20 -124.1 107.43 11.26 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.786 -1.166 . . . . 0.0 108.679 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.054 ' CG1' HG22 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -123.09 139.55 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 122.059 -0.401 . . . . 0.0 110.58 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.191 ' O ' HG23 ' A' ' 59' ' ' ILE . 12.8 tt0 -131.05 121.73 25.53 Favored 'General case' 0 C--N 1.284 -2.241 0 O-C-N 119.163 -2.21 . . . . 0.0 105.844 177.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.913 HG12 ' HB2' ' A' ' 16' ' ' CYS . 26.8 m -113.07 106.23 20.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -176.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.906 ' CE1' ' HA ' ' A' ' 41' ' ' ILE 0.257 6.8 t80 -115.55 89.17 3.04 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.881 -178.624 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.638 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -131.24 -46.04 1.0 Allowed 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.21 -0.931 . . . . 0.0 109.739 178.765 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.736 ' HA ' HG22 ' A' ' 41' ' ' ILE . 17.6 t 179.08 147.05 0.39 Allowed Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.451 -0.781 . . . . 0.0 110.924 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.721 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 50.7 Cg_endo -85.44 -26.24 1.41 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 124.317 1.693 . . . . 0.0 110.868 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -77.25 6.41 6.75 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.203 -0.935 . . . . 0.0 110.01 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.512 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -152.2 -171.59 0.28 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.413 -0.804 . . . . 0.0 110.487 179.041 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 13' ' ' CYS . 47.0 Cg_endo -84.93 107.51 1.1 Allowed 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.419 1.413 . . . . 0.0 109.137 177.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.688 ' CE1' ' O ' ' A' ' 10' ' ' SER . 17.1 m-85 -49.85 -82.7 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.584 -0.697 . . . . 0.0 109.14 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 1.049 ' SG ' HD11 ' A' ' 59' ' ' ILE . 35.4 m -155.61 46.65 0.28 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.314 -0.866 . . . . 0.0 109.544 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.749 ' HA ' HD13 ' A' ' 20' ' ' ILE . 48.9 Cg_endo -72.34 24.36 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.973 1.512 . . . . 0.0 111.335 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.416 ' H ' ' C ' ' A' ' 16' ' ' CYS . 6.8 tpt -110.44 -69.09 0.89 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.155 -0.966 . . . . 0.0 110.489 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.766 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -55.98 -19.51 12.77 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.047 -1.033 . . . . 0.0 109.662 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.093 HD12 HG11 ' A' ' 36' ' ' VAL . 13.1 pt -70.72 -40.14 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.682 ' N ' HG13 ' A' ' 20' ' ' ILE . 13.8 tp10 -54.53 -35.87 63.66 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.0 t -68.17 -45.28 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.801 ' CG1' ' HA ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -65.68 -35.53 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.732 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.956 ' OD2' HG11 ' A' ' 3' ' ' VAL . 2.4 t70 -67.95 -40.46 83.26 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.717 0.77 . . . . 0.0 109.124 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.479 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.6 OUTLIER -58.42 -46.95 85.45 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.371 0.605 . . . . 0.0 110.371 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.623 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.17 -38.68 51.26 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.935 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.802 ' HD3' HG22 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -74.82 -16.92 60.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.834 -1.166 . . . . 0.0 109.924 -179.005 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.632 ' CD ' ' OD1' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -73.31 -45.33 56.07 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 176.659 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.673 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -46.51 -37.06 7.37 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 122.057 0.932 . . . . 0.0 110.051 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.783 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -97.28 -68.09 0.82 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.783 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -84.35 88.97 1.56 Allowed Glycine 0 CA--C 1.544 1.86 0 C-N-CA 118.234 -1.936 . . . . 0.0 110.165 176.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.527 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -40.41 -27.7 0.05 Allowed 'General case' 0 N--CA 1.515 2.78 0 O-C-N 118.573 -2.722 . . . . 0.0 110.58 176.259 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 1.011 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -80.92 151.65 28.46 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.78 -0.575 . . . . 0.0 111.175 179.105 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.763 HD12 ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -130.2 154.8 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.79 -1.194 . . . . 0.0 110.064 179.128 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.619 ' O ' ' O ' ' A' ' 3' ' ' VAL . 14.2 t0 -151.74 80.8 1.28 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.093 HG11 HD12 ' A' ' 20' ' ' ILE . 46.5 t -97.44 129.42 47.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.78 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 5.0 mt-10 -108.86 146.02 34.38 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.772 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -142.38 112.24 6.87 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.457 1.122 . . . . 0.0 112.949 -175.231 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.72 ' CG2' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -112.21 164.31 8.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 112.218 -179.652 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.744 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -96.4 162.13 13.62 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.27 -0.894 . . . . 0.0 109.517 179.16 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 1.003 HD11 HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -70.34 -39.49 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.116 -0.99 . . . . 0.0 111.73 -179.452 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.744 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.6 ptm -80.94 -2.6 48.36 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.929 -1.107 . . . . 0.0 110.972 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.73 HG12 ' CG ' ' A' ' 40' ' ' ASP . 14.9 p -113.23 -44.57 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.072 -1.018 . . . . 0.0 109.948 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.808 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 4.8 t70 -107.38 52.03 0.73 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.454 -0.779 . . . . 0.0 109.083 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.574 ' HA ' ' CZ ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -64.33 -1.98 1.96 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 119.797 -1.814 . . . . 0.0 110.34 -179.135 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.912 ' O ' HG23 ' A' ' 49' ' ' ILE . 10.6 pt-20 -56.16 -21.55 23.48 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.864 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -46.88 -64.3 0.81 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 119.909 -1.744 . . . . 0.0 108.708 179.395 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.052 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -61.63 -6.01 2.25 Favored 'General case' 0 C--O 1.196 -1.72 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.864 -178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.912 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.7 OUTLIER -25.92 -41.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 119.715 -1.866 . . . . 0.0 106.874 176.721 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.862 ' OE1' ' O ' ' A' ' 47' ' ' LYS . 52.7 mp0 -52.57 -52.45 55.02 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.136 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 1.119 ' OH ' HG22 ' A' ' 68' ' ' VAL . 3.0 p90 -123.81 -32.01 3.35 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.298 -0.876 . . . . 0.0 110.398 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.668 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 45.44 4.32 0.01 OUTLIER Glycine 1 N--CA 1.519 4.172 0 O-C-N 121.37 -0.832 . . . . 0.0 111.786 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.677 ' H ' ' C ' ' A' ' 51' ' ' TYR . 9.5 mt -75.24 -81.12 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 175.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.63 ' O ' ' HE2' ' A' ' 51' ' ' TYR 0.271 0.3 OUTLIER -93.64 66.65 3.82 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.3 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 1.052 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.275 . . -107.46 117.26 33.64 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 119.97 -1.707 . . . . 0.0 110.162 -178.483 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.003 HG22 HD11 ' A' ' 41' ' ' ILE . 2.1 t -148.89 -63.31 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.055 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.79 ' HD3' ' HB ' ' A' ' 56' ' ' VAL . 59.3 Cg_endo -109.12 117.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.186 0 N-CA-C 109.654 -0.941 . . . . 0.0 109.654 176.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.956 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -163.22 178.46 8.19 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.554 1.169 . . . . 0.0 111.625 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.203 HG21 ' CD1' ' A' ' 76' ' ' LEU 0.258 1.1 mp -142.08 152.7 18.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 1.032 ' HB2' ' HD3' ' A' ' 66' ' ' ARG 0.263 . . -91.37 156.92 17.41 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.796 HG23 ' HB2' ' A' ' 79' ' ' ALA . 0.6 OUTLIER -102.38 91.83 2.12 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.449 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 -175.81 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.762 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -56.49 85.61 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -176.605 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.793 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 161.3 -42.83 0.4 Allowed Glycine 0 C--N 1.29 -1.986 0 N-CA-C 108.063 -2.015 . . . . 0.0 108.063 -177.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.699 ' C ' HG23 ' A' ' 65' ' ' VAL . 17.7 m -126.69 -60.82 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.793 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.699 HG23 ' C ' ' A' ' 64' ' ' VAL . 59.8 t -163.61 -99.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 120.758 -1.214 . . . . 0.0 112.565 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 1.032 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 2.0 ttp180 -169.03 162.97 11.23 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.956 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -147.09 173.12 12.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.359 -0.838 . . . . 0.0 111.676 -177.264 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.119 HG22 ' OH ' ' A' ' 51' ' ' TYR . 66.2 t -84.52 114.76 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.507 -0.746 . . . . 0.0 110.857 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.851 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.87 129.25 2.0 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 118.833 -1.651 . . . . 0.0 110.65 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.029 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -94.91 -81.41 0.02 OUTLIER Pre-proline 0 C--N 1.298 -1.641 0 O-C-N 121.177 -1.19 . . . . 0.0 107.946 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 1.029 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 56.7 Cg_endo -84.64 25.28 0.7 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 N-CA-C 108.831 -1.257 . . . . 0.0 108.831 176.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.544 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -101.53 59.65 0.88 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.426 0.632 . . . . 0.0 110.697 -179.209 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.698 ' HA ' HD13 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -69.3 -29.45 67.3 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.046 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.588 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.8 tm-20 -47.26 -42.55 20.8 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.197 -0.94 . . . . 0.0 110.471 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.726 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -45.44 -33.67 2.75 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.287 179.442 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.203 ' CD1' HG21 ' A' ' 59' ' ' ILE . 7.4 mp -64.7 -43.54 93.14 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.801 ' HA ' ' CG1' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -56.1 -35.84 67.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.275 -0.891 . . . . 0.0 109.526 179.216 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.737 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -81.39 -33.17 32.43 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.103 0.478 . . . . 0.0 110.062 179.515 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.796 ' HB2' HG23 ' A' ' 61' ' ' ILE . . . -69.91 -34.34 73.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.386 -0.821 . . . . 0.0 111.178 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.802 HG22 ' HD3' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -68.12 -42.86 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.585 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -64.51 -18.16 64.55 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 175.798 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.534 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.347 0.0 OUTLIER -104.59 -5.48 21.42 Favored 'General case' 0 CA--C 1.477 -1.847 0 CA-C-O 124.702 2.192 . . . . 0.0 109.224 -179.433 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.793 ' HB2' ' CA ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -87.33 -55.55 3.76 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 101.846 -3.39 . . . . 0.0 101.846 176.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.679 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -78.47 -21.77 48.55 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.243 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 2.1 tp10 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.026 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.512 ' SD ' ' OD1' ' A' ' 4' ' ' ASN . 8.6 ttp . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.599 0.714 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.93 HG22 ' N ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -80.38 -95.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.582 0.706 . . . . 0.0 110.291 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.93 ' N ' HG22 ' A' ' 2' ' ' VAL . 53.0 t -90.12 114.9 28.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.416 -0.803 . . . . 0.0 109.397 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.814 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.257 2.8 t-20 -138.28 105.83 5.57 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 117.984 -1.486 . . . . 0.0 107.919 178.428 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.865 ' CG1' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -121.35 139.55 48.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.235 -179.021 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.095 ' O ' HD21 ' A' ' 76' ' ' LEU . 6.8 tt0 -132.35 123.17 26.28 Favored 'General case' 0 C--N 1.285 -2.229 0 C-N-CA 116.438 -2.105 . . . . 0.0 105.911 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.064 HG12 ' CD1' ' A' ' 76' ' ' LEU . 3.0 m -113.21 104.18 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.944 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 4.8 t80 -113.5 96.26 5.79 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.28 -177.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.748 ' O ' ' O ' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -126.37 -69.02 0.79 Allowed 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.167 -0.958 . . . . 0.0 108.673 178.18 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.661 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 3.8 p 179.53 152.9 0.57 Allowed Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.273 -0.892 . . . . 0.0 110.793 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.619 ' HA ' ' OH ' ' A' ' 15' ' ' TYR . 50.8 Cg_endo -76.2 -27.33 8.23 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 124.437 1.756 . . . . 0.0 110.175 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.2 m -78.95 -17.0 56.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.678 -0.639 . . . . 0.0 109.949 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.415 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -124.55 179.94 0.99 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.885 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.628 ' O ' ' O ' ' A' ' 15' ' ' TYR . 51.3 Cg_endo -83.31 109.11 1.59 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 124.012 1.532 . . . . 0.0 109.817 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.661 ' CE1' ' O ' ' A' ' 10' ' ' SER . 4.7 m-85 -50.48 -117.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.938 ' CB ' HD11 ' A' ' 59' ' ' ILE . 18.7 m -155.16 40.32 0.13 Allowed Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.833 -1.167 . . . . 0.0 109.896 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.3 Cg_endo -75.76 30.3 0.38 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 O-C-N 123.653 1.344 . . . . 0.0 111.261 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.465 ' HG2' ' HG3' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -109.98 -59.49 1.92 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.969 -1.082 . . . . 0.0 110.713 -179.296 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.86 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -56.19 -19.71 14.82 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.36 -0.838 . . . . 0.0 110.397 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.92 HD12 ' C ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -73.36 -39.93 55.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.486 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.615 ' N ' HD12 ' A' ' 20' ' ' ILE . 14.1 tt0 -53.73 -35.08 60.82 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -68.89 -50.89 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.917 ' CG1' HG21 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -61.66 -33.55 57.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.349 178.567 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.773 ' OD2' HG11 ' A' ' 3' ' ' VAL . 8.4 t0 -66.4 -41.05 89.86 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.726 0.774 . . . . 0.0 109.071 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.482 ' OE1' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -56.88 -48.39 78.28 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.626 0.726 . . . . 0.0 109.317 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.487 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.55 -39.09 47.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.842 -0.536 . . . . 0.0 110.439 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.773 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -72.01 -16.65 62.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.993 -1.067 . . . . 0.0 109.877 -178.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.624 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -73.56 -44.2 58.02 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.608 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.684 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -49.71 -34.23 18.23 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.909 0.861 . . . . 0.0 110.206 179.578 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.739 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -94.89 -69.06 0.77 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.739 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -83.82 84.86 1.55 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 118.788 -1.672 . . . . 0.0 110.101 177.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.579 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -36.69 -32.07 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.655 0 O-C-N 118.768 -2.607 . . . . 0.0 110.65 177.55 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.887 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -78.51 151.4 32.57 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.492 178.405 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.776 HD12 ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -129.76 156.05 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.646 -1.283 . . . . 0.0 110.264 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.714 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 25.7 t0 -151.7 80.07 1.28 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.978 HG12 ' NZ ' ' A' ' 38' ' ' LYS . 47.4 t -98.34 129.78 48.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.868 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 11.8 mm-40 -112.4 140.54 47.04 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.978 ' NZ ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -141.82 112.29 7.09 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -175.063 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.935 HD13 ' HB2' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -130.39 163.26 36.54 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 CA-C-O 121.77 0.795 . . . . 0.0 112.496 -179.103 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.645 ' OD1' ' N ' ' A' ' 43' ' ' VAL . 9.6 p-10 -98.69 178.82 4.87 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.277 -0.89 . . . . 0.0 111.379 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 1.037 HD12 HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -69.28 -15.63 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.21 -0.931 . . . . 0.0 109.86 177.765 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.601 ' HG2' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -89.73 -14.61 34.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.814 -1.179 . . . . 0.0 111.981 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.8 HG11 HG22 ' A' ' 39' ' ' ILE . 8.9 p -113.95 -40.43 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.929 -1.107 . . . . 0.0 110.687 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.784 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 3.8 t70 -111.64 48.83 0.93 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.162 -0.961 . . . . 0.0 108.989 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.561 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 29.9 ttt180 -64.95 -1.08 1.81 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.08 -1.638 . . . . 0.0 109.814 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 1.071 ' O ' HG23 ' A' ' 49' ' ' ILE . 25.8 mm-40 -60.48 -22.98 64.13 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.244 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.856 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 1.1 tptt -45.85 -65.35 0.56 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.274 -1.516 . . . . 0.0 109.147 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.059 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -58.14 -11.18 2.36 Favored 'General case' 0 C--O 1.189 -2.083 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.264 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.108 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.7 pp -23.99 -40.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 119.933 -1.729 . . . . 0.0 107.262 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 1.108 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.9 OUTLIER -56.02 -50.78 69.94 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 115.316 -0.857 . . . . 0.0 108.995 178.572 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.872 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 3.1 p90 -122.35 -34.24 3.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.729 -0.607 . . . . 0.0 110.292 178.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.724 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 47.64 3.13 0.01 OUTLIER Glycine 0 N--CA 1.514 3.837 0 O-C-N 121.192 -0.943 . . . . 0.0 111.291 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.673 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 4.1 mt -75.45 -80.49 0.09 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.712 ' O ' ' HE2' ' A' ' 51' ' ' TYR 0.255 26.3 mtp -92.02 67.49 5.14 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.863 177.397 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 1.059 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.27 . . -108.9 110.7 22.09 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 120.448 -1.407 . . . . 0.0 109.048 -177.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.037 HG22 HD12 ' A' ' 41' ' ' ILE . 1.0 OUTLIER -149.42 -54.52 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.877 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.942 -179.146 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.796 ' HB2' ' CA ' ' A' ' 70' ' ' ALA . 59.2 Cg_endo -110.91 106.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.169 1.089 . . . . 0.0 110.212 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.912 ' HB3' ' CD2' ' A' ' 8' ' ' PHE . . . -161.62 179.77 7.91 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.623 -1.626 . . . . 0.0 112.181 -176.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.938 HD11 ' CB ' ' A' ' 16' ' ' CYS 0.264 0.3 OUTLIER -143.87 153.63 15.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 -179.808 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.92 ' HB3' ' CB ' ' A' ' 6' ' ' GLU 0.256 . . -92.16 153.78 19.11 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 101.82 -3.4 . . . . 0.0 101.82 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.62 HG23 ' CB ' ' A' ' 79' ' ' ALA 0.274 2.1 mt -102.66 93.6 2.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 -175.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.814 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.5 OUTLIER -55.6 84.76 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 113.12 -1.855 . . . . 0.0 107.145 -178.082 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.7 ' HA3' ' CB ' ' A' ' 83' ' ' GLU . . . 162.22 -45.8 0.36 Allowed Glycine 0 C--N 1.289 -2.038 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.796 ' O ' HG23 ' A' ' 65' ' ' VAL . 4.6 m -123.33 -61.13 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.447 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.8 HG12 ' N ' ' A' ' 66' ' ' ARG . 73.7 t -165.17 -101.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 O-C-N 120.909 -1.119 . . . . 0.0 112.235 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.901 ' HG3' ' O ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -156.01 166.24 34.05 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.539 -0.725 . . . . 0.0 109.747 -178.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.866 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -149.26 165.19 32.65 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.34 -0.85 . . . . 0.0 111.17 -178.752 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.652 HG22 ' OH ' ' A' ' 51' ' ' TYR . 94.5 t -81.07 121.09 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.354 -0.841 . . . . 0.0 110.203 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.825 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -164.03 114.18 0.59 Allowed Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.182 -1.485 . . . . 0.0 110.549 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.034 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -91.65 -82.79 0.02 OUTLIER Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 121.578 -0.954 . . . . 0.0 109.034 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 1.034 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 57.0 Cg_endo -84.42 26.52 0.65 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 N-CA-C 107.982 -1.584 . . . . 0.0 107.982 176.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.671 ' CB ' ' OE2' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -112.26 83.42 1.8 Allowed 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.657 ' C ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -82.37 -44.04 16.64 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.701 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.86 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -40.05 -30.91 0.1 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.158 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.751 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -49.7 -46.21 49.82 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.296 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.095 HD21 ' O ' ' A' ' 6' ' ' GLU . 27.3 mt -58.15 -43.54 87.4 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.785 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.27 -37.25 74.6 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.09 0.947 . . . . 0.0 109.857 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.788 ' O ' ' ND2' ' A' ' 81' ' ' ASN . 3.2 tt0 -78.28 -30.94 48.76 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.348 -0.845 . . . . 0.0 110.298 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.62 ' CB ' HG23 ' A' ' 61' ' ' ILE . . . -70.15 -38.56 75.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.124 -0.985 . . . . 0.0 111.249 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.917 HG21 ' CG1' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.59 -42.59 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.327 -0.858 . . . . 0.0 108.726 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.788 ' ND2' ' O ' ' A' ' 78' ' ' GLU . 0.0 OUTLIER -68.46 -22.51 64.57 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.22 177.225 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.615 ' O ' ' OD1' ' A' ' 82' ' ' ASP 0.312 0.0 OUTLIER -102.1 2.42 37.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 118.232 -2.793 . . . . 0.0 107.114 -177.549 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.7 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -94.14 -59.72 1.9 Allowed 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 103.321 -2.844 . . . . 0.0 103.321 176.689 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.597 ' SD ' ' HD2' ' A' ' 27' ' ' LYS . 3.3 ptt? -72.05 -17.96 61.98 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.601 177.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.587 ' OXT' ' HA ' ' A' ' 82' ' ' ASP . 3.2 mm-40 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.171 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.697 ' SD ' ' OE2' ' A' ' 83' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.272 0.558 . . . . 0.0 110.184 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.056 HG21 ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -79.95 -90.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.359 -0.838 . . . . 0.0 109.848 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.99 HG11 ' OD2' ' A' ' 24' ' ' ASP . 48.6 t -89.6 110.89 22.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.446 -0.783 . . . . 0.0 111.124 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.846 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 3.9 m-20 -124.02 107.11 10.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.621 -1.3 . . . . 0.0 109.085 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.076 ' CG1' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -121.14 138.22 52.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 O-C-N 121.711 -0.618 . . . . 0.0 111.758 178.865 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.201 ' O ' HG23 ' A' ' 59' ' ' ILE . 12.4 tt0 -130.64 119.78 22.96 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 115.614 -2.434 . . . . 0.0 106.079 177.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.979 HG12 ' HB2' ' A' ' 16' ' ' CYS . 19.5 m -111.48 107.33 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -176.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.871 ' CE1' ' O ' ' A' ' 44' ' ' ASP . 6.3 t80 -116.74 87.28 2.66 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.958 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.673 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -130.14 -46.22 1.12 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.859 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.765 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 17.5 t 179.59 148.33 0.45 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.226 -0.921 . . . . 0.0 110.666 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.711 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 50.5 Cg_endo -86.16 -26.31 1.16 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.103 1.581 . . . . 0.0 110.649 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -78.06 8.34 4.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.12 -0.987 . . . . 0.0 109.9 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.55 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -152.38 -171.29 0.27 Allowed Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.62 178.806 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.55 ' HD2' ' HB3' ' A' ' 13' ' ' CYS . 45.2 Cg_endo -85.05 107.12 1.05 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.742 1.391 . . . . 0.0 109.579 176.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.765 ' CE1' ' O ' ' A' ' 10' ' ' SER . 14.8 m-85 -49.39 -82.79 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.053 -1.029 . . . . 0.0 109.753 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 1.06 ' SG ' HD11 ' A' ' 59' ' ' ILE . 34.8 m -156.08 47.25 0.3 Allowed Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.36 -0.838 . . . . 0.0 109.724 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.767 ' HA ' HD13 ' A' ' 20' ' ' ILE . 47.4 Cg_endo -72.62 24.17 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.031 1.543 . . . . 0.0 111.075 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.427 ' H ' ' C ' ' A' ' 16' ' ' CYS . 6.5 tpt -110.16 -69.66 0.85 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.126 -0.983 . . . . 0.0 110.247 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.792 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -55.02 -20.08 8.43 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.12 -0.988 . . . . 0.0 109.291 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.086 HD12 HG11 ' A' ' 36' ' ' VAL . 12.8 pt -71.28 -40.26 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.0 109.141 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.707 ' N ' HG13 ' A' ' 20' ' ' ILE . 13.8 tp10 -53.79 -35.51 61.44 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.1 t -68.89 -44.73 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.789 0.804 . . . . 0.0 108.872 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.823 ' CG1' ' HB ' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -65.84 -34.48 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 121.681 0.753 . . . . 0.0 109.435 178.29 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.99 ' OD2' HG11 ' A' ' 3' ' ' VAL . 2.6 t70 -69.55 -38.82 77.61 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.993 0.901 . . . . 0.0 109.57 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.474 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -59.79 -46.3 89.62 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.536 0.684 . . . . 0.0 110.044 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.655 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.74 -39.14 45.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.522 -0.736 . . . . 0.0 111.077 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.815 ' HD3' HG22 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -73.8 -18.04 61.01 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 118.886 -1.126 . . . . 0.0 109.373 -178.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.722 ' CD ' ' OD1' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -72.5 -45.14 60.84 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 176.775 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.732 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -47.25 -37.16 10.06 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.676 0.75 . . . . 0.0 109.816 179.304 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.817 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -96.99 -65.56 0.96 Allowed 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.414 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.817 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -85.18 84.71 1.59 Allowed Glycine 0 N--CA 1.511 3.66 0 C-N-CA 118.493 -1.813 . . . . 0.0 111.167 176.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.587 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -38.13 -26.73 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.397 0 CA-C-N 121.653 2.727 . . . . 0.0 110.813 177.625 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 1.056 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -80.09 151.41 29.87 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.514 -0.741 . . . . 0.0 112.459 177.676 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.816 HD12 ' O ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -130.24 154.02 39.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 120.242 -1.536 . . . . 0.0 109.829 178.47 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.629 ' O ' ' O ' ' A' ' 3' ' ' VAL . 10.4 t0 -151.26 79.18 1.29 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.086 HG11 HD12 ' A' ' 20' ' ' ILE 0.254 44.5 t -96.96 127.26 49.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -178.723 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.861 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 4.8 mt-10 -108.47 144.58 35.9 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -177.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.807 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.9 112.42 7.85 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -174.855 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.751 ' CG2' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -112.25 165.5 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.288 -0.965 . . . . 0.0 112.241 -178.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.782 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -97.26 161.38 13.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.134 -0.979 . . . . 0.0 109.739 178.827 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 1.014 HD11 HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -70.08 -38.2 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 111.735 -179.004 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.782 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.4 ptm -80.79 -4.26 53.95 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.251 -0.979 . . . . 0.0 111.245 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.77 HG12 ' CG ' ' A' ' 40' ' ' ASP . 14.1 p -112.34 -44.8 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.139 -0.976 . . . . 0.0 110.138 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.871 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 4.2 t70 -106.91 52.91 0.7 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.068 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.624 ' HA ' ' CZ ' ' A' ' 8' ' ' PHE 0.268 0.0 OUTLIER -66.36 -0.37 2.61 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.56 -1.256 . . . . 0.0 109.557 -178.548 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.982 ' O ' HG23 ' A' ' 49' ' ' ILE . 10.4 pt-20 -55.56 -21.45 17.19 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 177.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.921 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -47.43 -63.62 1.0 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 123.711 1.72 . . . . 0.0 109.057 -178.319 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.134 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -57.75 -10.35 1.61 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.149 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.982 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -26.3 -41.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 O-C-N 119.57 -1.956 . . . . 0.0 107.1 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.896 ' OE1' ' O ' ' A' ' 47' ' ' LYS . 51.3 mp0 -51.95 -53.02 46.16 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.063 176.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 1.19 ' OH ' HG22 ' A' ' 68' ' ' VAL . 2.7 p90 -124.18 -30.0 3.51 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.224 -0.923 . . . . 0.0 110.152 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.744 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 43.31 5.73 0.01 OUTLIER Glycine 0 N--CA 1.506 3.309 0 CA-C-O 122.3 0.944 . . . . 0.0 111.576 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.722 ' N ' ' O ' ' A' ' 51' ' ' TYR . 9.3 mt -75.92 -77.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 175.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.619 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -96.11 64.38 2.34 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.116 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 1.134 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.295 . . -108.04 117.85 35.21 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 117.838 -1.545 . . . . 0.0 109.436 -177.14 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.014 HG22 HD11 ' A' ' 41' ' ' ILE . 2.1 t -148.64 -63.23 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.785 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.546 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.832 ' HD3' ' HB ' ' A' ' 56' ' ' VAL 0.252 56.5 Cg_endo -110.67 116.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 N-CA-C 108.593 -1.349 . . . . 0.0 108.593 177.145 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 1.007 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -161.96 176.28 10.95 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.88 -177.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.268 HG21 ' CD1' ' A' ' 76' ' ' LEU 0.25 1.1 mp -140.76 150.03 20.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.012 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 1.065 ' HB2' ' HD3' ' A' ' 66' ' ' ARG 0.308 . . -89.53 155.58 19.19 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 -178.177 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.799 HG23 ' HB2' ' A' ' 79' ' ' ALA 0.328 0.6 OUTLIER -101.94 93.16 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.918 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 -175.953 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.846 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -52.82 83.29 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 112.814 -1.994 . . . . 0.0 106.407 -178.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.834 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 162.47 -42.79 0.36 Allowed Glycine 0 C--N 1.293 -1.844 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.785 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.5 m -127.41 -59.3 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.808 -0.819 . . . . 0.0 111.035 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.785 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 58.7 t -164.32 -101.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 O-C-N 120.286 -1.509 . . . . 0.0 112.553 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 1.065 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 2.0 ttp180 -166.91 163.73 16.17 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 1.007 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -147.01 175.17 10.89 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.013 -1.054 . . . . 0.0 111.218 -177.188 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.19 HG22 ' OH ' ' A' ' 51' ' ' TYR . 70.3 t -85.58 113.88 24.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.11 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.854 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.08 129.95 2.19 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.063 -2.018 . . . . 0.0 109.903 177.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.101 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -94.84 -81.98 0.02 OUTLIER Pre-proline 0 C--N 1.294 -1.842 0 O-C-N 121.121 -1.223 . . . . 0.0 107.931 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 1.101 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 54.6 Cg_endo -84.34 24.53 0.75 Allowed 'Trans proline' 0 C--N 1.302 -1.904 0 N-CA-C 108.475 -1.394 . . . . 0.0 108.475 177.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.555 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -100.7 59.93 0.96 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.488 -0.757 . . . . 0.0 111.219 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.753 ' CB ' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -68.87 -29.32 67.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.38 -0.825 . . . . 0.0 109.898 178.477 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.599 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.8 tm-20 -47.71 -43.5 26.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 109.932 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.769 ' CD ' ' CD2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -44.38 -34.69 2.09 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.845 179.691 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.268 ' CD1' HG21 ' A' ' 59' ' ' ILE . 7.4 mp -64.22 -42.96 96.35 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.816 ' HA ' ' CG1' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.01 -35.31 69.09 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.901 0.858 . . . . 0.0 109.356 179.662 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.783 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -80.93 -32.87 34.45 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.498 -0.752 . . . . 0.0 110.38 178.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.799 ' HB2' HG23 ' A' ' 61' ' ' ILE . . . -70.95 -34.26 71.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.357 -0.839 . . . . 0.0 110.695 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.823 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -66.55 -43.33 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 122.179 0.99 . . . . 0.0 108.79 178.784 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -65.97 -19.51 65.89 Favored 'General case' 0 C--O 1.196 -1.759 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.042 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.62 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.421 0.0 OUTLIER -104.33 -5.74 21.49 Favored 'General case' 0 C--O 1.251 1.157 0 C-N-CA 116.525 -2.07 . . . . 0.0 105.898 -177.789 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.834 ' HB2' ' CA ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -85.69 -53.82 4.91 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 172.935 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.734 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -79.12 -21.28 46.81 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.372 -1.455 . . . . 0.0 110.567 -179.57 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 2.1 tp10 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.148 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.487 ' SD ' ' OD1' ' A' ' 4' ' ' ASN . 8.0 ttp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.303 0.573 . . . . 0.0 110.249 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.971 HG22 ' N ' ' A' ' 3' ' ' VAL . 0.9 OUTLIER -81.09 -92.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 0.0 110.412 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.971 ' N ' HG22 ' A' ' 2' ' ' VAL . 55.4 t -92.2 108.83 20.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.703 -0.623 . . . . 0.0 110.644 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.81 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 2.4 t-20 -129.11 106.83 9.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.045 -1.034 . . . . 0.0 109.278 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.888 HG21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.22 138.17 54.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 O-C-N 121.785 -0.572 . . . . 0.0 110.44 178.669 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.082 ' CB ' ' HB3' ' A' ' 60' ' ' ALA . 5.3 tt0 -129.1 107.58 9.7 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 117.483 -1.687 . . . . 0.0 110.016 178.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.092 HG12 ' CD1' ' A' ' 76' ' ' LEU . 2.9 m -96.74 109.78 23.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 122.892 1.329 . . . . 0.0 107.663 -178.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.955 ' HB2' HD13 ' A' ' 39' ' ' ILE . 2.2 t80 -118.53 90.01 3.24 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.041 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.664 HG23 ' HA ' ' A' ' 57' ' ' PRO . 0.6 OUTLIER -120.92 -68.59 0.89 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.53 -0.731 . . . . 0.0 109.66 178.814 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.756 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 3.8 p 179.65 154.4 0.64 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 110.682 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.657 ' N ' ' HB2' ' A' ' 40' ' ' ASP . 49.8 Cg_endo -76.94 -27.16 7.23 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.11 1.584 . . . . 0.0 110.468 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -79.58 -16.1 56.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.89 . . . . 0.0 109.924 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.486 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -125.0 -179.51 0.88 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 109.951 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.656 ' O ' ' O ' ' A' ' 15' ' ' TYR . 50.9 Cg_endo -83.5 108.07 1.46 Allowed 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.96 1.505 . . . . 0.0 110.319 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.756 ' CE1' ' O ' ' A' ' 10' ' ' SER . 4.8 m-85 -49.71 -117.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.932 . . . . 0.0 109.899 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.986 ' CB ' HD11 ' A' ' 59' ' ' ILE . 19.2 m -155.68 40.46 0.13 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.16 -0.962 . . . . 0.0 110.278 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.3 Cg_endo -76.0 30.07 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.961 1.506 . . . . 0.0 111.195 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.457 ' HG2' ' HG3' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -110.21 -59.37 1.95 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.816 -1.178 . . . . 0.0 110.671 -179.491 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.941 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -55.92 -19.3 11.59 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.272 -0.893 . . . . 0.0 109.894 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.986 HD12 ' C ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -75.22 -39.48 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.832 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.654 ' N ' HD12 ' A' ' 20' ' ' ILE . 14.6 tt0 -53.35 -33.19 52.55 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.372 -0.83 . . . . 0.0 108.98 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -71.77 -46.94 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 109.385 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.974 ' CG1' HG21 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -66.14 -26.91 39.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.473 -0.767 . . . . 0.0 109.246 178.171 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.839 ' OD2' HG11 ' A' ' 3' ' ' VAL . 8.7 t0 -73.69 -39.25 64.51 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.53 ' OE1' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -57.92 -46.14 85.44 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.419 179.303 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.504 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -80.12 -40.21 27.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.553 -0.717 . . . . 0.0 110.061 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.764 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -68.42 -21.82 64.64 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.198 -179.165 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.67 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -69.61 -44.47 70.64 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.058 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.786 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -48.97 -39.65 27.37 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.869 0.843 . . . . 0.0 109.116 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.786 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.69 -57.98 2.68 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.382 -0.824 . . . . 0.0 109.23 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.734 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -95.92 77.87 0.79 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.258 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.568 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -32.9 -26.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 119.272 1.536 . . . . 0.0 110.726 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.941 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -85.3 153.13 22.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.535 -0.728 . . . . 0.0 110.889 177.779 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.824 HD12 ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -129.59 154.91 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.823 -1.173 . . . . 0.0 110.93 178.146 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.636 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 26.2 t0 -150.2 74.86 1.21 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.491 -0.756 . . . . 0.0 109.393 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.991 HG12 ' NZ ' ' A' ' 38' ' ' LYS . 40.5 t -93.03 119.13 40.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 120.938 -1.101 . . . . 0.0 110.348 -178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.826 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 11.6 mm-40 -102.44 141.68 34.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.958 -1.089 . . . . 0.0 108.919 -178.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.991 ' NZ ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -140.93 120.68 13.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.511 -0.743 . . . . 0.0 111.728 -174.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.955 HD13 ' HB2' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -137.38 169.81 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.035 -1.04 . . . . 0.0 110.109 -178.95 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.662 ' OD2' ' HG2' ' A' ' 42' ' ' MET . 7.9 p-10 -106.3 175.57 5.45 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.533 -0.729 . . . . 0.0 110.756 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 1.02 HD12 HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -66.97 -9.58 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.975 -1.078 . . . . 0.0 111.09 177.23 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.662 ' HG2' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -95.25 -16.9 22.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 110.732 -179.695 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.846 HG11 HG22 ' A' ' 39' ' ' ILE . 8.7 p -112.69 -40.64 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.146 -0.971 . . . . 0.0 110.055 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.796 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 3.1 t70 -111.06 45.57 1.16 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.863 . . . . 0.0 110.361 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.653 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.272 30.9 ttt180 -62.69 -3.76 1.68 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.528 -178.578 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 1.068 ' O ' HG23 ' A' ' 49' ' ' ILE . 21.8 mm-40 -57.54 -18.68 20.51 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.347 -0.846 . . . . 0.0 110.63 175.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.87 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -51.86 -56.74 12.2 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.381 1.086 . . . . 0.0 110.292 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.103 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -62.35 -5.39 2.4 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.255 176.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.225 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.4 pp -34.58 -39.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 -174.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 1.225 ' N ' HD12 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -53.15 -51.49 61.82 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.038 177.592 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.853 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.1 p90 -123.56 -29.77 3.71 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.921 -1.112 . . . . 0.0 110.495 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.764 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 41.41 12.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.236 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.736 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.1 mt -84.09 -67.32 0.8 Allowed 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 122.767 1.27 . . . . 0.0 107.826 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.511 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 25.7 mtp -103.57 57.15 0.74 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.465 -1.243 . . . . 0.0 107.815 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 1.103 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.266 . . -99.75 108.34 20.64 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.863 1.316 . . . . 0.0 111.011 -176.173 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.02 HG22 HD12 ' A' ' 41' ' ' ILE . 0.9 OUTLIER -146.81 -59.65 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.29 -179.565 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.802 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 45.1 Cg_endo -103.1 105.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.257 1.135 . . . . 0.0 110.447 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.95 ' HB3' ' CD2' ' A' ' 8' ' ' PHE . . . -160.59 -178.04 6.61 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.963 0.887 . . . . 0.0 111.632 -176.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.986 HD11 ' CB ' ' A' ' 16' ' ' CYS . 0.3 OUTLIER -149.11 141.56 17.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.781 -0.574 . . . . 0.0 109.66 -179.657 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 1.082 ' HB3' ' CB ' ' A' ' 6' ' ' GLU 0.253 . . -82.0 137.86 35.03 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 117.207 -1.797 . . . . 0.0 107.021 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.731 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.395 1.7 mt -90.0 85.85 2.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 125.433 2.539 . . . . 0.0 106.266 -174.457 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.81 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.7 OUTLIER -43.55 83.34 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 112.231 -2.259 . . . . 0.0 108.439 177.741 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.752 ' HA3' ' CB ' ' A' ' 83' ' ' GLU . . . 162.02 -47.57 0.35 Allowed Glycine 0 N--CA 1.483 1.782 0 N-CA-C 106.783 -2.527 . . . . 0.0 106.783 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.847 ' O ' HG23 ' A' ' 65' ' ' VAL . 4.2 m -123.15 -60.03 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.745 -0.856 . . . . 0.0 111.232 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 64' ' ' VAL . 75.6 t -164.78 -104.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 120.454 -1.404 . . . . 0.0 112.001 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.839 ' N ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -154.46 165.24 37.02 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.638 -0.664 . . . . 0.0 109.956 -179.065 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.882 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.64 172.98 12.48 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.035 -1.041 . . . . 0.0 110.94 -179.351 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.681 HG22 ' OH ' ' A' ' 51' ' ' TYR . 77.1 t -88.67 120.04 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.536 -0.727 . . . . 0.0 109.286 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.839 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.18 114.33 0.6 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.198 -1.477 . . . . 0.0 110.66 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.074 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -91.91 -83.75 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 120.848 -1.383 . . . . 0.0 108.79 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 1.074 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 48.3 Cg_endo -81.61 19.24 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 N-CA-C 108.145 -1.521 . . . . 0.0 108.145 177.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.748 ' CB ' ' OE2' ' A' ' 75' ' ' GLU 0.278 0.6 OUTLIER -105.68 83.09 1.88 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 117.993 -1.483 . . . . 0.0 109.2 179.699 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.744 ' C ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -81.39 -41.11 22.43 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.31 177.425 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.941 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -43.26 -29.33 0.39 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.001 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.819 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -49.69 -45.98 49.49 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.508 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.092 ' CD1' HG12 ' A' ' 7' ' ' VAL . 28.8 mt -58.82 -42.49 89.31 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.423 -0.798 . . . . 0.0 109.188 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.805 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.54 -34.88 73.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.494 -0.754 . . . . 0.0 110.209 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.633 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 3.4 tt0 -80.95 -26.78 36.39 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.697 -0.627 . . . . 0.0 110.358 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.519 ' CB ' HG23 ' A' ' 61' ' ' ILE . . . -75.22 -37.4 61.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -0.944 . . . . 0.0 109.773 -178.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.974 HG21 ' CG1' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.9 -39.37 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.043 -1.036 . . . . 0.0 109.344 178.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.633 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -72.93 -28.55 62.51 Favored 'General case' 0 C--O 1.258 1.552 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.668 ' HA ' ' OXT' ' A' ' 85' ' ' GLU 0.556 0.0 OUTLIER -95.6 -8.85 33.8 Favored 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 114.2 -3.0 . . . . 0.0 109.582 -178.186 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.752 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -71.35 -61.51 1.74 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 118.414 -2.679 . . . . 0.0 111.432 162.619 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.67 ' SD ' ' HD2' ' A' ' 27' ' ' LYS . 3.5 ptt? -71.55 -20.64 62.0 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.499 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.668 ' OXT' ' HA ' ' A' ' 82' ' ' ASP . 3.2 mm-40 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.227 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.488 ' SD ' ' OD1' ' A' ' 4' ' ' ASN . 7.9 ttp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.25 0.548 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.979 HG22 ' N ' ' A' ' 3' ' ' VAL . 0.9 OUTLIER -81.05 -94.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 109.854 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.979 ' N ' HG22 ' A' ' 2' ' ' VAL . 53.3 t -89.6 111.64 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.568 -0.707 . . . . 0.0 110.296 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.791 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.349 2.4 t-20 -135.4 107.57 7.21 Favored 'General case' 0 C--O 1.189 -2.123 0 CA-C-O 125.404 2.526 . . . . 0.0 107.24 177.301 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.892 HG21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -118.19 136.72 54.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 116.352 -1.785 . . . . 0.0 111.921 179.568 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.077 ' CB ' ' HB3' ' A' ' 60' ' ' ALA 0.48 5.8 tt0 -133.77 124.38 26.5 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 127.31 3.433 . . . . 0.0 101.919 174.069 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 1.089 HG12 ' CD1' ' A' ' 76' ' ' LEU 0.397 10.3 m -113.78 110.42 32.09 Favored 'Isoleucine or valine' 0 C--O 1.168 -3.208 0 O-C-N 116.613 -3.804 . . . . 0.0 101.483 -177.034 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.944 ' HB2' HD13 ' A' ' 39' ' ' ILE 0.306 1.7 t80 -117.28 96.68 5.53 Favored 'General case' 0 C--N 1.377 1.776 0 CA-C-N 110.611 -2.995 . . . . 0.0 108.663 -178.292 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.672 HG23 ' HA ' ' A' ' 57' ' ' PRO . 0.7 OUTLIER -124.53 -69.22 0.81 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.89 -1.131 . . . . 0.0 108.653 178.687 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.757 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 3.8 p 179.6 154.35 0.63 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.967 . . . . 0.0 110.713 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.652 ' HA ' ' OH ' ' A' ' 15' ' ' TYR . 50.1 Cg_endo -76.96 -27.06 7.29 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.146 1.603 . . . . 0.0 110.458 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -79.71 -16.04 56.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.873 . . . . 0.0 109.954 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.487 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -125.01 -179.44 0.86 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.347 -0.846 . . . . 0.0 109.915 179.691 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.654 ' O ' ' O ' ' A' ' 15' ' ' TYR . 52.0 Cg_endo -83.58 108.06 1.44 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.963 1.507 . . . . 0.0 110.367 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.757 ' CE1' ' O ' ' A' ' 10' ' ' SER . 5.0 m-85 -49.77 -117.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 109.788 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.986 ' CB ' HD11 ' A' ' 59' ' ' ILE . 19.2 m -155.54 40.27 0.13 Allowed Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.113 -0.992 . . . . 0.0 110.348 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.3 Cg_endo -75.98 30.12 0.39 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.926 1.487 . . . . 0.0 111.183 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.455 ' HG2' ' HG3' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -110.14 -59.32 1.95 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.901 -1.124 . . . . 0.0 110.728 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.903 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -56.42 -18.5 11.37 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.063 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.988 HD12 ' C ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -75.72 -39.15 38.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.851 179.572 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.655 ' N ' HD12 ' A' ' 20' ' ' ILE . 14.5 tt0 -52.98 -34.25 55.19 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 108.757 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -70.73 -49.11 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.425 -0.797 . . . . 0.0 109.271 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.968 ' CG1' HG21 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -58.95 -35.55 57.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-O 122.707 1.241 . . . . 0.0 109.305 176.529 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.841 ' OD2' HG11 ' A' ' 3' ' ' VAL . 7.8 t0 -68.42 -41.57 80.18 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 122.848 1.308 . . . . 0.0 108.918 -178.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.53 ' OE1' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -56.19 -48.03 77.18 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.464 179.483 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.507 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -78.15 -39.68 40.24 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.854 0.835 . . . . 0.0 111.188 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.768 ' CB ' HG22 ' A' ' 3' ' ' VAL 0.288 0.0 OUTLIER -72.59 -16.13 61.74 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 117.17 -1.812 . . . . 0.0 109.013 -178.193 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.672 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -72.43 -43.25 64.08 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.821 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.735 ' HG3' ' N ' ' A' ' 30' ' ' PHE 0.287 0.0 OUTLIER -52.54 -32.59 41.41 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.765 179.794 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.769 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -94.42 -69.46 0.75 Allowed 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 102.954 -2.98 . . . . 0.0 102.954 -179.275 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.746 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -75.29 65.8 2.32 Favored Glycine 0 C--N 1.27 -3.111 1 CA-C-O 113.33 -4.039 . . . . 0.0 117.337 176.161 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.585 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -31.06 -29.61 0.01 OUTLIER 'General case' 0 C--N 1.254 -3.563 1 CA-C-N 124.806 4.303 . . . . 0.0 110.286 -175.408 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.946 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -74.73 149.53 39.78 Favored 'General case' 0 C--N 1.278 -2.52 0 O-C-N 120.132 -1.605 . . . . 0.0 113.903 174.076 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.821 HD12 ' O ' ' A' ' 33' ' ' LYS 0.262 0.4 OUTLIER -131.05 156.42 42.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 120.854 1.661 . . . . 0.0 110.589 174.793 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.68 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 26.2 t0 -151.22 79.19 1.3 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.983 HG12 ' NZ ' ' A' ' 38' ' ' LYS 0.351 61.9 t -100.63 127.41 53.75 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.94 0 CA-C-O 125.916 2.77 . . . . 0.0 104.764 -177.65 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.871 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.424 9.2 mm-40 -111.91 146.17 38.24 Favored 'General case' 0 C--O 1.183 -2.418 0 C-N-CA 113.685 -3.206 . . . . 0.0 103.99 -176.853 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.983 ' NZ ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -139.45 107.47 5.72 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 115.221 -2.323 . . . . 0.0 115.777 -170.036 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.944 HD13 ' HB2' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -131.72 166.87 27.72 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.556 0 CA-C-N 122.949 2.613 . . . . 0.0 112.311 -179.283 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.663 ' OD2' ' HG2' ' A' ' 42' ' ' MET . 4.0 p-10 -98.27 175.64 6.0 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.57 -1.331 . . . . 0.0 113.464 177.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 1.019 HD12 HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -64.63 -13.94 15.25 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.065 0 O-C-N 121.066 -1.021 . . . . 0.0 111.317 174.723 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.663 ' HG2' ' OD2' ' A' ' 40' ' ' ASP 0.379 0.0 OUTLIER -100.88 -5.07 26.62 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 115.276 -2.57 . . . . 0.0 110.538 -177.251 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.849 HG11 HG22 ' A' ' 39' ' ' ILE . 7.5 p -117.13 -41.11 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.967 -1.083 . . . . 0.0 109.048 177.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.786 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 3.1 t70 -111.56 46.69 1.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 110.254 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.708 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.378 30.3 ttt180 -66.2 -0.08 2.32 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 116.518 -2.073 . . . . 0.0 108.922 -177.754 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 1.052 ' O ' HG23 ' A' ' 49' ' ' ILE . 18.8 mm-40 -53.12 -26.71 17.55 Favored 'General case' 0 C--N 1.287 -2.142 0 O-C-N 120.785 -1.197 . . . . 0.0 109.831 172.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.88 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -48.28 -61.0 2.22 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.571 -1.331 . . . . 0.0 109.343 -176.091 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.026 ' CB ' ' HB2' ' A' ' 55' ' ' ALA 0.359 . . -54.3 -12.55 0.68 Allowed 'General case' 0 C--N 1.266 -3.054 0 C-N-CA 125.677 1.591 . . . . 0.0 112.053 176.101 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.229 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.5 pp -33.13 -39.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.79 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -172.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 1.229 ' N ' HD12 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -53.13 -51.6 61.42 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.251 176.522 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.846 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.1 p90 -123.44 -29.51 3.78 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.049 -1.032 . . . . 0.0 110.582 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.793 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.41 16.37 0.01 OUTLIER Glycine 0 N--CA 1.487 2.092 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.736 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.4 mt -87.55 -75.01 0.42 Allowed 'General case' 0 C--N 1.262 -3.197 0 N-CA-C 103.136 -2.912 . . . . 0.0 103.136 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.48 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 26.7 mtp -98.95 65.01 1.46 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.804 -1.544 . . . . 0.0 108.46 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 1.026 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.451 . . -110.98 112.48 24.33 Favored 'General case' 0 C--O 1.168 -3.184 1 CA-C-O 128.612 4.053 . . . . 0.0 105.685 -175.308 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.019 HG22 HD12 ' A' ' 41' ' ' ILE . 0.9 OUTLIER -148.32 -51.33 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.511 0 CA-C-N 110.476 -3.056 . . . . 0.0 112.15 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.839 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.473 19.3 Cg_endo -117.67 111.82 0.01 OUTLIER 'Trans proline' 0 C--O 1.148 -3.988 1 CA-C-O 130.685 4.369 . . . . 0.0 103.704 -179.756 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.934 ' HB3' ' CD2' ' A' ' 8' ' ' PHE . . . -160.88 178.32 9.53 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 109.578 -3.465 . . . . 0.0 111.405 -174.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.986 HD11 ' CB ' ' A' ' 16' ' ' CYS 0.26 0.3 OUTLIER -144.94 151.28 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.746 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 1.077 ' HB3' ' CB ' ' A' ' 6' ' ' GLU 0.503 . . -96.02 147.66 23.47 Favored 'General case' 0 C--O 1.187 -2.193 2 N-CA-C 98.196 -4.742 . . . . 0.0 98.196 -178.257 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.754 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.654 2.2 mt -99.68 96.55 5.02 Favored 'Isoleucine or valine' 0 C--N 1.408 3.112 3 C-N-CA 108.539 -5.264 . . . . 0.0 98.644 -170.689 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.791 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.6 OUTLIER -50.29 85.6 0.0 OUTLIER 'General case' 0 C--N 1.379 1.851 1 CA-C-N 107.205 -4.543 . . . . 0.0 107.516 177.499 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.757 ' HA3' ' CB ' ' A' ' 83' ' ' GLU . . . 161.95 -47.87 0.35 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 106.734 -2.546 . . . . 0.0 106.734 -178.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.844 ' O ' HG23 ' A' ' 65' ' ' VAL . 4.2 m -122.94 -59.86 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.72 -0.871 . . . . 0.0 111.468 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 64' ' ' VAL . 76.1 t -164.48 -104.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.264 -1.523 . . . . 0.0 111.827 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.837 ' N ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -153.89 166.11 33.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.703 -0.623 . . . . 0.0 110.111 -179.067 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.879 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -147.64 169.51 19.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.029 -1.044 . . . . 0.0 110.878 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.687 HG22 ' OH ' ' A' ' 51' ' ' TYR . 97.2 t -81.74 118.79 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.874 -1.141 . . . . 0.0 111.667 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.837 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.77 114.13 0.59 Allowed Glycine 0 C--N 1.281 -2.504 0 CA-C-N 120.595 1.543 . . . . 0.0 110.698 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.066 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -92.03 -83.08 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.754 0 O-C-N 120.742 -1.446 . . . . 0.0 109.04 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 1.066 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 43.1 Cg_endo -86.0 28.89 0.54 Allowed 'Trans proline' 0 C--N 1.318 -1.041 0 N-CA-C 107.894 -1.618 . . . . 0.0 107.894 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.746 ' CB ' ' OE2' ' A' ' 75' ' ' GLU 0.644 0.4 OUTLIER -120.76 95.02 4.54 Favored 'General case' 0 C--O 1.164 -3.427 2 C-N-CA 108.815 -5.154 . . . . 0.0 100.585 179.121 . . . . . . . . 5 4 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.727 ' C ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -83.15 -43.89 15.68 Favored 'General case' 0 C--N 1.371 1.537 1 CA-C-N 108.204 -4.089 . . . . 0.0 109.057 174.7 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.903 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -39.85 -32.33 0.15 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.811 -1.18 . . . . 0.0 108.504 178.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.818 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -49.36 -45.43 45.73 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.173 -179.272 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.089 ' CD1' HG12 ' A' ' 7' ' ' VAL . 29.3 mt -58.55 -42.99 89.14 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.786 0.803 . . . . 0.0 109.36 178.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.803 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.68 -36.85 74.84 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.261 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.626 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 3.6 tt0 -74.05 -35.01 64.27 Favored 'General case' 0 C--N 1.286 -2.165 0 O-C-N 120.775 -1.203 . . . . 0.0 110.624 178.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.486 ' CB ' HG23 ' A' ' 61' ' ' ILE . . . -72.6 -37.6 68.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.821 -1.175 . . . . 0.0 110.222 -175.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.968 HG21 ' CG1' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.5 -42.87 97.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 121.056 -1.027 . . . . 0.0 109.168 178.047 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.626 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -70.48 -25.84 63.35 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 120.776 -1.203 . . . . 0.0 109.843 178.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.797 ' HA ' ' OXT' ' A' ' 85' ' ' GLU 1.012 0.0 OUTLIER -108.61 15.03 24.09 Favored 'General case' 0 C--O 1.302 3.828 2 C-N-CA 104.258 -6.977 . . . . 0.0 101.538 -176.267 . . . . . . . . 5 4 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.757 ' CB ' ' HA3' ' A' ' 63' ' ' GLY 0.258 0.0 OUTLIER -89.52 -59.45 2.21 Favored 'General case' 0 C--N 1.314 -0.966 1 O-C-N 113.892 -5.505 . . . . 0.0 104.468 164.096 . . . . . . . . 5 4 . 1 . 013 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.67 ' SD ' ' HD2' ' A' ' 27' ' ' LYS 0.26 3.6 ptt? -73.42 -16.18 61.33 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.599 -1.24 . . . . 0.0 111.091 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.797 ' OXT' ' HA ' ' A' ' 82' ' ' ASP . 3.1 mm-40 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.81 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.623 ' HE3' ' OE2' ' A' ' 83' ' ' GLU . 2.8 ttp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.308 0.575 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.006 HG22 HG23 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -89.65 -91.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.401 -0.812 . . . . 0.0 110.438 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.006 HG23 HG22 ' A' ' 2' ' ' VAL . 79.0 t -91.13 111.93 24.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 O-C-N 121.811 -0.556 . . . . 0.0 110.665 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.806 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 1.9 m-80 -126.73 113.64 16.93 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.993 HD12 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -133.47 133.74 57.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.396 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.012 ' HB3' ' HB3' ' A' ' 60' ' ' ALA 0.277 0.0 OUTLIER -127.93 110.58 12.69 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 116.755 -1.978 . . . . 0.0 109.454 176.472 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.922 HG22 ' HA ' ' A' ' 38' ' ' LYS 0.255 33.3 m -99.51 100.64 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 124.107 1.908 . . . . 0.0 108.388 -177.752 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.899 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -116.98 95.0 4.8 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.617 -178.086 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.656 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 38.2 m -120.5 -79.78 0.61 Allowed 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.073 -1.017 . . . . 0.0 109.648 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.62 ' C ' ' OD1' ' A' ' 40' ' ' ASP . 0.2 OUTLIER 179.55 155.53 0.66 Allowed Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.853 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.699 ' HG3' ' CE ' ' A' ' 42' ' ' MET . 47.4 Cg_endo -73.95 -12.62 23.9 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 124.142 1.601 . . . . 0.0 110.465 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 12' ' ' THR . 0.5 OUTLIER -79.45 0.75 28.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.066 -1.021 . . . . 0.0 109.86 179.675 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.547 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -157.47 -170.25 0.24 Allowed Pre-proline 0 N--CA 1.485 1.317 0 O-C-N 121.625 -0.672 . . . . 0.0 110.132 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.643 ' O ' ' O ' ' A' ' 15' ' ' TYR . 55.2 Cg_endo -84.6 118.02 2.12 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.751 1.395 . . . . 0.0 110.735 175.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.752 ' CE1' ' OD1' ' A' ' 40' ' ' ASP . 2.7 m-85 -49.54 -113.94 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.381 -0.825 . . . . 0.0 109.773 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 1.179 ' SG ' HD11 ' A' ' 59' ' ' ILE . 33.4 m -155.0 39.91 0.13 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.163 -0.961 . . . . 0.0 110.329 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.952 ' HA ' HD13 ' A' ' 20' ' ' ILE . 55.4 Cg_endo -75.75 27.17 0.39 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.715 1.376 . . . . 0.0 111.192 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.739 ' CG ' ' CD ' ' A' ' 73' ' ' ARG . 0.1 OUTLIER -110.11 -63.22 1.4 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.947 -1.095 . . . . 0.0 110.583 -179.275 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.834 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -54.27 -21.43 9.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.284 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.993 ' HB ' HD12 ' A' ' 5' ' ' ILE . 2.6 pt -66.77 -42.19 88.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.489 0.662 . . . . 0.0 109.228 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.567 ' N ' ' CG1' ' A' ' 20' ' ' ILE . 2.5 tm-20 -54.16 -33.94 59.21 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.66 -41.42 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.785 0.802 . . . . 0.0 109.077 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -68.59 -30.06 46.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 121.667 0.746 . . . . 0.0 109.362 178.228 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.702 ' OD1' ' CG1' ' A' ' 34' ' ' ILE . 5.9 t70 -73.98 -38.09 64.26 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -45.55 88.3 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.699 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.529 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.65 -40.5 29.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.561 -0.712 . . . . 0.0 110.173 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.898 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -70.78 -20.54 62.59 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.943 -1.103 . . . . 0.0 109.567 -178.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.68 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -69.07 -47.88 64.17 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 176.261 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.749 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -45.64 -41.29 10.07 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.94 0.876 . . . . 0.0 109.21 179.02 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.749 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -90.63 -61.32 1.7 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 121.358 -0.839 . . . . 0.0 108.946 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.694 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -94.11 78.78 0.98 Allowed Glycine 0 N--CA 1.485 1.931 0 CA-C-O 118.805 -0.997 . . . . 0.0 111.413 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.538 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -35.58 -24.05 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 120.418 2.109 . . . . 0.0 111.164 -179.628 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.942 ' O ' HG21 ' A' ' 2' ' ' VAL . 6.6 mtpt -83.52 154.52 23.81 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.699 -0.625 . . . . 0.0 111.44 176.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.914 HD12 ' O ' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -127.97 157.41 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 118.839 -1.144 . . . . 0.0 111.072 177.449 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.596 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 7.2 t70 -150.38 64.31 0.95 Allowed 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.987 HG11 HD12 ' A' ' 20' ' ' ILE . 31.3 t -92.66 117.84 36.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 118.799 -1.161 . . . . 0.0 109.824 -178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.802 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.273 3.1 mt-10 -101.56 147.57 26.25 Favored 'General case' 0 C--O 1.195 -1.793 0 CA-C-O 122.474 1.13 . . . . 0.0 108.728 -177.744 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.922 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.74 119.25 13.05 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.172 -0.955 . . . . 0.0 112.019 -173.681 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.018 HD12 ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -130.4 178.41 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -0.962 . . . . 0.0 110.667 -178.903 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.752 ' OD1' ' CE1' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -109.28 179.55 4.12 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.637 -0.664 . . . . 0.0 111.401 176.023 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.882 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -61.76 -54.0 40.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.128 -0.982 . . . . 0.0 112.104 173.411 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.709 ' N ' HG22 ' A' ' 41' ' ' ILE . 5.2 ptp -71.71 0.28 9.2 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.427 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.742 HG21 HG22 ' A' ' 39' ' ' ILE . 1.1 m -111.9 -45.19 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 109.814 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 1.018 ' HB2' HD12 ' A' ' 39' ' ' ILE . 9.7 t70 -114.54 45.55 1.53 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.339 -0.851 . . . . 0.0 109.839 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.517 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.288 0.0 OUTLIER -67.99 -5.57 17.95 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.41 -1.316 . . . . 0.0 110.225 -178.411 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 1.026 ' O ' HG23 ' A' ' 49' ' ' ILE . 4.4 mt-10 -56.82 -18.93 14.71 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.312 -0.868 . . . . 0.0 110.471 173.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.843 ' HB3' ' CE2' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -49.92 -61.17 2.29 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 122.891 1.329 . . . . 0.0 110.306 -178.272 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.972 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -58.62 -4.93 0.48 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.84 177.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.164 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.2 pp -35.99 -41.62 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 -173.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 1.164 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.9 OUTLIER -50.43 -52.95 33.24 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.897 177.059 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.84 ' OH ' HG22 ' A' ' 68' ' ' VAL . 45.6 p90 -118.93 -36.86 3.33 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.088 -1.007 . . . . 0.0 110.354 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.766 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.96 14.0 0.01 OUTLIER Glycine 0 N--CA 1.495 2.584 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.701 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 42.7 mt -82.69 -63.3 1.4 Allowed 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 123.231 1.491 . . . . 0.0 109.256 177.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.454 ' C ' ' HE2' ' A' ' 51' ' ' TYR . 19.3 mtm -109.55 53.88 0.68 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.969 -1.468 . . . . 0.0 109.516 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.972 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.311 . . -103.52 124.44 48.77 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 117.821 -1.552 . . . . 0.0 111.117 -173.759 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.808 ' HA ' ' CG1' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -147.92 -60.74 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.408 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.656 -177.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.782 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.267 45.1 Cg_endo -108.14 113.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 CA-C-O 123.446 1.352 . . . . 0.0 110.334 177.814 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 1.111 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -161.39 178.6 9.01 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.223 -175.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.252 HG21 ' CD1' ' A' ' 76' ' ' LEU . 1.2 mp -147.47 143.8 19.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.771 -0.58 . . . . 0.0 109.762 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 1.012 ' HB3' ' HB3' ' A' ' 6' ' ' GLU 0.285 . . -82.74 143.07 31.14 Favored 'General case' 0 CA--C 1.487 -1.446 0 C-N-CA 115.912 -2.315 . . . . 0.0 109.092 -179.107 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.705 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.404 1.0 OUTLIER -91.09 87.5 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.731 0 CA-C-O 125.493 2.568 . . . . 0.0 107.478 -174.319 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.806 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.6 OUTLIER -42.28 80.61 0.0 OUTLIER 'General case' 0 C--O 1.2 -1.502 0 CA-C-N 112.601 -2.09 . . . . 0.0 109.618 177.296 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.782 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 161.33 -48.34 0.37 Allowed Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.56 -2.216 . . . . 0.0 107.56 -177.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.811 ' O ' HG23 ' A' ' 65' ' ' VAL . 4.9 m -120.16 -59.73 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.763 -0.845 . . . . 0.0 110.922 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 64' ' ' VAL . 74.5 t -164.64 -104.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.436 -1.415 . . . . 0.0 111.923 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.964 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 2.1 ttp180 -164.39 164.11 22.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.642 -0.661 . . . . 0.0 109.309 -178.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 1.111 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.1 -176.49 5.11 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.939 -1.101 . . . . 0.0 111.75 -176.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.84 HG22 ' OH ' ' A' ' 51' ' ' TYR . 79.5 t -94.63 114.98 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.83 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.85 125.16 1.35 Allowed Glycine 0 N--CA 1.49 2.282 0 C-N-CA 118.918 -1.611 . . . . 0.0 110.688 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.089 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -92.92 -79.8 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.047 -1.267 . . . . 0.0 108.326 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 1.089 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 54.0 Cg_endo -81.65 20.9 0.99 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.35 1.184 . . . . 0.0 109.355 177.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.602 ' OG ' ' HA3' ' A' ' 69' ' ' GLY . 1.5 p -98.55 64.67 1.55 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.362 -0.836 . . . . 0.0 111.378 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.739 ' CD ' ' CG ' ' A' ' 18' ' ' MET . 0.1 OUTLIER -73.93 -35.89 64.62 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.171 -0.955 . . . . 0.0 109.318 178.716 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.543 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -48.92 -37.42 19.85 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.049 -1.032 . . . . 0.0 109.236 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.74 ' CD ' ' CD2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -47.09 -36.86 8.75 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.515 -0.874 . . . . 0.0 108.83 179.541 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.252 ' CD1' HG21 ' A' ' 59' ' ' ILE . 8.9 mp -61.44 -44.74 96.59 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 177.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.789 ' HA ' ' CG1' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -56.85 -34.41 67.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.459 -0.776 . . . . 0.0 109.859 178.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -77.96 -31.75 51.0 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.684 -0.635 . . . . 0.0 109.708 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.426 ' HB2' HG23 ' A' ' 61' ' ' ILE . . . -68.56 -49.15 61.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.458 -0.776 . . . . 0.0 109.655 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.779 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 1.9 mp -51.96 -35.5 18.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 120.949 -1.094 . . . . 0.0 108.695 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.562 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 8.1 t-20 -68.1 -27.5 66.53 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.575 ' OD2' HG11 ' A' ' 64' ' ' VAL 0.553 37.8 t0 -95.25 -21.62 18.33 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 113.374 -3.33 . . . . 0.0 106.329 -177.698 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.782 ' HB2' ' CA ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -68.64 -46.1 70.08 Favored 'General case' 0 C--N 1.288 -2.076 0 O-C-N 119.504 -1.997 . . . . 0.0 108.916 170.054 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.804 ' CE ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -78.9 -23.38 44.84 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.484 178.378 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.489 ' O ' ' O ' ' A' ' 81' ' ' ASN . 11.3 tp10 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.289 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.732 ' SD ' ' ND2' ' A' ' 4' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.211 0.529 . . . . 0.0 110.232 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.953 HG21 ' O ' ' A' ' 33' ' ' LYS . 1.6 p -89.44 -96.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 0.0 110.265 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.999 HG11 ' OD1' ' A' ' 24' ' ' ASP . 55.4 t -92.17 119.55 39.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.453 -0.779 . . . . 0.0 110.18 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.751 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 4.6 t-20 -135.78 111.78 9.58 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 123.082 1.42 . . . . 0.0 109.194 179.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.055 ' HB ' HG13 ' A' ' 36' ' ' VAL . 4.1 mt -126.05 133.48 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.115 -0.991 . . . . 0.0 109.965 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.145 ' CB ' ' HB3' ' A' ' 60' ' ' ALA 0.272 15.3 tt0 -125.28 101.81 7.15 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 116.963 -1.895 . . . . 0.0 109.17 178.599 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.827 ' CG2' ' CB ' ' A' ' 38' ' ' LYS 0.251 29.0 m -97.66 111.33 27.24 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.438 0 CA-C-O 123.734 1.73 . . . . 0.0 107.621 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.911 ' CD2' ' HB3' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -118.55 90.57 3.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.01 -1.056 . . . . 0.0 109.342 -178.448 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.667 ' OG1' ' HA ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -121.35 -72.92 0.67 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.355 -0.841 . . . . 0.0 110.322 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.876 ' HA ' HG22 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -170.66 149.49 2.96 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.02 -1.05 . . . . 0.0 110.85 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.745 ' N ' ' HB3' ' A' ' 40' ' ' ASP . 46.4 Cg_endo -75.67 -28.91 7.71 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 124.019 1.536 . . . . 0.0 110.153 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.59 -15.02 58.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.859 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.644 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -124.95 -179.69 0.92 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.388 -0.82 . . . . 0.0 109.875 179.774 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.644 ' HD2' ' SG ' ' A' ' 13' ' ' CYS . 51.2 Cg_endo -83.56 111.12 1.74 Allowed 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.999 1.526 . . . . 0.0 110.417 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.762 ' CE1' ' O ' ' A' ' 10' ' ' SER . 17.9 m-85 -49.53 -111.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.908 . . . . 0.0 109.685 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.96 ' SG ' HD11 ' A' ' 59' ' ' ILE . 26.3 m -155.09 39.39 0.11 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.149 -0.97 . . . . 0.0 110.308 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.4 Cg_endo -76.18 23.07 0.48 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.84 1.442 . . . . 0.0 110.92 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.718 ' HB3' ' CD ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -103.18 -66.79 0.92 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.049 -1.032 . . . . 0.0 110.889 -179.292 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.968 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -55.14 -21.87 14.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.276 -0.89 . . . . 0.0 109.84 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.034 ' CD1' HD13 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -72.67 -39.45 60.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.504 -0.747 . . . . 0.0 109.533 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.673 ' N ' HD12 ' A' ' 20' ' ' ILE . 1.6 tt0 -49.17 -31.9 9.24 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 15.5 t -69.42 -45.59 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.534 -0.729 . . . . 0.0 109.386 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.905 HG13 HG21 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -68.9 -28.56 40.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.312 -0.868 . . . . 0.0 109.366 178.463 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.999 ' OD1' HG11 ' A' ' 3' ' ' VAL . 16.6 t0 -76.09 -36.71 58.82 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -58.75 -44.04 90.42 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.644 0.735 . . . . 0.0 109.381 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.497 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.54 -40.99 28.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.51 -0.744 . . . . 0.0 110.164 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.792 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -67.09 -23.35 65.84 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.932 -1.107 . . . . 0.0 109.082 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.801 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.82 -45.63 70.71 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.365 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.797 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -49.43 -40.3 36.03 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.783 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.797 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.9 -56.32 3.28 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.829 ' HA3' HG23 ' A' ' 2' ' ' VAL . . . -96.18 78.47 0.76 Allowed Glycine 0 N--CA 1.489 2.173 0 O-C-N 121.398 -0.813 . . . . 0.0 111.378 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.532 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -36.96 -21.62 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 119.309 1.555 . . . . 0.0 110.3 -179.468 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.953 ' O ' HG21 ' A' ' 2' ' ' VAL . 27.3 mtmm -85.06 154.6 21.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -0.999 . . . . 0.0 111.145 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.801 ' CD1' ' CG ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -129.28 150.21 34.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 118.883 -1.127 . . . . 0.0 111.048 178.463 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.618 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -150.43 68.49 0.97 Allowed 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.479 -0.763 . . . . 0.0 109.159 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.055 HG13 ' HB ' ' A' ' 5' ' ' ILE . 65.6 t -91.92 118.37 37.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 122.413 1.102 . . . . 0.0 109.519 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.806 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.267 8.6 mm-40 -100.13 131.01 46.33 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 123.321 1.534 . . . . 0.0 108.185 -178.678 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 1.067 ' C ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -139.56 122.1 16.23 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.753 -1.217 . . . . 0.0 111.559 -176.723 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.067 HD13 ' C ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -136.72 -163.54 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 122.31 1.052 . . . . 0.0 111.129 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.937 ' OD1' HG11 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -110.96 170.82 7.85 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.792 179.183 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 1.273 ' CD1' HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -65.86 -54.33 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.593 -0.692 . . . . 0.0 111.548 177.474 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.629 ' H ' HG23 ' A' ' 41' ' ' ILE . 6.4 ptm -65.26 -1.56 2.41 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.016 -1.073 . . . . 0.0 110.985 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.937 HG11 ' OD1' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -112.08 -48.9 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.018 -1.051 . . . . 0.0 110.705 178.063 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.724 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 3.0 t70 -105.9 48.51 0.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.954 . . . . 0.0 110.086 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.644 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.288 6.4 ttt-85 -63.35 -7.21 5.88 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 118.086 -1.445 . . . . 0.0 109.662 -178.554 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.983 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.3 mm-40 -51.33 -19.94 1.51 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.157 -0.964 . . . . 0.0 110.159 176.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.841 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -51.8 -58.72 5.61 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 122.188 0.994 . . . . 0.0 109.815 -179.399 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.057 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -62.88 -1.94 1.04 Allowed 'General case' 0 C--N 1.276 -2.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.68 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.983 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -35.34 -42.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 104.027 -2.582 . . . . 0.0 104.027 -176.383 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.503 ' N ' ' C ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -48.93 -51.33 30.78 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.195 176.754 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 1.261 ' OH ' HG22 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -125.93 -32.54 2.78 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.107 -0.996 . . . . 0.0 110.432 179.124 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.813 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 61.07 -33.52 0.05 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.804 HD12 ' H ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -49.57 -81.43 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.644 -1.503 . . . . 0.0 109.858 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.804 ' H ' HD12 ' A' ' 53' ' ' LEU . 24.7 mtt -79.45 54.3 1.7 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.401 -0.812 . . . . 0.0 108.944 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 1.057 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.288 . . -99.61 103.52 15.23 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 124.006 1.86 . . . . 0.0 110.174 -177.328 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.273 HG22 ' CD1' ' A' ' 41' ' ' ILE . 4.9 t -146.63 -72.86 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.414 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.801 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.829 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 51.4 Cg_endo -95.3 112.15 0.15 Allowed 'Trans proline' 0 C--O 1.197 -1.541 0 CA-C-O 123.872 1.53 . . . . 0.0 109.893 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 1.006 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -160.82 179.27 8.65 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.425 -1.422 . . . . 0.0 111.792 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.96 HD11 ' SG ' ' A' ' 16' ' ' CYS 0.253 0.3 OUTLIER -142.48 133.48 24.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.078 179.334 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 1.145 ' HB3' ' CB ' ' A' ' 6' ' ' GLU . . . -81.42 141.31 34.05 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 116.935 -1.906 . . . . 0.0 106.215 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.772 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.433 0.7 OUTLIER -90.09 86.75 2.6 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.69 0 C-N-CA 114.73 -2.788 . . . . 0.0 105.421 -175.576 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.751 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -44.31 82.34 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 112.634 -2.076 . . . . 0.0 108.76 177.78 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.772 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.49 -44.1 0.35 Allowed Glycine 0 N--CA 1.483 1.805 0 N-CA-C 107.207 -2.357 . . . . 0.0 107.207 -178.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.76 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.2 m -126.18 -59.01 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.537 -0.978 . . . . 0.0 111.302 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.76 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 93.2 t -163.59 -108.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 120.306 -1.496 . . . . 0.0 112.358 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.786 ' CZ ' ' HB2' ' A' ' 60' ' ' ALA . 3.5 ttt180 -165.14 164.64 20.21 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.769 -0.582 . . . . 0.0 109.653 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 1.006 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -144.95 177.01 9.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.92 -1.112 . . . . 0.0 111.177 -178.11 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.261 HG22 ' OH ' ' A' ' 51' ' ' TYR . 78.9 t -88.66 116.0 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.832 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.836 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.68 123.57 1.19 Allowed Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.72 -1.228 . . . . 0.0 110.447 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.115 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -93.9 -78.26 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 120.868 -1.372 . . . . 0.0 108.662 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 1.115 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 54.6 Cg_endo -79.26 20.39 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.654 1.344 . . . . 0.0 109.254 178.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.732 ' O ' HD13 ' A' ' 59' ' ' ILE 0.3 2.3 p -103.88 81.78 1.91 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 124.024 1.869 . . . . 0.0 109.989 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 1.196 ' O ' HD12 ' A' ' 76' ' ' LEU . 24.9 mtt180 -79.57 -36.12 38.68 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.643 -1.286 . . . . 0.0 110.03 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.968 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.5 tt0 -50.48 -25.35 3.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.319 -0.863 . . . . 0.0 109.726 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.781 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -53.67 -46.39 70.6 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.351 -0.843 . . . . 0.0 109.207 -179.594 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.196 HD12 ' O ' ' A' ' 73' ' ' ARG . 0.7 OUTLIER -60.18 -42.19 94.5 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.009 178.808 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.826 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.09 -33.95 69.64 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.399 -0.813 . . . . 0.0 109.78 179.548 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.766 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 31.5 tt0 -81.58 -27.75 34.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 110.146 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.606 ' CB ' ' HA ' ' A' ' 61' ' ' ILE . . . -74.47 -38.07 63.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.637 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.905 HG21 HG13 ' A' ' 23' ' ' VAL . 1.8 mp -63.35 -39.8 86.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.144 -0.972 . . . . 0.0 108.985 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.667 ' HA ' ' SD ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -74.96 -33.12 61.86 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.244 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 78' ' ' GLU 0.523 0.1 OUTLIER -91.34 -3.26 56.95 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 113.54 -3.264 . . . . 0.0 107.125 -178.814 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.758 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -82.26 -59.58 2.5 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 119.672 -1.893 . . . . 0.0 109.816 169.589 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.674 ' SD ' ' HD2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.94 -13.48 62.47 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.405 179.525 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.494 ' N ' ' HG2' ' A' ' 84' ' ' MET . 2.7 tm-20 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.196 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.731 ' SD ' ' ND2' ' A' ' 4' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.252 0.549 . . . . 0.0 110.211 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.955 HG21 ' O ' ' A' ' 33' ' ' LYS . 1.6 p -89.53 -97.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.842 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.003 HG11 ' OD1' ' A' ' 24' ' ' ASP . 53.2 t -89.51 121.69 39.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.343 -0.848 . . . . 0.0 109.987 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.747 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.292 5.3 t-20 -140.17 111.26 7.02 Favored 'General case' 0 C--O 1.19 -2.076 0 CA-C-O 125.057 2.361 . . . . 0.0 108.135 178.23 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.045 ' HB ' HG13 ' A' ' 36' ' ' VAL . 4.2 mt -121.63 133.85 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.195 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.151 ' CB ' ' HB3' ' A' ' 60' ' ' ALA 0.371 16.4 tt0 -129.11 111.12 12.62 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 115.218 -2.593 . . . . 0.0 105.063 177.026 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.829 ' CG2' ' CB ' ' A' ' 38' ' ' LYS 0.352 15.0 m -108.86 111.17 34.89 Favored 'Isoleucine or valine' 0 C--O 1.177 -2.748 0 CA-C-O 126.761 3.172 . . . . 0.0 103.822 -178.425 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.909 ' CD2' ' HB3' ' A' ' 58' ' ' ALA 0.277 0.4 OUTLIER -117.27 94.74 4.68 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 111.947 -2.388 . . . . 0.0 108.532 -178.608 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.668 ' OG1' ' HA ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -124.02 -69.84 0.79 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.095 -1.003 . . . . 0.0 110.601 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.885 ' HA ' HG22 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -174.96 146.83 1.0 Allowed Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 120.876 -1.14 . . . . 0.0 110.734 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.744 ' N ' ' HB3' ' A' ' 40' ' ' ASP . 50.7 Cg_endo -73.78 -29.01 10.93 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 O-C-N 123.802 1.422 . . . . 0.0 110.565 -178.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.63 -14.95 58.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.381 -0.824 . . . . 0.0 109.884 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.645 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -124.94 -179.65 0.91 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.388 -0.82 . . . . 0.0 109.846 179.732 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.645 ' HD2' ' SG ' ' A' ' 13' ' ' CYS . 51.8 Cg_endo -83.69 111.14 1.71 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.958 1.504 . . . . 0.0 110.444 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.765 ' CE1' ' O ' ' A' ' 10' ' ' SER . 18.1 m-85 -49.59 -111.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 109.606 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.96 ' SG ' HD11 ' A' ' 59' ' ' ILE . 26.7 m -155.06 39.4 0.12 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.17 -0.957 . . . . 0.0 110.353 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.4 Cg_endo -76.2 23.12 0.48 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.84 1.442 . . . . 0.0 110.95 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.719 ' HB3' ' CD ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -103.24 -66.64 0.93 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.049 -1.032 . . . . 0.0 110.85 -179.293 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.942 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -55.53 -21.34 16.47 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.284 -0.885 . . . . 0.0 109.898 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.035 ' CD1' HD13 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -73.0 -39.23 57.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.598 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.672 ' N ' HD12 ' A' ' 20' ' ' ILE . 1.6 tt0 -48.91 -32.66 9.34 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.434 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 16.4 t -68.54 -47.37 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.659 0.742 . . . . 0.0 109.279 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.898 HG13 HG21 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -64.07 -34.45 68.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-O 122.476 1.131 . . . . 0.0 109.513 177.451 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 1.003 ' OD1' HG11 ' A' ' 3' ' ' VAL . 15.2 t0 -71.66 -39.01 70.59 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 122.78 1.276 . . . . 0.0 108.949 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -57.24 -45.31 84.06 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.569 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.5 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -78.28 -40.5 36.81 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.782 0.801 . . . . 0.0 110.808 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.793 ' CB ' HG22 ' A' ' 3' ' ' VAL 0.252 0.0 OUTLIER -70.23 -19.19 63.16 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 117.627 -1.629 . . . . 0.0 108.904 -178.715 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.801 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -70.9 -44.75 65.59 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.38 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.763 ' HG3' ' N ' ' A' ' 30' ' ' PHE 0.26 0.0 OUTLIER -51.92 -35.44 45.63 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.411 179.246 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.776 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -92.54 -66.33 0.93 Allowed 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 104.098 -2.556 . . . . 0.0 104.098 -179.731 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.951 ' HA3' HG23 ' A' ' 2' ' ' VAL . . . -81.05 72.43 2.74 Favored Glycine 0 C--N 1.279 -2.623 0 CA-C-O 115.402 -2.888 . . . . 0.0 115.87 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.546 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -36.28 -23.97 0.01 OUTLIER 'General case' 0 C--N 1.262 -3.218 0 CA-C-N 123.092 3.446 . . . . 0.0 110.183 -177.546 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.955 ' O ' HG21 ' A' ' 2' ' ' VAL . 29.1 mtmm -77.35 152.55 34.4 Favored 'General case' 0 C--N 1.284 -2.281 0 O-C-N 120.263 -1.523 . . . . 0.0 113.384 175.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.801 ' CD1' ' CG ' ' A' ' 28' ' ' LYS 0.259 0.3 OUTLIER -130.66 151.37 35.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 C-N-CA 118.366 -1.334 . . . . 0.0 110.547 176.014 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.643 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -151.27 71.95 1.03 Allowed 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.045 HG13 ' HB ' ' A' ' 5' ' ' ILE 0.307 84.2 t -97.38 125.19 50.54 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.596 0 CA-C-O 124.556 2.122 . . . . 0.0 105.635 -177.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.822 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.413 7.3 mm-40 -109.37 133.53 52.94 Favored 'General case' 0 C--O 1.179 -2.625 0 CA-C-O 126.326 2.965 . . . . 0.0 104.438 -177.09 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 1.044 ' C ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -138.24 114.08 9.89 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.36 -1.745 . . . . 0.0 113.95 -173.145 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.044 HD13 ' C ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -133.88 -165.12 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 121.874 2.125 . . . . 0.0 111.835 179.468 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.936 ' OD1' HG11 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -104.54 172.14 6.95 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 178.398 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 1.271 ' CD1' HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -68.25 -55.21 17.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 121.387 -0.821 . . . . 0.0 110.644 176.581 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.646 ' H ' HG23 ' A' ' 41' ' ' ILE . 6.3 ptm -64.27 -0.46 1.26 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 118.612 -1.235 . . . . 0.0 111.594 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.936 HG11 ' OD1' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -113.09 -49.12 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.086 -1.009 . . . . 0.0 110.195 178.341 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.724 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 2.9 t70 -106.34 51.01 0.76 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 109.646 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.728 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.472 6.0 ttt-85 -71.26 2.27 4.96 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 115.044 -2.663 . . . . 0.0 108.711 -176.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.983 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.2 mm-40 -52.51 -23.87 7.05 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 120.348 -1.47 . . . . 0.0 109.108 172.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.869 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -49.18 -63.14 1.19 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.941 -1.099 . . . . 0.0 109.012 -178.161 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.999 ' CB ' ' HB2' ' A' ' 55' ' ' ALA 0.414 . . -51.42 -13.91 0.25 Allowed 'General case' 0 C--N 1.256 -3.485 0 C-N-CA 126.886 2.075 . . . . 0.0 111.555 175.372 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.983 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -30.75 -43.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 104.824 -2.287 . . . . 0.0 104.824 -172.957 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.56 ' N ' ' C ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -49.14 -51.37 32.64 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.186 176.414 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 1.261 ' OH ' HG22 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -125.89 -32.6 2.79 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.013 -1.054 . . . . 0.0 110.408 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.814 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 60.99 -33.36 0.05 OUTLIER Glycine 0 N--CA 1.488 2.139 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.805 HD12 ' H ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -49.6 -81.42 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.608 -1.525 . . . . 0.0 109.851 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.805 ' H ' HD12 ' A' ' 53' ' ' LEU . 24.7 mtt -80.28 58.92 3.22 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.999 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.394 . . -106.91 106.14 16.52 Favored 'General case' 0 C--O 1.179 -2.622 0 CA-C-O 126.912 3.244 . . . . 0.0 107.154 -176.623 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.271 HG22 ' CD1' ' A' ' 41' ' ' ILE . 4.8 t -147.77 -64.58 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.435 0 CA-C-N 112.149 -2.296 . . . . 0.0 112.84 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.848 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.449 18.0 Cg_endo -109.41 116.81 0.03 OUTLIER 'Trans proline' 0 C--O 1.157 -3.527 0 CA-C-O 129.507 3.878 . . . . 0.0 103.921 -179.544 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 1.003 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -160.85 177.54 10.3 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 110.639 -2.982 . . . . 0.0 111.646 -175.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.96 HD11 ' SG ' ' A' ' 16' ' ' CYS 0.294 0.2 OUTLIER -141.52 141.15 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.874 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 1.151 ' HB3' ' CB ' ' A' ' 6' ' ' GLU 0.399 . . -91.7 149.89 21.4 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 100.551 -3.87 . . . . 0.0 100.551 -177.225 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.772 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.728 1.1 mt -101.57 101.39 12.05 Favored 'Isoleucine or valine' 0 C--N 1.412 3.299 3 C-N-CA 107.032 -5.867 . . . . 0.0 97.379 -172.237 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.747 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -53.93 84.7 0.0 OUTLIER 'General case' 0 C--N 1.38 1.929 1 CA-C-N 106.549 -4.841 . . . . 0.0 106.888 178.083 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.772 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.24 -44.12 0.36 Allowed Glycine 0 N--CA 1.483 1.793 0 N-CA-C 107.176 -2.37 . . . . 0.0 107.176 -178.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.758 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.1 m -126.16 -59.15 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 O-C-N 121.503 -0.998 . . . . 0.0 111.311 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.758 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 93.8 t -163.1 -106.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 120.326 -1.484 . . . . 0.0 112.901 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.851 ' CZ ' ' HB2' ' A' ' 60' ' ' ALA . 3.4 ttt180 -167.74 163.58 14.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.676 -0.64 . . . . 0.0 109.397 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 1.003 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.53 174.4 11.2 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.848 -1.157 . . . . 0.0 111.268 -177.571 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.261 HG22 ' OH ' ' A' ' 51' ' ' TYR . 59.3 t -83.42 115.12 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.888 -1.133 . . . . 0.0 111.406 177.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.834 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.91 123.4 1.17 Allowed Glycine 0 C--N 1.281 -2.524 0 CA-C-N 119.755 1.161 . . . . 0.0 110.491 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.111 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -93.9 -76.74 0.03 OUTLIER Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 120.772 -1.428 . . . . 0.0 109.194 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 1.111 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 41.7 Cg_endo -83.23 24.93 0.71 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 N-CA-C 108.339 -1.447 . . . . 0.0 108.339 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.729 ' O ' HD13 ' A' ' 59' ' ' ILE 0.449 1.5 p -109.63 87.95 2.63 Favored 'General case' 0 N--CA 1.506 2.372 0 C-N-CA 113.829 -3.149 . . . . 0.0 106.577 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 1.195 ' O ' HD12 ' A' ' 76' ' ' LEU . 24.8 mtt180 -79.77 -40.38 28.84 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 112.871 -1.968 . . . . 0.0 109.201 175.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.942 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.4 tt0 -46.41 -28.22 1.29 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.025 -1.047 . . . . 0.0 109.835 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.778 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -53.12 -46.16 68.62 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.24 -0.912 . . . . 0.0 109.34 -178.537 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.195 HD12 ' O ' ' A' ' 73' ' ' ARG . 0.7 OUTLIER -60.0 -42.53 94.47 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.147 178.526 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.825 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.39 -34.99 69.44 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.821 179.364 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.774 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 31.1 tt0 -78.77 -31.32 46.08 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.031 -1.043 . . . . 0.0 110.216 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.637 ' CB ' ' HA ' ' A' ' 61' ' ' ILE . . . -73.07 -38.26 66.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.092 -1.005 . . . . 0.0 110.002 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.898 HG21 HG13 ' A' ' 23' ' ' VAL . 1.8 mp -61.61 -42.47 94.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.099 -1.001 . . . . 0.0 108.906 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.655 ' HA ' ' SD ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -72.24 -33.52 67.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.961 -1.087 . . . . 0.0 109.604 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 78' ' ' GLU 0.596 0.1 OUTLIER -94.01 0.82 56.22 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 112.027 -3.869 . . . . 0.0 105.573 -177.411 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.76 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -85.95 -59.81 2.19 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 119.546 -1.971 . . . . 0.0 107.841 170.598 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.674 ' SD ' ' HD2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.69 -12.67 61.68 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.737 179.656 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.491 ' N ' ' HG2' ' A' ' 84' ' ' MET . 2.7 tm-20 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.066 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.73 ' SD ' ' ND2' ' A' ' 4' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.314 0.578 . . . . 0.0 110.224 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.029 HG22 ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -90.13 -91.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 0.0 109.976 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.185 HG11 ' OD2' ' A' ' 24' ' ' ASP . 74.1 t -89.22 111.03 22.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.627 -0.671 . . . . 0.0 110.633 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.841 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 2.0 m120 -130.95 105.68 7.91 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.639 -1.224 . . . . 0.0 108.794 178.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.053 HG21 ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -120.7 137.37 54.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.031 179.425 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.037 ' HB3' ' HB3' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -131.01 119.77 22.51 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 119.057 -2.277 . . . . 0.0 107.389 177.939 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.968 HG22 ' HA ' ' A' ' 38' ' ' LYS . 23.0 m -105.64 144.78 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.982 ' CD2' ' HB3' ' A' ' 58' ' ' ALA . 2.1 t80 -141.0 79.52 1.7 Allowed 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 119.01 -1.076 . . . . 0.0 112.663 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.698 ' OG1' ' HA ' ' A' ' 15' ' ' TYR . 3.5 m -118.06 -68.64 0.9 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 118.852 -2.405 . . . . 0.0 110.238 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.774 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 1.3 p 179.61 164.61 0.79 Allowed Pre-proline 0 C--N 1.294 -1.843 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.732 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.666 ' HD3' ' CG ' ' A' ' 40' ' ' ASP . 49.8 Cg_endo -80.35 -28.3 3.03 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.278 1.673 . . . . 0.0 110.418 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -18.25 54.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 109.762 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.07 174.49 3.82 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.457 -0.777 . . . . 0.0 109.723 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.652 ' O ' ' O ' ' A' ' 15' ' ' TYR . 50.8 Cg_endo -83.18 114.53 2.21 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.925 1.487 . . . . 0.0 110.437 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.774 ' CE1' ' O ' ' A' ' 10' ' ' SER . 16.5 m-85 -49.22 -112.38 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.132 -0.98 . . . . 0.0 109.576 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.736 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 92.9 m -150.6 37.46 0.13 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.267 -0.895 . . . . 0.0 110.131 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.736 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 53.7 Cg_endo -76.49 17.16 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.021 1.538 . . . . 0.0 111.042 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.553 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -95.1 -68.04 0.82 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.012 -1.055 . . . . 0.0 110.752 -179.461 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.782 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -54.28 -22.51 12.05 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.23 -0.919 . . . . 0.0 109.53 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.053 ' HB ' HG21 ' A' ' 5' ' ' ILE . 5.2 pt -70.67 -39.25 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.507 -0.746 . . . . 0.0 109.623 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.734 ' N ' HG13 ' A' ' 20' ' ' ILE . 6.2 tt0 -48.83 -33.05 9.79 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 3.1 t -72.01 -46.73 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.896 HG21 ' HB ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -62.26 -31.86 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.03 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 1.185 ' OD2' HG11 ' A' ' 3' ' ' VAL . 5.2 t70 -69.45 -39.88 77.5 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.01 0.91 . . . . 0.0 109.196 178.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -46.01 84.81 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.617 0.722 . . . . 0.0 109.674 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.485 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.68 -40.05 42.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.669 -0.645 . . . . 0.0 110.614 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.904 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -69.95 -19.37 63.38 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.124 -1.03 . . . . 0.0 109.208 -179.057 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.799 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -72.52 -44.99 61.44 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.154 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.744 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -50.32 -33.39 19.99 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.851 0.834 . . . . 0.0 110.279 179.494 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.787 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -97.01 -65.79 0.94 Allowed 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 179.639 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.749 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -84.64 82.16 1.7 Allowed Glycine 0 N--CA 1.506 3.323 0 C-N-CA 119.182 -1.485 . . . . 0.0 111.427 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.593 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -35.43 -28.43 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 CA-C-N 121.463 2.631 . . . . 0.0 110.68 178.57 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.837 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -80.0 154.95 27.87 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.498 -0.751 . . . . 0.0 111.686 178.065 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.799 ' CD1' ' CG ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -129.66 151.48 35.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 O-C-N 120.353 -1.467 . . . . 0.0 110.048 178.646 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.598 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -151.3 76.78 1.23 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.943 HG22 ' CD1' ' A' ' 5' ' ' ILE 0.255 55.4 t -96.65 126.98 49.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -178.959 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 1.021 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.251 78.1 mt-10 -111.24 135.43 51.79 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -177.617 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.968 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -129.49 128.92 43.85 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -176.716 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.066 HG22 ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -135.08 171.66 17.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 O-C-N 120.132 -1.605 . . . . 0.0 111.516 178.642 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.767 ' OD1' HG22 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -102.72 170.8 7.79 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.803 0.811 . . . . 0.0 111.757 178.246 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.892 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -61.87 -37.39 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.425 -1.422 . . . . 0.0 109.332 178.489 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.678 ' HG3' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -82.37 -3.09 54.85 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.935 -1.103 . . . . 0.0 111.252 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.066 ' CG2' HG22 ' A' ' 39' ' ' ILE . 2.0 m -114.24 -46.18 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.055 -1.028 . . . . 0.0 109.755 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.937 ' HB2' HD12 ' A' ' 39' ' ' ILE . 1.6 t70 -104.97 40.98 1.4 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.237 -0.914 . . . . 0.0 109.627 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.607 ' NH2' ' HA3' ' A' ' 52' ' ' GLY 0.283 0.0 OUTLIER -65.69 -0.35 2.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.494 -1.379 . . . . 0.0 109.435 -178.823 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 1.148 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.3 mm-40 -62.54 -22.68 66.5 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.867 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -46.38 -66.55 0.39 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.965 -1.084 . . . . 0.0 108.422 -179.075 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.145 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -57.23 -7.63 0.58 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.666 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.225 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.6 pp -26.35 -41.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 O-C-N 119.163 -2.21 . . . . 0.0 106.573 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 1.225 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -52.92 -53.75 44.86 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.998 177.183 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.899 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 25.8 p90 -119.86 -32.8 4.14 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.132 -0.98 . . . . 0.0 109.984 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.722 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 42.38 8.82 0.01 OUTLIER Glycine 0 N--CA 1.502 3.08 0 CA-C-O 122.124 0.847 . . . . 0.0 111.474 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.715 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 4.6 mt -75.55 -81.08 0.08 Allowed 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 175.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.525 ' C ' ' HE2' ' A' ' 51' ' ' TYR . 4.0 mtp -95.74 63.66 2.42 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.443 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 1.145 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.273 . . -107.38 120.26 41.68 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 119.489 -2.007 . . . . 0.0 110.356 -177.803 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.816 ' CG2' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -148.76 -57.98 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.481 -178.709 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.816 ' HD3' ' CG2' ' A' ' 56' ' ' VAL . 59.1 Cg_endo -109.81 109.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 CA-C-O 122.892 1.122 . . . . 0.0 110.323 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 1.011 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -161.88 173.88 13.92 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.186 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.038 ' CG1' HD21 ' A' ' 76' ' ' LEU 0.253 0.3 OUTLIER -134.6 151.94 32.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 120.876 -1.14 . . . . 0.0 107.997 179.296 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 1.037 ' HB3' ' HB3' ' A' ' 6' ' ' GLU 0.297 . . -91.15 155.3 18.72 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.749 HG13 ' N ' ' A' ' 66' ' ' ARG 0.31 1.2 mt -101.29 91.29 2.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 -175.713 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.841 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -51.63 83.04 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 112.834 -1.984 . . . . 0.0 106.807 -178.369 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.714 ' HA3' ' HB2' ' A' ' 83' ' ' GLU . . . 162.41 -44.02 0.36 Allowed Glycine 0 C--N 1.29 -2.027 0 N-CA-C 107.733 -2.147 . . . . 0.0 107.733 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.821 ' O ' HG23 ' A' ' 65' ' ' VAL . 11.6 m -126.67 -58.97 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.903 -0.763 . . . . 0.0 111.139 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 64' ' ' VAL . 81.9 t -163.73 -101.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 120.338 -1.476 . . . . 0.0 112.955 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 1.016 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 1.8 ttp180 -167.17 160.09 13.5 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.444 -0.785 . . . . 0.0 109.343 -177.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 1.011 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -146.09 176.05 10.02 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.11 -0.994 . . . . 0.0 111.702 -177.236 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.816 ' CG2' ' HZ1' ' A' ' 47' ' ' LYS . 79.0 t -83.42 118.96 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.708 -0.62 . . . . 0.0 110.246 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.834 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.5 107.88 0.33 Allowed Glycine 0 N--CA 1.494 2.516 0 C-N-CA 118.536 -1.792 . . . . 0.0 110.386 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.124 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -88.94 -81.42 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 120.989 -1.3 . . . . 0.0 108.511 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 1.124 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 57.1 Cg_endo -83.6 17.04 1.75 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.243 1.128 . . . . 0.0 109.422 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.33 62.52 0.79 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.498 -0.751 . . . . 0.0 110.661 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.725 ' HG2' ' CB ' ' A' ' 16' ' ' CYS . 22.1 mtt180 -69.09 -31.43 70.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.381 -0.825 . . . . 0.0 109.327 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.782 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.2 tm-20 -48.39 -45.13 35.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.427 -0.796 . . . . 0.0 109.449 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.785 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -45.25 -29.11 0.91 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.701 -0.8 . . . . 0.0 108.982 179.715 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.038 HD21 ' CG1' ' A' ' 59' ' ' ILE . 3.2 mp -70.47 -39.92 73.98 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.521 -0.737 . . . . 0.0 109.047 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.853 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.49 -41.16 89.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.401 -0.812 . . . . 0.0 109.824 -179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.52 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 2.5 tm-20 -77.29 -26.62 52.52 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.192 0.52 . . . . 0.0 109.932 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.644 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -71.03 -41.9 70.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 110.978 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.041 ' CD1' HG23 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -62.57 -44.28 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.125 -0.984 . . . . 0.0 109.122 179.416 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.676 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -72.83 -27.76 62.14 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 177.573 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 1.026 ' O ' ' OD1' ' A' ' 82' ' ' ASP 0.328 0.1 OUTLIER -96.06 5.63 50.69 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 119.638 -1.914 . . . . 0.0 107.855 -179.416 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.763 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -96.08 -59.03 1.93 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 178.635 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.683 ' SD ' ' HD2' ' A' ' 27' ' ' LYS . 21.4 ptt? -68.63 -14.52 63.07 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 119.266 -0.974 . . . . 0.0 110.986 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--N 1.3 -1.559 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.002 179.722 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.734 ' SD ' ' ND2' ' A' ' 4' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.225 0.536 . . . . 0.0 110.21 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.029 HG22 ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -89.98 -91.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.303 -0.873 . . . . 0.0 110.59 179.846 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 1.179 HG11 ' OD2' ' A' ' 24' ' ' ASP 0.253 75.1 t -89.19 118.78 35.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.679 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.787 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.481 1.6 m120 -143.6 106.82 4.54 Favored 'General case' 0 C--O 1.16 -3.624 1 CA-C-O 129.728 4.585 . . . . 0.0 105.063 175.064 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.051 HG23 ' CD1' ' A' ' 80' ' ' ILE 0.253 0.0 OUTLIER -111.62 132.87 59.0 Favored 'Isoleucine or valine' 0 C--O 1.262 1.73 0 CA-C-N 109.986 -3.279 . . . . 0.0 114.688 178.217 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.017 ' HB3' ' HB3' ' A' ' 60' ' ' ALA 0.593 0.0 OUTLIER -135.8 126.51 27.28 Favored 'General case' 0 C--O 1.197 -1.674 2 CA-C-O 131.334 5.349 . . . . 0.0 104.281 172.239 . . . . . . . . 5 4 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.896 HG22 ' HA ' ' A' ' 38' ' ' LYS 0.339 14.6 m -108.02 156.5 8.52 Favored 'Isoleucine or valine' 0 C--N 1.386 2.191 0 CA-C-N 109.642 -3.436 . . . . 0.0 104.322 -175.699 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.956 ' CD2' ' HB3' ' A' ' 58' ' ' ALA . 1.9 t80 -154.15 76.14 1.04 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.516 -1.365 . . . . 0.0 111.052 -172.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.695 ' CB ' ' HA ' ' A' ' 15' ' ' TYR . 3.5 m -118.96 -70.06 0.81 Allowed 'General case' 0 C--N 1.269 -2.914 0 CA-C-N 120.65 1.568 . . . . 0.0 109.188 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.777 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 1.3 p 179.66 165.05 0.79 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.179 -0.951 . . . . 0.0 110.923 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.667 ' HD3' ' CG ' ' A' ' 40' ' ' ASP . 51.5 Cg_endo -80.4 -28.2 3.05 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.17 1.616 . . . . 0.0 110.511 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -18.25 53.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -0.894 . . . . 0.0 109.74 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -124.95 174.75 3.54 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.417 -0.802 . . . . 0.0 109.664 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.649 ' O ' ' O ' ' A' ' 15' ' ' TYR . 51.8 Cg_endo -83.41 114.69 2.15 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 123.943 1.496 . . . . 0.0 110.309 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.777 ' CE1' ' O ' ' A' ' 10' ' ' SER . 17.3 m-85 -49.41 -112.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.44 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.733 ' CB ' ' HG2' ' A' ' 73' ' ' ARG . 94.0 m -149.97 37.39 0.14 Allowed Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.132 -0.98 . . . . 0.0 110.27 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.723 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 54.4 Cg_endo -76.34 17.17 0.78 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.867 1.456 . . . . 0.0 111.036 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.554 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -95.11 -68.0 0.82 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.966 -1.084 . . . . 0.0 110.614 -179.367 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.751 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -55.28 -20.8 12.22 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.737 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.042 ' HB ' HG21 ' A' ' 5' ' ' ILE . 5.2 pt -71.91 -38.78 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.809 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.736 ' N ' HG13 ' A' ' 20' ' ' ILE . 6.4 tt0 -48.03 -33.59 8.22 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 3.1 t -72.47 -45.46 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-O 121.94 0.876 . . . . 0.0 109.338 179.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.881 HG21 ' HB ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -60.52 -33.09 53.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 122.737 1.256 . . . . 0.0 109.207 176.462 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 1.179 ' OD2' HG11 ' A' ' 3' ' ' VAL . 5.7 t70 -70.55 -40.67 73.26 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.933 1.349 . . . . 0.0 108.144 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.24 -46.45 82.98 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.712 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.474 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -76.76 -40.6 47.84 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.841 0.829 . . . . 0.0 110.827 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.908 ' CB ' HG22 ' A' ' 3' ' ' VAL 0.334 0.0 OUTLIER -73.86 -14.62 61.11 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 116.25 -2.18 . . . . 0.0 109.132 -177.337 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.792 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -72.47 -44.33 62.46 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.826 -1.171 . . . . 0.0 107.892 173.899 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.709 ' HG3' ' N ' ' A' ' 30' ' ' PHE 0.315 0.0 OUTLIER -53.96 -28.95 40.62 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.969 -179.315 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.783 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -99.85 -66.08 0.93 Allowed 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 -179.694 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.775 ' HA3' ' CG2' ' A' ' 2' ' ' VAL . . . -78.82 71.38 2.58 Favored Glycine 0 C--N 1.268 -3.232 0 CA-C-O 113.879 -3.734 . . . . 0.0 115.104 175.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.549 ' O ' ' OD1' ' A' ' 32' ' ' ASP 0.365 0.0 OUTLIER -39.06 -20.0 0.01 OUTLIER 'General case' 0 C--N 1.264 -3.109 1 CA-C-N 124.26 4.03 . . . . 0.0 111.81 -174.821 . . . . . . . . 5 4 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.844 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -75.01 150.71 38.87 Favored 'General case' 0 C--N 1.28 -2.418 0 C-N-CA 126.969 2.108 . . . . 0.0 113.943 171.053 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.792 ' CD1' ' CG ' ' A' ' 28' ' ' LYS 0.331 0.3 OUTLIER -131.09 155.07 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 C-N-CA 116.441 -2.104 . . . . 0.0 110.148 172.374 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.677 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -151.64 76.96 1.22 Allowed 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.09 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.953 HG22 ' CD1' ' A' ' 5' ' ' ILE 0.406 42.6 t -102.56 127.39 56.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 CA-C-O 126.947 3.261 . . . . 0.0 106.457 -177.56 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.976 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.505 68.6 mt-10 -116.01 134.47 54.92 Favored 'General case' 0 C--O 1.188 -2.156 0 O-C-N 118.861 -2.399 . . . . 0.0 107.114 -174.37 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.896 ' HA ' HG22 ' A' ' 7' ' ' VAL 0.576 0.0 OUTLIER -112.73 115.28 28.28 Favored 'General case' 0 C--O 1.298 3.649 2 CA-C-O 107.822 -5.847 . . . . 0.0 121.213 -170.817 . . . . . . . . 5 4 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.067 HG22 ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -132.54 178.24 5.92 Favored 'Isoleucine or valine' 1 C--N 1.232 -4.526 1 CA-C-N 131.381 6.446 . . . . 0.0 110.439 175.931 . . . . . . . . 5 4 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.762 ' OD1' HG22 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -103.22 166.05 10.66 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.068 -1.645 . . . . 0.0 113.04 177.022 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.9 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.4 OUTLIER -59.68 -38.01 73.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 118.15 -1.42 . . . . 0.0 111.899 173.032 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.678 ' HG3' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -80.84 -3.29 50.67 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.793 -1.163 . . . . 0.0 112.457 177.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.067 ' CG2' HG22 ' A' ' 39' ' ' ILE . 2.0 m -113.58 -46.24 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.062 -1.024 . . . . 0.0 109.787 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.941 ' HB2' HD12 ' A' ' 39' ' ' ILE . 1.6 t70 -103.82 37.08 2.13 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.28 -0.887 . . . . 0.0 110.473 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.597 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.369 0.0 OUTLIER -65.04 -2.18 2.57 Favored 'General case' 0 C--O 1.2 -1.533 0 C-N-CA 116.783 -1.967 . . . . 0.0 109.789 -176.998 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 1.092 ' O ' HG23 ' A' ' 49' ' ' ILE . 1.8 mm-40 -51.89 -26.71 10.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.021 -1.049 . . . . 0.0 111.635 170.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.832 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -50.15 -61.28 2.25 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.471 -1.393 . . . . 0.0 108.884 -175.018 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.064 ' CB ' ' HB2' ' A' ' 55' ' ' ALA 0.388 . . -51.69 -13.36 0.25 Allowed 'General case' 0 C--N 1.264 -3.14 0 C-N-CA 126.48 1.912 . . . . 0.0 112.065 174.697 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.244 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.3 pp -33.68 -38.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 -169.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 1.244 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.99 -53.59 39.78 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.053 176.12 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.88 ' CZ ' ' HB2' ' A' ' 48' ' ' ALA . 23.1 p90 -120.36 -31.51 4.33 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.083 -1.011 . . . . 0.0 110.29 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.777 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.93 14.65 0.01 OUTLIER Glycine 0 C--O 1.201 -1.962 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.485 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.731 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.4 mt -80.25 -76.03 0.24 Allowed 'General case' 0 C--N 1.253 -3.623 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 178.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.512 ' C ' ' HE2' ' A' ' 51' ' ' TYR . 3.8 mtp -103.07 61.5 0.79 Allowed 'General case' 0 C--O 1.25 1.095 0 O-C-N 119.546 -1.971 . . . . 0.0 108.405 -178.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 1.064 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.548 . . -113.97 125.45 54.03 Favored 'General case' 0 C--O 1.178 -2.68 1 CA-C-O 129.672 4.558 . . . . 0.0 106.724 -175.258 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.8 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -151.03 -55.04 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 CA-C-N 109.795 -3.366 . . . . 0.0 112.301 -175.957 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.8 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.559 38.6 Cg_endo -119.66 116.0 0.01 OUTLIER 'Trans proline' 0 C--O 1.157 -3.525 1 CA-C-O 132.508 5.129 . . . . 0.0 108.86 174.209 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 1.057 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -160.61 173.34 15.63 Favored 'General case' 0 C--N 1.378 1.811 1 CA-C-N 107.777 -4.283 . . . . 0.0 111.671 -174.36 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.039 ' CG1' HD21 ' A' ' 76' ' ' LEU 0.313 0.3 OUTLIER -137.2 156.95 34.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 117.833 -1.547 . . . . 0.0 107.404 177.724 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 1.017 ' HB3' ' HB3' ' A' ' 6' ' ' GLU 0.696 . . -106.41 155.57 19.42 Favored 'General case' 0 C--N 1.379 1.881 3 C-N-CA 107.591 -5.643 . . . . 0.0 97.618 -175.017 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.809 HG13 ' N ' ' A' ' 66' ' ' ARG 0.583 1.7 mt -103.67 91.07 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.186 -2.253 2 CA-C-O 131.758 5.551 . . . . 0.0 101.724 -164.733 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.787 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -42.97 81.58 0.0 OUTLIER 'General case' 0 C--N 1.37 1.462 1 CA-C-N 108.378 -4.01 . . . . 0.0 109.012 176.562 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.752 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.94 -45.71 0.37 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 106.908 -2.477 . . . . 0.0 106.908 -177.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.811 ' O ' HG23 ' A' ' 65' ' ' VAL . 10.9 m -125.67 -58.86 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.679 -0.895 . . . . 0.0 111.431 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 64' ' ' VAL . 80.3 t -163.42 -99.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.551 0 O-C-N 120.314 -1.491 . . . . 0.0 112.879 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 1.013 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 1.6 ttp180 -171.55 157.58 4.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.964 -1.085 . . . . 0.0 109.252 -176.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 1.057 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -143.9 176.04 9.56 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.333 -1.479 . . . . 0.0 111.023 -174.281 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.817 ' CG2' ' HZ1' ' A' ' 47' ' ' LYS . 70.8 t -80.79 117.26 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-O 117.386 -1.292 . . . . 0.0 110.942 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.824 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.81 108.28 0.34 Allowed Glycine 0 C--N 1.277 -2.74 0 CA-C-N 121.173 1.806 . . . . 0.0 110.577 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.101 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -90.16 -79.21 0.03 OUTLIER Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 120.734 -1.451 . . . . 0.0 108.936 178.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 1.101 ' CD ' ' HB3' ' A' ' 70' ' ' ALA 0.256 44.3 Cg_endo -88.53 20.0 1.22 Allowed 'Trans proline' 0 C--O 1.21 -0.918 0 C-N-CA 116.705 -1.73 . . . . 0.0 109.136 177.894 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.16 63.58 1.0 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.761 -1.212 . . . . 0.0 112.179 175.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.733 ' HG2' ' CB ' ' A' ' 16' ' ' CYS . 20.6 mtt180 -67.27 -33.36 75.15 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.889 -1.132 . . . . 0.0 109.708 177.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.751 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.2 tm-20 -47.31 -46.46 25.19 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.043 -1.035 . . . . 0.0 108.986 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.785 ' CD ' ' CE2' ' A' ' 67' ' ' PHE 0.268 0.0 OUTLIER -47.29 -26.43 1.24 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 118.561 -1.256 . . . . 0.0 109.047 -178.371 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.039 HD21 ' CG1' ' A' ' 59' ' ' ILE . 3.1 mp -70.71 -39.86 73.16 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.878 0.847 . . . . 0.0 109.368 177.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.825 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.69 -39.47 84.64 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-O 122.088 0.947 . . . . 0.0 111.14 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 2.6 tm-20 -75.84 -27.84 58.01 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 122.229 1.014 . . . . 0.0 110.058 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.629 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -74.71 -40.6 61.22 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 120.956 -1.09 . . . . 0.0 109.149 -175.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.051 ' CD1' HG23 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -60.82 -45.17 98.48 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.572 0 CA-C-O 122.587 1.184 . . . . 0.0 110.151 177.777 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.726 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.2 OUTLIER -71.84 -32.94 68.03 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.654 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.645 0.1 OUTLIER -99.36 5.95 46.26 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 112.477 -3.689 . . . . 0.0 106.696 -175.258 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.734 ' OE1' ' CA ' ' A' ' 63' ' ' GLY 0.284 0.0 OUTLIER -86.35 -60.68 1.93 Allowed 'General case' 0 N--CA 1.48 1.03 1 O-C-N 116.169 -4.082 . . . . 0.0 108.132 165.739 . . . . . . . . 5 4 . 1 . 018 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.726 ' HE2' ' HA ' ' A' ' 81' ' ' ASN . 21.4 ptt? -66.63 -14.84 62.95 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.946 -1.101 . . . . 0.0 111.456 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.778 -1.106 . . . . 0.0 110.253 177.939 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.675 ' O ' ' CZ ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.305 0.574 . . . . 0.0 110.276 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.995 HG23 ' HA3' ' A' ' 31' ' ' GLY . 11.5 p -84.65 -119.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.269 -0.894 . . . . 0.0 109.921 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.991 HG11 ' OD2' ' A' ' 24' ' ' ASP . 72.6 t -92.61 105.62 16.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.283 -0.886 . . . . 0.0 110.308 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.924 ' ND2' ' ND2' ' A' ' 62' ' ' ASN . 1.3 t-20 -129.2 109.0 10.79 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.755 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.028 HG21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -123.87 136.99 58.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.082 -1.011 . . . . 0.0 110.409 179.747 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.084 ' CB ' ' HB3' ' A' ' 60' ' ' ALA . 4.0 tp10 -125.05 104.07 8.35 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 117.916 -1.514 . . . . 0.0 108.782 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.822 ' CG2' ' CB ' ' A' ' 38' ' ' LYS . 15.7 m -93.88 104.73 16.07 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.434 0 CA-C-O 123.315 1.531 . . . . 0.0 108.43 -179.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.884 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 1.6 t80 -117.65 84.88 2.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.221 -0.924 . . . . 0.0 109.78 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.683 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -120.28 -53.28 2.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.529 -0.732 . . . . 0.0 109.882 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . 1.073 ' HA ' HG22 ' A' ' 41' ' ' ILE . 5.3 p 179.43 152.76 0.56 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.316 -0.865 . . . . 0.0 110.513 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.696 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 50.5 Cg_endo -84.52 -29.4 0.82 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.121 1.59 . . . . 0.0 110.205 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.549 ' OG1' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -79.81 -16.87 54.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.376 -0.828 . . . . 0.0 109.946 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.549 ' SG ' ' OG1' ' A' ' 12' ' ' THR . 1.4 m -124.97 179.97 1.0 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.417 -0.802 . . . . 0.0 109.954 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.631 ' O ' ' O ' ' A' ' 15' ' ' TYR . 52.3 Cg_endo -83.6 111.68 1.79 Allowed 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.993 1.522 . . . . 0.0 110.473 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.772 ' CE1' ' O ' ' A' ' 10' ' ' SER . 8.6 m-85 -49.51 -114.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.905 . . . . 0.0 109.728 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.91 ' O ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -155.19 40.7 0.14 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.167 -0.958 . . . . 0.0 110.054 179.543 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.698 ' CA ' HG11 ' A' ' 7' ' ' VAL . 50.1 Cg_endo -74.7 16.15 0.64 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.935 1.492 . . . . 0.0 111.039 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.746 ' CG ' ' HD3' ' A' ' 73' ' ' ARG . 5.1 ttm -84.81 -60.74 1.96 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.129 -0.982 . . . . 0.0 111.305 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.75 ' CB ' ' O ' ' A' ' 73' ' ' ARG . . . -56.41 -18.9 12.55 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.27 -0.894 . . . . 0.0 109.665 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.028 ' HB ' HG21 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -73.83 -40.15 52.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.458 -0.776 . . . . 0.0 109.327 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.72 ' N ' HD12 ' A' ' 20' ' ' ILE . 6.0 tm-20 -53.7 -36.11 61.85 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.1 t -75.94 -39.39 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.959 HG13 HG21 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -70.39 -26.8 29.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-O 122.022 0.915 . . . . 0.0 108.88 177.853 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.991 ' OD2' HG11 ' A' ' 3' ' ' VAL . 4.8 t70 -74.62 -37.45 62.82 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -45.01 91.58 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.314 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.457 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.26 -40.59 30.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.492 -0.755 . . . . 0.0 110.095 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.892 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -65.13 -26.31 68.13 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.182 -1.007 . . . . 0.0 108.871 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 1.024 ' CE ' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.89 -46.64 67.87 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.822 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.78 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -45.94 -42.08 12.4 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.654 0.74 . . . . 0.0 109.057 178.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.78 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -90.27 -56.04 3.37 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.414 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.995 ' HA3' HG23 ' A' ' 2' ' ' VAL . . . -96.08 79.05 0.77 Allowed Glycine 0 N--CA 1.489 2.196 0 O-C-N 121.482 -0.761 . . . . 0.0 111.276 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -37.71 -19.56 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 119.057 1.429 . . . . 0.0 110.767 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.684 ' N ' ' O ' ' A' ' 31' ' ' GLY . 9.5 mtpt -85.74 160.09 19.61 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.911 -1.118 . . . . 0.0 111.289 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.024 HD11 ' CE ' ' A' ' 28' ' ' LYS . 0.6 OUTLIER -130.54 129.33 64.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.084 178.447 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.661 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 8.4 t0 -136.86 74.37 1.49 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.333 -0.854 . . . . 0.0 109.175 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.695 HG13 ' CG1' ' A' ' 5' ' ' ILE . 46.1 t -92.23 115.85 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-O 122.428 1.108 . . . . 0.0 109.406 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.723 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 9.0 mt-10 -97.6 148.15 23.58 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.345 -1.342 . . . . 0.0 108.328 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.822 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.94 120.84 14.51 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.62 -1.3 . . . . 0.0 111.654 -177.376 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.993 HD12 ' CG ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -120.4 174.62 5.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.27 -0.894 . . . . 0.0 111.28 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.856 ' CG ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -112.07 167.69 10.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.074 -1.016 . . . . 0.0 112.629 179.111 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 1.073 HG22 ' HA ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -67.5 -36.21 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.646 -0.658 . . . . 0.0 112.53 178.315 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.776 ' N ' HD13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -90.61 -7.15 53.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.844 -1.16 . . . . 0.0 112.016 -179.09 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.856 HG12 ' CG ' ' A' ' 40' ' ' ASP . 14.0 p -111.27 -35.64 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.015 -1.053 . . . . 0.0 109.934 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.993 ' CG ' HD12 ' A' ' 39' ' ' ILE . 3.0 t70 -115.07 45.49 1.61 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.294 -0.879 . . . . 0.0 110.163 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 45' ' ' ARG 0.257 45.3 ttt180 -59.28 -5.69 0.79 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.462 -1.295 . . . . 0.0 109.406 -179.065 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 1.093 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.2 mm-40 -53.88 -20.88 6.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.335 -0.853 . . . . 0.0 110.329 177.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.855 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -51.95 -56.33 14.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.857 -1.152 . . . . 0.0 109.394 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.16 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -64.7 -2.52 2.52 Favored 'General case' 0 C--N 1.276 -2.609 0 O-C-N 120.896 -1.128 . . . . 0.0 111.467 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.261 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.5 pp -34.25 -37.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 -177.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 1.261 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.5 OUTLIER -55.39 -52.33 63.89 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.153 176.807 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.842 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.5 p90 -121.97 -27.26 4.63 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.129 -0.982 . . . . 0.0 110.278 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.793 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.23 13.18 0.01 OUTLIER Glycine 0 N--CA 1.489 2.197 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.669 ' N ' ' O ' ' A' ' 51' ' ' TYR . 6.4 mt -84.7 -66.0 0.94 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 123.981 1.848 . . . . 0.0 108.375 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.458 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 15.9 mmt -103.87 56.43 0.73 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.021 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 1.16 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.263 . . -99.24 105.41 17.44 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 123.387 1.565 . . . . 0.0 110.661 -176.104 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.966 HG22 HG13 ' A' ' 41' ' ' ILE . 2.0 t -146.4 -65.47 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 121.197 -0.939 . . . . 0.0 110.408 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.815 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 40.8 Cg_endo -97.35 102.7 0.08 OUTLIER 'Trans proline' 0 C--O 1.195 -1.661 0 CA-C-O 124.131 1.638 . . . . 0.0 108.728 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.912 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -156.14 -178.46 7.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.46 -1.4 . . . . 0.0 111.304 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.913 HG13 HD21 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -144.38 140.76 24.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.763 -0.585 . . . . 0.0 109.869 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 1.084 ' HB3' ' CB ' ' A' ' 6' ' ' GLU . . . -81.69 133.41 35.35 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.753 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.353 1.2 mt -85.36 81.25 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.221 0 C-N-CA 116.462 -2.095 . . . . 0.0 107.223 -176.283 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.924 ' ND2' ' ND2' ' A' ' 4' ' ' ASN . 8.3 m120 -44.3 85.87 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 114.512 -1.222 . . . . 0.0 107.895 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.753 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.73 -43.78 0.35 Allowed Glycine 0 N--CA 1.486 1.999 0 N-CA-C 106.177 -2.769 . . . . 0.0 106.177 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.88 ' O ' HG23 ' A' ' 65' ' ' VAL . 14.9 m -128.73 -60.97 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 121.791 -0.829 . . . . 0.0 110.761 179.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 64' ' ' VAL . 64.8 t -165.23 -103.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 120.321 -1.487 . . . . 0.0 111.679 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.843 ' N ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -153.28 164.26 38.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.786 -0.572 . . . . 0.0 109.828 -179.083 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.912 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.42 178.18 8.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.079 -1.013 . . . . 0.0 110.862 -179.737 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.476 HG22 ' OH ' ' A' ' 51' ' ' TYR . 96.0 t -89.45 122.08 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.286 -0.884 . . . . 0.0 109.078 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.847 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -160.96 101.83 0.2 Allowed Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.055 -1.545 . . . . 0.0 111.148 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.054 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -90.29 -83.92 0.02 OUTLIER Pre-proline 0 C--N 1.293 -1.848 0 O-C-N 120.825 -1.397 . . . . 0.0 108.484 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 1.054 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 48.8 Cg_endo -82.55 15.2 2.09 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 N-CA-C 108.909 -1.227 . . . . 0.0 108.909 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.56 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 26.2 p -100.22 69.95 1.51 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.264 -0.897 . . . . 0.0 111.269 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.76 ' HA ' HD13 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -74.87 -40.45 60.95 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.916 -1.115 . . . . 0.0 109.376 179.007 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.707 ' HA ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -46.03 -36.37 5.62 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.185 -0.947 . . . . 0.0 109.153 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.575 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -48.44 -41.61 29.86 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.493 -0.883 . . . . 0.0 108.712 179.318 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.913 HD21 HG13 ' A' ' 59' ' ' ILE . 7.1 mp -56.77 -40.06 75.16 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.675 0.75 . . . . 0.0 109.015 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.816 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -60.69 -42.47 97.22 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.617 0.722 . . . . 0.0 109.918 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.491 ' N ' ' CD2' ' A' ' 77' ' ' PHE . 1.2 tt0 -78.0 -22.73 48.87 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.298 -0.876 . . . . 0.0 110.369 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.567 ' HB1' HG23 ' A' ' 61' ' ' ILE . . . -79.25 -39.58 32.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.106 -0.996 . . . . 0.0 109.937 -178.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.959 HG21 HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -66.07 -32.14 56.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.909 -1.119 . . . . 0.0 108.862 178.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.516 ' HA ' ' HE3' ' A' ' 84' ' ' MET . 0.1 OUTLIER -78.38 -29.08 47.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.0 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.563 0.6 OUTLIER -93.36 -7.22 45.36 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 112.718 -3.593 . . . . 0.0 105.742 -179.003 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.798 ' CG ' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -74.99 -54.65 6.81 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.165 -1.584 . . . . 0.0 108.111 171.811 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.808 ' CE ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -75.51 -22.34 57.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.732 -0.605 . . . . 0.0 110.431 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 84' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.211 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.201 0.524 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 1.072 HG21 ' O ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -80.72 -92.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.329 -0.857 . . . . 0.0 110.354 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.963 ' N ' HG22 ' A' ' 2' ' ' VAL . 54.1 t -91.59 128.74 43.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.521 -0.737 . . . . 0.0 110.921 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.809 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 6.4 t-20 -140.63 107.6 5.43 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 123.06 1.409 . . . . 0.0 109.126 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.051 HD12 ' HB ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -135.91 136.18 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 O-C-N 121.032 -1.043 . . . . 0.0 112.032 -178.565 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 1.171 ' O ' HG23 ' A' ' 59' ' ' ILE . 1.4 tp10 -122.5 102.54 8.14 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 118.136 -1.425 . . . . 0.0 108.53 176.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.802 ' CG2' ' CB ' ' A' ' 38' ' ' LYS . 30.0 m -96.19 106.28 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 123.11 1.433 . . . . 0.0 109.327 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.847 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 1.1 t80 -118.19 101.88 8.56 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.67 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.848 HG22 ' N ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -134.03 -61.58 0.79 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.269 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . 1.024 ' HA ' HG22 ' A' ' 41' ' ' ILE . 3.1 t -175.07 144.63 0.83 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.118 -0.988 . . . . 0.0 111.073 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.756 ' N ' ' HB2' ' A' ' 40' ' ' ASP . 50.6 Cg_endo -76.63 -9.43 18.5 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 124.212 1.638 . . . . 0.0 110.652 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.05 -5.21 53.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.996 -1.065 . . . . 0.0 109.794 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.631 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 1.5 p -160.45 -165.65 0.13 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.494 -0.754 . . . . 0.0 110.09 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.631 ' CD ' ' CB ' ' A' ' 13' ' ' CYS . 53.2 Cg_endo -84.32 117.78 2.18 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.895 1.471 . . . . 0.0 110.35 177.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.772 ' HD2' HG23 ' A' ' 7' ' ' VAL . 2.1 m-85 -49.27 -83.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.93 . . . . 0.0 109.632 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.82 ' HB3' HD11 ' A' ' 76' ' ' LEU . 42.5 m -155.41 39.61 0.11 Allowed Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.213 -0.93 . . . . 0.0 109.961 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.708 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 52.9 Cg_endo -73.72 30.35 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.013 1.533 . . . . 0.0 111.142 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.402 ' H ' ' C ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -110.16 -61.93 1.59 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.952 -1.093 . . . . 0.0 110.369 -179.653 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.905 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -58.06 -20.11 36.85 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.457 -0.777 . . . . 0.0 110.033 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.051 ' HB ' HD12 ' A' ' 5' ' ' ILE . 23.0 pt -75.6 -38.99 39.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.492 -0.755 . . . . 0.0 109.531 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.675 ' N ' HG13 ' A' ' 20' ' ' ILE . 49.8 tt0 -49.43 -36.02 21.06 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.68 -43.02 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.917 HG13 HG21 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -69.85 -27.98 35.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.744 0.783 . . . . 0.0 109.234 178.117 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.702 ' OD2' HG11 ' A' ' 3' ' ' VAL . 4.4 t70 -75.77 -36.07 59.95 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -44.18 89.91 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.635 0.731 . . . . 0.0 109.289 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.53 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.45 -41.01 28.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.506 -0.746 . . . . 0.0 110.122 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.82 ' CE ' ' CE ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -67.67 -23.41 65.31 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.206 -179.327 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -69.35 -46.38 67.14 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.373 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.795 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -47.68 -40.66 20.6 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.726 0.774 . . . . 0.0 109.191 179.004 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.795 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.89 -58.06 2.64 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.489 -0.757 . . . . 0.0 109.017 179.587 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.736 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -96.64 77.85 0.72 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 111.341 -0.703 . . . . 0.0 111.341 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.588 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -32.94 -27.37 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 119.315 1.558 . . . . 0.0 110.168 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 1.072 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -88.68 158.37 18.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.417 -0.802 . . . . 0.0 111.259 178.253 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.79 HG23 HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -129.57 150.86 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.081 -1.012 . . . . 0.0 110.581 178.095 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -138.69 61.45 1.58 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.414 -0.804 . . . . 0.0 108.875 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.035 HG13 ' HB ' ' A' ' 5' ' ' ILE . 44.7 t -91.76 115.75 31.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.663 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.759 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 12.4 mt-10 -98.59 140.43 32.83 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.01 -1.076 . . . . 0.0 108.368 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.802 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -138.45 130.81 28.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.411 -0.805 . . . . 0.0 111.845 -176.648 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 1.016 HD12 ' CG ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -138.17 172.8 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.848 . . . . 0.0 109.898 179.598 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 1.083 ' CG ' HG12 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -105.33 169.84 8.23 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.175 -0.953 . . . . 0.0 110.975 179.008 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 1.267 ' CD1' HG22 ' A' ' 56' ' ' VAL . 0.6 OUTLIER -73.79 -17.88 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.254 -0.904 . . . . 0.0 111.593 179.251 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.771 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 2.6 ptt? -92.89 -15.59 26.21 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.809 -1.156 . . . . 0.0 110.21 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 1.083 HG12 ' CG ' ' A' ' 40' ' ' ASP . 14.0 p -111.2 -30.58 2.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 110.256 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 1.016 ' CG ' HD12 ' A' ' 39' ' ' ILE . 5.7 t0 -114.5 48.91 1.07 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.047 -1.033 . . . . 0.0 110.869 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.264 2.5 ttt180 -59.99 -8.8 2.5 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.319 -1.352 . . . . 0.0 109.627 -179.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 1.004 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -58.31 -17.08 17.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.634 174.639 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.816 ' HG2' ' CE1' ' A' ' 8' ' ' PHE . 0.6 OUTLIER -48.96 -61.38 2.09 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.416 1.103 . . . . 0.0 109.68 -178.058 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.155 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -62.06 0.08 0.45 Allowed 'General case' 0 C--N 1.283 -2.308 0 O-C-N 121.613 -0.679 . . . . 0.0 111.566 177.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.078 HD11 ' NE ' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -35.11 -38.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 -176.226 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.586 ' N ' ' C ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -54.81 -49.26 71.43 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.513 177.383 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.825 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -124.96 -28.47 3.46 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.953 -1.092 . . . . 0.0 110.361 179.173 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.777 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 41.15 11.17 0.01 OUTLIER Glycine 0 N--CA 1.486 2.023 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.68 ' N ' ' O ' ' A' ' 51' ' ' TYR . 6.2 mt -84.95 -61.52 1.76 Allowed 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 123.117 1.437 . . . . 0.0 108.344 177.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.545 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 26.0 mtm -110.21 62.88 0.6 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.031 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 1.155 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.268 . . -98.34 107.75 20.29 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 123.092 1.425 . . . . 0.0 111.327 -174.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.267 HG22 ' CD1' ' A' ' 41' ' ' ILE . 1.6 t -146.98 -66.81 0.02 OUTLIER Pre-proline 0 N--CA 1.486 1.368 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.487 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.856 ' CD ' HG12 ' A' ' 56' ' ' VAL . 41.8 Cg_endo -106.25 94.27 0.02 OUTLIER 'Trans proline' 0 C--O 1.206 -1.11 0 CA-C-O 122.701 1.042 . . . . 0.0 109.785 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 1.098 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -152.13 178.67 9.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.226 -0.922 . . . . 0.0 110.667 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 1.272 HG21 ' CD2' ' A' ' 76' ' ' LEU . 1.4 mp -149.91 147.38 16.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.619 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.923 ' HB3' ' CB ' ' A' ' 6' ' ' GLU . . . -81.58 138.03 35.44 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 117.4 -1.72 . . . . 0.0 106.452 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.754 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.382 0.9 OUTLIER -87.93 81.11 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-O 124.807 2.241 . . . . 0.0 106.486 -175.635 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.809 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -42.69 84.88 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 113.466 -1.697 . . . . 0.0 108.006 177.661 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.754 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.08 -47.09 0.38 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 106.328 -2.709 . . . . 0.0 106.328 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.797 ' O ' HG23 ' A' ' 65' ' ' VAL . 11.9 m -124.51 -60.76 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 121.846 -0.797 . . . . 0.0 111.19 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.811 HG12 ' N ' ' A' ' 66' ' ' ARG . 97.6 t -164.04 -107.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.126 -1.609 . . . . 0.0 113.146 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 1.078 ' NE ' HD11 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -156.23 153.65 29.49 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.769 -0.582 . . . . 0.0 109.947 -177.008 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 1.098 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.98 -175.65 4.83 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.982 -1.074 . . . . 0.0 111.75 -178.815 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.39 123.24 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.814 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.23 105.43 0.26 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 118.751 -1.69 . . . . 0.0 111.099 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 1.113 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -89.68 -82.34 0.03 OUTLIER Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 120.831 -1.394 . . . . 0.0 108.202 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 1.113 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 51.1 Cg_endo -82.99 15.22 2.14 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 N-CA-C 108.932 -1.218 . . . . 0.0 108.932 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.71 64.29 1.27 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.323 -0.86 . . . . 0.0 111.547 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.75 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.62 -32.15 65.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.04 -1.038 . . . . 0.0 109.358 178.754 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.905 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -51.23 -41.09 60.08 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.268 -0.895 . . . . 0.0 109.184 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.754 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -46.21 -29.36 1.55 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.465 -0.772 . . . . 0.0 109.267 179.581 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.272 ' CD2' HG21 ' A' ' 59' ' ' ILE . 13.1 mt -72.46 -40.84 66.7 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.812 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.87 -37.33 73.75 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.457 -0.777 . . . . 0.0 109.535 179.371 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -78.58 -26.76 45.57 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.512 -0.743 . . . . 0.0 110.297 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 83' ' ' GLU . . . -74.21 -37.98 63.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.922 . . . . 0.0 110.063 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.917 HG21 HG13 ' A' ' 23' ' ' VAL . 1.5 mp -63.7 -37.35 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.975 -1.078 . . . . 0.0 108.788 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -73.29 -32.79 64.84 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.151 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.668 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.47 0.3 OUTLIER -91.79 -6.55 51.55 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 115.191 -2.604 . . . . 0.0 108.157 -179.419 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.768 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -79.85 -55.02 5.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.361 -1.462 . . . . 0.0 109.419 169.992 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.82 ' CE ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.01 -23.16 64.97 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.338 179.751 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.474 ' CD ' ' C ' ' A' ' 85' ' ' GLU . 3.3 tm-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.257 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.591 ' CE ' ' CD ' ' A' ' 83' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.876 0.846 . . . . 0.0 110.845 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.004 HG21 ' O ' ' A' ' 33' ' ' LYS . 1.4 p -80.04 -96.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.965 -1.084 . . . . 0.0 110.337 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.047 HG21 HD12 ' A' ' 34' ' ' ILE . 47.6 t -89.97 129.05 41.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 121.561 -0.712 . . . . 0.0 109.936 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.983 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 0.7 OUTLIER -149.05 101.91 3.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.792 -1.192 . . . . 0.0 108.633 -179.068 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.046 HD12 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.37 138.93 52.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 113.847 -1.524 . . . . 0.0 113.651 -178.403 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 1.263 ' O ' HG23 ' A' ' 59' ' ' ILE . 13.6 tt0 -132.9 121.42 22.84 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 118.692 -2.505 . . . . 0.0 106.109 176.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.006 HG12 ' CD2' ' A' ' 76' ' ' LEU . 3.9 m -112.28 111.61 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.312 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -176.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.878 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -116.15 95.04 4.9 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.814 -178.252 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.824 ' O ' HD12 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -126.31 -59.42 1.31 Allowed 'General case' 0 C--N 1.291 -1.946 0 O-C-N 121.207 -0.933 . . . . 0.0 108.853 178.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.69 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 0.2 OUTLIER 179.09 146.47 0.38 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.825 -1.172 . . . . 0.0 110.704 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.668 ' CD ' ' HB2' ' A' ' 40' ' ' ASP . 48.2 Cg_endo -75.91 -30.17 6.18 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 124.445 1.76 . . . . 0.0 110.359 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.2 t -78.92 -14.34 59.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.58 -0.7 . . . . 0.0 110.081 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.512 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -124.74 179.14 1.17 Allowed Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.516 -0.74 . . . . 0.0 109.868 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.616 ' O ' ' O ' ' A' ' 15' ' ' TYR . 52.2 Cg_endo -83.58 107.02 1.35 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.959 1.505 . . . . 0.0 109.975 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.69 ' CE1' ' O ' ' A' ' 10' ' ' SER . 3.2 m-85 -50.18 -115.42 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.819 -0.551 . . . . 0.0 109.545 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.864 ' SG ' HD11 ' A' ' 59' ' ' ILE . 71.0 m -149.11 38.8 0.19 Allowed Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.941 -1.099 . . . . 0.0 109.423 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.893 ' HA ' HD13 ' A' ' 20' ' ' ILE . 53.2 Cg_endo -74.51 29.85 0.34 Allowed 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 123.829 1.436 . . . . 0.0 111.295 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.7 ' CG ' ' CZ ' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -106.37 -55.01 2.39 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.941 -1.099 . . . . 0.0 110.423 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.754 ' HB2' ' HD3' ' A' ' 73' ' ' ARG . . . -59.17 -19.93 49.39 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.314 -0.866 . . . . 0.0 109.933 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.228 HD12 ' CG1' ' A' ' 36' ' ' VAL . 3.2 pt -72.52 -41.78 63.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-O 121.253 0.549 . . . . 0.0 109.742 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.563 ' N ' ' CG1' ' A' ' 20' ' ' ILE . 7.7 tt0 -53.58 -35.21 60.59 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 t -71.03 -45.78 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.896 ' CG1' HG21 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -63.98 -33.92 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.07 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.701 ' OD2' HG21 ' A' ' 34' ' ' ILE . 31.0 t0 -66.81 -40.88 88.21 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.838 0.827 . . . . 0.0 109.673 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.29 -48.37 79.08 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.604 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.501 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.55 -39.09 47.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.77 -0.581 . . . . 0.0 110.443 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.772 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -72.96 -17.73 61.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.07 -1.019 . . . . 0.0 109.915 -178.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.933 ' HG2' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -71.51 -47.0 58.15 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.704 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -46.2 -37.42 7.08 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.863 0.839 . . . . 0.0 110.327 179.13 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.817 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -93.72 -72.4 0.61 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 178.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.817 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -82.98 89.82 1.52 Allowed Glycine 0 N--CA 1.487 2.047 0 C-N-CA 118.88 -1.628 . . . . 0.0 109.909 177.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.549 ' OD2' ' NZ ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -40.56 -29.62 0.09 Allowed 'General case' 0 N--CA 1.52 3.065 0 CA-C-N 122.217 3.008 . . . . 0.0 110.667 176.157 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 1.068 ' O ' HD13 ' A' ' 34' ' ' ILE . 9.4 mtmm -79.85 151.77 30.04 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.81 -0.556 . . . . 0.0 112.442 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.068 HD13 ' O ' ' A' ' 33' ' ' LYS . 16.5 mm -129.26 160.28 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 120.466 -1.396 . . . . 0.0 110.055 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.735 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -151.25 70.1 0.96 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.228 ' CG1' HD12 ' A' ' 20' ' ' ILE 0.255 85.7 t -96.93 123.23 49.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -179.197 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.847 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 7.8 mt-10 -108.84 148.29 30.82 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -177.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.703 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -142.78 110.7 5.93 Favored 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -174.459 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.9 HD12 ' CG ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -111.76 165.0 7.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 122.266 1.032 . . . . 0.0 113.24 -178.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.668 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -100.13 161.13 13.8 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.718 0.771 . . . . 0.0 110.931 178.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 1.015 HD11 ' C ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER -62.08 -18.74 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 120.473 -1.392 . . . . 0.0 110.99 179.438 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.668 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -91.23 -14.97 30.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.944 -1.097 . . . . 0.0 111.547 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.64 HG13 HG22 ' A' ' 39' ' ' ILE . 10.0 p -113.62 -31.35 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.131 -0.98 . . . . 0.0 110.63 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.9 ' CG ' HD12 ' A' ' 39' ' ' ILE . 41.9 t0 -112.56 37.93 2.91 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.454 -0.899 . . . . 0.0 110.087 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.522 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.296 0.0 OUTLIER -65.04 -3.49 3.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 119.956 -1.715 . . . . 0.0 109.086 -179.51 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 1.123 ' O ' HG23 ' A' ' 49' ' ' ILE . 1.7 mt-10 -60.0 -20.72 59.25 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.848 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -44.55 -63.37 0.91 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.305 -1.497 . . . . 0.0 109.072 -178.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.121 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -57.62 -11.23 1.94 Allowed 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.879 -1.51 . . . . 0.0 111.083 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.161 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.7 pp -24.0 -38.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.237 -1.539 . . . . 0.0 107.922 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 1.161 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -56.22 -51.6 67.5 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.873 177.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.83 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.0 p90 -122.84 -30.93 3.75 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.467 -0.771 . . . . 0.0 110.122 178.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.716 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 45.05 4.8 0.01 OUTLIER Glycine 1 N--CA 1.52 4.25 0 O-C-N 121.589 -0.695 . . . . 0.0 111.759 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.676 ' H ' ' C ' ' A' ' 51' ' ' TYR . 8.9 mt -75.68 -79.76 0.09 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 175.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.705 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 1.9 mtm -94.21 65.98 3.41 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.31 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 1.121 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.294 . . -108.23 108.64 19.75 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.346 -1.471 . . . . 0.0 109.79 -177.118 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.015 ' C ' HD11 ' A' ' 41' ' ' ILE . 2.6 t -147.76 -65.16 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.28 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.354 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.825 ' HD3' ' HB ' ' A' ' 56' ' ' VAL . 59.9 Cg_endo -105.44 106.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.302 -1.897 0 N-CA-C 109.11 -1.15 . . . . 0.0 109.11 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.962 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -160.71 177.83 10.07 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 112.694 -2.048 . . . . 0.0 111.686 -176.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.263 HG23 ' O ' ' A' ' 6' ' ' GLU 0.271 1.3 mp -146.53 154.3 12.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.019 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.993 ' HB3' ' HB3' ' A' ' 6' ' ' GLU 0.29 . . -87.72 155.49 19.9 Favored 'General case' 0 CA--C 1.479 -1.77 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.706 HG13 ' N ' ' A' ' 66' ' ' ARG 0.312 1.6 mt -104.12 92.19 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.038 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 -175.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.983 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.2 OUTLIER -54.74 86.25 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 126.274 2.234 . . . . 0.0 106.256 -178.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.761 ' HA3' ' HB2' ' A' ' 83' ' ' GLU . . . 162.02 -44.95 0.37 Allowed Glycine 0 C--N 1.292 -1.863 0 N-CA-C 107.777 -2.129 . . . . 0.0 107.777 -177.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.782 ' O ' HG23 ' A' ' 65' ' ' VAL . 11.5 m -126.69 -60.81 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.568 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 64' ' ' VAL . 74.6 t -164.38 -99.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 120.929 -1.107 . . . . 0.0 112.379 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.966 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -165.25 157.86 15.81 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.61 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.962 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -146.62 176.19 10.02 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.325 -0.859 . . . . 0.0 111.698 -176.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.748 HG22 ' OH ' ' A' ' 51' ' ' TYR . 7.9 t -84.98 121.58 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.693 -0.63 . . . . 0.0 110.363 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.82 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.67 110.08 0.41 Allowed Glycine 0 N--CA 1.498 2.823 0 O-C-N 119.863 -1.773 . . . . 0.0 110.694 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.051 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -90.49 -79.97 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.388 -1.066 . . . . 0.0 108.624 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 1.051 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 57.2 Cg_endo -83.91 18.27 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 N-CA-C 109.012 -1.188 . . . . 0.0 109.012 177.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -102.69 63.62 0.86 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.528 0.68 . . . . 0.0 110.176 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.754 ' HD3' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -70.57 -42.17 71.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 108.759 178.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.707 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 2.0 tt0 -44.07 -37.11 2.86 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.756 -0.59 . . . . 0.0 109.854 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.706 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -47.85 -37.79 14.65 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 120.029 -0.669 . . . . 0.0 109.894 179.354 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.161 ' CG ' HG21 ' A' ' 59' ' ' ILE . 9.7 mp -65.23 -41.52 94.3 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.804 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.2 -36.61 73.36 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 122.246 1.022 . . . . 0.0 109.873 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -78.9 -31.01 45.18 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 110.337 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.27 -38.01 75.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.514 -0.741 . . . . 0.0 111.158 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.896 HG21 ' CG1' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -65.66 -42.4 92.63 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 CA-C-O 121.75 0.786 . . . . 0.0 109.168 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.45 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -70.52 -21.09 62.77 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.618 176.302 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.416 ' O ' ' CG ' ' A' ' 82' ' ' ASP 0.356 0.3 OUTLIER -103.38 2.92 34.58 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 117.567 -1.653 . . . . 0.0 106.733 -178.65 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.82 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.33 -58.36 2.52 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 102.264 -3.235 . . . . 0.0 102.264 176.773 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.638 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 7.5 ptt? -69.47 -18.94 63.76 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.022 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.766 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.661 ' O ' ' SD ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.319 0.581 . . . . 0.0 110.217 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.051 HG21 ' O ' ' A' ' 33' ' ' LYS . 1.3 p -79.92 -95.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 109.894 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.042 HG21 HD12 ' A' ' 34' ' ' ILE . 52.1 t -88.89 129.13 40.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.476 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 1.042 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.292 0.7 OUTLIER -151.16 103.23 3.01 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 125.108 2.385 . . . . 0.0 108.446 179.562 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.067 HD12 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.5 137.26 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 CA-C-N 111.337 -2.665 . . . . 0.0 113.997 -178.165 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 1.244 ' O ' HG23 ' A' ' 59' ' ' ILE . 12.9 tt0 -131.72 119.89 21.97 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 115.458 -2.497 . . . . 0.0 105.862 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.035 HG12 ' CD2' ' A' ' 76' ' ' LEU . 4.2 m -111.61 111.6 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -176.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.879 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -116.4 93.71 4.34 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.021 -178.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.791 ' O ' HD12 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -124.43 -60.02 1.43 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.408 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.774 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 0.2 OUTLIER 179.7 147.72 0.44 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 110.621 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.732 ' CD ' ' HB2' ' A' ' 40' ' ' ASP . 48.4 Cg_endo -76.53 -30.07 5.39 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.273 1.67 . . . . 0.0 110.316 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.6 t -79.48 -13.55 59.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.938 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.58 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -125.03 179.58 1.09 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 109.946 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.648 ' O ' ' O ' ' A' ' 15' ' ' TYR . 52.1 Cg_endo -83.26 106.26 1.36 Allowed 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.984 1.518 . . . . 0.0 110.537 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.774 ' CE1' ' O ' ' A' ' 10' ' ' SER . 3.2 m-85 -49.73 -114.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.095 -1.003 . . . . 0.0 109.741 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.854 ' SG ' HD11 ' A' ' 59' ' ' ILE . 76.1 m -150.0 38.47 0.17 Allowed Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.404 -0.81 . . . . 0.0 109.921 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.889 ' HA ' HD13 ' A' ' 20' ' ' ILE . 50.9 Cg_endo -74.28 29.55 0.33 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.001 1.527 . . . . 0.0 111.129 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.794 ' CG ' ' CZ ' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -105.8 -56.28 2.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.082 -1.011 . . . . 0.0 110.253 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.779 ' HB2' ' HD3' ' A' ' 73' ' ' ARG . . . -58.32 -20.13 40.65 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.314 -0.866 . . . . 0.0 109.622 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.291 HD12 ' CG1' ' A' ' 36' ' ' VAL . 3.1 pt -72.93 -41.82 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.521 -0.737 . . . . 0.0 109.737 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.592 ' N ' ' CG1' ' A' ' 20' ' ' ILE . 7.8 tt0 -52.73 -35.11 55.39 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.4 t -71.65 -44.73 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 121.799 0.809 . . . . 0.0 109.063 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.936 ' CG1' HG21 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -64.66 -32.98 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.75 0.786 . . . . 0.0 109.107 177.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.76 ' OD2' HG21 ' A' ' 34' ' ' ILE . 28.5 t0 -68.53 -40.31 80.81 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.213 1.006 . . . . 0.0 109.477 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.43 -48.13 79.95 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.444 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.524 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -78.24 -39.4 40.39 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.635 -0.665 . . . . 0.0 110.672 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.781 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -71.56 -19.01 62.21 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.208 -178.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.904 ' HG2' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -70.86 -47.15 60.88 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 176.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.768 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -46.4 -37.89 8.21 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.781 0.8 . . . . 0.0 109.997 179.313 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.862 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -93.56 -70.3 0.71 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.862 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -84.82 87.71 1.56 Allowed Glycine 0 N--CA 1.504 3.213 0 C-N-CA 118.111 -1.995 . . . . 0.0 111.059 177.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.587 ' OD2' ' NZ ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -37.73 -28.93 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 O-C-N 118.337 -2.86 . . . . 0.0 111.017 176.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 1.105 ' O ' HD13 ' A' ' 34' ' ' ILE . 9.3 mtmm -81.27 151.77 27.93 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.105 HD13 ' O ' ' A' ' 33' ' ' LYS . 16.3 mm -128.96 160.3 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 119.926 -1.734 . . . . 0.0 110.039 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.778 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -151.14 70.01 0.97 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.392 -0.817 . . . . 0.0 108.842 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.291 ' CG1' HD12 ' A' ' 20' ' ' ILE 0.257 81.0 t -96.98 121.87 47.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -178.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.881 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 7.6 mt-10 -108.39 147.41 31.61 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.705 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -141.41 111.59 6.8 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -174.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.946 HD12 ' CG ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -112.02 166.08 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.101 -0.999 . . . . 0.0 113.256 -178.182 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.732 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -100.6 160.61 14.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.546 -0.722 . . . . 0.0 111.376 178.164 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 1.137 HD11 ' C ' ' A' ' 56' ' ' VAL 0.251 0.2 OUTLIER -62.65 -16.2 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.735 -1.228 . . . . 0.0 110.584 179.737 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.725 ' N ' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -93.2 -14.18 27.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.723 -1.236 . . . . 0.0 111.664 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.653 HG12 ' OD1' ' A' ' 40' ' ' ASP . 9.9 p -114.11 -31.07 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.009 -1.057 . . . . 0.0 110.748 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.946 ' CG ' HD12 ' A' ' 39' ' ' ILE . 43.0 t0 -112.51 37.32 3.09 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.116 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.544 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.341 0.0 OUTLIER -66.34 -1.26 3.23 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 117.49 -1.684 . . . . 0.0 108.666 -177.972 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 1.19 ' O ' HG23 ' A' ' 49' ' ' ILE . 1.7 mt-10 -60.11 -21.16 61.2 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.903 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -44.48 -63.27 0.93 Allowed 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 123.626 1.679 . . . . 0.0 109.011 -177.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.193 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -55.86 -12.81 1.49 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 113.51 -1.677 . . . . 0.0 111.458 177.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.229 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.7 pp -25.07 -38.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 O-C-N 119.524 -1.985 . . . . 0.0 107.244 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 1.229 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -55.55 -52.13 64.77 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.981 177.11 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.883 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 1.8 p90 -123.2 -28.63 3.98 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.239 -0.913 . . . . 0.0 110.014 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.767 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 43.22 5.12 0.01 OUTLIER Glycine 0 N--CA 1.504 3.179 0 CA-C-O 122.367 0.982 . . . . 0.0 111.835 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.739 ' N ' ' O ' ' A' ' 51' ' ' TYR . 8.7 mt -75.95 -75.95 0.17 Allowed 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 174.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.696 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 1.8 mtm -97.68 65.27 1.85 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 1.193 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.296 . . -108.57 109.27 20.46 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.165 -1.585 . . . . 0.0 109.074 -176.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.137 ' C ' HD11 ' A' ' 41' ' ' ILE . 2.6 t -147.83 -64.25 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.826 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.034 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.854 ' HD3' ' HB ' ' A' ' 56' ' ' VAL . 58.1 Cg_endo -105.64 104.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 N-CA-C 108.781 -1.276 . . . . 0.0 108.781 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 1.025 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -159.37 177.3 11.13 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 112.604 -2.089 . . . . 0.0 111.568 -176.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.244 HG23 ' O ' ' A' ' 6' ' ' GLU . 1.3 mp -146.07 153.04 13.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 O-C-N 121.502 -0.748 . . . . 0.0 109.124 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 1.014 ' HB3' ' HB3' ' A' ' 6' ' ' GLU 0.303 . . -87.3 154.62 20.55 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 102.67 -3.085 . . . . 0.0 102.67 -178.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.719 HG13 ' N ' ' A' ' 66' ' ' ARG 0.386 1.6 mt -103.72 93.42 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.599 0 N-CA-C 103.363 -2.828 . . . . 0.0 103.363 -175.357 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 1.042 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.2 OUTLIER -52.32 85.04 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 111.602 -2.545 . . . . 0.0 106.121 179.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.792 ' HA3' ' HB2' ' A' ' 83' ' ' GLU . . . 162.46 -44.64 0.35 Allowed Glycine 0 C--N 1.289 -2.037 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.857 ' O ' HG23 ' A' ' 65' ' ' VAL . 11.3 m -127.44 -59.33 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.993 -0.71 . . . . 0.0 110.949 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 64' ' ' VAL . 76.1 t -164.68 -101.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.488 0 O-C-N 120.346 -1.471 . . . . 0.0 112.529 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 1.009 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -162.99 158.96 22.88 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.47 -0.769 . . . . 0.0 109.058 -178.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 1.025 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -147.07 178.25 8.51 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.804 -1.185 . . . . 0.0 111.498 -177.272 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.78 HG22 ' OH ' ' A' ' 51' ' ' TYR . 8.3 t -86.57 120.94 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.446 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.826 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.89 110.25 0.43 Allowed Glycine 0 N--CA 1.496 2.673 0 C-N-CA 118.066 -2.016 . . . . 0.0 110.349 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.115 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -90.34 -80.52 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.087 -1.243 . . . . 0.0 108.546 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 1.115 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 55.9 Cg_endo -83.48 17.99 1.58 Allowed 'Trans proline' 0 C--N 1.301 -1.966 0 N-CA-C 108.897 -1.232 . . . . 0.0 108.897 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -102.32 64.35 0.91 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.347 -0.846 . . . . 0.0 110.636 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.794 ' CZ ' ' CG ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -71.99 -40.43 68.57 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.04 -1.037 . . . . 0.0 109.293 178.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.764 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 2.0 tt0 -45.24 -37.63 4.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.39 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.779 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -47.41 -38.05 12.6 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.293 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.234 ' CG ' HG21 ' A' ' 59' ' ' ILE . 9.5 mp -64.96 -40.95 95.78 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.425 -0.797 . . . . 0.0 109.214 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.847 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.55 -36.3 73.7 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.864 0.84 . . . . 0.0 109.847 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -78.3 -31.69 48.98 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.64 -0.662 . . . . 0.0 110.6 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -70.58 -38.46 74.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 0.0 111.048 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.936 HG21 ' CG1' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -64.2 -43.33 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 122.425 1.107 . . . . 0.0 109.183 179.079 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.452 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -70.24 -23.37 62.91 Favored 'General case' 0 C--O 1.2 -1.536 0 CA-C-O 117.899 -1.048 . . . . 0.0 109.179 176.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.371 0.2 OUTLIER -101.13 2.34 40.12 Favored 'General case' 0 C--O 1.263 1.778 0 C-N-CA 116.619 -2.032 . . . . 0.0 106.189 -178.064 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.844 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.12 -56.62 3.15 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 102.401 -3.185 . . . . 0.0 102.401 176.032 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.702 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 8.2 ptt? -70.53 -18.5 62.94 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.836 -1.165 . . . . 0.0 110.729 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 117.889 -1.053 . . . . 0.0 109.94 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.642 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.303 0.573 . . . . 0.0 110.201 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.027 HG22 ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -89.95 -92.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 0.0 109.947 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.186 HG11 ' OD2' ' A' ' 24' ' ' ASP . 75.1 t -89.15 112.42 24.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.55 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.841 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 1.0 OUTLIER -132.86 105.4 7.1 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.664 -1.273 . . . . 0.0 108.755 178.316 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.067 HG21 ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -120.4 138.17 51.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.812 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 1.063 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.3 122.76 26.99 Favored 'General case' 0 C--N 1.282 -2.335 0 C-N-CA 115.832 -2.347 . . . . 0.0 106.841 177.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.958 HG22 ' HA ' ' A' ' 38' ' ' LYS . 20.1 m -109.23 142.3 22.14 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.574 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.986 ' CD2' ' HB3' ' A' ' 58' ' ' ALA . 2.0 t80 -139.79 80.99 1.8 Allowed 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 117.979 -1.489 . . . . 0.0 112.823 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.701 ' OG1' ' HA ' ' A' ' 15' ' ' TYR . 3.4 m -117.81 -68.75 0.89 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 119.144 -2.222 . . . . 0.0 110.373 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.768 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 1.3 p 179.55 164.49 0.78 Allowed Pre-proline 0 C--N 1.293 -1.859 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.381 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.672 ' HD3' ' CG ' ' A' ' 40' ' ' ASP . 50.1 Cg_endo -80.27 -28.4 3.03 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.221 1.643 . . . . 0.0 110.424 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -18.37 54.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.749 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.07 174.36 3.95 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.418 -0.801 . . . . 0.0 109.696 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.651 ' O ' ' O ' ' A' ' 15' ' ' TYR . 51.7 Cg_endo -83.01 114.55 2.26 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.914 1.481 . . . . 0.0 110.422 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.768 ' CE1' ' O ' ' A' ' 10' ' ' SER . 16.3 m-85 -49.26 -112.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.597 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.735 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 92.5 m -150.57 37.58 0.14 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.199 -0.938 . . . . 0.0 110.081 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.735 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 53.9 Cg_endo -76.51 17.06 0.81 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.92 1.484 . . . . 0.0 111.027 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.551 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -95.1 -67.97 0.83 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.075 -1.016 . . . . 0.0 110.79 -179.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.781 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -54.28 -22.59 12.26 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.216 -0.928 . . . . 0.0 109.512 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.067 ' HB ' HG21 ' A' ' 5' ' ' ILE . 5.1 pt -70.58 -39.18 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.485 -0.759 . . . . 0.0 109.678 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.739 ' N ' HG13 ' A' ' 20' ' ' ILE . 6.1 tt0 -48.88 -33.45 10.72 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 3.2 t -71.41 -47.42 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.898 HG21 ' HB ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -61.4 -32.96 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.018 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 1.186 ' OD2' HG11 ' A' ' 3' ' ' VAL . 5.2 t70 -68.18 -40.38 82.25 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.994 0.902 . . . . 0.0 109.145 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -46.52 83.12 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.666 0.746 . . . . 0.0 109.626 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.485 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.31 -39.58 47.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.622 -0.674 . . . . 0.0 110.717 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.905 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -70.66 -18.18 62.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.917 -1.114 . . . . 0.0 109.328 -179.149 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.799 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -73.57 -45.05 55.71 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.222 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.74 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -50.14 -32.92 17.27 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.959 0.885 . . . . 0.0 110.465 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.783 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -97.19 -67.01 0.87 Allowed 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 179.09 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.755 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -84.97 86.29 1.56 Allowed Glycine 0 N--CA 1.505 3.261 0 C-N-CA 117.899 -2.096 . . . . 0.0 110.154 177.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.595 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -37.54 -29.29 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 O-C-N 118.319 -2.871 . . . . 0.0 110.188 177.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.836 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -78.63 155.56 29.5 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.822 -0.549 . . . . 0.0 111.774 178.189 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.799 ' CD1' ' CG ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -130.04 151.46 35.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 120.327 -1.483 . . . . 0.0 109.902 178.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.611 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -151.81 78.09 1.24 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.939 HG22 ' CD1' ' A' ' 5' ' ' ILE . 56.0 t -96.99 129.09 47.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 1.063 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 78.3 mt-10 -113.48 133.1 55.4 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.958 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -127.41 128.67 46.2 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 113.989 -1.459 . . . . 0.0 114.754 -177.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.069 HG22 ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -134.16 169.91 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 119.875 -1.766 . . . . 0.0 111.785 177.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.764 ' OD1' HG22 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -100.59 172.02 7.36 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.83 178.03 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.894 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -62.75 -37.88 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.711 -1.243 . . . . 0.0 109.36 178.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.678 ' HG3' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -80.95 -4.13 53.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.908 -1.12 . . . . 0.0 111.547 179.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.069 ' CG2' HG22 ' A' ' 39' ' ' ILE . 2.0 m -113.99 -45.97 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 120.954 -1.091 . . . . 0.0 110.033 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.933 ' HB2' HD12 ' A' ' 39' ' ' ILE . 1.6 t70 -105.27 41.84 1.31 Allowed 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.498 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.61 ' NH2' ' HA3' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -65.21 -1.71 2.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.118 -1.614 . . . . 0.0 109.5 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 1.151 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.3 mm-40 -62.81 -23.42 67.25 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.265 178.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.87 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -44.45 -68.81 0.17 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.182 -0.949 . . . . 0.0 108.487 179.405 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.138 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -55.57 -10.14 0.62 Allowed 'General case' 0 C--O 1.194 -1.866 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.549 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.207 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.6 pp -23.98 -41.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 119.412 -2.055 . . . . 0.0 105.956 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 1.207 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -54.0 -53.15 56.96 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.443 -0.798 . . . . 0.0 108.853 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.916 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 25.9 p90 -119.96 -32.24 4.26 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.269 -0.894 . . . . 0.0 110.161 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.723 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 42.81 6.36 0.01 OUTLIER Glycine 0 N--CA 1.499 2.874 0 CA-C-O 122.288 0.938 . . . . 0.0 111.572 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.714 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 4.5 mt -74.43 -80.66 0.08 Allowed 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.542 ' C ' ' HE2' ' A' ' 51' ' ' TYR 0.265 4.1 mtp -95.37 67.24 2.92 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.135 177.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 1.138 ' HB2' ' CB ' ' A' ' 48' ' ' ALA . . . -109.46 120.2 41.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 119.62 -1.925 . . . . 0.0 109.922 -178.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.828 HG23 ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -149.12 -56.39 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.936 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.722 -178.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.828 ' HD3' HG23 ' A' ' 56' ' ' VAL . 57.7 Cg_endo -111.63 109.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 122.931 0.964 . . . . 0.0 110.263 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 1.002 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -161.36 174.93 12.8 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.185 -1.371 . . . . 0.0 110.901 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.039 ' CG1' HD21 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -134.86 154.64 36.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.42 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 1.01 ' HB3' ' HB3' ' A' ' 6' ' ' GLU 0.26 . . -93.16 157.22 16.39 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 102.71 -3.07 . . . . 0.0 102.71 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.761 HG13 ' N ' ' A' ' 66' ' ' ARG 0.263 1.1 mt -101.87 91.94 2.2 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 -176.317 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.841 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -53.71 83.08 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -178.072 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.708 ' HA3' ' HB2' ' A' ' 83' ' ' GLU . . . 162.36 -43.49 0.36 Allowed Glycine 0 C--N 1.283 -2.363 0 N-CA-C 107.649 -2.181 . . . . 0.0 107.649 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.821 ' O ' HG23 ' A' ' 65' ' ' VAL . 11.9 m -126.95 -58.86 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.851 -0.794 . . . . 0.0 111.097 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 64' ' ' VAL . 81.0 t -163.78 -100.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 120.32 -1.488 . . . . 0.0 113.268 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 1.002 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 1.8 ttp180 -168.45 159.57 10.47 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.547 -0.72 . . . . 0.0 109.396 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 1.002 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -146.37 175.05 10.83 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.144 -0.973 . . . . 0.0 111.865 -177.33 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.756 ' CG2' ' HZ1' ' A' ' 47' ' ' LYS . 79.8 t -82.41 119.33 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.665 -0.647 . . . . 0.0 110.133 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.84 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.77 107.63 0.31 Allowed Glycine 0 N--CA 1.492 2.426 0 C-N-CA 118.655 -1.736 . . . . 0.0 110.578 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.118 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -88.57 -81.2 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.036 -1.273 . . . . 0.0 108.539 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 1.118 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 56.5 Cg_endo -84.5 18.52 1.54 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.407 1.214 . . . . 0.0 109.006 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.62 61.78 0.71 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.583 -0.698 . . . . 0.0 110.493 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.726 ' HG2' ' CB ' ' A' ' 16' ' ' CYS . 22.2 mtt180 -68.35 -32.25 72.21 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.849 -0.741 . . . . 0.0 109.276 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.781 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.2 tm-20 -47.44 -45.39 25.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 109.59 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.78 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -45.18 -29.11 0.88 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.061 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.039 HD21 ' CG1' ' A' ' 59' ' ' ILE . 3.2 mp -70.58 -39.96 73.56 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.511 -0.743 . . . . 0.0 109.059 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.855 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.11 -41.89 89.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.47 -0.769 . . . . 0.0 109.829 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.528 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 2.4 tm-20 -76.41 -27.99 56.5 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.248 0.547 . . . . 0.0 109.76 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.655 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -69.32 -42.54 75.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.04 -1.038 . . . . 0.0 111.286 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.044 ' CD1' HG23 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -61.97 -45.36 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.043 -1.035 . . . . 0.0 108.814 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.697 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -71.68 -27.07 62.79 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.45 0.643 . . . . 0.0 109.442 178.237 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 1.068 ' O ' ' OD1' ' A' ' 82' ' ' ASP 0.287 0.2 OUTLIER -97.69 8.14 45.2 Favored 'General case' 0 C--O 1.196 -1.762 0 O-C-N 118.918 -2.364 . . . . 0.0 107.82 -178.69 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.783 ' HG2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -101.17 -57.77 2.02 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.697 ' HE2' ' HA ' ' A' ' 81' ' ' ASN . 21.4 ptt? -68.23 -15.59 63.64 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.82 176.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.039 179.952 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.922 ' O ' ' HE3' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.31 0.576 . . . . 0.0 110.193 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.951 HG22 ' N ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -80.66 -94.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.157 -0.964 . . . . 0.0 110.195 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.96 HG11 ' CG ' ' A' ' 24' ' ' ASP . 54.6 t -93.03 91.31 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.422 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 1.053 ' H ' HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -116.88 108.01 15.3 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.942 0.877 . . . . 0.0 109.262 178.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.119 HG21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.07 141.18 45.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.283 -0.886 . . . . 0.0 110.306 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 1.135 ' CB ' ' HB3' ' A' ' 60' ' ' ALA 0.255 5.4 tt0 -130.12 101.9 6.01 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 117.708 -1.597 . . . . 0.0 109.235 178.134 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.86 HG12 ' CD2' ' A' ' 76' ' ' LEU . 3.3 m -95.52 110.45 24.22 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.423 0 CA-C-O 123.412 1.577 . . . . 0.0 108.085 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.883 ' CD2' ' HB3' ' A' ' 58' ' ' ALA . 1.6 t80 -118.51 91.03 3.46 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.965 -1.084 . . . . 0.0 110.203 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.94 HG22 ' N ' ' A' ' 10' ' ' SER . 0.7 OUTLIER -120.22 -69.62 0.83 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.777 . . . . 0.0 109.629 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.94 ' N ' HG22 ' A' ' 9' ' ' THR . 21.6 t 179.68 152.14 0.56 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 110.831 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 40' ' ' ASP . 49.8 Cg_endo -77.22 -15.94 15.83 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.175 1.618 . . . . 0.0 110.495 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 t -79.27 5.9 11.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.171 -0.956 . . . . 0.0 109.898 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.651 ' SG ' ' CD ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -160.8 -170.94 0.26 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 0.0 110.153 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.651 ' CD ' ' SG ' ' A' ' 13' ' ' CYS . 55.3 Cg_endo -84.2 113.54 1.79 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.882 1.464 . . . . 0.0 110.667 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.662 ' HA ' ' HB ' ' A' ' 9' ' ' THR . 7.4 m-85 -49.55 -112.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.627 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.866 ' CB ' HD11 ' A' ' 59' ' ' ILE . 58.5 m -152.34 39.19 0.14 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.043 -1.036 . . . . 0.0 110.414 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.706 ' HD3' ' N ' ' A' ' 16' ' ' CYS . 54.0 Cg_endo -76.9 17.17 0.85 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.9 1.474 . . . . 0.0 111.023 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.718 ' SD ' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -93.36 -64.71 1.06 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.092 -1.005 . . . . 0.0 112.078 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.825 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -55.96 -22.42 26.29 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.294 -0.879 . . . . 0.0 109.779 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.119 ' HB ' HG21 ' A' ' 5' ' ' ILE . 0.6 OUTLIER -71.28 -39.69 72.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.503 -0.748 . . . . 0.0 109.531 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.92 ' N ' HD12 ' A' ' 20' ' ' ILE . 3.1 tt0 -48.77 -31.83 7.62 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 2.8 t -71.59 -44.96 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.321 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.833 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -68.71 -26.54 33.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.301 -0.874 . . . . 0.0 109.22 178.418 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.96 ' CG ' HG11 ' A' ' 3' ' ' VAL . 14.1 t0 -74.67 -38.72 62.34 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -44.53 91.62 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.666 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.529 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.76 -40.13 29.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.456 -0.777 . . . . 0.0 110.443 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.778 ' N ' ' HE3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.3 -22.79 64.7 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.092 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 1.049 ' HG3' HD12 ' A' ' 34' ' ' ILE . 3.5 mtpt -69.93 -44.59 69.3 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 177.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.802 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -50.14 -39.98 44.95 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.681 0.753 . . . . 0.0 109.079 178.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.802 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.67 -55.22 3.73 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.786 ' O ' HG21 ' A' ' 2' ' ' VAL . . . -96.73 77.38 0.71 Allowed Glycine 0 N--CA 1.488 2.161 0 O-C-N 121.398 -0.814 . . . . 0.0 111.07 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.543 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -33.45 -24.64 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 118.998 1.399 . . . . 0.0 110.424 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.994 ' C ' HD13 ' A' ' 34' ' ' ILE . 1.1 mtmp? -85.42 155.57 21.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.131 -0.98 . . . . 0.0 110.813 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.049 HD12 ' HG3' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -129.33 149.48 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.939 178.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.688 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 36.3 t0 -150.31 71.9 1.08 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.495 -0.753 . . . . 0.0 109.254 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.824 HG22 ' CG1' ' A' ' 5' ' ' ILE . 58.4 t -91.34 117.39 34.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.57 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.809 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.25 91.1 mt-10 -100.5 138.06 38.07 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.433 -1.307 . . . . 0.0 108.301 -178.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.737 ' HB3' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -140.62 126.67 19.55 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.725 -1.235 . . . . 0.0 111.598 -177.383 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.116 HG22 HG21 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -139.65 176.0 6.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.486 -0.759 . . . . 0.0 109.653 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.738 ' CG ' HG13 ' A' ' 43' ' ' VAL . 2.1 p30 -114.22 172.9 6.73 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.858 -1.152 . . . . 0.0 111.947 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.856 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.7 OUTLIER -62.27 -5.29 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.41 -0.806 . . . . 0.0 112.03 176.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.738 ' HG3' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -99.94 -18.56 17.03 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.019 -1.051 . . . . 0.0 111.048 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.116 HG21 HG22 ' A' ' 39' ' ' ILE . 0.7 OUTLIER -113.01 -37.08 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.19 -0.944 . . . . 0.0 110.056 -178.389 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 1.034 ' HB2' HD12 ' A' ' 39' ' ' ILE . 5.2 t0 -114.22 52.52 0.83 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.2 -0.938 . . . . 0.0 110.977 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.416 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.255 72.2 ttt180 -65.87 -5.58 9.57 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.315 -1.354 . . . . 0.0 109.575 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 1.0 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.6 OUTLIER -60.11 -15.39 23.09 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.344 -0.848 . . . . 0.0 110.058 176.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.842 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -52.17 -58.46 6.54 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.124 -178.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.139 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -63.94 -0.8 1.2 Allowed 'General case' 0 C--N 1.279 -2.471 0 O-C-N 121.331 -0.856 . . . . 0.0 110.73 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.0 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -35.07 -38.7 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 -177.003 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.581 ' N ' ' C ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -53.73 -51.91 61.82 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.165 176.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.994 ' CZ ' HG22 ' A' ' 68' ' ' VAL . 1.6 p90 -123.2 -28.22 4.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.085 -1.009 . . . . 0.0 110.449 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.8 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.45 14.18 0.01 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.732 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.4 mt -85.87 -64.92 1.07 Allowed 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 123.674 1.702 . . . . 0.0 107.931 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.503 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 10.0 mtt -105.86 58.12 0.66 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.253 -1.34 . . . . 0.0 107.776 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 1.139 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.264 . . -99.0 106.78 19.08 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 123.467 1.604 . . . . 0.0 110.782 -175.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.789 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -146.72 -60.63 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.21 179.037 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.789 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 46.8 Cg_endo -100.0 104.76 0.05 OUTLIER 'Trans proline' 0 C--O 1.199 -1.47 0 CA-C-O 123.495 1.373 . . . . 0.0 110.429 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 1.031 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -160.14 -177.86 6.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.538 -1.352 . . . . 0.0 111.572 -178.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.266 ' CG1' HD11 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -149.16 137.18 14.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 1.135 ' HB3' ' CB ' ' A' ' 6' ' ' GLU . . . -80.87 140.44 35.36 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 117.155 -1.818 . . . . 0.0 106.987 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.762 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.413 0.7 OUTLIER -89.39 85.91 2.52 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.539 0 C-N-CA 115.302 -2.559 . . . . 0.0 106.058 -175.994 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.773 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.7 OUTLIER -44.12 83.24 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 113.098 -1.865 . . . . 0.0 108.622 177.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.762 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.07 -44.24 0.37 Allowed Glycine 0 N--CA 1.484 1.891 0 N-CA-C 107.042 -2.423 . . . . 0.0 107.042 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.786 ' O ' HG23 ' A' ' 65' ' ' VAL . 16.6 m -126.69 -59.13 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 O-C-N 121.622 -0.928 . . . . 0.0 111.378 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 64' ' ' VAL . 97.0 t -163.85 -106.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 120.289 -1.507 . . . . 0.0 112.249 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 1.072 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 1.8 ttp180 -162.4 165.47 26.35 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.716 -0.615 . . . . 0.0 109.55 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 1.031 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.0 177.83 8.48 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.97 -1.082 . . . . 0.0 111.06 -178.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.994 HG22 ' CZ ' ' A' ' 51' ' ' TYR . 22.5 t -93.18 116.55 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.297 -0.877 . . . . 0.0 109.865 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.832 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.41 126.58 1.58 Allowed Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.229 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.063 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -94.03 -83.05 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.759 0 O-C-N 120.921 -1.341 . . . . 0.0 108.709 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 1.063 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 51.4 Cg_endo -80.73 23.81 0.7 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 N-CA-C 109.11 -1.15 . . . . 0.0 109.11 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.51 70.52 1.96 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.238 -0.913 . . . . 0.0 111.432 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.742 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 11.9 mtm180 -76.77 -35.28 57.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.997 -1.064 . . . . 0.0 109.536 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.825 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -49.02 -32.29 9.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.664 179.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.781 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -50.9 -40.18 56.1 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.295 -0.878 . . . . 0.0 109.273 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.266 HD11 ' CG1' ' A' ' 59' ' ' ILE . 4.9 mp -64.32 -38.32 90.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.491 -0.755 . . . . 0.0 109.318 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.833 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -60.76 -42.94 98.43 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.868 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.803 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 4.5 tm-20 -78.54 -23.31 46.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 109.851 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.658 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -73.71 -37.01 65.3 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 109.446 -178.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.053 HD11 ' H ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -63.44 -46.08 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.067 -1.02 . . . . 0.0 109.076 178.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.593 ' N ' HG22 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -70.11 -33.59 72.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.35 -0.844 . . . . 0.0 108.742 179.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.448 8.0 t70 -88.08 -6.9 57.67 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 114.79 -2.764 . . . . 0.0 107.582 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.748 ' OE1' ' CA ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -81.14 -60.79 2.16 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 120.114 -1.617 . . . . 0.0 109.596 171.234 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.721 ' HE2' ' HZ3' ' A' ' 27' ' ' LYS . 10.3 ptt? -71.62 -12.29 61.27 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.71 -0.619 . . . . 0.0 110.497 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.599 ' CG ' ' OXT' ' A' ' 85' ' ' GLU . 2.1 tt0 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.177 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.2 ttm . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.248 0.547 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.972 HG22 ' N ' ' A' ' 3' ' ' VAL . 0.9 OUTLIER -80.51 -92.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 110.389 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.972 ' N ' HG22 ' A' ' 2' ' ' VAL . 54.6 t -92.76 119.76 40.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.671 -0.643 . . . . 0.0 110.495 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.8 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 9.4 t30 -138.49 114.57 10.14 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.571 1.177 . . . . 0.0 108.865 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.083 HD12 HD13 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -136.15 149.6 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.94 . . . . 0.0 110.724 -179.05 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 1.084 ' HB3' ' HB3' ' A' ' 60' ' ' ALA . 13.6 tt0 -135.09 106.11 6.64 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.007 -1.477 . . . . 0.0 109.701 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.855 HG22 ' HA ' ' A' ' 38' ' ' LYS . 22.3 m -95.16 104.3 15.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-O 123.1 1.429 . . . . 0.0 108.808 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.893 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 0.7 OUTLIER -117.08 87.91 2.8 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.049 -1.032 . . . . 0.0 109.564 -178.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 6.6 m -120.72 -62.72 1.42 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.352 -0.842 . . . . 0.0 109.586 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 1.055 ' HA ' HG22 ' A' ' 41' ' ' ILE . 12.8 p 179.81 156.41 0.72 Allowed Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.369 -0.832 . . . . 0.0 111.009 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.644 ' HD3' ' CG ' ' A' ' 40' ' ' ASP . 50.8 Cg_endo -84.77 -23.71 2.51 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 124.222 1.643 . . . . 0.0 110.589 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 t -79.37 13.65 1.86 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.159 -0.963 . . . . 0.0 110.055 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.543 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -160.72 -174.27 0.42 Allowed Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 121.417 -0.802 . . . . 0.0 110.184 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.614 ' O ' ' O ' ' A' ' 15' ' ' TYR . 54.4 Cg_endo -84.16 112.09 1.67 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.909 1.478 . . . . 0.0 110.689 177.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.755 ' CE1' ' O ' ' A' ' 10' ' ' SER . 19.3 m-85 -49.45 -110.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.311 -0.868 . . . . 0.0 109.609 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.757 ' CA ' ' HG3' ' A' ' 73' ' ' ARG . 37.6 m -154.81 39.78 0.13 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.027 -1.046 . . . . 0.0 110.57 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.688 ' HD3' ' N ' ' A' ' 16' ' ' CYS . 55.2 Cg_endo -77.26 16.56 1.0 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.767 1.404 . . . . 0.0 110.802 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.559 ' HB3' ' HG2' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -93.27 -64.28 1.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.996 -1.082 . . . . 0.0 112.142 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.722 ' CB ' ' HB3' ' A' ' 73' ' ' ARG . . . -57.48 -18.43 18.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.274 -0.891 . . . . 0.0 109.665 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.096 HG22 ' CB ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -75.71 -39.58 39.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.393 -0.817 . . . . 0.0 109.477 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.722 ' N ' HD12 ' A' ' 20' ' ' ILE . 29.8 tp10 -50.4 -32.84 18.72 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.29 -44.45 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.21 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.865 HG13 HG21 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -69.23 -28.08 37.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.673 0.749 . . . . 0.0 109.379 178.578 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.901 ' CG ' HG11 ' A' ' 3' ' ' VAL . 8.4 t0 -76.11 -36.75 58.73 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.7 -43.6 94.04 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.535 0.683 . . . . 0.0 109.623 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.502 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.9 -40.05 29.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.478 -0.764 . . . . 0.0 110.11 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.748 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -69.24 -22.23 63.87 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.218 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 1.036 ' CG ' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -69.92 -43.22 72.13 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.773 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -49.48 -39.63 34.33 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.788 0.804 . . . . 0.0 109.037 178.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.773 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.2 -56.68 3.18 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.746 ' O ' HG21 ' A' ' 2' ' ' VAL . . . -97.16 77.84 0.67 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.624 -0.991 . . . . 0.0 110.624 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.568 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -32.37 -27.16 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 119.105 1.452 . . . . 0.0 110.527 -179.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 1.129 ' C ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -85.95 157.05 20.24 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.347 -0.846 . . . . 0.0 110.938 178.202 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.129 HD12 ' C ' ' A' ' 33' ' ' LYS . 1.7 mp -128.98 157.98 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.044 -1.035 . . . . 0.0 110.765 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.692 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 3.4 t0 -150.21 62.48 0.97 Allowed 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.459 -0.775 . . . . 0.0 109.166 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.753 HG22 ' CD1' ' A' ' 5' ' ' ILE . 63.5 t -91.27 115.86 31.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 122.264 1.031 . . . . 0.0 109.862 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.74 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 3.5 mm-40 -97.94 145.08 26.82 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.932 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 1.033 ' C ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -139.98 121.48 15.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.075 -1.016 . . . . 0.0 111.453 -176.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.033 HD13 ' C ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -129.06 178.2 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 110.354 -179.152 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.737 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -113.88 165.65 12.37 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.217 -0.927 . . . . 0.0 111.06 178.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 1.238 ' CD1' HG12 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -49.58 -38.82 13.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.512 -0.743 . . . . 0.0 112.769 177.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.737 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.9 OUTLIER -86.88 -3.46 59.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.844 -1.16 . . . . 0.0 111.483 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.026 ' CG2' HG22 ' A' ' 39' ' ' ILE . 1.9 m -111.15 -44.07 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.97 -1.081 . . . . 0.0 109.801 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.761 ' HB2' ' CB ' ' A' ' 39' ' ' ILE . 4.0 t70 -112.37 45.37 1.3 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.356 -0.84 . . . . 0.0 110.029 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.682 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 2.4 ttt-85 -61.28 -4.64 1.26 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.849 -1.14 . . . . 0.0 109.469 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 1.071 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.1 mm-40 -55.02 -19.74 7.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.396 -0.815 . . . . 0.0 110.253 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.843 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -50.22 -59.1 4.28 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 122.413 1.102 . . . . 0.0 110.067 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.157 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -65.37 -0.09 1.71 Allowed 'General case' 0 C--N 1.281 -2.399 0 O-C-N 121.555 -0.716 . . . . 0.0 111.094 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.27 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.4 pp -35.64 -36.92 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 1.27 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.8 OUTLIER -54.09 -52.54 60.67 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.047 176.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 1.049 ' OH ' HG22 ' A' ' 68' ' ' VAL . 2.0 p90 -122.75 -28.22 4.19 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.088 -1.007 . . . . 0.0 110.203 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.789 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.62 14.3 0.01 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.657 ' N ' ' O ' ' A' ' 51' ' ' TYR . 4.4 mt -86.09 -62.77 1.44 Allowed 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 123.122 1.439 . . . . 0.0 108.462 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 19.9 mtp -106.72 53.83 0.69 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.158 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 1.157 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.268 . . -98.94 111.14 23.62 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 123.189 1.471 . . . . 0.0 110.903 -176.142 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.238 HG12 ' CD1' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -146.68 -68.38 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 110.459 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.844 ' HD3' ' CG2' ' A' ' 56' ' ' VAL . 51.0 Cg_endo -96.14 103.81 0.1 OUTLIER 'Trans proline' 0 C--O 1.2 -1.423 0 CA-C-O 123.396 1.332 . . . . 0.0 109.742 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 1.035 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -158.11 175.14 14.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.75 -1.219 . . . . 0.0 111.562 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.03 ' CG1' HD21 ' A' ' 76' ' ' LEU . 1.0 OUTLIER -138.39 135.58 44.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.613 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 1.084 ' HB3' ' HB3' ' A' ' 6' ' ' GLU . . . -81.51 139.59 35.06 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 117.361 -1.736 . . . . 0.0 107.058 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.756 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.372 1.0 OUTLIER -88.55 83.4 2.2 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.346 0 CA-C-O 124.786 2.232 . . . . 0.0 106.824 -175.895 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.8 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 4.5 m120 -43.11 82.68 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.616 -1.629 . . . . 0.0 108.767 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.756 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.04 -44.52 0.37 Allowed Glycine 0 N--CA 1.481 1.694 0 N-CA-C 107.414 -2.275 . . . . 0.0 107.414 -177.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.761 ' O ' HG23 ' A' ' 65' ' ' VAL . 17.0 m -125.78 -59.82 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 121.718 -0.872 . . . . 0.0 110.98 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.766 HG12 ' N ' ' A' ' 66' ' ' ARG . 88.6 t -163.81 -107.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 120.312 -1.492 . . . . 0.0 112.288 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 1.045 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 2.0 ttp180 -164.7 163.53 21.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.631 -0.668 . . . . 0.0 109.671 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 1.035 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -144.76 176.86 9.13 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.896 -1.127 . . . . 0.0 111.366 -178.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.049 HG22 ' OH ' ' A' ' 51' ' ' TYR . 79.8 t -89.14 115.82 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.651 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.858 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.57 124.8 1.31 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.564 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.093 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -92.85 -79.68 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 120.882 -1.364 . . . . 0.0 108.396 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 1.093 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 55.2 Cg_endo -81.01 25.29 0.64 Allowed 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.595 1.313 . . . . 0.0 109.228 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . 0.273 28.5 m -102.67 82.84 2.19 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 123.269 1.509 . . . . 0.0 110.007 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.757 ' HG3' ' CA ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -77.94 -35.74 50.1 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.947 -1.096 . . . . 0.0 109.988 177.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.71 ' HG2' ' CD2' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -46.1 -30.13 1.78 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.362 -0.836 . . . . 0.0 109.99 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.806 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -50.91 -42.69 59.56 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.27 -0.894 . . . . 0.0 109.193 179.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.096 ' CB ' HG22 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -63.49 -45.57 90.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.604 -0.685 . . . . 0.0 109.492 178.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.798 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -60.93 -38.57 86.26 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.639 0.733 . . . . 0.0 110.245 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.613 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 25.4 tt0 -80.22 -21.9 42.39 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.267 -0.896 . . . . 0.0 110.202 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.476 ' HB1' ' HA ' ' A' ' 61' ' ' ILE . . . -77.95 -39.77 41.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.207 -0.933 . . . . 0.0 109.643 -177.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.014 ' CD1' HG23 ' A' ' 5' ' ' ILE . 1.5 mp -65.72 -39.7 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.038 -1.039 . . . . 0.0 109.156 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.573 ' C ' ' OD1' ' A' ' 81' ' ' ASN . 0.1 OUTLIER -75.53 -32.02 60.32 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.118 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.613 ' HB3' ' O ' ' A' ' 78' ' ' GLU 0.455 0.4 OUTLIER -89.03 -8.39 54.09 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 114.989 -2.685 . . . . 0.0 108.115 -179.159 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.744 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -78.9 -60.71 2.27 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 119.968 -1.708 . . . . 0.0 110.196 169.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.639 ' SD ' ' HD2' ' A' ' 27' ' ' LYS . 4.7 ptt? -71.88 -9.16 57.93 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.782 -0.574 . . . . 0.0 110.822 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.572 ' OE2' ' C ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.898 -1.049 . . . . 0.0 109.973 -177.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.226 0.536 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.065 HG21 ' O ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -80.5 -92.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.333 -0.854 . . . . 0.0 110.359 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.954 ' N ' HG22 ' A' ' 2' ' ' VAL . 53.6 t -91.51 128.49 43.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.483 -0.76 . . . . 0.0 110.565 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.786 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 63.3 t30 -140.3 108.38 5.75 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 123.202 1.477 . . . . 0.0 108.604 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.047 HD12 ' HB ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -136.15 135.92 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 O-C-N 120.747 -1.221 . . . . 0.0 112.061 -178.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 1.15 ' O ' HG23 ' A' ' 59' ' ' ILE 0.253 1.4 tp10 -122.66 102.06 7.83 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 123.196 1.474 . . . . 0.0 108.587 176.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.8 ' CG2' ' CB ' ' A' ' 38' ' ' LYS . 29.5 m -95.42 106.39 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 123.582 1.658 . . . . 0.0 109.51 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.841 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 1.1 t80 -117.92 102.15 8.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.071 -1.018 . . . . 0.0 109.76 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.846 HG22 ' N ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -134.0 -61.9 0.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.955 . . . . 0.0 110.214 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 1.027 ' HA ' HG22 ' A' ' 41' ' ' ILE . 3.1 t -175.13 144.63 0.82 Allowed Pre-proline 0 N--CA 1.487 1.386 0 O-C-N 121.118 -0.989 . . . . 0.0 111.152 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.752 ' N ' ' HB2' ' A' ' 40' ' ' ASP . 48.7 Cg_endo -76.76 -9.39 18.31 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 124.135 1.597 . . . . 0.0 110.475 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.95 -5.0 52.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.21 -0.931 . . . . 0.0 109.843 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.624 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 1.4 p -160.61 -166.15 0.14 Allowed Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.385 -0.822 . . . . 0.0 110.056 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.624 ' CD ' ' CB ' ' A' ' 13' ' ' CYS . 55.6 Cg_endo -84.17 117.8 2.23 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.863 1.454 . . . . 0.0 110.617 176.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.773 ' HD2' HG23 ' A' ' 7' ' ' VAL . 2.1 m-85 -49.27 -84.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.0 109.56 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.814 ' HB3' HD11 ' A' ' 76' ' ' LEU . 42.2 m -155.22 39.69 0.12 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.124 -0.985 . . . . 0.0 109.968 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.7 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 53.4 Cg_endo -73.78 30.4 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.881 1.464 . . . . 0.0 111.146 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.4 ' H ' ' C ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -110.17 -61.85 1.6 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.029 -1.044 . . . . 0.0 110.433 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.9 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -58.1 -20.06 37.03 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.464 -0.773 . . . . 0.0 110.062 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.047 ' HB ' HD12 ' A' ' 5' ' ' ILE . 23.0 pt -75.62 -39.07 39.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.479 -0.763 . . . . 0.0 109.513 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.672 ' N ' HG13 ' A' ' 20' ' ' ILE . 49.7 tt0 -49.63 -35.86 22.56 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.8 -42.46 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.048 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.912 HG13 HG21 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -70.88 -26.66 28.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-O 121.825 0.821 . . . . 0.0 109.185 178.299 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.698 ' OD2' HG11 ' A' ' 3' ' ' VAL . 4.6 t70 -76.9 -35.84 57.09 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -43.99 91.07 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.622 0.725 . . . . 0.0 109.321 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.529 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.44 -41.01 28.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.622 -0.674 . . . . 0.0 110.165 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.813 ' CE ' ' CE ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -67.72 -23.38 65.26 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.306 -179.404 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -69.32 -46.42 67.14 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.791 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -47.47 -41.0 19.69 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.585 0.707 . . . . 0.0 109.124 178.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.791 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.57 -57.87 2.72 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.731 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -97.15 78.28 0.67 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.583 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -33.46 -27.24 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 119.394 1.597 . . . . 0.0 110.101 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 1.065 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -88.72 158.02 18.33 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.197 -0.939 . . . . 0.0 111.339 178.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.792 HG23 HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -129.47 151.03 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.406 -0.917 . . . . 0.0 110.685 178.127 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -138.82 61.14 1.58 Allowed 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.445 -0.784 . . . . 0.0 108.97 179.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.025 HG13 ' HB ' ' A' ' 5' ' ' ILE . 44.6 t -91.59 115.48 30.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 122.454 1.121 . . . . 0.0 109.681 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.753 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.25 12.2 mt-10 -98.07 141.02 31.53 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.375 -178.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.8 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -138.45 130.9 28.94 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.765 -1.21 . . . . 0.0 112.127 -176.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.013 HD12 ' CG ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -138.53 173.12 12.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.525 -0.734 . . . . 0.0 110.006 179.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 1.071 ' CG ' HG12 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -105.84 169.68 8.34 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.102 -0.999 . . . . 0.0 110.889 179.234 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 1.258 ' CD1' HG22 ' A' ' 56' ' ' VAL . 0.6 OUTLIER -73.16 -19.32 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.444 -0.785 . . . . 0.0 111.598 179.16 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.756 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 2.4 ptt? -90.62 -18.1 25.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.06 -1.025 . . . . 0.0 110.634 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.071 HG12 ' CG ' ' A' ' 40' ' ' ASP . 13.3 p -110.01 -29.78 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.344 -0.847 . . . . 0.0 110.77 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 1.013 ' CG ' HD12 ' A' ' 39' ' ' ILE . 5.7 t0 -114.7 48.19 1.16 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.021 -1.049 . . . . 0.0 110.843 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.26 2.3 ttt180 -59.09 -8.29 1.45 Allowed 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 118.263 -1.375 . . . . 0.0 109.974 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.988 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.5 OUTLIER -61.34 -13.41 19.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 109.175 175.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.813 ' HG2' ' HB3' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -51.71 -60.16 3.47 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.168 0.985 . . . . 0.0 108.959 -178.521 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.134 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -64.2 1.57 0.71 Allowed 'General case' 0 C--N 1.278 -2.533 0 O-C-N 121.119 -0.988 . . . . 0.0 110.55 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.077 HD11 ' NE ' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -35.67 -38.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 -177.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.56 ' N ' ' C ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -54.62 -49.36 70.68 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.668 176.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.825 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -124.93 -28.55 3.46 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.999 -1.063 . . . . 0.0 110.411 179.21 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.787 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.14 13.3 0.01 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.66 ' N ' ' O ' ' A' ' 51' ' ' TYR . 6.2 mt -86.52 -60.94 1.85 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 123.526 1.631 . . . . 0.0 107.88 177.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.533 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 26.0 mtm -110.55 62.35 0.6 Allowed 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.633 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 1.134 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.278 . . -98.35 107.78 20.32 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 123.622 1.677 . . . . 0.0 111.124 -174.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.258 HG22 ' CD1' ' A' ' 41' ' ' ILE . 1.6 t -146.66 -68.42 0.02 OUTLIER Pre-proline 0 N--CA 1.484 1.232 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.23 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.845 ' CD ' HG12 ' A' ' 56' ' ' VAL . 55.6 Cg_endo -104.22 93.46 0.03 OUTLIER 'Trans proline' 0 C--O 1.201 -1.327 0 CA-C-O 123.528 1.386 . . . . 0.0 111.257 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 1.097 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -151.2 179.32 8.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.32 -1.488 . . . . 0.0 110.957 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.264 HG21 ' CD2' ' A' ' 76' ' ' LEU . 1.4 mp -149.92 147.47 16.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.463 -0.773 . . . . 0.0 110.508 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.927 ' HB3' ' CB ' ' A' ' 6' ' ' GLU . . . -81.59 137.9 35.44 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.755 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.406 1.0 OUTLIER -87.8 82.34 2.05 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.555 0 C-N-CA 115.318 -2.553 . . . . 0.0 105.277 -175.756 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.786 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -44.3 85.67 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 113.3 -1.773 . . . . 0.0 107.851 177.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.755 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.0 -47.12 0.38 Allowed Glycine 0 N--CA 1.482 1.716 0 N-CA-C 106.471 -2.652 . . . . 0.0 106.471 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.787 ' O ' HG23 ' A' ' 65' ' ' VAL . 11.9 m -124.49 -60.86 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 121.82 -0.812 . . . . 0.0 111.094 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.805 HG12 ' N ' ' A' ' 66' ' ' ARG . 96.7 t -164.01 -107.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 120.104 -1.623 . . . . 0.0 113.185 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 1.077 ' NE ' HD11 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -156.18 153.69 29.64 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.671 -0.643 . . . . 0.0 110.13 -177.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 1.097 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.52 -174.93 4.53 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.905 -1.122 . . . . 0.0 111.836 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.92 122.95 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.812 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.33 105.59 0.26 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 118.865 -1.636 . . . . 0.0 111.153 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.103 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -89.74 -82.74 0.02 OUTLIER Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 120.824 -1.397 . . . . 0.0 108.146 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 1.103 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 55.7 Cg_endo -82.19 14.76 2.16 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 O-C-N 123.28 1.147 . . . . 0.0 109.499 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.48 64.48 1.32 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.218 -0.926 . . . . 0.0 111.587 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.746 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.59 -32.15 65.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.897 -1.127 . . . . 0.0 109.361 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.9 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -51.34 -40.99 60.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.923 . . . . 0.0 109.244 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.744 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -46.32 -29.31 1.6 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.465 -0.772 . . . . 0.0 109.344 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.264 ' CD2' HG21 ' A' ' 59' ' ' ILE . 13.1 mt -72.46 -40.85 66.69 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.803 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.94 -36.98 73.28 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.799 0.809 . . . . 0.0 109.646 179.279 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -79.44 -25.79 41.9 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.328 -0.858 . . . . 0.0 110.123 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.463 ' HB1' HG22 ' A' ' 61' ' ' ILE . . . -74.95 -37.91 61.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.161 -0.962 . . . . 0.0 109.743 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.912 HG21 HG13 ' A' ' 23' ' ' VAL . 1.5 mp -63.64 -37.41 79.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.957 -1.09 . . . . 0.0 108.807 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.421 ' ND2' ' C ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -72.94 -33.89 66.2 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.64 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.501 0.3 OUTLIER -90.95 -6.58 53.88 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 114.114 -3.035 . . . . 0.0 107.454 -179.059 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.756 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -78.7 -55.19 5.37 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 119.859 -1.776 . . . . 0.0 109.838 170.091 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.813 ' CE ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.04 -23.26 64.96 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.171 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.471 ' CD ' ' C ' ' A' ' 85' ' ' GLU . 3.3 tm-20 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.234 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.239 0.542 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.06 HG21 ' O ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -80.45 -94.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.284 -0.885 . . . . 0.0 110.583 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.981 ' N ' HG22 ' A' ' 2' ' ' VAL . 57.6 t -87.84 133.11 31.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 O-C-N 121.395 -0.816 . . . . 0.0 112.692 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.84 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.51 64.0 t30 -153.92 106.51 2.85 Favored 'General case' 0 N--CA 1.518 2.939 1 CA-C-O 129.399 4.428 . . . . 0.0 109.208 177.868 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.05 HD12 ' HB ' ' A' ' 20' ' ' ILE 0.414 0.2 OUTLIER -119.3 130.57 73.77 Favored 'Isoleucine or valine' 0 C--O 1.264 1.834 0 CA-C-N 108.689 -3.869 . . . . 0.0 117.903 -174.823 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 1.27 ' O ' HG23 ' A' ' 59' ' ' ILE 0.644 1.2 tp10 -133.7 123.3 24.72 Favored 'General case' 0 C--N 1.269 -2.895 2 CA-C-O 131.792 5.567 . . . . 0.0 106.17 166.824 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.797 HG23 ' HD2' ' A' ' 15' ' ' TYR 0.257 25.0 m -113.19 100.86 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.517 1 O-C-N 114.476 -5.14 . . . . 0.0 109.155 -171.42 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.862 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 1.2 t80 -113.79 104.98 12.74 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 111.69 -2.505 . . . . 0.0 108.623 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.838 HG22 ' N ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -135.6 -60.61 0.74 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.929 0.871 . . . . 0.0 110.564 177.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 1.044 ' HA ' HG22 ' A' ' 41' ' ' ILE . 3.1 t -177.57 143.62 0.51 Allowed Pre-proline 0 N--CA 1.487 1.414 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.41 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.75 ' N ' ' HB2' ' A' ' 40' ' ' ASP . 47.2 Cg_endo -76.08 -9.52 19.28 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 124.119 1.589 . . . . 0.0 110.225 -178.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.14 -5.19 53.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.056 -1.027 . . . . 0.0 109.843 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.633 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 1.4 p -159.75 -165.88 0.13 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.353 -0.842 . . . . 0.0 110.138 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.633 ' CD ' ' CB ' ' A' ' 13' ' ' CYS . 55.3 Cg_endo -84.22 117.65 2.2 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.865 1.455 . . . . 0.0 110.582 176.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.797 ' HD2' HG23 ' A' ' 7' ' ' VAL . 2.0 m-85 -49.22 -83.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 109.625 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.814 ' HB3' HD11 ' A' ' 76' ' ' LEU . 42.7 m -155.29 39.59 0.12 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.146 -0.971 . . . . 0.0 109.962 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 52.9 Cg_endo -73.69 30.3 0.32 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.977 1.514 . . . . 0.0 111.141 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.401 ' H ' ' C ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -110.06 -61.98 1.58 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.966 -1.084 . . . . 0.0 110.348 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.862 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -58.86 -19.11 38.91 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.099 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.05 ' HB ' HD12 ' A' ' 5' ' ' ILE . 22.8 pt -75.95 -38.0 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.141 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.675 ' N ' HG13 ' A' ' 20' ' ' ILE . 50.1 tt0 -49.0 -37.58 20.78 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.42 -44.87 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-O 122.05 0.929 . . . . 0.0 109.297 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.909 HG13 HG21 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -63.01 -35.71 72.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 122.789 1.281 . . . . 0.0 109.92 175.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.698 ' OD2' HG11 ' A' ' 3' ' ' VAL . 4.0 t70 -70.64 -39.03 73.92 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.903 1.335 . . . . 0.0 108.298 -177.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -46.35 81.94 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.062 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.518 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -76.74 -41.6 44.36 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.636 0.731 . . . . 0.0 110.297 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.821 ' CE ' ' CE ' ' A' ' 84' ' ' MET 0.272 0.0 OUTLIER -72.02 -17.71 62.01 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 117.471 -1.691 . . . . 0.0 109.632 -177.32 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.626 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -70.33 -45.86 65.35 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 120.923 -1.111 . . . . 0.0 108.223 173.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.722 ' HG3' ' N ' ' A' ' 30' ' ' PHE 0.317 0.0 OUTLIER -52.97 -28.8 25.45 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.014 -179.042 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.777 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -102.17 -59.16 1.75 Allowed 'General case' 0 C--N 1.274 -2.706 0 O-C-N 119.108 -2.245 . . . . 0.0 106.67 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.772 ' HA3' ' CG2' ' A' ' 2' ' ' VAL . . . -80.23 58.85 4.61 Favored Glycine 1 C--N 1.24 -4.8 1 CA-C-O 113.008 -4.218 . . . . 0.0 116.433 174.526 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.571 ' C ' ' O ' ' A' ' 31' ' ' GLY 0.428 0.0 OUTLIER -36.45 -19.65 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.219 1 CA-C-N 125.182 4.491 . . . . 0.0 112.901 -168.647 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 1.06 ' O ' HG21 ' A' ' 2' ' ' VAL 0.293 0.0 OUTLIER -75.96 151.29 37.29 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 127.536 2.334 . . . . 0.0 115.69 167.953 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.799 HG23 HG23 ' A' ' 36' ' ' VAL 0.342 0.3 OUTLIER -130.67 155.77 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 C-N-CA 115.569 -2.452 . . . . 0.0 109.84 170.575 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.71 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.3 OUTLIER -139.96 64.76 1.44 Allowed 'General case' 0 C--N 1.313 -1.015 0 O-C-N 121.349 -0.844 . . . . 0.0 108.783 -178.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.027 HG13 ' HB ' ' A' ' 5' ' ' ILE 0.405 58.1 t -102.29 125.05 56.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 125.728 2.68 . . . . 0.0 108.709 -177.383 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 1.049 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.489 10.2 mt-10 -116.02 129.29 56.3 Favored 'General case' 0 C--O 1.176 -2.802 0 O-C-N 118.655 -2.528 . . . . 0.0 107.81 -173.201 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.764 ' CB ' ' CG2' ' A' ' 7' ' ' VAL 0.642 0.0 OUTLIER -106.83 111.18 23.58 Favored 'General case' 0 C--O 1.274 2.347 2 CA-C-O 107.928 -5.796 . . . . 0.0 121.166 -170.665 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.016 HD12 ' CG ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -130.11 166.54 27.45 Favored 'Isoleucine or valine' 1 C--N 1.212 -5.405 1 CA-C-N 131.377 6.444 . . . . 0.0 109.713 178.267 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 1.077 ' CG ' HG12 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -97.82 169.84 9.38 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.776 -1.203 . . . . 0.0 112.279 173.193 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 1.258 ' CD1' HG22 ' A' ' 56' ' ' VAL . 0.7 OUTLIER -74.33 -21.34 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.03 -1.044 . . . . 0.0 111.402 176.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.738 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 2.0 ptt? -86.27 -16.62 37.0 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.901 -1.124 . . . . 0.0 112.915 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.077 HG12 ' CG ' ' A' ' 40' ' ' ASP . 14.5 p -112.83 -27.06 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.914 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 1.016 ' CG ' HD12 ' A' ' 39' ' ' ILE . 5.7 t0 -115.14 51.13 0.93 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.184 -0.947 . . . . 0.0 110.6 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.457 2.6 ttt180 -70.31 0.99 5.41 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 115.833 -2.347 . . . . 0.0 109.793 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 1.013 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -53.92 -24.46 16.38 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.545 -1.347 . . . . 0.0 110.798 165.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.825 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -47.58 -62.49 1.42 Allowed 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 122.767 1.27 . . . . 0.0 109.023 -174.034 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.125 ' CB ' ' HB2' ' A' ' 55' ' ' ALA 0.425 . . -51.01 -13.66 0.17 Allowed 'General case' 0 C--N 1.268 -2.975 0 C-N-CA 125.105 1.362 . . . . 0.0 113.021 173.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.076 HD11 ' NE ' ' A' ' 66' ' ' ARG 0.256 0.2 OUTLIER -32.92 -37.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 O-C-N 117.768 -3.083 . . . . 0.0 103.528 -168.342 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.637 ' N ' ' C ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -55.0 -49.27 71.92 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.581 176.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.816 ' CE1' ' HE3' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -124.95 -28.14 3.5 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.979 -1.076 . . . . 0.0 110.397 179.157 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.761 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 41.69 12.08 0.01 OUTLIER Glycine 0 C--O 1.19 -2.617 0 CA-C-O 122.025 0.792 . . . . 0.0 112.416 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 5.6 mt -83.84 -75.02 0.35 Allowed 'General case' 0 C--N 1.247 -3.85 0 N-CA-C 103.971 -2.603 . . . . 0.0 103.971 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.607 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 26.9 mtm -103.23 69.2 1.0 Allowed 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.228 -1.545 . . . . 0.0 107.092 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 1.125 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.579 . . -113.08 117.75 32.86 Favored 'General case' 0 C--O 1.195 -1.78 1 CA-C-O 129.698 4.571 . . . . 0.0 109.073 -175.749 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.258 HG22 ' CD1' ' A' ' 41' ' ' ILE . 1.7 t -152.77 -60.71 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.654 0 CA-C-N 109.02 -3.718 . . . . 0.0 112.242 -175.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.817 ' CD ' HG12 ' A' ' 56' ' ' VAL 0.502 43.5 Cg_endo -119.83 105.87 0.0 OUTLIER 'Trans proline' 0 C--O 1.19 -1.88 0 CA-C-O 129.276 3.782 . . . . 0.0 110.974 172.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 1.067 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -159.59 176.55 11.9 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 110.015 -3.266 . . . . 0.0 111.219 -176.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.279 HG21 ' CD2' ' A' ' 76' ' ' LEU 0.271 1.3 mp -149.55 160.75 4.99 Favored 'Isoleucine or valine' 0 C--O 1.272 2.274 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.743 -177.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.961 ' HA ' ' HA ' ' A' ' 66' ' ' ARG 0.699 . . -107.98 152.36 24.58 Favored 'General case' 0 CA--C 1.448 -2.955 2 O-C-N 115.554 -4.466 . . . . 0.0 102.705 -177.209 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.725 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.619 1.5 mt -106.46 91.17 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.441 -3.221 1 CA-C-O 132.436 5.874 . . . . 0.0 101.871 -161.084 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.84 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -45.65 83.91 0.0 OUTLIER 'General case' 0 C--N 1.367 1.335 1 CA-C-N 106.099 -5.046 . . . . 0.0 107.29 177.735 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.725 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.06 -47.03 0.38 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 106.348 -2.701 . . . . 0.0 106.348 -177.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.799 ' O ' HG23 ' A' ' 65' ' ' VAL . 12.1 m -124.64 -60.65 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 O-C-N 121.836 -0.802 . . . . 0.0 111.126 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 64' ' ' VAL . 99.4 t -164.12 -103.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.406 0 O-C-N 120.123 -1.611 . . . . 0.0 113.312 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 1.076 ' NE ' HD11 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -162.01 150.3 14.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.441 -0.787 . . . . 0.0 109.783 -175.002 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 1.067 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -146.06 -179.18 6.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.72 -1.238 . . . . 0.0 110.877 -176.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.2 t -85.89 120.89 36.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 116.761 -1.59 . . . . 0.0 110.299 176.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.817 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.24 106.42 0.28 Allowed Glycine 0 N--CA 1.497 2.705 0 CA-C-N 122.316 2.325 . . . . 0.0 110.674 177.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.105 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -90.24 -79.96 0.03 OUTLIER Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 120.81 -1.406 . . . . 0.0 108.787 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 1.105 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 48.3 Cg_endo -88.86 20.63 1.09 Allowed 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 117.312 -1.325 . . . . 0.0 108.969 177.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.61 63.88 1.09 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.017 -1.052 . . . . 0.0 112.227 176.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.727 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -69.81 -35.65 74.99 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.733 177.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.862 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -47.13 -44.09 21.32 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.092 0.949 . . . . 0.0 108.76 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.756 ' CD ' ' CE2' ' A' ' 67' ' ' PHE 0.274 0.0 OUTLIER -48.75 -26.02 2.13 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.182 -177.293 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.279 ' CD2' HG21 ' A' ' 59' ' ' ILE . 12.6 mt -72.48 -41.11 66.36 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.831 0.824 . . . . 0.0 109.629 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.812 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.29 -37.6 72.68 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 122.045 0.926 . . . . 0.0 110.287 179.173 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -74.43 -32.16 62.55 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.85 0.833 . . . . 0.0 110.354 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 83' ' ' GLU . . . -73.77 -37.23 65.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.021 -1.049 . . . . 0.0 110.187 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.909 HG21 HG13 ' A' ' 23' ' ' VAL . 1.5 mp -60.33 -41.12 86.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 120.826 -1.172 . . . . 0.0 109.39 176.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.437 ' ND2' ' C ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -70.29 -32.76 70.69 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.764 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.632 0.1 OUTLIER -102.57 5.23 39.17 Favored 'General case' 0 CA--C 1.487 -1.445 0 C-N-CA 114.455 -2.898 . . . . 0.0 108.762 -176.61 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.777 ' HB2' ' O ' ' A' ' 62' ' ' ASN 0.299 0.2 OUTLIER -87.84 -55.84 3.59 Favored 'General case' 0 N--CA 1.489 1.498 1 O-C-N 115.611 -4.43 . . . . 0.0 107.568 164.472 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.821 ' CE ' ' CE ' ' A' ' 27' ' ' LYS 0.27 0.0 OUTLIER -67.94 -18.37 64.74 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 119.963 1.256 . . . . 0.0 112.209 178.792 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.477 ' CD ' ' C ' ' A' ' 85' ' ' GLU . 3.2 tm-20 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 120.859 -1.151 . . . . 0.0 110.609 177.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.689 ' SD ' ' OE2' ' A' ' 83' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.333 0.587 . . . . 0.0 110.153 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.062 HG21 ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -79.67 -89.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 110.236 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.993 HG11 ' OD2' ' A' ' 24' ' ' ASP . 48.3 t -90.95 111.13 23.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.462 -0.774 . . . . 0.0 110.595 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.819 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 3.9 m-20 -123.85 107.46 11.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.81 -1.181 . . . . 0.0 109.235 177.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.064 ' CG1' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -122.33 137.16 56.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.491 -0.756 . . . . 0.0 110.923 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 1.023 ' O ' HG23 ' A' ' 59' ' ' ILE . 11.0 tt0 -128.4 110.67 12.55 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 118.896 -2.378 . . . . 0.0 108.966 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.986 HG12 ' HB2' ' A' ' 16' ' ' CYS 0.263 20.9 m -101.96 110.14 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -177.719 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.855 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 5.4 t80 -117.98 83.65 2.04 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.05 -176.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.686 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -127.54 -45.92 1.47 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.157 0.503 . . . . 0.0 110.193 179.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.768 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 17.6 t 179.64 148.39 0.45 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.175 -0.953 . . . . 0.0 110.637 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.712 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 50.7 Cg_endo -86.16 -26.16 1.2 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.151 1.606 . . . . 0.0 110.704 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -78.79 12.26 2.21 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.12 -0.988 . . . . 0.0 109.985 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.546 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -157.22 -172.2 0.31 Allowed Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.415 -0.803 . . . . 0.0 110.68 178.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 13' ' ' CYS . 51.6 Cg_endo -84.53 107.26 1.17 Allowed 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.125 1.592 . . . . 0.0 110.056 176.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.768 ' CE1' ' O ' ' A' ' 10' ' ' SER . 14.8 m-85 -49.45 -83.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.77 -1.206 . . . . 0.0 109.689 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 1.062 ' SG ' HD11 ' A' ' 59' ' ' ILE . 34.6 m -155.86 47.21 0.3 Allowed Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.38 -0.825 . . . . 0.0 109.792 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.767 ' HA ' HD13 ' A' ' 20' ' ' ILE . 47.1 Cg_endo -72.49 24.13 0.28 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 124.077 1.567 . . . . 0.0 111.111 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.429 ' H ' ' C ' ' A' ' 16' ' ' CYS . 6.5 tpt -110.07 -69.74 0.85 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.059 -1.026 . . . . 0.0 110.15 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.791 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -55.12 -19.84 8.55 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.247 -0.908 . . . . 0.0 109.343 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.1 HD12 HG11 ' A' ' 36' ' ' VAL . 13.0 pt -71.49 -40.34 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.405 -0.81 . . . . 0.0 109.15 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.708 ' N ' HG13 ' A' ' 20' ' ' ILE . 13.8 tp10 -53.67 -34.92 60.32 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.07 -42.9 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.441 -0.787 . . . . 0.0 109.017 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.811 ' CG1' ' HB ' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -67.77 -31.77 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.793 0.806 . . . . 0.0 109.515 178.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.993 ' OD2' HG11 ' A' ' 3' ' ' VAL . 3.2 t70 -72.53 -38.06 68.15 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 122.077 0.941 . . . . 0.0 108.466 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.478 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -60.42 -45.24 94.32 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.057 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.648 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -78.61 -39.43 37.31 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.591 -0.693 . . . . 0.0 110.853 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.817 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -73.1 -19.81 61.07 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 118.926 -1.11 . . . . 0.0 109.094 -178.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.721 ' CD ' ' OD1' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -70.76 -45.52 64.62 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 176.396 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.744 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -46.68 -39.57 11.65 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.975 0.893 . . . . 0.0 109.265 179.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.75 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -95.51 -58.2 2.19 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.75 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -94.03 82.43 0.99 Allowed Glycine 0 N--CA 1.499 2.867 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.565 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -37.43 -24.52 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 O-C-N 119.349 -2.265 . . . . 0.0 110.372 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 1.062 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -82.83 151.99 25.82 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.579 -0.7 . . . . 0.0 111.845 177.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.801 HD12 ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -129.9 153.75 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.09 -1.631 . . . . 0.0 110.569 177.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.569 ' O ' ' O ' ' A' ' 3' ' ' VAL . 9.8 t0 -150.64 76.42 1.25 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.287 -0.883 . . . . 0.0 109.067 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.1 HG11 HD12 ' A' ' 20' ' ' ILE 0.254 51.5 t -94.4 122.47 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 120.697 -1.252 . . . . 0.0 109.014 -178.719 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.814 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.265 4.4 mt-10 -103.8 145.59 29.87 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -177.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.811 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -140.29 116.15 10.31 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.629 -174.107 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.745 ' CG2' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -116.56 166.04 11.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 O-C-N 120.575 -1.328 . . . . 0.0 111.269 -178.151 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.779 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -98.19 159.89 14.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.117 -0.989 . . . . 0.0 109.666 178.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 1.025 HD11 HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -68.64 -37.44 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.077 -1.014 . . . . 0.0 112.19 -179.266 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.779 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.7 ptm -82.48 -3.81 56.42 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.055 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.771 HG12 ' CG ' ' A' ' 40' ' ' ASP . 13.6 p -112.24 -45.15 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 109.728 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.828 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 4.2 t70 -106.61 50.04 0.78 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.082 -1.011 . . . . 0.0 110.021 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.647 ' HA ' ' CZ ' ' A' ' 8' ' ' PHE 0.286 0.0 OUTLIER -64.01 -3.13 2.34 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 118.571 -1.252 . . . . 0.0 109.442 -177.929 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.953 ' O ' HG23 ' A' ' 49' ' ' ILE . 10.9 pt-20 -52.04 -20.87 2.68 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.491 -0.755 . . . . 0.0 110.088 175.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.907 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -50.36 -58.9 4.66 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.453 -1.405 . . . . 0.0 109.772 -178.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.083 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -61.42 -5.7 1.87 Allowed 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.837 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.953 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -32.44 -39.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 -175.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.832 ' OE1' ' O ' ' A' ' 47' ' ' LYS . 51.4 mp0 -51.34 -53.07 39.78 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.056 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 1.2 ' OH ' HG22 ' A' ' 68' ' ' VAL . 2.4 p90 -124.5 -29.67 3.46 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.884 -1.135 . . . . 0.0 110.26 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.726 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 41.49 11.27 0.01 OUTLIER Glycine 0 N--CA 1.498 2.812 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.681 ' N ' ' O ' ' A' ' 51' ' ' TYR . 8.6 mt -81.13 -71.53 0.47 Allowed 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.52 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -102.4 59.3 0.81 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 -178.258 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 1.083 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.302 . . -103.67 116.2 31.9 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.24 -1.538 . . . . 0.0 109.905 -175.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.025 HG22 HD11 ' A' ' 41' ' ' ILE . 2.1 t -147.1 -66.93 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.472 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.846 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 53.1 Cg_endo -105.67 114.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.176 0 N-CA-C 109.586 -0.967 . . . . 0.0 109.586 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 1.057 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -161.28 175.57 12.14 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.296 1.046 . . . . 0.0 111.521 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.272 HG21 ' CD1' ' A' ' 76' ' ' LEU 0.253 1.1 mp -141.67 144.67 25.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 108.995 179.383 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 1.027 ' HB2' ' HD3' ' A' ' 66' ' ' ARG 0.289 . . -84.93 147.51 26.7 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 -177.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.712 HG23 ' HB2' ' A' ' 79' ' ' ALA 0.39 0.7 OUTLIER -95.42 88.44 2.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 115.315 -2.554 . . . . 0.0 105.233 -175.126 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.819 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.2 OUTLIER -45.77 82.71 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 O-C-N 126.009 2.068 . . . . 0.0 109.094 177.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.819 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 161.99 -43.56 0.37 Allowed Glycine 0 C--N 1.288 -2.088 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.778 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.2 m -126.83 -59.37 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.882 -0.775 . . . . 0.0 111.052 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.778 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 59.8 t -164.04 -104.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 120.393 -1.442 . . . . 0.0 112.194 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 1.027 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 1.9 ttp180 -164.44 164.16 22.05 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 1.057 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -146.05 177.68 8.78 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.925 -1.11 . . . . 0.0 111.118 -177.306 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.2 HG22 ' OH ' ' A' ' 51' ' ' TYR . 96.5 t -88.86 114.39 27.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.686 -0.634 . . . . 0.0 109.978 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.856 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.66 128.72 1.92 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 118.63 -1.748 . . . . 0.0 110.168 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.083 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -93.82 -82.72 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 121.098 -1.236 . . . . 0.0 108.032 177.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 1.083 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 52.8 Cg_endo -83.24 23.19 0.84 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 N-CA-C 108.541 -1.369 . . . . 0.0 108.541 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.553 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -99.59 61.45 1.17 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.445 -0.784 . . . . 0.0 111.334 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.749 ' CB ' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -70.64 -26.75 63.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 0.0 109.926 178.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.604 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.6 tm-20 -50.56 -42.43 55.39 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.249 -0.907 . . . . 0.0 109.32 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.768 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -44.54 -34.81 2.25 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.371 -0.932 . . . . 0.0 108.819 179.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.272 ' CD1' HG21 ' A' ' 59' ' ' ILE . 7.4 mp -64.12 -42.76 96.71 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.809 ' HA ' ' CG1' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.74 -34.15 69.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 109.404 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.778 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -82.38 -30.57 30.17 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.481 -0.762 . . . . 0.0 110.405 178.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.712 ' HB2' HG23 ' A' ' 61' ' ' ILE . . . -73.37 -33.1 64.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.424 -0.798 . . . . 0.0 109.907 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.816 HG22 ' HD3' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -67.46 -42.37 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 0.0 108.756 178.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.43 -23.63 66.32 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.557 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.544 0.0 OUTLIER -100.94 -12.37 18.99 Favored 'General case' 0 C--O 1.198 -1.656 0 C-N-CA 115.357 -2.537 . . . . 0.0 108.838 -177.246 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.819 ' HB2' ' CA ' ' A' ' 63' ' ' GLY 0.251 0.0 OUTLIER -75.35 -54.04 7.73 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 119.517 -1.989 . . . . 0.0 108.454 165.215 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.724 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -79.14 -22.03 45.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.004 -1.06 . . . . 0.0 110.417 179.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 2.1 tp10 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.166 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.769 ' SD ' ' OE2' ' A' ' 83' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 121.925 0.869 . . . . 0.0 110.721 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.011 HG21 ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -79.89 -91.6 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 120.794 -1.191 . . . . 0.0 109.95 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.956 HG11 ' OD2' ' A' ' 24' ' ' ASP . 42.8 t -90.07 111.59 23.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.521 -0.737 . . . . 0.0 110.174 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.762 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 3.5 m-20 -124.1 107.43 11.26 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.786 -1.166 . . . . 0.0 108.679 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.054 ' CG1' HG22 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -123.09 139.55 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 122.059 -0.401 . . . . 0.0 110.58 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 1.191 ' O ' HG23 ' A' ' 59' ' ' ILE . 12.8 tt0 -131.05 121.73 25.53 Favored 'General case' 0 C--N 1.284 -2.241 0 O-C-N 119.163 -2.21 . . . . 0.0 105.844 177.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.913 HG12 ' HB2' ' A' ' 16' ' ' CYS . 26.8 m -113.07 106.23 20.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -176.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.906 ' CE1' ' HA ' ' A' ' 41' ' ' ILE 0.257 6.8 t80 -115.55 89.17 3.04 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.881 -178.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.638 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -131.24 -46.04 1.0 Allowed 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.21 -0.931 . . . . 0.0 109.739 178.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.736 ' HA ' HG22 ' A' ' 41' ' ' ILE . 17.6 t 179.08 147.05 0.39 Allowed Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.451 -0.781 . . . . 0.0 110.924 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.721 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 50.7 Cg_endo -85.44 -26.24 1.41 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 124.317 1.693 . . . . 0.0 110.868 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -77.25 6.41 6.75 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.203 -0.935 . . . . 0.0 110.01 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.512 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -152.2 -171.59 0.28 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.413 -0.804 . . . . 0.0 110.487 179.041 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 13' ' ' CYS . 47.0 Cg_endo -84.93 107.51 1.1 Allowed 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.419 1.413 . . . . 0.0 109.137 177.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.688 ' CE1' ' O ' ' A' ' 10' ' ' SER . 17.1 m-85 -49.85 -82.7 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.584 -0.697 . . . . 0.0 109.14 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 1.049 ' SG ' HD11 ' A' ' 59' ' ' ILE . 35.4 m -155.61 46.65 0.28 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.314 -0.866 . . . . 0.0 109.544 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.749 ' HA ' HD13 ' A' ' 20' ' ' ILE . 48.9 Cg_endo -72.34 24.36 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.973 1.512 . . . . 0.0 111.335 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.416 ' H ' ' C ' ' A' ' 16' ' ' CYS . 6.8 tpt -110.44 -69.09 0.89 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.155 -0.966 . . . . 0.0 110.489 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.766 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -55.98 -19.51 12.77 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.047 -1.033 . . . . 0.0 109.662 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.093 HD12 HG11 ' A' ' 36' ' ' VAL . 13.1 pt -70.72 -40.14 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.682 ' N ' HG13 ' A' ' 20' ' ' ILE . 13.8 tp10 -54.53 -35.87 63.66 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.0 t -68.17 -45.28 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.801 ' CG1' ' HA ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -65.68 -35.53 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.956 ' OD2' HG11 ' A' ' 3' ' ' VAL . 2.4 t70 -67.95 -40.46 83.26 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.717 0.77 . . . . 0.0 109.124 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.479 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.6 OUTLIER -58.42 -46.95 85.45 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.371 0.605 . . . . 0.0 110.371 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.623 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.17 -38.68 51.26 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.935 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.802 ' HD3' HG22 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -74.82 -16.92 60.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.834 -1.166 . . . . 0.0 109.924 -179.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.632 ' CD ' ' OD1' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -73.31 -45.33 56.07 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 176.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.673 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -46.51 -37.06 7.37 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 122.057 0.932 . . . . 0.0 110.051 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.783 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -97.28 -68.09 0.82 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.783 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -84.35 88.97 1.56 Allowed Glycine 0 CA--C 1.544 1.86 0 C-N-CA 118.234 -1.936 . . . . 0.0 110.165 176.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.527 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -40.41 -27.7 0.05 Allowed 'General case' 0 N--CA 1.515 2.78 0 O-C-N 118.573 -2.722 . . . . 0.0 110.58 176.259 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 1.011 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -80.92 151.65 28.46 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.78 -0.575 . . . . 0.0 111.175 179.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.763 HD12 ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -130.2 154.8 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.79 -1.194 . . . . 0.0 110.064 179.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.619 ' O ' ' O ' ' A' ' 3' ' ' VAL . 14.2 t0 -151.74 80.8 1.28 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.093 HG11 HD12 ' A' ' 20' ' ' ILE . 46.5 t -97.44 129.42 47.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.78 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 5.0 mt-10 -108.86 146.02 34.38 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.772 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -142.38 112.24 6.87 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.457 1.122 . . . . 0.0 112.949 -175.231 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.72 ' CG2' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -112.21 164.31 8.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 112.218 -179.652 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.744 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -96.4 162.13 13.62 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.27 -0.894 . . . . 0.0 109.517 179.16 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 1.003 HD11 HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -70.34 -39.49 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.116 -0.99 . . . . 0.0 111.73 -179.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.744 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.6 ptm -80.94 -2.6 48.36 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.929 -1.107 . . . . 0.0 110.972 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.73 HG12 ' CG ' ' A' ' 40' ' ' ASP . 14.9 p -113.23 -44.57 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.072 -1.018 . . . . 0.0 109.948 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.808 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 4.8 t70 -107.38 52.03 0.73 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.454 -0.779 . . . . 0.0 109.083 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.574 ' HA ' ' CZ ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -64.33 -1.98 1.96 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 119.797 -1.814 . . . . 0.0 110.34 -179.135 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.912 ' O ' HG23 ' A' ' 49' ' ' ILE . 10.6 pt-20 -56.16 -21.55 23.48 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.864 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -46.88 -64.3 0.81 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 119.909 -1.744 . . . . 0.0 108.708 179.395 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.052 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -61.63 -6.01 2.25 Favored 'General case' 0 C--O 1.196 -1.72 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.864 -178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.912 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.7 OUTLIER -25.92 -41.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 119.715 -1.866 . . . . 0.0 106.874 176.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.862 ' OE1' ' O ' ' A' ' 47' ' ' LYS . 52.7 mp0 -52.57 -52.45 55.02 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.136 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 1.119 ' OH ' HG22 ' A' ' 68' ' ' VAL . 3.0 p90 -123.81 -32.01 3.35 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.298 -0.876 . . . . 0.0 110.398 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.668 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 45.44 4.32 0.01 OUTLIER Glycine 1 N--CA 1.519 4.172 0 O-C-N 121.37 -0.832 . . . . 0.0 111.786 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.677 ' H ' ' C ' ' A' ' 51' ' ' TYR . 9.5 mt -75.24 -81.12 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 175.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.63 ' O ' ' HE2' ' A' ' 51' ' ' TYR 0.271 0.3 OUTLIER -93.64 66.65 3.82 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.3 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 1.052 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.275 . . -107.46 117.26 33.64 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 119.97 -1.707 . . . . 0.0 110.162 -178.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.003 HG22 HD11 ' A' ' 41' ' ' ILE . 2.1 t -148.89 -63.31 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.055 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.79 ' HD3' ' HB ' ' A' ' 56' ' ' VAL . 59.3 Cg_endo -109.12 117.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.186 0 N-CA-C 109.654 -0.941 . . . . 0.0 109.654 176.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.956 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -163.22 178.46 8.19 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.554 1.169 . . . . 0.0 111.625 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.203 HG21 ' CD1' ' A' ' 76' ' ' LEU 0.258 1.1 mp -142.08 152.7 18.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 1.032 ' HB2' ' HD3' ' A' ' 66' ' ' ARG 0.263 . . -91.37 156.92 17.41 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.796 HG23 ' HB2' ' A' ' 79' ' ' ALA . 0.6 OUTLIER -102.38 91.83 2.12 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.449 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 -175.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.762 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -56.49 85.61 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -176.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.793 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 161.3 -42.83 0.4 Allowed Glycine 0 C--N 1.29 -1.986 0 N-CA-C 108.063 -2.015 . . . . 0.0 108.063 -177.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.699 ' C ' HG23 ' A' ' 65' ' ' VAL . 17.7 m -126.69 -60.82 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.793 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.699 HG23 ' C ' ' A' ' 64' ' ' VAL . 59.8 t -163.61 -99.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 120.758 -1.214 . . . . 0.0 112.565 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 1.032 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 2.0 ttp180 -169.03 162.97 11.23 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.956 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -147.09 173.12 12.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.359 -0.838 . . . . 0.0 111.676 -177.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.119 HG22 ' OH ' ' A' ' 51' ' ' TYR . 66.2 t -84.52 114.76 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.507 -0.746 . . . . 0.0 110.857 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.851 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.87 129.25 2.0 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 118.833 -1.651 . . . . 0.0 110.65 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.029 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -94.91 -81.41 0.02 OUTLIER Pre-proline 0 C--N 1.298 -1.641 0 O-C-N 121.177 -1.19 . . . . 0.0 107.946 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 1.029 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 56.7 Cg_endo -84.64 25.28 0.7 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 N-CA-C 108.831 -1.257 . . . . 0.0 108.831 176.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.544 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -101.53 59.65 0.88 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.426 0.632 . . . . 0.0 110.697 -179.209 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.698 ' HA ' HD13 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -69.3 -29.45 67.3 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.588 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.8 tm-20 -47.26 -42.55 20.8 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.197 -0.94 . . . . 0.0 110.471 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.726 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -45.44 -33.67 2.75 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.287 179.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.203 ' CD1' HG21 ' A' ' 59' ' ' ILE . 7.4 mp -64.7 -43.54 93.14 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.801 ' HA ' ' CG1' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -56.1 -35.84 67.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.275 -0.891 . . . . 0.0 109.526 179.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.737 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -81.39 -33.17 32.43 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.103 0.478 . . . . 0.0 110.062 179.515 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.796 ' HB2' HG23 ' A' ' 61' ' ' ILE . . . -69.91 -34.34 73.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.386 -0.821 . . . . 0.0 111.178 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.802 HG22 ' HD3' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -68.12 -42.86 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.585 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -64.51 -18.16 64.55 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 175.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.534 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.347 0.0 OUTLIER -104.59 -5.48 21.42 Favored 'General case' 0 CA--C 1.477 -1.847 0 CA-C-O 124.702 2.192 . . . . 0.0 109.224 -179.433 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.793 ' HB2' ' CA ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -87.33 -55.55 3.76 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 101.846 -3.39 . . . . 0.0 101.846 176.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.679 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -78.47 -21.77 48.55 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.243 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 2.1 tp10 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.026 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.512 ' SD ' ' OD1' ' A' ' 4' ' ' ASN . 8.6 ttp . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.599 0.714 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.93 HG22 ' N ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -80.38 -95.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.582 0.706 . . . . 0.0 110.291 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.93 ' N ' HG22 ' A' ' 2' ' ' VAL . 53.0 t -90.12 114.9 28.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.416 -0.803 . . . . 0.0 109.397 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.814 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.257 2.8 t-20 -138.28 105.83 5.57 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 117.984 -1.486 . . . . 0.0 107.919 178.428 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.865 ' CG1' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -121.35 139.55 48.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.235 -179.021 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 1.095 ' O ' HD21 ' A' ' 76' ' ' LEU . 6.8 tt0 -132.35 123.17 26.28 Favored 'General case' 0 C--N 1.285 -2.229 0 C-N-CA 116.438 -2.105 . . . . 0.0 105.911 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.064 HG12 ' CD1' ' A' ' 76' ' ' LEU . 3.0 m -113.21 104.18 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.944 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 4.8 t80 -113.5 96.26 5.79 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.28 -177.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.748 ' O ' ' O ' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -126.37 -69.02 0.79 Allowed 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.167 -0.958 . . . . 0.0 108.673 178.18 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.661 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 3.8 p 179.53 152.9 0.57 Allowed Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.273 -0.892 . . . . 0.0 110.793 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.619 ' HA ' ' OH ' ' A' ' 15' ' ' TYR . 50.8 Cg_endo -76.2 -27.33 8.23 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 124.437 1.756 . . . . 0.0 110.175 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.2 m -78.95 -17.0 56.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.678 -0.639 . . . . 0.0 109.949 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.415 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -124.55 179.94 0.99 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.885 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.628 ' O ' ' O ' ' A' ' 15' ' ' TYR . 51.3 Cg_endo -83.31 109.11 1.59 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 124.012 1.532 . . . . 0.0 109.817 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.661 ' CE1' ' O ' ' A' ' 10' ' ' SER . 4.7 m-85 -50.48 -117.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.938 ' CB ' HD11 ' A' ' 59' ' ' ILE . 18.7 m -155.16 40.32 0.13 Allowed Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.833 -1.167 . . . . 0.0 109.896 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.3 Cg_endo -75.76 30.3 0.38 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 O-C-N 123.653 1.344 . . . . 0.0 111.261 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.465 ' HG2' ' HG3' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -109.98 -59.49 1.92 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.969 -1.082 . . . . 0.0 110.713 -179.296 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.86 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -56.19 -19.71 14.82 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.36 -0.838 . . . . 0.0 110.397 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.92 HD12 ' C ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -73.36 -39.93 55.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.486 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.615 ' N ' HD12 ' A' ' 20' ' ' ILE . 14.1 tt0 -53.73 -35.08 60.82 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -68.89 -50.89 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.917 ' CG1' HG21 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -61.66 -33.55 57.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.349 178.567 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.773 ' OD2' HG11 ' A' ' 3' ' ' VAL . 8.4 t0 -66.4 -41.05 89.86 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.726 0.774 . . . . 0.0 109.071 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.482 ' OE1' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -56.88 -48.39 78.28 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.626 0.726 . . . . 0.0 109.317 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.487 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.55 -39.09 47.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.842 -0.536 . . . . 0.0 110.439 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.773 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -72.01 -16.65 62.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.993 -1.067 . . . . 0.0 109.877 -178.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.624 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -73.56 -44.2 58.02 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.608 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.684 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -49.71 -34.23 18.23 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.909 0.861 . . . . 0.0 110.206 179.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.739 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -94.89 -69.06 0.77 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.739 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -83.82 84.86 1.55 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 118.788 -1.672 . . . . 0.0 110.101 177.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.579 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -36.69 -32.07 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.655 0 O-C-N 118.768 -2.607 . . . . 0.0 110.65 177.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.887 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -78.51 151.4 32.57 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.492 178.405 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.776 HD12 ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -129.76 156.05 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.646 -1.283 . . . . 0.0 110.264 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.714 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 25.7 t0 -151.7 80.07 1.28 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.978 HG12 ' NZ ' ' A' ' 38' ' ' LYS . 47.4 t -98.34 129.78 48.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.868 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 11.8 mm-40 -112.4 140.54 47.04 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.978 ' NZ ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -141.82 112.29 7.09 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -175.063 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.935 HD13 ' HB2' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -130.39 163.26 36.54 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 CA-C-O 121.77 0.795 . . . . 0.0 112.496 -179.103 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.645 ' OD1' ' N ' ' A' ' 43' ' ' VAL . 9.6 p-10 -98.69 178.82 4.87 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.277 -0.89 . . . . 0.0 111.379 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 1.037 HD12 HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -69.28 -15.63 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.21 -0.931 . . . . 0.0 109.86 177.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.601 ' HG2' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -89.73 -14.61 34.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.814 -1.179 . . . . 0.0 111.981 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.8 HG11 HG22 ' A' ' 39' ' ' ILE . 8.9 p -113.95 -40.43 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.929 -1.107 . . . . 0.0 110.687 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.784 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 3.8 t70 -111.64 48.83 0.93 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.162 -0.961 . . . . 0.0 108.989 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.561 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 29.9 ttt180 -64.95 -1.08 1.81 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.08 -1.638 . . . . 0.0 109.814 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 1.071 ' O ' HG23 ' A' ' 49' ' ' ILE . 25.8 mm-40 -60.48 -22.98 64.13 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.244 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.856 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 1.1 tptt -45.85 -65.35 0.56 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.274 -1.516 . . . . 0.0 109.147 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.059 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -58.14 -11.18 2.36 Favored 'General case' 0 C--O 1.189 -2.083 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.264 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.108 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.7 pp -23.99 -40.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 119.933 -1.729 . . . . 0.0 107.262 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 1.108 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.9 OUTLIER -56.02 -50.78 69.94 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 115.316 -0.857 . . . . 0.0 108.995 178.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.872 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 3.1 p90 -122.35 -34.24 3.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.729 -0.607 . . . . 0.0 110.292 178.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.724 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 47.64 3.13 0.01 OUTLIER Glycine 0 N--CA 1.514 3.837 0 O-C-N 121.192 -0.943 . . . . 0.0 111.291 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.673 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 4.1 mt -75.45 -80.49 0.09 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.712 ' O ' ' HE2' ' A' ' 51' ' ' TYR 0.255 26.3 mtp -92.02 67.49 5.14 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.863 177.397 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 1.059 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.27 . . -108.9 110.7 22.09 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 120.448 -1.407 . . . . 0.0 109.048 -177.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.037 HG22 HD12 ' A' ' 41' ' ' ILE . 1.0 OUTLIER -149.42 -54.52 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.877 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.942 -179.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.796 ' HB2' ' CA ' ' A' ' 70' ' ' ALA . 59.2 Cg_endo -110.91 106.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.169 1.089 . . . . 0.0 110.212 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.912 ' HB3' ' CD2' ' A' ' 8' ' ' PHE . . . -161.62 179.77 7.91 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.623 -1.626 . . . . 0.0 112.181 -176.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.938 HD11 ' CB ' ' A' ' 16' ' ' CYS 0.264 0.3 OUTLIER -143.87 153.63 15.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 -179.808 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.92 ' HB3' ' CB ' ' A' ' 6' ' ' GLU 0.256 . . -92.16 153.78 19.11 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 101.82 -3.4 . . . . 0.0 101.82 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.62 HG23 ' CB ' ' A' ' 79' ' ' ALA 0.274 2.1 mt -102.66 93.6 2.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 -175.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.814 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.5 OUTLIER -55.6 84.76 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 113.12 -1.855 . . . . 0.0 107.145 -178.082 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.7 ' HA3' ' CB ' ' A' ' 83' ' ' GLU . . . 162.22 -45.8 0.36 Allowed Glycine 0 C--N 1.289 -2.038 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.796 ' O ' HG23 ' A' ' 65' ' ' VAL . 4.6 m -123.33 -61.13 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.447 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.8 HG12 ' N ' ' A' ' 66' ' ' ARG . 73.7 t -165.17 -101.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 O-C-N 120.909 -1.119 . . . . 0.0 112.235 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.901 ' HG3' ' O ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -156.01 166.24 34.05 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.539 -0.725 . . . . 0.0 109.747 -178.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.866 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -149.26 165.19 32.65 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.34 -0.85 . . . . 0.0 111.17 -178.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.652 HG22 ' OH ' ' A' ' 51' ' ' TYR . 94.5 t -81.07 121.09 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.354 -0.841 . . . . 0.0 110.203 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.825 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -164.03 114.18 0.59 Allowed Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.182 -1.485 . . . . 0.0 110.549 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.034 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -91.65 -82.79 0.02 OUTLIER Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 121.578 -0.954 . . . . 0.0 109.034 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 1.034 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 57.0 Cg_endo -84.42 26.52 0.65 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 N-CA-C 107.982 -1.584 . . . . 0.0 107.982 176.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.671 ' CB ' ' OE2' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -112.26 83.42 1.8 Allowed 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.657 ' C ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -82.37 -44.04 16.64 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.86 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -40.05 -30.91 0.1 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.158 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.751 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -49.7 -46.21 49.82 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.296 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.095 HD21 ' O ' ' A' ' 6' ' ' GLU . 27.3 mt -58.15 -43.54 87.4 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.785 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.27 -37.25 74.6 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.09 0.947 . . . . 0.0 109.857 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.64 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 3.2 tt0 -78.28 -30.94 48.76 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.348 -0.845 . . . . 0.0 110.298 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.62 ' CB ' HG23 ' A' ' 61' ' ' ILE . . . -70.15 -38.56 75.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.124 -0.985 . . . . 0.0 111.249 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.917 HG21 ' CG1' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.59 -42.59 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.327 -0.858 . . . . 0.0 108.726 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.64 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -68.46 -22.51 64.57 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.22 177.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.615 ' O ' ' OD1' ' A' ' 82' ' ' ASP 0.312 0.0 OUTLIER -102.1 2.42 37.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 118.232 -2.793 . . . . 0.0 107.114 -177.549 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.7 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -94.14 -59.72 1.9 Allowed 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 103.321 -2.844 . . . . 0.0 103.321 176.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.597 ' SD ' ' HD2' ' A' ' 27' ' ' LYS . 3.3 ptt? -72.05 -17.96 61.98 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.601 177.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.587 ' OXT' ' HA ' ' A' ' 82' ' ' ASP . 3.2 mm-40 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.171 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.697 ' SD ' ' OE2' ' A' ' 83' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.272 0.558 . . . . 0.0 110.184 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.056 HG21 ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -79.95 -90.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.359 -0.838 . . . . 0.0 109.848 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.99 HG11 ' OD2' ' A' ' 24' ' ' ASP . 48.6 t -89.6 110.89 22.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.446 -0.783 . . . . 0.0 111.124 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.846 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 3.9 m-20 -124.02 107.11 10.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.621 -1.3 . . . . 0.0 109.085 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.076 ' CG1' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -121.14 138.22 52.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 O-C-N 121.711 -0.618 . . . . 0.0 111.758 178.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 1.201 ' O ' HG23 ' A' ' 59' ' ' ILE . 12.4 tt0 -130.64 119.78 22.96 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 115.614 -2.434 . . . . 0.0 106.079 177.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.979 HG12 ' HB2' ' A' ' 16' ' ' CYS . 19.5 m -111.48 107.33 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -176.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.871 ' CE1' ' O ' ' A' ' 44' ' ' ASP . 6.3 t80 -116.74 87.28 2.66 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.958 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.673 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -130.14 -46.22 1.12 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.765 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 17.5 t 179.59 148.33 0.45 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.226 -0.921 . . . . 0.0 110.666 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.711 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 50.5 Cg_endo -86.16 -26.31 1.16 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.103 1.581 . . . . 0.0 110.649 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -78.06 8.34 4.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.12 -0.987 . . . . 0.0 109.9 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.55 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -152.38 -171.29 0.27 Allowed Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.62 178.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.55 ' HD2' ' HB3' ' A' ' 13' ' ' CYS . 45.2 Cg_endo -85.05 107.12 1.05 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.742 1.391 . . . . 0.0 109.579 176.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.765 ' CE1' ' O ' ' A' ' 10' ' ' SER . 14.8 m-85 -49.39 -82.79 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.053 -1.029 . . . . 0.0 109.753 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 1.06 ' SG ' HD11 ' A' ' 59' ' ' ILE . 34.8 m -156.08 47.25 0.3 Allowed Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.36 -0.838 . . . . 0.0 109.724 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.767 ' HA ' HD13 ' A' ' 20' ' ' ILE . 47.4 Cg_endo -72.62 24.17 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.031 1.543 . . . . 0.0 111.075 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.427 ' H ' ' C ' ' A' ' 16' ' ' CYS . 6.5 tpt -110.16 -69.66 0.85 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.126 -0.983 . . . . 0.0 110.247 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.792 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -55.02 -20.08 8.43 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.12 -0.988 . . . . 0.0 109.291 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.086 HD12 HG11 ' A' ' 36' ' ' VAL . 12.8 pt -71.28 -40.26 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.0 109.141 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.707 ' N ' HG13 ' A' ' 20' ' ' ILE . 13.8 tp10 -53.79 -35.51 61.44 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.1 t -68.89 -44.73 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.789 0.804 . . . . 0.0 108.872 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.823 ' CG1' ' HB ' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -65.84 -34.48 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 121.681 0.753 . . . . 0.0 109.435 178.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.99 ' OD2' HG11 ' A' ' 3' ' ' VAL . 2.6 t70 -69.55 -38.82 77.61 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.993 0.901 . . . . 0.0 109.57 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.474 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -59.79 -46.3 89.62 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.536 0.684 . . . . 0.0 110.044 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.655 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.74 -39.14 45.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.522 -0.736 . . . . 0.0 111.077 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.815 ' HD3' HG22 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -73.8 -18.04 61.01 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 118.886 -1.126 . . . . 0.0 109.373 -178.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.722 ' CD ' ' OD1' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -72.5 -45.14 60.84 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 176.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.732 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -47.25 -37.16 10.06 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.676 0.75 . . . . 0.0 109.816 179.304 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.817 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -96.99 -65.56 0.96 Allowed 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.414 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.817 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -85.18 84.71 1.59 Allowed Glycine 0 N--CA 1.511 3.66 0 C-N-CA 118.493 -1.813 . . . . 0.0 111.167 176.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.587 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -38.13 -26.73 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.397 0 CA-C-N 121.653 2.727 . . . . 0.0 110.813 177.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 1.056 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -80.09 151.41 29.87 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.514 -0.741 . . . . 0.0 112.459 177.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.816 HD12 ' O ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -130.24 154.02 39.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 120.242 -1.536 . . . . 0.0 109.829 178.47 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.629 ' O ' ' O ' ' A' ' 3' ' ' VAL . 10.4 t0 -151.26 79.18 1.29 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.086 HG11 HD12 ' A' ' 20' ' ' ILE 0.254 44.5 t -96.96 127.26 49.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -178.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.861 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 4.8 mt-10 -108.47 144.58 35.9 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -177.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.807 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.9 112.42 7.85 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -174.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.751 ' CG2' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -112.25 165.5 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.288 -0.965 . . . . 0.0 112.241 -178.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.782 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -97.26 161.38 13.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.134 -0.979 . . . . 0.0 109.739 178.827 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 1.014 HD11 HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -70.08 -38.2 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 111.735 -179.004 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.782 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.4 ptm -80.79 -4.26 53.95 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.251 -0.979 . . . . 0.0 111.245 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.77 HG12 ' CG ' ' A' ' 40' ' ' ASP . 14.1 p -112.34 -44.8 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.139 -0.976 . . . . 0.0 110.138 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.871 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 4.2 t70 -106.91 52.91 0.7 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.068 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.624 ' HA ' ' CZ ' ' A' ' 8' ' ' PHE 0.268 0.0 OUTLIER -66.36 -0.37 2.61 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.56 -1.256 . . . . 0.0 109.557 -178.548 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.982 ' O ' HG23 ' A' ' 49' ' ' ILE . 10.4 pt-20 -55.56 -21.45 17.19 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 177.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.921 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -47.43 -63.62 1.0 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 123.711 1.72 . . . . 0.0 109.057 -178.319 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.134 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -57.75 -10.35 1.61 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.149 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.982 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -26.3 -41.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 O-C-N 119.57 -1.956 . . . . 0.0 107.1 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.896 ' OE1' ' O ' ' A' ' 47' ' ' LYS . 51.3 mp0 -51.95 -53.02 46.16 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.063 176.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 1.19 ' OH ' HG22 ' A' ' 68' ' ' VAL . 2.7 p90 -124.18 -30.0 3.51 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.224 -0.923 . . . . 0.0 110.152 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.744 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 43.31 5.73 0.01 OUTLIER Glycine 0 N--CA 1.506 3.309 0 CA-C-O 122.3 0.944 . . . . 0.0 111.576 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.722 ' N ' ' O ' ' A' ' 51' ' ' TYR . 9.3 mt -75.92 -77.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 175.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.619 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -96.11 64.38 2.34 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.116 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 1.134 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.295 . . -108.04 117.85 35.21 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 117.838 -1.545 . . . . 0.0 109.436 -177.14 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.014 HG22 HD11 ' A' ' 41' ' ' ILE . 2.1 t -148.64 -63.23 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.785 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.546 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.832 ' HD3' ' HB ' ' A' ' 56' ' ' VAL 0.252 56.5 Cg_endo -110.67 116.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 N-CA-C 108.593 -1.349 . . . . 0.0 108.593 177.145 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 1.007 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -161.96 176.28 10.95 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.88 -177.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.268 HG21 ' CD1' ' A' ' 76' ' ' LEU 0.25 1.1 mp -140.76 150.03 20.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.012 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 1.065 ' HB2' ' HD3' ' A' ' 66' ' ' ARG 0.308 . . -89.53 155.58 19.19 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 -178.177 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.799 HG23 ' HB2' ' A' ' 79' ' ' ALA 0.328 0.6 OUTLIER -101.94 93.16 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.918 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 -175.953 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.846 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -52.82 83.29 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 112.814 -1.994 . . . . 0.0 106.407 -178.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.834 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 162.47 -42.79 0.36 Allowed Glycine 0 C--N 1.293 -1.844 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.785 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.5 m -127.41 -59.3 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.808 -0.819 . . . . 0.0 111.035 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.785 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 58.7 t -164.32 -101.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 O-C-N 120.286 -1.509 . . . . 0.0 112.553 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 1.065 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 2.0 ttp180 -166.91 163.73 16.17 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 1.007 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -147.01 175.17 10.89 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.013 -1.054 . . . . 0.0 111.218 -177.188 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.19 HG22 ' OH ' ' A' ' 51' ' ' TYR . 70.3 t -85.58 113.88 24.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.11 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.854 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.08 129.95 2.19 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.063 -2.018 . . . . 0.0 109.903 177.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.101 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -94.84 -81.98 0.02 OUTLIER Pre-proline 0 C--N 1.294 -1.842 0 O-C-N 121.121 -1.223 . . . . 0.0 107.931 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 1.101 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 54.6 Cg_endo -84.34 24.53 0.75 Allowed 'Trans proline' 0 C--N 1.302 -1.904 0 N-CA-C 108.475 -1.394 . . . . 0.0 108.475 177.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.555 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -100.7 59.93 0.96 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.488 -0.757 . . . . 0.0 111.219 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.753 ' CB ' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -68.87 -29.32 67.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.38 -0.825 . . . . 0.0 109.898 178.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.599 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.8 tm-20 -47.71 -43.5 26.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 109.932 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.769 ' CD ' ' CD2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -44.38 -34.69 2.09 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.845 179.691 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.268 ' CD1' HG21 ' A' ' 59' ' ' ILE . 7.4 mp -64.22 -42.96 96.35 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.816 ' HA ' ' CG1' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.01 -35.31 69.09 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.901 0.858 . . . . 0.0 109.356 179.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.783 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -80.93 -32.87 34.45 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.498 -0.752 . . . . 0.0 110.38 178.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.799 ' HB2' HG23 ' A' ' 61' ' ' ILE . . . -70.95 -34.26 71.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.357 -0.839 . . . . 0.0 110.695 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.823 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -66.55 -43.33 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 122.179 0.99 . . . . 0.0 108.79 178.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -65.97 -19.51 65.89 Favored 'General case' 0 C--O 1.196 -1.759 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.042 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.62 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.421 0.0 OUTLIER -104.33 -5.74 21.49 Favored 'General case' 0 C--O 1.251 1.157 0 C-N-CA 116.525 -2.07 . . . . 0.0 105.898 -177.789 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.834 ' HB2' ' CA ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -85.69 -53.82 4.91 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 172.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.734 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -79.12 -21.28 46.81 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.372 -1.455 . . . . 0.0 110.567 -179.57 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 2.1 tp10 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.148 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.487 ' SD ' ' OD1' ' A' ' 4' ' ' ASN . 8.0 ttp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.303 0.573 . . . . 0.0 110.249 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.971 HG22 ' N ' ' A' ' 3' ' ' VAL . 0.9 OUTLIER -81.09 -92.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 0.0 110.412 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.971 ' N ' HG22 ' A' ' 2' ' ' VAL . 55.4 t -92.2 108.83 20.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.703 -0.623 . . . . 0.0 110.644 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.81 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 2.4 t-20 -129.11 106.83 9.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.045 -1.034 . . . . 0.0 109.278 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.888 HG21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.22 138.17 54.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 O-C-N 121.785 -0.572 . . . . 0.0 110.44 178.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 1.082 ' CB ' ' HB3' ' A' ' 60' ' ' ALA . 5.3 tt0 -129.1 107.58 9.7 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 117.483 -1.687 . . . . 0.0 110.016 178.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.092 HG12 ' CD1' ' A' ' 76' ' ' LEU . 2.9 m -96.74 109.78 23.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 122.892 1.329 . . . . 0.0 107.663 -178.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.955 ' HB2' HD13 ' A' ' 39' ' ' ILE . 2.2 t80 -118.53 90.01 3.24 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.041 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.664 HG23 ' HA ' ' A' ' 57' ' ' PRO . 0.6 OUTLIER -120.92 -68.59 0.89 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.53 -0.731 . . . . 0.0 109.66 178.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.756 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 3.8 p 179.65 154.4 0.64 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 110.682 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.657 ' N ' ' HB2' ' A' ' 40' ' ' ASP . 49.8 Cg_endo -76.94 -27.16 7.23 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.11 1.584 . . . . 0.0 110.468 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -79.58 -16.1 56.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.89 . . . . 0.0 109.924 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.486 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -125.0 -179.51 0.88 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 109.951 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.656 ' O ' ' O ' ' A' ' 15' ' ' TYR . 50.9 Cg_endo -83.5 108.07 1.46 Allowed 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.96 1.505 . . . . 0.0 110.319 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.756 ' CE1' ' O ' ' A' ' 10' ' ' SER . 4.8 m-85 -49.71 -117.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.932 . . . . 0.0 109.899 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.986 ' CB ' HD11 ' A' ' 59' ' ' ILE . 19.2 m -155.68 40.46 0.13 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.16 -0.962 . . . . 0.0 110.278 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.3 Cg_endo -76.0 30.07 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.961 1.506 . . . . 0.0 111.195 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.457 ' HG2' ' HG3' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -110.21 -59.37 1.95 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.816 -1.178 . . . . 0.0 110.671 -179.491 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.941 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -55.92 -19.3 11.59 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.272 -0.893 . . . . 0.0 109.894 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.986 HD12 ' C ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -75.22 -39.48 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.832 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.654 ' N ' HD12 ' A' ' 20' ' ' ILE . 14.6 tt0 -53.35 -33.19 52.55 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.372 -0.83 . . . . 0.0 108.98 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -71.77 -46.94 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 109.385 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.974 ' CG1' HG21 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -66.14 -26.91 39.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.473 -0.767 . . . . 0.0 109.246 178.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.839 ' OD2' HG11 ' A' ' 3' ' ' VAL . 8.7 t0 -73.69 -39.25 64.51 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.53 ' OE1' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -57.92 -46.14 85.44 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.419 179.303 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.504 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -80.12 -40.21 27.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.553 -0.717 . . . . 0.0 110.061 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.764 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -68.42 -21.82 64.64 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.198 -179.165 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.67 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -69.61 -44.47 70.64 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.058 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.786 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -48.97 -39.65 27.37 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.869 0.843 . . . . 0.0 109.116 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.786 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.69 -57.98 2.68 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.382 -0.824 . . . . 0.0 109.23 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.734 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -95.92 77.87 0.79 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.258 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.568 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -32.9 -26.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 119.272 1.536 . . . . 0.0 110.726 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.941 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -85.3 153.13 22.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.535 -0.728 . . . . 0.0 110.889 177.779 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.824 HD12 ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -129.59 154.91 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.823 -1.173 . . . . 0.0 110.93 178.146 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.636 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 26.2 t0 -150.2 74.86 1.21 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.491 -0.756 . . . . 0.0 109.393 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.991 HG12 ' NZ ' ' A' ' 38' ' ' LYS . 40.5 t -93.03 119.13 40.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 120.938 -1.101 . . . . 0.0 110.348 -178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.826 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 11.6 mm-40 -102.44 141.68 34.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.958 -1.089 . . . . 0.0 108.919 -178.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.991 ' NZ ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -140.93 120.68 13.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.511 -0.743 . . . . 0.0 111.728 -174.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.955 HD13 ' HB2' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -137.38 169.81 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.035 -1.04 . . . . 0.0 110.109 -178.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.662 ' OD2' ' HG2' ' A' ' 42' ' ' MET . 7.9 p-10 -106.3 175.57 5.45 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.533 -0.729 . . . . 0.0 110.756 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 1.02 HD12 HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -66.97 -9.58 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.975 -1.078 . . . . 0.0 111.09 177.23 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.662 ' HG2' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -95.25 -16.9 22.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 110.732 -179.695 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.846 HG11 HG22 ' A' ' 39' ' ' ILE . 8.7 p -112.69 -40.64 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.146 -0.971 . . . . 0.0 110.055 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.796 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 3.1 t70 -111.06 45.57 1.16 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.863 . . . . 0.0 110.361 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.653 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.272 30.9 ttt180 -62.69 -3.76 1.68 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.528 -178.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 1.068 ' O ' HG23 ' A' ' 49' ' ' ILE . 21.8 mm-40 -57.54 -18.68 20.51 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.347 -0.846 . . . . 0.0 110.63 175.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.87 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -51.86 -56.74 12.2 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.381 1.086 . . . . 0.0 110.292 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.103 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -62.35 -5.39 2.4 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.255 176.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.225 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.4 pp -34.58 -39.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 -174.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 1.225 ' N ' HD12 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -53.15 -51.49 61.82 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.038 177.592 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.853 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.1 p90 -123.56 -29.77 3.71 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.921 -1.112 . . . . 0.0 110.495 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.764 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 41.41 12.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.236 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.736 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.1 mt -84.09 -67.32 0.8 Allowed 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 122.767 1.27 . . . . 0.0 107.826 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.511 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 25.7 mtp -103.57 57.15 0.74 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.465 -1.243 . . . . 0.0 107.815 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 1.103 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.266 . . -99.75 108.34 20.64 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.863 1.316 . . . . 0.0 111.011 -176.173 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.02 HG22 HD12 ' A' ' 41' ' ' ILE . 0.9 OUTLIER -146.81 -59.65 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.29 -179.565 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.802 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 45.1 Cg_endo -103.1 105.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.257 1.135 . . . . 0.0 110.447 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.95 ' HB3' ' CD2' ' A' ' 8' ' ' PHE . . . -160.59 -178.04 6.61 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.963 0.887 . . . . 0.0 111.632 -176.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.986 HD11 ' CB ' ' A' ' 16' ' ' CYS . 0.3 OUTLIER -149.11 141.56 17.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.781 -0.574 . . . . 0.0 109.66 -179.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 1.082 ' HB3' ' CB ' ' A' ' 6' ' ' GLU 0.253 . . -82.0 137.86 35.03 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 117.207 -1.797 . . . . 0.0 107.021 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.731 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.395 1.7 mt -90.0 85.85 2.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 125.433 2.539 . . . . 0.0 106.266 -174.457 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.81 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.7 OUTLIER -43.55 83.34 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 112.231 -2.259 . . . . 0.0 108.439 177.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.752 ' HA3' ' CB ' ' A' ' 83' ' ' GLU . . . 162.02 -47.57 0.35 Allowed Glycine 0 N--CA 1.483 1.782 0 N-CA-C 106.783 -2.527 . . . . 0.0 106.783 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.847 ' O ' HG23 ' A' ' 65' ' ' VAL . 4.2 m -123.15 -60.03 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.745 -0.856 . . . . 0.0 111.232 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 64' ' ' VAL . 75.6 t -164.78 -104.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 120.454 -1.404 . . . . 0.0 112.001 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.839 ' N ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -154.46 165.24 37.02 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.638 -0.664 . . . . 0.0 109.956 -179.065 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.882 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.64 172.98 12.48 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.035 -1.041 . . . . 0.0 110.94 -179.351 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.681 HG22 ' OH ' ' A' ' 51' ' ' TYR . 77.1 t -88.67 120.04 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.536 -0.727 . . . . 0.0 109.286 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.839 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.18 114.33 0.6 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.198 -1.477 . . . . 0.0 110.66 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.074 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -91.91 -83.75 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 120.848 -1.383 . . . . 0.0 108.79 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 1.074 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 48.3 Cg_endo -81.61 19.24 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 N-CA-C 108.145 -1.521 . . . . 0.0 108.145 177.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.748 ' CB ' ' OE2' ' A' ' 75' ' ' GLU 0.278 0.6 OUTLIER -105.68 83.09 1.88 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 117.993 -1.483 . . . . 0.0 109.2 179.699 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.744 ' C ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -81.39 -41.11 22.43 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.31 177.425 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.941 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -43.26 -29.33 0.39 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.001 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.819 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -49.69 -45.98 49.49 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.508 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.092 ' CD1' HG12 ' A' ' 7' ' ' VAL . 28.8 mt -58.82 -42.49 89.31 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.423 -0.798 . . . . 0.0 109.188 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.805 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.54 -34.88 73.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.494 -0.754 . . . . 0.0 110.209 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.633 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 3.4 tt0 -80.95 -26.78 36.39 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.697 -0.627 . . . . 0.0 110.358 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.519 ' CB ' HG23 ' A' ' 61' ' ' ILE . . . -75.22 -37.4 61.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -0.944 . . . . 0.0 109.773 -178.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.974 HG21 ' CG1' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.9 -39.37 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.043 -1.036 . . . . 0.0 109.344 178.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.633 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -72.93 -28.55 62.51 Favored 'General case' 0 C--O 1.258 1.552 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.668 ' HA ' ' OXT' ' A' ' 85' ' ' GLU 0.556 0.0 OUTLIER -95.6 -8.85 33.8 Favored 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 114.2 -3.0 . . . . 0.0 109.582 -178.186 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.752 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -71.35 -61.51 1.74 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 118.414 -2.679 . . . . 0.0 111.432 162.619 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.67 ' SD ' ' HD2' ' A' ' 27' ' ' LYS . 3.5 ptt? -71.55 -20.64 62.0 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.499 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.668 ' OXT' ' HA ' ' A' ' 82' ' ' ASP . 3.2 mm-40 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.227 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.488 ' SD ' ' OD1' ' A' ' 4' ' ' ASN . 7.9 ttp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.25 0.548 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.979 HG22 ' N ' ' A' ' 3' ' ' VAL . 0.9 OUTLIER -81.05 -94.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 109.854 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.979 ' N ' HG22 ' A' ' 2' ' ' VAL . 53.3 t -89.6 111.64 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.568 -0.707 . . . . 0.0 110.296 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.791 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.349 2.4 t-20 -135.4 107.57 7.21 Favored 'General case' 0 C--O 1.189 -2.123 0 CA-C-O 125.404 2.526 . . . . 0.0 107.24 177.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.892 HG21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -118.19 136.72 54.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 116.352 -1.785 . . . . 0.0 111.921 179.568 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 1.077 ' CB ' ' HB3' ' A' ' 60' ' ' ALA 0.48 5.8 tt0 -133.77 124.38 26.5 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 127.31 3.433 . . . . 0.0 101.919 174.069 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 1.089 HG12 ' CD1' ' A' ' 76' ' ' LEU 0.397 10.3 m -113.78 110.42 32.09 Favored 'Isoleucine or valine' 0 C--O 1.168 -3.208 0 O-C-N 116.613 -3.804 . . . . 0.0 101.483 -177.034 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.944 ' HB2' HD13 ' A' ' 39' ' ' ILE 0.306 1.7 t80 -117.28 96.68 5.53 Favored 'General case' 0 C--N 1.377 1.776 0 CA-C-N 110.611 -2.995 . . . . 0.0 108.663 -178.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.672 HG23 ' HA ' ' A' ' 57' ' ' PRO . 0.7 OUTLIER -124.53 -69.22 0.81 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.89 -1.131 . . . . 0.0 108.653 178.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.757 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 3.8 p 179.6 154.35 0.63 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.967 . . . . 0.0 110.713 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.652 ' HA ' ' OH ' ' A' ' 15' ' ' TYR . 50.1 Cg_endo -76.96 -27.06 7.29 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.146 1.603 . . . . 0.0 110.458 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -79.71 -16.04 56.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.873 . . . . 0.0 109.954 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.487 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -125.01 -179.44 0.86 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.347 -0.846 . . . . 0.0 109.915 179.691 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.654 ' O ' ' O ' ' A' ' 15' ' ' TYR . 52.0 Cg_endo -83.58 108.06 1.44 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.963 1.507 . . . . 0.0 110.367 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.757 ' CE1' ' O ' ' A' ' 10' ' ' SER . 5.0 m-85 -49.77 -117.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 109.788 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.986 ' CB ' HD11 ' A' ' 59' ' ' ILE . 19.2 m -155.54 40.27 0.13 Allowed Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.113 -0.992 . . . . 0.0 110.348 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.3 Cg_endo -75.98 30.12 0.39 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.926 1.487 . . . . 0.0 111.183 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.455 ' HG2' ' HG3' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -110.14 -59.32 1.95 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.901 -1.124 . . . . 0.0 110.728 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.903 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -56.42 -18.5 11.37 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.063 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.988 HD12 ' C ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -75.72 -39.15 38.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.851 179.572 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.655 ' N ' HD12 ' A' ' 20' ' ' ILE . 14.5 tt0 -52.98 -34.25 55.19 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 108.757 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -70.73 -49.11 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.425 -0.797 . . . . 0.0 109.271 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.968 ' CG1' HG21 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -58.95 -35.55 57.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-O 122.707 1.241 . . . . 0.0 109.305 176.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.841 ' OD2' HG11 ' A' ' 3' ' ' VAL . 7.8 t0 -68.42 -41.57 80.18 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 122.848 1.308 . . . . 0.0 108.918 -178.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.53 ' OE1' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -56.19 -48.03 77.18 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.464 179.483 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.507 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -78.15 -39.68 40.24 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.854 0.835 . . . . 0.0 111.188 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.768 ' CB ' HG22 ' A' ' 3' ' ' VAL 0.288 0.0 OUTLIER -72.59 -16.13 61.74 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 117.17 -1.812 . . . . 0.0 109.013 -178.193 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.672 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -72.43 -43.25 64.08 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.735 ' HG3' ' N ' ' A' ' 30' ' ' PHE 0.287 0.0 OUTLIER -52.54 -32.59 41.41 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.765 179.794 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.769 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -94.42 -69.46 0.75 Allowed 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 102.954 -2.98 . . . . 0.0 102.954 -179.275 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.746 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -75.29 65.8 2.32 Favored Glycine 0 C--N 1.27 -3.111 1 CA-C-O 113.33 -4.039 . . . . 0.0 117.337 176.161 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.585 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -31.06 -29.61 0.01 OUTLIER 'General case' 0 C--N 1.254 -3.563 1 CA-C-N 124.806 4.303 . . . . 0.0 110.286 -175.408 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.946 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -74.73 149.53 39.78 Favored 'General case' 0 C--N 1.278 -2.52 0 O-C-N 120.132 -1.605 . . . . 0.0 113.903 174.076 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.821 HD12 ' O ' ' A' ' 33' ' ' LYS 0.262 0.4 OUTLIER -131.05 156.42 42.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 120.854 1.661 . . . . 0.0 110.589 174.793 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.68 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 26.2 t0 -151.22 79.19 1.3 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.983 HG12 ' NZ ' ' A' ' 38' ' ' LYS 0.351 61.9 t -100.63 127.41 53.75 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.94 0 CA-C-O 125.916 2.77 . . . . 0.0 104.764 -177.65 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.871 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.424 9.2 mm-40 -111.91 146.17 38.24 Favored 'General case' 0 C--O 1.183 -2.418 0 C-N-CA 113.685 -3.206 . . . . 0.0 103.99 -176.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.983 ' NZ ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -139.45 107.47 5.72 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 115.221 -2.323 . . . . 0.0 115.777 -170.036 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.944 HD13 ' HB2' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -131.72 166.87 27.72 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.556 0 CA-C-N 122.949 2.613 . . . . 0.0 112.311 -179.283 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.663 ' OD2' ' HG2' ' A' ' 42' ' ' MET . 4.0 p-10 -98.27 175.64 6.0 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.57 -1.331 . . . . 0.0 113.464 177.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 1.019 HD12 HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -64.63 -13.94 15.25 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.065 0 O-C-N 121.066 -1.021 . . . . 0.0 111.317 174.723 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.663 ' HG2' ' OD2' ' A' ' 40' ' ' ASP 0.379 0.0 OUTLIER -100.88 -5.07 26.62 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 115.276 -2.57 . . . . 0.0 110.538 -177.251 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.849 HG11 HG22 ' A' ' 39' ' ' ILE . 7.5 p -117.13 -41.11 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.967 -1.083 . . . . 0.0 109.048 177.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.786 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 3.1 t70 -111.56 46.69 1.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 110.254 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.708 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.378 30.3 ttt180 -66.2 -0.08 2.32 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 116.518 -2.073 . . . . 0.0 108.922 -177.754 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 1.052 ' O ' HG23 ' A' ' 49' ' ' ILE . 18.8 mm-40 -53.12 -26.71 17.55 Favored 'General case' 0 C--N 1.287 -2.142 0 O-C-N 120.785 -1.197 . . . . 0.0 109.831 172.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.88 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -48.28 -61.0 2.22 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.571 -1.331 . . . . 0.0 109.343 -176.091 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.026 ' CB ' ' HB2' ' A' ' 55' ' ' ALA 0.359 . . -54.3 -12.55 0.68 Allowed 'General case' 0 C--N 1.266 -3.054 0 C-N-CA 125.677 1.591 . . . . 0.0 112.053 176.101 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.229 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.5 pp -33.13 -39.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.79 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -172.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 1.229 ' N ' HD12 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -53.13 -51.6 61.42 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.251 176.522 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.846 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.1 p90 -123.44 -29.51 3.78 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.049 -1.032 . . . . 0.0 110.582 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.793 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.41 16.37 0.01 OUTLIER Glycine 0 N--CA 1.487 2.092 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.736 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.4 mt -87.55 -75.01 0.42 Allowed 'General case' 0 C--N 1.262 -3.197 0 N-CA-C 103.136 -2.912 . . . . 0.0 103.136 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.48 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 26.7 mtp -98.95 65.01 1.46 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.804 -1.544 . . . . 0.0 108.46 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 1.026 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.451 . . -110.98 112.48 24.33 Favored 'General case' 0 C--O 1.168 -3.184 1 CA-C-O 128.612 4.053 . . . . 0.0 105.685 -175.308 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.019 HG22 HD12 ' A' ' 41' ' ' ILE . 0.9 OUTLIER -148.32 -51.33 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.511 0 CA-C-N 110.476 -3.056 . . . . 0.0 112.15 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.839 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.473 19.3 Cg_endo -117.67 111.82 0.01 OUTLIER 'Trans proline' 0 C--O 1.148 -3.988 1 CA-C-O 130.685 4.369 . . . . 0.0 103.704 -179.756 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.934 ' HB3' ' CD2' ' A' ' 8' ' ' PHE . . . -160.88 178.32 9.53 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 109.578 -3.465 . . . . 0.0 111.405 -174.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.986 HD11 ' CB ' ' A' ' 16' ' ' CYS 0.26 0.3 OUTLIER -144.94 151.28 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.746 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 1.077 ' HB3' ' CB ' ' A' ' 6' ' ' GLU 0.503 . . -96.02 147.66 23.47 Favored 'General case' 0 C--O 1.187 -2.193 2 N-CA-C 98.196 -4.742 . . . . 0.0 98.196 -178.257 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.754 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.654 2.2 mt -99.68 96.55 5.02 Favored 'Isoleucine or valine' 0 C--N 1.408 3.112 3 C-N-CA 108.539 -5.264 . . . . 0.0 98.644 -170.689 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.791 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.6 OUTLIER -50.29 85.6 0.0 OUTLIER 'General case' 0 C--N 1.379 1.851 1 CA-C-N 107.205 -4.543 . . . . 0.0 107.516 177.499 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.757 ' HA3' ' CB ' ' A' ' 83' ' ' GLU . . . 161.95 -47.87 0.35 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 106.734 -2.546 . . . . 0.0 106.734 -178.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.844 ' O ' HG23 ' A' ' 65' ' ' VAL . 4.2 m -122.94 -59.86 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.72 -0.871 . . . . 0.0 111.468 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 64' ' ' VAL . 76.1 t -164.48 -104.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.264 -1.523 . . . . 0.0 111.827 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.837 ' N ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -153.89 166.11 33.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.703 -0.623 . . . . 0.0 110.111 -179.067 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.879 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -147.64 169.51 19.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.029 -1.044 . . . . 0.0 110.878 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.687 HG22 ' OH ' ' A' ' 51' ' ' TYR . 97.2 t -81.74 118.79 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.874 -1.141 . . . . 0.0 111.667 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.837 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.77 114.13 0.59 Allowed Glycine 0 C--N 1.281 -2.504 0 CA-C-N 120.595 1.543 . . . . 0.0 110.698 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.066 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -92.03 -83.08 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.754 0 O-C-N 120.742 -1.446 . . . . 0.0 109.04 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 1.066 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 43.1 Cg_endo -86.0 28.89 0.54 Allowed 'Trans proline' 0 C--N 1.318 -1.041 0 N-CA-C 107.894 -1.618 . . . . 0.0 107.894 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.746 ' CB ' ' OE2' ' A' ' 75' ' ' GLU 0.644 0.4 OUTLIER -120.76 95.02 4.54 Favored 'General case' 0 C--O 1.164 -3.427 2 C-N-CA 108.815 -5.154 . . . . 0.0 100.585 179.121 . . . . . . . . 5 4 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.727 ' C ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -83.15 -43.89 15.68 Favored 'General case' 0 C--N 1.371 1.537 1 CA-C-N 108.204 -4.089 . . . . 0.0 109.057 174.7 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.903 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -39.85 -32.33 0.15 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.811 -1.18 . . . . 0.0 108.504 178.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.818 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -49.36 -45.43 45.73 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.173 -179.272 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.089 ' CD1' HG12 ' A' ' 7' ' ' VAL . 29.3 mt -58.55 -42.99 89.14 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.786 0.803 . . . . 0.0 109.36 178.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.803 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.68 -36.85 74.84 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.261 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.626 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 3.6 tt0 -74.05 -35.01 64.27 Favored 'General case' 0 C--N 1.286 -2.165 0 O-C-N 120.775 -1.203 . . . . 0.0 110.624 178.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.486 ' CB ' HG23 ' A' ' 61' ' ' ILE . . . -72.6 -37.6 68.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.821 -1.175 . . . . 0.0 110.222 -175.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.968 HG21 ' CG1' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.5 -42.87 97.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 121.056 -1.027 . . . . 0.0 109.168 178.047 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.626 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -70.48 -25.84 63.35 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 120.776 -1.203 . . . . 0.0 109.843 178.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.797 ' HA ' ' OXT' ' A' ' 85' ' ' GLU 1.012 0.0 OUTLIER -108.61 15.03 24.09 Favored 'General case' 0 C--O 1.302 3.828 2 C-N-CA 104.258 -6.977 . . . . 0.0 101.538 -176.267 . . . . . . . . 5 4 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.757 ' CB ' ' HA3' ' A' ' 63' ' ' GLY 0.258 0.0 OUTLIER -89.52 -59.45 2.21 Favored 'General case' 0 C--N 1.314 -0.966 1 O-C-N 113.892 -5.505 . . . . 0.0 104.468 164.096 . . . . . . . . 5 4 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.67 ' SD ' ' HD2' ' A' ' 27' ' ' LYS 0.26 3.6 ptt? -73.42 -16.18 61.33 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.599 -1.24 . . . . 0.0 111.091 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.797 ' OXT' ' HA ' ' A' ' 82' ' ' ASP . 3.1 mm-40 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.81 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.623 ' HE3' ' OE2' ' A' ' 83' ' ' GLU . 2.8 ttp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.308 0.575 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.006 HG22 HG23 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -89.65 -91.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.401 -0.812 . . . . 0.0 110.438 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.006 HG23 HG22 ' A' ' 2' ' ' VAL . 79.0 t -91.13 111.93 24.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 O-C-N 121.811 -0.556 . . . . 0.0 110.665 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.806 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 1.9 m-80 -126.73 113.64 16.93 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.993 HD12 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -133.47 133.74 57.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.396 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 1.012 ' HB3' ' HB3' ' A' ' 60' ' ' ALA 0.277 0.0 OUTLIER -127.93 110.58 12.69 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 116.755 -1.978 . . . . 0.0 109.454 176.472 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.922 HG22 ' HA ' ' A' ' 38' ' ' LYS 0.255 33.3 m -99.51 100.64 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 124.107 1.908 . . . . 0.0 108.388 -177.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.899 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -116.98 95.0 4.8 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.617 -178.086 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.656 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 38.2 m -120.5 -79.78 0.61 Allowed 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.073 -1.017 . . . . 0.0 109.648 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.62 ' C ' ' OD1' ' A' ' 40' ' ' ASP . 0.2 OUTLIER 179.55 155.53 0.66 Allowed Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.853 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.699 ' HG3' ' CE ' ' A' ' 42' ' ' MET . 47.4 Cg_endo -73.95 -12.62 23.9 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 124.142 1.601 . . . . 0.0 110.465 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 12' ' ' THR . 0.5 OUTLIER -79.45 0.75 28.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.066 -1.021 . . . . 0.0 109.86 179.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.547 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -157.47 -170.25 0.24 Allowed Pre-proline 0 N--CA 1.485 1.317 0 O-C-N 121.625 -0.672 . . . . 0.0 110.132 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.643 ' O ' ' O ' ' A' ' 15' ' ' TYR . 55.2 Cg_endo -84.6 118.02 2.12 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.751 1.395 . . . . 0.0 110.735 175.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.752 ' CE1' ' OD1' ' A' ' 40' ' ' ASP . 2.7 m-85 -49.54 -113.94 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.381 -0.825 . . . . 0.0 109.773 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 1.179 ' SG ' HD11 ' A' ' 59' ' ' ILE . 33.4 m -155.0 39.91 0.13 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.163 -0.961 . . . . 0.0 110.329 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.952 ' HA ' HD13 ' A' ' 20' ' ' ILE . 55.4 Cg_endo -75.75 27.17 0.39 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.715 1.376 . . . . 0.0 111.192 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.739 ' CG ' ' CD ' ' A' ' 73' ' ' ARG . 0.1 OUTLIER -110.11 -63.22 1.4 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.947 -1.095 . . . . 0.0 110.583 -179.275 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.834 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -54.27 -21.43 9.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.284 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.993 ' HB ' HD12 ' A' ' 5' ' ' ILE . 2.6 pt -66.77 -42.19 88.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.489 0.662 . . . . 0.0 109.228 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.567 ' N ' ' CG1' ' A' ' 20' ' ' ILE . 2.5 tm-20 -54.16 -33.94 59.21 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.66 -41.42 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.785 0.802 . . . . 0.0 109.077 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -68.59 -30.06 46.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 121.667 0.746 . . . . 0.0 109.362 178.228 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.702 ' OD1' ' CG1' ' A' ' 34' ' ' ILE . 5.9 t70 -73.98 -38.09 64.26 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -45.55 88.3 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.699 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.529 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.65 -40.5 29.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.561 -0.712 . . . . 0.0 110.173 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.898 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -70.78 -20.54 62.59 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.943 -1.103 . . . . 0.0 109.567 -178.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.68 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -69.07 -47.88 64.17 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 176.261 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.749 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -45.64 -41.29 10.07 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.94 0.876 . . . . 0.0 109.21 179.02 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.749 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -90.63 -61.32 1.7 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 121.358 -0.839 . . . . 0.0 108.946 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.694 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -94.11 78.78 0.98 Allowed Glycine 0 N--CA 1.485 1.931 0 CA-C-O 118.805 -0.997 . . . . 0.0 111.413 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.538 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -35.58 -24.05 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 120.418 2.109 . . . . 0.0 111.164 -179.628 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.942 ' O ' HG21 ' A' ' 2' ' ' VAL . 6.6 mtpt -83.52 154.52 23.81 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.699 -0.625 . . . . 0.0 111.44 176.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.914 HD12 ' O ' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -127.97 157.41 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 118.839 -1.144 . . . . 0.0 111.072 177.449 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.596 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 7.2 t70 -150.38 64.31 0.95 Allowed 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.987 HG11 HD12 ' A' ' 20' ' ' ILE . 31.3 t -92.66 117.84 36.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 118.799 -1.161 . . . . 0.0 109.824 -178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.802 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.273 3.1 mt-10 -101.56 147.57 26.25 Favored 'General case' 0 C--O 1.195 -1.793 0 CA-C-O 122.474 1.13 . . . . 0.0 108.728 -177.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.922 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.74 119.25 13.05 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.172 -0.955 . . . . 0.0 112.019 -173.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.018 HD12 ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -130.4 178.41 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -0.962 . . . . 0.0 110.667 -178.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.752 ' OD1' ' CE1' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -109.28 179.55 4.12 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.637 -0.664 . . . . 0.0 111.401 176.023 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.882 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -61.76 -54.0 40.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.128 -0.982 . . . . 0.0 112.104 173.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.709 ' N ' HG22 ' A' ' 41' ' ' ILE . 5.2 ptp -71.71 0.28 9.2 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.427 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.742 HG21 HG22 ' A' ' 39' ' ' ILE . 1.1 m -111.9 -45.19 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 109.814 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 1.018 ' HB2' HD12 ' A' ' 39' ' ' ILE . 9.7 t70 -114.54 45.55 1.53 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.339 -0.851 . . . . 0.0 109.839 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.517 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.288 0.0 OUTLIER -67.99 -5.57 17.95 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.41 -1.316 . . . . 0.0 110.225 -178.411 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 1.026 ' O ' HG23 ' A' ' 49' ' ' ILE . 4.4 mt-10 -56.82 -18.93 14.71 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.312 -0.868 . . . . 0.0 110.471 173.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.843 ' HB3' ' CE2' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -49.92 -61.17 2.29 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 122.891 1.329 . . . . 0.0 110.306 -178.272 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.972 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -58.62 -4.93 0.48 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.84 177.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.164 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.2 pp -35.99 -41.62 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 -173.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 1.164 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.9 OUTLIER -50.43 -52.95 33.24 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.897 177.059 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.84 ' OH ' HG22 ' A' ' 68' ' ' VAL . 45.6 p90 -118.93 -36.86 3.33 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.088 -1.007 . . . . 0.0 110.354 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.766 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.96 14.0 0.01 OUTLIER Glycine 0 N--CA 1.495 2.584 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.701 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 42.7 mt -82.69 -63.3 1.4 Allowed 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 123.231 1.491 . . . . 0.0 109.256 177.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.454 ' C ' ' HE2' ' A' ' 51' ' ' TYR . 19.3 mtm -109.55 53.88 0.68 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.969 -1.468 . . . . 0.0 109.516 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.972 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.311 . . -103.52 124.44 48.77 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 117.821 -1.552 . . . . 0.0 111.117 -173.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.808 ' HA ' ' CG1' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -147.92 -60.74 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.408 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.656 -177.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.782 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.267 45.1 Cg_endo -108.14 113.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 CA-C-O 123.446 1.352 . . . . 0.0 110.334 177.814 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 1.111 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -161.39 178.6 9.01 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.223 -175.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.252 HG21 ' CD1' ' A' ' 76' ' ' LEU . 1.2 mp -147.47 143.8 19.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.771 -0.58 . . . . 0.0 109.762 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 1.012 ' HB3' ' HB3' ' A' ' 6' ' ' GLU 0.285 . . -82.74 143.07 31.14 Favored 'General case' 0 CA--C 1.487 -1.446 0 C-N-CA 115.912 -2.315 . . . . 0.0 109.092 -179.107 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.705 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.404 1.0 OUTLIER -91.09 87.5 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.731 0 CA-C-O 125.493 2.568 . . . . 0.0 107.478 -174.319 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.806 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.6 OUTLIER -42.28 80.61 0.0 OUTLIER 'General case' 0 C--O 1.2 -1.502 0 CA-C-N 112.601 -2.09 . . . . 0.0 109.618 177.296 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.782 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 161.33 -48.34 0.37 Allowed Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.56 -2.216 . . . . 0.0 107.56 -177.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.811 ' O ' HG23 ' A' ' 65' ' ' VAL . 4.9 m -120.16 -59.73 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.763 -0.845 . . . . 0.0 110.922 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 64' ' ' VAL . 74.5 t -164.64 -104.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.436 -1.415 . . . . 0.0 111.923 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.964 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 2.1 ttp180 -164.39 164.11 22.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.642 -0.661 . . . . 0.0 109.309 -178.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 1.111 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.1 -176.49 5.11 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.939 -1.101 . . . . 0.0 111.75 -176.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.84 HG22 ' OH ' ' A' ' 51' ' ' TYR . 79.5 t -94.63 114.98 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.83 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.85 125.16 1.35 Allowed Glycine 0 N--CA 1.49 2.282 0 C-N-CA 118.918 -1.611 . . . . 0.0 110.688 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.089 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -92.92 -79.8 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.047 -1.267 . . . . 0.0 108.326 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 1.089 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 54.0 Cg_endo -81.65 20.9 0.99 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.35 1.184 . . . . 0.0 109.355 177.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.602 ' OG ' ' HA3' ' A' ' 69' ' ' GLY . 1.5 p -98.55 64.67 1.55 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.362 -0.836 . . . . 0.0 111.378 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.739 ' CD ' ' CG ' ' A' ' 18' ' ' MET . 0.1 OUTLIER -73.93 -35.89 64.62 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.171 -0.955 . . . . 0.0 109.318 178.716 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.543 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -48.92 -37.42 19.85 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.049 -1.032 . . . . 0.0 109.236 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.74 ' CD ' ' CD2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -47.09 -36.86 8.75 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.515 -0.874 . . . . 0.0 108.83 179.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.252 ' CD1' HG21 ' A' ' 59' ' ' ILE . 8.9 mp -61.44 -44.74 96.59 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 177.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.789 ' HA ' ' CG1' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -56.85 -34.41 67.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.459 -0.776 . . . . 0.0 109.859 178.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -77.96 -31.75 51.0 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.684 -0.635 . . . . 0.0 109.708 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.426 ' HB2' HG23 ' A' ' 61' ' ' ILE . . . -68.56 -49.15 61.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.458 -0.776 . . . . 0.0 109.655 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.779 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 1.9 mp -51.96 -35.5 18.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 120.949 -1.094 . . . . 0.0 108.695 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.562 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 8.1 t-20 -68.1 -27.5 66.53 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.575 ' OD2' HG11 ' A' ' 64' ' ' VAL 0.553 37.8 t0 -95.25 -21.62 18.33 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 113.374 -3.33 . . . . 0.0 106.329 -177.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.782 ' HB2' ' CA ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -68.64 -46.1 70.08 Favored 'General case' 0 C--N 1.288 -2.076 0 O-C-N 119.504 -1.997 . . . . 0.0 108.916 170.054 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.804 ' CE ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -78.9 -23.38 44.84 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.484 178.378 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.489 ' O ' ' O ' ' A' ' 81' ' ' ASN . 11.3 tp10 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.289 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.583 ' SD ' ' OD1' ' A' ' 4' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.211 0.529 . . . . 0.0 110.232 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.953 HG21 ' O ' ' A' ' 33' ' ' LYS . 1.6 p -89.44 -96.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 0.0 110.265 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.999 HG11 ' OD1' ' A' ' 24' ' ' ASP . 55.4 t -92.17 119.55 39.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.453 -0.779 . . . . 0.0 110.18 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.751 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -135.78 111.78 9.58 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 123.082 1.42 . . . . 0.0 109.194 179.245 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.055 ' HB ' HG13 ' A' ' 36' ' ' VAL . 4.1 mt -126.05 133.48 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.115 -0.991 . . . . 0.0 109.965 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 1.145 ' CB ' ' HB3' ' A' ' 60' ' ' ALA 0.272 15.3 tt0 -125.28 101.81 7.15 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 116.963 -1.895 . . . . 0.0 109.17 178.599 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.827 ' CG2' ' CB ' ' A' ' 38' ' ' LYS 0.251 29.0 m -97.66 111.33 27.24 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.438 0 CA-C-O 123.734 1.73 . . . . 0.0 107.621 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.911 ' CD2' ' HB3' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -118.55 90.57 3.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.01 -1.056 . . . . 0.0 109.342 -178.448 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.667 ' OG1' ' HA ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -121.35 -72.92 0.67 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.355 -0.841 . . . . 0.0 110.322 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.876 ' HA ' HG22 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -170.66 149.49 2.96 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.02 -1.05 . . . . 0.0 110.85 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.745 ' N ' ' HB3' ' A' ' 40' ' ' ASP . 46.4 Cg_endo -75.67 -28.91 7.71 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 124.019 1.536 . . . . 0.0 110.153 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.59 -15.02 58.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.859 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.644 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -124.95 -179.69 0.92 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.388 -0.82 . . . . 0.0 109.875 179.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.644 ' HD2' ' SG ' ' A' ' 13' ' ' CYS . 51.2 Cg_endo -83.56 111.12 1.74 Allowed 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.999 1.526 . . . . 0.0 110.417 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.762 ' CE1' ' O ' ' A' ' 10' ' ' SER . 17.9 m-85 -49.53 -111.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.908 . . . . 0.0 109.685 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.96 ' SG ' HD11 ' A' ' 59' ' ' ILE . 26.3 m -155.09 39.39 0.11 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.149 -0.97 . . . . 0.0 110.308 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.4 Cg_endo -76.18 23.07 0.48 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.84 1.442 . . . . 0.0 110.92 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.718 ' HB3' ' CD ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -103.18 -66.79 0.92 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.049 -1.032 . . . . 0.0 110.889 -179.292 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.968 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -55.14 -21.87 14.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.276 -0.89 . . . . 0.0 109.84 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.034 ' CD1' HD13 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -72.67 -39.45 60.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.504 -0.747 . . . . 0.0 109.533 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.673 ' N ' HD12 ' A' ' 20' ' ' ILE . 1.6 tt0 -49.17 -31.9 9.24 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 15.5 t -69.42 -45.59 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.534 -0.729 . . . . 0.0 109.386 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.905 HG13 HG21 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -68.9 -28.56 40.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.312 -0.868 . . . . 0.0 109.366 178.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.999 ' OD1' HG11 ' A' ' 3' ' ' VAL . 16.6 t0 -76.09 -36.71 58.82 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -58.75 -44.04 90.42 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.644 0.735 . . . . 0.0 109.381 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.497 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.54 -40.99 28.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.51 -0.744 . . . . 0.0 110.164 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.792 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -67.09 -23.35 65.84 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.932 -1.107 . . . . 0.0 109.082 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.801 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.82 -45.63 70.71 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.365 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.797 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -49.43 -40.3 36.03 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.797 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.9 -56.32 3.28 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.829 ' HA3' HG23 ' A' ' 2' ' ' VAL . . . -96.18 78.47 0.76 Allowed Glycine 0 N--CA 1.489 2.173 0 O-C-N 121.398 -0.813 . . . . 0.0 111.378 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.532 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -36.96 -21.62 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 119.309 1.555 . . . . 0.0 110.3 -179.468 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.953 ' O ' HG21 ' A' ' 2' ' ' VAL . 27.3 mtmm -85.06 154.6 21.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -0.999 . . . . 0.0 111.145 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.801 ' CD1' ' CG ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -129.28 150.21 34.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 118.883 -1.127 . . . . 0.0 111.048 178.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.618 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -150.43 68.49 0.97 Allowed 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.479 -0.763 . . . . 0.0 109.159 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.055 HG13 ' HB ' ' A' ' 5' ' ' ILE . 65.6 t -91.92 118.37 37.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 122.413 1.102 . . . . 0.0 109.519 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.806 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.267 8.6 mm-40 -100.13 131.01 46.33 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 123.321 1.534 . . . . 0.0 108.185 -178.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 1.067 ' C ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -139.56 122.1 16.23 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.753 -1.217 . . . . 0.0 111.559 -176.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.067 HD13 ' C ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -136.72 -163.54 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 122.31 1.052 . . . . 0.0 111.129 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.937 ' OD1' HG11 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -110.96 170.82 7.85 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.792 179.183 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 1.273 ' CD1' HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -65.86 -54.33 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.593 -0.692 . . . . 0.0 111.548 177.474 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.629 ' H ' HG23 ' A' ' 41' ' ' ILE . 6.4 ptm -65.26 -1.56 2.41 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.016 -1.073 . . . . 0.0 110.985 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.937 HG11 ' OD1' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -112.08 -48.9 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.018 -1.051 . . . . 0.0 110.705 178.063 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.724 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 3.0 t70 -105.9 48.51 0.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.954 . . . . 0.0 110.086 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.644 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.288 6.4 ttt-85 -63.35 -7.21 5.88 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 118.086 -1.445 . . . . 0.0 109.662 -178.554 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.983 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.3 mm-40 -51.33 -19.94 1.51 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.157 -0.964 . . . . 0.0 110.159 176.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.841 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -51.8 -58.72 5.61 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 122.188 0.994 . . . . 0.0 109.815 -179.399 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.057 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -62.88 -1.94 1.04 Allowed 'General case' 0 C--N 1.276 -2.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.68 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.983 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -35.34 -42.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 104.027 -2.582 . . . . 0.0 104.027 -176.383 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.503 ' N ' ' C ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -48.93 -51.33 30.78 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.195 176.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 1.261 ' OH ' HG22 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -125.93 -32.54 2.78 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.107 -0.996 . . . . 0.0 110.432 179.124 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.813 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 61.07 -33.52 0.05 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.804 HD12 ' H ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -49.57 -81.43 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.644 -1.503 . . . . 0.0 109.858 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.804 ' H ' HD12 ' A' ' 53' ' ' LEU . 24.7 mtt -79.45 54.3 1.7 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.401 -0.812 . . . . 0.0 108.944 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 1.057 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.288 . . -99.61 103.52 15.23 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 124.006 1.86 . . . . 0.0 110.174 -177.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.273 HG22 ' CD1' ' A' ' 41' ' ' ILE . 4.9 t -146.63 -72.86 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.414 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.801 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.829 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 51.4 Cg_endo -95.3 112.15 0.15 Allowed 'Trans proline' 0 C--O 1.197 -1.541 0 CA-C-O 123.872 1.53 . . . . 0.0 109.893 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 1.006 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -160.82 179.27 8.65 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.425 -1.422 . . . . 0.0 111.792 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.96 HD11 ' SG ' ' A' ' 16' ' ' CYS 0.253 0.3 OUTLIER -142.48 133.48 24.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.078 179.334 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 1.145 ' HB3' ' CB ' ' A' ' 6' ' ' GLU . . . -81.42 141.31 34.05 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 116.935 -1.906 . . . . 0.0 106.215 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.772 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.433 0.7 OUTLIER -90.09 86.75 2.6 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.69 0 C-N-CA 114.73 -2.788 . . . . 0.0 105.421 -175.576 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.751 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -44.31 82.34 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 112.634 -2.076 . . . . 0.0 108.76 177.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.772 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.49 -44.1 0.35 Allowed Glycine 0 N--CA 1.483 1.805 0 N-CA-C 107.207 -2.357 . . . . 0.0 107.207 -178.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.76 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.2 m -126.18 -59.01 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.537 -0.978 . . . . 0.0 111.302 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.76 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 93.2 t -163.59 -108.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 120.306 -1.496 . . . . 0.0 112.358 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.786 ' CZ ' ' HB2' ' A' ' 60' ' ' ALA . 3.5 ttt180 -165.14 164.64 20.21 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.769 -0.582 . . . . 0.0 109.653 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 1.006 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -144.95 177.01 9.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.92 -1.112 . . . . 0.0 111.177 -178.11 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.261 HG22 ' OH ' ' A' ' 51' ' ' TYR . 78.9 t -88.66 116.0 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.832 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.836 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.68 123.57 1.19 Allowed Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.72 -1.228 . . . . 0.0 110.447 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.115 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -93.9 -78.26 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 120.868 -1.372 . . . . 0.0 108.662 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 1.115 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 54.6 Cg_endo -79.26 20.39 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.654 1.344 . . . . 0.0 109.254 178.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.732 ' O ' HD13 ' A' ' 59' ' ' ILE 0.3 2.3 p -103.88 81.78 1.91 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 124.024 1.869 . . . . 0.0 109.989 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 1.196 ' O ' HD12 ' A' ' 76' ' ' LEU . 24.9 mtt180 -79.57 -36.12 38.68 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.643 -1.286 . . . . 0.0 110.03 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.968 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.5 tt0 -50.48 -25.35 3.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.319 -0.863 . . . . 0.0 109.726 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.781 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -53.67 -46.39 70.6 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.351 -0.843 . . . . 0.0 109.207 -179.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.196 HD12 ' O ' ' A' ' 73' ' ' ARG . 0.7 OUTLIER -60.18 -42.19 94.5 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.009 178.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.826 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.09 -33.95 69.64 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.399 -0.813 . . . . 0.0 109.78 179.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.766 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 31.5 tt0 -81.58 -27.75 34.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 110.146 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.606 ' CB ' ' HA ' ' A' ' 61' ' ' ILE . . . -74.47 -38.07 63.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.637 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.905 HG21 HG13 ' A' ' 23' ' ' VAL . 1.8 mp -63.35 -39.8 86.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.144 -0.972 . . . . 0.0 108.985 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.67 ' ND2' ' O ' ' A' ' 78' ' ' GLU . 0.1 OUTLIER -74.96 -33.12 61.86 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.244 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 78' ' ' GLU 0.523 0.1 OUTLIER -91.34 -3.26 56.95 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 113.54 -3.264 . . . . 0.0 107.125 -178.814 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.758 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -82.26 -59.58 2.5 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 119.672 -1.893 . . . . 0.0 109.816 169.589 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.674 ' SD ' ' HD2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.94 -13.48 62.47 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.405 179.525 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.494 ' N ' ' HG2' ' A' ' 84' ' ' MET . 2.7 tm-20 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.196 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.582 ' SD ' ' OD1' ' A' ' 4' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.252 0.549 . . . . 0.0 110.211 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.955 HG21 ' O ' ' A' ' 33' ' ' LYS . 1.6 p -89.53 -97.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.842 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.003 HG11 ' OD1' ' A' ' 24' ' ' ASP . 53.2 t -89.51 121.69 39.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.343 -0.848 . . . . 0.0 109.987 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.747 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.292 0.2 OUTLIER -140.17 111.26 7.02 Favored 'General case' 0 C--O 1.19 -2.076 0 CA-C-O 125.057 2.361 . . . . 0.0 108.135 178.23 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.045 ' HB ' HG13 ' A' ' 36' ' ' VAL . 4.2 mt -121.63 133.85 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.195 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 1.151 ' CB ' ' HB3' ' A' ' 60' ' ' ALA 0.371 16.4 tt0 -129.11 111.12 12.62 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 115.218 -2.593 . . . . 0.0 105.063 177.026 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.829 ' CG2' ' CB ' ' A' ' 38' ' ' LYS 0.352 15.0 m -108.86 111.17 34.89 Favored 'Isoleucine or valine' 0 C--O 1.177 -2.748 0 CA-C-O 126.761 3.172 . . . . 0.0 103.822 -178.425 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.909 ' CD2' ' HB3' ' A' ' 58' ' ' ALA 0.277 0.4 OUTLIER -117.27 94.74 4.68 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 111.947 -2.388 . . . . 0.0 108.532 -178.608 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.668 ' OG1' ' HA ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -124.02 -69.84 0.79 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.095 -1.003 . . . . 0.0 110.601 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.885 ' HA ' HG22 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -174.96 146.83 1.0 Allowed Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 120.876 -1.14 . . . . 0.0 110.734 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.744 ' N ' ' HB3' ' A' ' 40' ' ' ASP . 50.7 Cg_endo -73.78 -29.01 10.93 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 O-C-N 123.802 1.422 . . . . 0.0 110.565 -178.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.63 -14.95 58.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.381 -0.824 . . . . 0.0 109.884 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.645 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -124.94 -179.65 0.91 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.388 -0.82 . . . . 0.0 109.846 179.732 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.645 ' HD2' ' SG ' ' A' ' 13' ' ' CYS . 51.8 Cg_endo -83.69 111.14 1.71 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.958 1.504 . . . . 0.0 110.444 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.765 ' CE1' ' O ' ' A' ' 10' ' ' SER . 18.1 m-85 -49.59 -111.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 109.606 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.96 ' SG ' HD11 ' A' ' 59' ' ' ILE . 26.7 m -155.06 39.4 0.12 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.17 -0.957 . . . . 0.0 110.353 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.4 Cg_endo -76.2 23.12 0.48 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.84 1.442 . . . . 0.0 110.95 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.719 ' HB3' ' CD ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -103.24 -66.64 0.93 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.049 -1.032 . . . . 0.0 110.85 -179.293 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.942 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -55.53 -21.34 16.47 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.284 -0.885 . . . . 0.0 109.898 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.035 ' CD1' HD13 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -73.0 -39.23 57.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.598 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.672 ' N ' HD12 ' A' ' 20' ' ' ILE . 1.6 tt0 -48.91 -32.66 9.34 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.434 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 16.4 t -68.54 -47.37 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.659 0.742 . . . . 0.0 109.279 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.898 HG13 HG21 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -64.07 -34.45 68.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-O 122.476 1.131 . . . . 0.0 109.513 177.451 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 1.003 ' OD1' HG11 ' A' ' 3' ' ' VAL . 15.2 t0 -71.66 -39.01 70.59 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 122.78 1.276 . . . . 0.0 108.949 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -57.24 -45.31 84.06 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.569 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.5 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -78.28 -40.5 36.81 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.782 0.801 . . . . 0.0 110.808 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.793 ' CB ' HG22 ' A' ' 3' ' ' VAL 0.252 0.0 OUTLIER -70.23 -19.19 63.16 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 117.627 -1.629 . . . . 0.0 108.904 -178.715 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.801 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -70.9 -44.75 65.59 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.763 ' HG3' ' N ' ' A' ' 30' ' ' PHE 0.26 0.0 OUTLIER -51.92 -35.44 45.63 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.411 179.246 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.776 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -92.54 -66.33 0.93 Allowed 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 104.098 -2.556 . . . . 0.0 104.098 -179.731 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.951 ' HA3' HG23 ' A' ' 2' ' ' VAL . . . -81.05 72.43 2.74 Favored Glycine 0 C--N 1.279 -2.623 0 CA-C-O 115.402 -2.888 . . . . 0.0 115.87 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.546 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -36.28 -23.97 0.01 OUTLIER 'General case' 0 C--N 1.262 -3.218 0 CA-C-N 123.092 3.446 . . . . 0.0 110.183 -177.546 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.955 ' O ' HG21 ' A' ' 2' ' ' VAL . 29.1 mtmm -77.35 152.55 34.4 Favored 'General case' 0 C--N 1.284 -2.281 0 O-C-N 120.263 -1.523 . . . . 0.0 113.384 175.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.801 ' CD1' ' CG ' ' A' ' 28' ' ' LYS 0.259 0.3 OUTLIER -130.66 151.37 35.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 C-N-CA 118.366 -1.334 . . . . 0.0 110.547 176.014 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.643 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -151.27 71.95 1.03 Allowed 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.045 HG13 ' HB ' ' A' ' 5' ' ' ILE 0.307 84.2 t -97.38 125.19 50.54 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.596 0 CA-C-O 124.556 2.122 . . . . 0.0 105.635 -177.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.822 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.413 7.3 mm-40 -109.37 133.53 52.94 Favored 'General case' 0 C--O 1.179 -2.625 0 CA-C-O 126.326 2.965 . . . . 0.0 104.438 -177.09 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 1.044 ' C ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -138.24 114.08 9.89 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.36 -1.745 . . . . 0.0 113.95 -173.145 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.044 HD13 ' C ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -133.88 -165.12 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 121.874 2.125 . . . . 0.0 111.835 179.468 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.936 ' OD1' HG11 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -104.54 172.14 6.95 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 178.398 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 1.271 ' CD1' HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -68.25 -55.21 17.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 121.387 -0.821 . . . . 0.0 110.644 176.581 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.646 ' H ' HG23 ' A' ' 41' ' ' ILE . 6.3 ptm -64.27 -0.46 1.26 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 118.612 -1.235 . . . . 0.0 111.594 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.936 HG11 ' OD1' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -113.09 -49.12 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.086 -1.009 . . . . 0.0 110.195 178.341 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.724 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 2.9 t70 -106.34 51.01 0.76 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 109.646 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.728 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.472 6.0 ttt-85 -71.26 2.27 4.96 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 115.044 -2.663 . . . . 0.0 108.711 -176.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.983 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.2 mm-40 -52.51 -23.87 7.05 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 120.348 -1.47 . . . . 0.0 109.108 172.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.869 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -49.18 -63.14 1.19 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.941 -1.099 . . . . 0.0 109.012 -178.161 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.999 ' CB ' ' HB2' ' A' ' 55' ' ' ALA 0.414 . . -51.42 -13.91 0.25 Allowed 'General case' 0 C--N 1.256 -3.485 0 C-N-CA 126.886 2.075 . . . . 0.0 111.555 175.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.983 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -30.75 -43.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 104.824 -2.287 . . . . 0.0 104.824 -172.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.56 ' N ' ' C ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -49.14 -51.37 32.64 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.186 176.414 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 1.261 ' OH ' HG22 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -125.89 -32.6 2.79 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.013 -1.054 . . . . 0.0 110.408 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.814 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 60.99 -33.36 0.05 OUTLIER Glycine 0 N--CA 1.488 2.139 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.805 HD12 ' H ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -49.6 -81.42 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.608 -1.525 . . . . 0.0 109.851 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.805 ' H ' HD12 ' A' ' 53' ' ' LEU . 24.7 mtt -80.28 58.92 3.22 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.999 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.394 . . -106.91 106.14 16.52 Favored 'General case' 0 C--O 1.179 -2.622 0 CA-C-O 126.912 3.244 . . . . 0.0 107.154 -176.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.271 HG22 ' CD1' ' A' ' 41' ' ' ILE . 4.8 t -147.77 -64.58 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.435 0 CA-C-N 112.149 -2.296 . . . . 0.0 112.84 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.848 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.449 18.0 Cg_endo -109.41 116.81 0.03 OUTLIER 'Trans proline' 0 C--O 1.157 -3.527 0 CA-C-O 129.507 3.878 . . . . 0.0 103.921 -179.544 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 1.003 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -160.85 177.54 10.3 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 110.639 -2.982 . . . . 0.0 111.646 -175.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.96 HD11 ' SG ' ' A' ' 16' ' ' CYS 0.294 0.2 OUTLIER -141.52 141.15 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.874 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 1.151 ' HB3' ' CB ' ' A' ' 6' ' ' GLU 0.399 . . -91.7 149.89 21.4 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 100.551 -3.87 . . . . 0.0 100.551 -177.225 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.772 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.728 1.1 mt -101.57 101.39 12.05 Favored 'Isoleucine or valine' 0 C--N 1.412 3.299 3 C-N-CA 107.032 -5.867 . . . . 0.0 97.379 -172.237 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.747 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -53.93 84.7 0.0 OUTLIER 'General case' 0 C--N 1.38 1.929 1 CA-C-N 106.549 -4.841 . . . . 0.0 106.888 178.083 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.772 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.24 -44.12 0.36 Allowed Glycine 0 N--CA 1.483 1.793 0 N-CA-C 107.176 -2.37 . . . . 0.0 107.176 -178.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.758 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.1 m -126.16 -59.15 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 O-C-N 121.503 -0.998 . . . . 0.0 111.311 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.758 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 93.8 t -163.1 -106.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 120.326 -1.484 . . . . 0.0 112.901 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.851 ' CZ ' ' HB2' ' A' ' 60' ' ' ALA . 3.4 ttt180 -167.74 163.58 14.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.676 -0.64 . . . . 0.0 109.397 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 1.003 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.53 174.4 11.2 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.848 -1.157 . . . . 0.0 111.268 -177.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.261 HG22 ' OH ' ' A' ' 51' ' ' TYR . 59.3 t -83.42 115.12 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.888 -1.133 . . . . 0.0 111.406 177.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.834 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.91 123.4 1.17 Allowed Glycine 0 C--N 1.281 -2.524 0 CA-C-N 119.755 1.161 . . . . 0.0 110.491 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.111 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -93.9 -76.74 0.03 OUTLIER Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 120.772 -1.428 . . . . 0.0 109.194 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 1.111 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 41.7 Cg_endo -83.23 24.93 0.71 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 N-CA-C 108.339 -1.447 . . . . 0.0 108.339 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.729 ' O ' HD13 ' A' ' 59' ' ' ILE 0.449 1.5 p -109.63 87.95 2.63 Favored 'General case' 0 N--CA 1.506 2.372 0 C-N-CA 113.829 -3.149 . . . . 0.0 106.577 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 1.195 ' O ' HD12 ' A' ' 76' ' ' LEU . 24.8 mtt180 -79.77 -40.38 28.84 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 112.871 -1.968 . . . . 0.0 109.201 175.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.942 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.4 tt0 -46.41 -28.22 1.29 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.025 -1.047 . . . . 0.0 109.835 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.778 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -53.12 -46.16 68.62 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.24 -0.912 . . . . 0.0 109.34 -178.537 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.195 HD12 ' O ' ' A' ' 73' ' ' ARG . 0.7 OUTLIER -60.0 -42.53 94.47 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.147 178.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.825 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.39 -34.99 69.44 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.821 179.364 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.774 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 31.1 tt0 -78.77 -31.32 46.08 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.031 -1.043 . . . . 0.0 110.216 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.637 ' CB ' ' HA ' ' A' ' 61' ' ' ILE . . . -73.07 -38.26 66.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.092 -1.005 . . . . 0.0 110.002 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.898 HG21 HG13 ' A' ' 23' ' ' VAL . 1.8 mp -61.61 -42.47 94.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.099 -1.001 . . . . 0.0 108.906 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.668 ' ND2' ' O ' ' A' ' 78' ' ' GLU . 0.1 OUTLIER -72.24 -33.52 67.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.961 -1.087 . . . . 0.0 109.604 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 78' ' ' GLU 0.596 0.1 OUTLIER -94.01 0.82 56.22 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 112.027 -3.869 . . . . 0.0 105.573 -177.411 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.76 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -85.95 -59.81 2.19 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 119.546 -1.971 . . . . 0.0 107.841 170.598 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.674 ' SD ' ' HD2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.69 -12.67 61.68 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.737 179.656 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.491 ' N ' ' HG2' ' A' ' 84' ' ' MET . 2.7 tm-20 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.066 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.645 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.314 0.578 . . . . 0.0 110.224 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.029 HG22 ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -90.13 -91.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 0.0 109.976 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.185 HG11 ' OD2' ' A' ' 24' ' ' ASP . 74.1 t -89.22 111.03 22.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.627 -0.671 . . . . 0.0 110.633 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.841 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 1.0 OUTLIER -130.95 105.68 7.91 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.639 -1.224 . . . . 0.0 108.794 178.031 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.053 HG21 ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -120.7 137.37 54.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.031 179.425 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 1.037 ' HB3' ' HB3' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -131.01 119.77 22.51 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 119.057 -2.277 . . . . 0.0 107.389 177.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.968 HG22 ' HA ' ' A' ' 38' ' ' LYS . 23.0 m -105.64 144.78 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.982 ' CD2' ' HB3' ' A' ' 58' ' ' ALA . 2.1 t80 -141.0 79.52 1.7 Allowed 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 119.01 -1.076 . . . . 0.0 112.663 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.698 ' OG1' ' HA ' ' A' ' 15' ' ' TYR . 3.5 m -118.06 -68.64 0.9 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 118.852 -2.405 . . . . 0.0 110.238 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.774 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 1.3 p 179.61 164.61 0.79 Allowed Pre-proline 0 C--N 1.294 -1.843 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.732 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.666 ' HD3' ' CG ' ' A' ' 40' ' ' ASP . 49.8 Cg_endo -80.35 -28.3 3.03 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.278 1.673 . . . . 0.0 110.418 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -18.25 54.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 109.762 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.07 174.49 3.82 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.457 -0.777 . . . . 0.0 109.723 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.652 ' O ' ' O ' ' A' ' 15' ' ' TYR . 50.8 Cg_endo -83.18 114.53 2.21 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.925 1.487 . . . . 0.0 110.437 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.774 ' CE1' ' O ' ' A' ' 10' ' ' SER . 16.5 m-85 -49.22 -112.38 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.132 -0.98 . . . . 0.0 109.576 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.736 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 92.9 m -150.6 37.46 0.13 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.267 -0.895 . . . . 0.0 110.131 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.736 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 53.7 Cg_endo -76.49 17.16 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.021 1.538 . . . . 0.0 111.042 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.553 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -95.1 -68.04 0.82 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.012 -1.055 . . . . 0.0 110.752 -179.461 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.782 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -54.28 -22.51 12.05 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.23 -0.919 . . . . 0.0 109.53 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.053 ' HB ' HG21 ' A' ' 5' ' ' ILE . 5.2 pt -70.67 -39.25 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.507 -0.746 . . . . 0.0 109.623 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.734 ' N ' HG13 ' A' ' 20' ' ' ILE . 6.2 tt0 -48.83 -33.05 9.79 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 3.1 t -72.01 -46.73 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.896 HG21 ' HB ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -62.26 -31.86 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.03 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 1.185 ' OD2' HG11 ' A' ' 3' ' ' VAL . 5.2 t70 -69.45 -39.88 77.5 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.01 0.91 . . . . 0.0 109.196 178.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -46.01 84.81 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.617 0.722 . . . . 0.0 109.674 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.485 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.68 -40.05 42.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.669 -0.645 . . . . 0.0 110.614 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.904 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -69.95 -19.37 63.38 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.124 -1.03 . . . . 0.0 109.208 -179.057 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.799 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -72.52 -44.99 61.44 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.154 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.744 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -50.32 -33.39 19.99 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.851 0.834 . . . . 0.0 110.279 179.494 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.787 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -97.01 -65.79 0.94 Allowed 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 179.639 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.749 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -84.64 82.16 1.7 Allowed Glycine 0 N--CA 1.506 3.323 0 C-N-CA 119.182 -1.485 . . . . 0.0 111.427 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.593 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -35.43 -28.43 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 CA-C-N 121.463 2.631 . . . . 0.0 110.68 178.57 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.837 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -80.0 154.95 27.87 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.498 -0.751 . . . . 0.0 111.686 178.065 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.799 ' CD1' ' CG ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -129.66 151.48 35.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 O-C-N 120.353 -1.467 . . . . 0.0 110.048 178.646 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.598 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -151.3 76.78 1.23 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.943 HG22 ' CD1' ' A' ' 5' ' ' ILE 0.255 55.4 t -96.65 126.98 49.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -178.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 1.021 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.251 78.1 mt-10 -111.24 135.43 51.79 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -177.617 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.968 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -129.49 128.92 43.85 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -176.716 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.066 HG22 ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -135.08 171.66 17.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 O-C-N 120.132 -1.605 . . . . 0.0 111.516 178.642 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.767 ' OD1' HG22 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -102.72 170.8 7.79 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.803 0.811 . . . . 0.0 111.757 178.246 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.892 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -61.87 -37.39 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.425 -1.422 . . . . 0.0 109.332 178.489 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.678 ' HG3' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -82.37 -3.09 54.85 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.935 -1.103 . . . . 0.0 111.252 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.066 ' CG2' HG22 ' A' ' 39' ' ' ILE . 2.0 m -114.24 -46.18 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.055 -1.028 . . . . 0.0 109.755 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.937 ' HB2' HD12 ' A' ' 39' ' ' ILE . 1.6 t70 -104.97 40.98 1.4 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.237 -0.914 . . . . 0.0 109.627 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.607 ' NH2' ' HA3' ' A' ' 52' ' ' GLY 0.283 0.0 OUTLIER -65.69 -0.35 2.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.494 -1.379 . . . . 0.0 109.435 -178.823 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 1.148 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.3 mm-40 -62.54 -22.68 66.5 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.867 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -46.38 -66.55 0.39 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.965 -1.084 . . . . 0.0 108.422 -179.075 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.145 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -57.23 -7.63 0.58 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.666 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.225 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.6 pp -26.35 -41.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 O-C-N 119.163 -2.21 . . . . 0.0 106.573 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 1.225 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -52.92 -53.75 44.86 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.998 177.183 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.899 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 25.8 p90 -119.86 -32.8 4.14 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.132 -0.98 . . . . 0.0 109.984 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.722 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 42.38 8.82 0.01 OUTLIER Glycine 0 N--CA 1.502 3.08 0 CA-C-O 122.124 0.847 . . . . 0.0 111.474 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.715 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 4.6 mt -75.55 -81.08 0.08 Allowed 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 175.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.525 ' C ' ' HE2' ' A' ' 51' ' ' TYR . 4.0 mtp -95.74 63.66 2.42 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.443 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 1.145 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.273 . . -107.38 120.26 41.68 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 119.489 -2.007 . . . . 0.0 110.356 -177.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.816 ' CG2' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -148.76 -57.98 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.481 -178.709 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.816 ' HD3' ' CG2' ' A' ' 56' ' ' VAL . 59.1 Cg_endo -109.81 109.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 CA-C-O 122.892 1.122 . . . . 0.0 110.323 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 1.011 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -161.88 173.88 13.92 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.186 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.038 ' CG1' HD21 ' A' ' 76' ' ' LEU 0.253 0.3 OUTLIER -134.6 151.94 32.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 120.876 -1.14 . . . . 0.0 107.997 179.296 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 1.037 ' HB3' ' HB3' ' A' ' 6' ' ' GLU 0.297 . . -91.15 155.3 18.72 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.749 HG13 ' N ' ' A' ' 66' ' ' ARG 0.31 1.2 mt -101.29 91.29 2.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 -175.713 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.841 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -51.63 83.04 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 112.834 -1.984 . . . . 0.0 106.807 -178.369 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.714 ' HA3' ' HB2' ' A' ' 83' ' ' GLU . . . 162.41 -44.02 0.36 Allowed Glycine 0 C--N 1.29 -2.027 0 N-CA-C 107.733 -2.147 . . . . 0.0 107.733 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.821 ' O ' HG23 ' A' ' 65' ' ' VAL . 11.6 m -126.67 -58.97 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.903 -0.763 . . . . 0.0 111.139 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 64' ' ' VAL . 81.9 t -163.73 -101.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 120.338 -1.476 . . . . 0.0 112.955 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 1.016 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 1.8 ttp180 -167.17 160.09 13.5 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.444 -0.785 . . . . 0.0 109.343 -177.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 1.011 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -146.09 176.05 10.02 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.11 -0.994 . . . . 0.0 111.702 -177.236 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.816 ' CG2' ' HZ1' ' A' ' 47' ' ' LYS . 79.0 t -83.42 118.96 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.708 -0.62 . . . . 0.0 110.246 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.834 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.5 107.88 0.33 Allowed Glycine 0 N--CA 1.494 2.516 0 C-N-CA 118.536 -1.792 . . . . 0.0 110.386 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.124 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -88.94 -81.42 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 120.989 -1.3 . . . . 0.0 108.511 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 1.124 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 57.1 Cg_endo -83.6 17.04 1.75 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.243 1.128 . . . . 0.0 109.422 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.33 62.52 0.79 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.498 -0.751 . . . . 0.0 110.661 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.725 ' HG2' ' CB ' ' A' ' 16' ' ' CYS . 22.1 mtt180 -69.09 -31.43 70.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.381 -0.825 . . . . 0.0 109.327 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.782 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.2 tm-20 -48.39 -45.13 35.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.427 -0.796 . . . . 0.0 109.449 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.785 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -45.25 -29.11 0.91 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.701 -0.8 . . . . 0.0 108.982 179.715 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.038 HD21 ' CG1' ' A' ' 59' ' ' ILE . 3.2 mp -70.47 -39.92 73.98 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.521 -0.737 . . . . 0.0 109.047 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.853 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.49 -41.16 89.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.401 -0.812 . . . . 0.0 109.824 -179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.52 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 2.5 tm-20 -77.29 -26.62 52.52 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.192 0.52 . . . . 0.0 109.932 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.644 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -71.03 -41.9 70.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 110.978 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.041 ' CD1' HG23 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -62.57 -44.28 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.125 -0.984 . . . . 0.0 109.122 179.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.676 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -72.83 -27.76 62.14 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 177.573 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 1.026 ' O ' ' OD1' ' A' ' 82' ' ' ASP 0.328 0.1 OUTLIER -96.06 5.63 50.69 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 119.638 -1.914 . . . . 0.0 107.855 -179.416 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.763 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -96.08 -59.03 1.93 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 178.635 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.683 ' SD ' ' HD2' ' A' ' 27' ' ' LYS . 21.4 ptt? -68.63 -14.52 63.07 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 119.266 -0.974 . . . . 0.0 110.986 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--N 1.3 -1.559 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.002 179.722 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.649 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.225 0.536 . . . . 0.0 110.21 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.029 HG22 ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -89.98 -91.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.303 -0.873 . . . . 0.0 110.59 179.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 1.179 HG11 ' OD2' ' A' ' 24' ' ' ASP 0.253 75.1 t -89.19 118.78 35.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.787 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.481 0.9 OUTLIER -143.6 106.82 4.54 Favored 'General case' 0 C--O 1.16 -3.624 1 CA-C-O 129.728 4.585 . . . . 0.0 105.063 175.064 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.051 HG23 ' CD1' ' A' ' 80' ' ' ILE 0.253 0.0 OUTLIER -111.62 132.87 59.0 Favored 'Isoleucine or valine' 0 C--O 1.262 1.73 0 CA-C-N 109.986 -3.279 . . . . 0.0 114.688 178.217 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 1.017 ' HB3' ' HB3' ' A' ' 60' ' ' ALA 0.593 0.0 OUTLIER -135.8 126.51 27.28 Favored 'General case' 0 C--O 1.197 -1.674 2 CA-C-O 131.334 5.349 . . . . 0.0 104.281 172.239 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.896 HG22 ' HA ' ' A' ' 38' ' ' LYS 0.339 14.6 m -108.02 156.5 8.52 Favored 'Isoleucine or valine' 0 C--N 1.386 2.191 0 CA-C-N 109.642 -3.436 . . . . 0.0 104.322 -175.699 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.956 ' CD2' ' HB3' ' A' ' 58' ' ' ALA . 1.9 t80 -154.15 76.14 1.04 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.516 -1.365 . . . . 0.0 111.052 -172.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.695 ' CB ' ' HA ' ' A' ' 15' ' ' TYR . 3.5 m -118.96 -70.06 0.81 Allowed 'General case' 0 C--N 1.269 -2.914 0 CA-C-N 120.65 1.568 . . . . 0.0 109.188 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.777 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 1.3 p 179.66 165.05 0.79 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.179 -0.951 . . . . 0.0 110.923 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.667 ' HD3' ' CG ' ' A' ' 40' ' ' ASP . 51.5 Cg_endo -80.4 -28.2 3.05 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.17 1.616 . . . . 0.0 110.511 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -18.25 53.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -0.894 . . . . 0.0 109.74 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -124.95 174.75 3.54 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.417 -0.802 . . . . 0.0 109.664 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.649 ' O ' ' O ' ' A' ' 15' ' ' TYR . 51.8 Cg_endo -83.41 114.69 2.15 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 123.943 1.496 . . . . 0.0 110.309 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.777 ' CE1' ' O ' ' A' ' 10' ' ' SER . 17.3 m-85 -49.41 -112.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.44 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.733 ' CB ' ' HG2' ' A' ' 73' ' ' ARG . 94.0 m -149.97 37.39 0.14 Allowed Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.132 -0.98 . . . . 0.0 110.27 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.723 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 54.4 Cg_endo -76.34 17.17 0.78 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.867 1.456 . . . . 0.0 111.036 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.554 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -95.11 -68.0 0.82 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.966 -1.084 . . . . 0.0 110.614 -179.367 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.751 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -55.28 -20.8 12.22 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.737 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.042 ' HB ' HG21 ' A' ' 5' ' ' ILE . 5.2 pt -71.91 -38.78 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.809 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.736 ' N ' HG13 ' A' ' 20' ' ' ILE . 6.4 tt0 -48.03 -33.59 8.22 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 3.1 t -72.47 -45.46 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-O 121.94 0.876 . . . . 0.0 109.338 179.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.881 HG21 ' HB ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -60.52 -33.09 53.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 122.737 1.256 . . . . 0.0 109.207 176.462 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 1.179 ' OD2' HG11 ' A' ' 3' ' ' VAL . 5.7 t70 -70.55 -40.67 73.26 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.933 1.349 . . . . 0.0 108.144 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.24 -46.45 82.98 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.712 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.474 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -76.76 -40.6 47.84 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.841 0.829 . . . . 0.0 110.827 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.908 ' CB ' HG22 ' A' ' 3' ' ' VAL 0.334 0.0 OUTLIER -73.86 -14.62 61.11 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 116.25 -2.18 . . . . 0.0 109.132 -177.337 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.792 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -72.47 -44.33 62.46 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.826 -1.171 . . . . 0.0 107.892 173.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.709 ' HG3' ' N ' ' A' ' 30' ' ' PHE 0.315 0.0 OUTLIER -53.96 -28.95 40.62 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.969 -179.315 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.783 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -99.85 -66.08 0.93 Allowed 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 -179.694 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.775 ' HA3' ' CG2' ' A' ' 2' ' ' VAL . . . -78.82 71.38 2.58 Favored Glycine 0 C--N 1.268 -3.232 0 CA-C-O 113.879 -3.734 . . . . 0.0 115.104 175.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.549 ' O ' ' OD1' ' A' ' 32' ' ' ASP 0.365 0.0 OUTLIER -39.06 -20.0 0.01 OUTLIER 'General case' 0 C--N 1.264 -3.109 1 CA-C-N 124.26 4.03 . . . . 0.0 111.81 -174.821 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.844 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -75.01 150.71 38.87 Favored 'General case' 0 C--N 1.28 -2.418 0 C-N-CA 126.969 2.108 . . . . 0.0 113.943 171.053 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.792 ' CD1' ' CG ' ' A' ' 28' ' ' LYS 0.331 0.3 OUTLIER -131.09 155.07 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 C-N-CA 116.441 -2.104 . . . . 0.0 110.148 172.374 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.677 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -151.64 76.96 1.22 Allowed 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.09 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.953 HG22 ' CD1' ' A' ' 5' ' ' ILE 0.406 42.6 t -102.56 127.39 56.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 CA-C-O 126.947 3.261 . . . . 0.0 106.457 -177.56 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.976 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.505 68.6 mt-10 -116.01 134.47 54.92 Favored 'General case' 0 C--O 1.188 -2.156 0 O-C-N 118.861 -2.399 . . . . 0.0 107.114 -174.37 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.896 ' HA ' HG22 ' A' ' 7' ' ' VAL 0.576 0.0 OUTLIER -112.73 115.28 28.28 Favored 'General case' 0 C--O 1.298 3.649 2 CA-C-O 107.822 -5.847 . . . . 0.0 121.213 -170.817 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.067 HG22 ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -132.54 178.24 5.92 Favored 'Isoleucine or valine' 1 C--N 1.232 -4.526 1 CA-C-N 131.381 6.446 . . . . 0.0 110.439 175.931 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.762 ' OD1' HG22 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -103.22 166.05 10.66 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.068 -1.645 . . . . 0.0 113.04 177.022 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.9 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.4 OUTLIER -59.68 -38.01 73.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 118.15 -1.42 . . . . 0.0 111.899 173.032 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.678 ' HG3' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -80.84 -3.29 50.67 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.793 -1.163 . . . . 0.0 112.457 177.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.067 ' CG2' HG22 ' A' ' 39' ' ' ILE . 2.0 m -113.58 -46.24 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.062 -1.024 . . . . 0.0 109.787 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.941 ' HB2' HD12 ' A' ' 39' ' ' ILE . 1.6 t70 -103.82 37.08 2.13 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.28 -0.887 . . . . 0.0 110.473 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.597 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.369 0.0 OUTLIER -65.04 -2.18 2.57 Favored 'General case' 0 C--O 1.2 -1.533 0 C-N-CA 116.783 -1.967 . . . . 0.0 109.789 -176.998 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 1.092 ' O ' HG23 ' A' ' 49' ' ' ILE . 1.8 mm-40 -51.89 -26.71 10.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.021 -1.049 . . . . 0.0 111.635 170.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.832 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -50.15 -61.28 2.25 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.471 -1.393 . . . . 0.0 108.884 -175.018 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.064 ' CB ' ' HB2' ' A' ' 55' ' ' ALA 0.388 . . -51.69 -13.36 0.25 Allowed 'General case' 0 C--N 1.264 -3.14 0 C-N-CA 126.48 1.912 . . . . 0.0 112.065 174.697 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.244 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.3 pp -33.68 -38.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 -169.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 1.244 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.99 -53.59 39.78 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.053 176.12 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.88 ' CZ ' ' HB2' ' A' ' 48' ' ' ALA . 23.1 p90 -120.36 -31.51 4.33 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.083 -1.011 . . . . 0.0 110.29 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.777 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.93 14.65 0.01 OUTLIER Glycine 0 C--O 1.201 -1.962 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.485 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.731 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.4 mt -80.25 -76.03 0.24 Allowed 'General case' 0 C--N 1.253 -3.623 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 178.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.512 ' C ' ' HE2' ' A' ' 51' ' ' TYR . 3.8 mtp -103.07 61.5 0.79 Allowed 'General case' 0 C--O 1.25 1.095 0 O-C-N 119.546 -1.971 . . . . 0.0 108.405 -178.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 1.064 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.548 . . -113.97 125.45 54.03 Favored 'General case' 0 C--O 1.178 -2.68 1 CA-C-O 129.672 4.558 . . . . 0.0 106.724 -175.258 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.8 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -151.03 -55.04 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 CA-C-N 109.795 -3.366 . . . . 0.0 112.301 -175.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.8 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.559 38.6 Cg_endo -119.66 116.0 0.01 OUTLIER 'Trans proline' 0 C--O 1.157 -3.525 1 CA-C-O 132.508 5.129 . . . . 0.0 108.86 174.209 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 1.057 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -160.61 173.34 15.63 Favored 'General case' 0 C--N 1.378 1.811 1 CA-C-N 107.777 -4.283 . . . . 0.0 111.671 -174.36 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.039 ' CG1' HD21 ' A' ' 76' ' ' LEU 0.313 0.3 OUTLIER -137.2 156.95 34.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 117.833 -1.547 . . . . 0.0 107.404 177.724 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 1.017 ' HB3' ' HB3' ' A' ' 6' ' ' GLU 0.696 . . -106.41 155.57 19.42 Favored 'General case' 0 C--N 1.379 1.881 3 C-N-CA 107.591 -5.643 . . . . 0.0 97.618 -175.017 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.809 HG13 ' N ' ' A' ' 66' ' ' ARG 0.583 1.7 mt -103.67 91.07 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.186 -2.253 2 CA-C-O 131.758 5.551 . . . . 0.0 101.724 -164.733 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.787 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -42.97 81.58 0.0 OUTLIER 'General case' 0 C--N 1.37 1.462 1 CA-C-N 108.378 -4.01 . . . . 0.0 109.012 176.562 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.752 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.94 -45.71 0.37 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 106.908 -2.477 . . . . 0.0 106.908 -177.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.811 ' O ' HG23 ' A' ' 65' ' ' VAL . 10.9 m -125.67 -58.86 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.679 -0.895 . . . . 0.0 111.431 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 64' ' ' VAL . 80.3 t -163.42 -99.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.551 0 O-C-N 120.314 -1.491 . . . . 0.0 112.879 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 1.013 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 1.6 ttp180 -171.55 157.58 4.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.964 -1.085 . . . . 0.0 109.252 -176.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 1.057 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -143.9 176.04 9.56 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.333 -1.479 . . . . 0.0 111.023 -174.281 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.817 ' CG2' ' HZ1' ' A' ' 47' ' ' LYS . 70.8 t -80.79 117.26 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-O 117.386 -1.292 . . . . 0.0 110.942 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.824 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.81 108.28 0.34 Allowed Glycine 0 C--N 1.277 -2.74 0 CA-C-N 121.173 1.806 . . . . 0.0 110.577 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.101 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -90.16 -79.21 0.03 OUTLIER Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 120.734 -1.451 . . . . 0.0 108.936 178.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 1.101 ' CD ' ' HB3' ' A' ' 70' ' ' ALA 0.256 44.3 Cg_endo -88.53 20.0 1.22 Allowed 'Trans proline' 0 C--O 1.21 -0.918 0 C-N-CA 116.705 -1.73 . . . . 0.0 109.136 177.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.16 63.58 1.0 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.761 -1.212 . . . . 0.0 112.179 175.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.733 ' HG2' ' CB ' ' A' ' 16' ' ' CYS . 20.6 mtt180 -67.27 -33.36 75.15 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.889 -1.132 . . . . 0.0 109.708 177.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.751 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.2 tm-20 -47.31 -46.46 25.19 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.043 -1.035 . . . . 0.0 108.986 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.785 ' CD ' ' CE2' ' A' ' 67' ' ' PHE 0.268 0.0 OUTLIER -47.29 -26.43 1.24 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 118.561 -1.256 . . . . 0.0 109.047 -178.371 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.039 HD21 ' CG1' ' A' ' 59' ' ' ILE . 3.1 mp -70.71 -39.86 73.16 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.878 0.847 . . . . 0.0 109.368 177.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.825 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.69 -39.47 84.64 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-O 122.088 0.947 . . . . 0.0 111.14 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 2.6 tm-20 -75.84 -27.84 58.01 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 122.229 1.014 . . . . 0.0 110.058 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.629 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -74.71 -40.6 61.22 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 120.956 -1.09 . . . . 0.0 109.149 -175.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.051 ' CD1' HG23 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -60.82 -45.17 98.48 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.572 0 CA-C-O 122.587 1.184 . . . . 0.0 110.151 177.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.726 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.2 OUTLIER -71.84 -32.94 68.03 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.654 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.645 0.1 OUTLIER -99.36 5.95 46.26 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 112.477 -3.689 . . . . 0.0 106.696 -175.258 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.734 ' OE1' ' CA ' ' A' ' 63' ' ' GLY 0.284 0.0 OUTLIER -86.35 -60.68 1.93 Allowed 'General case' 0 N--CA 1.48 1.03 1 O-C-N 116.169 -4.082 . . . . 0.0 108.132 165.739 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.726 ' HE2' ' HA ' ' A' ' 81' ' ' ASN . 21.4 ptt? -66.63 -14.84 62.95 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.946 -1.101 . . . . 0.0 111.456 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.778 -1.106 . . . . 0.0 110.253 177.939 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.675 ' O ' ' CZ ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.305 0.574 . . . . 0.0 110.276 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.995 HG23 ' HA3' ' A' ' 31' ' ' GLY . 11.5 p -84.65 -119.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.269 -0.894 . . . . 0.0 109.921 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.991 HG11 ' OD2' ' A' ' 24' ' ' ASP . 72.6 t -92.61 105.62 16.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.283 -0.886 . . . . 0.0 110.308 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.91 ' O ' HD11 ' A' ' 80' ' ' ILE . 54.3 t30 -129.2 109.0 10.79 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.755 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.028 HG21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -123.87 136.99 58.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.082 -1.011 . . . . 0.0 110.409 179.747 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 1.084 ' CB ' ' HB3' ' A' ' 60' ' ' ALA . 4.0 tp10 -125.05 104.07 8.35 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 117.916 -1.514 . . . . 0.0 108.782 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.822 ' CG2' ' CB ' ' A' ' 38' ' ' LYS . 15.7 m -93.88 104.73 16.07 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.434 0 CA-C-O 123.315 1.531 . . . . 0.0 108.43 -179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.884 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 1.6 t80 -117.65 84.88 2.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.221 -0.924 . . . . 0.0 109.78 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.683 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -120.28 -53.28 2.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.529 -0.732 . . . . 0.0 109.882 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 1.073 ' HA ' HG22 ' A' ' 41' ' ' ILE . 5.3 p 179.43 152.76 0.56 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.316 -0.865 . . . . 0.0 110.513 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.696 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 50.5 Cg_endo -84.52 -29.4 0.82 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.121 1.59 . . . . 0.0 110.205 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.549 ' OG1' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -79.81 -16.87 54.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.376 -0.828 . . . . 0.0 109.946 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.549 ' SG ' ' OG1' ' A' ' 12' ' ' THR . 1.4 m -124.97 179.97 1.0 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.417 -0.802 . . . . 0.0 109.954 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.631 ' O ' ' O ' ' A' ' 15' ' ' TYR . 52.3 Cg_endo -83.6 111.68 1.79 Allowed 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.993 1.522 . . . . 0.0 110.473 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.772 ' CE1' ' O ' ' A' ' 10' ' ' SER . 8.6 m-85 -49.51 -114.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.905 . . . . 0.0 109.728 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.91 ' O ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -155.19 40.7 0.14 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.167 -0.958 . . . . 0.0 110.054 179.543 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.698 ' CA ' HG11 ' A' ' 7' ' ' VAL . 50.1 Cg_endo -74.7 16.15 0.64 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.935 1.492 . . . . 0.0 111.039 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.746 ' CG ' ' HD3' ' A' ' 73' ' ' ARG . 5.1 ttm -84.81 -60.74 1.96 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.129 -0.982 . . . . 0.0 111.305 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.75 ' CB ' ' O ' ' A' ' 73' ' ' ARG . . . -56.41 -18.9 12.55 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.27 -0.894 . . . . 0.0 109.665 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.028 ' HB ' HG21 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -73.83 -40.15 52.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.458 -0.776 . . . . 0.0 109.327 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.72 ' N ' HD12 ' A' ' 20' ' ' ILE . 6.0 tm-20 -53.7 -36.11 61.85 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.1 t -75.94 -39.39 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.959 HG13 HG21 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -70.39 -26.8 29.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-O 122.022 0.915 . . . . 0.0 108.88 177.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.991 ' OD2' HG11 ' A' ' 3' ' ' VAL . 4.8 t70 -74.62 -37.45 62.82 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -45.01 91.58 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.314 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.457 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.26 -40.59 30.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.492 -0.755 . . . . 0.0 110.095 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.892 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -65.13 -26.31 68.13 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.182 -1.007 . . . . 0.0 108.871 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 1.024 ' CE ' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.89 -46.64 67.87 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.822 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.78 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -45.94 -42.08 12.4 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.654 0.74 . . . . 0.0 109.057 178.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.78 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -90.27 -56.04 3.37 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.414 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.995 ' HA3' HG23 ' A' ' 2' ' ' VAL . . . -96.08 79.05 0.77 Allowed Glycine 0 N--CA 1.489 2.196 0 O-C-N 121.482 -0.761 . . . . 0.0 111.276 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -37.71 -19.56 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 119.057 1.429 . . . . 0.0 110.767 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.684 ' N ' ' O ' ' A' ' 31' ' ' GLY . 9.5 mtpt -85.74 160.09 19.61 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.911 -1.118 . . . . 0.0 111.289 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.024 HD11 ' CE ' ' A' ' 28' ' ' LYS . 0.6 OUTLIER -130.54 129.33 64.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.084 178.447 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.661 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 8.4 t0 -136.86 74.37 1.49 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.333 -0.854 . . . . 0.0 109.175 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.695 HG13 ' CG1' ' A' ' 5' ' ' ILE . 46.1 t -92.23 115.85 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-O 122.428 1.108 . . . . 0.0 109.406 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.723 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 9.0 mt-10 -97.6 148.15 23.58 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.345 -1.342 . . . . 0.0 108.328 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.822 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.94 120.84 14.51 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.62 -1.3 . . . . 0.0 111.654 -177.376 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.993 HD12 ' CG ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -120.4 174.62 5.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.27 -0.894 . . . . 0.0 111.28 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.856 ' CG ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -112.07 167.69 10.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.074 -1.016 . . . . 0.0 112.629 179.111 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 1.073 HG22 ' HA ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -67.5 -36.21 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.646 -0.658 . . . . 0.0 112.53 178.315 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.776 ' N ' HD13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -90.61 -7.15 53.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.844 -1.16 . . . . 0.0 112.016 -179.09 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.856 HG12 ' CG ' ' A' ' 40' ' ' ASP . 14.0 p -111.27 -35.64 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.015 -1.053 . . . . 0.0 109.934 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.993 ' CG ' HD12 ' A' ' 39' ' ' ILE . 3.0 t70 -115.07 45.49 1.61 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.294 -0.879 . . . . 0.0 110.163 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 45' ' ' ARG 0.257 45.3 ttt180 -59.28 -5.69 0.79 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.462 -1.295 . . . . 0.0 109.406 -179.065 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 1.093 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.2 mm-40 -53.88 -20.88 6.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.335 -0.853 . . . . 0.0 110.329 177.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.855 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -51.95 -56.33 14.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.857 -1.152 . . . . 0.0 109.394 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.16 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -64.7 -2.52 2.52 Favored 'General case' 0 C--N 1.276 -2.609 0 O-C-N 120.896 -1.128 . . . . 0.0 111.467 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.261 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.5 pp -34.25 -37.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 -177.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 1.261 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.5 OUTLIER -55.39 -52.33 63.89 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.153 176.807 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.842 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.5 p90 -121.97 -27.26 4.63 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.129 -0.982 . . . . 0.0 110.278 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.793 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.23 13.18 0.01 OUTLIER Glycine 0 N--CA 1.489 2.197 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.669 ' N ' ' O ' ' A' ' 51' ' ' TYR . 6.4 mt -84.7 -66.0 0.94 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 123.981 1.848 . . . . 0.0 108.375 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.458 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 15.9 mmt -103.87 56.43 0.73 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.021 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 1.16 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.263 . . -99.24 105.41 17.44 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 123.387 1.565 . . . . 0.0 110.661 -176.104 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.966 HG22 HG13 ' A' ' 41' ' ' ILE . 2.0 t -146.4 -65.47 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 121.197 -0.939 . . . . 0.0 110.408 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.815 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 40.8 Cg_endo -97.35 102.7 0.08 OUTLIER 'Trans proline' 0 C--O 1.195 -1.661 0 CA-C-O 124.131 1.638 . . . . 0.0 108.728 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.912 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -156.14 -178.46 7.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.46 -1.4 . . . . 0.0 111.304 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.913 HG13 HD21 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -144.38 140.76 24.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.763 -0.585 . . . . 0.0 109.869 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 1.084 ' HB3' ' CB ' ' A' ' 6' ' ' GLU . . . -81.69 133.41 35.35 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.753 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.353 1.2 mt -85.36 81.25 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.221 0 C-N-CA 116.462 -2.095 . . . . 0.0 107.223 -176.283 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.798 ' O ' ' CG ' ' A' ' 83' ' ' GLU . 27.6 m-80 -44.3 85.87 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 114.512 -1.222 . . . . 0.0 107.895 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.753 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.73 -43.78 0.35 Allowed Glycine 0 N--CA 1.486 1.999 0 N-CA-C 106.177 -2.769 . . . . 0.0 106.177 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.88 ' O ' HG23 ' A' ' 65' ' ' VAL . 14.9 m -128.73 -60.97 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 121.791 -0.829 . . . . 0.0 110.761 179.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 64' ' ' VAL . 64.8 t -165.23 -103.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 120.321 -1.487 . . . . 0.0 111.679 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.843 ' N ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -153.28 164.26 38.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.786 -0.572 . . . . 0.0 109.828 -179.083 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.912 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.42 178.18 8.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.079 -1.013 . . . . 0.0 110.862 -179.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.476 HG22 ' OH ' ' A' ' 51' ' ' TYR . 96.0 t -89.45 122.08 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.286 -0.884 . . . . 0.0 109.078 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.847 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -160.96 101.83 0.2 Allowed Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.055 -1.545 . . . . 0.0 111.148 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.054 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -90.29 -83.92 0.02 OUTLIER Pre-proline 0 C--N 1.293 -1.848 0 O-C-N 120.825 -1.397 . . . . 0.0 108.484 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 1.054 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 48.8 Cg_endo -82.55 15.2 2.09 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 N-CA-C 108.909 -1.227 . . . . 0.0 108.909 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.56 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 26.2 p -100.22 69.95 1.51 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.264 -0.897 . . . . 0.0 111.269 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.76 ' HA ' HD13 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -74.87 -40.45 60.95 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.916 -1.115 . . . . 0.0 109.376 179.007 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.707 ' HA ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -46.03 -36.37 5.62 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.185 -0.947 . . . . 0.0 109.153 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.575 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -48.44 -41.61 29.86 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.493 -0.883 . . . . 0.0 108.712 179.318 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.913 HD21 HG13 ' A' ' 59' ' ' ILE . 7.1 mp -56.77 -40.06 75.16 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.675 0.75 . . . . 0.0 109.015 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.816 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -60.69 -42.47 97.22 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.617 0.722 . . . . 0.0 109.918 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.491 ' N ' ' CD2' ' A' ' 77' ' ' PHE . 1.2 tt0 -78.0 -22.73 48.87 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.298 -0.876 . . . . 0.0 110.369 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.567 ' HB1' HG23 ' A' ' 61' ' ' ILE . . . -79.25 -39.58 32.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.106 -0.996 . . . . 0.0 109.937 -178.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.959 HG21 HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -66.07 -32.14 56.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.909 -1.119 . . . . 0.0 108.862 178.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.516 ' HA ' ' HE3' ' A' ' 84' ' ' MET . 0.1 OUTLIER -78.38 -29.08 47.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.0 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.563 0.6 OUTLIER -93.36 -7.22 45.36 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 112.718 -3.593 . . . . 0.0 105.742 -179.003 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.798 ' CG ' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -74.99 -54.65 6.81 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.165 -1.584 . . . . 0.0 108.111 171.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.808 ' CE ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -75.51 -22.34 57.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.732 -0.605 . . . . 0.0 110.431 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 84' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.211 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.201 0.524 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 1.072 HG21 ' O ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -80.72 -92.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.329 -0.857 . . . . 0.0 110.354 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.963 ' N ' HG22 ' A' ' 2' ' ' VAL . 54.1 t -91.59 128.74 43.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.521 -0.737 . . . . 0.0 110.921 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.809 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 62.8 t30 -140.63 107.6 5.43 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 123.06 1.409 . . . . 0.0 109.126 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.051 HD12 ' HB ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -135.91 136.18 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 O-C-N 121.032 -1.043 . . . . 0.0 112.032 -178.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 1.171 ' O ' HG23 ' A' ' 59' ' ' ILE . 1.4 tp10 -122.5 102.54 8.14 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 118.136 -1.425 . . . . 0.0 108.53 176.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.802 ' CG2' ' CB ' ' A' ' 38' ' ' LYS . 30.0 m -96.19 106.28 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 123.11 1.433 . . . . 0.0 109.327 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.847 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 1.1 t80 -118.19 101.88 8.56 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.67 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.848 HG22 ' N ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -134.03 -61.58 0.79 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.269 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 1.024 ' HA ' HG22 ' A' ' 41' ' ' ILE . 3.1 t -175.07 144.63 0.83 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.118 -0.988 . . . . 0.0 111.073 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.756 ' N ' ' HB2' ' A' ' 40' ' ' ASP . 50.6 Cg_endo -76.63 -9.43 18.5 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 124.212 1.638 . . . . 0.0 110.652 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.05 -5.21 53.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.996 -1.065 . . . . 0.0 109.794 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.631 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 1.5 p -160.45 -165.65 0.13 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.494 -0.754 . . . . 0.0 110.09 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.631 ' CD ' ' CB ' ' A' ' 13' ' ' CYS . 53.2 Cg_endo -84.32 117.78 2.18 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.895 1.471 . . . . 0.0 110.35 177.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.772 ' HD2' HG23 ' A' ' 7' ' ' VAL . 2.1 m-85 -49.27 -83.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.93 . . . . 0.0 109.632 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.82 ' HB3' HD11 ' A' ' 76' ' ' LEU . 42.5 m -155.41 39.61 0.11 Allowed Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.213 -0.93 . . . . 0.0 109.961 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.708 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 52.9 Cg_endo -73.72 30.35 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.013 1.533 . . . . 0.0 111.142 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.402 ' H ' ' C ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -110.16 -61.93 1.59 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.952 -1.093 . . . . 0.0 110.369 -179.653 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.905 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -58.06 -20.11 36.85 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.457 -0.777 . . . . 0.0 110.033 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.051 ' HB ' HD12 ' A' ' 5' ' ' ILE . 23.0 pt -75.6 -38.99 39.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.492 -0.755 . . . . 0.0 109.531 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.675 ' N ' HG13 ' A' ' 20' ' ' ILE . 49.8 tt0 -49.43 -36.02 21.06 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.68 -43.02 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.917 HG13 HG21 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -69.85 -27.98 35.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.744 0.783 . . . . 0.0 109.234 178.117 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.702 ' OD2' HG11 ' A' ' 3' ' ' VAL . 4.4 t70 -75.77 -36.07 59.95 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -44.18 89.91 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.635 0.731 . . . . 0.0 109.289 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.53 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.45 -41.01 28.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.506 -0.746 . . . . 0.0 110.122 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.82 ' CE ' ' CE ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -67.67 -23.41 65.31 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.206 -179.327 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -69.35 -46.38 67.14 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.373 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.795 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -47.68 -40.66 20.6 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.726 0.774 . . . . 0.0 109.191 179.004 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.795 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.89 -58.06 2.64 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.489 -0.757 . . . . 0.0 109.017 179.587 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.736 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -96.64 77.85 0.72 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 111.341 -0.703 . . . . 0.0 111.341 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.588 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -32.94 -27.37 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 119.315 1.558 . . . . 0.0 110.168 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 1.072 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -88.68 158.37 18.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.417 -0.802 . . . . 0.0 111.259 178.253 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.79 HG23 HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -129.57 150.86 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.081 -1.012 . . . . 0.0 110.581 178.095 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -138.69 61.45 1.58 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.414 -0.804 . . . . 0.0 108.875 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.035 HG13 ' HB ' ' A' ' 5' ' ' ILE . 44.7 t -91.76 115.75 31.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.663 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.759 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 12.4 mt-10 -98.59 140.43 32.83 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.01 -1.076 . . . . 0.0 108.368 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.802 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -138.45 130.81 28.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.411 -0.805 . . . . 0.0 111.845 -176.648 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 1.016 HD12 ' CG ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -138.17 172.8 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.848 . . . . 0.0 109.898 179.598 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 1.083 ' CG ' HG12 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -105.33 169.84 8.23 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.175 -0.953 . . . . 0.0 110.975 179.008 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 1.267 ' CD1' HG22 ' A' ' 56' ' ' VAL . 0.6 OUTLIER -73.79 -17.88 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.254 -0.904 . . . . 0.0 111.593 179.251 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.771 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 2.6 ptt? -92.89 -15.59 26.21 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.809 -1.156 . . . . 0.0 110.21 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 1.083 HG12 ' CG ' ' A' ' 40' ' ' ASP . 14.0 p -111.2 -30.58 2.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 110.256 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 1.016 ' CG ' HD12 ' A' ' 39' ' ' ILE . 5.7 t0 -114.5 48.91 1.07 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.047 -1.033 . . . . 0.0 110.869 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.264 2.5 ttt180 -59.99 -8.8 2.5 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.319 -1.352 . . . . 0.0 109.627 -179.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 1.004 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -58.31 -17.08 17.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.634 174.639 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.816 ' HG2' ' CE1' ' A' ' 8' ' ' PHE . 0.6 OUTLIER -48.96 -61.38 2.09 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.416 1.103 . . . . 0.0 109.68 -178.058 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.155 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -62.06 0.08 0.45 Allowed 'General case' 0 C--N 1.283 -2.308 0 O-C-N 121.613 -0.679 . . . . 0.0 111.566 177.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.078 HD11 ' NE ' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -35.11 -38.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 -176.226 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.586 ' N ' ' C ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -54.81 -49.26 71.43 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.513 177.383 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.825 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -124.96 -28.47 3.46 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.953 -1.092 . . . . 0.0 110.361 179.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.777 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 41.15 11.17 0.01 OUTLIER Glycine 0 N--CA 1.486 2.023 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.68 ' N ' ' O ' ' A' ' 51' ' ' TYR . 6.2 mt -84.95 -61.52 1.76 Allowed 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 123.117 1.437 . . . . 0.0 108.344 177.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.545 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 26.0 mtm -110.21 62.88 0.6 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.031 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 1.155 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.268 . . -98.34 107.75 20.29 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 123.092 1.425 . . . . 0.0 111.327 -174.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.267 HG22 ' CD1' ' A' ' 41' ' ' ILE . 1.6 t -146.98 -66.81 0.02 OUTLIER Pre-proline 0 N--CA 1.486 1.368 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.487 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.856 ' CD ' HG12 ' A' ' 56' ' ' VAL . 41.8 Cg_endo -106.25 94.27 0.02 OUTLIER 'Trans proline' 0 C--O 1.206 -1.11 0 CA-C-O 122.701 1.042 . . . . 0.0 109.785 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 1.098 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -152.13 178.67 9.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.226 -0.922 . . . . 0.0 110.667 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 1.272 HG21 ' CD2' ' A' ' 76' ' ' LEU . 1.4 mp -149.91 147.38 16.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.619 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.923 ' HB3' ' CB ' ' A' ' 6' ' ' GLU . . . -81.58 138.03 35.44 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 117.4 -1.72 . . . . 0.0 106.452 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.754 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.382 0.9 OUTLIER -87.93 81.11 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-O 124.807 2.241 . . . . 0.0 106.486 -175.635 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.809 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -42.69 84.88 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 113.466 -1.697 . . . . 0.0 108.006 177.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.754 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.08 -47.09 0.38 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 106.328 -2.709 . . . . 0.0 106.328 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.797 ' O ' HG23 ' A' ' 65' ' ' VAL . 11.9 m -124.51 -60.76 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 121.846 -0.797 . . . . 0.0 111.19 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.811 HG12 ' N ' ' A' ' 66' ' ' ARG . 97.6 t -164.04 -107.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.126 -1.609 . . . . 0.0 113.146 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 1.078 ' NE ' HD11 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -156.23 153.65 29.49 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.769 -0.582 . . . . 0.0 109.947 -177.008 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 1.098 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.98 -175.65 4.83 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.982 -1.074 . . . . 0.0 111.75 -178.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.39 123.24 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.814 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.23 105.43 0.26 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 118.751 -1.69 . . . . 0.0 111.099 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 1.113 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -89.68 -82.34 0.03 OUTLIER Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 120.831 -1.394 . . . . 0.0 108.202 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 1.113 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 51.1 Cg_endo -82.99 15.22 2.14 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 N-CA-C 108.932 -1.218 . . . . 0.0 108.932 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.71 64.29 1.27 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.323 -0.86 . . . . 0.0 111.547 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.75 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.62 -32.15 65.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.04 -1.038 . . . . 0.0 109.358 178.754 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.905 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -51.23 -41.09 60.08 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.268 -0.895 . . . . 0.0 109.184 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.754 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -46.21 -29.36 1.55 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.465 -0.772 . . . . 0.0 109.267 179.581 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.272 ' CD2' HG21 ' A' ' 59' ' ' ILE . 13.1 mt -72.46 -40.84 66.7 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.812 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.87 -37.33 73.75 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.457 -0.777 . . . . 0.0 109.535 179.371 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -78.58 -26.76 45.57 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.512 -0.743 . . . . 0.0 110.297 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 83' ' ' GLU . . . -74.21 -37.98 63.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.922 . . . . 0.0 110.063 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.917 HG21 HG13 ' A' ' 23' ' ' VAL . 1.5 mp -63.7 -37.35 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.975 -1.078 . . . . 0.0 108.788 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.43 ' ND2' ' C ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -73.29 -32.79 64.84 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.151 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.668 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.47 0.3 OUTLIER -91.79 -6.55 51.55 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 115.191 -2.604 . . . . 0.0 108.157 -179.419 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.768 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -79.85 -55.02 5.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.361 -1.462 . . . . 0.0 109.419 169.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.82 ' CE ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.01 -23.16 64.97 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.338 179.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.474 ' CD ' ' C ' ' A' ' 85' ' ' GLU . 3.3 tm-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.257 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.591 ' CE ' ' CD ' ' A' ' 83' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.876 0.846 . . . . 0.0 110.845 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.004 HG21 ' O ' ' A' ' 33' ' ' LYS . 1.4 p -80.04 -96.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 O-C-N 120.965 -1.084 . . . . 0.0 110.337 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.047 HG21 HD12 ' A' ' 34' ' ' ILE . 47.6 t -89.97 129.05 41.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 O-C-N 121.561 -0.712 . . . . 0.0 109.936 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.983 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 0.7 OUTLIER -149.05 101.91 3.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.792 -1.192 . . . . 0.0 108.633 -179.068 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.046 HD12 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.37 138.93 52.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 113.847 -1.524 . . . . 0.0 113.651 -178.403 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.263 ' O ' HG23 ' A' ' 59' ' ' ILE . 13.6 tt0 -132.9 121.42 22.84 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 118.692 -2.505 . . . . 0.0 106.109 176.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.006 HG12 ' CD2' ' A' ' 76' ' ' LEU . 3.9 m -112.28 111.61 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.312 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -176.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.878 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -116.15 95.04 4.9 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.814 -178.252 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.824 ' O ' HD12 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -126.31 -59.42 1.31 Allowed 'General case' 0 C--N 1.291 -1.946 0 O-C-N 121.207 -0.933 . . . . 0.0 108.853 178.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.69 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 0.2 OUTLIER 179.09 146.47 0.38 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.825 -1.172 . . . . 0.0 110.704 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.668 ' CD ' ' HB2' ' A' ' 40' ' ' ASP . 48.2 Cg_endo -75.91 -30.17 6.18 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 124.445 1.76 . . . . 0.0 110.359 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.2 t -78.92 -14.34 59.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.58 -0.7 . . . . 0.0 110.081 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.512 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -124.74 179.14 1.17 Allowed Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.516 -0.74 . . . . 0.0 109.868 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.616 ' O ' ' O ' ' A' ' 15' ' ' TYR . 52.2 Cg_endo -83.58 107.02 1.35 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.959 1.505 . . . . 0.0 109.975 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.69 ' CE1' ' O ' ' A' ' 10' ' ' SER . 3.2 m-85 -50.18 -115.42 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.819 -0.551 . . . . 0.0 109.545 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.864 ' SG ' HD11 ' A' ' 59' ' ' ILE . 71.0 m -149.11 38.8 0.19 Allowed Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.941 -1.099 . . . . 0.0 109.423 178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.893 ' HA ' HD13 ' A' ' 20' ' ' ILE . 53.2 Cg_endo -74.51 29.85 0.34 Allowed 'Trans proline' 0 C--N 1.317 -1.105 0 O-C-N 123.829 1.436 . . . . 0.0 111.295 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.7 ' CG ' ' CZ ' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -106.37 -55.01 2.39 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.941 -1.099 . . . . 0.0 110.423 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.754 ' HB2' ' HD3' ' A' ' 73' ' ' ARG . . . -59.17 -19.93 49.39 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.314 -0.866 . . . . 0.0 109.933 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.228 HD12 ' CG1' ' A' ' 36' ' ' VAL . 3.2 pt -72.52 -41.78 63.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 CA-C-O 121.253 0.549 . . . . 0.0 109.742 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.563 ' N ' ' CG1' ' A' ' 20' ' ' ILE . 7.7 tt0 -53.58 -35.21 60.59 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.1 t -71.03 -45.78 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.896 ' CG1' HG21 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -63.98 -33.92 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.07 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.701 ' OD2' HG21 ' A' ' 34' ' ' ILE . 31.0 t0 -66.81 -40.88 88.21 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.838 0.827 . . . . 0.0 109.673 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.29 -48.37 79.08 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.604 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.501 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.55 -39.09 47.07 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.77 -0.581 . . . . 0.0 110.443 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.772 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -72.96 -17.73 61.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.07 -1.019 . . . . 0.0 109.915 -178.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.933 ' HG2' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -71.51 -47.0 58.15 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.704 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -46.2 -37.42 7.08 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.863 0.839 . . . . 0.0 110.327 179.13 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.817 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -93.72 -72.4 0.61 Allowed 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 178.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.817 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -82.98 89.82 1.52 Allowed Glycine 0 N--CA 1.487 2.047 0 C-N-CA 118.88 -1.628 . . . . 0.0 109.909 177.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.549 ' OD2' ' NZ ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -40.56 -29.62 0.09 Allowed 'General case' 0 N--CA 1.52 3.065 0 CA-C-N 122.217 3.008 . . . . 0.0 110.667 176.157 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 1.068 ' O ' HD13 ' A' ' 34' ' ' ILE . 9.4 mtmm -79.85 151.77 30.04 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.81 -0.556 . . . . 0.0 112.442 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.068 HD13 ' O ' ' A' ' 33' ' ' LYS . 16.5 mm -129.26 160.28 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 120.466 -1.396 . . . . 0.0 110.055 178.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.735 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -151.25 70.1 0.96 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.228 ' CG1' HD12 ' A' ' 20' ' ' ILE 0.255 85.7 t -96.93 123.23 49.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 -179.197 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.847 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 7.8 mt-10 -108.84 148.29 30.82 Favored 'General case' 0 C--O 1.203 -1.381 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -177.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.703 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -142.78 110.7 5.93 Favored 'General case' 0 N--CA 1.508 2.451 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -174.459 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.9 HD12 ' CG ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -111.76 165.0 7.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-O 122.266 1.032 . . . . 0.0 113.24 -178.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.668 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -100.13 161.13 13.8 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.718 0.771 . . . . 0.0 110.931 178.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 1.015 HD11 ' C ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER -62.08 -18.74 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 120.473 -1.392 . . . . 0.0 110.99 179.438 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.668 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -91.23 -14.97 30.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.944 -1.097 . . . . 0.0 111.547 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.64 HG13 HG22 ' A' ' 39' ' ' ILE . 10.0 p -113.62 -31.35 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.131 -0.98 . . . . 0.0 110.63 -178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.9 ' CG ' HD12 ' A' ' 39' ' ' ILE . 41.9 t0 -112.56 37.93 2.91 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.454 -0.899 . . . . 0.0 110.087 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.522 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.296 0.0 OUTLIER -65.04 -3.49 3.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 119.956 -1.715 . . . . 0.0 109.086 -179.51 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 1.123 ' O ' HG23 ' A' ' 49' ' ' ILE . 1.7 mt-10 -60.0 -20.72 59.25 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 175.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.848 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -44.55 -63.37 0.91 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.305 -1.497 . . . . 0.0 109.072 -178.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.121 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -57.62 -11.23 1.94 Allowed 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 113.879 -1.51 . . . . 0.0 111.083 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.161 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.7 pp -24.0 -38.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.237 -1.539 . . . . 0.0 107.922 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 1.161 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -56.22 -51.6 67.5 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.873 177.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.83 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.0 p90 -122.84 -30.93 3.75 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.467 -0.771 . . . . 0.0 110.122 178.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.716 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 45.05 4.8 0.01 OUTLIER Glycine 1 N--CA 1.52 4.25 0 O-C-N 121.589 -0.695 . . . . 0.0 111.759 179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.676 ' H ' ' C ' ' A' ' 51' ' ' TYR . 8.9 mt -75.68 -79.76 0.09 Allowed 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 175.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.705 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 1.9 mtm -94.21 65.98 3.41 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.31 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 1.121 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.294 . . -108.23 108.64 19.75 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.346 -1.471 . . . . 0.0 109.79 -177.118 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.015 ' C ' HD11 ' A' ' 41' ' ' ILE . 2.6 t -147.76 -65.16 0.02 OUTLIER Pre-proline 0 N--CA 1.485 1.28 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.354 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.825 ' HD3' ' HB ' ' A' ' 56' ' ' VAL . 59.9 Cg_endo -105.44 106.08 0.03 OUTLIER 'Trans proline' 0 C--N 1.302 -1.897 0 N-CA-C 109.11 -1.15 . . . . 0.0 109.11 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.962 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -160.71 177.83 10.07 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 112.694 -2.048 . . . . 0.0 111.686 -176.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.263 HG23 ' O ' ' A' ' 6' ' ' GLU 0.271 1.3 mp -146.53 154.3 12.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.019 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.993 ' HB3' ' HB3' ' A' ' 6' ' ' GLU 0.29 . . -87.72 155.49 19.9 Favored 'General case' 0 CA--C 1.479 -1.77 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.706 HG13 ' N ' ' A' ' 66' ' ' ARG 0.312 1.6 mt -104.12 92.19 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.038 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 -175.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.983 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.2 OUTLIER -54.74 86.25 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 O-C-N 126.274 2.234 . . . . 0.0 106.256 -178.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.761 ' HA3' ' HB2' ' A' ' 83' ' ' GLU . . . 162.02 -44.95 0.37 Allowed Glycine 0 C--N 1.292 -1.863 0 N-CA-C 107.777 -2.129 . . . . 0.0 107.777 -177.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.782 ' O ' HG23 ' A' ' 65' ' ' VAL . 11.5 m -126.69 -60.81 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.568 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.782 HG23 ' O ' ' A' ' 64' ' ' VAL . 74.6 t -164.38 -99.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 O-C-N 120.929 -1.107 . . . . 0.0 112.379 -179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.966 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -165.25 157.86 15.81 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -177.61 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.962 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -146.62 176.19 10.02 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.325 -0.859 . . . . 0.0 111.698 -176.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.748 HG22 ' OH ' ' A' ' 51' ' ' TYR . 7.9 t -84.98 121.58 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.693 -0.63 . . . . 0.0 110.363 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.82 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.67 110.08 0.41 Allowed Glycine 0 N--CA 1.498 2.823 0 O-C-N 119.863 -1.773 . . . . 0.0 110.694 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.051 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -90.49 -79.97 0.03 OUTLIER Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.388 -1.066 . . . . 0.0 108.624 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 1.051 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 57.2 Cg_endo -83.91 18.27 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 N-CA-C 109.012 -1.188 . . . . 0.0 109.012 177.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -102.69 63.62 0.86 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.528 0.68 . . . . 0.0 110.176 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.754 ' HD3' ' HB2' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -70.57 -42.17 71.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.319 -0.863 . . . . 0.0 108.759 178.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.707 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 2.0 tt0 -44.07 -37.11 2.86 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.756 -0.59 . . . . 0.0 109.854 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.706 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -47.85 -37.79 14.65 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 120.029 -0.669 . . . . 0.0 109.894 179.354 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.161 ' CG ' HG21 ' A' ' 59' ' ' ILE . 9.7 mp -65.23 -41.52 94.3 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.804 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.2 -36.61 73.36 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 122.246 1.022 . . . . 0.0 109.873 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -78.9 -31.01 45.18 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 110.337 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.27 -38.01 75.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.514 -0.741 . . . . 0.0 111.158 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.896 HG21 ' CG1' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -65.66 -42.4 92.63 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 CA-C-O 121.75 0.786 . . . . 0.0 109.168 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.45 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -70.52 -21.09 62.77 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.618 176.302 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.416 ' O ' ' CG ' ' A' ' 82' ' ' ASP 0.356 0.3 OUTLIER -103.38 2.92 34.58 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 117.567 -1.653 . . . . 0.0 106.733 -178.65 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.82 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.33 -58.36 2.52 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 102.264 -3.235 . . . . 0.0 102.264 176.773 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.638 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 7.5 ptt? -69.47 -18.94 63.76 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.022 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.766 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.661 ' O ' ' SD ' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.319 0.581 . . . . 0.0 110.217 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.051 HG21 ' O ' ' A' ' 33' ' ' LYS . 1.3 p -79.92 -95.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 109.894 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.042 HG21 HD12 ' A' ' 34' ' ' ILE . 52.1 t -88.89 129.13 40.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.841 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.476 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 1.042 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.292 0.7 OUTLIER -151.16 103.23 3.01 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 125.108 2.385 . . . . 0.0 108.446 179.562 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.067 HD12 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.5 137.26 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 CA-C-N 111.337 -2.665 . . . . 0.0 113.997 -178.165 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.244 ' O ' HG23 ' A' ' 59' ' ' ILE . 12.9 tt0 -131.72 119.89 21.97 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 115.458 -2.497 . . . . 0.0 105.862 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.035 HG12 ' CD2' ' A' ' 76' ' ' LEU . 4.2 m -111.61 111.6 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.138 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 -176.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.879 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -116.4 93.71 4.34 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.021 -178.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.791 ' O ' HD12 ' A' ' 41' ' ' ILE . 0.6 OUTLIER -124.43 -60.02 1.43 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.408 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.774 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 0.2 OUTLIER 179.7 147.72 0.44 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 110.621 179.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.732 ' CD ' ' HB2' ' A' ' 40' ' ' ASP . 48.4 Cg_endo -76.53 -30.07 5.39 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.273 1.67 . . . . 0.0 110.316 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.6 t -79.48 -13.55 59.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.938 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.58 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -125.03 179.58 1.09 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.319 -0.863 . . . . 0.0 109.946 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.648 ' O ' ' O ' ' A' ' 15' ' ' TYR . 52.1 Cg_endo -83.26 106.26 1.36 Allowed 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.984 1.518 . . . . 0.0 110.537 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.774 ' CE1' ' O ' ' A' ' 10' ' ' SER . 3.2 m-85 -49.73 -114.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.095 -1.003 . . . . 0.0 109.741 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.854 ' SG ' HD11 ' A' ' 59' ' ' ILE . 76.1 m -150.0 38.47 0.17 Allowed Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.404 -0.81 . . . . 0.0 109.921 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.889 ' HA ' HD13 ' A' ' 20' ' ' ILE . 50.9 Cg_endo -74.28 29.55 0.33 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.001 1.527 . . . . 0.0 111.129 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.794 ' CG ' ' CZ ' ' A' ' 73' ' ' ARG . 0.6 OUTLIER -105.8 -56.28 2.2 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.082 -1.011 . . . . 0.0 110.253 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.779 ' HB2' ' HD3' ' A' ' 73' ' ' ARG . . . -58.32 -20.13 40.65 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.314 -0.866 . . . . 0.0 109.622 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.291 HD12 ' CG1' ' A' ' 36' ' ' VAL . 3.1 pt -72.93 -41.82 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.521 -0.737 . . . . 0.0 109.737 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.592 ' N ' ' CG1' ' A' ' 20' ' ' ILE . 7.8 tt0 -52.73 -35.11 55.39 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 10.4 t -71.65 -44.73 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 121.799 0.809 . . . . 0.0 109.063 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.936 ' CG1' HG21 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -64.66 -32.98 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.75 0.786 . . . . 0.0 109.107 177.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.76 ' OD2' HG21 ' A' ' 34' ' ' ILE . 28.5 t0 -68.53 -40.31 80.81 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.213 1.006 . . . . 0.0 109.477 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.43 -48.13 79.95 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.444 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.524 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -78.24 -39.4 40.39 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.635 -0.665 . . . . 0.0 110.672 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.781 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -71.56 -19.01 62.21 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.163 -1.015 . . . . 0.0 109.208 -178.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.904 ' HG2' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -70.86 -47.15 60.88 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 176.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.768 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -46.4 -37.89 8.21 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.781 0.8 . . . . 0.0 109.997 179.313 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.862 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -93.56 -70.3 0.71 Allowed 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.862 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -84.82 87.71 1.56 Allowed Glycine 0 N--CA 1.504 3.213 0 C-N-CA 118.111 -1.995 . . . . 0.0 111.059 177.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.587 ' OD2' ' NZ ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -37.73 -28.93 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 O-C-N 118.337 -2.86 . . . . 0.0 111.017 176.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 1.105 ' O ' HD13 ' A' ' 34' ' ' ILE . 9.3 mtmm -81.27 151.77 27.93 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.105 HD13 ' O ' ' A' ' 33' ' ' LYS . 16.3 mm -128.96 160.3 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 119.926 -1.734 . . . . 0.0 110.039 177.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.778 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -151.14 70.01 0.97 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.392 -0.817 . . . . 0.0 108.842 179.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.291 ' CG1' HD12 ' A' ' 20' ' ' ILE 0.257 81.0 t -96.98 121.87 47.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 -178.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.881 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 7.6 mt-10 -108.39 147.41 31.61 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -176.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.705 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -141.41 111.59 6.8 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -174.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.946 HD12 ' CG ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -112.02 166.08 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.101 -0.999 . . . . 0.0 113.256 -178.182 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.732 ' HB2' ' CD ' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -100.6 160.61 14.21 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.546 -0.722 . . . . 0.0 111.376 178.164 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 1.137 HD11 ' C ' ' A' ' 56' ' ' VAL 0.251 0.2 OUTLIER -62.65 -16.2 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.735 -1.228 . . . . 0.0 110.584 179.737 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.725 ' N ' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -93.2 -14.18 27.44 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.723 -1.236 . . . . 0.0 111.664 179.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.653 HG12 ' OD1' ' A' ' 40' ' ' ASP . 9.9 p -114.11 -31.07 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.009 -1.057 . . . . 0.0 110.748 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.946 ' CG ' HD12 ' A' ' 39' ' ' ILE . 43.0 t0 -112.51 37.32 3.09 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.073 -1.051 . . . . 0.0 110.116 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.544 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.341 0.0 OUTLIER -66.34 -1.26 3.23 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 117.49 -1.684 . . . . 0.0 108.666 -177.972 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 1.19 ' O ' HG23 ' A' ' 49' ' ' ILE . 1.7 mt-10 -60.11 -21.16 61.2 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 174.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.903 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -44.48 -63.27 0.93 Allowed 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 123.626 1.679 . . . . 0.0 109.011 -177.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.193 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -55.86 -12.81 1.49 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 113.51 -1.677 . . . . 0.0 111.458 177.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.229 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.7 pp -25.07 -38.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 O-C-N 119.524 -1.985 . . . . 0.0 107.244 -178.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 1.229 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -55.55 -52.13 64.77 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 114.52 -1.218 . . . . 0.0 108.981 177.11 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.883 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 1.8 p90 -123.2 -28.63 3.98 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.239 -0.913 . . . . 0.0 110.014 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.767 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 43.22 5.12 0.01 OUTLIER Glycine 0 N--CA 1.504 3.179 0 CA-C-O 122.367 0.982 . . . . 0.0 111.835 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.739 ' N ' ' O ' ' A' ' 51' ' ' TYR . 8.7 mt -75.95 -75.95 0.17 Allowed 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 174.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.696 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 1.8 mtm -97.68 65.27 1.85 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 1.193 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.296 . . -108.57 109.27 20.46 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.165 -1.585 . . . . 0.0 109.074 -176.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.137 ' C ' HD11 ' A' ' 41' ' ' ILE . 2.6 t -147.83 -64.25 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.826 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.034 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.854 ' HD3' ' HB ' ' A' ' 56' ' ' VAL . 58.1 Cg_endo -105.64 104.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 N-CA-C 108.781 -1.276 . . . . 0.0 108.781 177.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 1.025 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -159.37 177.3 11.13 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 112.604 -2.089 . . . . 0.0 111.568 -176.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.244 HG23 ' O ' ' A' ' 6' ' ' GLU . 1.3 mp -146.07 153.04 13.51 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 O-C-N 121.502 -0.748 . . . . 0.0 109.124 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 1.014 ' HB3' ' HB3' ' A' ' 6' ' ' GLU 0.303 . . -87.3 154.62 20.55 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 102.67 -3.085 . . . . 0.0 102.67 -178.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.719 HG13 ' N ' ' A' ' 66' ' ' ARG 0.386 1.6 mt -103.72 93.42 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.599 0 N-CA-C 103.363 -2.828 . . . . 0.0 103.363 -175.357 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 1.042 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.2 OUTLIER -52.32 85.04 0.0 OUTLIER 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 111.602 -2.545 . . . . 0.0 106.121 179.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.792 ' HA3' ' HB2' ' A' ' 83' ' ' GLU . . . 162.46 -44.64 0.35 Allowed Glycine 0 C--N 1.289 -2.037 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 -178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.857 ' O ' HG23 ' A' ' 65' ' ' VAL . 11.3 m -127.44 -59.33 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.993 -0.71 . . . . 0.0 110.949 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.857 HG23 ' O ' ' A' ' 64' ' ' VAL . 76.1 t -164.68 -101.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.488 0 O-C-N 120.346 -1.471 . . . . 0.0 112.529 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 1.009 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -162.99 158.96 22.88 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.47 -0.769 . . . . 0.0 109.058 -178.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 1.025 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -147.07 178.25 8.51 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.804 -1.185 . . . . 0.0 111.498 -177.272 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.78 HG22 ' OH ' ' A' ' 51' ' ' TYR . 8.3 t -86.57 120.94 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.446 177.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.826 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.89 110.25 0.43 Allowed Glycine 0 N--CA 1.496 2.673 0 C-N-CA 118.066 -2.016 . . . . 0.0 110.349 178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.115 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -90.34 -80.52 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.087 -1.243 . . . . 0.0 108.546 178.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 1.115 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 55.9 Cg_endo -83.48 17.99 1.58 Allowed 'Trans proline' 0 C--N 1.301 -1.966 0 N-CA-C 108.897 -1.232 . . . . 0.0 108.897 177.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.464 ' O ' ' HB2' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -102.32 64.35 0.91 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.347 -0.846 . . . . 0.0 110.636 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.794 ' CZ ' ' CG ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -71.99 -40.43 68.57 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.04 -1.037 . . . . 0.0 109.293 178.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.764 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 2.0 tt0 -45.24 -37.63 4.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.39 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.779 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -47.41 -38.05 12.6 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.293 -179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.234 ' CG ' HG21 ' A' ' 59' ' ' ILE . 9.5 mp -64.96 -40.95 95.78 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.425 -0.797 . . . . 0.0 109.214 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.847 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.55 -36.3 73.7 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-O 121.864 0.84 . . . . 0.0 109.847 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -78.3 -31.69 48.98 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.64 -0.662 . . . . 0.0 110.6 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -70.58 -38.46 74.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.36 -0.837 . . . . 0.0 111.048 -179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.936 HG21 ' CG1' ' A' ' 23' ' ' VAL . 0.3 OUTLIER -64.2 -43.33 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 122.425 1.107 . . . . 0.0 109.183 179.079 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.452 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -70.24 -23.37 62.91 Favored 'General case' 0 C--O 1.2 -1.536 0 CA-C-O 117.899 -1.048 . . . . 0.0 109.179 176.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.371 0.2 OUTLIER -101.13 2.34 40.12 Favored 'General case' 0 C--O 1.263 1.778 0 C-N-CA 116.619 -2.032 . . . . 0.0 106.189 -178.064 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.844 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -90.12 -56.62 3.15 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 102.401 -3.185 . . . . 0.0 102.401 176.032 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.702 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 8.2 ptt? -70.53 -18.5 62.94 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.836 -1.165 . . . . 0.0 110.729 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 117.889 -1.053 . . . . 0.0 109.94 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.642 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.303 0.573 . . . . 0.0 110.201 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.027 HG22 ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -89.95 -92.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.295 -0.878 . . . . 0.0 109.947 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.186 HG11 ' OD2' ' A' ' 24' ' ' ASP . 75.1 t -89.15 112.42 24.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.55 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.841 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 1.0 OUTLIER -132.86 105.4 7.1 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.664 -1.273 . . . . 0.0 108.755 178.316 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.067 HG21 ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -120.4 138.17 51.8 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.812 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.063 ' HA ' ' O ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -131.3 122.76 26.99 Favored 'General case' 0 C--N 1.282 -2.335 0 C-N-CA 115.832 -2.347 . . . . 0.0 106.841 177.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.958 HG22 ' HA ' ' A' ' 38' ' ' LYS . 20.1 m -109.23 142.3 22.14 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.574 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.986 ' CD2' ' HB3' ' A' ' 58' ' ' ALA . 2.0 t80 -139.79 80.99 1.8 Allowed 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 117.979 -1.489 . . . . 0.0 112.823 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.701 ' OG1' ' HA ' ' A' ' 15' ' ' TYR . 3.4 m -117.81 -68.75 0.89 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 119.144 -2.222 . . . . 0.0 110.373 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.768 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 1.3 p 179.55 164.49 0.78 Allowed Pre-proline 0 C--N 1.293 -1.859 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.381 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.672 ' HD3' ' CG ' ' A' ' 40' ' ' ASP . 50.1 Cg_endo -80.27 -28.4 3.03 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 124.221 1.643 . . . . 0.0 110.424 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.81 -18.37 54.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.749 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.07 174.36 3.95 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.418 -0.801 . . . . 0.0 109.696 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.651 ' O ' ' O ' ' A' ' 15' ' ' TYR . 51.7 Cg_endo -83.01 114.55 2.26 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.914 1.481 . . . . 0.0 110.422 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.768 ' CE1' ' O ' ' A' ' 10' ' ' SER . 16.3 m-85 -49.26 -112.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.166 -0.959 . . . . 0.0 109.597 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.735 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 92.5 m -150.57 37.58 0.14 Allowed Pre-proline 0 N--CA 1.495 1.795 0 O-C-N 121.199 -0.938 . . . . 0.0 110.081 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.735 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 53.9 Cg_endo -76.51 17.06 0.81 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.92 1.484 . . . . 0.0 111.027 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.551 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -95.1 -67.97 0.83 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.075 -1.016 . . . . 0.0 110.79 -179.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.781 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -54.28 -22.59 12.26 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.216 -0.928 . . . . 0.0 109.512 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.067 ' HB ' HG21 ' A' ' 5' ' ' ILE . 5.1 pt -70.58 -39.18 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.485 -0.759 . . . . 0.0 109.678 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.739 ' N ' HG13 ' A' ' 20' ' ' ILE . 6.1 tt0 -48.88 -33.45 10.72 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 3.2 t -71.41 -47.42 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.898 HG21 ' HB ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -61.4 -32.96 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.018 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 1.186 ' OD2' HG11 ' A' ' 3' ' ' VAL . 5.2 t70 -68.18 -40.38 82.25 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.994 0.902 . . . . 0.0 109.145 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -46.52 83.12 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.666 0.746 . . . . 0.0 109.626 179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.485 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.31 -39.58 47.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.622 -0.674 . . . . 0.0 110.717 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.905 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -70.66 -18.18 62.85 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.917 -1.114 . . . . 0.0 109.328 -179.149 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.799 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -73.57 -45.05 55.71 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.222 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.74 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -50.14 -32.92 17.27 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.959 0.885 . . . . 0.0 110.465 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.783 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -97.19 -67.01 0.87 Allowed 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 106.203 -1.777 . . . . 0.0 106.203 179.09 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.755 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -84.97 86.29 1.56 Allowed Glycine 0 N--CA 1.505 3.261 0 C-N-CA 117.899 -2.096 . . . . 0.0 110.154 177.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.595 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -37.54 -29.29 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 O-C-N 118.319 -2.871 . . . . 0.0 110.188 177.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.836 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -78.63 155.56 29.5 Favored 'General case' 0 N--CA 1.507 2.39 0 O-C-N 121.822 -0.549 . . . . 0.0 111.774 178.189 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.799 ' CD1' ' CG ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -130.04 151.46 35.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 120.327 -1.483 . . . . 0.0 109.902 178.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.611 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -151.81 78.09 1.24 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.939 HG22 ' CD1' ' A' ' 5' ' ' ILE . 56.0 t -96.99 129.09 47.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 1.063 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 78.3 mt-10 -113.48 133.1 55.4 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.958 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -127.41 128.67 46.2 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 113.989 -1.459 . . . . 0.0 114.754 -177.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.069 HG22 ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -134.16 169.91 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 119.875 -1.766 . . . . 0.0 111.785 177.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.764 ' OD1' HG22 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -100.59 172.02 7.36 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.83 178.03 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.894 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -62.75 -37.88 80.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.711 -1.243 . . . . 0.0 109.36 178.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.678 ' HG3' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -80.95 -4.13 53.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.908 -1.12 . . . . 0.0 111.547 179.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.069 ' CG2' HG22 ' A' ' 39' ' ' ILE . 2.0 m -113.99 -45.97 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 120.954 -1.091 . . . . 0.0 110.033 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.933 ' HB2' HD12 ' A' ' 39' ' ' ILE . 1.6 t70 -105.27 41.84 1.31 Allowed 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.498 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.61 ' NH2' ' HA3' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -65.21 -1.71 2.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.118 -1.614 . . . . 0.0 109.5 -179.37 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 1.151 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.3 mm-40 -62.81 -23.42 67.25 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.265 178.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.87 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -44.45 -68.81 0.17 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.182 -0.949 . . . . 0.0 108.487 179.405 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.138 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -55.57 -10.14 0.62 Allowed 'General case' 0 C--O 1.194 -1.866 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.549 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.207 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.6 pp -23.98 -41.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 119.412 -2.055 . . . . 0.0 105.956 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 1.207 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -54.0 -53.15 56.96 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.443 -0.798 . . . . 0.0 108.853 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.916 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 25.9 p90 -119.96 -32.24 4.26 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.269 -0.894 . . . . 0.0 110.161 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.723 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 42.81 6.36 0.01 OUTLIER Glycine 0 N--CA 1.499 2.874 0 CA-C-O 122.288 0.938 . . . . 0.0 111.572 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.714 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 4.5 mt -74.43 -80.66 0.08 Allowed 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.542 ' C ' ' HE2' ' A' ' 51' ' ' TYR 0.265 4.1 mtp -95.37 67.24 2.92 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.135 177.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 1.138 ' HB2' ' CB ' ' A' ' 48' ' ' ALA . . . -109.46 120.2 41.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 119.62 -1.925 . . . . 0.0 109.922 -178.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.828 HG23 ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -149.12 -56.39 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.936 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.722 -178.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.828 ' HD3' HG23 ' A' ' 56' ' ' VAL . 57.7 Cg_endo -111.63 109.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 122.931 0.964 . . . . 0.0 110.263 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 1.002 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -161.36 174.93 12.8 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.185 -1.371 . . . . 0.0 110.901 -178.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.039 ' CG1' HD21 ' A' ' 76' ' ' LEU . 0.3 OUTLIER -134.86 154.64 36.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.42 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 1.01 ' HB3' ' HB3' ' A' ' 6' ' ' GLU 0.26 . . -93.16 157.22 16.39 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 102.71 -3.07 . . . . 0.0 102.71 179.925 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.761 HG13 ' N ' ' A' ' 66' ' ' ARG 0.263 1.1 mt -101.87 91.94 2.2 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.54 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 -176.317 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.841 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -53.71 83.08 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -178.072 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.708 ' HA3' ' HB2' ' A' ' 83' ' ' GLU . . . 162.36 -43.49 0.36 Allowed Glycine 0 C--N 1.283 -2.363 0 N-CA-C 107.649 -2.181 . . . . 0.0 107.649 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.821 ' O ' HG23 ' A' ' 65' ' ' VAL . 11.9 m -126.95 -58.86 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.851 -0.794 . . . . 0.0 111.097 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 64' ' ' VAL . 81.0 t -163.78 -100.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 120.32 -1.488 . . . . 0.0 113.268 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 1.002 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 1.8 ttp180 -168.45 159.57 10.47 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.547 -0.72 . . . . 0.0 109.396 -177.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 1.002 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -146.37 175.05 10.83 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.144 -0.973 . . . . 0.0 111.865 -177.33 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.756 ' CG2' ' HZ1' ' A' ' 47' ' ' LYS . 79.8 t -82.41 119.33 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.665 -0.647 . . . . 0.0 110.133 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.84 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.77 107.63 0.31 Allowed Glycine 0 N--CA 1.492 2.426 0 C-N-CA 118.655 -1.736 . . . . 0.0 110.578 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.118 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -88.57 -81.2 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.036 -1.273 . . . . 0.0 108.539 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 1.118 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 56.5 Cg_endo -84.5 18.52 1.54 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 O-C-N 123.407 1.214 . . . . 0.0 109.006 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.62 61.78 0.71 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.583 -0.698 . . . . 0.0 110.493 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.726 ' HG2' ' CB ' ' A' ' 16' ' ' CYS . 22.2 mtt180 -68.35 -32.25 72.21 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.849 -0.741 . . . . 0.0 109.276 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.781 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.2 tm-20 -47.44 -45.39 25.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 109.59 179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.78 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -45.18 -29.11 0.88 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.061 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.039 HD21 ' CG1' ' A' ' 59' ' ' ILE . 3.2 mp -70.58 -39.96 73.56 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.511 -0.743 . . . . 0.0 109.059 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.855 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.11 -41.89 89.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.47 -0.769 . . . . 0.0 109.829 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.528 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 2.4 tm-20 -76.41 -27.99 56.5 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.248 0.547 . . . . 0.0 109.76 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.655 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -69.32 -42.54 75.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.04 -1.038 . . . . 0.0 111.286 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.044 ' CD1' HG23 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -61.97 -45.36 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.043 -1.035 . . . . 0.0 108.814 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.697 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -71.68 -27.07 62.79 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.45 0.643 . . . . 0.0 109.442 178.237 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 1.068 ' O ' ' OD1' ' A' ' 82' ' ' ASP 0.287 0.2 OUTLIER -97.69 8.14 45.2 Favored 'General case' 0 C--O 1.196 -1.762 0 O-C-N 118.918 -2.364 . . . . 0.0 107.82 -178.69 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.783 ' HG2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -101.17 -57.77 2.02 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 178.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.697 ' HE2' ' HA ' ' A' ' 81' ' ' ASN . 21.4 ptt? -68.23 -15.59 63.64 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.82 176.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.039 179.952 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.922 ' O ' ' HE3' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.31 0.576 . . . . 0.0 110.193 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.951 HG22 ' N ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -80.66 -94.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.157 -0.964 . . . . 0.0 110.195 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.96 HG11 ' CG ' ' A' ' 24' ' ' ASP . 54.6 t -93.03 91.31 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.422 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 1.053 ' H ' HD11 ' A' ' 80' ' ' ILE . 0.2 OUTLIER -116.88 108.01 15.3 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.942 0.877 . . . . 0.0 109.262 178.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.119 HG21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.07 141.18 45.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 O-C-N 121.283 -0.886 . . . . 0.0 110.306 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.135 ' CB ' ' HB3' ' A' ' 60' ' ' ALA 0.255 5.4 tt0 -130.12 101.9 6.01 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 117.708 -1.597 . . . . 0.0 109.235 178.134 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.86 HG12 ' CD2' ' A' ' 76' ' ' LEU . 3.3 m -95.52 110.45 24.22 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.423 0 CA-C-O 123.412 1.577 . . . . 0.0 108.085 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.883 ' CD2' ' HB3' ' A' ' 58' ' ' ALA . 1.6 t80 -118.51 91.03 3.46 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 120.965 -1.084 . . . . 0.0 110.203 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.94 HG22 ' N ' ' A' ' 10' ' ' SER . 0.7 OUTLIER -120.22 -69.62 0.83 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.777 . . . . 0.0 109.629 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.94 ' N ' HG22 ' A' ' 9' ' ' THR . 21.6 t 179.68 152.14 0.56 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 110.831 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 40' ' ' ASP . 49.8 Cg_endo -77.22 -15.94 15.83 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 124.175 1.618 . . . . 0.0 110.495 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 t -79.27 5.9 11.21 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.171 -0.956 . . . . 0.0 109.898 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.651 ' SG ' ' CD ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -160.8 -170.94 0.26 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 0.0 110.153 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.651 ' CD ' ' SG ' ' A' ' 13' ' ' CYS . 55.3 Cg_endo -84.2 113.54 1.79 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.882 1.464 . . . . 0.0 110.667 177.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.662 ' HA ' ' HB ' ' A' ' 9' ' ' THR . 7.4 m-85 -49.55 -112.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.627 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.866 ' CB ' HD11 ' A' ' 59' ' ' ILE . 58.5 m -152.34 39.19 0.14 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.043 -1.036 . . . . 0.0 110.414 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.706 ' HD3' ' N ' ' A' ' 16' ' ' CYS . 54.0 Cg_endo -76.9 17.17 0.85 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.9 1.474 . . . . 0.0 111.023 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.718 ' SD ' ' N ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -93.36 -64.71 1.06 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.092 -1.005 . . . . 0.0 112.078 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.825 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -55.96 -22.42 26.29 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.294 -0.879 . . . . 0.0 109.779 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.119 ' HB ' HG21 ' A' ' 5' ' ' ILE . 0.6 OUTLIER -71.28 -39.69 72.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.503 -0.748 . . . . 0.0 109.531 179.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.92 ' N ' HD12 ' A' ' 20' ' ' ILE . 3.1 tt0 -48.77 -31.83 7.62 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 2.8 t -71.59 -44.96 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.321 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.833 ' CG2' ' HA ' ' A' ' 77' ' ' PHE . 0.6 OUTLIER -68.71 -26.54 33.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.301 -0.874 . . . . 0.0 109.22 178.418 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.96 ' CG ' HG11 ' A' ' 3' ' ' VAL . 14.1 t0 -74.67 -38.72 62.34 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -44.53 91.62 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.666 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.529 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.76 -40.13 29.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.456 -0.777 . . . . 0.0 110.443 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.778 ' N ' ' HE3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.3 -22.79 64.7 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.092 -179.434 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 1.049 ' HG3' HD12 ' A' ' 34' ' ' ILE . 3.5 mtpt -69.93 -44.59 69.3 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 177.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.802 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -50.14 -39.98 44.95 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.681 0.753 . . . . 0.0 109.079 178.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.802 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.67 -55.22 3.73 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.786 ' O ' HG21 ' A' ' 2' ' ' VAL . . . -96.73 77.38 0.71 Allowed Glycine 0 N--CA 1.488 2.161 0 O-C-N 121.398 -0.814 . . . . 0.0 111.07 179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.543 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -33.45 -24.64 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 118.998 1.399 . . . . 0.0 110.424 -179.567 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.994 ' C ' HD13 ' A' ' 34' ' ' ILE . 1.1 mtmp? -85.42 155.57 21.21 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.131 -0.98 . . . . 0.0 110.813 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.049 HD12 ' HG3' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -129.33 149.48 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.939 178.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.688 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 36.3 t0 -150.31 71.9 1.08 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.495 -0.753 . . . . 0.0 109.254 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.824 HG22 ' CG1' ' A' ' 5' ' ' ILE . 58.4 t -91.34 117.39 34.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.57 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.809 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.25 91.1 mt-10 -100.5 138.06 38.07 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.433 -1.307 . . . . 0.0 108.301 -178.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.737 ' HB3' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -140.62 126.67 19.55 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.725 -1.235 . . . . 0.0 111.598 -177.383 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.116 HG22 HG21 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -139.65 176.0 6.39 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 O-C-N 121.486 -0.759 . . . . 0.0 109.653 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.738 ' CG ' HG13 ' A' ' 43' ' ' VAL . 2.1 p30 -114.22 172.9 6.73 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.858 -1.152 . . . . 0.0 111.947 178.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.856 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.7 OUTLIER -62.27 -5.29 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.41 -0.806 . . . . 0.0 112.03 176.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.738 ' HG3' ' CG1' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -99.94 -18.56 17.03 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.019 -1.051 . . . . 0.0 111.048 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.116 HG21 HG22 ' A' ' 39' ' ' ILE . 0.7 OUTLIER -113.01 -37.08 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.19 -0.944 . . . . 0.0 110.056 -178.389 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 1.034 ' HB2' HD12 ' A' ' 39' ' ' ILE . 5.2 t0 -114.22 52.52 0.83 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.2 -0.938 . . . . 0.0 110.977 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.416 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.255 72.2 ttt180 -65.87 -5.58 9.57 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.315 -1.354 . . . . 0.0 109.575 -179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 1.0 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.6 OUTLIER -60.11 -15.39 23.09 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.344 -0.848 . . . . 0.0 110.058 176.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.842 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -52.17 -58.46 6.54 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.124 -178.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.139 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -63.94 -0.8 1.2 Allowed 'General case' 0 C--N 1.279 -2.471 0 O-C-N 121.331 -0.856 . . . . 0.0 110.73 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.0 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -35.07 -38.7 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 -177.003 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.581 ' N ' ' C ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -53.73 -51.91 61.82 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.165 176.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.994 ' CZ ' HG22 ' A' ' 68' ' ' VAL . 1.6 p90 -123.2 -28.22 4.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.085 -1.009 . . . . 0.0 110.449 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.8 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.45 14.18 0.01 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.732 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.4 mt -85.87 -64.92 1.07 Allowed 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 123.674 1.702 . . . . 0.0 107.931 177.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.503 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 10.0 mtt -105.86 58.12 0.66 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.253 -1.34 . . . . 0.0 107.776 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 1.139 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.264 . . -99.0 106.78 19.08 Favored 'General case' 0 C--N 1.296 -1.761 0 CA-C-O 123.467 1.604 . . . . 0.0 110.782 -175.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.789 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -146.72 -60.63 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.21 179.037 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.789 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 46.8 Cg_endo -100.0 104.76 0.05 OUTLIER 'Trans proline' 0 C--O 1.199 -1.47 0 CA-C-O 123.495 1.373 . . . . 0.0 110.429 179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 1.031 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -160.14 -177.86 6.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.538 -1.352 . . . . 0.0 111.572 -178.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.266 ' CG1' HD11 ' A' ' 76' ' ' LEU . 0.6 OUTLIER -149.16 137.18 14.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 1.135 ' HB3' ' CB ' ' A' ' 6' ' ' GLU . . . -80.87 140.44 35.36 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 117.155 -1.818 . . . . 0.0 106.987 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.762 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.413 0.7 OUTLIER -89.39 85.91 2.52 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.539 0 C-N-CA 115.302 -2.559 . . . . 0.0 106.058 -175.994 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.773 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.7 OUTLIER -44.12 83.24 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 113.098 -1.865 . . . . 0.0 108.622 177.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.762 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.07 -44.24 0.37 Allowed Glycine 0 N--CA 1.484 1.891 0 N-CA-C 107.042 -2.423 . . . . 0.0 107.042 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.786 ' O ' HG23 ' A' ' 65' ' ' VAL . 16.6 m -126.69 -59.13 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 O-C-N 121.622 -0.928 . . . . 0.0 111.378 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 64' ' ' VAL . 97.0 t -163.85 -106.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 120.289 -1.507 . . . . 0.0 112.249 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 1.072 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 1.8 ttp180 -162.4 165.47 26.35 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.716 -0.615 . . . . 0.0 109.55 -178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 1.031 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.0 177.83 8.48 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.97 -1.082 . . . . 0.0 111.06 -178.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.994 HG22 ' CZ ' ' A' ' 51' ' ' TYR . 22.5 t -93.18 116.55 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.297 -0.877 . . . . 0.0 109.865 178.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.832 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.41 126.58 1.58 Allowed Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.59 -1.291 . . . . 0.0 110.229 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.063 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -94.03 -83.05 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.759 0 O-C-N 120.921 -1.341 . . . . 0.0 108.709 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 1.063 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 51.4 Cg_endo -80.73 23.81 0.7 Allowed 'Trans proline' 0 C--N 1.308 -1.563 0 N-CA-C 109.11 -1.15 . . . . 0.0 109.11 177.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.51 70.52 1.96 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.238 -0.913 . . . . 0.0 111.432 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.742 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 11.9 mtm180 -76.77 -35.28 57.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.997 -1.064 . . . . 0.0 109.536 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.825 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -49.02 -32.29 9.05 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 109.664 179.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.781 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -50.9 -40.18 56.1 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.295 -0.878 . . . . 0.0 109.273 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.266 HD11 ' CG1' ' A' ' 59' ' ' ILE . 4.9 mp -64.32 -38.32 90.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.491 -0.755 . . . . 0.0 109.318 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.833 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -60.76 -42.94 98.43 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.868 179.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.803 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 4.5 tm-20 -78.54 -23.31 46.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.32 -0.862 . . . . 0.0 109.851 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.658 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -73.71 -37.01 65.3 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.245 -0.909 . . . . 0.0 109.446 -178.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.053 HD11 ' H ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -63.44 -46.08 96.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.067 -1.02 . . . . 0.0 109.076 178.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.593 ' N ' HG22 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -70.11 -33.59 72.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.35 -0.844 . . . . 0.0 108.742 179.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.448 8.0 t70 -88.08 -6.9 57.67 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 114.79 -2.764 . . . . 0.0 107.582 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.748 ' OE1' ' CA ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -81.14 -60.79 2.16 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 120.114 -1.617 . . . . 0.0 109.596 171.234 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.721 ' HE2' ' HZ3' ' A' ' 27' ' ' LYS . 10.3 ptt? -71.62 -12.29 61.27 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.71 -0.619 . . . . 0.0 110.497 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.599 ' CG ' ' OXT' ' A' ' 85' ' ' GLU . 2.1 tt0 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.177 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.2 ttm . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.248 0.547 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.972 HG22 ' N ' ' A' ' 3' ' ' VAL . 0.9 OUTLIER -80.51 -92.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 110.389 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.972 ' N ' HG22 ' A' ' 2' ' ' VAL . 54.6 t -92.76 119.76 40.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 121.671 -0.643 . . . . 0.0 110.495 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.8 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 9.4 t30 -138.49 114.57 10.14 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.571 1.177 . . . . 0.0 108.865 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.083 HD12 HD13 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -136.15 149.6 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.197 -0.94 . . . . 0.0 110.724 -179.05 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.084 ' HB3' ' HB3' ' A' ' 60' ' ' ALA . 13.6 tt0 -135.09 106.11 6.64 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.007 -1.477 . . . . 0.0 109.701 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.855 HG22 ' HA ' ' A' ' 38' ' ' LYS . 22.3 m -95.16 104.3 15.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 CA-C-O 123.1 1.429 . . . . 0.0 108.808 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.893 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 0.7 OUTLIER -117.08 87.91 2.8 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.049 -1.032 . . . . 0.0 109.564 -178.756 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 57' ' ' PRO . 6.6 m -120.72 -62.72 1.42 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.352 -0.842 . . . . 0.0 109.586 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 1.055 ' HA ' HG22 ' A' ' 41' ' ' ILE . 12.8 p 179.81 156.41 0.72 Allowed Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.369 -0.832 . . . . 0.0 111.009 179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.644 ' HD3' ' CG ' ' A' ' 40' ' ' ASP . 50.8 Cg_endo -84.77 -23.71 2.51 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 124.222 1.643 . . . . 0.0 110.589 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 t -79.37 13.65 1.86 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.159 -0.963 . . . . 0.0 110.055 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.543 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -160.72 -174.27 0.42 Allowed Pre-proline 0 N--CA 1.487 1.402 0 O-C-N 121.417 -0.802 . . . . 0.0 110.184 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.614 ' O ' ' O ' ' A' ' 15' ' ' TYR . 54.4 Cg_endo -84.16 112.09 1.67 Allowed 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 123.909 1.478 . . . . 0.0 110.689 177.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.755 ' CE1' ' O ' ' A' ' 10' ' ' SER . 19.3 m-85 -49.45 -110.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.311 -0.868 . . . . 0.0 109.609 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.757 ' CA ' ' HG3' ' A' ' 73' ' ' ARG . 37.6 m -154.81 39.78 0.13 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.027 -1.046 . . . . 0.0 110.57 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.688 ' HD3' ' N ' ' A' ' 16' ' ' CYS . 55.2 Cg_endo -77.26 16.56 1.0 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.767 1.404 . . . . 0.0 110.802 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.559 ' HB3' ' HG2' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -93.27 -64.28 1.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.996 -1.082 . . . . 0.0 112.142 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.722 ' CB ' ' HB3' ' A' ' 73' ' ' ARG . . . -57.48 -18.43 18.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.274 -0.891 . . . . 0.0 109.665 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.096 HG22 ' CB ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -75.71 -39.58 39.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.393 -0.817 . . . . 0.0 109.477 179.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.722 ' N ' HD12 ' A' ' 20' ' ' ILE . 29.8 tp10 -50.4 -32.84 18.72 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.4 t -70.29 -44.45 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.21 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.865 HG13 HG21 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -69.23 -28.08 37.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.673 0.749 . . . . 0.0 109.379 178.578 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.901 ' CG ' HG11 ' A' ' 3' ' ' VAL . 8.4 t0 -76.11 -36.75 58.73 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.7 -43.6 94.04 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.535 0.683 . . . . 0.0 109.623 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.502 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.9 -40.05 29.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.478 -0.764 . . . . 0.0 110.11 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.748 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -69.24 -22.23 63.87 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.145 -1.022 . . . . 0.0 109.218 -179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 1.036 ' CG ' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -69.92 -43.22 72.13 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 177.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.773 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -49.48 -39.63 34.33 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.788 0.804 . . . . 0.0 109.037 178.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.773 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.2 -56.68 3.18 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.746 ' O ' HG21 ' A' ' 2' ' ' VAL . . . -97.16 77.84 0.67 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.624 -0.991 . . . . 0.0 110.624 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.568 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -32.37 -27.16 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 119.105 1.452 . . . . 0.0 110.527 -179.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 1.129 ' C ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -85.95 157.05 20.24 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.347 -0.846 . . . . 0.0 110.938 178.202 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.129 HD12 ' C ' ' A' ' 33' ' ' LYS . 1.7 mp -128.98 157.98 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.044 -1.035 . . . . 0.0 110.765 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.692 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 3.4 t0 -150.21 62.48 0.97 Allowed 'General case' 0 C--N 1.307 -1.256 0 O-C-N 121.459 -0.775 . . . . 0.0 109.166 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.753 HG22 ' CD1' ' A' ' 5' ' ' ILE . 63.5 t -91.27 115.86 31.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 122.264 1.031 . . . . 0.0 109.862 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.74 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 3.5 mm-40 -97.94 145.08 26.82 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.065 -1.054 . . . . 0.0 108.932 -179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 1.033 ' C ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -139.98 121.48 15.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.075 -1.016 . . . . 0.0 111.453 -176.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.033 HD13 ' C ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -129.06 178.2 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 110.354 -179.152 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.737 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -113.88 165.65 12.37 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.217 -0.927 . . . . 0.0 111.06 178.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 1.238 ' CD1' HG12 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -49.58 -38.82 13.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.512 -0.743 . . . . 0.0 112.769 177.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.737 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 0.9 OUTLIER -86.88 -3.46 59.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.844 -1.16 . . . . 0.0 111.483 -179.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.026 ' CG2' HG22 ' A' ' 39' ' ' ILE . 1.9 m -111.15 -44.07 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.97 -1.081 . . . . 0.0 109.801 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.761 ' HB2' ' CB ' ' A' ' 39' ' ' ILE . 4.0 t70 -112.37 45.37 1.3 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.356 -0.84 . . . . 0.0 110.029 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.682 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 2.4 ttt-85 -61.28 -4.64 1.26 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.849 -1.14 . . . . 0.0 109.469 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 1.071 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.1 mm-40 -55.02 -19.74 7.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.396 -0.815 . . . . 0.0 110.253 176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.843 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -50.22 -59.1 4.28 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 122.413 1.102 . . . . 0.0 110.067 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.157 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -65.37 -0.09 1.71 Allowed 'General case' 0 C--N 1.281 -2.399 0 O-C-N 121.555 -0.716 . . . . 0.0 111.094 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.27 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.4 pp -35.64 -36.92 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 104.207 -2.516 . . . . 0.0 104.207 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 1.27 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.8 OUTLIER -54.09 -52.54 60.67 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.889 -1.051 . . . . 0.0 109.047 176.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 1.049 ' OH ' HG22 ' A' ' 68' ' ' VAL . 2.0 p90 -122.75 -28.22 4.19 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.088 -1.007 . . . . 0.0 110.203 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.789 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.62 14.3 0.01 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.657 ' N ' ' O ' ' A' ' 51' ' ' TYR . 4.4 mt -86.09 -62.77 1.44 Allowed 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 123.122 1.439 . . . . 0.0 108.462 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 19.9 mtp -106.72 53.83 0.69 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.158 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 1.157 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.268 . . -98.94 111.14 23.62 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 123.189 1.471 . . . . 0.0 110.903 -176.142 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.238 HG12 ' CD1' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -146.68 -68.38 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 110.459 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.844 ' HD3' ' CG2' ' A' ' 56' ' ' VAL . 51.0 Cg_endo -96.14 103.81 0.1 OUTLIER 'Trans proline' 0 C--O 1.2 -1.423 0 CA-C-O 123.396 1.332 . . . . 0.0 109.742 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 1.035 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -158.11 175.14 14.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.75 -1.219 . . . . 0.0 111.562 -178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.03 ' CG1' HD21 ' A' ' 76' ' ' LEU . 1.0 OUTLIER -138.39 135.58 44.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.613 -179.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 1.084 ' HB3' ' HB3' ' A' ' 6' ' ' GLU . . . -81.51 139.59 35.06 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 117.361 -1.736 . . . . 0.0 107.058 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.756 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.372 1.0 OUTLIER -88.55 83.4 2.2 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.346 0 CA-C-O 124.786 2.232 . . . . 0.0 106.824 -175.895 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.8 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 4.5 m120 -43.11 82.68 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 113.616 -1.629 . . . . 0.0 108.767 178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.756 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.04 -44.52 0.37 Allowed Glycine 0 N--CA 1.481 1.694 0 N-CA-C 107.414 -2.275 . . . . 0.0 107.414 -177.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.761 ' O ' HG23 ' A' ' 65' ' ' VAL . 17.0 m -125.78 -59.82 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 121.718 -0.872 . . . . 0.0 110.98 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.766 HG12 ' N ' ' A' ' 66' ' ' ARG . 88.6 t -163.81 -107.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 120.312 -1.492 . . . . 0.0 112.288 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 1.045 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 2.0 ttp180 -164.7 163.53 21.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.631 -0.668 . . . . 0.0 109.671 -178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 1.035 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -144.76 176.86 9.13 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.896 -1.127 . . . . 0.0 111.366 -178.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.049 HG22 ' OH ' ' A' ' 51' ' ' TYR . 79.8 t -89.14 115.82 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.651 178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.858 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.57 124.8 1.31 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.629 -1.272 . . . . 0.0 110.564 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.093 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -92.85 -79.68 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 120.882 -1.364 . . . . 0.0 108.396 178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 1.093 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 55.2 Cg_endo -81.01 25.29 0.64 Allowed 'Trans proline' 0 C--N 1.313 -1.342 0 O-C-N 123.595 1.313 . . . . 0.0 109.228 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . 0.273 28.5 m -102.67 82.84 2.19 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 123.269 1.509 . . . . 0.0 110.007 -179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.757 ' HG3' ' CA ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -77.94 -35.74 50.1 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.947 -1.096 . . . . 0.0 109.988 177.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.71 ' HG2' ' CD2' ' A' ' 77' ' ' PHE . 0.0 OUTLIER -46.1 -30.13 1.78 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.362 -0.836 . . . . 0.0 109.99 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.806 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -50.91 -42.69 59.56 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.27 -0.894 . . . . 0.0 109.193 179.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.096 ' CB ' HG22 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -63.49 -45.57 90.13 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.604 -0.685 . . . . 0.0 109.492 178.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.798 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -60.93 -38.57 86.26 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.639 0.733 . . . . 0.0 110.245 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.613 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 25.4 tt0 -80.22 -21.9 42.39 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.267 -0.896 . . . . 0.0 110.202 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.476 ' HB1' ' HA ' ' A' ' 61' ' ' ILE . . . -77.95 -39.77 41.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.207 -0.933 . . . . 0.0 109.643 -177.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.014 ' CD1' HG23 ' A' ' 5' ' ' ILE . 1.5 mp -65.72 -39.7 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.038 -1.039 . . . . 0.0 109.156 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.573 ' C ' ' OD1' ' A' ' 81' ' ' ASN . 0.1 OUTLIER -75.53 -32.02 60.32 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.118 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.613 ' HB3' ' O ' ' A' ' 78' ' ' GLU 0.455 0.4 OUTLIER -89.03 -8.39 54.09 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 114.989 -2.685 . . . . 0.0 108.115 -179.159 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.744 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -78.9 -60.71 2.27 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 119.968 -1.708 . . . . 0.0 110.196 169.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.639 ' SD ' ' HD2' ' A' ' 27' ' ' LYS . 4.7 ptt? -71.88 -9.16 57.93 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.782 -0.574 . . . . 0.0 110.822 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.572 ' OE2' ' C ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.898 -1.049 . . . . 0.0 109.973 -177.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.226 0.536 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.065 HG21 ' O ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -80.5 -92.87 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.333 -0.854 . . . . 0.0 110.359 179.851 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.954 ' N ' HG22 ' A' ' 2' ' ' VAL . 53.6 t -91.51 128.49 43.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.483 -0.76 . . . . 0.0 110.565 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.786 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 63.3 t30 -140.3 108.38 5.75 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 123.202 1.477 . . . . 0.0 108.604 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.047 HD12 ' HB ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -136.15 135.92 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 O-C-N 120.747 -1.221 . . . . 0.0 112.061 -178.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.15 ' O ' HG23 ' A' ' 59' ' ' ILE 0.253 1.4 tp10 -122.66 102.06 7.83 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 123.196 1.474 . . . . 0.0 108.587 176.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.8 ' CG2' ' CB ' ' A' ' 38' ' ' LYS . 29.5 m -95.42 106.39 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-O 123.582 1.658 . . . . 0.0 109.51 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.841 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 1.1 t80 -117.92 102.15 8.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.071 -1.018 . . . . 0.0 109.76 -179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.846 HG22 ' N ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -134.0 -61.9 0.78 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.955 . . . . 0.0 110.214 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 1.027 ' HA ' HG22 ' A' ' 41' ' ' ILE . 3.1 t -175.13 144.63 0.82 Allowed Pre-proline 0 N--CA 1.487 1.386 0 O-C-N 121.118 -0.989 . . . . 0.0 111.152 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.752 ' N ' ' HB2' ' A' ' 40' ' ' ASP . 48.7 Cg_endo -76.76 -9.39 18.31 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 O-C-N 124.135 1.597 . . . . 0.0 110.475 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.95 -5.0 52.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.21 -0.931 . . . . 0.0 109.843 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.624 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 1.4 p -160.61 -166.15 0.14 Allowed Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.385 -0.822 . . . . 0.0 110.056 -179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.624 ' CD ' ' CB ' ' A' ' 13' ' ' CYS . 55.6 Cg_endo -84.17 117.8 2.23 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.863 1.454 . . . . 0.0 110.617 176.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.773 ' HD2' HG23 ' A' ' 7' ' ' VAL . 2.1 m-85 -49.27 -84.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.0 109.56 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.814 ' HB3' HD11 ' A' ' 76' ' ' LEU . 42.2 m -155.22 39.69 0.12 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.124 -0.985 . . . . 0.0 109.968 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.7 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 53.4 Cg_endo -73.78 30.4 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.881 1.464 . . . . 0.0 111.146 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.4 ' H ' ' C ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -110.17 -61.85 1.6 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.029 -1.044 . . . . 0.0 110.433 -179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.9 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -58.1 -20.06 37.03 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.464 -0.773 . . . . 0.0 110.062 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.047 ' HB ' HD12 ' A' ' 5' ' ' ILE . 23.0 pt -75.62 -39.07 39.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.479 -0.763 . . . . 0.0 109.513 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.672 ' N ' HG13 ' A' ' 20' ' ' ILE . 49.7 tt0 -49.63 -35.86 22.56 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.8 -42.46 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.048 178.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.912 HG13 HG21 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -70.88 -26.66 28.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 CA-C-O 121.825 0.821 . . . . 0.0 109.185 178.299 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.698 ' OD2' HG11 ' A' ' 3' ' ' VAL . 4.6 t70 -76.9 -35.84 57.09 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.89 -43.99 91.07 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.622 0.725 . . . . 0.0 109.321 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.529 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.44 -41.01 28.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.622 -0.674 . . . . 0.0 110.165 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.813 ' CE ' ' CE ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -67.72 -23.38 65.26 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.306 -179.404 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -69.32 -46.42 67.14 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.791 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -47.47 -41.0 19.69 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.585 0.707 . . . . 0.0 109.124 178.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.791 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.57 -57.87 2.72 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.731 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -97.15 78.28 0.67 Allowed Glycine 0 N--CA 1.488 2.111 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.583 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -33.46 -27.24 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 119.394 1.597 . . . . 0.0 110.101 -179.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 1.065 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -88.72 158.02 18.33 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.197 -0.939 . . . . 0.0 111.339 178.366 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.792 HG23 HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -129.47 151.03 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.406 -0.917 . . . . 0.0 110.685 178.127 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.574 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -138.82 61.14 1.58 Allowed 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.445 -0.784 . . . . 0.0 108.97 179.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.025 HG13 ' HB ' ' A' ' 5' ' ' ILE . 44.6 t -91.59 115.48 30.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 122.454 1.121 . . . . 0.0 109.681 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.753 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.25 12.2 mt-10 -98.07 141.02 31.53 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 118.63 -1.228 . . . . 0.0 108.375 -178.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.8 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -138.45 130.9 28.94 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.765 -1.21 . . . . 0.0 112.127 -176.748 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.013 HD12 ' CG ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -138.53 173.12 12.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.525 -0.734 . . . . 0.0 110.006 179.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 1.071 ' CG ' HG12 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -105.84 169.68 8.34 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.102 -0.999 . . . . 0.0 110.889 179.234 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 1.258 ' CD1' HG22 ' A' ' 56' ' ' VAL . 0.6 OUTLIER -73.16 -19.32 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.444 -0.785 . . . . 0.0 111.598 179.16 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.756 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 2.4 ptt? -90.62 -18.1 25.75 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.06 -1.025 . . . . 0.0 110.634 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.071 HG12 ' CG ' ' A' ' 40' ' ' ASP . 13.3 p -110.01 -29.78 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.344 -0.847 . . . . 0.0 110.77 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 1.013 ' CG ' HD12 ' A' ' 39' ' ' ILE . 5.7 t0 -114.7 48.19 1.16 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.021 -1.049 . . . . 0.0 110.843 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.26 2.3 ttt180 -59.09 -8.29 1.45 Allowed 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 118.263 -1.375 . . . . 0.0 109.974 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.988 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.5 OUTLIER -61.34 -13.41 19.32 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 109.175 175.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.813 ' HG2' ' HB3' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -51.71 -60.16 3.47 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 122.168 0.985 . . . . 0.0 108.959 -178.521 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.134 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -64.2 1.57 0.71 Allowed 'General case' 0 C--N 1.278 -2.533 0 O-C-N 121.119 -0.988 . . . . 0.0 110.55 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.077 HD11 ' NE ' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -35.67 -38.77 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 -177.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.56 ' N ' ' C ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -54.62 -49.36 70.68 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.668 176.717 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.825 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -124.93 -28.55 3.46 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.999 -1.063 . . . . 0.0 110.411 179.21 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.787 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.14 13.3 0.01 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.66 ' N ' ' O ' ' A' ' 51' ' ' TYR . 6.2 mt -86.52 -60.94 1.85 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 123.526 1.631 . . . . 0.0 107.88 177.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.533 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 26.0 mtm -110.55 62.35 0.6 Allowed 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.443 -1.253 . . . . 0.0 107.633 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 1.134 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.278 . . -98.35 107.78 20.32 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 123.622 1.677 . . . . 0.0 111.124 -174.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.258 HG22 ' CD1' ' A' ' 41' ' ' ILE . 1.6 t -146.66 -68.42 0.02 OUTLIER Pre-proline 0 N--CA 1.484 1.232 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.23 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.845 ' CD ' HG12 ' A' ' 56' ' ' VAL . 55.6 Cg_endo -104.22 93.46 0.03 OUTLIER 'Trans proline' 0 C--O 1.201 -1.327 0 CA-C-O 123.528 1.386 . . . . 0.0 111.257 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 1.097 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -151.2 179.32 8.4 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.32 -1.488 . . . . 0.0 110.957 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.264 HG21 ' CD2' ' A' ' 76' ' ' LEU . 1.4 mp -149.92 147.47 16.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.463 -0.773 . . . . 0.0 110.508 -179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.927 ' HB3' ' CB ' ' A' ' 6' ' ' GLU . . . -81.59 137.9 35.44 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.755 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.406 1.0 OUTLIER -87.8 82.34 2.05 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.555 0 C-N-CA 115.318 -2.553 . . . . 0.0 105.277 -175.756 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.786 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -44.3 85.67 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 113.3 -1.773 . . . . 0.0 107.851 177.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.755 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.0 -47.12 0.38 Allowed Glycine 0 N--CA 1.482 1.716 0 N-CA-C 106.471 -2.652 . . . . 0.0 106.471 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.787 ' O ' HG23 ' A' ' 65' ' ' VAL . 11.9 m -124.49 -60.86 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 O-C-N 121.82 -0.812 . . . . 0.0 111.094 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.805 HG12 ' N ' ' A' ' 66' ' ' ARG . 96.7 t -164.01 -107.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 120.104 -1.623 . . . . 0.0 113.185 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 1.077 ' NE ' HD11 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -156.18 153.69 29.64 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.671 -0.643 . . . . 0.0 110.13 -177.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 1.097 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.52 -174.93 4.53 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.905 -1.122 . . . . 0.0 111.836 -178.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.92 122.95 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.812 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.33 105.59 0.26 Allowed Glycine 0 N--CA 1.488 2.163 0 C-N-CA 118.865 -1.636 . . . . 0.0 111.153 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.103 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -89.74 -82.74 0.02 OUTLIER Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 120.824 -1.397 . . . . 0.0 108.146 178.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 1.103 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 55.7 Cg_endo -82.19 14.76 2.16 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 O-C-N 123.28 1.147 . . . . 0.0 109.499 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.48 64.48 1.32 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.218 -0.926 . . . . 0.0 111.587 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.746 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.59 -32.15 65.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.897 -1.127 . . . . 0.0 109.361 178.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.9 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -51.34 -40.99 60.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.923 . . . . 0.0 109.244 179.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.744 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -46.32 -29.31 1.6 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.465 -0.772 . . . . 0.0 109.344 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.264 ' CD2' HG21 ' A' ' 59' ' ' ILE . 13.1 mt -72.46 -40.85 66.69 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.803 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.94 -36.98 73.28 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-O 121.799 0.809 . . . . 0.0 109.646 179.279 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -79.44 -25.79 41.9 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.328 -0.858 . . . . 0.0 110.123 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.463 ' HB1' HG22 ' A' ' 61' ' ' ILE . . . -74.95 -37.91 61.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.161 -0.962 . . . . 0.0 109.743 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.912 HG21 HG13 ' A' ' 23' ' ' VAL . 1.5 mp -63.64 -37.41 79.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.957 -1.09 . . . . 0.0 108.807 178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.421 ' ND2' ' C ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -72.94 -33.89 66.2 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.64 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.501 0.3 OUTLIER -90.95 -6.58 53.88 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 114.114 -3.035 . . . . 0.0 107.454 -179.059 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.756 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -78.7 -55.19 5.37 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 119.859 -1.776 . . . . 0.0 109.838 170.091 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.813 ' CE ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.04 -23.26 64.96 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.171 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.471 ' CD ' ' C ' ' A' ' 85' ' ' GLU . 3.3 tm-20 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.234 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.239 0.542 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.06 HG21 ' O ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -80.45 -94.43 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.284 -0.885 . . . . 0.0 110.583 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.981 ' N ' HG22 ' A' ' 2' ' ' VAL . 57.6 t -87.84 133.11 31.33 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 O-C-N 121.395 -0.816 . . . . 0.0 112.692 178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.84 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.51 64.0 t30 -153.92 106.51 2.85 Favored 'General case' 0 N--CA 1.518 2.939 1 CA-C-O 129.399 4.428 . . . . 0.0 109.208 177.868 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.05 HD12 ' HB ' ' A' ' 20' ' ' ILE 0.414 0.2 OUTLIER -119.3 130.57 73.77 Favored 'Isoleucine or valine' 0 C--O 1.264 1.834 0 CA-C-N 108.689 -3.869 . . . . 0.0 117.903 -174.823 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.27 ' O ' HG23 ' A' ' 59' ' ' ILE 0.644 1.2 tp10 -133.7 123.3 24.72 Favored 'General case' 0 C--N 1.269 -2.895 2 CA-C-O 131.792 5.567 . . . . 0.0 106.17 166.824 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.797 HG23 ' HD2' ' A' ' 15' ' ' TYR 0.257 25.0 m -113.19 100.86 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.517 1 O-C-N 114.476 -5.14 . . . . 0.0 109.155 -171.42 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.862 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 1.2 t80 -113.79 104.98 12.74 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 111.69 -2.505 . . . . 0.0 108.623 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.838 HG22 ' N ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -135.6 -60.61 0.74 Allowed 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.929 0.871 . . . . 0.0 110.564 177.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 1.044 ' HA ' HG22 ' A' ' 41' ' ' ILE . 3.1 t -177.57 143.62 0.51 Allowed Pre-proline 0 N--CA 1.487 1.414 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.41 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.75 ' N ' ' HB2' ' A' ' 40' ' ' ASP . 47.2 Cg_endo -76.08 -9.52 19.28 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 124.119 1.589 . . . . 0.0 110.225 -178.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.14 -5.19 53.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.056 -1.027 . . . . 0.0 109.843 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.633 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 1.4 p -159.75 -165.88 0.13 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.353 -0.842 . . . . 0.0 110.138 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.633 ' CD ' ' CB ' ' A' ' 13' ' ' CYS . 55.3 Cg_endo -84.22 117.65 2.2 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.865 1.455 . . . . 0.0 110.582 176.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.797 ' HD2' HG23 ' A' ' 7' ' ' VAL . 2.0 m-85 -49.22 -83.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.215 -0.928 . . . . 0.0 109.625 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.814 ' HB3' HD11 ' A' ' 76' ' ' LEU . 42.7 m -155.29 39.59 0.12 Allowed Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.146 -0.971 . . . . 0.0 109.962 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.707 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 52.9 Cg_endo -73.69 30.3 0.32 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.977 1.514 . . . . 0.0 111.141 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.401 ' H ' ' C ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -110.06 -61.98 1.58 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.966 -1.084 . . . . 0.0 110.348 -179.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.862 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -58.86 -19.11 38.91 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.099 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.05 ' HB ' HD12 ' A' ' 5' ' ' ILE . 22.8 pt -75.95 -38.0 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.141 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.675 ' N ' HG13 ' A' ' 20' ' ' ILE . 50.1 tt0 -49.0 -37.58 20.78 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.42 -44.87 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-O 122.05 0.929 . . . . 0.0 109.297 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.909 HG13 HG21 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -63.01 -35.71 72.75 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 CA-C-O 122.789 1.281 . . . . 0.0 109.92 175.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.698 ' OD2' HG11 ' A' ' 3' ' ' VAL . 4.0 t70 -70.64 -39.03 73.92 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 122.903 1.335 . . . . 0.0 108.298 -177.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -46.35 81.94 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.062 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.518 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -76.74 -41.6 44.36 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.636 0.731 . . . . 0.0 110.297 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.821 ' CE ' ' CE ' ' A' ' 84' ' ' MET 0.272 0.0 OUTLIER -72.02 -17.71 62.01 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 117.471 -1.691 . . . . 0.0 109.632 -177.32 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.626 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -70.33 -45.86 65.35 Favored 'General case' 0 N--CA 1.485 1.303 0 O-C-N 120.923 -1.111 . . . . 0.0 108.223 173.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.722 ' HG3' ' N ' ' A' ' 30' ' ' PHE 0.317 0.0 OUTLIER -52.97 -28.8 25.45 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.014 -179.042 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.777 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -102.17 -59.16 1.75 Allowed 'General case' 0 C--N 1.274 -2.706 0 O-C-N 119.108 -2.245 . . . . 0.0 106.67 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.772 ' HA3' ' CG2' ' A' ' 2' ' ' VAL . . . -80.23 58.85 4.61 Favored Glycine 1 C--N 1.24 -4.8 1 CA-C-O 113.008 -4.218 . . . . 0.0 116.433 174.526 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.571 ' C ' ' O ' ' A' ' 31' ' ' GLY 0.428 0.0 OUTLIER -36.45 -19.65 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.219 1 CA-C-N 125.182 4.491 . . . . 0.0 112.901 -168.647 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 1.06 ' O ' HG21 ' A' ' 2' ' ' VAL 0.293 0.0 OUTLIER -75.96 151.29 37.29 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 127.536 2.334 . . . . 0.0 115.69 167.953 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.799 HG23 HG23 ' A' ' 36' ' ' VAL 0.342 0.3 OUTLIER -130.67 155.77 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 C-N-CA 115.569 -2.452 . . . . 0.0 109.84 170.575 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.71 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.3 OUTLIER -139.96 64.76 1.44 Allowed 'General case' 0 C--N 1.313 -1.015 0 O-C-N 121.349 -0.844 . . . . 0.0 108.783 -178.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.027 HG13 ' HB ' ' A' ' 5' ' ' ILE 0.405 58.1 t -102.29 125.05 56.58 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 125.728 2.68 . . . . 0.0 108.709 -177.383 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 1.049 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.489 10.2 mt-10 -116.02 129.29 56.3 Favored 'General case' 0 C--O 1.176 -2.802 0 O-C-N 118.655 -2.528 . . . . 0.0 107.81 -173.201 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.764 ' CB ' ' CG2' ' A' ' 7' ' ' VAL 0.642 0.0 OUTLIER -106.83 111.18 23.58 Favored 'General case' 0 C--O 1.274 2.347 2 CA-C-O 107.928 -5.796 . . . . 0.0 121.166 -170.665 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.016 HD12 ' CG ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -130.11 166.54 27.45 Favored 'Isoleucine or valine' 1 C--N 1.212 -5.405 1 CA-C-N 131.377 6.444 . . . . 0.0 109.713 178.267 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 1.077 ' CG ' HG12 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -97.82 169.84 9.38 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 120.776 -1.203 . . . . 0.0 112.279 173.193 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 1.258 ' CD1' HG22 ' A' ' 56' ' ' VAL . 0.7 OUTLIER -74.33 -21.34 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.03 -1.044 . . . . 0.0 111.402 176.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.738 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 2.0 ptt? -86.27 -16.62 37.0 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.901 -1.124 . . . . 0.0 112.915 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.077 HG12 ' CG ' ' A' ' 40' ' ' ASP . 14.5 p -112.83 -27.06 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 119.034 -1.066 . . . . 0.0 110.914 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 1.016 ' CG ' HD12 ' A' ' 39' ' ' ILE . 5.7 t0 -115.14 51.13 0.93 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.184 -0.947 . . . . 0.0 110.6 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.457 2.6 ttt180 -70.31 0.99 5.41 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 115.833 -2.347 . . . . 0.0 109.793 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 1.013 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -53.92 -24.46 16.38 Favored 'General case' 0 C--N 1.307 -1.244 0 O-C-N 120.545 -1.347 . . . . 0.0 110.798 165.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.825 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -47.58 -62.49 1.42 Allowed 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 122.767 1.27 . . . . 0.0 109.023 -174.034 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.125 ' CB ' ' HB2' ' A' ' 55' ' ' ALA 0.425 . . -51.01 -13.66 0.17 Allowed 'General case' 0 C--N 1.268 -2.975 0 C-N-CA 125.105 1.362 . . . . 0.0 113.021 173.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.076 HD11 ' NE ' ' A' ' 66' ' ' ARG 0.256 0.2 OUTLIER -32.92 -37.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 O-C-N 117.768 -3.083 . . . . 0.0 103.528 -168.342 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.637 ' N ' ' C ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -55.0 -49.27 71.92 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.581 176.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.816 ' CE1' ' HE3' ' A' ' 47' ' ' LYS . 0.3 OUTLIER -124.95 -28.14 3.5 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.979 -1.076 . . . . 0.0 110.397 179.157 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.761 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 41.69 12.08 0.01 OUTLIER Glycine 0 C--O 1.19 -2.617 0 CA-C-O 122.025 0.792 . . . . 0.0 112.416 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 5.6 mt -83.84 -75.02 0.35 Allowed 'General case' 0 C--N 1.247 -3.85 0 N-CA-C 103.971 -2.603 . . . . 0.0 103.971 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.607 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 26.9 mtm -103.23 69.2 1.0 Allowed 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.228 -1.545 . . . . 0.0 107.092 -178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 1.125 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.579 . . -113.08 117.75 32.86 Favored 'General case' 0 C--O 1.195 -1.78 1 CA-C-O 129.698 4.571 . . . . 0.0 109.073 -175.749 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.258 HG22 ' CD1' ' A' ' 41' ' ' ILE . 1.7 t -152.77 -60.71 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.654 0 CA-C-N 109.02 -3.718 . . . . 0.0 112.242 -175.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.817 ' CD ' HG12 ' A' ' 56' ' ' VAL 0.502 43.5 Cg_endo -119.83 105.87 0.0 OUTLIER 'Trans proline' 0 C--O 1.19 -1.88 0 CA-C-O 129.276 3.782 . . . . 0.0 110.974 172.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 1.067 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -159.59 176.55 11.9 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 110.015 -3.266 . . . . 0.0 111.219 -176.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.279 HG21 ' CD2' ' A' ' 76' ' ' LEU 0.271 1.3 mp -149.55 160.75 4.99 Favored 'Isoleucine or valine' 0 C--O 1.272 2.274 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.743 -177.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.961 ' HA ' ' HA ' ' A' ' 66' ' ' ARG 0.699 . . -107.98 152.36 24.58 Favored 'General case' 0 CA--C 1.448 -2.955 2 O-C-N 115.554 -4.466 . . . . 0.0 102.705 -177.209 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.725 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.619 1.5 mt -106.46 91.17 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.441 -3.221 1 CA-C-O 132.436 5.874 . . . . 0.0 101.871 -161.084 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.84 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -45.65 83.91 0.0 OUTLIER 'General case' 0 C--N 1.367 1.335 1 CA-C-N 106.099 -5.046 . . . . 0.0 107.29 177.735 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.725 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.06 -47.03 0.38 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 106.348 -2.701 . . . . 0.0 106.348 -177.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.799 ' O ' HG23 ' A' ' 65' ' ' VAL . 12.1 m -124.64 -60.65 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 O-C-N 121.836 -0.802 . . . . 0.0 111.126 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 64' ' ' VAL . 99.4 t -164.12 -103.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.406 0 O-C-N 120.123 -1.611 . . . . 0.0 113.312 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 1.076 ' NE ' HD11 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -162.01 150.3 14.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.441 -0.787 . . . . 0.0 109.783 -175.002 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 1.067 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -146.06 -179.18 6.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.72 -1.238 . . . . 0.0 110.877 -176.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.2 t -85.89 120.89 36.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 116.761 -1.59 . . . . 0.0 110.299 176.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.817 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.24 106.42 0.28 Allowed Glycine 0 N--CA 1.497 2.705 0 CA-C-N 122.316 2.325 . . . . 0.0 110.674 177.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.105 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -90.24 -79.96 0.03 OUTLIER Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 120.81 -1.406 . . . . 0.0 108.787 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 1.105 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 48.3 Cg_endo -88.86 20.63 1.09 Allowed 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 117.312 -1.325 . . . . 0.0 108.969 177.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.61 63.88 1.09 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.017 -1.052 . . . . 0.0 112.227 176.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.727 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -69.81 -35.65 74.99 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.733 177.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.862 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -47.13 -44.09 21.32 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 122.092 0.949 . . . . 0.0 108.76 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.756 ' CD ' ' CE2' ' A' ' 67' ' ' PHE 0.274 0.0 OUTLIER -48.75 -26.02 2.13 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 118.968 -1.093 . . . . 0.0 109.182 -177.293 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.279 ' CD2' HG21 ' A' ' 59' ' ' ILE . 12.6 mt -72.48 -41.11 66.36 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.831 0.824 . . . . 0.0 109.629 176.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.812 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.29 -37.6 72.68 Favored 'General case' 0 N--CA 1.487 1.394 0 CA-C-O 122.045 0.926 . . . . 0.0 110.287 179.173 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -74.43 -32.16 62.55 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.85 0.833 . . . . 0.0 110.354 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 83' ' ' GLU . . . -73.77 -37.23 65.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.021 -1.049 . . . . 0.0 110.187 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.909 HG21 HG13 ' A' ' 23' ' ' VAL . 1.5 mp -60.33 -41.12 86.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 120.826 -1.172 . . . . 0.0 109.39 176.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.437 ' ND2' ' C ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -70.29 -32.76 70.69 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 -179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.764 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.632 0.1 OUTLIER -102.57 5.23 39.17 Favored 'General case' 0 CA--C 1.487 -1.445 0 C-N-CA 114.455 -2.898 . . . . 0.0 108.762 -176.61 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.777 ' HB2' ' O ' ' A' ' 62' ' ' ASN 0.299 0.2 OUTLIER -87.84 -55.84 3.59 Favored 'General case' 0 N--CA 1.489 1.498 1 O-C-N 115.611 -4.43 . . . . 0.0 107.568 164.472 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.821 ' CE ' ' CE ' ' A' ' 27' ' ' LYS 0.27 0.0 OUTLIER -67.94 -18.37 64.74 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 119.963 1.256 . . . . 0.0 112.209 178.792 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.477 ' CD ' ' C ' ' A' ' 85' ' ' GLU . 3.2 tm-20 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 120.859 -1.151 . . . . 0.0 110.609 177.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.689 ' SD ' ' OE2' ' A' ' 83' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.333 0.587 . . . . 0.0 110.153 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.062 HG21 ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -79.67 -89.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.911 . . . . 0.0 110.236 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.993 HG11 ' OD2' ' A' ' 24' ' ' ASP . 48.3 t -90.95 111.13 23.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.462 -0.774 . . . . 0.0 110.595 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.819 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 3.9 m-20 -123.85 107.46 11.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.81 -1.181 . . . . 0.0 109.235 177.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.064 ' CG1' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -122.33 137.16 56.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 O-C-N 121.491 -0.756 . . . . 0.0 110.923 178.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.023 ' O ' HG23 ' A' ' 59' ' ' ILE . 11.0 tt0 -128.4 110.67 12.55 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 118.896 -2.378 . . . . 0.0 108.966 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.986 HG12 ' HB2' ' A' ' 16' ' ' CYS 0.263 20.9 m -101.96 110.14 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -177.719 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.855 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 5.4 t80 -117.98 83.65 2.04 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.05 -176.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.686 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.3 OUTLIER -127.54 -45.92 1.47 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.157 0.503 . . . . 0.0 110.193 179.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.768 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 17.6 t 179.64 148.39 0.45 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.175 -0.953 . . . . 0.0 110.637 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.712 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 50.7 Cg_endo -86.16 -26.16 1.2 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.151 1.606 . . . . 0.0 110.704 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -78.79 12.26 2.21 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.12 -0.988 . . . . 0.0 109.985 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.546 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -157.22 -172.2 0.31 Allowed Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.415 -0.803 . . . . 0.0 110.68 178.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 13' ' ' CYS . 51.6 Cg_endo -84.53 107.26 1.17 Allowed 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 124.125 1.592 . . . . 0.0 110.056 176.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.768 ' CE1' ' O ' ' A' ' 10' ' ' SER . 14.8 m-85 -49.45 -83.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.77 -1.206 . . . . 0.0 109.689 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 1.062 ' SG ' HD11 ' A' ' 59' ' ' ILE . 34.6 m -155.86 47.21 0.3 Allowed Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.38 -0.825 . . . . 0.0 109.792 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.767 ' HA ' HD13 ' A' ' 20' ' ' ILE . 47.1 Cg_endo -72.49 24.13 0.28 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 124.077 1.567 . . . . 0.0 111.111 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.429 ' H ' ' C ' ' A' ' 16' ' ' CYS . 6.5 tpt -110.07 -69.74 0.85 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.059 -1.026 . . . . 0.0 110.15 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.791 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -55.12 -19.84 8.55 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.247 -0.908 . . . . 0.0 109.343 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.1 HD12 HG11 ' A' ' 36' ' ' VAL . 13.0 pt -71.49 -40.34 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.405 -0.81 . . . . 0.0 109.15 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.708 ' N ' HG13 ' A' ' 20' ' ' ILE . 13.8 tp10 -53.67 -34.92 60.32 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.6 t -70.07 -42.9 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.441 -0.787 . . . . 0.0 109.017 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.811 ' CG1' ' HB ' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -67.77 -31.77 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.793 0.806 . . . . 0.0 109.515 178.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.993 ' OD2' HG11 ' A' ' 3' ' ' VAL . 3.2 t70 -72.53 -38.06 68.15 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 122.077 0.941 . . . . 0.0 108.466 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.478 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -60.42 -45.24 94.32 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.057 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.648 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -78.61 -39.43 37.31 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.591 -0.693 . . . . 0.0 110.853 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.817 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -73.1 -19.81 61.07 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 118.926 -1.11 . . . . 0.0 109.094 -178.717 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.721 ' CD ' ' OD1' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -70.76 -45.52 64.62 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 176.396 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.744 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -46.68 -39.57 11.65 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 121.975 0.893 . . . . 0.0 109.265 179.358 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.75 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -95.51 -58.2 2.19 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.75 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -94.03 82.43 0.99 Allowed Glycine 0 N--CA 1.499 2.867 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.565 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -37.43 -24.52 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.262 0 O-C-N 119.349 -2.265 . . . . 0.0 110.372 179.286 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 1.062 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -82.83 151.99 25.82 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.579 -0.7 . . . . 0.0 111.845 177.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.801 HD12 ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -129.9 153.75 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.09 -1.631 . . . . 0.0 110.569 177.564 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.569 ' O ' ' O ' ' A' ' 3' ' ' VAL . 9.8 t0 -150.64 76.42 1.25 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.287 -0.883 . . . . 0.0 109.067 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.1 HG11 HD12 ' A' ' 20' ' ' ILE 0.254 51.5 t -94.4 122.47 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 120.697 -1.252 . . . . 0.0 109.014 -178.719 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.814 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.265 4.4 mt-10 -103.8 145.59 29.87 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -177.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.811 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -140.29 116.15 10.31 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.629 -174.107 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.745 ' CG2' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -116.56 166.04 11.22 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 O-C-N 120.575 -1.328 . . . . 0.0 111.269 -178.151 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.779 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -98.19 159.89 14.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.117 -0.989 . . . . 0.0 109.666 178.669 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 1.025 HD11 HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -68.64 -37.44 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.077 -1.014 . . . . 0.0 112.19 -179.266 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.779 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.7 ptm -82.48 -3.81 56.42 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.288 -0.965 . . . . 0.0 111.055 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.771 HG12 ' CG ' ' A' ' 40' ' ' ASP . 13.6 p -112.24 -45.15 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 0.0 109.728 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.828 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 4.2 t70 -106.61 50.04 0.78 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.082 -1.011 . . . . 0.0 110.021 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.647 ' HA ' ' CZ ' ' A' ' 8' ' ' PHE 0.286 0.0 OUTLIER -64.01 -3.13 2.34 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 118.571 -1.252 . . . . 0.0 109.442 -177.929 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.953 ' O ' HG23 ' A' ' 49' ' ' ILE . 10.9 pt-20 -52.04 -20.87 2.68 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.491 -0.755 . . . . 0.0 110.088 175.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.907 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -50.36 -58.9 4.66 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.453 -1.405 . . . . 0.0 109.772 -178.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.083 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -61.42 -5.7 1.87 Allowed 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.837 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.953 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -32.44 -39.47 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 N-CA-C 104.782 -2.303 . . . . 0.0 104.782 -175.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.832 ' OE1' ' O ' ' A' ' 47' ' ' LYS . 51.4 mp0 -51.34 -53.07 39.78 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.056 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 1.2 ' OH ' HG22 ' A' ' 68' ' ' VAL . 2.4 p90 -124.5 -29.67 3.46 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.884 -1.135 . . . . 0.0 110.26 179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.726 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 41.49 11.27 0.01 OUTLIER Glycine 0 N--CA 1.498 2.812 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.681 ' N ' ' O ' ' A' ' 51' ' ' TYR . 8.6 mt -81.13 -71.53 0.47 Allowed 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.52 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -102.4 59.3 0.81 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 -178.258 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 1.083 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.302 . . -103.67 116.2 31.9 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.24 -1.538 . . . . 0.0 109.905 -175.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.025 HG22 HD11 ' A' ' 41' ' ' ILE . 2.1 t -147.1 -66.93 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.506 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.472 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.846 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 53.1 Cg_endo -105.67 114.92 0.04 OUTLIER 'Trans proline' 0 N--CA 1.488 1.176 0 N-CA-C 109.586 -0.967 . . . . 0.0 109.586 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 1.057 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -161.28 175.57 12.14 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 122.296 1.046 . . . . 0.0 111.521 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.272 HG21 ' CD1' ' A' ' 76' ' ' LEU 0.253 1.1 mp -141.67 144.67 25.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 121.172 -0.955 . . . . 0.0 108.995 179.383 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 1.027 ' HB2' ' HD3' ' A' ' 66' ' ' ARG 0.289 . . -84.93 147.51 26.7 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 -177.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.712 HG23 ' HB2' ' A' ' 79' ' ' ALA 0.39 0.7 OUTLIER -95.42 88.44 2.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 C-N-CA 115.315 -2.554 . . . . 0.0 105.233 -175.126 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.819 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.2 OUTLIER -45.77 82.71 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 O-C-N 126.009 2.068 . . . . 0.0 109.094 177.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.819 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 161.99 -43.56 0.37 Allowed Glycine 0 C--N 1.288 -2.088 0 N-CA-C 107.348 -2.301 . . . . 0.0 107.348 -178.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.778 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.2 m -126.83 -59.37 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.882 -0.775 . . . . 0.0 111.052 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.778 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 59.8 t -164.04 -104.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 120.393 -1.442 . . . . 0.0 112.194 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 1.027 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 1.9 ttp180 -164.44 164.16 22.05 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 1.057 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -146.05 177.68 8.78 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.925 -1.11 . . . . 0.0 111.118 -177.306 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.2 HG22 ' OH ' ' A' ' 51' ' ' TYR . 96.5 t -88.86 114.39 27.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.686 -0.634 . . . . 0.0 109.978 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.856 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.66 128.72 1.92 Allowed Glycine 0 N--CA 1.492 2.372 0 C-N-CA 118.63 -1.748 . . . . 0.0 110.168 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.083 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -93.82 -82.72 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 121.098 -1.236 . . . . 0.0 108.032 177.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 1.083 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 52.8 Cg_endo -83.24 23.19 0.84 Allowed 'Trans proline' 0 C--N 1.306 -1.707 0 N-CA-C 108.541 -1.369 . . . . 0.0 108.541 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.553 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -99.59 61.45 1.17 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.445 -0.784 . . . . 0.0 111.334 179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.749 ' CB ' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -70.64 -26.75 63.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 0.0 109.926 178.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.604 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.6 tm-20 -50.56 -42.43 55.39 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.249 -0.907 . . . . 0.0 109.32 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.768 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -44.54 -34.81 2.25 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.371 -0.932 . . . . 0.0 108.819 179.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.272 ' CD1' HG21 ' A' ' 59' ' ' ILE . 7.4 mp -64.12 -42.76 96.71 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.809 ' HA ' ' CG1' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.74 -34.15 69.22 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.881 . . . . 0.0 109.404 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.778 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -82.38 -30.57 30.17 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.481 -0.762 . . . . 0.0 110.405 178.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.712 ' HB2' HG23 ' A' ' 61' ' ' ILE . . . -73.37 -33.1 64.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.424 -0.798 . . . . 0.0 109.907 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.816 HG22 ' HD3' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -67.46 -42.37 87.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 0.0 108.756 178.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.43 -23.63 66.32 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.557 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.544 0.0 OUTLIER -100.94 -12.37 18.99 Favored 'General case' 0 C--O 1.198 -1.656 0 C-N-CA 115.357 -2.537 . . . . 0.0 108.838 -177.246 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.819 ' HB2' ' CA ' ' A' ' 63' ' ' GLY 0.251 0.0 OUTLIER -75.35 -54.04 7.73 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 119.517 -1.989 . . . . 0.0 108.454 165.215 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.724 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -79.14 -22.03 45.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.004 -1.06 . . . . 0.0 110.417 179.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 2.1 tp10 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.166 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.769 ' SD ' ' OE2' ' A' ' 83' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.824 0 CA-C-O 121.925 0.869 . . . . 0.0 110.721 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.011 HG21 ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -79.89 -91.6 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 O-C-N 120.794 -1.191 . . . . 0.0 109.95 179.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.956 HG11 ' OD2' ' A' ' 24' ' ' ASP . 42.8 t -90.07 111.59 23.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.521 -0.737 . . . . 0.0 110.174 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.762 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 3.5 m-20 -124.1 107.43 11.26 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 118.786 -1.166 . . . . 0.0 108.679 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.054 ' CG1' HG22 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -123.09 139.55 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 122.059 -0.401 . . . . 0.0 110.58 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.191 ' O ' HG23 ' A' ' 59' ' ' ILE . 12.8 tt0 -131.05 121.73 25.53 Favored 'General case' 0 C--N 1.284 -2.241 0 O-C-N 119.163 -2.21 . . . . 0.0 105.844 177.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.913 HG12 ' HB2' ' A' ' 16' ' ' CYS . 26.8 m -113.07 106.23 20.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -176.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.906 ' CE1' ' HA ' ' A' ' 41' ' ' ILE 0.257 6.8 t80 -115.55 89.17 3.04 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.881 -178.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.638 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -131.24 -46.04 1.0 Allowed 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.21 -0.931 . . . . 0.0 109.739 178.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.736 ' HA ' HG22 ' A' ' 41' ' ' ILE . 17.6 t 179.08 147.05 0.39 Allowed Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.451 -0.781 . . . . 0.0 110.924 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.721 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 50.7 Cg_endo -85.44 -26.24 1.41 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 124.317 1.693 . . . . 0.0 110.868 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -77.25 6.41 6.75 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.203 -0.935 . . . . 0.0 110.01 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.512 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -152.2 -171.59 0.28 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.413 -0.804 . . . . 0.0 110.487 179.041 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 13' ' ' CYS . 47.0 Cg_endo -84.93 107.51 1.1 Allowed 'Trans proline' 0 C--N 1.313 -1.318 0 C-N-CA 121.419 1.413 . . . . 0.0 109.137 177.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.688 ' CE1' ' O ' ' A' ' 10' ' ' SER . 17.1 m-85 -49.85 -82.7 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.584 -0.697 . . . . 0.0 109.14 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 1.049 ' SG ' HD11 ' A' ' 59' ' ' ILE . 35.4 m -155.61 46.65 0.28 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.314 -0.866 . . . . 0.0 109.544 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.749 ' HA ' HD13 ' A' ' 20' ' ' ILE . 48.9 Cg_endo -72.34 24.36 0.27 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.973 1.512 . . . . 0.0 111.335 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.416 ' H ' ' C ' ' A' ' 16' ' ' CYS . 6.8 tpt -110.44 -69.09 0.89 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.155 -0.966 . . . . 0.0 110.489 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.766 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -55.98 -19.51 12.77 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.047 -1.033 . . . . 0.0 109.662 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.093 HD12 HG11 ' A' ' 36' ' ' VAL . 13.1 pt -70.72 -40.14 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.682 ' N ' HG13 ' A' ' 20' ' ' ILE . 13.8 tp10 -54.53 -35.87 63.66 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.0 t -68.17 -45.28 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.801 ' CG1' ' HA ' ' A' ' 77' ' ' PHE . 0.2 OUTLIER -65.68 -35.53 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.956 ' OD2' HG11 ' A' ' 3' ' ' VAL . 2.4 t70 -67.95 -40.46 83.26 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.717 0.77 . . . . 0.0 109.124 178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.479 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.6 OUTLIER -58.42 -46.95 85.45 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.371 0.605 . . . . 0.0 110.371 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.623 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.17 -38.68 51.26 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.935 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.802 ' HD3' HG22 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -74.82 -16.92 60.68 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.834 -1.166 . . . . 0.0 109.924 -179.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.632 ' CD ' ' OD1' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -73.31 -45.33 56.07 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 176.659 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.673 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -46.51 -37.06 7.37 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 122.057 0.932 . . . . 0.0 110.051 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.783 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -97.28 -68.09 0.82 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 179.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.783 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -84.35 88.97 1.56 Allowed Glycine 0 CA--C 1.544 1.86 0 C-N-CA 118.234 -1.936 . . . . 0.0 110.165 176.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.527 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -40.41 -27.7 0.05 Allowed 'General case' 0 N--CA 1.515 2.78 0 O-C-N 118.573 -2.722 . . . . 0.0 110.58 176.259 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 1.011 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.2 OUTLIER -80.92 151.65 28.46 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.78 -0.575 . . . . 0.0 111.175 179.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.763 HD12 ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -130.2 154.8 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.79 -1.194 . . . . 0.0 110.064 179.128 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.619 ' O ' ' O ' ' A' ' 3' ' ' VAL . 14.2 t0 -151.74 80.8 1.28 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.093 HG11 HD12 ' A' ' 20' ' ' ILE . 46.5 t -97.44 129.42 47.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.78 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 5.0 mt-10 -108.86 146.02 34.38 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.772 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -142.38 112.24 6.87 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.457 1.122 . . . . 0.0 112.949 -175.231 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.72 ' CG2' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -112.21 164.31 8.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.129 -0.982 . . . . 0.0 112.218 -179.652 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.744 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -96.4 162.13 13.62 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.27 -0.894 . . . . 0.0 109.517 179.16 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 1.003 HD11 HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -70.34 -39.49 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.116 -0.99 . . . . 0.0 111.73 -179.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.744 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.6 ptm -80.94 -2.6 48.36 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.929 -1.107 . . . . 0.0 110.972 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.73 HG12 ' CG ' ' A' ' 40' ' ' ASP . 14.9 p -113.23 -44.57 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.072 -1.018 . . . . 0.0 109.948 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.808 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 4.8 t70 -107.38 52.03 0.73 Allowed 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.454 -0.779 . . . . 0.0 109.083 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.574 ' HA ' ' CZ ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -64.33 -1.98 1.96 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 119.797 -1.814 . . . . 0.0 110.34 -179.135 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.912 ' O ' HG23 ' A' ' 49' ' ' ILE . 10.6 pt-20 -56.16 -21.55 23.48 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 178.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.864 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -46.88 -64.3 0.81 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 119.909 -1.744 . . . . 0.0 108.708 179.395 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.052 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -61.63 -6.01 2.25 Favored 'General case' 0 C--O 1.196 -1.72 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.864 -178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.912 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.7 OUTLIER -25.92 -41.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 119.715 -1.866 . . . . 0.0 106.874 176.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.862 ' OE1' ' O ' ' A' ' 47' ' ' LYS . 52.7 mp0 -52.57 -52.45 55.02 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.136 177.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 1.119 ' OH ' HG22 ' A' ' 68' ' ' VAL . 3.0 p90 -123.81 -32.01 3.35 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.298 -0.876 . . . . 0.0 110.398 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.668 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 45.44 4.32 0.01 OUTLIER Glycine 1 N--CA 1.519 4.172 0 O-C-N 121.37 -0.832 . . . . 0.0 111.786 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.677 ' H ' ' C ' ' A' ' 51' ' ' TYR . 9.5 mt -75.24 -81.12 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 175.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.63 ' O ' ' HE2' ' A' ' 51' ' ' TYR 0.271 0.3 OUTLIER -93.64 66.65 3.82 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.3 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 1.052 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.275 . . -107.46 117.26 33.64 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 119.97 -1.707 . . . . 0.0 110.162 -178.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.003 HG22 HD11 ' A' ' 41' ' ' ILE . 2.1 t -148.89 -63.31 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.055 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.79 ' HD3' ' HB ' ' A' ' 56' ' ' VAL . 59.3 Cg_endo -109.12 117.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.315 -1.186 0 N-CA-C 109.654 -0.941 . . . . 0.0 109.654 176.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.956 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -163.22 178.46 8.19 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 122.554 1.169 . . . . 0.0 111.625 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.203 HG21 ' CD1' ' A' ' 76' ' ' LEU 0.258 1.1 mp -142.08 152.7 18.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.61 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 1.032 ' HB2' ' HD3' ' A' ' 66' ' ' ARG 0.263 . . -91.37 156.92 17.41 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.796 HG23 ' HB2' ' A' ' 79' ' ' ALA . 0.6 OUTLIER -102.38 91.83 2.12 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.449 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 -175.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.762 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -56.49 85.61 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 -176.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.793 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 161.3 -42.83 0.4 Allowed Glycine 0 C--N 1.29 -1.986 0 N-CA-C 108.063 -2.015 . . . . 0.0 108.063 -177.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.699 ' C ' HG23 ' A' ' 65' ' ' VAL . 17.7 m -126.69 -60.82 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.793 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.699 HG23 ' C ' ' A' ' 64' ' ' VAL . 59.8 t -163.61 -99.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 O-C-N 120.758 -1.214 . . . . 0.0 112.565 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 1.032 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 2.0 ttp180 -169.03 162.97 11.23 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.956 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -147.09 173.12 12.77 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.359 -0.838 . . . . 0.0 111.676 -177.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.119 HG22 ' OH ' ' A' ' 51' ' ' TYR . 66.2 t -84.52 114.76 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.507 -0.746 . . . . 0.0 110.857 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.851 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.87 129.25 2.0 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 118.833 -1.651 . . . . 0.0 110.65 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.029 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -94.91 -81.41 0.02 OUTLIER Pre-proline 0 C--N 1.298 -1.641 0 O-C-N 121.177 -1.19 . . . . 0.0 107.946 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 1.029 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 56.7 Cg_endo -84.64 25.28 0.7 Allowed 'Trans proline' 0 C--N 1.313 -1.316 0 N-CA-C 108.831 -1.257 . . . . 0.0 108.831 176.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.544 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -101.53 59.65 0.88 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.426 0.632 . . . . 0.0 110.697 -179.209 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.698 ' HA ' HD13 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -69.3 -29.45 67.3 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.588 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.8 tm-20 -47.26 -42.55 20.8 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.197 -0.94 . . . . 0.0 110.471 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.726 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -45.44 -33.67 2.75 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.287 179.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.203 ' CD1' HG21 ' A' ' 59' ' ' ILE . 7.4 mp -64.7 -43.54 93.14 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.801 ' HA ' ' CG1' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -56.1 -35.84 67.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.275 -0.891 . . . . 0.0 109.526 179.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.737 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -81.39 -33.17 32.43 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.103 0.478 . . . . 0.0 110.062 179.515 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.796 ' HB2' HG23 ' A' ' 61' ' ' ILE . . . -69.91 -34.34 73.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.386 -0.821 . . . . 0.0 111.178 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.802 HG22 ' HD3' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -68.12 -42.86 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.585 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.433 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -64.51 -18.16 64.55 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 175.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.534 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.347 0.0 OUTLIER -104.59 -5.48 21.42 Favored 'General case' 0 CA--C 1.477 -1.847 0 CA-C-O 124.702 2.192 . . . . 0.0 109.224 -179.433 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.793 ' HB2' ' CA ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -87.33 -55.55 3.76 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 101.846 -3.39 . . . . 0.0 101.846 176.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.679 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -78.47 -21.77 48.55 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.243 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 2.1 tp10 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.026 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.512 ' SD ' ' OD1' ' A' ' 4' ' ' ASN . 8.6 ttp . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.599 0.714 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.93 HG22 ' N ' ' A' ' 3' ' ' VAL . 1.0 OUTLIER -80.38 -95.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.582 0.706 . . . . 0.0 110.291 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.93 ' N ' HG22 ' A' ' 2' ' ' VAL . 53.0 t -90.12 114.9 28.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.416 -0.803 . . . . 0.0 109.397 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.814 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.257 2.8 t-20 -138.28 105.83 5.57 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 117.984 -1.486 . . . . 0.0 107.919 178.428 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.865 ' CG1' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -121.35 139.55 48.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 114.537 -1.21 . . . . 0.0 111.235 -179.021 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.095 ' O ' HD21 ' A' ' 76' ' ' LEU . 6.8 tt0 -132.35 123.17 26.28 Favored 'General case' 0 C--N 1.285 -2.229 0 C-N-CA 116.438 -2.105 . . . . 0.0 105.911 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.064 HG12 ' CD1' ' A' ' 76' ' ' LEU . 3.0 m -113.21 104.18 16.6 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.374 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 -177.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.944 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 4.8 t80 -113.5 96.26 5.79 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.28 -177.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.748 ' O ' ' O ' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -126.37 -69.02 0.79 Allowed 'General case' 0 C--N 1.293 -1.888 0 O-C-N 121.167 -0.958 . . . . 0.0 108.673 178.18 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.661 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 3.8 p 179.53 152.9 0.57 Allowed Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.273 -0.892 . . . . 0.0 110.793 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.619 ' HA ' ' OH ' ' A' ' 15' ' ' TYR . 50.8 Cg_endo -76.2 -27.33 8.23 Favored 'Trans proline' 0 C--N 1.314 -1.247 0 O-C-N 124.437 1.756 . . . . 0.0 110.175 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.2 m -78.95 -17.0 56.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.678 -0.639 . . . . 0.0 109.949 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.415 ' HB2' ' OG ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -124.55 179.94 0.99 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.885 -179.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.628 ' O ' ' O ' ' A' ' 15' ' ' TYR . 51.3 Cg_endo -83.31 109.11 1.59 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 124.012 1.532 . . . . 0.0 109.817 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.661 ' CE1' ' O ' ' A' ' 10' ' ' SER . 4.7 m-85 -50.48 -117.84 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.938 ' CB ' HD11 ' A' ' 59' ' ' ILE . 18.7 m -155.16 40.32 0.13 Allowed Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.833 -1.167 . . . . 0.0 109.896 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.3 Cg_endo -75.76 30.3 0.38 Allowed 'Trans proline' 0 N--CA 1.489 1.224 0 O-C-N 123.653 1.344 . . . . 0.0 111.261 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.465 ' HG2' ' HG3' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -109.98 -59.49 1.92 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.969 -1.082 . . . . 0.0 110.713 -179.296 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.86 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -56.19 -19.71 14.82 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.36 -0.838 . . . . 0.0 110.397 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.92 HD12 ' C ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -73.36 -39.93 55.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 120.101 -0.639 . . . . 0.0 109.486 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.615 ' N ' HD12 ' A' ' 20' ' ' ILE . 14.1 tt0 -53.73 -35.08 60.82 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -68.89 -50.89 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.917 ' CG1' HG21 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -61.66 -33.55 57.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.349 178.567 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.773 ' OD2' HG11 ' A' ' 3' ' ' VAL . 8.4 t0 -66.4 -41.05 89.86 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.726 0.774 . . . . 0.0 109.071 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.482 ' OE1' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -56.88 -48.39 78.28 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.626 0.726 . . . . 0.0 109.317 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.487 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.55 -39.09 47.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.842 -0.536 . . . . 0.0 110.439 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.773 ' HB2' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -72.01 -16.65 62.06 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.993 -1.067 . . . . 0.0 109.877 -178.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.624 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -73.56 -44.2 58.02 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 176.608 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.684 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -49.71 -34.23 18.23 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.909 0.861 . . . . 0.0 110.206 179.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.739 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -94.89 -69.06 0.77 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 179.536 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.739 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -83.82 84.86 1.55 Allowed Glycine 0 N--CA 1.493 2.457 0 C-N-CA 118.788 -1.672 . . . . 0.0 110.101 177.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.579 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -36.69 -32.07 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.655 0 O-C-N 118.768 -2.607 . . . . 0.0 110.65 177.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.887 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -78.51 151.4 32.57 Favored 'General case' 0 N--CA 1.51 2.557 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.492 178.405 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.776 HD12 ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -129.76 156.05 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 120.646 -1.283 . . . . 0.0 110.264 178.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.714 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 25.7 t0 -151.7 80.07 1.28 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.978 HG12 ' NZ ' ' A' ' 38' ' ' LYS . 47.4 t -98.34 129.78 48.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.868 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 11.8 mm-40 -112.4 140.54 47.04 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.978 ' NZ ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -141.82 112.29 7.09 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -175.063 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.935 HD13 ' HB2' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -130.39 163.26 36.54 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 CA-C-O 121.77 0.795 . . . . 0.0 112.496 -179.103 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.645 ' OD1' ' N ' ' A' ' 43' ' ' VAL . 9.6 p-10 -98.69 178.82 4.87 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.277 -0.89 . . . . 0.0 111.379 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 1.037 HD12 HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -69.28 -15.63 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.21 -0.931 . . . . 0.0 109.86 177.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.601 ' HG2' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -89.73 -14.61 34.3 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.814 -1.179 . . . . 0.0 111.981 179.642 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.8 HG11 HG22 ' A' ' 39' ' ' ILE . 8.9 p -113.95 -40.43 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.929 -1.107 . . . . 0.0 110.687 -179.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.784 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 3.8 t70 -111.64 48.83 0.93 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.162 -0.961 . . . . 0.0 108.989 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.561 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 29.9 ttt180 -64.95 -1.08 1.81 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.08 -1.638 . . . . 0.0 109.814 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 1.071 ' O ' HG23 ' A' ' 49' ' ' ILE . 25.8 mm-40 -60.48 -22.98 64.13 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.244 177.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.856 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 1.1 tptt -45.85 -65.35 0.56 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.274 -1.516 . . . . 0.0 109.147 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.059 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -58.14 -11.18 2.36 Favored 'General case' 0 C--O 1.189 -2.083 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.264 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.108 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.7 pp -23.99 -40.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 119.933 -1.729 . . . . 0.0 107.262 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 1.108 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.9 OUTLIER -56.02 -50.78 69.94 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 115.316 -0.857 . . . . 0.0 108.995 178.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.872 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 3.1 p90 -122.35 -34.24 3.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.729 -0.607 . . . . 0.0 110.292 178.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.724 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 47.64 3.13 0.01 OUTLIER Glycine 0 N--CA 1.514 3.837 0 O-C-N 121.192 -0.943 . . . . 0.0 111.291 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.673 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 4.1 mt -75.45 -80.49 0.09 Allowed 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.712 ' O ' ' HE2' ' A' ' 51' ' ' TYR 0.255 26.3 mtp -92.02 67.49 5.14 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.863 177.397 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 1.059 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.27 . . -108.9 110.7 22.09 Favored 'General case' 0 N--CA 1.485 1.291 0 O-C-N 120.448 -1.407 . . . . 0.0 109.048 -177.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.037 HG22 HD12 ' A' ' 41' ' ' ILE . 1.0 OUTLIER -149.42 -54.52 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.877 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.942 -179.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.796 ' HB2' ' CA ' ' A' ' 70' ' ' ALA . 59.2 Cg_endo -110.91 106.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.169 1.089 . . . . 0.0 110.212 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.912 ' HB3' ' CD2' ' A' ' 8' ' ' PHE . . . -161.62 179.77 7.91 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 113.623 -1.626 . . . . 0.0 112.181 -176.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.938 HD11 ' CB ' ' A' ' 16' ' ' CYS 0.264 0.3 OUTLIER -143.87 153.63 15.83 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 108.201 -1.036 . . . . 0.0 108.201 -179.808 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.92 ' HB3' ' CB ' ' A' ' 6' ' ' GLU 0.256 . . -92.16 153.78 19.11 Favored 'General case' 0 CA--C 1.48 -1.738 0 N-CA-C 101.82 -3.4 . . . . 0.0 101.82 178.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.62 HG23 ' CB ' ' A' ' 79' ' ' ALA 0.274 2.1 mt -102.66 93.6 2.8 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 -175.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.814 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.5 OUTLIER -55.6 84.76 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 113.12 -1.855 . . . . 0.0 107.145 -178.082 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.7 ' HA3' ' CB ' ' A' ' 83' ' ' GLU . . . 162.22 -45.8 0.36 Allowed Glycine 0 C--N 1.289 -2.038 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -177.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.796 ' O ' HG23 ' A' ' 65' ' ' VAL . 4.6 m -123.33 -61.13 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.447 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.8 HG12 ' N ' ' A' ' 66' ' ' ARG . 73.7 t -165.17 -101.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 O-C-N 120.909 -1.119 . . . . 0.0 112.235 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.901 ' HG3' ' O ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -156.01 166.24 34.05 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.539 -0.725 . . . . 0.0 109.747 -178.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.866 ' C ' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -149.26 165.19 32.65 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.34 -0.85 . . . . 0.0 111.17 -178.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.652 HG22 ' OH ' ' A' ' 51' ' ' TYR . 94.5 t -81.07 121.09 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.354 -0.841 . . . . 0.0 110.203 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.825 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -164.03 114.18 0.59 Allowed Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.182 -1.485 . . . . 0.0 110.549 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.034 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -91.65 -82.79 0.02 OUTLIER Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 121.578 -0.954 . . . . 0.0 109.034 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 1.034 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 57.0 Cg_endo -84.42 26.52 0.65 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 N-CA-C 107.982 -1.584 . . . . 0.0 107.982 176.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.671 ' CB ' ' OE2' ' A' ' 75' ' ' GLU . 0.6 OUTLIER -112.26 83.42 1.8 Allowed 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.657 ' C ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -82.37 -44.04 16.64 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.86 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -40.05 -30.91 0.1 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.158 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.751 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -49.7 -46.21 49.82 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.296 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.095 HD21 ' O ' ' A' ' 6' ' ' GLU . 27.3 mt -58.15 -43.54 87.4 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.785 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.27 -37.25 74.6 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 122.09 0.947 . . . . 0.0 109.857 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.64 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 3.2 tt0 -78.28 -30.94 48.76 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.348 -0.845 . . . . 0.0 110.298 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.62 ' CB ' HG23 ' A' ' 61' ' ' ILE . . . -70.15 -38.56 75.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.124 -0.985 . . . . 0.0 111.249 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.917 HG21 ' CG1' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.59 -42.59 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.327 -0.858 . . . . 0.0 108.726 179.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.64 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -68.46 -22.51 64.57 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.22 177.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.615 ' O ' ' OD1' ' A' ' 82' ' ' ASP 0.312 0.0 OUTLIER -102.1 2.42 37.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 118.232 -2.793 . . . . 0.0 107.114 -177.549 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.7 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -94.14 -59.72 1.9 Allowed 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 103.321 -2.844 . . . . 0.0 103.321 176.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.597 ' SD ' ' HD2' ' A' ' 27' ' ' LYS . 3.3 ptt? -72.05 -17.96 61.98 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.601 177.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.587 ' OXT' ' HA ' ' A' ' 82' ' ' ASP . 3.2 mm-40 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 117.923 -1.037 . . . . 0.0 110.171 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.697 ' SD ' ' OE2' ' A' ' 83' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.272 0.558 . . . . 0.0 110.184 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.056 HG21 ' O ' ' A' ' 33' ' ' LYS . 0.7 OUTLIER -79.95 -90.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.359 -0.838 . . . . 0.0 109.848 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.99 HG11 ' OD2' ' A' ' 24' ' ' ASP . 48.6 t -89.6 110.89 22.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 O-C-N 121.446 -0.783 . . . . 0.0 111.124 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.846 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 3.9 m-20 -124.02 107.11 10.95 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.621 -1.3 . . . . 0.0 109.085 177.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.076 ' CG1' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -121.14 138.22 52.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 O-C-N 121.711 -0.618 . . . . 0.0 111.758 178.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.201 ' O ' HG23 ' A' ' 59' ' ' ILE . 12.4 tt0 -130.64 119.78 22.96 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 115.614 -2.434 . . . . 0.0 106.079 177.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.979 HG12 ' HB2' ' A' ' 16' ' ' CYS . 19.5 m -111.48 107.33 22.69 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.318 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -176.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.871 ' CE1' ' O ' ' A' ' 44' ' ' ASP . 6.3 t80 -116.74 87.28 2.66 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.958 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.673 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.4 OUTLIER -130.14 -46.22 1.12 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.765 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 17.5 t 179.59 148.33 0.45 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.226 -0.921 . . . . 0.0 110.666 179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.711 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 50.5 Cg_endo -86.16 -26.31 1.16 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.103 1.581 . . . . 0.0 110.649 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.2 m -78.06 8.34 4.92 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.12 -0.987 . . . . 0.0 109.9 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.55 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -152.38 -171.29 0.27 Allowed Pre-proline 0 N--CA 1.485 1.275 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.62 178.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.55 ' HD2' ' HB3' ' A' ' 13' ' ' CYS . 45.2 Cg_endo -85.05 107.12 1.05 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.742 1.391 . . . . 0.0 109.579 176.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.765 ' CE1' ' O ' ' A' ' 10' ' ' SER . 14.8 m-85 -49.39 -82.79 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.053 -1.029 . . . . 0.0 109.753 179.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 1.06 ' SG ' HD11 ' A' ' 59' ' ' ILE . 34.8 m -156.08 47.25 0.3 Allowed Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 121.36 -0.838 . . . . 0.0 109.724 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.767 ' HA ' HD13 ' A' ' 20' ' ' ILE . 47.4 Cg_endo -72.62 24.17 0.28 Allowed 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.031 1.543 . . . . 0.0 111.075 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.427 ' H ' ' C ' ' A' ' 16' ' ' CYS . 6.5 tpt -110.16 -69.66 0.85 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.126 -0.983 . . . . 0.0 110.247 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.792 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -55.02 -20.08 8.43 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.12 -0.988 . . . . 0.0 109.291 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.086 HD12 HG11 ' A' ' 36' ' ' VAL . 12.8 pt -71.28 -40.26 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.0 109.141 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.707 ' N ' HG13 ' A' ' 20' ' ' ILE . 13.8 tp10 -53.79 -35.51 61.44 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.1 t -68.89 -44.73 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 CA-C-O 121.789 0.804 . . . . 0.0 108.872 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.823 ' CG1' ' HB ' ' A' ' 80' ' ' ILE . 0.2 OUTLIER -65.84 -34.48 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-O 121.681 0.753 . . . . 0.0 109.435 178.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.99 ' OD2' HG11 ' A' ' 3' ' ' VAL . 2.6 t70 -69.55 -38.82 77.61 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.993 0.901 . . . . 0.0 109.57 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.474 ' HA ' ' HE3' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -59.79 -46.3 89.62 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.536 0.684 . . . . 0.0 110.044 179.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.655 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.74 -39.14 45.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.522 -0.736 . . . . 0.0 111.077 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.815 ' HD3' HG22 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -73.8 -18.04 61.01 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 118.886 -1.126 . . . . 0.0 109.373 -178.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.722 ' CD ' ' OD1' ' A' ' 24' ' ' ASP . 0.0 OUTLIER -72.5 -45.14 60.84 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 176.775 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.732 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -47.25 -37.16 10.06 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 121.676 0.75 . . . . 0.0 109.816 179.304 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.817 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -96.99 -65.56 0.96 Allowed 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 179.414 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.817 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -85.18 84.71 1.59 Allowed Glycine 0 N--CA 1.511 3.66 0 C-N-CA 118.493 -1.813 . . . . 0.0 111.167 176.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.587 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -38.13 -26.73 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.397 0 CA-C-N 121.653 2.727 . . . . 0.0 110.813 177.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 1.056 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -80.09 151.41 29.87 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.514 -0.741 . . . . 0.0 112.459 177.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.816 HD12 ' O ' ' A' ' 33' ' ' LYS . 0.3 OUTLIER -130.24 154.02 39.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 120.242 -1.536 . . . . 0.0 109.829 178.47 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.629 ' O ' ' O ' ' A' ' 3' ' ' VAL . 10.4 t0 -151.26 79.18 1.29 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.086 HG11 HD12 ' A' ' 20' ' ' ILE 0.254 44.5 t -96.96 127.26 49.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 -178.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.861 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 4.8 mt-10 -108.47 144.58 35.9 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -177.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.807 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.9 112.42 7.85 Favored 'General case' 0 N--CA 1.509 2.507 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -174.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.751 ' CG2' ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -112.25 165.5 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.288 -0.965 . . . . 0.0 112.241 -178.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.782 ' OD1' ' N ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -97.26 161.38 13.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.134 -0.979 . . . . 0.0 109.739 178.827 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 1.014 HD11 HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -70.08 -38.2 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 111.735 -179.004 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.782 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 8.4 ptm -80.79 -4.26 53.95 Favored 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 119.251 -0.979 . . . . 0.0 111.245 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.77 HG12 ' CG ' ' A' ' 40' ' ' ASP . 14.1 p -112.34 -44.8 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.139 -0.976 . . . . 0.0 110.138 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.871 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 4.2 t70 -106.91 52.91 0.7 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.19 -0.944 . . . . 0.0 109.068 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.624 ' HA ' ' CZ ' ' A' ' 8' ' ' PHE 0.268 0.0 OUTLIER -66.36 -0.37 2.61 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.56 -1.256 . . . . 0.0 109.557 -178.548 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.982 ' O ' HG23 ' A' ' 49' ' ' ILE . 10.4 pt-20 -55.56 -21.45 17.19 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 177.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.921 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -47.43 -63.62 1.0 Allowed 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 123.711 1.72 . . . . 0.0 109.057 -178.319 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.134 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -57.75 -10.35 1.61 Allowed 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 113.554 -1.657 . . . . 0.0 111.149 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.982 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.6 OUTLIER -26.3 -41.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 O-C-N 119.57 -1.956 . . . . 0.0 107.1 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.896 ' OE1' ' O ' ' A' ' 47' ' ' LYS . 51.3 mp0 -51.95 -53.02 46.16 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.063 176.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 1.19 ' OH ' HG22 ' A' ' 68' ' ' VAL . 2.7 p90 -124.18 -30.0 3.51 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.224 -0.923 . . . . 0.0 110.152 178.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.744 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 43.31 5.73 0.01 OUTLIER Glycine 0 N--CA 1.506 3.309 0 CA-C-O 122.3 0.944 . . . . 0.0 111.576 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.722 ' N ' ' O ' ' A' ' 51' ' ' TYR . 9.3 mt -75.92 -77.13 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 175.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.619 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 0.2 OUTLIER -96.11 64.38 2.34 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.116 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 1.134 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.295 . . -108.04 117.85 35.21 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 117.838 -1.545 . . . . 0.0 109.436 -177.14 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.014 HG22 HD11 ' A' ' 41' ' ' ILE . 2.1 t -148.64 -63.23 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.785 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.546 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.832 ' HD3' ' HB ' ' A' ' 56' ' ' VAL 0.252 56.5 Cg_endo -110.67 116.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 N-CA-C 108.593 -1.349 . . . . 0.0 108.593 177.145 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 1.007 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -161.96 176.28 10.95 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 114.285 -1.325 . . . . 0.0 111.88 -177.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.268 HG21 ' CD1' ' A' ' 76' ' ' LEU 0.25 1.1 mp -140.76 150.03 20.86 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.012 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 1.065 ' HB2' ' HD3' ' A' ' 66' ' ' ARG 0.308 . . -89.53 155.58 19.19 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 -178.177 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.799 HG23 ' HB2' ' A' ' 79' ' ' ALA 0.328 0.6 OUTLIER -101.94 93.16 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.918 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 -175.953 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.846 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -52.82 83.29 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 112.814 -1.994 . . . . 0.0 106.407 -178.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.834 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 162.47 -42.79 0.36 Allowed Glycine 0 C--N 1.293 -1.844 0 N-CA-C 107.459 -2.256 . . . . 0.0 107.459 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.785 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.5 m -127.41 -59.3 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.808 -0.819 . . . . 0.0 111.035 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.785 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 58.7 t -164.32 -101.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 O-C-N 120.286 -1.509 . . . . 0.0 112.553 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 1.065 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 2.0 ttp180 -166.91 163.73 16.17 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -178.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 1.007 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -147.01 175.17 10.89 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.013 -1.054 . . . . 0.0 111.218 -177.188 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.19 HG22 ' OH ' ' A' ' 51' ' ' TYR . 70.3 t -85.58 113.88 24.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.11 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.854 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.08 129.95 2.19 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 118.063 -2.018 . . . . 0.0 109.903 177.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.101 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -94.84 -81.98 0.02 OUTLIER Pre-proline 0 C--N 1.294 -1.842 0 O-C-N 121.121 -1.223 . . . . 0.0 107.931 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 1.101 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 54.6 Cg_endo -84.34 24.53 0.75 Allowed 'Trans proline' 0 C--N 1.302 -1.904 0 N-CA-C 108.475 -1.394 . . . . 0.0 108.475 177.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.555 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -100.7 59.93 0.96 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.488 -0.757 . . . . 0.0 111.219 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.753 ' CB ' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -68.87 -29.32 67.59 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.38 -0.825 . . . . 0.0 109.898 178.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.599 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.8 tm-20 -47.71 -43.5 26.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.227 -0.921 . . . . 0.0 109.932 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.769 ' CD ' ' CD2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -44.38 -34.69 2.09 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.845 179.691 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.268 ' CD1' HG21 ' A' ' 59' ' ' ILE . 7.4 mp -64.22 -42.96 96.35 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.816 ' HA ' ' CG1' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.01 -35.31 69.09 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.901 0.858 . . . . 0.0 109.356 179.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.783 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.5 OUTLIER -80.93 -32.87 34.45 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.498 -0.752 . . . . 0.0 110.38 178.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.799 ' HB2' HG23 ' A' ' 61' ' ' ILE . . . -70.95 -34.26 71.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.357 -0.839 . . . . 0.0 110.695 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.823 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -66.55 -43.33 90.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 122.179 0.99 . . . . 0.0 108.79 178.784 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.429 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 0.6 OUTLIER -65.97 -19.51 65.89 Favored 'General case' 0 C--O 1.196 -1.759 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.042 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.62 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.421 0.0 OUTLIER -104.33 -5.74 21.49 Favored 'General case' 0 C--O 1.251 1.157 0 C-N-CA 116.525 -2.07 . . . . 0.0 105.898 -177.789 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.834 ' HB2' ' CA ' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -85.69 -53.82 4.91 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 172.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.734 ' N ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -79.12 -21.28 46.81 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.372 -1.455 . . . . 0.0 110.567 -179.57 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 85' ' ' GLU . 2.1 tp10 . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.148 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.487 ' SD ' ' OD1' ' A' ' 4' ' ' ASN . 8.0 ttp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.303 0.573 . . . . 0.0 110.249 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.971 HG22 ' N ' ' A' ' 3' ' ' VAL . 0.9 OUTLIER -81.09 -92.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.222 -0.924 . . . . 0.0 110.412 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.971 ' N ' HG22 ' A' ' 2' ' ' VAL . 55.4 t -92.2 108.83 20.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.703 -0.623 . . . . 0.0 110.644 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.81 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 2.4 t-20 -129.11 106.83 9.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.045 -1.034 . . . . 0.0 109.278 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.888 HG21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -124.22 138.17 54.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 O-C-N 121.785 -0.572 . . . . 0.0 110.44 178.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.082 ' CB ' ' HB3' ' A' ' 60' ' ' ALA . 5.3 tt0 -129.1 107.58 9.7 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 117.483 -1.687 . . . . 0.0 110.016 178.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.092 HG12 ' CD1' ' A' ' 76' ' ' LEU . 2.9 m -96.74 109.78 23.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 122.892 1.329 . . . . 0.0 107.663 -178.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.955 ' HB2' HD13 ' A' ' 39' ' ' ILE . 2.2 t80 -118.53 90.01 3.24 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.041 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.664 HG23 ' HA ' ' A' ' 57' ' ' PRO . 0.6 OUTLIER -120.92 -68.59 0.89 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.53 -0.731 . . . . 0.0 109.66 178.814 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.756 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 3.8 p 179.65 154.4 0.64 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 110.682 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.657 ' N ' ' HB2' ' A' ' 40' ' ' ASP . 49.8 Cg_endo -76.94 -27.16 7.23 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.11 1.584 . . . . 0.0 110.468 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -79.58 -16.1 56.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.277 -0.89 . . . . 0.0 109.924 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.486 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -125.0 -179.51 0.88 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.355 -0.841 . . . . 0.0 109.951 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.656 ' O ' ' O ' ' A' ' 15' ' ' TYR . 50.9 Cg_endo -83.5 108.07 1.46 Allowed 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.96 1.505 . . . . 0.0 110.319 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.756 ' CE1' ' O ' ' A' ' 10' ' ' SER . 4.8 m-85 -49.71 -117.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.932 . . . . 0.0 109.899 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.986 ' CB ' HD11 ' A' ' 59' ' ' ILE . 19.2 m -155.68 40.46 0.13 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.16 -0.962 . . . . 0.0 110.278 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.3 Cg_endo -76.0 30.07 0.39 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.961 1.506 . . . . 0.0 111.195 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.457 ' HG2' ' HG3' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -110.21 -59.37 1.95 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.816 -1.178 . . . . 0.0 110.671 -179.491 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.941 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -55.92 -19.3 11.59 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.272 -0.893 . . . . 0.0 109.894 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.986 HD12 ' C ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -75.22 -39.48 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.832 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.654 ' N ' HD12 ' A' ' 20' ' ' ILE . 14.6 tt0 -53.35 -33.19 52.55 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.372 -0.83 . . . . 0.0 108.98 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -71.77 -46.94 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.363 -0.836 . . . . 0.0 109.385 179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.974 ' CG1' HG21 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -66.14 -26.91 39.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.473 -0.767 . . . . 0.0 109.246 178.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.839 ' OD2' HG11 ' A' ' 3' ' ' VAL . 8.7 t0 -73.69 -39.25 64.51 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.53 ' OE1' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -57.92 -46.14 85.44 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.419 179.303 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.504 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -80.12 -40.21 27.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.553 -0.717 . . . . 0.0 110.061 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.764 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -68.42 -21.82 64.64 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.198 -179.165 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.67 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -69.61 -44.47 70.64 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.058 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.786 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -48.97 -39.65 27.37 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.869 0.843 . . . . 0.0 109.116 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.786 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.69 -57.98 2.68 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.382 -0.824 . . . . 0.0 109.23 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.734 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -95.92 77.87 0.79 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.258 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.568 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -32.9 -26.65 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 119.272 1.536 . . . . 0.0 110.726 -179.463 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.941 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -85.3 153.13 22.78 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.535 -0.728 . . . . 0.0 110.889 177.779 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.824 HD12 ' O ' ' A' ' 33' ' ' LYS . 0.4 OUTLIER -129.59 154.91 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 120.823 -1.173 . . . . 0.0 110.93 178.146 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.636 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 26.2 t0 -150.2 74.86 1.21 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.491 -0.756 . . . . 0.0 109.393 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.991 HG12 ' NZ ' ' A' ' 38' ' ' LYS . 40.5 t -93.03 119.13 40.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 O-C-N 120.938 -1.101 . . . . 0.0 110.348 -178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.826 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 11.6 mm-40 -102.44 141.68 34.88 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.958 -1.089 . . . . 0.0 108.919 -178.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.991 ' NZ ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -140.93 120.68 13.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.511 -0.743 . . . . 0.0 111.728 -174.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.955 HD13 ' HB2' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -137.38 169.81 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.035 -1.04 . . . . 0.0 110.109 -178.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.662 ' OD2' ' HG2' ' A' ' 42' ' ' MET . 7.9 p-10 -106.3 175.57 5.45 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.533 -0.729 . . . . 0.0 110.756 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 1.02 HD12 HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -66.97 -9.58 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.975 -1.078 . . . . 0.0 111.09 177.23 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.662 ' HG2' ' OD2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -95.25 -16.9 22.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 110.732 -179.695 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.846 HG11 HG22 ' A' ' 39' ' ' ILE . 8.7 p -112.69 -40.64 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.146 -0.971 . . . . 0.0 110.055 -178.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.796 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 3.1 t70 -111.06 45.57 1.16 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.863 . . . . 0.0 110.361 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.653 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.272 30.9 ttt180 -62.69 -3.76 1.68 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.528 -178.578 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 1.068 ' O ' HG23 ' A' ' 49' ' ' ILE . 21.8 mm-40 -57.54 -18.68 20.51 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.347 -0.846 . . . . 0.0 110.63 175.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.87 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -51.86 -56.74 12.2 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.381 1.086 . . . . 0.0 110.292 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.103 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -62.35 -5.39 2.4 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.255 176.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.225 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.4 pp -34.58 -39.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 104.216 -2.513 . . . . 0.0 104.216 -174.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 1.225 ' N ' HD12 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -53.15 -51.49 61.82 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.038 177.592 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.853 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.1 p90 -123.56 -29.77 3.71 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.921 -1.112 . . . . 0.0 110.495 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.764 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 41.41 12.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.236 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.736 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.1 mt -84.09 -67.32 0.8 Allowed 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 122.767 1.27 . . . . 0.0 107.826 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.511 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 25.7 mtp -103.57 57.15 0.74 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.465 -1.243 . . . . 0.0 107.815 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 1.103 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.266 . . -99.75 108.34 20.64 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 122.863 1.316 . . . . 0.0 111.011 -176.173 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.02 HG22 HD12 ' A' ' 41' ' ' ILE . 0.9 OUTLIER -146.81 -59.65 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.29 -179.565 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.802 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 45.1 Cg_endo -103.1 105.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.257 1.135 . . . . 0.0 110.447 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.95 ' HB3' ' CD2' ' A' ' 8' ' ' PHE . . . -160.59 -178.04 6.61 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.963 0.887 . . . . 0.0 111.632 -176.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.986 HD11 ' CB ' ' A' ' 16' ' ' CYS . 0.3 OUTLIER -149.11 141.56 17.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.781 -0.574 . . . . 0.0 109.66 -179.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 1.082 ' HB3' ' CB ' ' A' ' 6' ' ' GLU 0.253 . . -82.0 137.86 35.03 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 117.207 -1.797 . . . . 0.0 107.021 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.731 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.395 1.7 mt -90.0 85.85 2.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 125.433 2.539 . . . . 0.0 106.266 -174.457 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.81 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.7 OUTLIER -43.55 83.34 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 112.231 -2.259 . . . . 0.0 108.439 177.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.752 ' HA3' ' CB ' ' A' ' 83' ' ' GLU . . . 162.02 -47.57 0.35 Allowed Glycine 0 N--CA 1.483 1.782 0 N-CA-C 106.783 -2.527 . . . . 0.0 106.783 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.847 ' O ' HG23 ' A' ' 65' ' ' VAL . 4.2 m -123.15 -60.03 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.745 -0.856 . . . . 0.0 111.232 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 64' ' ' VAL . 75.6 t -164.78 -104.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 120.454 -1.404 . . . . 0.0 112.001 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.839 ' N ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -154.46 165.24 37.02 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.638 -0.664 . . . . 0.0 109.956 -179.065 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.882 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.64 172.98 12.48 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.035 -1.041 . . . . 0.0 110.94 -179.351 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.681 HG22 ' OH ' ' A' ' 51' ' ' TYR . 77.1 t -88.67 120.04 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.536 -0.727 . . . . 0.0 109.286 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.839 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.18 114.33 0.6 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.198 -1.477 . . . . 0.0 110.66 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.074 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -91.91 -83.75 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 120.848 -1.383 . . . . 0.0 108.79 178.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 1.074 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 48.3 Cg_endo -81.61 19.24 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 N-CA-C 108.145 -1.521 . . . . 0.0 108.145 177.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.748 ' CB ' ' OE2' ' A' ' 75' ' ' GLU 0.278 0.6 OUTLIER -105.68 83.09 1.88 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 117.993 -1.483 . . . . 0.0 109.2 179.699 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.744 ' C ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -81.39 -41.11 22.43 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.31 177.425 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.941 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -43.26 -29.33 0.39 Allowed 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.001 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.819 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -49.69 -45.98 49.49 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.508 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.092 ' CD1' HG12 ' A' ' 7' ' ' VAL . 28.8 mt -58.82 -42.49 89.31 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.423 -0.798 . . . . 0.0 109.188 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.805 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.54 -34.88 73.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.494 -0.754 . . . . 0.0 110.209 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.633 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 3.4 tt0 -80.95 -26.78 36.39 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.697 -0.627 . . . . 0.0 110.358 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.519 ' CB ' HG23 ' A' ' 61' ' ' ILE . . . -75.22 -37.4 61.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -0.944 . . . . 0.0 109.773 -178.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.974 HG21 ' CG1' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.9 -39.37 84.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.043 -1.036 . . . . 0.0 109.344 178.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.633 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -72.93 -28.55 62.51 Favored 'General case' 0 C--O 1.258 1.552 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 178.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.668 ' HA ' ' OXT' ' A' ' 85' ' ' GLU 0.556 0.0 OUTLIER -95.6 -8.85 33.8 Favored 'General case' 0 CA--C 1.49 -1.336 0 C-N-CA 114.2 -3.0 . . . . 0.0 109.582 -178.186 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.752 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -71.35 -61.51 1.74 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 118.414 -2.679 . . . . 0.0 111.432 162.619 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.67 ' SD ' ' HD2' ' A' ' 27' ' ' LYS . 3.5 ptt? -71.55 -20.64 62.0 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.499 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.668 ' OXT' ' HA ' ' A' ' 82' ' ' ASP . 3.2 mm-40 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.942 -1.028 . . . . 0.0 110.227 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.488 ' SD ' ' OD1' ' A' ' 4' ' ' ASN . 7.9 ttp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.25 0.548 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.979 HG22 ' N ' ' A' ' 3' ' ' VAL . 0.9 OUTLIER -81.05 -94.52 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 109.854 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.979 ' N ' HG22 ' A' ' 2' ' ' VAL . 53.3 t -89.6 111.64 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.568 -0.707 . . . . 0.0 110.296 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.791 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.349 2.4 t-20 -135.4 107.57 7.21 Favored 'General case' 0 C--O 1.189 -2.123 0 CA-C-O 125.404 2.526 . . . . 0.0 107.24 177.301 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.892 HG21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -118.19 136.72 54.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-O 116.352 -1.785 . . . . 0.0 111.921 179.568 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.077 ' CB ' ' HB3' ' A' ' 60' ' ' ALA 0.48 5.8 tt0 -133.77 124.38 26.5 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 127.31 3.433 . . . . 0.0 101.919 174.069 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 1.089 HG12 ' CD1' ' A' ' 76' ' ' LEU 0.397 10.3 m -113.78 110.42 32.09 Favored 'Isoleucine or valine' 0 C--O 1.168 -3.208 0 O-C-N 116.613 -3.804 . . . . 0.0 101.483 -177.034 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.944 ' HB2' HD13 ' A' ' 39' ' ' ILE 0.306 1.7 t80 -117.28 96.68 5.53 Favored 'General case' 0 C--N 1.377 1.776 0 CA-C-N 110.611 -2.995 . . . . 0.0 108.663 -178.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.672 HG23 ' HA ' ' A' ' 57' ' ' PRO . 0.7 OUTLIER -124.53 -69.22 0.81 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.89 -1.131 . . . . 0.0 108.653 178.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.757 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 3.8 p 179.6 154.35 0.63 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.152 -0.967 . . . . 0.0 110.713 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.652 ' HA ' ' OH ' ' A' ' 15' ' ' TYR . 50.1 Cg_endo -76.96 -27.06 7.29 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.146 1.603 . . . . 0.0 110.458 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -79.71 -16.04 56.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -0.873 . . . . 0.0 109.954 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.487 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -125.01 -179.44 0.86 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.347 -0.846 . . . . 0.0 109.915 179.691 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.654 ' O ' ' O ' ' A' ' 15' ' ' TYR . 52.0 Cg_endo -83.58 108.06 1.44 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.963 1.507 . . . . 0.0 110.367 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.757 ' CE1' ' O ' ' A' ' 10' ' ' SER . 5.0 m-85 -49.77 -117.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.199 -0.938 . . . . 0.0 109.788 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.986 ' CB ' HD11 ' A' ' 59' ' ' ILE . 19.2 m -155.54 40.27 0.13 Allowed Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.113 -0.992 . . . . 0.0 110.348 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.685 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.3 Cg_endo -75.98 30.12 0.39 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.926 1.487 . . . . 0.0 111.183 -179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.455 ' HG2' ' HG3' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -110.14 -59.32 1.95 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.901 -1.124 . . . . 0.0 110.728 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.903 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -56.42 -18.5 11.37 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.063 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.988 HD12 ' C ' ' A' ' 20' ' ' ILE . 0.3 OUTLIER -75.72 -39.15 38.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 C-N-CA 119.661 -0.816 . . . . 0.0 109.851 179.572 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.655 ' N ' HD12 ' A' ' 20' ' ' ILE . 14.5 tt0 -52.98 -34.25 55.19 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 108.757 178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 t -70.73 -49.11 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.425 -0.797 . . . . 0.0 109.271 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.968 ' CG1' HG21 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -58.95 -35.55 57.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 CA-C-O 122.707 1.241 . . . . 0.0 109.305 176.529 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.841 ' OD2' HG11 ' A' ' 3' ' ' VAL . 7.8 t0 -68.42 -41.57 80.18 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 122.848 1.308 . . . . 0.0 108.918 -178.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.53 ' OE1' ' O ' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -56.19 -48.03 77.18 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.464 179.483 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.507 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -78.15 -39.68 40.24 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.854 0.835 . . . . 0.0 111.188 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.768 ' CB ' HG22 ' A' ' 3' ' ' VAL 0.288 0.0 OUTLIER -72.59 -16.13 61.74 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 117.17 -1.812 . . . . 0.0 109.013 -178.193 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.672 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.8 OUTLIER -72.43 -43.25 64.08 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 175.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.735 ' HG3' ' N ' ' A' ' 30' ' ' PHE 0.287 0.0 OUTLIER -52.54 -32.59 41.41 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.765 179.794 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.769 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -94.42 -69.46 0.75 Allowed 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 102.954 -2.98 . . . . 0.0 102.954 -179.275 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.746 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -75.29 65.8 2.32 Favored Glycine 0 C--N 1.27 -3.111 1 CA-C-O 113.33 -4.039 . . . . 0.0 117.337 176.161 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.585 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -31.06 -29.61 0.01 OUTLIER 'General case' 0 C--N 1.254 -3.563 1 CA-C-N 124.806 4.303 . . . . 0.0 110.286 -175.408 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.946 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -74.73 149.53 39.78 Favored 'General case' 0 C--N 1.278 -2.52 0 O-C-N 120.132 -1.605 . . . . 0.0 113.903 174.076 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.821 HD12 ' O ' ' A' ' 33' ' ' LYS 0.262 0.4 OUTLIER -131.05 156.42 42.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-N 120.854 1.661 . . . . 0.0 110.589 174.793 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.68 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 26.2 t0 -151.22 79.19 1.3 Allowed 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.983 HG12 ' NZ ' ' A' ' 38' ' ' LYS 0.351 61.9 t -100.63 127.41 53.75 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.94 0 CA-C-O 125.916 2.77 . . . . 0.0 104.764 -177.65 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.871 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.424 9.2 mm-40 -111.91 146.17 38.24 Favored 'General case' 0 C--O 1.183 -2.418 0 C-N-CA 113.685 -3.206 . . . . 0.0 103.99 -176.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.983 ' NZ ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -139.45 107.47 5.72 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-O 115.221 -2.323 . . . . 0.0 115.777 -170.036 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.944 HD13 ' HB2' ' A' ' 8' ' ' PHE . 0.5 OUTLIER -131.72 166.87 27.72 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.556 0 CA-C-N 122.949 2.613 . . . . 0.0 112.311 -179.283 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.663 ' OD2' ' HG2' ' A' ' 42' ' ' MET . 4.0 p-10 -98.27 175.64 6.0 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.57 -1.331 . . . . 0.0 113.464 177.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 1.019 HD12 HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -64.63 -13.94 15.25 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.065 0 O-C-N 121.066 -1.021 . . . . 0.0 111.317 174.723 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.663 ' HG2' ' OD2' ' A' ' 40' ' ' ASP 0.379 0.0 OUTLIER -100.88 -5.07 26.62 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 115.276 -2.57 . . . . 0.0 110.538 -177.251 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.849 HG11 HG22 ' A' ' 39' ' ' ILE . 7.5 p -117.13 -41.11 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.967 -1.083 . . . . 0.0 109.048 177.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.786 ' O ' ' CE1' ' A' ' 8' ' ' PHE . 3.1 t70 -111.56 46.69 1.09 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 110.254 -179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.708 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.378 30.3 ttt180 -66.2 -0.08 2.32 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 116.518 -2.073 . . . . 0.0 108.922 -177.754 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 1.052 ' O ' HG23 ' A' ' 49' ' ' ILE . 18.8 mm-40 -53.12 -26.71 17.55 Favored 'General case' 0 C--N 1.287 -2.142 0 O-C-N 120.785 -1.197 . . . . 0.0 109.831 172.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.88 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -48.28 -61.0 2.22 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.571 -1.331 . . . . 0.0 109.343 -176.091 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.026 ' CB ' ' HB2' ' A' ' 55' ' ' ALA 0.359 . . -54.3 -12.55 0.68 Allowed 'General case' 0 C--N 1.266 -3.054 0 C-N-CA 125.677 1.591 . . . . 0.0 112.053 176.101 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.229 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.5 pp -33.13 -39.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.214 -0.79 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -172.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 1.229 ' N ' HD12 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -53.13 -51.6 61.42 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.251 176.522 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.846 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.1 p90 -123.44 -29.51 3.78 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.049 -1.032 . . . . 0.0 110.582 179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.793 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.41 16.37 0.01 OUTLIER Glycine 0 N--CA 1.487 2.092 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.736 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.4 mt -87.55 -75.01 0.42 Allowed 'General case' 0 C--N 1.262 -3.197 0 N-CA-C 103.136 -2.912 . . . . 0.0 103.136 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.48 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 26.7 mtp -98.95 65.01 1.46 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 113.804 -1.544 . . . . 0.0 108.46 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 1.026 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.451 . . -110.98 112.48 24.33 Favored 'General case' 0 C--O 1.168 -3.184 1 CA-C-O 128.612 4.053 . . . . 0.0 105.685 -175.308 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.019 HG22 HD12 ' A' ' 41' ' ' ILE . 0.9 OUTLIER -148.32 -51.33 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.511 0 CA-C-N 110.476 -3.056 . . . . 0.0 112.15 -179.911 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.839 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.473 19.3 Cg_endo -117.67 111.82 0.01 OUTLIER 'Trans proline' 0 C--O 1.148 -3.988 1 CA-C-O 130.685 4.369 . . . . 0.0 103.704 -179.756 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.934 ' HB3' ' CD2' ' A' ' 8' ' ' PHE . . . -160.88 178.32 9.53 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 109.578 -3.465 . . . . 0.0 111.405 -174.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.986 HD11 ' CB ' ' A' ' 16' ' ' CYS 0.26 0.3 OUTLIER -144.94 151.28 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.746 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 1.077 ' HB3' ' CB ' ' A' ' 6' ' ' GLU 0.503 . . -96.02 147.66 23.47 Favored 'General case' 0 C--O 1.187 -2.193 2 N-CA-C 98.196 -4.742 . . . . 0.0 98.196 -178.257 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.754 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.654 2.2 mt -99.68 96.55 5.02 Favored 'Isoleucine or valine' 0 C--N 1.408 3.112 3 C-N-CA 108.539 -5.264 . . . . 0.0 98.644 -170.689 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.791 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.6 OUTLIER -50.29 85.6 0.0 OUTLIER 'General case' 0 C--N 1.379 1.851 1 CA-C-N 107.205 -4.543 . . . . 0.0 107.516 177.499 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.757 ' HA3' ' CB ' ' A' ' 83' ' ' GLU . . . 161.95 -47.87 0.35 Allowed Glycine 0 N--CA 1.482 1.721 0 N-CA-C 106.734 -2.546 . . . . 0.0 106.734 -178.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.844 ' O ' HG23 ' A' ' 65' ' ' VAL . 4.2 m -122.94 -59.86 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.72 -0.871 . . . . 0.0 111.468 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.844 HG23 ' O ' ' A' ' 64' ' ' VAL . 76.1 t -164.48 -104.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.264 -1.523 . . . . 0.0 111.827 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.837 ' N ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -153.89 166.11 33.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.703 -0.623 . . . . 0.0 110.111 -179.067 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.879 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -147.64 169.51 19.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.029 -1.044 . . . . 0.0 110.878 -179.438 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.687 HG22 ' OH ' ' A' ' 51' ' ' TYR . 97.2 t -81.74 118.79 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.874 -1.141 . . . . 0.0 111.667 177.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.837 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.77 114.13 0.59 Allowed Glycine 0 C--N 1.281 -2.504 0 CA-C-N 120.595 1.543 . . . . 0.0 110.698 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.066 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -92.03 -83.08 0.02 OUTLIER Pre-proline 0 C--N 1.296 -1.754 0 O-C-N 120.742 -1.446 . . . . 0.0 109.04 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 1.066 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 43.1 Cg_endo -86.0 28.89 0.54 Allowed 'Trans proline' 0 C--N 1.318 -1.041 0 N-CA-C 107.894 -1.618 . . . . 0.0 107.894 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.746 ' CB ' ' OE2' ' A' ' 75' ' ' GLU 0.644 0.4 OUTLIER -120.76 95.02 4.54 Favored 'General case' 0 C--O 1.164 -3.427 2 C-N-CA 108.815 -5.154 . . . . 0.0 100.585 179.121 . . . . . . . . 5 4 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.727 ' C ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -83.15 -43.89 15.68 Favored 'General case' 0 C--N 1.371 1.537 1 CA-C-N 108.204 -4.089 . . . . 0.0 109.057 174.7 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.903 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -39.85 -32.33 0.15 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.811 -1.18 . . . . 0.0 108.504 178.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.818 ' HG2' ' CZ ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -49.36 -45.43 45.73 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.173 -179.272 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.089 ' CD1' HG12 ' A' ' 7' ' ' VAL . 29.3 mt -58.55 -42.99 89.14 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.786 0.803 . . . . 0.0 109.36 178.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.803 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.68 -36.85 74.84 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.261 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.626 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 3.6 tt0 -74.05 -35.01 64.27 Favored 'General case' 0 C--N 1.286 -2.165 0 O-C-N 120.775 -1.203 . . . . 0.0 110.624 178.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.486 ' CB ' HG23 ' A' ' 61' ' ' ILE . . . -72.6 -37.6 68.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.821 -1.175 . . . . 0.0 110.222 -175.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.968 HG21 ' CG1' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.5 -42.87 97.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 O-C-N 121.056 -1.027 . . . . 0.0 109.168 178.047 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.626 ' OD1' ' O ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -70.48 -25.84 63.35 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 120.776 -1.203 . . . . 0.0 109.843 178.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.797 ' HA ' ' OXT' ' A' ' 85' ' ' GLU 1.012 0.0 OUTLIER -108.61 15.03 24.09 Favored 'General case' 0 C--O 1.302 3.828 2 C-N-CA 104.258 -6.977 . . . . 0.0 101.538 -176.267 . . . . . . . . 5 4 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.757 ' CB ' ' HA3' ' A' ' 63' ' ' GLY 0.258 0.0 OUTLIER -89.52 -59.45 2.21 Favored 'General case' 0 C--N 1.314 -0.966 1 O-C-N 113.892 -5.505 . . . . 0.0 104.468 164.096 . . . . . . . . 5 4 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.67 ' SD ' ' HD2' ' A' ' 27' ' ' LYS 0.26 3.6 ptt? -73.42 -16.18 61.33 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.599 -1.24 . . . . 0.0 111.091 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.797 ' OXT' ' HA ' ' A' ' 82' ' ' ASP . 3.1 mm-40 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.81 178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.623 ' HE3' ' OE2' ' A' ' 83' ' ' GLU . 2.8 ttp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.308 0.575 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.006 HG22 HG23 ' A' ' 3' ' ' VAL . 0.8 OUTLIER -89.65 -91.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.401 -0.812 . . . . 0.0 110.438 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.006 HG23 HG22 ' A' ' 2' ' ' VAL . 79.0 t -91.13 111.93 24.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 O-C-N 121.811 -0.556 . . . . 0.0 110.665 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.806 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 1.9 m-80 -126.73 113.64 16.93 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.993 HD12 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -133.47 133.74 57.32 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.396 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.012 ' HB3' ' HB3' ' A' ' 60' ' ' ALA 0.277 0.0 OUTLIER -127.93 110.58 12.69 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 116.755 -1.978 . . . . 0.0 109.454 176.472 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.922 HG22 ' HA ' ' A' ' 38' ' ' LYS 0.255 33.3 m -99.51 100.64 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 CA-C-O 124.107 1.908 . . . . 0.0 108.388 -177.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.899 ' CE2' ' HB3' ' A' ' 58' ' ' ALA . 0.1 OUTLIER -116.98 95.0 4.8 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.617 -178.086 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.656 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 38.2 m -120.5 -79.78 0.61 Allowed 'General case' 0 C--N 1.294 -1.81 0 O-C-N 121.073 -1.017 . . . . 0.0 109.648 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.62 ' C ' ' OD1' ' A' ' 40' ' ' ASP . 0.2 OUTLIER 179.55 155.53 0.66 Allowed Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.853 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.699 ' HG3' ' CE ' ' A' ' 42' ' ' MET . 47.4 Cg_endo -73.95 -12.62 23.9 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 124.142 1.601 . . . . 0.0 110.465 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 12' ' ' THR . 0.5 OUTLIER -79.45 0.75 28.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.066 -1.021 . . . . 0.0 109.86 179.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.547 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -157.47 -170.25 0.24 Allowed Pre-proline 0 N--CA 1.485 1.317 0 O-C-N 121.625 -0.672 . . . . 0.0 110.132 179.755 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.643 ' O ' ' O ' ' A' ' 15' ' ' TYR . 55.2 Cg_endo -84.6 118.02 2.12 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.751 1.395 . . . . 0.0 110.735 175.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.752 ' CE1' ' OD1' ' A' ' 40' ' ' ASP . 2.7 m-85 -49.54 -113.94 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.381 -0.825 . . . . 0.0 109.773 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 1.179 ' SG ' HD11 ' A' ' 59' ' ' ILE . 33.4 m -155.0 39.91 0.13 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.163 -0.961 . . . . 0.0 110.329 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.952 ' HA ' HD13 ' A' ' 20' ' ' ILE . 55.4 Cg_endo -75.75 27.17 0.39 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.715 1.376 . . . . 0.0 111.192 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.739 ' CG ' ' CD ' ' A' ' 73' ' ' ARG . 0.1 OUTLIER -110.11 -63.22 1.4 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.947 -1.095 . . . . 0.0 110.583 -179.275 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.834 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -54.27 -21.43 9.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.284 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.993 ' HB ' HD12 ' A' ' 5' ' ' ILE . 2.6 pt -66.77 -42.19 88.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.489 0.662 . . . . 0.0 109.228 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.567 ' N ' ' CG1' ' A' ' 20' ' ' ILE . 2.5 tm-20 -54.16 -33.94 59.21 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.7 t -71.66 -41.42 71.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.785 0.802 . . . . 0.0 109.077 178.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.834 HG23 ' O ' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -68.59 -30.06 46.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 121.667 0.746 . . . . 0.0 109.362 178.228 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.702 ' OD1' ' CG1' ' A' ' 34' ' ' ILE . 5.9 t70 -73.98 -38.09 64.26 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -45.55 88.3 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.699 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.529 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.65 -40.5 29.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.561 -0.712 . . . . 0.0 110.173 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.898 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -70.78 -20.54 62.59 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.943 -1.103 . . . . 0.0 109.567 -178.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.68 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -69.07 -47.88 64.17 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 176.261 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.749 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -45.64 -41.29 10.07 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.94 0.876 . . . . 0.0 109.21 179.02 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.749 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -90.63 -61.32 1.7 Allowed 'General case' 0 C--N 1.291 -1.956 0 O-C-N 121.358 -0.839 . . . . 0.0 108.946 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.694 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -94.11 78.78 0.98 Allowed Glycine 0 N--CA 1.485 1.931 0 CA-C-O 118.805 -0.997 . . . . 0.0 111.413 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.538 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -35.58 -24.05 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 120.418 2.109 . . . . 0.0 111.164 -179.628 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.942 ' O ' HG21 ' A' ' 2' ' ' VAL . 6.6 mtpt -83.52 154.52 23.81 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.699 -0.625 . . . . 0.0 111.44 176.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.914 HD12 ' O ' ' A' ' 33' ' ' LYS . 0.8 OUTLIER -127.97 157.41 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 118.839 -1.144 . . . . 0.0 111.072 177.449 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.596 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 7.2 t70 -150.38 64.31 0.95 Allowed 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.987 HG11 HD12 ' A' ' 20' ' ' ILE . 31.3 t -92.66 117.84 36.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 C-N-CA 118.799 -1.161 . . . . 0.0 109.824 -178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.802 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.273 3.1 mt-10 -101.56 147.57 26.25 Favored 'General case' 0 C--O 1.195 -1.793 0 CA-C-O 122.474 1.13 . . . . 0.0 108.728 -177.744 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.922 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.74 119.25 13.05 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.172 -0.955 . . . . 0.0 112.019 -173.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.018 HD12 ' HB2' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -130.4 178.41 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -0.962 . . . . 0.0 110.667 -178.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.752 ' OD1' ' CE1' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -109.28 179.55 4.12 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.637 -0.664 . . . . 0.0 111.401 176.023 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.882 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -61.76 -54.0 40.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.128 -0.982 . . . . 0.0 112.104 173.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.709 ' N ' HG22 ' A' ' 41' ' ' ILE . 5.2 ptp -71.71 0.28 9.2 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.427 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.742 HG21 HG22 ' A' ' 39' ' ' ILE . 1.1 m -111.9 -45.19 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.203 -0.936 . . . . 0.0 109.814 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 1.018 ' HB2' HD12 ' A' ' 39' ' ' ILE . 9.7 t70 -114.54 45.55 1.53 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.339 -0.851 . . . . 0.0 109.839 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.517 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.288 0.0 OUTLIER -67.99 -5.57 17.95 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.41 -1.316 . . . . 0.0 110.225 -178.411 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 1.026 ' O ' HG23 ' A' ' 49' ' ' ILE . 4.4 mt-10 -56.82 -18.93 14.71 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.312 -0.868 . . . . 0.0 110.471 173.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.843 ' HB3' ' CE2' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -49.92 -61.17 2.29 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-O 122.891 1.329 . . . . 0.0 110.306 -178.272 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.972 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -58.62 -4.93 0.48 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.84 177.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.164 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.2 pp -35.99 -41.62 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 -173.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 1.164 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.9 OUTLIER -50.43 -52.95 33.24 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.897 177.059 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.84 ' OH ' HG22 ' A' ' 68' ' ' VAL . 45.6 p90 -118.93 -36.86 3.33 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.088 -1.007 . . . . 0.0 110.354 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.766 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.96 14.0 0.01 OUTLIER Glycine 0 N--CA 1.495 2.584 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.701 ' HG ' ' O ' ' A' ' 51' ' ' TYR . 42.7 mt -82.69 -63.3 1.4 Allowed 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 123.231 1.491 . . . . 0.0 109.256 177.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.454 ' C ' ' HE2' ' A' ' 51' ' ' TYR . 19.3 mtm -109.55 53.88 0.68 Allowed 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 113.969 -1.468 . . . . 0.0 109.516 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.972 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.311 . . -103.52 124.44 48.77 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 117.821 -1.552 . . . . 0.0 111.117 -173.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.808 ' HA ' ' CG1' ' A' ' 41' ' ' ILE . 0.0 OUTLIER -147.92 -60.74 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.408 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.656 -177.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.782 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.267 45.1 Cg_endo -108.14 113.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 CA-C-O 123.446 1.352 . . . . 0.0 110.334 177.814 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 1.111 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -161.39 178.6 9.01 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.223 -175.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.252 HG21 ' CD1' ' A' ' 76' ' ' LEU . 1.2 mp -147.47 143.8 19.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.771 -0.58 . . . . 0.0 109.762 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 1.012 ' HB3' ' HB3' ' A' ' 6' ' ' GLU 0.285 . . -82.74 143.07 31.14 Favored 'General case' 0 CA--C 1.487 -1.446 0 C-N-CA 115.912 -2.315 . . . . 0.0 109.092 -179.107 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.705 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.404 1.0 OUTLIER -91.09 87.5 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.731 0 CA-C-O 125.493 2.568 . . . . 0.0 107.478 -174.319 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.806 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.6 OUTLIER -42.28 80.61 0.0 OUTLIER 'General case' 0 C--O 1.2 -1.502 0 CA-C-N 112.601 -2.09 . . . . 0.0 109.618 177.296 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.782 ' CA ' ' HB2' ' A' ' 83' ' ' GLU . . . 161.33 -48.34 0.37 Allowed Glycine 0 N--CA 1.484 1.835 0 N-CA-C 107.56 -2.216 . . . . 0.0 107.56 -177.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.811 ' O ' HG23 ' A' ' 65' ' ' VAL . 4.9 m -120.16 -59.73 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.763 -0.845 . . . . 0.0 110.922 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 64' ' ' VAL . 74.5 t -164.64 -104.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 120.436 -1.415 . . . . 0.0 111.923 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.964 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 2.1 ttp180 -164.39 164.11 22.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.642 -0.661 . . . . 0.0 109.309 -178.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 1.111 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.1 -176.49 5.11 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.939 -1.101 . . . . 0.0 111.75 -176.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.84 HG22 ' OH ' ' A' ' 51' ' ' TYR . 79.5 t -94.63 114.98 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.83 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.85 125.16 1.35 Allowed Glycine 0 N--CA 1.49 2.282 0 C-N-CA 118.918 -1.611 . . . . 0.0 110.688 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.089 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -92.92 -79.8 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.047 -1.267 . . . . 0.0 108.326 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 1.089 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 54.0 Cg_endo -81.65 20.9 0.99 Allowed 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.35 1.184 . . . . 0.0 109.355 177.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.602 ' OG ' ' HA3' ' A' ' 69' ' ' GLY . 1.5 p -98.55 64.67 1.55 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.362 -0.836 . . . . 0.0 111.378 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.739 ' CD ' ' CG ' ' A' ' 18' ' ' MET . 0.1 OUTLIER -73.93 -35.89 64.62 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.171 -0.955 . . . . 0.0 109.318 178.716 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.543 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -48.92 -37.42 19.85 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.049 -1.032 . . . . 0.0 109.236 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.74 ' CD ' ' CD2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -47.09 -36.86 8.75 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.515 -0.874 . . . . 0.0 108.83 179.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.252 ' CD1' HG21 ' A' ' 59' ' ' ILE . 8.9 mp -61.44 -44.74 96.59 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 177.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.789 ' HA ' ' CG1' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -56.85 -34.41 67.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.459 -0.776 . . . . 0.0 109.859 178.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -77.96 -31.75 51.0 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.684 -0.635 . . . . 0.0 109.708 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.426 ' HB2' HG23 ' A' ' 61' ' ' ILE . . . -68.56 -49.15 61.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.458 -0.776 . . . . 0.0 109.655 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.779 ' HB ' ' CG1' ' A' ' 23' ' ' VAL . 1.9 mp -51.96 -35.5 18.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 120.949 -1.094 . . . . 0.0 108.695 178.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.562 ' OD1' ' O ' ' A' ' 81' ' ' ASN . 8.1 t-20 -68.1 -27.5 66.53 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.575 ' OD2' HG11 ' A' ' 64' ' ' VAL 0.553 37.8 t0 -95.25 -21.62 18.33 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 113.374 -3.33 . . . . 0.0 106.329 -177.698 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.782 ' HB2' ' CA ' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -68.64 -46.1 70.08 Favored 'General case' 0 C--N 1.288 -2.076 0 O-C-N 119.504 -1.997 . . . . 0.0 108.916 170.054 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.804 ' CE ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -78.9 -23.38 44.84 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.484 178.378 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.489 ' O ' ' O ' ' A' ' 81' ' ' ASN . 11.3 tp10 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.003 -0.998 . . . . 0.0 110.289 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.583 ' SD ' ' OD1' ' A' ' 4' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.211 0.529 . . . . 0.0 110.232 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.953 HG21 ' O ' ' A' ' 33' ' ' LYS . 1.6 p -89.44 -96.08 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 0.0 110.265 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.999 HG11 ' OD1' ' A' ' 24' ' ' ASP . 55.4 t -92.17 119.55 39.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.453 -0.779 . . . . 0.0 110.18 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.751 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -135.78 111.78 9.58 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 123.082 1.42 . . . . 0.0 109.194 179.245 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.055 ' HB ' HG13 ' A' ' 36' ' ' VAL . 4.1 mt -126.05 133.48 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.115 -0.991 . . . . 0.0 109.965 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.145 ' CB ' ' HB3' ' A' ' 60' ' ' ALA 0.272 15.3 tt0 -125.28 101.81 7.15 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 116.963 -1.895 . . . . 0.0 109.17 178.599 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.827 ' CG2' ' CB ' ' A' ' 38' ' ' LYS 0.251 29.0 m -97.66 111.33 27.24 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.438 0 CA-C-O 123.734 1.73 . . . . 0.0 107.621 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.911 ' CD2' ' HB3' ' A' ' 58' ' ' ALA . 0.4 OUTLIER -118.55 90.57 3.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.01 -1.056 . . . . 0.0 109.342 -178.448 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.667 ' OG1' ' HA ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -121.35 -72.92 0.67 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.355 -0.841 . . . . 0.0 110.322 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.876 ' HA ' HG22 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -170.66 149.49 2.96 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.02 -1.05 . . . . 0.0 110.85 -179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.745 ' N ' ' HB3' ' A' ' 40' ' ' ASP . 46.4 Cg_endo -75.67 -28.91 7.71 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 124.019 1.536 . . . . 0.0 110.153 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.59 -15.02 58.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.246 -0.909 . . . . 0.0 109.859 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.644 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -124.95 -179.69 0.92 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.388 -0.82 . . . . 0.0 109.875 179.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.644 ' HD2' ' SG ' ' A' ' 13' ' ' CYS . 51.2 Cg_endo -83.56 111.12 1.74 Allowed 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.999 1.526 . . . . 0.0 110.417 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.762 ' CE1' ' O ' ' A' ' 10' ' ' SER . 17.9 m-85 -49.53 -111.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.908 . . . . 0.0 109.685 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.96 ' SG ' HD11 ' A' ' 59' ' ' ILE . 26.3 m -155.09 39.39 0.11 Allowed Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.149 -0.97 . . . . 0.0 110.308 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.4 Cg_endo -76.18 23.07 0.48 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.84 1.442 . . . . 0.0 110.92 -179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.718 ' HB3' ' CD ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -103.18 -66.79 0.92 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.049 -1.032 . . . . 0.0 110.889 -179.292 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.968 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -55.14 -21.87 14.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.276 -0.89 . . . . 0.0 109.84 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.034 ' CD1' HD13 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -72.67 -39.45 60.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.504 -0.747 . . . . 0.0 109.533 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.673 ' N ' HD12 ' A' ' 20' ' ' ILE . 1.6 tt0 -49.17 -31.9 9.24 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 15.5 t -69.42 -45.59 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.534 -0.729 . . . . 0.0 109.386 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.905 HG13 HG21 ' A' ' 80' ' ' ILE . 0.6 OUTLIER -68.9 -28.56 40.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.312 -0.868 . . . . 0.0 109.366 178.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.999 ' OD1' HG11 ' A' ' 3' ' ' VAL . 16.6 t0 -76.09 -36.71 58.82 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -58.75 -44.04 90.42 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.644 0.735 . . . . 0.0 109.381 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.497 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.54 -40.99 28.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.51 -0.744 . . . . 0.0 110.164 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.792 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -67.09 -23.35 65.84 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 118.932 -1.107 . . . . 0.0 109.082 -179.557 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.801 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.82 -45.63 70.71 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 177.365 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.797 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -49.43 -40.3 36.03 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.783 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.797 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.9 -56.32 3.28 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.829 ' HA3' HG23 ' A' ' 2' ' ' VAL . . . -96.18 78.47 0.76 Allowed Glycine 0 N--CA 1.489 2.173 0 O-C-N 121.398 -0.813 . . . . 0.0 111.378 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.532 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -36.96 -21.62 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 119.309 1.555 . . . . 0.0 110.3 -179.468 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.953 ' O ' HG21 ' A' ' 2' ' ' VAL . 27.3 mtmm -85.06 154.6 21.97 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.101 -0.999 . . . . 0.0 111.145 178.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.801 ' CD1' ' CG ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -129.28 150.21 34.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 118.883 -1.127 . . . . 0.0 111.048 178.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.618 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -150.43 68.49 0.97 Allowed 'General case' 0 N--CA 1.485 1.299 0 O-C-N 121.479 -0.763 . . . . 0.0 109.159 179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.055 HG13 ' HB ' ' A' ' 5' ' ' ILE . 65.6 t -91.92 118.37 37.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-O 122.413 1.102 . . . . 0.0 109.519 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.806 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.267 8.6 mm-40 -100.13 131.01 46.33 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 123.321 1.534 . . . . 0.0 108.185 -178.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 1.067 ' C ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -139.56 122.1 16.23 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.753 -1.217 . . . . 0.0 111.559 -176.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.067 HD13 ' C ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -136.72 -163.54 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 122.31 1.052 . . . . 0.0 111.129 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.937 ' OD1' HG11 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -110.96 170.82 7.85 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.792 179.183 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 1.273 ' CD1' HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -65.86 -54.33 28.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.593 -0.692 . . . . 0.0 111.548 177.474 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.629 ' H ' HG23 ' A' ' 41' ' ' ILE . 6.4 ptm -65.26 -1.56 2.41 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.016 -1.073 . . . . 0.0 110.985 -178.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.937 HG11 ' OD1' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -112.08 -48.9 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.018 -1.051 . . . . 0.0 110.705 178.063 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.724 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 3.0 t70 -105.9 48.51 0.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.173 -0.954 . . . . 0.0 110.086 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.644 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.288 6.4 ttt-85 -63.35 -7.21 5.88 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 118.086 -1.445 . . . . 0.0 109.662 -178.554 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.983 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.3 mm-40 -51.33 -19.94 1.51 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.157 -0.964 . . . . 0.0 110.159 176.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.841 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -51.8 -58.72 5.61 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 122.188 0.994 . . . . 0.0 109.815 -179.399 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.057 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -62.88 -1.94 1.04 Allowed 'General case' 0 C--N 1.276 -2.628 0 O-C-N 121.257 -0.902 . . . . 0.0 110.68 178.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.983 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -35.34 -42.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 104.027 -2.582 . . . . 0.0 104.027 -176.383 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.503 ' N ' ' C ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -48.93 -51.33 30.78 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.195 176.754 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 1.261 ' OH ' HG22 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -125.93 -32.54 2.78 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.107 -0.996 . . . . 0.0 110.432 179.124 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.813 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 61.07 -33.52 0.05 OUTLIER Glycine 0 N--CA 1.489 2.219 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.804 HD12 ' H ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -49.57 -81.43 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.644 -1.503 . . . . 0.0 109.858 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.804 ' H ' HD12 ' A' ' 53' ' ' LEU . 24.7 mtt -79.45 54.3 1.7 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.401 -0.812 . . . . 0.0 108.944 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 1.057 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.288 . . -99.61 103.52 15.23 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 124.006 1.86 . . . . 0.0 110.174 -177.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.273 HG22 ' CD1' ' A' ' 41' ' ' ILE . 4.9 t -146.63 -72.86 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.414 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.801 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.829 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 51.4 Cg_endo -95.3 112.15 0.15 Allowed 'Trans proline' 0 C--O 1.197 -1.541 0 CA-C-O 123.872 1.53 . . . . 0.0 109.893 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 1.006 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -160.82 179.27 8.65 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.425 -1.422 . . . . 0.0 111.792 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.96 HD11 ' SG ' ' A' ' 16' ' ' CYS 0.253 0.3 OUTLIER -142.48 133.48 24.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.078 179.334 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 1.145 ' HB3' ' CB ' ' A' ' 6' ' ' GLU . . . -81.42 141.31 34.05 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 116.935 -1.906 . . . . 0.0 106.215 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.772 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.433 0.7 OUTLIER -90.09 86.75 2.6 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.69 0 C-N-CA 114.73 -2.788 . . . . 0.0 105.421 -175.576 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.751 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -44.31 82.34 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 112.634 -2.076 . . . . 0.0 108.76 177.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.772 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.49 -44.1 0.35 Allowed Glycine 0 N--CA 1.483 1.805 0 N-CA-C 107.207 -2.357 . . . . 0.0 107.207 -178.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.76 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.2 m -126.18 -59.01 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.537 -0.978 . . . . 0.0 111.302 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.76 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 93.2 t -163.59 -108.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 120.306 -1.496 . . . . 0.0 112.358 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.786 ' CZ ' ' HB2' ' A' ' 60' ' ' ALA . 3.5 ttt180 -165.14 164.64 20.21 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.769 -0.582 . . . . 0.0 109.653 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 1.006 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -144.95 177.01 9.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.92 -1.112 . . . . 0.0 111.177 -178.11 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.261 HG22 ' OH ' ' A' ' 51' ' ' TYR . 78.9 t -88.66 116.0 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.832 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.836 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.68 123.57 1.19 Allowed Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.72 -1.228 . . . . 0.0 110.447 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.115 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -93.9 -78.26 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 120.868 -1.372 . . . . 0.0 108.662 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 1.115 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 54.6 Cg_endo -79.26 20.39 0.84 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.654 1.344 . . . . 0.0 109.254 178.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.732 ' O ' HD13 ' A' ' 59' ' ' ILE 0.3 2.3 p -103.88 81.78 1.91 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 124.024 1.869 . . . . 0.0 109.989 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 1.196 ' O ' HD12 ' A' ' 76' ' ' LEU . 24.9 mtt180 -79.57 -36.12 38.68 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.643 -1.286 . . . . 0.0 110.03 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.968 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.5 tt0 -50.48 -25.35 3.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.319 -0.863 . . . . 0.0 109.726 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.781 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -53.67 -46.39 70.6 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.351 -0.843 . . . . 0.0 109.207 -179.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.196 HD12 ' O ' ' A' ' 73' ' ' ARG . 0.7 OUTLIER -60.18 -42.19 94.5 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.643 -0.823 . . . . 0.0 109.009 178.808 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.826 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -58.09 -33.95 69.64 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.399 -0.813 . . . . 0.0 109.78 179.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.766 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 31.5 tt0 -81.58 -27.75 34.13 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.288 -0.882 . . . . 0.0 110.146 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.606 ' CB ' ' HA ' ' A' ' 61' ' ' ILE . . . -74.47 -38.07 63.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.238 -0.914 . . . . 0.0 109.637 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.905 HG21 HG13 ' A' ' 23' ' ' VAL . 1.8 mp -63.35 -39.8 86.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.144 -0.972 . . . . 0.0 108.985 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.67 ' ND2' ' O ' ' A' ' 78' ' ' GLU . 0.1 OUTLIER -74.96 -33.12 61.86 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.244 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.415 ' HB3' ' O ' ' A' ' 78' ' ' GLU 0.523 0.1 OUTLIER -91.34 -3.26 56.95 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 113.54 -3.264 . . . . 0.0 107.125 -178.814 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.758 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -82.26 -59.58 2.5 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 119.672 -1.893 . . . . 0.0 109.816 169.589 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.674 ' SD ' ' HD2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.94 -13.48 62.47 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.405 179.525 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.494 ' N ' ' HG2' ' A' ' 84' ' ' MET . 2.7 tm-20 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.027 -0.987 . . . . 0.0 110.196 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.582 ' SD ' ' OD1' ' A' ' 4' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.252 0.549 . . . . 0.0 110.211 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.955 HG21 ' O ' ' A' ' 33' ' ' LYS . 1.6 p -89.53 -97.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.842 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.003 HG11 ' OD1' ' A' ' 24' ' ' ASP . 53.2 t -89.51 121.69 39.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.343 -0.848 . . . . 0.0 109.987 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.747 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.292 0.2 OUTLIER -140.17 111.26 7.02 Favored 'General case' 0 C--O 1.19 -2.076 0 CA-C-O 125.057 2.361 . . . . 0.0 108.135 178.23 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.045 ' HB ' HG13 ' A' ' 36' ' ' VAL . 4.2 mt -121.63 133.85 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-N 114.214 -1.357 . . . . 0.0 111.195 -179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.151 ' CB ' ' HB3' ' A' ' 60' ' ' ALA 0.371 16.4 tt0 -129.11 111.12 12.62 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 115.218 -2.593 . . . . 0.0 105.063 177.026 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.829 ' CG2' ' CB ' ' A' ' 38' ' ' LYS 0.352 15.0 m -108.86 111.17 34.89 Favored 'Isoleucine or valine' 0 C--O 1.177 -2.748 0 CA-C-O 126.761 3.172 . . . . 0.0 103.822 -178.425 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.909 ' CD2' ' HB3' ' A' ' 58' ' ' ALA 0.277 0.4 OUTLIER -117.27 94.74 4.68 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 111.947 -2.388 . . . . 0.0 108.532 -178.608 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.668 ' OG1' ' HA ' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -124.02 -69.84 0.79 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.095 -1.003 . . . . 0.0 110.601 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.885 ' HA ' HG22 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -174.96 146.83 1.0 Allowed Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 120.876 -1.14 . . . . 0.0 110.734 -179.586 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.744 ' N ' ' HB3' ' A' ' 40' ' ' ASP . 50.7 Cg_endo -73.78 -29.01 10.93 Favored 'Trans proline' 0 C--N 1.319 -1.007 0 O-C-N 123.802 1.422 . . . . 0.0 110.565 -178.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.63 -14.95 58.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.381 -0.824 . . . . 0.0 109.884 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.645 ' SG ' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -124.94 -179.65 0.91 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.388 -0.82 . . . . 0.0 109.846 179.732 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.645 ' HD2' ' SG ' ' A' ' 13' ' ' CYS . 51.8 Cg_endo -83.69 111.14 1.71 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.958 1.504 . . . . 0.0 110.444 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.765 ' CE1' ' O ' ' A' ' 10' ' ' SER . 18.1 m-85 -49.59 -111.16 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.218 -0.926 . . . . 0.0 109.606 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.96 ' SG ' HD11 ' A' ' 59' ' ' ILE . 26.7 m -155.06 39.4 0.12 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.17 -0.957 . . . . 0.0 110.353 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.692 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 55.4 Cg_endo -76.2 23.12 0.48 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.84 1.442 . . . . 0.0 110.95 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.719 ' HB3' ' CD ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -103.24 -66.64 0.93 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.049 -1.032 . . . . 0.0 110.85 -179.293 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.942 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -55.53 -21.34 16.47 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.284 -0.885 . . . . 0.0 109.898 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.035 ' CD1' HD13 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -73.0 -39.23 57.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.598 179.496 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.672 ' N ' HD12 ' A' ' 20' ' ' ILE . 1.6 tt0 -48.91 -32.66 9.34 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.434 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 16.4 t -68.54 -47.37 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.659 0.742 . . . . 0.0 109.279 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.898 HG13 HG21 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -64.07 -34.45 68.76 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-O 122.476 1.131 . . . . 0.0 109.513 177.451 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 1.003 ' OD1' HG11 ' A' ' 3' ' ' VAL . 15.2 t0 -71.66 -39.01 70.59 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 122.78 1.276 . . . . 0.0 108.949 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -57.24 -45.31 84.06 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.569 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.5 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -78.28 -40.5 36.81 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.782 0.801 . . . . 0.0 110.808 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.793 ' CB ' HG22 ' A' ' 3' ' ' VAL 0.252 0.0 OUTLIER -70.23 -19.19 63.16 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 117.627 -1.629 . . . . 0.0 108.904 -178.715 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.801 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -70.9 -44.75 65.59 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.763 ' HG3' ' N ' ' A' ' 30' ' ' PHE 0.26 0.0 OUTLIER -51.92 -35.44 45.63 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.411 179.246 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.776 ' CG ' ' N ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -92.54 -66.33 0.93 Allowed 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 104.098 -2.556 . . . . 0.0 104.098 -179.731 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.951 ' HA3' HG23 ' A' ' 2' ' ' VAL . . . -81.05 72.43 2.74 Favored Glycine 0 C--N 1.279 -2.623 0 CA-C-O 115.402 -2.888 . . . . 0.0 115.87 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.546 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -36.28 -23.97 0.01 OUTLIER 'General case' 0 C--N 1.262 -3.218 0 CA-C-N 123.092 3.446 . . . . 0.0 110.183 -177.546 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.955 ' O ' HG21 ' A' ' 2' ' ' VAL . 29.1 mtmm -77.35 152.55 34.4 Favored 'General case' 0 C--N 1.284 -2.281 0 O-C-N 120.263 -1.523 . . . . 0.0 113.384 175.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.801 ' CD1' ' CG ' ' A' ' 28' ' ' LYS 0.259 0.3 OUTLIER -130.66 151.37 35.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 C-N-CA 118.366 -1.334 . . . . 0.0 110.547 176.014 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.643 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -151.27 71.95 1.03 Allowed 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.045 HG13 ' HB ' ' A' ' 5' ' ' ILE 0.307 84.2 t -97.38 125.19 50.54 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.596 0 CA-C-O 124.556 2.122 . . . . 0.0 105.635 -177.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.822 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.413 7.3 mm-40 -109.37 133.53 52.94 Favored 'General case' 0 C--O 1.179 -2.625 0 CA-C-O 126.326 2.965 . . . . 0.0 104.438 -177.09 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 1.044 ' C ' HD13 ' A' ' 39' ' ' ILE . 0.0 OUTLIER -138.24 114.08 9.89 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.36 -1.745 . . . . 0.0 113.95 -173.145 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.044 HD13 ' C ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -133.88 -165.12 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 CA-C-N 121.874 2.125 . . . . 0.0 111.835 179.468 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.936 ' OD1' HG11 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -104.54 172.14 6.95 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 178.398 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 1.271 ' CD1' HG22 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -68.25 -55.21 17.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 O-C-N 121.387 -0.821 . . . . 0.0 110.644 176.581 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.646 ' H ' HG23 ' A' ' 41' ' ' ILE . 6.3 ptm -64.27 -0.46 1.26 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 118.612 -1.235 . . . . 0.0 111.594 -178.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.936 HG11 ' OD1' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -113.09 -49.12 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.086 -1.009 . . . . 0.0 110.195 178.341 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.724 ' O ' ' CD1' ' A' ' 8' ' ' PHE . 2.9 t70 -106.34 51.01 0.76 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 0.0 109.646 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.728 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.472 6.0 ttt-85 -71.26 2.27 4.96 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 115.044 -2.663 . . . . 0.0 108.711 -176.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.983 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.2 mm-40 -52.51 -23.87 7.05 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 120.348 -1.47 . . . . 0.0 109.108 172.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.869 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -49.18 -63.14 1.19 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.941 -1.099 . . . . 0.0 109.012 -178.161 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.999 ' CB ' ' HB2' ' A' ' 55' ' ' ALA 0.414 . . -51.42 -13.91 0.25 Allowed 'General case' 0 C--N 1.256 -3.485 0 C-N-CA 126.886 2.075 . . . . 0.0 111.555 175.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.983 HG23 ' O ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -30.75 -43.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 104.824 -2.287 . . . . 0.0 104.824 -172.957 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.56 ' N ' ' C ' ' A' ' 48' ' ' ALA . 1.0 OUTLIER -49.14 -51.37 32.64 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.186 176.414 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 1.261 ' OH ' HG22 ' A' ' 68' ' ' VAL . 1.0 OUTLIER -125.89 -32.6 2.79 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.013 -1.054 . . . . 0.0 110.408 179.2 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.814 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 60.99 -33.36 0.05 OUTLIER Glycine 0 N--CA 1.488 2.139 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.805 HD12 ' H ' ' A' ' 54' ' ' MET . 0.1 OUTLIER -49.6 -81.42 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.608 -1.525 . . . . 0.0 109.851 -179.978 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.805 ' H ' HD12 ' A' ' 53' ' ' LEU . 24.7 mtt -80.28 58.92 3.22 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 179.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.999 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.394 . . -106.91 106.14 16.52 Favored 'General case' 0 C--O 1.179 -2.622 0 CA-C-O 126.912 3.244 . . . . 0.0 107.154 -176.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.271 HG22 ' CD1' ' A' ' 41' ' ' ILE . 4.8 t -147.77 -64.58 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.435 0 CA-C-N 112.149 -2.296 . . . . 0.0 112.84 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.848 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.449 18.0 Cg_endo -109.41 116.81 0.03 OUTLIER 'Trans proline' 0 C--O 1.157 -3.527 0 CA-C-O 129.507 3.878 . . . . 0.0 103.921 -179.544 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 1.003 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -160.85 177.54 10.3 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 110.639 -2.982 . . . . 0.0 111.646 -175.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.96 HD11 ' SG ' ' A' ' 16' ' ' CYS 0.294 0.2 OUTLIER -141.52 141.15 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.874 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 1.151 ' HB3' ' CB ' ' A' ' 6' ' ' GLU 0.399 . . -91.7 149.89 21.4 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 100.551 -3.87 . . . . 0.0 100.551 -177.225 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.772 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.728 1.1 mt -101.57 101.39 12.05 Favored 'Isoleucine or valine' 0 C--N 1.412 3.299 3 C-N-CA 107.032 -5.867 . . . . 0.0 97.379 -172.237 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.747 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -53.93 84.7 0.0 OUTLIER 'General case' 0 C--N 1.38 1.929 1 CA-C-N 106.549 -4.841 . . . . 0.0 106.888 178.083 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.772 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.24 -44.12 0.36 Allowed Glycine 0 N--CA 1.483 1.793 0 N-CA-C 107.176 -2.37 . . . . 0.0 107.176 -178.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.758 ' O ' ' CG2' ' A' ' 65' ' ' VAL . 17.1 m -126.16 -59.15 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 O-C-N 121.503 -0.998 . . . . 0.0 111.311 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.758 ' CG2' ' O ' ' A' ' 64' ' ' VAL . 93.8 t -163.1 -106.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 120.326 -1.484 . . . . 0.0 112.901 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.851 ' CZ ' ' HB2' ' A' ' 60' ' ' ALA . 3.4 ttt180 -167.74 163.58 14.26 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.676 -0.64 . . . . 0.0 109.397 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 1.003 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.53 174.4 11.2 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.848 -1.157 . . . . 0.0 111.268 -177.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.261 HG22 ' OH ' ' A' ' 51' ' ' TYR . 59.3 t -83.42 115.12 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.888 -1.133 . . . . 0.0 111.406 177.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.834 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.91 123.4 1.17 Allowed Glycine 0 C--N 1.281 -2.524 0 CA-C-N 119.755 1.161 . . . . 0.0 110.491 179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.111 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -93.9 -76.74 0.03 OUTLIER Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 120.772 -1.428 . . . . 0.0 109.194 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 1.111 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 41.7 Cg_endo -83.23 24.93 0.71 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 N-CA-C 108.339 -1.447 . . . . 0.0 108.339 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.729 ' O ' HD13 ' A' ' 59' ' ' ILE 0.449 1.5 p -109.63 87.95 2.63 Favored 'General case' 0 N--CA 1.506 2.372 0 C-N-CA 113.829 -3.149 . . . . 0.0 106.577 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 1.195 ' O ' HD12 ' A' ' 76' ' ' LEU . 24.8 mtt180 -79.77 -40.38 28.84 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 112.871 -1.968 . . . . 0.0 109.201 175.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.942 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.4 tt0 -46.41 -28.22 1.29 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.025 -1.047 . . . . 0.0 109.835 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.778 ' HG3' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -53.12 -46.16 68.62 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.24 -0.912 . . . . 0.0 109.34 -178.537 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.195 HD12 ' O ' ' A' ' 73' ' ' ARG . 0.7 OUTLIER -60.0 -42.53 94.47 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.147 178.526 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.825 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.39 -34.99 69.44 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.821 179.364 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.774 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 31.1 tt0 -78.77 -31.32 46.08 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.031 -1.043 . . . . 0.0 110.216 178.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.637 ' CB ' ' HA ' ' A' ' 61' ' ' ILE . . . -73.07 -38.26 66.49 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.092 -1.005 . . . . 0.0 110.002 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.898 HG21 HG13 ' A' ' 23' ' ' VAL . 1.8 mp -61.61 -42.47 94.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 O-C-N 121.099 -1.001 . . . . 0.0 108.906 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.668 ' ND2' ' O ' ' A' ' 78' ' ' GLU . 0.1 OUTLIER -72.24 -33.52 67.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.961 -1.087 . . . . 0.0 109.604 179.166 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 78' ' ' GLU 0.596 0.1 OUTLIER -94.01 0.82 56.22 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 112.027 -3.869 . . . . 0.0 105.573 -177.411 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.76 ' CB ' ' HA3' ' A' ' 63' ' ' GLY . 0.0 OUTLIER -85.95 -59.81 2.19 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 119.546 -1.971 . . . . 0.0 107.841 170.598 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.674 ' SD ' ' HD2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.69 -12.67 61.68 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.737 179.656 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.491 ' N ' ' HG2' ' A' ' 84' ' ' MET . 2.7 tm-20 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.066 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.645 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.314 0.578 . . . . 0.0 110.224 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.029 HG22 ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -90.13 -91.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.193 -0.942 . . . . 0.0 109.976 179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.185 HG11 ' OD2' ' A' ' 24' ' ' ASP . 74.1 t -89.22 111.03 22.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 121.627 -0.671 . . . . 0.0 110.633 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.841 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 1.0 OUTLIER -130.95 105.68 7.91 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 118.639 -1.224 . . . . 0.0 108.794 178.031 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.053 HG21 ' HB ' ' A' ' 20' ' ' ILE . 0.1 OUTLIER -120.7 137.37 54.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.031 179.425 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.037 ' HB3' ' HB3' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -131.01 119.77 22.51 Favored 'General case' 0 C--N 1.287 -2.131 0 O-C-N 119.057 -2.277 . . . . 0.0 107.389 177.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.968 HG22 ' HA ' ' A' ' 38' ' ' LYS . 23.0 m -105.64 144.78 14.62 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.982 ' CD2' ' HB3' ' A' ' 58' ' ' ALA . 2.1 t80 -141.0 79.52 1.7 Allowed 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 119.01 -1.076 . . . . 0.0 112.663 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.698 ' OG1' ' HA ' ' A' ' 15' ' ' TYR . 3.5 m -118.06 -68.64 0.9 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 118.852 -2.405 . . . . 0.0 110.238 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.774 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 1.3 p 179.61 164.61 0.79 Allowed Pre-proline 0 C--N 1.294 -1.843 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.732 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.666 ' HD3' ' CG ' ' A' ' 40' ' ' ASP . 49.8 Cg_endo -80.35 -28.3 3.03 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.278 1.673 . . . . 0.0 110.418 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -18.25 54.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -0.931 . . . . 0.0 109.762 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -125.07 174.49 3.82 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.457 -0.777 . . . . 0.0 109.723 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.652 ' O ' ' O ' ' A' ' 15' ' ' TYR . 50.8 Cg_endo -83.18 114.53 2.21 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.925 1.487 . . . . 0.0 110.437 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.774 ' CE1' ' O ' ' A' ' 10' ' ' SER . 16.5 m-85 -49.22 -112.38 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.132 -0.98 . . . . 0.0 109.576 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.736 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 92.9 m -150.6 37.46 0.13 Allowed Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.267 -0.895 . . . . 0.0 110.131 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.736 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 53.7 Cg_endo -76.49 17.16 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.021 1.538 . . . . 0.0 111.042 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.553 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -95.1 -68.04 0.82 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.012 -1.055 . . . . 0.0 110.752 -179.461 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.782 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -54.28 -22.51 12.05 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.23 -0.919 . . . . 0.0 109.53 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.053 ' HB ' HG21 ' A' ' 5' ' ' ILE . 5.2 pt -70.67 -39.25 75.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.507 -0.746 . . . . 0.0 109.623 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.734 ' N ' HG13 ' A' ' 20' ' ' ILE . 6.2 tt0 -48.83 -33.05 9.79 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 3.1 t -72.01 -46.73 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.896 HG21 ' HB ' ' A' ' 80' ' ' ILE . 0.4 OUTLIER -62.26 -31.86 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.03 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 1.185 ' OD2' HG11 ' A' ' 3' ' ' VAL . 5.2 t70 -69.45 -39.88 77.5 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 122.01 0.91 . . . . 0.0 109.196 178.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.67 -46.01 84.81 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.617 0.722 . . . . 0.0 109.674 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.485 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -77.68 -40.05 42.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.669 -0.645 . . . . 0.0 110.614 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.904 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -69.95 -19.37 63.38 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.124 -1.03 . . . . 0.0 109.208 -179.057 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.799 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -72.52 -44.99 61.44 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.154 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.744 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -50.32 -33.39 19.99 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.851 0.834 . . . . 0.0 110.279 179.494 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.787 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -97.01 -65.79 0.94 Allowed 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 179.639 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.749 ' N ' ' CG ' ' A' ' 30' ' ' PHE . . . -84.64 82.16 1.7 Allowed Glycine 0 N--CA 1.506 3.323 0 C-N-CA 119.182 -1.485 . . . . 0.0 111.427 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.593 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -35.43 -28.43 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 CA-C-N 121.463 2.631 . . . . 0.0 110.68 178.57 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.837 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -80.0 154.95 27.87 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.498 -0.751 . . . . 0.0 111.686 178.065 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.799 ' CD1' ' CG ' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -129.66 151.48 35.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 O-C-N 120.353 -1.467 . . . . 0.0 110.048 178.646 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.598 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -151.3 76.78 1.23 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.943 HG22 ' CD1' ' A' ' 5' ' ' ILE 0.255 55.4 t -96.65 126.98 49.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -178.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 1.021 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.251 78.1 mt-10 -111.24 135.43 51.79 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 -177.617 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.968 ' HA ' HG22 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -129.49 128.92 43.85 Favored 'General case' 0 N--CA 1.503 2.199 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -176.716 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.066 HG22 ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -135.08 171.66 17.29 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 O-C-N 120.132 -1.605 . . . . 0.0 111.516 178.642 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.767 ' OD1' HG22 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -102.72 170.8 7.79 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 121.803 0.811 . . . . 0.0 111.757 178.246 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.892 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.3 OUTLIER -61.87 -37.39 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.425 -1.422 . . . . 0.0 109.332 178.489 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.678 ' HG3' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -82.37 -3.09 54.85 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.935 -1.103 . . . . 0.0 111.252 179.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.066 ' CG2' HG22 ' A' ' 39' ' ' ILE . 2.0 m -114.24 -46.18 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.055 -1.028 . . . . 0.0 109.755 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.937 ' HB2' HD12 ' A' ' 39' ' ' ILE . 1.6 t70 -104.97 40.98 1.4 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.237 -0.914 . . . . 0.0 109.627 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.607 ' NH2' ' HA3' ' A' ' 52' ' ' GLY 0.283 0.0 OUTLIER -65.69 -0.35 2.07 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.494 -1.379 . . . . 0.0 109.435 -178.823 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 1.148 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.3 mm-40 -62.54 -22.68 66.5 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.867 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.9 OUTLIER -46.38 -66.55 0.39 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.965 -1.084 . . . . 0.0 108.422 -179.075 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.145 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -57.23 -7.63 0.58 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.666 179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.225 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.6 pp -26.35 -41.26 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 O-C-N 119.163 -2.21 . . . . 0.0 106.573 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 1.225 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -52.92 -53.75 44.86 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.978 -1.01 . . . . 0.0 108.998 177.183 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.899 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 25.8 p90 -119.86 -32.8 4.14 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.132 -0.98 . . . . 0.0 109.984 178.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.722 ' N ' ' HB1' ' A' ' 48' ' ' ALA . . . 42.38 8.82 0.01 OUTLIER Glycine 0 N--CA 1.502 3.08 0 CA-C-O 122.124 0.847 . . . . 0.0 111.474 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.715 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 4.6 mt -75.55 -81.08 0.08 Allowed 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 175.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.525 ' C ' ' HE2' ' A' ' 51' ' ' TYR . 4.0 mtp -95.74 63.66 2.42 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.443 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 1.145 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.273 . . -107.38 120.26 41.68 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 119.489 -2.007 . . . . 0.0 110.356 -177.803 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.816 ' CG2' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -148.76 -57.98 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.678 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.481 -178.709 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.816 ' HD3' ' CG2' ' A' ' 56' ' ' VAL . 59.1 Cg_endo -109.81 109.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.367 0 CA-C-O 122.892 1.122 . . . . 0.0 110.323 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 1.011 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -161.88 173.88 13.92 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 114.391 -1.277 . . . . 0.0 111.186 -178.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.038 ' CG1' HD21 ' A' ' 76' ' ' LEU 0.253 0.3 OUTLIER -134.6 151.94 32.51 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 O-C-N 120.876 -1.14 . . . . 0.0 107.997 179.296 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 1.037 ' HB3' ' HB3' ' A' ' 6' ' ' GLU 0.297 . . -91.15 155.3 18.72 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.749 HG13 ' N ' ' A' ' 66' ' ' ARG 0.31 1.2 mt -101.29 91.29 2.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 -175.713 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.841 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -51.63 83.04 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 112.834 -1.984 . . . . 0.0 106.807 -178.369 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.714 ' HA3' ' HB2' ' A' ' 83' ' ' GLU . . . 162.41 -44.02 0.36 Allowed Glycine 0 C--N 1.29 -2.027 0 N-CA-C 107.733 -2.147 . . . . 0.0 107.733 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.821 ' O ' HG23 ' A' ' 65' ' ' VAL . 11.6 m -126.67 -58.97 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.903 -0.763 . . . . 0.0 111.139 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 64' ' ' VAL . 81.9 t -163.73 -101.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.344 0 O-C-N 120.338 -1.476 . . . . 0.0 112.955 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 1.016 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 1.8 ttp180 -167.17 160.09 13.5 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.444 -0.785 . . . . 0.0 109.343 -177.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 1.011 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -146.09 176.05 10.02 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.11 -0.994 . . . . 0.0 111.702 -177.236 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.816 ' CG2' ' HZ1' ' A' ' 47' ' ' LYS . 79.0 t -83.42 118.96 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.708 -0.62 . . . . 0.0 110.246 178.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.834 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.5 107.88 0.33 Allowed Glycine 0 N--CA 1.494 2.516 0 C-N-CA 118.536 -1.792 . . . . 0.0 110.386 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.124 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -88.94 -81.42 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 120.989 -1.3 . . . . 0.0 108.511 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 1.124 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 57.1 Cg_endo -83.6 17.04 1.75 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.243 1.128 . . . . 0.0 109.422 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.33 62.52 0.79 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.498 -0.751 . . . . 0.0 110.661 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.725 ' HG2' ' CB ' ' A' ' 16' ' ' CYS . 22.1 mtt180 -69.09 -31.43 70.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.381 -0.825 . . . . 0.0 109.327 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.782 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.2 tm-20 -48.39 -45.13 35.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.427 -0.796 . . . . 0.0 109.449 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.785 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -45.25 -29.11 0.91 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.701 -0.8 . . . . 0.0 108.982 179.715 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.038 HD21 ' CG1' ' A' ' 59' ' ' ILE . 3.2 mp -70.47 -39.92 73.98 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.521 -0.737 . . . . 0.0 109.047 178.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.853 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.49 -41.16 89.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.401 -0.812 . . . . 0.0 109.824 -179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.52 ' O ' ' OD1' ' A' ' 81' ' ' ASN . 2.5 tm-20 -77.29 -26.62 52.52 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.192 0.52 . . . . 0.0 109.932 178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.644 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -71.03 -41.9 70.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 110.978 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.041 ' CD1' HG23 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -62.57 -44.28 99.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.125 -0.984 . . . . 0.0 109.122 179.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.676 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.1 OUTLIER -72.83 -27.76 62.14 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 177.573 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 1.026 ' O ' ' OD1' ' A' ' 82' ' ' ASP 0.328 0.1 OUTLIER -96.06 5.63 50.69 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 119.638 -1.914 . . . . 0.0 107.855 -179.416 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.763 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -96.08 -59.03 1.93 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 178.635 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.683 ' SD ' ' HD2' ' A' ' 27' ' ' LYS . 21.4 ptt? -68.63 -14.52 63.07 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 119.266 -0.974 . . . . 0.0 110.986 178.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--N 1.3 -1.559 0 CA-C-O 117.91 -1.043 . . . . 0.0 110.002 179.722 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.649 ' HG3' ' ND2' ' A' ' 4' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.225 0.536 . . . . 0.0 110.21 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.029 HG22 ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -89.98 -91.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.303 -0.873 . . . . 0.0 110.59 179.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 1.179 HG11 ' OD2' ' A' ' 24' ' ' ASP 0.253 75.1 t -89.19 118.78 35.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.787 ' O ' ' CB ' ' A' ' 62' ' ' ASN 0.481 0.9 OUTLIER -143.6 106.82 4.54 Favored 'General case' 0 C--O 1.16 -3.624 1 CA-C-O 129.728 4.585 . . . . 0.0 105.063 175.064 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.051 HG23 ' CD1' ' A' ' 80' ' ' ILE 0.253 0.0 OUTLIER -111.62 132.87 59.0 Favored 'Isoleucine or valine' 0 C--O 1.262 1.73 0 CA-C-N 109.986 -3.279 . . . . 0.0 114.688 178.217 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.017 ' HB3' ' HB3' ' A' ' 60' ' ' ALA 0.593 0.0 OUTLIER -135.8 126.51 27.28 Favored 'General case' 0 C--O 1.197 -1.674 2 CA-C-O 131.334 5.349 . . . . 0.0 104.281 172.239 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.896 HG22 ' HA ' ' A' ' 38' ' ' LYS 0.339 14.6 m -108.02 156.5 8.52 Favored 'Isoleucine or valine' 0 C--N 1.386 2.191 0 CA-C-N 109.642 -3.436 . . . . 0.0 104.322 -175.699 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.956 ' CD2' ' HB3' ' A' ' 58' ' ' ALA . 1.9 t80 -154.15 76.14 1.04 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.516 -1.365 . . . . 0.0 111.052 -172.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.695 ' CB ' ' HA ' ' A' ' 15' ' ' TYR . 3.5 m -118.96 -70.06 0.81 Allowed 'General case' 0 C--N 1.269 -2.914 0 CA-C-N 120.65 1.568 . . . . 0.0 109.188 -179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.777 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 1.3 p 179.66 165.05 0.79 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.179 -0.951 . . . . 0.0 110.923 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.667 ' HD3' ' CG ' ' A' ' 40' ' ' ASP . 51.5 Cg_endo -80.4 -28.2 3.05 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 124.17 1.616 . . . . 0.0 110.511 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -18.25 53.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -0.894 . . . . 0.0 109.74 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -124.95 174.75 3.54 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.417 -0.802 . . . . 0.0 109.664 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.649 ' O ' ' O ' ' A' ' 15' ' ' TYR . 51.8 Cg_endo -83.41 114.69 2.15 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 123.943 1.496 . . . . 0.0 110.309 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.777 ' CE1' ' O ' ' A' ' 10' ' ' SER . 17.3 m-85 -49.41 -112.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.218 -0.926 . . . . 0.0 109.44 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.733 ' CB ' ' HG2' ' A' ' 73' ' ' ARG . 94.0 m -149.97 37.39 0.14 Allowed Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.132 -0.98 . . . . 0.0 110.27 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.723 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 54.4 Cg_endo -76.34 17.17 0.78 Allowed 'Trans proline' 0 C--N 1.308 -1.592 0 O-C-N 123.867 1.456 . . . . 0.0 111.036 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.554 ' HB3' ' HD3' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -95.11 -68.0 0.82 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.966 -1.084 . . . . 0.0 110.614 -179.367 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.751 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -55.28 -20.8 12.22 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.737 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.042 ' HB ' HG21 ' A' ' 5' ' ' ILE . 5.2 pt -71.91 -38.78 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.809 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.736 ' N ' HG13 ' A' ' 20' ' ' ILE . 6.4 tt0 -48.03 -33.59 8.22 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 3.1 t -72.47 -45.46 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-O 121.94 0.876 . . . . 0.0 109.338 179.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.881 HG21 ' HB ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -60.52 -33.09 53.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 122.737 1.256 . . . . 0.0 109.207 176.462 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 1.179 ' OD2' HG11 ' A' ' 3' ' ' VAL . 5.7 t70 -70.55 -40.67 73.26 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.933 1.349 . . . . 0.0 108.144 -178.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.24 -46.45 82.98 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.712 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.474 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -76.76 -40.6 47.84 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.841 0.829 . . . . 0.0 110.827 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.908 ' CB ' HG22 ' A' ' 3' ' ' VAL 0.334 0.0 OUTLIER -73.86 -14.62 61.11 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 116.25 -2.18 . . . . 0.0 109.132 -177.337 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.792 ' CG ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -72.47 -44.33 62.46 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.826 -1.171 . . . . 0.0 107.892 173.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.709 ' HG3' ' N ' ' A' ' 30' ' ' PHE 0.315 0.0 OUTLIER -53.96 -28.95 40.62 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.969 -179.315 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.783 ' CE2' ' HA ' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -99.85 -66.08 0.93 Allowed 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 103.557 -2.757 . . . . 0.0 103.557 -179.694 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.775 ' HA3' ' CG2' ' A' ' 2' ' ' VAL . . . -78.82 71.38 2.58 Favored Glycine 0 C--N 1.268 -3.232 0 CA-C-O 113.879 -3.734 . . . . 0.0 115.104 175.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.549 ' O ' ' OD1' ' A' ' 32' ' ' ASP 0.365 0.0 OUTLIER -39.06 -20.0 0.01 OUTLIER 'General case' 0 C--N 1.264 -3.109 1 CA-C-N 124.26 4.03 . . . . 0.0 111.81 -174.821 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.844 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -75.01 150.71 38.87 Favored 'General case' 0 C--N 1.28 -2.418 0 C-N-CA 126.969 2.108 . . . . 0.0 113.943 171.053 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.792 ' CD1' ' CG ' ' A' ' 28' ' ' LYS 0.331 0.3 OUTLIER -131.09 155.07 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 C-N-CA 116.441 -2.104 . . . . 0.0 110.148 172.374 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.677 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -151.64 76.96 1.22 Allowed 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.09 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.953 HG22 ' CD1' ' A' ' 5' ' ' ILE 0.406 42.6 t -102.56 127.39 56.27 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.872 0 CA-C-O 126.947 3.261 . . . . 0.0 106.457 -177.56 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.976 ' O ' ' HA ' ' A' ' 6' ' ' GLU 0.505 68.6 mt-10 -116.01 134.47 54.92 Favored 'General case' 0 C--O 1.188 -2.156 0 O-C-N 118.861 -2.399 . . . . 0.0 107.114 -174.37 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.896 ' HA ' HG22 ' A' ' 7' ' ' VAL 0.576 0.0 OUTLIER -112.73 115.28 28.28 Favored 'General case' 0 C--O 1.298 3.649 2 CA-C-O 107.822 -5.847 . . . . 0.0 121.213 -170.817 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.067 HG22 ' CG2' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -132.54 178.24 5.92 Favored 'Isoleucine or valine' 1 C--N 1.232 -4.526 1 CA-C-N 131.381 6.446 . . . . 0.0 110.439 175.931 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.762 ' OD1' HG22 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -103.22 166.05 10.66 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.068 -1.645 . . . . 0.0 113.04 177.022 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.9 ' HA ' ' CE1' ' A' ' 8' ' ' PHE . 0.4 OUTLIER -59.68 -38.01 73.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 118.15 -1.42 . . . . 0.0 111.899 173.032 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.678 ' HG3' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -80.84 -3.29 50.67 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.793 -1.163 . . . . 0.0 112.457 177.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.067 ' CG2' HG22 ' A' ' 39' ' ' ILE . 2.0 m -113.58 -46.24 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.062 -1.024 . . . . 0.0 109.787 179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.941 ' HB2' HD12 ' A' ' 39' ' ' ILE . 1.6 t70 -103.82 37.08 2.13 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.28 -0.887 . . . . 0.0 110.473 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.597 ' HA ' ' CE1' ' A' ' 8' ' ' PHE 0.369 0.0 OUTLIER -65.04 -2.18 2.57 Favored 'General case' 0 C--O 1.2 -1.533 0 C-N-CA 116.783 -1.967 . . . . 0.0 109.789 -176.998 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 1.092 ' O ' HG23 ' A' ' 49' ' ' ILE . 1.8 mm-40 -51.89 -26.71 10.76 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.021 -1.049 . . . . 0.0 111.635 170.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.832 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.7 OUTLIER -50.15 -61.28 2.25 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.471 -1.393 . . . . 0.0 108.884 -175.018 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.064 ' CB ' ' HB2' ' A' ' 55' ' ' ALA 0.388 . . -51.69 -13.36 0.25 Allowed 'General case' 0 C--N 1.264 -3.14 0 C-N-CA 126.48 1.912 . . . . 0.0 112.065 174.697 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.244 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.3 pp -33.68 -38.06 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 -169.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 1.244 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -51.99 -53.59 39.78 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.053 176.12 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.88 ' CZ ' ' HB2' ' A' ' 48' ' ' ALA . 23.1 p90 -120.36 -31.51 4.33 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.083 -1.011 . . . . 0.0 110.29 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.777 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.93 14.65 0.01 OUTLIER Glycine 0 C--O 1.201 -1.962 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.485 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.731 ' CD2' ' O ' ' A' ' 51' ' ' TYR . 5.4 mt -80.25 -76.03 0.24 Allowed 'General case' 0 C--N 1.253 -3.623 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 178.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.512 ' C ' ' HE2' ' A' ' 51' ' ' TYR . 3.8 mtp -103.07 61.5 0.79 Allowed 'General case' 0 C--O 1.25 1.095 0 O-C-N 119.546 -1.971 . . . . 0.0 108.405 -178.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 1.064 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.548 . . -113.97 125.45 54.03 Favored 'General case' 0 C--O 1.178 -2.68 1 CA-C-O 129.672 4.558 . . . . 0.0 106.724 -175.258 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.8 ' CB ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -151.03 -55.04 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.56 0 CA-C-N 109.795 -3.366 . . . . 0.0 112.301 -175.957 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.8 ' HD3' ' CB ' ' A' ' 56' ' ' VAL 0.559 38.6 Cg_endo -119.66 116.0 0.01 OUTLIER 'Trans proline' 0 C--O 1.157 -3.525 1 CA-C-O 132.508 5.129 . . . . 0.0 108.86 174.209 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 1.057 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -160.61 173.34 15.63 Favored 'General case' 0 C--N 1.378 1.811 1 CA-C-N 107.777 -4.283 . . . . 0.0 111.671 -174.36 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.039 ' CG1' HD21 ' A' ' 76' ' ' LEU 0.313 0.3 OUTLIER -137.2 156.95 34.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 C-N-CA 117.833 -1.547 . . . . 0.0 107.404 177.724 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 1.017 ' HB3' ' HB3' ' A' ' 6' ' ' GLU 0.696 . . -106.41 155.57 19.42 Favored 'General case' 0 C--N 1.379 1.881 3 C-N-CA 107.591 -5.643 . . . . 0.0 97.618 -175.017 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.809 HG13 ' N ' ' A' ' 66' ' ' ARG 0.583 1.7 mt -103.67 91.07 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.186 -2.253 2 CA-C-O 131.758 5.551 . . . . 0.0 101.724 -164.733 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.787 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.1 OUTLIER -42.97 81.58 0.0 OUTLIER 'General case' 0 C--N 1.37 1.462 1 CA-C-N 108.378 -4.01 . . . . 0.0 109.012 176.562 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.752 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.94 -45.71 0.37 Allowed Glycine 0 N--CA 1.485 1.928 0 N-CA-C 106.908 -2.477 . . . . 0.0 106.908 -177.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.811 ' O ' HG23 ' A' ' 65' ' ' VAL . 10.9 m -125.67 -58.86 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.679 -0.895 . . . . 0.0 111.431 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 64' ' ' VAL . 80.3 t -163.42 -99.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.551 0 O-C-N 120.314 -1.491 . . . . 0.0 112.879 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 1.013 ' HD3' ' HB2' ' A' ' 60' ' ' ALA . 1.6 ttp180 -171.55 157.58 4.83 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.964 -1.085 . . . . 0.0 109.252 -176.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 1.057 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -143.9 176.04 9.56 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.333 -1.479 . . . . 0.0 111.023 -174.281 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.817 ' CG2' ' HZ1' ' A' ' 47' ' ' LYS . 70.8 t -80.79 117.26 26.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 CA-C-O 117.386 -1.292 . . . . 0.0 110.942 176.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.824 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.81 108.28 0.34 Allowed Glycine 0 C--N 1.277 -2.74 0 CA-C-N 121.173 1.806 . . . . 0.0 110.577 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.101 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -90.16 -79.21 0.03 OUTLIER Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 120.734 -1.451 . . . . 0.0 108.936 178.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 1.101 ' CD ' ' HB3' ' A' ' 70' ' ' ALA 0.256 44.3 Cg_endo -88.53 20.0 1.22 Allowed 'Trans proline' 0 C--O 1.21 -0.918 0 C-N-CA 116.705 -1.73 . . . . 0.0 109.136 177.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.16 63.58 1.0 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.761 -1.212 . . . . 0.0 112.179 175.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.733 ' HG2' ' CB ' ' A' ' 16' ' ' CYS . 20.6 mtt180 -67.27 -33.36 75.15 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 120.889 -1.132 . . . . 0.0 109.708 177.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.751 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 1.2 tm-20 -47.31 -46.46 25.19 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.043 -1.035 . . . . 0.0 108.986 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.785 ' CD ' ' CE2' ' A' ' 67' ' ' PHE 0.268 0.0 OUTLIER -47.29 -26.43 1.24 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 118.561 -1.256 . . . . 0.0 109.047 -178.371 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.039 HD21 ' CG1' ' A' ' 59' ' ' ILE . 3.1 mp -70.71 -39.86 73.16 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 121.878 0.847 . . . . 0.0 109.368 177.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.825 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -59.69 -39.47 84.64 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-O 122.088 0.947 . . . . 0.0 111.14 179.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 82' ' ' ASP . 2.6 tm-20 -75.84 -27.84 58.01 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 122.229 1.014 . . . . 0.0 110.058 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.629 ' O ' ' HB3' ' A' ' 83' ' ' GLU . . . -74.71 -40.6 61.22 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 120.956 -1.09 . . . . 0.0 109.149 -175.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.051 ' CD1' HG23 ' A' ' 5' ' ' ILE . 0.9 OUTLIER -60.82 -45.17 98.48 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.572 0 CA-C-O 122.587 1.184 . . . . 0.0 110.151 177.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.726 ' HA ' ' HE2' ' A' ' 84' ' ' MET . 0.2 OUTLIER -71.84 -32.94 68.03 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.654 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.645 0.1 OUTLIER -99.36 5.95 46.26 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 112.477 -3.689 . . . . 0.0 106.696 -175.258 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.734 ' OE1' ' CA ' ' A' ' 63' ' ' GLY 0.284 0.0 OUTLIER -86.35 -60.68 1.93 Allowed 'General case' 0 N--CA 1.48 1.03 1 O-C-N 116.169 -4.082 . . . . 0.0 108.132 165.739 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.726 ' HE2' ' HA ' ' A' ' 81' ' ' ASN . 21.4 ptt? -66.63 -14.84 62.95 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.946 -1.101 . . . . 0.0 111.456 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.778 -1.106 . . . . 0.0 110.253 177.939 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.675 ' O ' ' CZ ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.305 0.574 . . . . 0.0 110.276 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.995 HG23 ' HA3' ' A' ' 31' ' ' GLY . 11.5 p -84.65 -119.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.269 -0.894 . . . . 0.0 109.921 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.991 HG11 ' OD2' ' A' ' 24' ' ' ASP . 72.6 t -92.61 105.62 16.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.283 -0.886 . . . . 0.0 110.308 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.91 ' O ' HD11 ' A' ' 80' ' ' ILE . 54.3 t30 -129.2 109.0 10.79 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.755 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.028 HG21 ' HB ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -123.87 136.99 58.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.082 -1.011 . . . . 0.0 110.409 179.747 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.084 ' CB ' ' HB3' ' A' ' 60' ' ' ALA . 4.0 tp10 -125.05 104.07 8.35 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 117.916 -1.514 . . . . 0.0 108.782 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.822 ' CG2' ' CB ' ' A' ' 38' ' ' LYS . 15.7 m -93.88 104.73 16.07 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.434 0 CA-C-O 123.315 1.531 . . . . 0.0 108.43 -179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.884 ' CE1' ' HA ' ' A' ' 41' ' ' ILE . 1.6 t80 -117.65 84.88 2.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.221 -0.924 . . . . 0.0 109.78 -179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.683 ' O ' ' HB ' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -120.28 -53.28 2.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.529 -0.732 . . . . 0.0 109.882 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 1.073 ' HA ' HG22 ' A' ' 41' ' ' ILE . 5.3 p 179.43 152.76 0.56 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.316 -0.865 . . . . 0.0 110.513 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.696 ' HD3' ' OD1' ' A' ' 40' ' ' ASP . 50.5 Cg_endo -84.52 -29.4 0.82 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.121 1.59 . . . . 0.0 110.205 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.549 ' OG1' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -79.81 -16.87 54.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.376 -0.828 . . . . 0.0 109.946 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.549 ' SG ' ' OG1' ' A' ' 12' ' ' THR . 1.4 m -124.97 179.97 1.0 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.417 -0.802 . . . . 0.0 109.954 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.631 ' O ' ' O ' ' A' ' 15' ' ' TYR . 52.3 Cg_endo -83.6 111.68 1.79 Allowed 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.993 1.522 . . . . 0.0 110.473 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.772 ' CE1' ' O ' ' A' ' 10' ' ' SER . 8.6 m-85 -49.51 -114.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.251 -0.905 . . . . 0.0 109.728 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.91 ' O ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -155.19 40.7 0.14 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.167 -0.958 . . . . 0.0 110.054 179.543 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.698 ' CA ' HG11 ' A' ' 7' ' ' VAL . 50.1 Cg_endo -74.7 16.15 0.64 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.935 1.492 . . . . 0.0 111.039 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.746 ' CG ' ' HD3' ' A' ' 73' ' ' ARG . 5.1 ttm -84.81 -60.74 1.96 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.129 -0.982 . . . . 0.0 111.305 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.75 ' CB ' ' O ' ' A' ' 73' ' ' ARG . . . -56.41 -18.9 12.55 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.27 -0.894 . . . . 0.0 109.665 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.028 ' HB ' HG21 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -73.83 -40.15 52.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.458 -0.776 . . . . 0.0 109.327 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.72 ' N ' HD12 ' A' ' 20' ' ' ILE . 6.0 tm-20 -53.7 -36.11 61.85 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 29.1 t -75.94 -39.39 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.959 HG13 HG21 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -70.39 -26.8 29.7 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-O 122.022 0.915 . . . . 0.0 108.88 177.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.991 ' OD2' HG11 ' A' ' 3' ' ' VAL . 4.8 t70 -74.62 -37.45 62.82 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.97 -45.01 91.58 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.314 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.457 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.26 -40.59 30.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.492 -0.755 . . . . 0.0 110.095 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.892 ' CB ' HG22 ' A' ' 3' ' ' VAL . 0.0 OUTLIER -65.13 -26.31 68.13 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.182 -1.007 . . . . 0.0 108.871 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 1.024 ' CE ' HD11 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.89 -46.64 67.87 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 177.822 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.78 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -45.94 -42.08 12.4 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.654 0.74 . . . . 0.0 109.057 178.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.78 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -90.27 -56.04 3.37 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.414 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.995 ' HA3' HG23 ' A' ' 2' ' ' VAL . . . -96.08 79.05 0.77 Allowed Glycine 0 N--CA 1.489 2.196 0 O-C-N 121.482 -0.761 . . . . 0.0 111.276 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.496 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -37.71 -19.56 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.056 0 CA-C-N 119.057 1.429 . . . . 0.0 110.767 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.684 ' N ' ' O ' ' A' ' 31' ' ' GLY . 9.5 mtpt -85.74 160.09 19.61 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.911 -1.118 . . . . 0.0 111.289 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.024 HD11 ' CE ' ' A' ' 28' ' ' LYS . 0.6 OUTLIER -130.54 129.33 64.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.025 -1.07 . . . . 0.0 110.084 178.447 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.661 ' O ' ' HA ' ' A' ' 4' ' ' ASN . 8.4 t0 -136.86 74.37 1.49 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.333 -0.854 . . . . 0.0 109.175 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.695 HG13 ' CG1' ' A' ' 5' ' ' ILE . 46.1 t -92.23 115.85 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 CA-C-O 122.428 1.108 . . . . 0.0 109.406 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.723 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 9.0 mt-10 -97.6 148.15 23.58 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.345 -1.342 . . . . 0.0 108.328 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.822 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.94 120.84 14.51 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.62 -1.3 . . . . 0.0 111.654 -177.376 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.993 HD12 ' CG ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -120.4 174.62 5.15 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 O-C-N 121.27 -0.894 . . . . 0.0 111.28 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.856 ' CG ' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -112.07 167.69 10.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.074 -1.016 . . . . 0.0 112.629 179.111 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 1.073 HG22 ' HA ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -67.5 -36.21 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.646 -0.658 . . . . 0.0 112.53 178.315 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.776 ' N ' HD13 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -90.61 -7.15 53.53 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.844 -1.16 . . . . 0.0 112.016 -179.09 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.856 HG12 ' CG ' ' A' ' 40' ' ' ASP . 14.0 p -111.27 -35.64 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.015 -1.053 . . . . 0.0 109.934 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.993 ' CG ' HD12 ' A' ' 39' ' ' ILE . 3.0 t70 -115.07 45.49 1.61 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.294 -0.879 . . . . 0.0 110.163 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 45' ' ' ARG 0.257 45.3 ttt180 -59.28 -5.69 0.79 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 118.462 -1.295 . . . . 0.0 109.406 -179.065 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 1.093 ' O ' HG23 ' A' ' 49' ' ' ILE . 2.2 mm-40 -53.88 -20.88 6.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.335 -0.853 . . . . 0.0 110.329 177.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.855 ' HG3' ' N ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -51.95 -56.33 14.84 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.857 -1.152 . . . . 0.0 109.394 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.16 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -64.7 -2.52 2.52 Favored 'General case' 0 C--N 1.276 -2.609 0 O-C-N 120.896 -1.128 . . . . 0.0 111.467 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.261 HD12 ' N ' ' A' ' 50' ' ' GLU . 2.5 pp -34.25 -37.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 -177.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 1.261 ' N ' HD12 ' A' ' 49' ' ' ILE . 0.5 OUTLIER -55.39 -52.33 63.89 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.153 176.807 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.842 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 2.5 p90 -121.97 -27.26 4.63 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.129 -0.982 . . . . 0.0 110.278 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.793 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 40.23 13.18 0.01 OUTLIER Glycine 0 N--CA 1.489 2.197 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.669 ' N ' ' O ' ' A' ' 51' ' ' TYR . 6.4 mt -84.7 -66.0 0.94 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 123.981 1.848 . . . . 0.0 108.375 177.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.458 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 15.9 mmt -103.87 56.43 0.73 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.021 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 1.16 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.263 . . -99.24 105.41 17.44 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 123.387 1.565 . . . . 0.0 110.661 -176.104 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.966 HG22 HG13 ' A' ' 41' ' ' ILE . 2.0 t -146.4 -65.47 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.39 0 O-C-N 121.197 -0.939 . . . . 0.0 110.408 178.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.815 ' HD3' ' CB ' ' A' ' 56' ' ' VAL . 40.8 Cg_endo -97.35 102.7 0.08 OUTLIER 'Trans proline' 0 C--O 1.195 -1.661 0 CA-C-O 124.131 1.638 . . . . 0.0 108.728 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.912 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -156.14 -178.46 7.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.46 -1.4 . . . . 0.0 111.304 -179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.913 HG13 HD21 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -144.38 140.76 24.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.763 -0.585 . . . . 0.0 109.869 -179.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 1.084 ' HB3' ' CB ' ' A' ' 6' ' ' GLU . . . -81.69 133.41 35.35 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.753 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.353 1.2 mt -85.36 81.25 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.206 -1.221 0 C-N-CA 116.462 -2.095 . . . . 0.0 107.223 -176.283 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.798 ' O ' ' CG ' ' A' ' 83' ' ' GLU . 27.6 m-80 -44.3 85.87 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 114.512 -1.222 . . . . 0.0 107.895 177.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.753 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 162.73 -43.78 0.35 Allowed Glycine 0 N--CA 1.486 1.999 0 N-CA-C 106.177 -2.769 . . . . 0.0 106.177 -177.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.88 ' O ' HG23 ' A' ' 65' ' ' VAL . 14.9 m -128.73 -60.97 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 121.791 -0.829 . . . . 0.0 110.761 179.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.88 HG23 ' O ' ' A' ' 64' ' ' VAL . 64.8 t -165.23 -103.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 120.321 -1.487 . . . . 0.0 111.679 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.843 ' N ' HG12 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -153.28 164.26 38.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.786 -0.572 . . . . 0.0 109.828 -179.083 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.912 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.42 178.18 8.3 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.079 -1.013 . . . . 0.0 110.862 -179.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.476 HG22 ' OH ' ' A' ' 51' ' ' TYR . 96.0 t -89.45 122.08 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.286 -0.884 . . . . 0.0 109.078 178.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.847 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -160.96 101.83 0.2 Allowed Glycine 0 N--CA 1.487 2.053 0 C-N-CA 119.055 -1.545 . . . . 0.0 111.148 -179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.054 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -90.29 -83.92 0.02 OUTLIER Pre-proline 0 C--N 1.293 -1.848 0 O-C-N 120.825 -1.397 . . . . 0.0 108.484 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 1.054 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 48.8 Cg_endo -82.55 15.2 2.09 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 N-CA-C 108.909 -1.227 . . . . 0.0 108.909 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.56 ' OG ' ' CA ' ' A' ' 69' ' ' GLY . 26.2 p -100.22 69.95 1.51 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.264 -0.897 . . . . 0.0 111.269 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.76 ' HA ' HD13 ' A' ' 76' ' ' LEU . 0.4 OUTLIER -74.87 -40.45 60.95 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.916 -1.115 . . . . 0.0 109.376 179.007 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.707 ' HA ' ' CB ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -46.03 -36.37 5.62 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.185 -0.947 . . . . 0.0 109.153 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.575 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -48.44 -41.61 29.86 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.493 -0.883 . . . . 0.0 108.712 179.318 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.913 HD21 HG13 ' A' ' 59' ' ' ILE . 7.1 mp -56.77 -40.06 75.16 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.675 0.75 . . . . 0.0 109.015 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.816 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -60.69 -42.47 97.22 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.617 0.722 . . . . 0.0 109.918 179.927 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.491 ' N ' ' CD2' ' A' ' 77' ' ' PHE . 1.2 tt0 -78.0 -22.73 48.87 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.298 -0.876 . . . . 0.0 110.369 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.567 ' HB1' HG23 ' A' ' 61' ' ' ILE . . . -79.25 -39.58 32.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.106 -0.996 . . . . 0.0 109.937 -178.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.959 HG21 HG13 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -66.07 -32.14 56.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.909 -1.119 . . . . 0.0 108.862 178.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.516 ' HA ' ' HE3' ' A' ' 84' ' ' MET . 0.1 OUTLIER -78.38 -29.08 47.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.0 179.048 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.563 0.6 OUTLIER -93.36 -7.22 45.36 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 112.718 -3.593 . . . . 0.0 105.742 -179.003 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.798 ' CG ' ' O ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -74.99 -54.65 6.81 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.165 -1.584 . . . . 0.0 108.111 171.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.808 ' CE ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -75.51 -22.34 57.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.732 -0.605 . . . . 0.0 110.431 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 84' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.938 -1.029 . . . . 0.0 110.211 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.201 0.524 . . . . 0.0 110.237 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 1.072 HG21 ' O ' ' A' ' 33' ' ' LYS . 0.9 OUTLIER -80.72 -92.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.329 -0.857 . . . . 0.0 110.354 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.963 ' N ' HG22 ' A' ' 2' ' ' VAL . 54.1 t -91.59 128.74 43.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.521 -0.737 . . . . 0.0 110.921 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.809 ' O ' ' CB ' ' A' ' 62' ' ' ASN . 62.8 t30 -140.63 107.6 5.43 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 123.06 1.409 . . . . 0.0 109.126 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.051 HD12 ' HB ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -135.91 136.18 50.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 O-C-N 121.032 -1.043 . . . . 0.0 112.032 -178.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 1.171 ' O ' HG23 ' A' ' 59' ' ' ILE . 1.4 tp10 -122.5 102.54 8.14 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 118.136 -1.425 . . . . 0.0 108.53 176.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.802 ' CG2' ' CB ' ' A' ' 38' ' ' LYS . 30.0 m -96.19 106.28 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 123.11 1.433 . . . . 0.0 109.327 -178.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.847 ' CE2' ' HA ' ' A' ' 41' ' ' ILE . 1.1 t80 -118.19 101.88 8.56 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.67 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.848 HG22 ' N ' ' A' ' 10' ' ' SER . 0.5 OUTLIER -134.03 -61.58 0.79 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.269 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 1.024 ' HA ' HG22 ' A' ' 41' ' ' ILE . 3.1 t -175.07 144.63 0.83 Allowed Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.118 -0.988 . . . . 0.0 111.073 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.756 ' N ' ' HB2' ' A' ' 40' ' ' ASP . 50.6 Cg_endo -76.63 -9.43 18.5 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 124.212 1.638 . . . . 0.0 110.652 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -79.05 -5.21 53.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.996 -1.065 . . . . 0.0 109.794 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.631 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 1.5 p -160.45 -165.65 0.13 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.494 -0.754 . . . . 0.0 110.09 179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.631 ' CD ' ' CB ' ' A' ' 13' ' ' CYS . 53.2 Cg_endo -84.32 117.78 2.18 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.895 1.471 . . . . 0.0 110.35 177.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.772 ' HD2' HG23 ' A' ' 7' ' ' VAL . 2.1 m-85 -49.27 -83.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.93 . . . . 0.0 109.632 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.82 ' HB3' HD11 ' A' ' 76' ' ' LEU . 42.5 m -155.41 39.61 0.11 Allowed Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.213 -0.93 . . . . 0.0 109.961 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.708 ' CD ' ' N ' ' A' ' 16' ' ' CYS . 52.9 Cg_endo -73.72 30.35 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 124.013 1.533 . . . . 0.0 111.142 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.402 ' H ' ' C ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -110.16 -61.93 1.59 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.952 -1.093 . . . . 0.0 110.369 -179.653 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.905 ' HB1' ' HA ' ' A' ' 74' ' ' GLU . . . -58.06 -20.11 36.85 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.457 -0.777 . . . . 0.0 110.033 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.051 ' HB ' HD12 ' A' ' 5' ' ' ILE . 23.0 pt -75.6 -38.99 39.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.492 -0.755 . . . . 0.0 109.531 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.675 ' N ' HG13 ' A' ' 20' ' ' ILE . 49.8 tt0 -49.43 -36.02 21.06 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.6 t -72.68 -43.02 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.917 HG13 HG21 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -69.85 -27.98 35.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.744 0.783 . . . . 0.0 109.234 178.117 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.702 ' OD2' HG11 ' A' ' 3' ' ' VAL . 4.4 t70 -75.77 -36.07 59.95 Favored 'General case' 0 N--CA 1.485 1.307 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.62 -44.18 89.91 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.635 0.731 . . . . 0.0 109.289 179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.53 ' C ' ' HE3' ' A' ' 27' ' ' LYS . . . -79.45 -41.01 28.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.506 -0.746 . . . . 0.0 110.122 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.82 ' CE ' ' CE ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -67.67 -23.41 65.31 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.206 -179.327 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -69.35 -46.38 67.14 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.373 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.795 ' HG3' ' N ' ' A' ' 30' ' ' PHE . 0.0 OUTLIER -47.68 -40.66 20.6 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.726 0.774 . . . . 0.0 109.191 179.004 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.795 ' N ' ' HG3' ' A' ' 29' ' ' GLU . 0.0 OUTLIER -89.89 -58.06 2.64 Favored 'General case' 0 C--N 1.294 -1.841 0 O-C-N 121.489 -0.757 . . . . 0.0 109.017 179.587 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.736 ' O ' ' N ' ' A' ' 33' ' ' LYS . . . -96.64 77.85 0.72 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 111.341 -0.703 . . . . 0.0 111.341 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.588 ' C ' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -32.94 -27.37 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 119.315 1.558 . . . . 0.0 110.168 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 1.072 ' O ' HG21 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -88.68 158.37 18.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.417 -0.802 . . . . 0.0 111.259 178.253 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.79 HG23 HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -129.57 150.86 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.081 -1.012 . . . . 0.0 110.581 178.095 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.579 ' CB ' ' O ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -138.69 61.45 1.58 Allowed 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.414 -0.804 . . . . 0.0 108.875 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.035 HG13 ' HB ' ' A' ' 5' ' ' ILE . 44.7 t -91.76 115.75 31.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.663 -178.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.759 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 12.4 mt-10 -98.59 140.43 32.83 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.01 -1.076 . . . . 0.0 108.368 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.802 ' CB ' ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -138.45 130.81 28.82 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.411 -0.805 . . . . 0.0 111.845 -176.648 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 1.016 HD12 ' CG ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -138.17 172.8 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.848 . . . . 0.0 109.898 179.598 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 1.083 ' CG ' HG12 ' A' ' 43' ' ' VAL . 0.7 OUTLIER -105.33 169.84 8.23 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.175 -0.953 . . . . 0.0 110.975 179.008 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 1.267 ' CD1' HG22 ' A' ' 56' ' ' VAL . 0.6 OUTLIER -73.79 -17.88 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.254 -0.904 . . . . 0.0 111.593 179.251 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.771 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 2.6 ptt? -92.89 -15.59 26.21 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.809 -1.156 . . . . 0.0 110.21 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 1.083 HG12 ' CG ' ' A' ' 40' ' ' ASP . 14.0 p -111.2 -30.58 2.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 110.256 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 1.016 ' CG ' HD12 ' A' ' 39' ' ' ILE . 5.7 t0 -114.5 48.91 1.07 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.047 -1.033 . . . . 0.0 110.869 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . 0.264 2.5 ttt180 -59.99 -8.8 2.5 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 118.319 -1.352 . . . . 0.0 109.627 -179.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 1.004 ' O ' HG23 ' A' ' 49' ' ' ILE . 0.4 OUTLIER -58.31 -17.08 17.12 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.634 174.639 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.816 ' HG2' ' CE1' ' A' ' 8' ' ' PHE . 0.6 OUTLIER -48.96 -61.38 2.09 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.416 1.103 . . . . 0.0 109.68 -178.058 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.155 ' CB ' ' HB2' ' A' ' 55' ' ' ALA . . . -62.06 0.08 0.45 Allowed 'General case' 0 C--N 1.283 -2.308 0 O-C-N 121.613 -0.679 . . . . 0.0 111.566 177.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.078 HD11 ' NE ' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -35.11 -38.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 -176.226 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.586 ' N ' ' C ' ' A' ' 48' ' ' ALA . 0.4 OUTLIER -54.81 -49.26 71.43 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.513 177.383 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.825 ' CE1' ' HA ' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -124.96 -28.47 3.46 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.953 -1.092 . . . . 0.0 110.361 179.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.777 ' N ' ' O ' ' A' ' 48' ' ' ALA . . . 41.15 11.17 0.01 OUTLIER Glycine 0 N--CA 1.486 2.023 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.68 ' N ' ' O ' ' A' ' 51' ' ' TYR . 6.2 mt -84.95 -61.52 1.76 Allowed 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 123.117 1.437 . . . . 0.0 108.344 177.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.545 ' O ' ' HE2' ' A' ' 51' ' ' TYR . 26.0 mtm -110.21 62.88 0.6 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.031 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 1.155 ' HB2' ' CB ' ' A' ' 48' ' ' ALA 0.268 . . -98.34 107.75 20.29 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 123.092 1.425 . . . . 0.0 111.327 -174.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.267 HG22 ' CD1' ' A' ' 41' ' ' ILE . 1.6 t -146.98 -66.81 0.02 OUTLIER Pre-proline 0 N--CA 1.486 1.368 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.487 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.856 ' CD ' HG12 ' A' ' 56' ' ' VAL . 41.8 Cg_endo -106.25 94.27 0.02 OUTLIER 'Trans proline' 0 C--O 1.206 -1.11 0 CA-C-O 122.701 1.042 . . . . 0.0 109.785 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 1.098 ' HB1' ' O ' ' A' ' 67' ' ' PHE . . . -152.13 178.67 9.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.226 -0.922 . . . . 0.0 110.667 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 1.272 HG21 ' CD2' ' A' ' 76' ' ' LEU . 1.4 mp -149.91 147.38 16.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.619 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.923 ' HB3' ' CB ' ' A' ' 6' ' ' GLU . . . -81.58 138.03 35.44 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 117.4 -1.72 . . . . 0.0 106.452 178.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.754 ' O ' ' N ' ' A' ' 63' ' ' GLY 0.382 0.9 OUTLIER -87.93 81.11 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-O 124.807 2.241 . . . . 0.0 106.486 -175.635 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.809 ' CB ' ' O ' ' A' ' 4' ' ' ASN . 0.4 OUTLIER -42.69 84.88 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 113.466 -1.697 . . . . 0.0 108.006 177.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.754 ' N ' ' O ' ' A' ' 61' ' ' ILE . . . 161.08 -47.09 0.38 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 106.328 -2.709 . . . . 0.0 106.328 -177.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.797 ' O ' HG23 ' A' ' 65' ' ' VAL . 11.9 m -124.51 -60.76 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 O-C-N 121.846 -0.797 . . . . 0.0 111.19 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.811 HG12 ' N ' ' A' ' 66' ' ' ARG . 97.6 t -164.04 -107.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 120.126 -1.609 . . . . 0.0 113.146 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 1.078 ' NE ' HD11 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -156.23 153.65 29.49 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.769 -0.582 . . . . 0.0 109.947 -177.008 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 1.098 ' O ' ' HB1' ' A' ' 58' ' ' ALA . 0.0 OUTLIER -145.98 -175.65 4.83 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.982 -1.074 . . . . 0.0 111.75 -178.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.39 123.24 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.814 ' HA3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.23 105.43 0.26 Allowed Glycine 0 N--CA 1.489 2.216 0 C-N-CA 118.751 -1.69 . . . . 0.0 111.099 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 1.113 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . . . -89.68 -82.34 0.03 OUTLIER Pre-proline 0 C--N 1.303 -1.426 0 O-C-N 120.831 -1.394 . . . . 0.0 108.202 178.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 1.113 ' CD ' ' HB3' ' A' ' 70' ' ' ALA . 51.1 Cg_endo -82.99 15.22 2.14 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 N-CA-C 108.932 -1.218 . . . . 0.0 108.932 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.71 64.29 1.27 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.323 -0.86 . . . . 0.0 111.547 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.75 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -72.62 -32.15 65.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.04 -1.038 . . . . 0.0 109.358 178.754 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.905 ' HA ' ' HB1' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -51.23 -41.09 60.08 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.268 -0.895 . . . . 0.0 109.184 179.696 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.754 ' CD ' ' CE2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -46.21 -29.36 1.55 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.465 -0.772 . . . . 0.0 109.267 179.581 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.272 ' CD2' HG21 ' A' ' 59' ' ' ILE . 13.1 mt -72.46 -40.84 66.7 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 178.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.812 ' HA ' ' CG2' ' A' ' 23' ' ' VAL . 0.0 OUTLIER -57.87 -37.33 73.75 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.457 -0.777 . . . . 0.0 109.535 179.371 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -78.58 -26.76 45.57 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.512 -0.743 . . . . 0.0 110.297 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 83' ' ' GLU . . . -74.21 -37.98 63.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.922 . . . . 0.0 110.063 -178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.917 HG21 HG13 ' A' ' 23' ' ' VAL . 1.5 mp -63.7 -37.35 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 120.975 -1.078 . . . . 0.0 108.788 178.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.43 ' ND2' ' C ' ' A' ' 81' ' ' ASN . 0.0 OUTLIER -73.29 -32.79 64.84 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.151 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.668 ' OD1' ' C ' ' A' ' 82' ' ' ASP 0.47 0.3 OUTLIER -91.79 -6.55 51.55 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 115.191 -2.604 . . . . 0.0 108.157 -179.419 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.768 ' HB2' ' O ' ' A' ' 62' ' ' ASN . 0.2 OUTLIER -79.85 -55.02 5.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.361 -1.462 . . . . 0.0 109.419 169.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.82 ' CE ' ' CE ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -68.01 -23.16 64.97 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.338 179.751 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.474 ' CD ' ' C ' ' A' ' 85' ' ' GLU . 3.3 tm-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.976 -1.012 . . . . 0.0 110.257 179.469 . . . . . . . . 1 1 . 1 stop_ save_